nid,citation_short,citation,data_source,iso3,country,location_name,adj_id,district,year,number_resistant,sample_size,percent_resistant,is_outlier,pathogen,drug
5079,Francisco(2018),"Francisco M, Costa SS, Belas A, et al. First report on antimicrobial resistance and molecular characterisation of Salmonella enterica serotype Typhi isolated from human specimens in Luanda, Angola. Journal of Global Antimicrobial Resistance 2018; 13: 246-9.",Systematic review,AGO,Angola,Clínica Sagrada Esperança,915,Luanda,2014,0,10,0,0,Salmonella Typhi,Multidrug resistance (MDR)
918,Ki-Zerbo (2000),"Ki-Zerbo GA, Sawadogo AB, Kyelem N, Zoubga A, Thiombiano R, Durand G. Enterobacteriaceae bacteriemia in human deficiency virus seropositive in patients at Bobo-Dioulasso hospital (Burkina Faso): Study of 26 cases. Med Mal Infect 2000; 30(12): 753-6.",Systematic review,BFA,Burkina Faso,Bobo-Dioulasso Hospital,960,Hauts-bassins,1995,0,13,0,0,Salmonella Typhi,Multidrug resistance (MDR)
2946,Marks (2017),"Marks F, Kalckreuth V, Aaby P, et al. Incidence of invasive Salmonella disease in sub-Saharan Africa: A multicentre population-based surveillance study. Lancet Glob Health 2017; 5(3): e310-e23.",Systematic review,BFA,Burkina Faso,Unkown Hospitals in Nioko II and Polesgo,954,Centre,2013,0,18,0,0,Salmonella Typhi,Multidrug resistance (MDR)
1082,Maltha (2014),"Maltha J, Guiraud I, Kabore B, et al. Frequency of severe malaria and invasive bacterial infections among children admitted to a rural hospital in Burkina Faso. PLoS ONE 2014; 9(2).",Systematic review,BFA,Burkina Faso,Centre Medical avec Antenne chirurgicale (CMA) Saint Camille of Nanoro;The Health Center Urbain (Nanoro),957,Centre-ouest,2013,0,12,0,0,Salmonella Typhi,Multidrug resistance (MDR)
3907,Vandenberg (2010),"Vandenberg O, Nyarukweba DZ, Ndeba PM, et al. Microbiologic and clinical features of Salmonella species isolated from bacteremic children in eastern Democratic Republic of Congo. Pediatr Infect Dis J 2010; 29(6): 504-10.",Systematic review,COD,Democratic Republic of the Congo,Children’s Hospital of Lwiro (Lwiro Pediatric Hospital),1016,Sud-Kivu,2004,25,29,86.2,1,Salmonella Typhi,Multidrug resistance (MDR)
1647,Muyembe-Tamfum (2009),"Muyembe-Tamfum JJ, Veyi J, Kaswa M, Lunguya O, Verhaegen J, Boelaert M. An outbreak of peritonitis caused by multidrug-resistant Salmonella Typhi in Kinshasa, Democratic Republic of Congo. Travel Med Infect Dis 2009; 7(1): 40-3.",Systematic review,COD,Democratic Republic of the Congo,General Reference Hospital Kinshasa;General Reference Hospital Ndjili;Hôpital Roi Baudouin;University Hospital Kinshasa (UNIKIN),1012,Kinshasa,2005,11,11,100,1,Salmonella Typhi,Multidrug resistance (MDR)
1494,Phoba (2012),"Phoba MF, Lunguya O, Mayimon DV, et al. Multidrug-resistant Salmonella enterica, Democratic Republic of the Congo. Emerg Infect Dis 2012; 18(10): 1693-4.",Systematic review,COD,Democratic Republic of the Congo,Hospital of Saint Luc (Kisantu),1007,Bas-Congo,2010,4,17,23.5,0,Salmonella Typhi,Multidrug resistance (MDR)
4370,Kalonji (2015),"Kalonji LM, Post A, Phoba MF, et al. Invasive Salmonella infections at multiple aurveillance aites in the Democratic Republic of the Congo, 2011-2014. Clin Infect Dis 2015; 61: S346-S53.",Systematic review,COD,Democratic Republic of the Congo,Unknown healthcare facilities in Bas Congo,1007,Bas-Congo,2011,6,29,20.7,0,Salmonella Typhi,Multidrug resistance (MDR)
4370,Kalonji (2015),"Kalonji LM, Post A, Phoba MF, et al. Invasive Salmonella infections at multiple aurveillance aites in the Democratic Republic of the Congo, 2011-2014. Clin Infect Dis 2015; 61: S346-S53.",Systematic review,COD,Democratic Republic of the Congo,Unknown healthcare facilities in Bas Congo,1007,Bas-Congo,2012,11,25,44,0,Salmonella Typhi,Multidrug resistance (MDR)
4370,Kalonji (2015),"Kalonji LM, Post A, Phoba MF, et al. Invasive Salmonella infections at multiple aurveillance aites in the Democratic Republic of the Congo, 2011-2014. Clin Infect Dis 2015; 61: S346-S53.",Systematic review,COD,Democratic Republic of the Congo,Unknown healthcare facilities in Equateur,1008,Equateur,2012,8,18,44.4,0,Salmonella Typhi,Multidrug resistance (MDR)
923,Phoba (2014),"Phoba MF, De Boeck H, Ifeka BB, et al. Epidemic increase in Salmonella bloodstream infection in children, Bwamanda, the Democratic Republic of Congo. Eur J Clin Microbiol Infect Dis 2014; 33(1): 79-87.",Systematic review,COD,Democratic Republic of the Congo,Hôpital Général de Référence (HGR) de Bwamanda,1008,Equateur,2012,6,18,33.3,0,Salmonella Typhi,Multidrug resistance (MDR)
4370,Kalonji (2015),"Kalonji LM, Post A, Phoba MF, et al. Invasive Salmonella infections at multiple aurveillance aites in the Democratic Republic of the Congo, 2011-2014. Clin Infect Dis 2015; 61: S346-S53.",Systematic review,COD,Democratic Republic of the Congo,Unknown healthcare facilities in Bas Congo,1007,Bas-Congo,2013,5,32,15.6,0,Salmonella Typhi,Multidrug resistance (MDR)
4370,Kalonji (2015),"Kalonji LM, Post A, Phoba MF, et al. Invasive Salmonella infections at multiple aurveillance aites in the Democratic Republic of the Congo, 2011-2014. Clin Infect Dis 2015; 61: S346-S53.",Systematic review,COD,Democratic Republic of the Congo,Unknown healthcare facilities in Orientale,1015,Province Orientale,2013,0,5,0,1,Salmonella Typhi,Multidrug resistance (MDR)
4370,Kalonji (2015),"Kalonji LM, Post A, Phoba MF, et al. Invasive Salmonella infections at multiple aurveillance aites in the Democratic Republic of the Congo, 2011-2014. Clin Infect Dis 2015; 61: S346-S53.",Systematic review,COD,Democratic Republic of the Congo,Unknown healthcare facilities in Bas Congo,1007,Bas-Congo,2014,8,12,66.7,0,Salmonella Typhi,Multidrug resistance (MDR)
4370,Kalonji (2015),"Kalonji LM, Post A, Phoba MF, et al. Invasive Salmonella infections at multiple aurveillance aites in the Democratic Republic of the Congo, 2011-2014. Clin Infect Dis 2015; 61: S346-S53.",Systematic review,COD,Democratic Republic of the Congo,Unknown healthcare facilities in Kinshasa,1012,Kinshasa,2014,9,17,52.9,0,Salmonella Typhi,Multidrug resistance (MDR)
4370,Kalonji (2015),"Kalonji LM, Post A, Phoba MF, et al. Invasive Salmonella infections at multiple aurveillance aites in the Democratic Republic of the Congo, 2011-2014. Clin Infect Dis 2015; 61: S346-S53.",Systematic review,COD,Democratic Republic of the Congo,Unknown healthcare facilities in Orientale,1015,Province Orientale,2014,3,5,60,0,Salmonella Typhi,Multidrug resistance (MDR)
251,Wolday(1998),"Wolday D, Erge W. Antimicrobial sensitivity pattern of Salmonella: comparison of isolates from HIV-infected and HIV-uninfected patients. Trop Doct 1998; 28(3): 139-41.",Systematic review,ETH,Ethiopia,Tikur Anbessa (Black Lion) Hospital,1042,Addis Ababa,1993,1,21,4.8,0,Salmonella Typhi,Multidrug resistance (MDR)
3359,Mache(1997),"Mache A, Mengistu Y, Cowley S. Salmonella serogroups identified from adult diarrhoeal out-patients in Addis Ababa, Ethiopia: Antibiotic resistance and plasmid profile analysis. East Afr Med J 1997; 74(3): 183-6.",Systematic review,ETH,Ethiopia,Tikur Anbessa (Black Lion) Hospital;Zewditu Hospital;Yekatit 12 Hospital;Menelik II Hospital;Arada Clinic,1042,Addis Ababa,1995,2,7,28.6,1,Salmonella Typhi,Multidrug resistance (MDR)
3346,Aseffa(1997),"Aseffa A, Gedlu E, Asmelash T. Antibiotic resistance of prevalent Salmonella and shigella strains in northwest Ethiopia. East Afr Med J 1997; 74(11): 708-13.",Systematic review,ETH,Ethiopia,Gondar College Teaching Hospital,1044,Amhara,1995,0,17,0,0,Salmonella Typhi,Multidrug resistance (MDR)
751,Wasihun(2015)<U+1D47>,"Wasihun AG, Wlekidan LN, Gebremariam SA, et al. Diagnosis and Treatment of Typhoid Fever and Associated Prevailing Drug Resistance in Northern Ethiopia. Int J Infect Dis 2015; 35: 96-102.",Systematic review,ETH,Ethiopia,Mekelle Hospital,1050,Tigray,2014,1,8,12.5,0,Salmonella Typhi,Multidrug resistance (MDR)
2357,Okome-Nkoumou(2000),"Okome-Nkoumou M, Ayo Nkana E, Bekale J, Kombila M. [Typhoid and paratyphoid fever in adults in the Internal Medicine Department at Libreville (Gabon)]. Sante 2000; 10(3): 205-9.",Systematic review,GAB,Gabon,Foundation Jeanne Ebori,1053,Estuaire,1994,6,71,8.5,0,Salmonella Typhi,Multidrug resistance (MDR)
1432,Mills-Robertson(2002),"Mills-Robertson F, Addy ME, Mensah P, Crupper SS. Molecular characterization of antibiotic resistance in clinical Salmonella Typhi isolated in Ghana. FEMS Microbiology Letters 2002; 215(2): 249-53.",Systematic review,GHA,Ghana,Korle-Bu Teaching Hospital;Noguchi Memorial Institute for Medical Research,1066,Greater Accra,1998,10,58,17.2,0,Salmonella Typhi,Multidrug resistance (MDR)
127,Mills-Robertson(2003),"Mills-Robertson F, Crupper SS, Addy ME, Mensah P. Antibiotic resistance and genotyping of clinical group B Salmonella isolated in Accra, Ghana. J Appl Microbiol 2003; 94(2): 289-94.",Systematic review,GHA,Ghana,Korle-Bu Teaching Hospital;Noguchi Memorial Institute for Medical Research,1066,Greater Accra,1999,28,31,90.3,0,Salmonella Typhi,Multidrug resistance (MDR)
4536,Eibacha (2016),"Eibacha D, Al-Emrana HM, Dekker DM, et al. The emergence of reduced ciprofloxacin susceptibility in Salmonella enterica causing bloodstream infections in rural Ghana. Clin Infect Dis 2016; 62(Suppl. 1): S32-S6.",Systematic review,GHA,Ghana,Agogo Presbyterian Hospital,1062,Ashanti,2008,59,89,66.3,0,Salmonella Typhi,Multidrug resistance (MDR)
1382,Huenger (2010),"Huenger F, Agyekum A, Nkrumah B, et al. Massive emergence of multidrug-resistant Enterobacteriaceae in blood culture isolates of children in Ghana. Clin Microbiol Infect 2010; 16: S88.",Systematic review,GHA,Ghana,Agogo Presbyterian Hospital,1062,Ashanti,2008,23,39,59,0,Salmonella Typhi,Multidrug resistance (MDR)
2369,Marks (2010),"Marks F, Adu-Sarkodie Y, Hunger F, et al. Typhoid fever among children, ghana. Emerg Infect Dis 2010; 16(11): 1796-7.",Systematic review,GHA,Ghana,Agogo Presbyterian Hospital,1062,Ashanti,2008,26,37,70.3,0,Salmonella Typhi,Multidrug resistance (MDR)
4666,Agyekum (2010),"Agyekum A. Prevalence of bacteria causing bacteraemia in children under five years in Agogo, Asante-Akyem and their antimicrobial susceptibility patterns: Kwame Nkrumha University of Science & Technology, Kumasi; 2010.",Systematic review,GHA,Ghana,Agogo Presbyterian Hospital,1062,Ashanti,2008,14,23,60.9,0,Salmonella Typhi,Multidrug resistance (MDR)
2946,Marks (2017),"Marks F, Kalckreuth V, Aaby P, et al. Incidence of invasive Salmonella disease in sub-Saharan Africa: A multicentre population-based surveillance study. Lancet Glob Health 2017; 5(3): e310-e23.",Systematic review,GHA,Ghana,Agogo Presbyterian Hospital,1062,Ashanti,2011,44,66,66.7,0,Salmonella Typhi,Multidrug resistance (MDR)
2410,Kariuki (2010),"Kariuki S, Revathi G, Kiiru J, et al. Typhoid in Kenya is associated with a dominant multidrug-resistant Salmonella enterica serovar Typhi haplotype that is also widespread in Southeast Asia. J Clin Microbiol 2010; 48(6): 2171-6.",Systematic review,KEN,Kenya,Unknown hospitals in Nairobi province,1106,Nairobi,1991,5,45,11.1,0,Salmonella Typhi,Multidrug resistance (MDR)
2796,Kariuki (2000),"Kariuki S, Gilks C, Revathi G, Hart CA. Genotypic analysis of multidrug-resistant Salmonella enterica Serovar Typhi, Kenya. Emerg Infect Dis 2000; 6(6): 649-51.",Systematic review,KEN,Kenya,Kenyatta National Hospital,1106,Nairobi,1991,0,16,0,0,Salmonella Typhi,Multidrug resistance (MDR)
3351,Dougle (1997),"Dougle M, Hendriks E, Sanders E, Dorigo-Zetsma JW. Laboratory investigations in the diagnosis of septicaemia and malaria. East Afr Med J 1997; 74(6): 353-6.",Systematic review,KEN,Kenya,St Marys Hospital Mumias,1110,Western,1994,0,24,0,0,Salmonella Typhi,Multidrug resistance (MDR)
2410,Kariuki (2010),"Kariuki S, Revathi G, Kiiru J, et al. Typhoid in Kenya is associated with a dominant multidrug-resistant Salmonella enterica serovar Typhi haplotype that is also widespread in Southeast Asia. J Clin Microbiol 2010; 48(6): 2171-6.",Systematic review,KEN,Kenya,Unknown hospitals in Nairobi province,1106,Nairobi,1997,85,142,59.9,0,Salmonella Typhi,Multidrug resistance (MDR)
2796,Kariuki (2000),"Kariuki S, Gilks C, Revathi G, Hart CA. Genotypic analysis of multidrug-resistant Salmonella enterica Serovar Typhi, Kenya. Emerg Infect Dis 2000; 6(6): 649-51.",Systematic review,KEN,Kenya,Kenyatta National Hospital,1106,Nairobi,1998,5,22,22.7,0,Salmonella Typhi,Multidrug resistance (MDR)
3627,Brooks(2006),"Brooks JT, Ochieng JB, Kumar L, et al. Surveillance for bacterial diarrhea and antimicrobial resistance in rural western Kenya, 1997-2003. Clin Infect Dis 2006; 43(4): 393-401.",Systematic review,KEN,Kenya,Unknown hospitals and clinics in Asembo Bay,1108,Nyanza,2000,2,8,25,0,Salmonella Typhi,Multidrug resistance (MDR)
2332,Mengo (2010),"Mengo DM, Kariuki S, Muigai A, Revathi G. Trends in Salmonella enteric serovar Typhi in Nairobi, Kenya from 2004 to 2006. J Infect Dev Ctries 2010; 4(6): 393-6.",Systematic review,KEN,Kenya,Aga Khan University Hospital (Nairobi);Kenyatta National Hospital,1106,Nairobi,2004,22,32,68.8,0,Salmonella Typhi,Multidrug resistance (MDR)
5099,Mutai (2018),"Mutai WC, Muigai AWT, Waiyaki P and Kariuki S. Multi-drug resistant Salmonella enterica serovar Typhi isolates with reduced susceptibility to ciprofloxacin in Kenya.BMC Microbiology 2018;18(1):187",Systematic review,KEN,Kenya,Aga Khan University Hospital (Nairobi);Kenyatta National Hospital,1106,Nairobi,2004,48,59,81.4,0,Salmonella Typhi,Multidrug resistance (MDR)
2410,Kariuki (2010),"Kariuki S, Revathi G, Kiiru J, et al. Typhoid in Kenya is associated with a dominant multidrug-resistant Salmonella enterica serovar Typhi haplotype that is also widespread in Southeast Asia. J Clin Microbiol 2010; 48(6): 2171-6.",Systematic review,KEN,Kenya,Unknown hospitals in Nairobi province,1106,Nairobi,2005,105,136,77.2,0,Salmonella Typhi,Multidrug resistance (MDR)
5099,Mutai (2018),"Mutai WC, Muigai AWT, Waiyaki P and Kariuki S. Multi-drug resistant Salmonella enterica serovar Typhi isolates with reduced susceptibility to ciprofloxacin in Kenya.BMC Microbiology 2018;18(1):187",Systematic review,KEN,Kenya,Aga Khan University Hospital (Nairobi);Kenyatta National Hospital,1106,Nairobi,2005,29,47,61.7,0,Salmonella Typhi,Multidrug resistance (MDR)
2332,Mengo (2010),"Mengo DM, Kariuki S, Muigai A, Revathi G. Trends in Salmonella enteric serovar Typhi in Nairobi, Kenya from 2004 to 2006. J Infect Dev Ctries 2010; 4(6): 393-6.",Systematic review,KEN,Kenya,Aga Khan University Hospital (Nairobi);Kenyatta National Hospital,1106,Nairobi,2005,25,39,64.1,0,Salmonella Typhi,Multidrug resistance (MDR)
3753,Onyango(2008),"Onyango D, Machioni F, Kakai R, Waindi EN. Multidrug resistance of Salmonella enterica serovars Typhi and Typhimurium isolated from clinical samples at two rural hospitals in Western Kenya. J Infect Dev Ctries 2008; 2(2): 106-11.",Systematic review,KEN,Kenya,St Elizabeth Mukumu Hospital,1110,Western,2005,22,33,66.7,0,Salmonella Typhi,Multidrug resistance (MDR)
2332,Mengo (2010),"Mengo DM, Kariuki S, Muigai A, Revathi G. Trends in Salmonella enteric serovar Typhi in Nairobi, Kenya from 2004 to 2006. J Infect Dev Ctries 2010; 4(6): 393-6.",Systematic review,KEN,Kenya,Aga Khan University Hospital (Nairobi);Kenyatta National Hospital,1106,Nairobi,2006,20,29,69,0,Salmonella Typhi,Multidrug resistance (MDR)
5099,Mutai (2018),"Mutai WC, Muigai AWT, Waiyaki P and Kariuki S. Multi-drug resistant Salmonella enterica serovar Typhi isolates with reduced susceptibility to ciprofloxacin in Kenya.BMC Microbiology 2018;18(1):187",Systematic review,KEN,Kenya,Aga Khan University Hospital (Nairobi);Kenyatta National Hospital,1106,Nairobi,2006,21,37,56.8,0,Salmonella Typhi,Multidrug resistance (MDR)
1743,Breiman (2012),"Breiman RF, Cosmas L, Njuguna H, et al. Population-based incidence of typhoid fever in an urban informal settlement and a rural area in Kenya: implications for typhoid vaccine use in Africa. PLoS ONE 2012; 7(1): e29119.",Systematic review,KEN,Kenya,Kibera,1106,Nairobi,2008,106.01,131,80.9,0,Salmonella Typhi,Multidrug resistance (MDR)
1743,Breiman (2012),"Breiman RF, Cosmas L, Njuguna H, et al. Population-based incidence of typhoid fever in an urban informal settlement and a rural area in Kenya: implications for typhoid vaccine use in Africa. PLoS ONE 2012; 7(1): e29119.",Systematic review,KEN,Kenya,Lwak,1108,Nyanza,2008,14,22,63.6,0,Salmonella Typhi,Multidrug resistance (MDR)
2946,Marks (2017),"Marks F, Kalckreuth V, Aaby P, et al. Incidence of invasive Salmonella disease in sub-Saharan Africa: A multicentre population-based surveillance study. Lancet Glob Health 2017; 5(3): e310-e23.",Systematic review,KEN,Kenya,Unkown Hospitals in Kibera,1106,Nairobi,2013,52,61,85.2,0,Salmonella Typhi,Multidrug resistance (MDR)
5086,Kavai(2018),"Kavai SM, Kangogo M, Muigai AWT, Kariuki S. Analysis of Trends in Resistance to Fluoroquinolones and Extended Spectrum Beta-Lactams among Salmonella Typhi Isolates Obtained from Patients at Four Outpatient Clinics in Nairobi County, Kenya. Advances in Microbiology 2018; 8(7): 578-88.",Systematic review,KEN,Kenya,Mbagathi District Hospital;Unkown faciltlies in Mukuru Kwa Njenga;Unkown faciltlies in Mukuru Reuben,1106,Nairobi,2014,159,287,55.4,0,Salmonella Typhi,Multidrug resistance (MDR)
321,Gordon (2001),"Gordon MA, Walsh AL, Chaponda M, et al. Bacteraemia and mortality among adult medical admissions in Malawi - Predominance of non-Typhi Salmonellae and Streptococcus pneumoniae. J Infect 2001; 42(1): 44-9.",Systematic review,MWI,Malawi,Queen Elizabeth Central Hospital,1185,Southern Region,1998,0,12,0,0,Salmonella Typhi,Multidrug resistance (MDR)
5136,Musicha(2019)<U+1D43>,"Musicha P, Feasey N. MLWBC1998_2014. Blantyre, Malawi; 2019.",Dataset,MWI,Malawi,Queen Elizabeth Central Hospital,1185,Southern Region,1998,0,34,0,0,Salmonella Typhi,Multidrug resistance (MDR)
5136,Musicha(2019)<U+1D43>,"Musicha P, Feasey N. MLWBC1998_2014. Blantyre, Malawi; 2019.",Dataset,MWI,Malawi,Queen Elizabeth Central Hospital,1185,Southern Region,1999,2,14,14.3,0,Salmonella Typhi,Multidrug resistance (MDR)
5136,Musicha(2019)<U+1D43>,"Musicha P, Feasey N. MLWBC1998_2014. Blantyre, Malawi; 2019.",Dataset,MWI,Malawi,Queen Elizabeth Central Hospital,1185,Southern Region,2000,1,12,8.3,0,Salmonella Typhi,Multidrug resistance (MDR)
5136,Musicha(2019)<U+1D43>,"Musicha P, Feasey N. MLWBC1998_2014. Blantyre, Malawi; 2019.",Dataset,MWI,Malawi,Queen Elizabeth Central Hospital,1185,Southern Region,2001,0,6,0,0,Salmonella Typhi,Multidrug resistance (MDR)
5136,Musicha(2019)<U+1D43>,"Musicha P, Feasey N. MLWBC1998_2014. Blantyre, Malawi; 2019.",Dataset,MWI,Malawi,Queen Elizabeth Central Hospital,1185,Southern Region,2002,4,6,66.7,1,Salmonella Typhi,Multidrug resistance (MDR)
5136,Musicha(2019)<U+1D43>,"Musicha P, Feasey N. MLWBC1998_2014. Blantyre, Malawi; 2019.",Dataset,MWI,Malawi,Queen Elizabeth Central Hospital,1185,Southern Region,2003,1,9,11.1,0,Salmonella Typhi,Multidrug resistance (MDR)
5136,Musicha(2019)<U+1D43>,"Musicha P, Feasey N. MLWBC1998_2014. Blantyre, Malawi; 2019.",Dataset,MWI,Malawi,Queen Elizabeth Central Hospital,1185,Southern Region,2004,0,13,0,0,Salmonella Typhi,Multidrug resistance (MDR)
5136,Musicha(2019)<U+1D43>,"Musicha P, Feasey N. MLWBC1998_2014. Blantyre, Malawi; 2019.",Dataset,MWI,Malawi,Queen Elizabeth Central Hospital,1185,Southern Region,2005,0,20,0,0,Salmonella Typhi,Multidrug resistance (MDR)
5136,Musicha(2019)<U+1D43>,"Musicha P, Feasey N. MLWBC1998_2014. Blantyre, Malawi; 2019.",Dataset,MWI,Malawi,Queen Elizabeth Central Hospital,1185,Southern Region,2006,0,18,0,0,Salmonella Typhi,Multidrug resistance (MDR)
5136,Musicha(2019)<U+1D43>,"Musicha P, Feasey N. MLWBC1998_2014. Blantyre, Malawi; 2019.",Dataset,MWI,Malawi,Queen Elizabeth Central Hospital,1185,Southern Region,2007,0,11,0,0,Salmonella Typhi,Multidrug resistance (MDR)
5136,Musicha(2019)<U+1D43>,"Musicha P, Feasey N. MLWBC1998_2014. Blantyre, Malawi; 2019.",Dataset,MWI,Malawi,Queen Elizabeth Central Hospital,1185,Southern Region,2008,1,16,6.3,0,Salmonella Typhi,Multidrug resistance (MDR)
5136,Musicha(2019)<U+1D43>,"Musicha P, Feasey N. MLWBC1998_2014. Blantyre, Malawi; 2019.",Dataset,MWI,Malawi,Queen Elizabeth Central Hospital,1185,Southern Region,2009,0,24,0,0,Salmonella Typhi,Multidrug resistance (MDR)
5136,Musicha(2019)<U+1D43>,"Musicha P, Feasey N. MLWBC1998_2014. Blantyre, Malawi; 2019.",Dataset,MWI,Malawi,Queen Elizabeth Central Hospital,1185,Southern Region,2010,7,20,35,0,Salmonella Typhi,Multidrug resistance (MDR)
5136,Musicha(2019)<U+1D43>,"Musicha P, Feasey N. MLWBC1998_2014. Blantyre, Malawi; 2019.",Dataset,MWI,Malawi,Queen Elizabeth Central Hospital,1185,Southern Region,2011,44,69,63.8,0,Salmonella Typhi,Multidrug resistance (MDR)
5136,Musicha(2019)<U+1D43>,"Musicha P, Feasey N. MLWBC1998_2014. Blantyre, Malawi; 2019.",Dataset,MWI,Malawi,Queen Elizabeth Central Hospital,1185,Southern Region,2012,173,190,91.1,0,Salmonella Typhi,Multidrug resistance (MDR)
5136,Musicha(2019)<U+1D43>,"Musicha P, Feasey N. MLWBC1998_2014. Blantyre, Malawi; 2019.",Dataset,MWI,Malawi,Queen Elizabeth Central Hospital,1185,Southern Region,2013,866,887,97.6,0,Salmonella Typhi,Multidrug resistance (MDR)
5136,Musicha(2019)<U+1D43>,"Musicha P, Feasey N. MLWBC1998_2014. Blantyre, Malawi; 2019.",Dataset,MWI,Malawi,Queen Elizabeth Central Hospital,1185,Southern Region,2014,753,779,96.7,0,Salmonella Typhi,Multidrug resistance (MDR)
5137,Musicha(2019)<U+1D47>,"Musicha P, Feasey N. BC_data_2015_16.2. Blantrye, Malawi; 2019.",Dataset,MWI,Malawi,Queen Elizabeth Central Hospital,1185,Southern Region,2015,553,565,97.9,0,Salmonella Typhi,Multidrug resistance (MDR)
5137,Musicha(2019)<U+1D47>,"Musicha P, Feasey N. BC_data_2015_16.2. Blantrye, Malawi; 2019.",Dataset,MWI,Malawi,Queen Elizabeth Central Hospital,1185,Southern Region,2016,286,298,96,0,Salmonella Typhi,Multidrug resistance (MDR)
5065,Akinyemi (2018),"Akinyemi KO, Oyefolu AOB, Mutiu WB, et al. Typhoid fever: tracking the trend in Nigeria. (Special Issue: Tackling typhoid - what do global and country trends teach us?).American Journal of Tropical Medicine and Hygiene 2018;99(3 Suppl):41-47",Systematic review,NGA,Nigeria,Lagos University Teaching Hospital;General Hospital Lagos,1212,Lagos,1993,6,11,54.5,1,Salmonella Typhi,Multidrug resistance (MDR)
5065,Akinyemi (2018),"Akinyemi KO, Oyefolu AOB, Mutiu WB, et al. Typhoid fever: tracking the trend in Nigeria. (Special Issue: Tackling typhoid - what do global and country trends teach us?).American Journal of Tropical Medicine and Hygiene 2018;99(3 Suppl):41-47",Systematic review,NGA,Nigeria,Lagos University Teaching Hospital;General Hospital Lagos,1212,Lagos,1994,0,8,0,0,Salmonella Typhi,Multidrug resistance (MDR)
5065,Akinyemi (2018),"Akinyemi KO, Oyefolu AOB, Mutiu WB, et al. Typhoid fever: tracking the trend in Nigeria. (Special Issue: Tackling typhoid - what do global and country trends teach us?).American Journal of Tropical Medicine and Hygiene 2018;99(3 Suppl):41-47",Systematic review,NGA,Nigeria,Lagos University Teaching Hospital;General Hospital Lagos,1212,Lagos,1995,0,16,0,0,Salmonella Typhi,Multidrug resistance (MDR)
5065,Akinyemi (2018),"Akinyemi KO, Oyefolu AOB, Mutiu WB, et al. Typhoid fever: tracking the trend in Nigeria. (Special Issue: Tackling typhoid - what do global and country trends teach us?).American Journal of Tropical Medicine and Hygiene 2018;99(3 Suppl):41-47",Systematic review,NGA,Nigeria,Lagos University Teaching Hospital;General Hospital Lagos,1212,Lagos,1996,6,11,54.5,0,Salmonella Typhi,Multidrug resistance (MDR)
5065,Akinyemi (2018),"Akinyemi KO, Oyefolu AOB, Mutiu WB, et al. Typhoid fever: tracking the trend in Nigeria. (Special Issue: Tackling typhoid - what do global and country trends teach us?).American Journal of Tropical Medicine and Hygiene 2018;99(3 Suppl):41-47",Systematic review,NGA,Nigeria,Lagos University Teaching Hospital;General Hospital Lagos,1212,Lagos,1997,8,12,66.7,0,Salmonella Typhi,Multidrug resistance (MDR)
2338,Akinyemi(2007)<U+1D47>,"Akinyemi KO, Smith SI, Oyefolu AO, Fasure KA, Coker AO. Trends of multiple drug resistance in Salmonella enterica serovar Typhi in Lagos, Nigeria. East and Central African Journal of Surgery 2007; 12(1): 83-8.",Systematic review,NGA,Nigeria,Central Public Health Laboratories (Yaba),1212,Lagos,1997,20,29,69,0,Salmonella Typhi,Multidrug resistance (MDR)
1783,Akinyemi (2000),"Akinyemi KO, Coker AO, Olukoya DK, Oyefolu AO, Amorighoye EP, Omonigbehin EO. Prevalence of multi-drug resistant Salmonella Typhi among clinically diagnosed typhoid fever patients in Lagos, Nigeria. Z Naturforsch [C] 2000; 55(5-6): 489-93.",Systematic review,NGA,Nigeria,Central Bank of Nigeria Health Clinics (Satellite Town);Central Public Health Laboratories (Yaba);Infectious Diseases Hospital (Lagos),1212,Lagos,1998,25,68,36.8,1,Salmonella Typhi,Multidrug resistance (MDR)
5065,Akinyemi (2018),"Akinyemi KO, Oyefolu AOB, Mutiu WB, et al. Typhoid fever: tracking the trend in Nigeria. (Special Issue: Tackling typhoid - what do global and country trends teach us?).American Journal of Tropical Medicine and Hygiene 2018;99(3 Suppl):41-47",Systematic review,NGA,Nigeria,Lagos University Teaching Hospital;General Hospital Lagos,1212,Lagos,1998,29,34,85.3,0,Salmonella Typhi,Multidrug resistance (MDR)
2338,Akinyemi(2007)<U+1D47>,"Akinyemi KO, Smith SI, Oyefolu AO, Fasure KA, Coker AO. Trends of multiple drug resistance in Salmonella enterica serovar Typhi in Lagos, Nigeria. East and Central African Journal of Surgery 2007; 12(1): 83-8.",Systematic review,NGA,Nigeria,Central Public Health Laboratories (Yaba),1212,Lagos,1998,28,37,75.7,0,Salmonella Typhi,Multidrug resistance (MDR)
356,Okwori(2011),"Okwori EE, Nwadioha SI, Nwokedi EOP, Odimayo M, Jombo G. Bacterial pathogens and their antimicrobial susceptibility in Otukpo Benue state of Nigeria. Asian Pacific Journal of Tropical Biomedicine 2011; 2(12).",Systematic review,NGA,Nigeria,Otukpo General Hospital,1198,Benue,1999,835.92,1707,49,0,Salmonella Typhi,Multidrug resistance (MDR)
5065,Akinyemi (2018),"Akinyemi KO, Oyefolu AOB, Mutiu WB, et al. Typhoid fever: tracking the trend in Nigeria. (Special Issue: Tackling typhoid - what do global and country trends teach us?).American Journal of Tropical Medicine and Hygiene 2018;99(3 Suppl):41-47",Systematic review,NGA,Nigeria,Lagos University Teaching Hospital;General Hospital Lagos,1212,Lagos,1999,28,33,84.8,0,Salmonella Typhi,Multidrug resistance (MDR)
2338,Akinyemi(2007)<U+1D47>,"Akinyemi KO, Smith SI, Oyefolu AO, Fasure KA, Coker AO. Trends of multiple drug resistance in Salmonella enterica serovar Typhi in Lagos, Nigeria. East and Central African Journal of Surgery 2007; 12(1): 83-8.",Systematic review,NGA,Nigeria,Central Public Health Laboratories (Yaba),1212,Lagos,1999,20,26,76.9,0,Salmonella Typhi,Multidrug resistance (MDR)
5065,Akinyemi (2018),"Akinyemi KO, Oyefolu AOB, Mutiu WB, et al. Typhoid fever: tracking the trend in Nigeria. (Special Issue: Tackling typhoid - what do global and country trends teach us?).American Journal of Tropical Medicine and Hygiene 2018;99(3 Suppl):41-47",Systematic review,NGA,Nigeria,Lagos University Teaching Hospital;General Hospital Lagos,1212,Lagos,2000,15,18,83.3,0,Salmonella Typhi,Multidrug resistance (MDR)
2338,Akinyemi(2007)<U+1D47>,"Akinyemi KO, Smith SI, Oyefolu AO, Fasure KA, Coker AO. Trends of multiple drug resistance in Salmonella enterica serovar Typhi in Lagos, Nigeria. East and Central African Journal of Surgery 2007; 12(1): 83-8.",Systematic review,NGA,Nigeria,Central Public Health Laboratories (Yaba),1212,Lagos,2000,30,38,78.9,0,Salmonella Typhi,Multidrug resistance (MDR)
1467,Akinyemi (2005),"Akinyemi KO, Smith SI, Bola Oyefolu AO, Coker AO. Multidrug resistance in Salmonella enterica serovar Typhi isolated from patients with typhoid fever complications in Lagos, Nigeria. Public Health 2005; 119(4): 321-7.",Systematic review,NGA,Nigeria,Central Bank of Nigeria Health Clinics (Satellite Town);Ikeja General Hospital;Infectious Diseases Hospital (Lagos);Lagos University Teaching Hospital,1212,Lagos,2001,25,41,61,0,Salmonella Typhi,Multidrug resistance (MDR)
5065,Akinyemi (2018),"Akinyemi KO, Oyefolu AOB, Mutiu WB, et al. Typhoid fever: tracking the trend in Nigeria. (Special Issue: Tackling typhoid - what do global and country trends teach us?).American Journal of Tropical Medicine and Hygiene 2018;99(3 Suppl):41-47",Systematic review,NGA,Nigeria,Lagos University Teaching Hospital;General Hospital Lagos,1212,Lagos,2001,5,8,62.5,0,Salmonella Typhi,Multidrug resistance (MDR)
2338,Akinyemi(2007)<U+1D47>,"Akinyemi KO, Smith SI, Oyefolu AO, Fasure KA, Coker AO. Trends of multiple drug resistance in Salmonella enterica serovar Typhi in Lagos, Nigeria. East and Central African Journal of Surgery 2007; 12(1): 83-8.",Systematic review,NGA,Nigeria,Central Public Health Laboratories (Yaba),1212,Lagos,2001,28,33,84.8,0,Salmonella Typhi,Multidrug resistance (MDR)
5065,Akinyemi (2018),"Akinyemi KO, Oyefolu AOB, Mutiu WB, et al. Typhoid fever: tracking the trend in Nigeria. (Special Issue: Tackling typhoid - what do global and country trends teach us?).American Journal of Tropical Medicine and Hygiene 2018;99(3 Suppl):41-47",Systematic review,NGA,Nigeria,Lagos University Teaching Hospital;General Hospital Lagos,1212,Lagos,2002,14,18,77.8,0,Salmonella Typhi,Multidrug resistance (MDR)
2338,Akinyemi(2007)<U+1D47>,"Akinyemi KO, Smith SI, Oyefolu AO, Fasure KA, Coker AO. Trends of multiple drug resistance in Salmonella enterica serovar Typhi in Lagos, Nigeria. East and Central African Journal of Surgery 2007; 12(1): 83-8.",Systematic review,NGA,Nigeria,Central Public Health Laboratories (Yaba),1212,Lagos,2002,31,35,88.6,0,Salmonella Typhi,Multidrug resistance (MDR)
3686,Doughari(2007),"Doughari JH, Elmahmood AM, Nggada HP. Retrospective study on the antibiotic resistant pattern of Salmonella Typhi from some clinical samples. African Journal of Microbiology Research 2007; 1(3): 33-6.",Systematic review,NGA,Nigeria,Peace Hospital;Freedom Polyclinic Hospitals;Specialist Hospital;Biomedical Laboratory (Yola),1195,Adamawa,2003,421.03,744,56.6,0,Salmonella Typhi,Multidrug resistance (MDR)
5065,Akinyemi (2018),"Akinyemi KO, Oyefolu AOB, Mutiu WB, et al. Typhoid fever: tracking the trend in Nigeria. (Special Issue: Tackling typhoid - what do global and country trends teach us?).American Journal of Tropical Medicine and Hygiene 2018;99(3 Suppl):41-47",Systematic review,NGA,Nigeria,Lagos University Teaching Hospital;General Hospital Lagos,1212,Lagos,2003,19,22,86.4,0,Salmonella Typhi,Multidrug resistance (MDR)
2338,Akinyemi(2007)<U+1D47>,"Akinyemi KO, Smith SI, Oyefolu AO, Fasure KA, Coker AO. Trends of multiple drug resistance in Salmonella enterica serovar Typhi in Lagos, Nigeria. East and Central African Journal of Surgery 2007; 12(1): 83-8.",Systematic review,NGA,Nigeria,Central Public Health Laboratories (Yaba),1212,Lagos,2003,31,37,83.8,0,Salmonella Typhi,Multidrug resistance (MDR)
5065,Akinyemi (2018),"Akinyemi KO, Oyefolu AOB, Mutiu WB, et al. Typhoid fever: tracking the trend in Nigeria. (Special Issue: Tackling typhoid - what do global and country trends teach us?).American Journal of Tropical Medicine and Hygiene 2018;99(3 Suppl):41-47",Systematic review,NGA,Nigeria,Lagos University Teaching Hospital;General Hospital Lagos,1212,Lagos,2004,23,26,88.5,0,Salmonella Typhi,Multidrug resistance (MDR)
2338,Akinyemi(2007)<U+1D47>,"Akinyemi KO, Smith SI, Oyefolu AO, Fasure KA, Coker AO. Trends of multiple drug resistance in Salmonella enterica serovar Typhi in Lagos, Nigeria. East and Central African Journal of Surgery 2007; 12(1): 83-8.",Systematic review,NGA,Nigeria,Central Public Health Laboratories (Yaba),1212,Lagos,2004,33,39,84.6,0,Salmonella Typhi,Multidrug resistance (MDR)
2069,Akinyemi(2007)<U+1D43>,"Akinyemi KO, Bamiro BS, Coker AO. Salmonellosis in Lagos, Nigeria: incidence of Plasmodium falciparum-associated co-infection, patterns of antimicrobial resistance, and emergence of reduced susceptibility to fluoroquinolones. J Health Popul Nutr 2007; 25(3): 351-8.",Systematic review,NGA,Nigeria,Central Bank of Nigeria Health Clinics (Satellite Town);Central Medical Laboratory Health Centre;Ikeja General Hospital;Infectious Diseases Hospital (Lagos),1212,Lagos,2005,15,21,71.4,0,Salmonella Typhi,Multidrug resistance (MDR)
5065,Akinyemi (2018),"Akinyemi KO, Oyefolu AOB, Mutiu WB, et al. Typhoid fever: tracking the trend in Nigeria. (Special Issue: Tackling typhoid - what do global and country trends teach us?).American Journal of Tropical Medicine and Hygiene 2018;99(3 Suppl):41-47",Systematic review,NGA,Nigeria,Lagos University Teaching Hospital;General Hospital Lagos,1212,Lagos,2005,24,28,85.7,0,Salmonella Typhi,Multidrug resistance (MDR)
258,Fashae(2010),"Fashae K, Ogunsola F, Aarestrup FM, Hendriksen RS. Antimicrobial susceptibility and serovars of Salmonella from chickens and humans in Ibadan, Nigeria. J Infect Dev Ctries 2010; 4(8): 484-94.",Systematic review,NGA,Nigeria,Unknown hospitals and diagnostic laboratory in Ibadan province,1216,Oyo,2005,0,7,0,1,Salmonella Typhi,Multidrug resistance (MDR)
1232,Abdullahi(2010),"Abdullahi M. Incidence and antimicrobial susceptibility pattern of Salmonella species in children attending some hospitals in Kano Metropolis, Kano State-Nigeria. Bayero Journal of Pure and Applied Sciences 2010; 3(1): 202-6.",Systematic review,NGA,Nigeria,Five unkown hospitals in Kano Metropolis,1207,Kano,2006,5,12,41.7,1,Salmonella Typhi,Multidrug resistance (MDR)
5065,Akinyemi (2018),"Akinyemi KO, Oyefolu AOB, Mutiu WB, et al. Typhoid fever: tracking the trend in Nigeria. (Special Issue: Tackling typhoid - what do global and country trends teach us?).American Journal of Tropical Medicine and Hygiene 2018;99(3 Suppl):41-47",Systematic review,NGA,Nigeria,Lagos University Teaching Hospital;General Hospital Lagos,1212,Lagos,2006,14,16,87.5,0,Salmonella Typhi,Multidrug resistance (MDR)
5065,Akinyemi (2018),"Akinyemi KO, Oyefolu AOB, Mutiu WB, et al. Typhoid fever: tracking the trend in Nigeria. (Special Issue: Tackling typhoid - what do global and country trends teach us?).American Journal of Tropical Medicine and Hygiene 2018;99(3 Suppl):41-47",Systematic review,NGA,Nigeria,Lagos University Teaching Hospital;General Hospital Lagos,1212,Lagos,2007,21,23,91.3,0,Salmonella Typhi,Multidrug resistance (MDR)
1773,Adeshina (2009),"Adeshina GO, Osuagwu NO, Okeke CLE, Ehinmidu JO, Bolaji RO. Prevalence and susceptibility of Salmonella Typhi and Salmonella ParaTyphi in Zaria, Nigeria. International Journal of Health Research 2009; 2(4): 355-60.",Systematic review,NGA,Nigeria,Ahmadu Bello University Sick Bay Clinic;Federal College of Education;Salama Clinics;Savanna Polyclinics,1206,Kaduna,2008,40,71,56.3,0,Salmonella Typhi,Multidrug resistance (MDR)
2103,Abdullahi(2012),"Abdullahi B, Olonitola OS, Jatau ED, Usman AD. Serological characterization and antimicrobial susceptibility patterns of clinical isolates of Salmonella from patients attending General Hospital, Funtua, Nigeria. Bayero Journal of Pure and Applied Sciences 2012; 5(1): 72-7.",Systematic review,NGA,Nigeria,General Hospital Funtua,1208,Katsina,2008,6,16,37.5,1,Salmonella Typhi,Multidrug resistance (MDR)
5065,Akinyemi (2018),"Akinyemi KO, Oyefolu AOB, Mutiu WB, et al. Typhoid fever: tracking the trend in Nigeria. (Special Issue: Tackling typhoid - what do global and country trends teach us?).American Journal of Tropical Medicine and Hygiene 2018;99(3 Suppl):41-47",Systematic review,NGA,Nigeria,Lagos University Teaching Hospital;General Hospital Lagos,1212,Lagos,2008,28,30,93.3,0,Salmonella Typhi,Multidrug resistance (MDR)
5065,Akinyemi (2018),"Akinyemi KO, Oyefolu AOB, Mutiu WB, et al. Typhoid fever: tracking the trend in Nigeria. (Special Issue: Tackling typhoid - what do global and country trends teach us?).American Journal of Tropical Medicine and Hygiene 2018;99(3 Suppl):41-47",Systematic review,NGA,Nigeria,Lagos University Teaching Hospital;General Hospital Lagos,1212,Lagos,2009,24,25,96,0,Salmonella Typhi,Multidrug resistance (MDR)
5065,Akinyemi (2018),"Akinyemi KO, Oyefolu AOB, Mutiu WB, et al. Typhoid fever: tracking the trend in Nigeria. (Special Issue: Tackling typhoid - what do global and country trends teach us?).American Journal of Tropical Medicine and Hygiene 2018;99(3 Suppl):41-47",Systematic review,NGA,Nigeria,Lagos University Teaching Hospital;General Hospital Lagos,1212,Lagos,2010,17,18,94.4,0,Salmonella Typhi,Multidrug resistance (MDR)
158,Abdullahi(2014),"Abdullahi B, Abdulfatai K, Wartu JR, Mzungu I, Muhammad HID, Abdulsalam AO. Antibiotics susceptibility patterns and characterization of clinical Salmonella serotypes in Katsina State, Nigeria. African Journal of Microbiology Research 2014; 8(9): 915-21.",Systematic review,NGA,Nigeria,General Hospital Funtua;General Hospital Katsina;Turai Umaru Yar’adua Maternity and Children Hospital,1208,Katsina,2011,27,44,61.4,0,Salmonella Typhi,Multidrug resistance (MDR)
5065,Akinyemi (2018),"Akinyemi KO, Oyefolu AOB, Mutiu WB, et al. Typhoid fever: tracking the trend in Nigeria. (Special Issue: Tackling typhoid - what do global and country trends teach us?).American Journal of Tropical Medicine and Hygiene 2018;99(3 Suppl):41-47",Systematic review,NGA,Nigeria,Lagos University Teaching Hospital;General Hospital Lagos,1212,Lagos,2011,25,25,100,0,Salmonella Typhi,Multidrug resistance (MDR)
109,Abdullahi (2015),"Abdullahi M, Olonitola SO, Umoh VJ, Inabo IH. Antibacterial resistance profile and PCR detection of antibiotic resistance genes in Salmonella serovars isolated from blood samples of hospitalized subjects in Kano, North-West, Nigeria. Br Microbiol Res J 2015; 5(3): 245-56.",Systematic review,NGA,Nigeria,Aminu Kano Teaching Hospital;Khadijat Memorial Private Hospital;Mohammed Abdullahi Wase Specialist Hospital;Murtala Mohammed Specialist Hospital;Sheik Waziru Gidado General Hospital;Sir Sunusi Specialist Hospital,1207,Kano,2012,5,39,12.8,1,Salmonella Typhi,Multidrug resistance (MDR)
5065,Akinyemi (2018),"Akinyemi KO, Oyefolu AOB, Mutiu WB, et al. Typhoid fever: tracking the trend in Nigeria. (Special Issue: Tackling typhoid - what do global and country trends teach us?).American Journal of Tropical Medicine and Hygiene 2018;99(3 Suppl):41-47",Systematic review,NGA,Nigeria,Lagos University Teaching Hospital;General Hospital Lagos,1212,Lagos,2012,20,20,100,0,Salmonella Typhi,Multidrug resistance (MDR)
5065,Akinyemi (2018),"Akinyemi KO, Oyefolu AOB, Mutiu WB, et al. Typhoid fever: tracking the trend in Nigeria. (Special Issue: Tackling typhoid - what do global and country trends teach us?).American Journal of Tropical Medicine and Hygiene 2018;99(3 Suppl):41-47",Systematic review,NGA,Nigeria,Lagos University Teaching Hospital;General Hospital Lagos,1212,Lagos,2013,20,20,100,0,Salmonella Typhi,Multidrug resistance (MDR)
4209,Agada(2014),"Agada GOA, Abdullahi IO, Aminu M, et al. Prevalence and antibiotic resistance profile of Salmonella isolates from commercial poultry and poultry farm-handlers in Jos, Plateau State, Nigeria. Br Microbiol Res J 2014; 4(4): 462-79.",Systematic review,NGA,Nigeria,Jos North,1228,Plateau,2013,3,10,30,1,Salmonella Typhi,Multidrug resistance (MDR)
5065,Akinyemi (2018),"Akinyemi KO, Oyefolu AOB, Mutiu WB, et al. Typhoid fever: tracking the trend in Nigeria. (Special Issue: Tackling typhoid - what do global and country trends teach us?).American Journal of Tropical Medicine and Hygiene 2018;99(3 Suppl):41-47",Systematic review,NGA,Nigeria,Lagos University Teaching Hospital;General Hospital Lagos,1212,Lagos,2014,7,7,100,0,Salmonella Typhi,Multidrug resistance (MDR)
5065,Akinyemi (2018),"Akinyemi KO, Oyefolu AOB, Mutiu WB, et al. Typhoid fever: tracking the trend in Nigeria. (Special Issue: Tackling typhoid - what do global and country trends teach us?).American Journal of Tropical Medicine and Hygiene 2018;99(3 Suppl):41-47",Systematic review,NGA,Nigeria,Lagos University Teaching Hospital;General Hospital Lagos,1212,Lagos,2015,11,11,100,0,Salmonella Typhi,Multidrug resistance (MDR)
276,Ashok(2010),"Ashok R, Peter K, Joselyne N, Emma N. Antimicrobial susceptibility patterns of Salmonella Typhi from Kigali, Rwanda. Shiraz E Medical Journal 2010; 11(3): 117-21.",Systematic review,RWA,Rwanda,King Faisal Hospital,1233,Kigali City/Umujyi wa Kigali,2007,3,33,9.1,0,Salmonella Typhi,Multidrug resistance (MDR)
276,Ashok(2010),"Ashok R, Peter K, Joselyne N, Emma N. Antimicrobial susceptibility patterns of Salmonella Typhi from Kigali, Rwanda. Shiraz E Medical Journal 2010; 11(3): 117-21.",Systematic review,RWA,Rwanda,King Faisal Hospital,1233,Kigali City/Umujyi wa Kigali,2008,9,36,25,0,Salmonella Typhi,Multidrug resistance (MDR)
233,Dromigny(2003),"Dromigny JA, Perrier-Gros-Claude JD. Antimicrobial resistance of Salmonella enterica serotype Typhi in Dakar, Senegal. Clin Infect Dis 2003; 37(3): 465-6.",Systematic review,SEN,Senegal,Unkown healthcare facilities in Dakar,1243,Dakar,1995,1,232,0.4,0,Salmonella Typhi,Multidrug resistance (MDR)
1769,Harrois(2014),"Harrois D, Breurec S, Seck A, et al. Prevalence and characterization of extended-spectrum beta-lactamase-producing clinical Salmonella enterica isolates in Dakar, Senegal, from 1999 to 2009. Clin Microbiol Infect 2014; 20(2): O109-16.",Systematic review,SEN,Senegal,Bio24 Laboratory;Hopital Aristide Le Dantec;Hopital Principal;Institut Pasteur,1243,Dakar,1999,0,17,0,0,Salmonella Typhi,Multidrug resistance (MDR)
3599,Lefebvre (2005),"Lefebvre N, Gning SB, Nabeth P, et al. Clinical and laboratory features of typhoid fever in Senegal. A 70-case study [French]. Med Trop 2005; 65(6): 543-8.",Systematic review,SEN,Senegal,Hopital Principal,1243,Dakar,1999,0,5,0,0,Salmonella Typhi,Multidrug resistance (MDR)
1769,Harrois(2014),"Harrois D, Breurec S, Seck A, et al. Prevalence and characterization of extended-spectrum beta-lactamase-producing clinical Salmonella enterica isolates in Dakar, Senegal, from 1999 to 2009. Clin Microbiol Infect 2014; 20(2): O109-16.",Systematic review,SEN,Senegal,Bio24 Laboratory;Hopital Aristide Le Dantec;Hopital Principal;Institut Pasteur,1243,Dakar,2000,0,10,0,0,Salmonella Typhi,Multidrug resistance (MDR)
1769,Harrois(2014),"Harrois D, Breurec S, Seck A, et al. Prevalence and characterization of extended-spectrum beta-lactamase-producing clinical Salmonella enterica isolates in Dakar, Senegal, from 1999 to 2009. Clin Microbiol Infect 2014; 20(2): O109-16.",Systematic review,SEN,Senegal,Bio24 Laboratory;Hopital Aristide Le Dantec;Hopital Principal;Institut Pasteur,1243,Dakar,2001,0,8,0,0,Salmonella Typhi,Multidrug resistance (MDR)
1769,Harrois(2014),"Harrois D, Breurec S, Seck A, et al. Prevalence and characterization of extended-spectrum beta-lactamase-producing clinical Salmonella enterica isolates in Dakar, Senegal, from 1999 to 2009. Clin Microbiol Infect 2014; 20(2): O109-16.",Systematic review,SEN,Senegal,Bio24 Laboratory;Hopital Aristide Le Dantec;Hopital Principal;Institut Pasteur,1243,Dakar,2002,0,12,0,0,Salmonella Typhi,Multidrug resistance (MDR)
1769,Harrois(2014),"Harrois D, Breurec S, Seck A, et al. Prevalence and characterization of extended-spectrum beta-lactamase-producing clinical Salmonella enterica isolates in Dakar, Senegal, from 1999 to 2009. Clin Microbiol Infect 2014; 20(2): O109-16.",Systematic review,SEN,Senegal,Bio24 Laboratory;Hopital Aristide Le Dantec;Hopital Principal;Institut Pasteur,1243,Dakar,2003,0,10,0,0,Salmonella Typhi,Multidrug resistance (MDR)
1769,Harrois(2014),"Harrois D, Breurec S, Seck A, et al. Prevalence and characterization of extended-spectrum beta-lactamase-producing clinical Salmonella enterica isolates in Dakar, Senegal, from 1999 to 2009. Clin Microbiol Infect 2014; 20(2): O109-16.",Systematic review,SEN,Senegal,Bio24 Laboratory;Hopital Aristide Le Dantec;Hopital Principal;Institut Pasteur,1243,Dakar,2007,0,5,0,0,Salmonella Typhi,Multidrug resistance (MDR)
1769,Harrois(2014),"Harrois D, Breurec S, Seck A, et al. Prevalence and characterization of extended-spectrum beta-lactamase-producing clinical Salmonella enterica isolates in Dakar, Senegal, from 1999 to 2009. Clin Microbiol Infect 2014; 20(2): O109-16.",Systematic review,SEN,Senegal,Bio24 Laboratory;Hopital Aristide Le Dantec;Hopital Principal;Institut Pasteur,1243,Dakar,2008,0,15,0,0,Salmonella Typhi,Multidrug resistance (MDR)
2946,Marks (2017),"Marks F, Kalckreuth V, Aaby P, et al. Incidence of invasive Salmonella disease in sub-Saharan Africa: A multicentre population-based surveillance study. Lancet Glob Health 2017; 5(3): e310-e23.",Systematic review,SEN,Senegal,Unknown hospitals in Pikine,1243,Dakar,2012,0,7,0,0,Salmonella Typhi,Multidrug resistance (MDR)
848,Dagnra(2007),"Dagnra AY, Akolly K, Gbadoe A, Aho K, David M. Emergence of multidrug resistant Salmonella strains in Lome (Togo). [French]. Med Mal Infect 2007; 37(5): 266-9.",Systematic review,TGO,Togo,Centre Hospitalier et Universitaire Tokoin (Lome),1315,Maritime,2000,10,65,15.4,0,Salmonella Typhi,Multidrug resistance (MDR)
848,Dagnra(2007),"Dagnra AY, Akolly K, Gbadoe A, Aho K, David M. Emergence of multidrug resistant Salmonella strains in Lome (Togo). [French]. Med Mal Infect 2007; 37(5): 266-9.",Systematic review,TGO,Togo,Centre Hospitalier et Universitaire Tokoin (Lome),1315,Maritime,2004,57,82,69.5,0,Salmonella Typhi,Multidrug resistance (MDR)
2946,Marks (2017),"Marks F, Kalckreuth V, Aaby P, et al. Incidence of invasive Salmonella disease in sub-Saharan Africa: A multicentre population-based surveillance study. Lancet Glob Health 2017; 5(3): e310-e23.",Systematic review,TZA,Tanzania,Unknown hospitals in Moshi (urban and rural),1324,Kilimanjaro,2012,6,10,60,0,Salmonella Typhi,Multidrug resistance (MDR)
394,Mahende (2015),"Mahende C, Ngasala B, Lusingu J, et al. Bloodstream bacterial infection among outpatient children with acute febrile illness in north-eastern Tanzania. BMC Res Notes 2015; 8: 289.",Systematic review,TZA,Tanzania,Korogwe District Hospital,1342,Tanga,2013,15,17,88.2,0,Salmonella Typhi,Multidrug resistance (MDR)
4422,Onken(2015),"Onken A, Said AK, Jorstad M, Jenum PA, Blomberg B. Prevalence and Antimicrobial Resistance of Microbes Causing Bloodstream Infections in Unguja, Zanzibar. PLoS ONE 2015; 10(12).",Systematic review,TZA,Tanzania,Mnazi Mmoja hospital (MMH),1343,Unguja Urban West,2013,6,7,85.7,0,Salmonella Typhi,Multidrug resistance (MDR)
1352,Neil(2012),"Neil KP, Sodha SV, Lukwago L, et al. A large outbreak of typhoid fever associated with a high rate of intestinal perforation in Kasese District, Uganda, 2008-2009. Clin Infect Dis 2012; 54(8): 1091-9.",Systematic review,UGA,Uganda,Kasese District,1422,Kasese,2009,1,21,4.8,0,Salmonella Typhi,Multidrug resistance (MDR)
1103,Hendriksen(2015),"Hendriksen RS, Leekitcharoenphon P, Lukjancenko O, et al. Genomic signature of multidrug-resistant Salmonella enterica serovar Typhi isolates related to a massive outbreak in Zambia between 2010 and 2012. J Clin Microbiol 2015; 53(1): 262-72.",Systematic review,ZMB,Zambia,University Teaching Hospital (Lusaka),1460,Lusaka,2010,29,35,82.9,0,Salmonella Typhi,Multidrug resistance (MDR)
1103,Hendriksen(2015),"Hendriksen RS, Leekitcharoenphon P, Lukjancenko O, et al. Genomic signature of multidrug-resistant Salmonella enterica serovar Typhi isolates related to a massive outbreak in Zambia between 2010 and 2012. J Clin Microbiol 2015; 53(1): 262-72.",Systematic review,ZMB,Zambia,University Teaching Hospital (Lusaka),1460,Lusaka,2011,78,94,83,0,Salmonella Typhi,Multidrug resistance (MDR)
1103,Hendriksen(2015),"Hendriksen RS, Leekitcharoenphon P, Lukjancenko O, et al. Genomic signature of multidrug-resistant Salmonella enterica serovar Typhi isolates related to a massive outbreak in Zambia between 2010 and 2012. J Clin Microbiol 2015; 53(1): 262-72.",Systematic review,ZMB,Zambia,University Teaching Hospital (Lusaka),1460,Lusaka,2012,21,26,80.8,0,Salmonella Typhi,Multidrug resistance (MDR)
5056,Mashe(2017),"Mashe T, Mugabe M, Stray-Pedersen B, et al. Antibiotic resistance trends of Salmonella enterica serotype Typhi in Zimbabwe (2012-2017). Antimicrobial Resistance and Infection Control Conference: International Conference on Prevention and Infection Control, ICPIC 2017; 6(Supplement 3).",Systematic review,ZWE,Zimbabwe,Unknown clinics and hospitals in Harare,1466,Harare,2015,181,285,63.5,0,Salmonella Typhi,Multidrug resistance (MDR)
3286,Wen-xiang(1993),"Wen-xiang H, Ji-zhao D, Qi-nan W, Xing-pin Z, Chong-zhi L. Plasmid profile analysis and antibiotics susceptibility testing of multiresistant S. Typhi [Chinese]. Chinese Journal of Antibiotics 1993; 18(3): 196-201.",Systematic review,CHN,China,First Affiliated Hospital of Chongqing Medical University (Yu Zhong District),6,Chongqing Shi,1990,58,106,54.7,0,Salmonella Typhi,Multidrug resistance (MDR)
2327,Dong(2010),"Dong BQ, Yang J, Wang XY, et al. Trends and disease burden of enteric fever in Guangxi province, China, 1994-2004. Bull World Health Organ 2010; 88(9): 689-96.",Systematic review,CHN,China,Center for Disease Control and Prevention Guangxi,10,Guangxi Zhuangzu Zizhiqu,1999,2,339,0.6,0,Salmonella Typhi,Multidrug resistance (MDR)
1248,Su(2005),"Su LH, Wu TL, Chia JH, Chu C, Kuo AJ, Chiu CH. Increasing ceftriaxone resistance in Salmonella isolates from a university hospital in Taiwan. J Antimicrob Chemother 2005; 55(6): 846-52.",Systematic review,CHN,China,Chang Gung Memorial Hospital,30,Taiwan Sheng,1999,0,16,0,0,Salmonella Typhi,Multidrug resistance (MDR)
570,Chen(2006),"Chen M, Wu J, Jiang J. Clinical and laboratory analysis of 79 cases of typhoid fever and paratyphoid fever. [Chinese]. Journal of Tropical Medicine 2006; 6(5): 570-2.",Systematic review,CHN,China,First Affiliated Hospital of Guangxi Medical University,10,Guangxi Zhuangzu Zizhiqu,2000,17,60,28.3,0,Salmonella Typhi,Multidrug resistance (MDR)
647,Ling (2006),"Ling JH, Wang Y, Li JJ, Xu YC, Xie XL, Chen MJ. Comparison of antimicrobial susceptability of common gram-negative isolates from blood stream between Hong Kong and Beijing patients. [Chinese]. Chinese Journal of Infection and Chemotherapy 2006; 6(4): 251-4.",Systematic review,CHN,China,Peking Union Medical College Hospital,5,Beijing Shi,2001,0,23,0,0,Salmonella Typhi,Multidrug resistance (MDR)
1248,Su(2005),"Su LH, Wu TL, Chia JH, Chu C, Kuo AJ, Chiu CH. Increasing ceftriaxone resistance in Salmonella isolates from a university hospital in Taiwan. J Antimicrob Chemother 2005; 55(6): 846-52.",Systematic review,CHN,China,Chang Gung Memorial Hospital,30,Taiwan Sheng,2001,0,6,0,0,Salmonella Typhi,Multidrug resistance (MDR)
569,Wan(2008),"Wan L, Xiao K, Ye X. Clinical analysis of typhoid fever and paratyphoid fever. [Chinese]. China Tropical Medicine 2008; 8(2): 225-6.",Systematic review,CHN,China,The Second Affiliated Hospital of Guangzhou Medical College,9,Guangdong Sheng,2002,1,15,6.7,0,Salmonella Typhi,Multidrug resistance (MDR)
2180,Ochiai (2008),"Ochiai RL, Acosta CJ, Danovaro-Holliday MC, et al. A study of typhoid fever in five Asian countries: Disease burden and implications for controls. Bull World Health Organ 2008; 86(4): 260-8.",Systematic review,CHN,China,Hechi,10,Guangxi Zhuangzu Zizhiqu,2002,0,15,0,0,Salmonella Typhi,Multidrug resistance (MDR)
1248,Su(2005),"Su LH, Wu TL, Chia JH, Chu C, Kuo AJ, Chiu CH. Increasing ceftriaxone resistance in Salmonella isolates from a university hospital in Taiwan. J Antimicrob Chemother 2005; 55(6): 846-52.",Systematic review,CHN,China,Chang Gung Memorial Hospital,30,Taiwan Sheng,2002,0,5,0,0,Salmonella Typhi,Multidrug resistance (MDR)
2188,Chuang(2009),"Chuang CH, Su LH, Perera J, et al. Surveillance of antimicrobial resistance of Salmonella enterica serotype Typhi in seven Asian countries. Epidemiol Infect 2009; 137(2): 266-9.",Systematic review,CHN,China,Chang Gung Memorial Hospital;National Taiwan University Hospital,30,Taiwan Sheng,2003,4,15,26.7,0,Salmonella Typhi,Multidrug resistance (MDR)
930,Wang (2014),"Wang M, Kan B, Yang J, et al. Epidemiological characteristics of typhoid fever and antibiotic susceptibility testing of Salmonella Typhi isolates in Guangxi, 1994-2013 [Chinese]. Chung Hua Liu Hsing Ping Hsueh Tsa Chih 2014; 35(8): 930-4.",Systematic review,CHN,China,Guangxi,10,Guangxi Zhuangzu Zizhiqu,2004,1.99,475,0.4,0,Salmonella Typhi,Multidrug resistance (MDR)
1095,Wu (2010),"Wu W, Wang H, Lu J, et al. Genetic diversity of Salmonella enteric serovar Typhi and ParaTyphi in Shenzhen, China from 2002 through 2007. BMC Microbiol 2010; 10: 32.",Systematic review,CHN,China,Shenzhen People's Hospital,9,Guangdong Sheng,2005,0,25,0,0,Salmonella Typhi,Multidrug resistance (MDR)
244,Jiang(2015),"Jiang Y, Zuo H, Niu H, et al. Antimicrobial resistance surveillance of Salmonella isolates from the First People's Hospital of Yunnan Province, China. J Infect Dev Ctries 2015; 9(4): 333-7.",Systematic review,CHN,China,First People’s Hospital of Yunnan Province,34,Yunnan Sheng,2006,0,37,0,0,Salmonella Typhi,Multidrug resistance (MDR)
4229,Chiou(2014),"Chiou CS, Lauderdale TL, Phung DC, et al. Antimicrobial resistance in Salmonella enterica serovar Typhi isolates from Bangladesh, Indonesia, Taiwan, and Vietnam. Antimicrob Agents Chemother 2014; 58(11): 6501-7.",Systematic review,CHN,China,"Centers for Disease Control, Taiwan",30,Taiwan Sheng,2008,0,36,0,0,Salmonella Typhi,Multidrug resistance (MDR)
2909,Song(2017),"Song Q, Yang Y, Lin W, Yi B, Xu G. Epidemiological characteristics and clinical treatment outcome of typhoid fever in Ningbo, China, 2005-2014: Pulsed-field gel electorophoresis results revealing great proportion of common transmission sources. Jpn J Infect Dis 2017; 70(5): 513-7.",Systematic review,CHN,China,Ningbo Municipal Centre for Disease Control and Prevention,35,Zhejiang Sheng,2010,0,88,0,0,Salmonella Typhi,Multidrug resistance (MDR)
1052,Lee(2013),"Lee C, Su L, Huang Y, Chiu C. First isolation of ciprofloxacin-resistant Salmonella enterica serovar Typhi in Taiwan. Journal of Microbiology, Immunology and Infection 2013; 46(6): 469-73.",Systematic review,CHN,China,Chang Gung Memorial Hospital,30,Taiwan Sheng,2011,0,8,0,0,Salmonella Typhi,Multidrug resistance (MDR)
623,Isbandrio(1994),"Isbandrio BB, Gasem MH, Dolmans WMV, Hoogkamp-Korstanje JAA. Comparative activities of three quinolones and seven comparison standard drugs against Salmonella Typhi from Indonesia [1]. J Antimicrob Chemother 1994; 33(5): 1055-6.",Systematic review,IDN,Indonesia,Dr Kariadi Hospital,67,JAWA TENGAH,1991,0,218,0,0,Salmonella Typhi,Multidrug resistance (MDR)
3151,Amdani (1998),"Amdani SK. Antibiotic resistance pattern of pediatric typhoid fever patients at Harapan Kita Children and Maternity Hospital Jakarta, 1996. Med J Indones 1998; 7: 253-6.",Systematic review,IDN,Indonesia,Harapan Kita Children's and Maternity Hospital,57,DKI JAKARTA,1996,3,114,2.6,0,Salmonella Typhi,Multidrug resistance (MDR)
3140,Setiabudi (1998),"Setiabudi D, Azhali MS, Garna H, Chairulfatah A. Antibiotic resistance patterns of pediatric typhoid fever at the Department of Child Health, Hasan Sadikin General Hospital, Bandung. Med J Indones 1998; 7: 289.",Systematic review,IDN,Indonesia,Dr. Hasan Sadikin General Hospital,61,JAWA BARAT,1996,3,45,6.7,0,Salmonella Typhi,Multidrug resistance (MDR)
3143,Parwati(1998),"Parwati I, Samaun E. Multidrug resistance Salmonella in dr. Hasan Sadikin general hospital, Bandung. Med J Indones 1998; 7: 194.",Systematic review,IDN,Indonesia,Dr. Hasan Sadikin General Hospital,61,JAWA BARAT,1996,15,374,4,0,Salmonella Typhi,Multidrug resistance (MDR)
1694,Gasem(2003),"Gasem MH, Keuter M, Dolmans WM, Van Der Ven-Jongekrijg J, Djokomoeljanto R, Van Der Meer JW. Persistence of Salmonellae in blood and bone marrow: randomized controlled trial comparing ciprofloxacin and chloramphenicol treatments against enteric fever. Antimicrob Agents Chemother 2003; 47(5): 1727-31.",Systematic review,IDN,Indonesia,Dr Kariadi Hospital,67,JAWA TENGAH,1997,0,50,0,0,Salmonella Typhi,Multidrug resistance (MDR)
976,Punjabi (2012),"Punjabi NH, Taylor WR, Murphy GS, et al. Etiology of acute, non-malaria, febrile illnesses in Jayapura, northeastern Papua, Indonesia. Am J Trop Med Hyg 2012; 86(1): 46-51.",Systematic review,IDN,Indonesia,Jayapura Provincial Hospital,75,PAPUA,1999,0,13,0,0,Salmonella Typhi,Multidrug resistance (MDR)
1940,Vollaard (2004),"Vollaard AM, Ali S, van Asten HA, et al. Risk factors for typhoid and paratyphoid fever in Jakarta, Indonesia. JAMA 2004; 291(21): 2607-15.",Systematic review,IDN,Indonesia,Four unknown hospitals in Jatinegara and eight private outpatient clinics in the surrounding area,57,DKI JAKARTA,2002,3,88,3.4,0,Salmonella Typhi,Multidrug resistance (MDR)
883,Punjabi (2013),"Punjabi NH, Agtini MD, Ochiai RL, et al. Enteric fever burden in North Jakarta, Indonesia: a prospective, community-based study. J Infect Dev Ctries 2013; 7(11): 781-7.",Systematic review,IDN,Indonesia,Tanjung Priok & Koja,57,DKI JAKARTA,2002,0,221,0,0,Salmonella Typhi,Multidrug resistance (MDR)
843,Yanagi (2009),"Yanagi D, de Vries GC, Rahardjo D, et al. Emergence of fluoroquinolone-resistant strains of Salmonella enterica in Surabaya, Indonesia. Diagn Microbiol Infect Dis 2009; 64(4): 422-6.",Systematic review,IDN,Indonesia,Dr. Soetomo General Hospital,44,JAWA TIMUR,2006,0,9,0,0,Salmonella Typhi,Multidrug resistance (MDR)
5133,Alam(2016),"Alam A. Pola resistensi Salmonella enterica Serotipe Typhi, departemen Ilmu Kesehatan anak RSHS, Tahun 2006–2010. Sari Pediatri 2016; 12(5): 296-301.",Systematic review,IDN,Indonesia,Dr. Hasan Sadikin General Hospital,61,JAWA BARAT,2006,0,62,0,0,Salmonella Typhi,Multidrug resistance (MDR)
5133,Alam(2016),"Alam A. Pola resistensi Salmonella enterica Serotipe Typhi, departemen Ilmu Kesehatan anak RSHS, Tahun 2006–2010. Sari Pediatri 2016; 12(5): 296-301.",Systematic review,IDN,Indonesia,Dr. Hasan Sadikin General Hospital,61,JAWA BARAT,2007,0,53,0,0,Salmonella Typhi,Multidrug resistance (MDR)
843,Yanagi (2009),"Yanagi D, de Vries GC, Rahardjo D, et al. Emergence of fluoroquinolone-resistant strains of Salmonella enterica in Surabaya, Indonesia. Diagn Microbiol Infect Dis 2009; 64(4): 422-6.",Systematic review,IDN,Indonesia,Dr. Soetomo General Hospital,44,JAWA TIMUR,2008,3,8,37.5,1,Salmonella Typhi,Multidrug resistance (MDR)
5133,Alam(2016),"Alam A. Pola resistensi Salmonella enterica Serotipe Typhi, departemen Ilmu Kesehatan anak RSHS, Tahun 2006–2010. Sari Pediatri 2016; 12(5): 296-301.",Systematic review,IDN,Indonesia,Dr. Hasan Sadikin General Hospital,61,JAWA BARAT,2008,0,28,0,0,Salmonella Typhi,Multidrug resistance (MDR)
5133,Alam(2016),"Alam A. Pola resistensi Salmonella enterica Serotipe Typhi, departemen Ilmu Kesehatan anak RSHS, Tahun 2006–2010. Sari Pediatri 2016; 12(5): 296-301.",Systematic review,IDN,Indonesia,Dr. Hasan Sadikin General Hospital,61,JAWA BARAT,2009,0,22,0,0,Salmonella Typhi,Multidrug resistance (MDR)
5133,Alam(2016),"Alam A. Pola resistensi Salmonella enterica Serotipe Typhi, departemen Ilmu Kesehatan anak RSHS, Tahun 2006–2010. Sari Pediatri 2016; 12(5): 296-301.",Systematic review,IDN,Indonesia,Dr. Hasan Sadikin General Hospital,61,JAWA BARAT,2010,0,27,0,0,Salmonella Typhi,Multidrug resistance (MDR)
852,Kasper (2010),"Kasper MR, Sokhal B, Blair PJ, Wierzba TF, Putnam SD. Emergence of multidrug-resistant Salmonella enterica serovar Typhi with reduced susceptibility to fluoroquinolones in Cambodia. Diagn Microbiol Infect Dis 2010; 66(2): 207-9.",Systematic review,KHM,Cambodia,Unknown healthcare facilities in Kandal district;Unknown healthcare facilities in Oudong district,84,Kandal,2008,23,41,56.1,0,Salmonella Typhi,Multidrug resistance (MDR)
316,Vlieghe (2012),"Vlieghe ER, Phe T, De Smet B, et al. Azithromycin and ciprofloxacin resistance in Salmonella bloodstream infections in Cambodian adults. PLoS Negl Trop Dis 2012; 6(12): e1933.",Systematic review,KHM,Cambodia,Sihanouk Hospital Center of Hope,92,Phnom Penh,2009,15,20,75,0,Salmonella Typhi,Multidrug resistance (MDR)
891,Ngoun (2012),"Ngoun C, Emary K, Khun PA, et al. Enteric fever in Cambodian children is dominated by multidrug resistant H58 Salmonella enterica serovar Typhi with decreased susceptibility to ciprofloxacin. Int J Infect Dis 2012; 16: e427.",Systematic review,KHM,Cambodia,Angkor Hospital for Children;Angkor Hospital for Children Satellite Clinic,97,Siemreap,2009,126,148,85.1,0,Salmonella Typhi,Multidrug resistance (MDR)
1689,Stoesser (2013),"Stoesser N, Moore CE, Pocock JM, et al. Pediatric bloodstream infections in Cambodia, 2007 to 2011. Pediatr Infect Dis J 2013; 32(7): e272-e6.",Systematic review,KHM,Cambodia,Angkor Hospital for Children;Angkor Hospital for Children Satellite Clinic,97,Siemreap,2009,108,130,83.1,0,Salmonella Typhi,Multidrug resistance (MDR)
2955,Kuijpers (2017),"Kuijpers LMF, Phe T, Veng CH, et al. The clinical and microbiological characteristics of enteric fever in Cambodia, 2008-2015. PLoS Negl Trop Dis 2017; 11(9): e0005964.",Systematic review,KHM,Cambodia,Sihanouk Hospital Center of Hope,92,Phnom Penh,2010,22,35,62.9,0,Salmonella Typhi,Multidrug resistance (MDR)
2809,Chheng (2013),"Chheng K, Carter MJ, Emary K, et al. A prospective study of the causes of febrile illness requiring hospitalization in children in Cambodia. PLoS ONE 2013; 8(4): e60634.",Systematic review,KHM,Cambodia,Angkor Hospital for Children,97,Siemreap,2010,18,21,85.7,0,Salmonella Typhi,Multidrug resistance (MDR)
2955,Kuijpers (2017),"Kuijpers LMF, Phe T, Veng CH, et al. The clinical and microbiological characteristics of enteric fever in Cambodia, 2008-2015. PLoS Negl Trop Dis 2017; 11(9): e0005964.",Systematic review,KHM,Cambodia,Sihanouk Hospital Center of Hope,92,Phnom Penh,2014,5,29,17.2,0,Salmonella Typhi,Multidrug resistance (MDR)
5134,Turner(2019),Turner P. GRAM_data_AHC-COMRU_2015. Cambodia; 2019.,Dataset,KHM,Cambodia,Angkor Hospital for Children,97,Siemreap,2015,25,34,73.5,0,Salmonella Typhi,Multidrug resistance (MDR)
5134,Turner(2019),Turner P. GRAM_data_AHC-COMRU_2015. Cambodia; 2019.,Dataset,KHM,Cambodia,Angkor Hospital for Children Satellite Clinic,97,Siemreap,2015,5,7,71.4,0,Salmonella Typhi,Multidrug resistance (MDR)
5148,Roberts (2019),"Roberts T. LOMRU blood culture database. Vientiene, Laos; 2019",Dataset,LAO,Laos,Mahosot Hospital,117,Vientiane capital,2000,2,36,5.6,0,Salmonella Typhi,Multidrug resistance (MDR)
5148,Roberts (2019),"Roberts T. LOMRU blood culture database. Vientiene, Laos; 2019",Dataset,LAO,Laos,Mahosot Hospital,117,Vientiane capital,2001,6,38,15.8,0,Salmonella Typhi,Multidrug resistance (MDR)
5148,Roberts (2019),"Roberts T. LOMRU blood culture database. Vientiene, Laos; 2019",Dataset,LAO,Laos,Mahosot Hospital,117,Vientiane capital,2002,4,99,4,0,Salmonella Typhi,Multidrug resistance (MDR)
5148,Roberts (2019),"Roberts T. LOMRU blood culture database. Vientiene, Laos; 2019",Dataset,LAO,Laos,Mahosot Hospital,117,Vientiane capital,2003,4,37,10.8,0,Salmonella Typhi,Multidrug resistance (MDR)
5148,Roberts (2019),"Roberts T. LOMRU blood culture database. Vientiene, Laos; 2019",Dataset,LAO,Laos,Mahosot Hospital,117,Vientiane capital,2004,1,31,3.2,0,Salmonella Typhi,Multidrug resistance (MDR)
5148,Roberts (2019),"Roberts T. LOMRU blood culture database. Vientiene, Laos; 2019",Dataset,LAO,Laos,Mahosot Hospital,117,Vientiane capital,2005,0,22,0,0,Salmonella Typhi,Multidrug resistance (MDR)
5148,Roberts (2019),"Roberts T. LOMRU blood culture database. Vientiene, Laos; 2019",Dataset,LAO,Laos,Mahosot Hospital,117,Vientiane capital,2006,0,42,0,0,Salmonella Typhi,Multidrug resistance (MDR)
5148,Roberts (2019),"Roberts T. LOMRU blood culture database. Vientiene, Laos; 2019",Dataset,LAO,Laos,Mahosot Hospital,117,Vientiane capital,2007,0,24,0,0,Salmonella Typhi,Multidrug resistance (MDR)
5148,Roberts (2019),"Roberts T. LOMRU blood culture database. Vientiene, Laos; 2019",Dataset,LAO,Laos,Setthathirath Hospital,117,Vientiane capital,2007,0,5,0,0,Salmonella Typhi,Multidrug resistance (MDR)
5148,Roberts (2019),"Roberts T. LOMRU blood culture database. Vientiene, Laos; 2019",Dataset,LAO,Laos,Mahosot Hospital,117,Vientiane capital,2008,1,34,2.9,0,Salmonella Typhi,Multidrug resistance (MDR)
5148,Roberts (2019),"Roberts T. LOMRU blood culture database. Vientiene, Laos; 2019",Dataset,LAO,Laos,Setthathirath Hospital,117,Vientiane capital,2008,0,5,0,0,Salmonella Typhi,Multidrug resistance (MDR)
434,Mayxay (2013),"Mayxay M, Castonguay-Vanier J, Chansamouth V, et al. Causes of non-malarial fever in Laos: a prospective study. Lancet Glob Health 2013; 1(1): e46-54.",Systematic review,LAO,Laos,Luang Namtha Provincial Hospital,110,Louang-Namtha,2009,0,28,0,0,Salmonella Typhi,Multidrug resistance (MDR)
5148,Roberts (2019),"Roberts T. LOMRU blood culture database. Vientiene, Laos; 2019",Dataset,LAO,Laos,Mahosot Hospital,117,Vientiane capital,2009,1,31,3.2,0,Salmonella Typhi,Multidrug resistance (MDR)
5148,Roberts (2019),"Roberts T. LOMRU blood culture database. Vientiene, Laos; 2019",Dataset,LAO,Laos,Setthathirath Hospital,117,Vientiane capital,2009,0,7,0,0,Salmonella Typhi,Multidrug resistance (MDR)
5148,Roberts (2019),"Roberts T. LOMRU blood culture database. Vientiene, Laos; 2019",Dataset,LAO,Laos,Mahosot Hospital,117,Vientiane capital,2010,0,28,0,0,Salmonella Typhi,Multidrug resistance (MDR)
5148,Roberts (2019),"Roberts T. LOMRU blood culture database. Vientiene, Laos; 2019",Dataset,LAO,Laos,Mahosot Hospital,117,Vientiane capital,2011,0,15,0,0,Salmonella Typhi,Multidrug resistance (MDR)
5148,Roberts (2019),"Roberts T. LOMRU blood culture database. Vientiene, Laos; 2019",Dataset,LAO,Laos,Mahosot Hospital,117,Vientiane capital,2012,0,8,0,0,Salmonella Typhi,Multidrug resistance (MDR)
5148,Roberts (2019),"Roberts T. LOMRU blood culture database. Vientiene, Laos; 2019",Dataset,LAO,Laos,Mahosot Hospital,117,Vientiane capital,2013,0,26,0,0,Salmonella Typhi,Multidrug resistance (MDR)
5148,Roberts (2019),"Roberts T. LOMRU blood culture database. Vientiene, Laos; 2019",Dataset,LAO,Laos,Setthathirath Hospital,117,Vientiane capital,2013,1,5,20,1,Salmonella Typhi,Multidrug resistance (MDR)
5148,Roberts (2019),"Roberts T. LOMRU blood culture database. Vientiene, Laos; 2019",Dataset,LAO,Laos,Mahosot Hospital,117,Vientiane capital,2014,0,26,0,0,Salmonella Typhi,Multidrug resistance (MDR)
5148,Roberts (2019),"Roberts T. LOMRU blood culture database. Vientiene, Laos; 2019",Dataset,LAO,Laos,Mahosot Hospital,117,Vientiane capital,2015,0,9,0,0,Salmonella Typhi,Multidrug resistance (MDR)
5148,Roberts (2019),"Roberts T. LOMRU blood culture database. Vientiene, Laos; 2019",Dataset,LAO,Laos,Mahosot Hospital,117,Vientiane capital,2016,0,21,0,0,Salmonella Typhi,Multidrug resistance (MDR)
5148,Roberts (2019),"Roberts T. LOMRU blood culture database. Vientiene, Laos; 2019",Dataset,LAO,Laos,Mahosot Hospital,117,Vientiane capital,2017,0,7,0,0,Salmonella Typhi,Multidrug resistance (MDR)
5148,Roberts (2019),"Roberts T. LOMRU blood culture database. Vientiene, Laos; 2019",Dataset,LAO,Laos,Mahosot Hospital,117,Vientiane capital,2018,0,20,0,0,Salmonella Typhi,Multidrug resistance (MDR)
2033,Karunaratne(2000),"Karunaratne GK, Wickremesinghe RS, Perera KC. Salmonella Typhi and chloramphenicol resistance. Ceylon Med J 2000; 45(3): 136-7.",Systematic review,LKA,Sri Lanka,Medical Research Institute,128,Western,1998,20,72,27.8,0,Salmonella Typhi,Multidrug resistance (MDR)
2033,Karunaratne(2000),"Karunaratne GK, Wickremesinghe RS, Perera KC. Salmonella Typhi and chloramphenicol resistance. Ceylon Med J 2000; 45(3): 136-7.",Systematic review,LKA,Sri Lanka,Medical Research Institute,128,Western,1999,40,149,26.8,0,Salmonella Typhi,Multidrug resistance (MDR)
2188,Chuang(2009),"Chuang CH, Su LH, Perera J, et al. Surveillance of antimicrobial resistance of Salmonella enterica serotype Typhi in seven Asian countries. Epidemiol Infect 2009; 137(2): 266-9.",Systematic review,LKA,Sri Lanka,National Hospital of Sri Lanka,128,Western,2003,1,17,5.9,0,Salmonella Typhi,Multidrug resistance (MDR)
390,Shwe (2002),"Shwe TN, Nyein MM, Yi W, Mon A. Blood culture isolates from children admitted to Medical Unit III, Yangon Children's Hospital, 1998. Southeast Asian J Trop Med Public Health 2002; 33(4): 764-71.",Systematic review,MMR,Myanmar,Yangon Children's Hospital,134,Yangon Division,1999,24,28,85.7,0,Salmonella Typhi,Multidrug resistance (MDR)
3715,Tunung(2007),"Tunung R, Chai LC, Usha MR, et al. Incidence and characterization of Salmonella species in street food and clinical samples. Journal of Food Safety 2007; 27(4): 345-61.",Systematic review,MYS,Malaysia,Unknown hospital in Klang,170,Selangor,2004,1,8,12.5,0,Salmonella Typhi,Multidrug resistance (MDR)
388,Abucejo (2001),"Abucejo PE, Capeding MR, Lupisan SP, et al. Blood culture confirmed typhoid fever in a provincial hospital in the Philippines. Southeast Asian J Trop Med Public Health 2001; 32(3): 531-6.",Systematic review,PHL,Philippines,Governor Celestino Gallares Memorial Hospital,181,Region VII (Central Visayas),1996,0,422,0,0,Salmonella Typhi,Multidrug resistance (MDR)
2188,Chuang(2009),"Chuang CH, Su LH, Perera J, et al. Surveillance of antimicrobial resistance of Salmonella enterica serotype Typhi in seven Asian countries. Epidemiol Infect 2009; 137(2): 266-9.",Systematic review,PHL,Philippines,Research Institute for Tropical Medicine,176,National Capital region (NCR),2003,0,28,0,0,Salmonella Typhi,Multidrug resistance (MDR)
3394,Komolpis (1999),"Komolpis P, Srifuengfung S, Dhiraputra C, Pingwang B. Salmonella bacteremia: serotype distribution and antimicrobial susceptibility during 1991-1995. Journal of Infectious Diseases and Antimicrobial Agents 1999; 16(2): 49-52.",Systematic review,THA,Thailand,Siriraj Hospital,236,Bangkok,1993,2,16,12.5,0,Salmonella Typhi,Multidrug resistance (MDR)
2413,Limpitikul (2014),"Limpitikul W, Henpraserttae N, Saksawad R, Laoprasopwattana K. Typhoid outbreak in Songkhla, Thailand 2009-2011: Clinical outcomes, susceptibility patterns, and reliability of serology tests. PLoS ONE 2014; 9(11).",Systematic review,THA,Thailand,Hat Yai Hospital,296,Songkhla,2010,0,8,0,0,Salmonella Typhi,Multidrug resistance (MDR)
2413,Limpitikul (2014),"Limpitikul W, Henpraserttae N, Saksawad R, Laoprasopwattana K. Typhoid outbreak in Songkhla, Thailand 2009-2011: Clinical outcomes, susceptibility patterns, and reliability of serology tests. PLoS ONE 2014; 9(11).",Systematic review,THA,Thailand,Songklanagarind Hospital,296,Songkhla,2010,0,27,0,0,Salmonella Typhi,Multidrug resistance (MDR)
2413,Limpitikul (2014),"Limpitikul W, Henpraserttae N, Saksawad R, Laoprasopwattana K. Typhoid outbreak in Songkhla, Thailand 2009-2011: Clinical outcomes, susceptibility patterns, and reliability of serology tests. PLoS ONE 2014; 9(11).",Systematic review,THA,Thailand,Songkhla Hospital,296,Songkhla,2010,0,333,0,0,Salmonella Typhi,Multidrug resistance (MDR)
1426,Wain(2003),"Wain J, Diem Nga LT, Kidgell C, et al. Molecular analysis of incHI1 antimicrobial resistance plasmids from Salmonella serovar Typhi strains associated with typhoid fever. Antimicrob Agents Chemother 2003; 47(9): 2732-9.",Systematic review,VNM,Vietnam,Centre for Tropical Diseases,328,Ho Chi Minh,1990,2,100,2,1,Salmonella Typhi,Multidrug resistance (MDR)
1447,Ling(2000),"Ling JM, Lo NW, Ho YM, et al. Molecular methods for the epidemiological typing of Salmonella enterica serotype Typhi from Hong Kong and Vietnam. J Clin Microbiol 2000; 38(1): 292-300.",Systematic review,VNM,Vietnam,Centre for Tropical Diseases;Cho Quan Hospital,328,Ho Chi Minh,1990,0,73,0,1,Salmonella Typhi,Multidrug resistance (MDR)
1426,Wain(2003),"Wain J, Diem Nga LT, Kidgell C, et al. Molecular analysis of incHI1 antimicrobial resistance plasmids from Salmonella serovar Typhi strains associated with typhoid fever. Antimicrob Agents Chemother 2003; 47(9): 2732-9.",Systematic review,VNM,Vietnam,Centre for Tropical Diseases,328,Ho Chi Minh,1992,35,128,27.3,1,Salmonella Typhi,Multidrug resistance (MDR)
651,Smith(1994),"Smith MD, Duong NM, Hoa NTT, et al. Comparison of ofloxacin and ceftriaxone for short-course treatment of enteric fever. Antimicrob Agents Chemother 1994; 38(8): 1716-20.",Systematic review,VNM,Vietnam,Centre for Tropical Diseases,328,Ho Chi Minh,1993,26,41,63.4,0,Salmonella Typhi,Multidrug resistance (MDR)
1426,Wain(2003),"Wain J, Diem Nga LT, Kidgell C, et al. Molecular analysis of incHI1 antimicrobial resistance plasmids from Salmonella serovar Typhi strains associated with typhoid fever. Antimicrob Agents Chemother 2003; 47(9): 2732-9.",Systematic review,VNM,Vietnam,Centre for Tropical Diseases,328,Ho Chi Minh,1993,117,195,60,0,Salmonella Typhi,Multidrug resistance (MDR)
1859,Hien (1994),"Hien TT, Duong NM, Ha HD, et al. A randomized comparative study of fleroxacin and ceftriaxone in enteric fever. Trans R Soc Trop Med Hyg 1994; 88(4): 464-5.",Systematic review,VNM,Vietnam,Centre for Tropical Diseases;Cho Quan Hospital,328,Ho Chi Minh,1993,12,27,44.4,0,Salmonella Typhi,Multidrug resistance (MDR)
2124,Hien (1995),"Hien TT, Bethell DB, Hoa NTT, et al. Short course of ofloxacin for treatment of multidrug-resistant typhoid. Clin Infect Dis 1995; 20(4): 917-23.",Systematic review,VNM,Vietnam,Dong Hoa & Dong Thanh,369,Kien Giang,1993,190.01,207,91.8,0,Salmonella Typhi,Multidrug resistance (MDR)
621,Hoa (1998),"Hoa NTT, Diep TS, Wain J, et al. Community-acquired septicaemia in southern Viet Nam: The importance of multidrug-resistant Salmonella Typhi. Trans R Soc Trop Med Hyg 1998; 92(5): 503-8.",Systematic review,VNM,Vietnam,Centre for Tropical Diseases,328,Ho Chi Minh,1994,206,294,70.1,0,Salmonella Typhi,Multidrug resistance (MDR)
1426,Wain(2003),"Wain J, Diem Nga LT, Kidgell C, et al. Molecular analysis of incHI1 antimicrobial resistance plasmids from Salmonella serovar Typhi strains associated with typhoid fever. Antimicrob Agents Chemother 2003; 47(9): 2732-9.",Systematic review,VNM,Vietnam,Centre for Tropical Diseases,328,Ho Chi Minh,1994,311,414,75.1,0,Salmonella Typhi,Multidrug resistance (MDR)
2126,Chinh (1997),"Chinh NT, Solomon T, Thong MX, et al. Short courses of ofloxacin for the treatment of enteric fever. Trans R Soc Trop Med Hyg 1997; 91(3): 347-9.",Systematic review,VNM,Vietnam,Centre for Tropical Diseases;Cho Quan Hospital,328,Ho Chi Minh,1994,75,95,78.9,0,Salmonella Typhi,Multidrug resistance (MDR)
3145,Ly (1998),"Ly N, Chinh N, Parry C, Diep T, Wain J, White N. Randomised trial of azithromycin versus ofloxacin for the treatment of typhoid fever in adult. Med J Indones 1998; 7: 202-6.",Systematic review,VNM,Vietnam,Centre for Tropical Diseases,328,Ho Chi Minh,1994,17,26,65.4,0,Salmonella Typhi,Multidrug resistance (MDR)
4065,Nga (2012),"Nga TVT, Parry CM, Le T, et al. The decline of typhoid and the rise of non-typhoid Salmonellae and fungal infections in a changing HIV landscape: Bloodstream infection trends over 15 years in southern Vietnam. Trans R Soc Trop Med Hyg 2012; 106(1): 26-34.",Systematic review,VNM,Vietnam,Centre for Tropical Diseases,328,Ho Chi Minh,1994,410,497,82.5,0,Salmonella Typhi,Multidrug resistance (MDR)
1426,Wain(2003),"Wain J, Diem Nga LT, Kidgell C, et al. Molecular analysis of incHI1 antimicrobial resistance plasmids from Salmonella serovar Typhi strains associated with typhoid fever. Antimicrob Agents Chemother 2003; 47(9): 2732-9.",Systematic review,VNM,Vietnam,Centre for Tropical Diseases,328,Ho Chi Minh,1995,618,692,89.3,0,Salmonella Typhi,Multidrug resistance (MDR)
1831,Wain (1998),"Wain J, Diep TS, Ho VA, et al. Quantitation of bacteria in blood of typhoid fever patients and relationship between counts and clinical features, transmissibility, and antibiotic resistance. J Clin Microbiol 1998; 36(6): 1683-7.",Systematic review,VNM,Vietnam,Centre for Tropical Diseases,328,Ho Chi Minh,1995,313,375,83.5,0,Salmonella Typhi,Multidrug resistance (MDR)
4065,Nga (2012),"Nga TVT, Parry CM, Le T, et al. The decline of typhoid and the rise of non-typhoid Salmonellae and fungal infections in a changing HIV landscape: Bloodstream infection trends over 15 years in southern Vietnam. Trans R Soc Trop Med Hyg 2012; 106(1): 26-34.",Systematic review,VNM,Vietnam,Centre for Tropical Diseases,328,Ho Chi Minh,1995,659,716,92,0,Salmonella Typhi,Multidrug resistance (MDR)
640,Vinh (2005),"Vinh H, Duong NM, Phuong le T, et al. Comparative trial of short-course ofloxacin for uncomplicated typhoid fever in Vietnamese children. Ann Trop Paediatr 2005; 25(1): 17-22.",Systematic review,VNM,Vietnam,Dong Thap Provincial Hospital,360,Dong Thap,1995,182,202,90.1,0,Salmonella Typhi,Multidrug resistance (MDR)
272,Nguyen Dac(2007),"Nguyen Dac T, Suthisarnsuntorn U, Kalambaheti T, Wonglumsom W, Tunyong W. Antimicrobial susceptibility patterns and phage types of Salmonella Typhi from Vietnam. Southeast Asian J Trop Med Public Health 2007; 38(3): 487-92.",Systematic review,VNM,Vietnam,National Hospital (HCMC),328,Ho Chi Minh,1996,9,14,64.3,0,Salmonella Typhi,Multidrug resistance (MDR)
1426,Wain(2003),"Wain J, Diem Nga LT, Kidgell C, et al. Molecular analysis of incHI1 antimicrobial resistance plasmids from Salmonella serovar Typhi strains associated with typhoid fever. Antimicrob Agents Chemother 2003; 47(9): 2732-9.",Systematic review,VNM,Vietnam,Centre for Tropical Diseases,328,Ho Chi Minh,1996,243,311,78.1,0,Salmonella Typhi,Multidrug resistance (MDR)
1861,Chinh (2000),"Chinh NT, Parry CM, Ly NT, et al. A randomized controlled comparison of azithromycin and ofloxacin for treatment of multidrug-resistant or nalidixic acid-resistant enteric fever. Antimicrob Agents Chemother 2000; 44(7): 1855-9.",Systematic review,VNM,Vietnam,Centre for Tropical Diseases,328,Ho Chi Minh,1996,68,86,79.1,0,Salmonella Typhi,Multidrug resistance (MDR)
4065,Nga (2012),"Nga TVT, Parry CM, Le T, et al. The decline of typhoid and the rise of non-typhoid Salmonellae and fungal infections in a changing HIV landscape: Bloodstream infection trends over 15 years in southern Vietnam. Trans R Soc Trop Med Hyg 2012; 106(1): 26-34.",Systematic review,VNM,Vietnam,Centre for Tropical Diseases,328,Ho Chi Minh,1996,293,357,82.1,0,Salmonella Typhi,Multidrug resistance (MDR)
1832,Wain (2001),"Wain J, Bay PVB, Vinh H, et al. Quantitation of bacteria in bone marrow from patients with typhoid fever: Relationship between counts and clinical features. J Clin Microbiol 2001; 39(4): 1571-6.",Systematic review,VNM,Vietnam,Dong Thap Provincial Hospital,360,Dong Thap,1996,83,89,93.3,0,Salmonella Typhi,Multidrug resistance (MDR)
272,Nguyen Dac(2007),"Nguyen Dac T, Suthisarnsuntorn U, Kalambaheti T, Wonglumsom W, Tunyong W. Antimicrobial susceptibility patterns and phage types of Salmonella Typhi from Vietnam. Southeast Asian J Trop Med Public Health 2007; 38(3): 487-92.",Systematic review,VNM,Vietnam,National Hospital (Hanoi),368,Ha Noi,1996,38,52,73.1,0,Salmonella Typhi,Multidrug resistance (MDR)
272,Nguyen Dac(2007),"Nguyen Dac T, Suthisarnsuntorn U, Kalambaheti T, Wonglumsom W, Tunyong W. Antimicrobial susceptibility patterns and phage types of Salmonella Typhi from Vietnam. Southeast Asian J Trop Med Public Health 2007; 38(3): 487-92.",Systematic review,VNM,Vietnam,National Hospital (Hue),373,Thua Thien Hue,1996,37,45,82.2,0,Salmonella Typhi,Multidrug resistance (MDR)
636,Phuong (1999),"Phuong CXT, Kneen R, Anh NT, Luat TD, White NJ, Parry CM. A comparative study of ofloxacin and cefixime for treatment of typhoid fever in children. Pediatr Infect Dis J 1999; 18(3): 245-8.",Systematic review,VNM,Vietnam,Dong Nai Pediatric Centre,374,Dong Nai,1996,70,82,85.4,0,Salmonella Typhi,Multidrug resistance (MDR)
4065,Nga (2012),"Nga TVT, Parry CM, Le T, et al. The decline of typhoid and the rise of non-typhoid Salmonellae and fungal infections in a changing HIV landscape: Bloodstream infection trends over 15 years in southern Vietnam. Trans R Soc Trop Med Hyg 2012; 106(1): 26-34.",Systematic review,VNM,Vietnam,Centre for Tropical Diseases,328,Ho Chi Minh,1997,261,346,75.4,0,Salmonella Typhi,Multidrug resistance (MDR)
4065,Nga (2012),"Nga TVT, Parry CM, Le T, et al. The decline of typhoid and the rise of non-typhoid Salmonellae and fungal infections in a changing HIV landscape: Bloodstream infection trends over 15 years in southern Vietnam. Trans R Soc Trop Med Hyg 2012; 106(1): 26-34.",Systematic review,VNM,Vietnam,Centre for Tropical Diseases,328,Ho Chi Minh,1998,527,599,88,0,Salmonella Typhi,Multidrug resistance (MDR)
4065,Nga (2012),"Nga TVT, Parry CM, Le T, et al. The decline of typhoid and the rise of non-typhoid Salmonellae and fungal infections in a changing HIV landscape: Bloodstream infection trends over 15 years in southern Vietnam. Trans R Soc Trop Med Hyg 2012; 106(1): 26-34.",Systematic review,VNM,Vietnam,Centre for Tropical Diseases,328,Ho Chi Minh,1999,115,171,67.3,0,Salmonella Typhi,Multidrug resistance (MDR)
4065,Nga (2012),"Nga TVT, Parry CM, Le T, et al. The decline of typhoid and the rise of non-typhoid Salmonellae and fungal infections in a changing HIV landscape: Bloodstream infection trends over 15 years in southern Vietnam. Trans R Soc Trop Med Hyg 2012; 106(1): 26-34.",Systematic review,VNM,Vietnam,Centre for Tropical Diseases,328,Ho Chi Minh,2000,41,96,42.7,0,Salmonella Typhi,Multidrug resistance (MDR)
1862,Parry(2007),"Parry CM, Ho VA, Phuong le T, et al. Randomized controlled comparison of ofloxacin, azithromycin, and an ofloxacin-azithromycin combination for treatment of multidrug-resistant and nalidixic acid-resistant typhoid fever. Antimicrob Agents Chemother 2007; 51(3): 819-25.",Systematic review,VNM,Vietnam,Dong Thap Provincial Hospital,360,Dong Thap,2000,165,187,88.2,0,Salmonella Typhi,Multidrug resistance (MDR)
4065,Nga (2012),"Nga TVT, Parry CM, Le T, et al. The decline of typhoid and the rise of non-typhoid Salmonellae and fungal infections in a changing HIV landscape: Bloodstream infection trends over 15 years in southern Vietnam. Trans R Soc Trop Med Hyg 2012; 106(1): 26-34.",Systematic review,VNM,Vietnam,Centre for Tropical Diseases,328,Ho Chi Minh,2001,45,80,56.3,0,Salmonella Typhi,Multidrug resistance (MDR)
4065,Nga (2012),"Nga TVT, Parry CM, Le T, et al. The decline of typhoid and the rise of non-typhoid Salmonellae and fungal infections in a changing HIV landscape: Bloodstream infection trends over 15 years in southern Vietnam. Trans R Soc Trop Med Hyg 2012; 106(1): 26-34.",Systematic review,VNM,Vietnam,Centre for Tropical Diseases,328,Ho Chi Minh,2002,65,91,71.4,0,Salmonella Typhi,Multidrug resistance (MDR)
2188,Chuang(2009),"Chuang CH, Su LH, Perera J, et al. Surveillance of antimicrobial resistance of Salmonella enterica serotype Typhi in seven Asian countries. Epidemiol Infect 2009; 137(2): 266-9.",Systematic review,VNM,Vietnam,University Hospital (HCMC),328,Ho Chi Minh,2003,75,102,73.5,0,Salmonella Typhi,Multidrug resistance (MDR)
4065,Nga (2012),"Nga TVT, Parry CM, Le T, et al. The decline of typhoid and the rise of non-typhoid Salmonellae and fungal infections in a changing HIV landscape: Bloodstream infection trends over 15 years in southern Vietnam. Trans R Soc Trop Med Hyg 2012; 106(1): 26-34.",Systematic review,VNM,Vietnam,Centre for Tropical Diseases,328,Ho Chi Minh,2003,29,49,59.2,0,Salmonella Typhi,Multidrug resistance (MDR)
2180,Ochiai (2008),"Ochiai RL, Acosta CJ, Danovaro-Holliday MC, et al. A study of typhoid fever in five Asian countries: Disease burden and implications for controls. Bull World Health Organ 2008; 86(4): 260-8.",Systematic review,VNM,Vietnam,Hue,373,Thua Thien Hue,2003,4,18,22.2,0,Salmonella Typhi,Multidrug resistance (MDR)
4065,Nga (2012),"Nga TVT, Parry CM, Le T, et al. The decline of typhoid and the rise of non-typhoid Salmonellae and fungal infections in a changing HIV landscape: Bloodstream infection trends over 15 years in southern Vietnam. Trans R Soc Trop Med Hyg 2012; 106(1): 26-34.",Systematic review,VNM,Vietnam,Centre for Tropical Diseases,328,Ho Chi Minh,2004,31,52,59.6,0,Salmonella Typhi,Multidrug resistance (MDR)
4065,Nga (2012),"Nga TVT, Parry CM, Le T, et al. The decline of typhoid and the rise of non-typhoid Salmonellae and fungal infections in a changing HIV landscape: Bloodstream infection trends over 15 years in southern Vietnam. Trans R Soc Trop Med Hyg 2012; 106(1): 26-34.",Systematic review,VNM,Vietnam,Centre for Tropical Diseases,328,Ho Chi Minh,2005,14,30,46.7,0,Salmonella Typhi,Multidrug resistance (MDR)
4065,Nga (2012),"Nga TVT, Parry CM, Le T, et al. The decline of typhoid and the rise of non-typhoid Salmonellae and fungal infections in a changing HIV landscape: Bloodstream infection trends over 15 years in southern Vietnam. Trans R Soc Trop Med Hyg 2012; 106(1): 26-34.",Systematic review,VNM,Vietnam,Centre for Tropical Diseases,328,Ho Chi Minh,2006,8,20,40,0,Salmonella Typhi,Multidrug resistance (MDR)
4065,Nga (2012),"Nga TVT, Parry CM, Le T, et al. The decline of typhoid and the rise of non-typhoid Salmonellae and fungal infections in a changing HIV landscape: Bloodstream infection trends over 15 years in southern Vietnam. Trans R Soc Trop Med Hyg 2012; 106(1): 26-34.",Systematic review,VNM,Vietnam,Centre for Tropical Diseases,328,Ho Chi Minh,2007,7,40,17.5,0,Salmonella Typhi,Multidrug resistance (MDR)
4065,Nga (2012),"Nga TVT, Parry CM, Le T, et al. The decline of typhoid and the rise of non-typhoid Salmonellae and fungal infections in a changing HIV landscape: Bloodstream infection trends over 15 years in southern Vietnam. Trans R Soc Trop Med Hyg 2012; 106(1): 26-34.",Systematic review,VNM,Vietnam,Centre for Tropical Diseases,328,Ho Chi Minh,2008,6,34,17.6,0,Salmonella Typhi,Multidrug resistance (MDR)
705,Rahman (2002),"Rahman M, Ahmad A, Shoma S. Decline in epidemic of multidrug resistant Salmonella Typhi is not associated with increased incidence of antibiotic-susceptible strain in Bangladesh. Epidemiol Infect 2002; 129(1): 29-34.",Systematic review,BGD,Bangladesh,ICDDR,823,Dhaka,1990,8,99,8.1,0,Salmonella Typhi,Multidrug resistance (MDR)
849,Rahman (2006),"Rahman M, Siddique AK, Shoma S, et al. Emergence of multidrug-resistant Salmonella enterica serotype Typhi with decreased ciprofloxacin susceptibility in Bangladesh. Epidemiol Infect 2006; 134(2): 433-8.",Systematic review,BGD,Bangladesh,ICDDR,823,Dhaka,1990,8,99,8.1,0,Salmonella Typhi,Multidrug resistance (MDR)
1518,Albert(1991),"Albert MJ, Haider K, Nahar S, Kibriya AKMG, Hossain MA. Multiresistant Salmonella Typhi in Bangladesh [4]. J Antimicrob Chemother 1991; 27(4): 554-5.",Systematic review,BGD,Bangladesh,ICDDR,823,Dhaka,1990,16,106,15.1,0,Salmonella Typhi,Multidrug resistance (MDR)
137,Saha (1994),Saha SK. Antibiotic resistance of Salmonella Typhi in Bangladesh. J Antimicrob Chemother 1994; 33(1): 190-1.,Systematic review,BGD,Bangladesh,Dhaka Shishu Hospital,823,Dhaka,1991,138,236,58.5,0,Salmonella Typhi,Multidrug resistance (MDR)
705,Rahman (2002),"Rahman M, Ahmad A, Shoma S. Decline in epidemic of multidrug resistant Salmonella Typhi is not associated with increased incidence of antibiotic-susceptible strain in Bangladesh. Epidemiol Infect 2002; 129(1): 29-34.",Systematic review,BGD,Bangladesh,ICDDR,823,Dhaka,1991,60,231,26,0,Salmonella Typhi,Multidrug resistance (MDR)
849,Rahman (2006),"Rahman M, Siddique AK, Shoma S, et al. Emergence of multidrug-resistant Salmonella enterica serotype Typhi with decreased ciprofloxacin susceptibility in Bangladesh. Epidemiol Infect 2006; 134(2): 433-8.",Systematic review,BGD,Bangladesh,ICDDR,823,Dhaka,1991,72,231,31.2,0,Salmonella Typhi,Multidrug resistance (MDR)
705,Rahman (2002),"Rahman M, Ahmad A, Shoma S. Decline in epidemic of multidrug resistant Salmonella Typhi is not associated with increased incidence of antibiotic-susceptible strain in Bangladesh. Epidemiol Infect 2002; 129(1): 29-34.",Systematic review,BGD,Bangladesh,ICDDR,823,Dhaka,1992,126,309,40.8,0,Salmonella Typhi,Multidrug resistance (MDR)
849,Rahman (2006),"Rahman M, Siddique AK, Shoma S, et al. Emergence of multidrug-resistant Salmonella enterica serotype Typhi with decreased ciprofloxacin susceptibility in Bangladesh. Epidemiol Infect 2006; 134(2): 433-8.",Systematic review,BGD,Bangladesh,ICDDR,823,Dhaka,1992,127,309,41.1,0,Salmonella Typhi,Multidrug resistance (MDR)
1877,Hoque(1992),"Hoque SS, Alam AN, Islam MR, Khan MR. Recent advances in the treatment of typhoid: With special emphasis on multidrug resistant Salmonella Typhi in Bangladesh. Bangladesh J Child Health 1992; 16(1-2): 15-9.",Systematic review,BGD,Bangladesh,ICDDR,823,Dhaka,1992,182.68,475,38.5,0,Salmonella Typhi,Multidrug resistance (MDR)
705,Rahman (2002),"Rahman M, Ahmad A, Shoma S. Decline in epidemic of multidrug resistant Salmonella Typhi is not associated with increased incidence of antibiotic-susceptible strain in Bangladesh. Epidemiol Infect 2002; 129(1): 29-34.",Systematic review,BGD,Bangladesh,ICDDR,823,Dhaka,1993,191,479,39.9,0,Salmonella Typhi,Multidrug resistance (MDR)
849,Rahman (2006),"Rahman M, Siddique AK, Shoma S, et al. Emergence of multidrug-resistant Salmonella enterica serotype Typhi with decreased ciprofloxacin susceptibility in Bangladesh. Epidemiol Infect 2006; 134(2): 433-8.",Systematic review,BGD,Bangladesh,ICDDR,823,Dhaka,1993,192,479,40.1,0,Salmonella Typhi,Multidrug resistance (MDR)
705,Rahman (2002),"Rahman M, Ahmad A, Shoma S. Decline in epidemic of multidrug resistant Salmonella Typhi is not associated with increased incidence of antibiotic-susceptible strain in Bangladesh. Epidemiol Infect 2002; 129(1): 29-34.",Systematic review,BGD,Bangladesh,ICDDR,823,Dhaka,1994,240,547,43.9,0,Salmonella Typhi,Multidrug resistance (MDR)
717,Saha (1997),"Saha SK, Saha S, Ruhulamin M, Hanif M, Islam M. Decreasing trend of multiresistant Salmonella Typhi in Bangladesh. J Antimicrob Chemother 1997; 39(4): 554-6.",Systematic review,BGD,Bangladesh,Dhaka Shishu Hospital;Popular Diagnostic Center,823,Dhaka,1994,127,273,46.5,0,Salmonella Typhi,Multidrug resistance (MDR)
849,Rahman (2006),"Rahman M, Siddique AK, Shoma S, et al. Emergence of multidrug-resistant Salmonella enterica serotype Typhi with decreased ciprofloxacin susceptibility in Bangladesh. Epidemiol Infect 2006; 134(2): 433-8.",Systematic review,BGD,Bangladesh,ICDDR,823,Dhaka,1994,241,547,44.1,0,Salmonella Typhi,Multidrug resistance (MDR)
717,Saha (1997),"Saha SK, Saha S, Ruhulamin M, Hanif M, Islam M. Decreasing trend of multiresistant Salmonella Typhi in Bangladesh. J Antimicrob Chemother 1997; 39(4): 554-6.",Systematic review,BGD,Bangladesh,Dhaka Shishu Hospital,823,Dhaka,1994,42,59,71.2,0,Salmonella Typhi,Multidrug resistance (MDR)
717,Saha (1997),"Saha SK, Saha S, Ruhulamin M, Hanif M, Islam M. Decreasing trend of multiresistant Salmonella Typhi in Bangladesh. J Antimicrob Chemother 1997; 39(4): 554-6.",Systematic review,BGD,Bangladesh,Popular Diagnostic Center,823,Dhaka,1994,86.99,214,40.6,0,Salmonella Typhi,Multidrug resistance (MDR)
705,Rahman (2002),"Rahman M, Ahmad A, Shoma S. Decline in epidemic of multidrug resistant Salmonella Typhi is not associated with increased incidence of antibiotic-susceptible strain in Bangladesh. Epidemiol Infect 2002; 129(1): 29-34.",Systematic review,BGD,Bangladesh,ICDDR,823,Dhaka,1995,165,582,28.4,0,Salmonella Typhi,Multidrug resistance (MDR)
717,Saha (1997),"Saha SK, Saha S, Ruhulamin M, Hanif M, Islam M. Decreasing trend of multiresistant Salmonella Typhi in Bangladesh. J Antimicrob Chemother 1997; 39(4): 554-6.",Systematic review,BGD,Bangladesh,Dhaka Shishu Hospital,823,Dhaka,1995,57,193,29.5,0,Salmonella Typhi,Multidrug resistance (MDR)
849,Rahman (2006),"Rahman M, Siddique AK, Shoma S, et al. Emergence of multidrug-resistant Salmonella enterica serotype Typhi with decreased ciprofloxacin susceptibility in Bangladesh. Epidemiol Infect 2006; 134(2): 433-8.",Systematic review,BGD,Bangladesh,ICDDR,823,Dhaka,1995,169,582,29,0,Salmonella Typhi,Multidrug resistance (MDR)
2795,Hermans (1996),"Hermans PW, Saha SK, van Leeuwen WJ, Verbrugh HA, van Belkum A, Goessens WH. Molecular typing of Salmonella Typhi strains from Dhaka (Bangladesh) and development of DNA probes identifying plasmid-encoded multidrug-resistant isolates. J Clin Microbiol 1996; 34(6): 1373-9.",Systematic review,BGD,Bangladesh,Dhaka,823,Dhaka,1995,50,78,64.1,0,Salmonella Typhi,Multidrug resistance (MDR)
717,Saha (1997),"Saha SK, Saha S, Ruhulamin M, Hanif M, Islam M. Decreasing trend of multiresistant Salmonella Typhi in Bangladesh. J Antimicrob Chemother 1997; 39(4): 554-6.",Systematic review,BGD,Bangladesh,Popular Diagnostic Center,823,Dhaka,1995,43.01,141,30.5,0,Salmonella Typhi,Multidrug resistance (MDR)
708,Asna (2000),"Asna SMZH, Ashraful Haq J. Decrease of antibiotic resistance in Salmonella Typhi isolated from patients attending hospitals of Dhaka City over a 3 year period. Int J Antimicrob Agents 2000; 16(3): 249-51.",Systematic review,BGD,Bangladesh,Unknown hospitals in Dhaka,823,Dhaka,1996,28,47,59.6,0,Salmonella Typhi,Multidrug resistance (MDR)
705,Rahman (2002),"Rahman M, Ahmad A, Shoma S. Decline in epidemic of multidrug resistant Salmonella Typhi is not associated with increased incidence of antibiotic-susceptible strain in Bangladesh. Epidemiol Infect 2002; 129(1): 29-34.",Systematic review,BGD,Bangladesh,ICDDR,823,Dhaka,1996,82,375,21.9,0,Salmonella Typhi,Multidrug resistance (MDR)
717,Saha (1997),"Saha SK, Saha S, Ruhulamin M, Hanif M, Islam M. Decreasing trend of multiresistant Salmonella Typhi in Bangladesh. J Antimicrob Chemother 1997; 39(4): 554-6.",Systematic review,BGD,Bangladesh,Dhaka Shishu Hospital;Popular Diagnostic Center,823,Dhaka,1996,18,101,17.8,0,Salmonella Typhi,Multidrug resistance (MDR)
849,Rahman (2006),"Rahman M, Siddique AK, Shoma S, et al. Emergence of multidrug-resistant Salmonella enterica serotype Typhi with decreased ciprofloxacin susceptibility in Bangladesh. Epidemiol Infect 2006; 134(2): 433-8.",Systematic review,BGD,Bangladesh,ICDDR,823,Dhaka,1996,82,375,21.9,0,Salmonella Typhi,Multidrug resistance (MDR)
717,Saha (1997),"Saha SK, Saha S, Ruhulamin M, Hanif M, Islam M. Decreasing trend of multiresistant Salmonella Typhi in Bangladesh. J Antimicrob Chemother 1997; 39(4): 554-6.",Systematic review,BGD,Bangladesh,Dhaka Shishu Hospital,823,Dhaka,1996,4,12,33.3,0,Salmonella Typhi,Multidrug resistance (MDR)
717,Saha (1997),"Saha SK, Saha S, Ruhulamin M, Hanif M, Islam M. Decreasing trend of multiresistant Salmonella Typhi in Bangladesh. J Antimicrob Chemother 1997; 39(4): 554-6.",Systematic review,BGD,Bangladesh,Popular Diagnostic Center,823,Dhaka,1996,15,89,16.9,0,Salmonella Typhi,Multidrug resistance (MDR)
708,Asna (2000),"Asna SMZH, Ashraful Haq J. Decrease of antibiotic resistance in Salmonella Typhi isolated from patients attending hospitals of Dhaka City over a 3 year period. Int J Antimicrob Agents 2000; 16(3): 249-51.",Systematic review,BGD,Bangladesh,Unknown hospitals in Dhaka,823,Dhaka,1997,16,50,32,0,Salmonella Typhi,Multidrug resistance (MDR)
849,Rahman (2006),"Rahman M, Siddique AK, Shoma S, et al. Emergence of multidrug-resistant Salmonella enterica serotype Typhi with decreased ciprofloxacin susceptibility in Bangladesh. Epidemiol Infect 2006; 134(2): 433-8.",Systematic review,BGD,Bangladesh,ICDDR,823,Dhaka,1997,68,226,30.1,0,Salmonella Typhi,Multidrug resistance (MDR)
708,Asna (2000),"Asna SMZH, Ashraful Haq J. Decrease of antibiotic resistance in Salmonella Typhi isolated from patients attending hospitals of Dhaka City over a 3 year period. Int J Antimicrob Agents 2000; 16(3): 249-51.",Systematic review,BGD,Bangladesh,Unknown hospitals in Dhaka,823,Dhaka,1998,1,54,1.9,0,Salmonella Typhi,Multidrug resistance (MDR)
849,Rahman (2006),"Rahman M, Siddique AK, Shoma S, et al. Emergence of multidrug-resistant Salmonella enterica serotype Typhi with decreased ciprofloxacin susceptibility in Bangladesh. Epidemiol Infect 2006; 134(2): 433-8.",Systematic review,BGD,Bangladesh,ICDDR,823,Dhaka,1998,70,306,22.9,0,Salmonella Typhi,Multidrug resistance (MDR)
849,Rahman (2006),"Rahman M, Siddique AK, Shoma S, et al. Emergence of multidrug-resistant Salmonella enterica serotype Typhi with decreased ciprofloxacin susceptibility in Bangladesh. Epidemiol Infect 2006; 134(2): 433-8.",Systematic review,BGD,Bangladesh,ICDDR,823,Dhaka,1999,54,174,31,0,Salmonella Typhi,Multidrug resistance (MDR)
1871,Saha (2001),"Saha SK, Darmstadt GL, Baqui AH, et al. Rapid identification and antibiotic susceptibility testing of Salmonella enterica serovar Typhi isolated from blood: implications for therapy. J Clin Microbiol 2001; 39(10): 3583-5.",Systematic review,BGD,Bangladesh,Unknown private hospitals and clinics in Dhaka,823,Dhaka,1999,15,108,13.9,0,Salmonella Typhi,Multidrug resistance (MDR)
5115,Tanmoy (2018),"Tanmoy AM, Westeel E, Bruyne KD, et al. Salmonella enterica serovar Typhi in Bangladesh: exploration of genomic diversity and antimicrobial resistance.mBio 2018;9(6):02112-18",Systematic review,BGD,Bangladesh,Dhaka Shishu Hospital,823,Dhaka,1999,6,16,37.5,0,Salmonella Typhi,Multidrug resistance (MDR)
849,Rahman (2006),"Rahman M, Siddique AK, Shoma S, et al. Emergence of multidrug-resistant Salmonella enterica serotype Typhi with decreased ciprofloxacin susceptibility in Bangladesh. Epidemiol Infect 2006; 134(2): 433-8.",Systematic review,BGD,Bangladesh,ICDDR,823,Dhaka,2000,37,153,24.2,0,Salmonella Typhi,Multidrug resistance (MDR)
5115,Tanmoy (2018),"Tanmoy AM, Westeel E, Bruyne KD, et al. Salmonella enterica serovar Typhi in Bangladesh: exploration of genomic diversity and antimicrobial resistance.mBio 2018;9(6):02112-18",Systematic review,BGD,Bangladesh,Dhaka Shishu Hospital,823,Dhaka,2000,9,26,34.6,0,Salmonella Typhi,Multidrug resistance (MDR)
1427,Mamun (2004),"Mamun KZ, Tabassum S, Ashna SM, Hart CA. Molecular analysis of multi-drug resistant Salmonella Typhi from urban paediatric population of Bangladesh. Bangladesh Med Res Counc Bull 2004; 30(3): 81-6.",Systematic review,BGD,Bangladesh,Unknown clinics in Narayanganj district,823,Dhaka,2000,20,30,66.7,0,Salmonella Typhi,Multidrug resistance (MDR)
339,Brooks (2005),"Brooks WA, Hossain A, Goswami D, et al. Bacteremic typhoid fever in children in an urban slum, Bangladesh. Emerg Infect Dis 2005; 11(2): 326-9.",Systematic review,BGD,Bangladesh,Kamalapur,823,Dhaka,2001,27,49,55.1,0,Salmonella Typhi,Multidrug resistance (MDR)
849,Rahman (2006),"Rahman M, Siddique AK, Shoma S, et al. Emergence of multidrug-resistant Salmonella enterica serotype Typhi with decreased ciprofloxacin susceptibility in Bangladesh. Epidemiol Infect 2006; 134(2): 433-8.",Systematic review,BGD,Bangladesh,ICDDR,823,Dhaka,2001,76,212,35.8,0,Salmonella Typhi,Multidrug resistance (MDR)
5115,Tanmoy (2018),"Tanmoy AM, Westeel E, Bruyne KD, et al. Salmonella enterica serovar Typhi in Bangladesh: exploration of genomic diversity and antimicrobial resistance.mBio 2018;9(6):02112-18",Systematic review,BGD,Bangladesh,Dhaka Shishu Hospital,823,Dhaka,2001,15,20,75,0,Salmonella Typhi,Multidrug resistance (MDR)
849,Rahman (2006),"Rahman M, Siddique AK, Shoma S, et al. Emergence of multidrug-resistant Salmonella enterica serotype Typhi with decreased ciprofloxacin susceptibility in Bangladesh. Epidemiol Infect 2006; 134(2): 433-8.",Systematic review,BGD,Bangladesh,ICDDR,823,Dhaka,2002,73,173,42.2,0,Salmonella Typhi,Multidrug resistance (MDR)
5115,Tanmoy (2018),"Tanmoy AM, Westeel E, Bruyne KD, et al. Salmonella enterica serovar Typhi in Bangladesh: exploration of genomic diversity and antimicrobial resistance.mBio 2018;9(6):02112-18",Systematic review,BGD,Bangladesh,Dhaka Shishu Hospital,823,Dhaka,2002,13,14,92.9,1,Salmonella Typhi,Multidrug resistance (MDR)
405,Aliya (2010),"Aliya N, Ram PK, Brooks WA, et al. Burden of typhoid and paratyphoid fever in a densely populated urban community, Dhaka, Bangladesh. Int J Infect Dis 2010; 14(Suppl. 3): e93-e9.",Systematic review,BGD,Bangladesh,Kamalapur,823,Dhaka,2004,16,40,40,0,Salmonella Typhi,Multidrug resistance (MDR)
1502,Kato(2007),"Kato Y, Fukayama M, Adachi T, et al. Multidrug-resistant typhoid fever outbreak in travelers returning from Bangladesh. Emerg Infect Dis 2007; 13(12): 1954-5.",Systematic review,BGD,Bangladesh,Dhaka,823,Dhaka,2004,6,6,100,1,Salmonella Typhi,Multidrug resistance (MDR)
5115,Tanmoy (2018),"Tanmoy AM, Westeel E, Bruyne KD, et al. Salmonella enterica serovar Typhi in Bangladesh: exploration of genomic diversity and antimicrobial resistance.mBio 2018;9(6):02112-18",Systematic review,BGD,Bangladesh,Dhaka Shishu Hospital,823,Dhaka,2004,8,15,53.3,0,Salmonella Typhi,Multidrug resistance (MDR)
1493,Dilruba (2006),"Dilruba A, D'Costa LT, Khorshed A, Nair GB, Hossain MA. Multidrug-resistant Salmonella enterica serovar Typhi isolates with high-level resistance to ciprofloxacin in Dhaka, Bangladesh. Antimicrob Agents Chemother 2006; 50(10): 3516-7.",Systematic review,BGD,Bangladesh,ICDDR,823,Dhaka,2005,247,428,57.7,0,Salmonella Typhi,Multidrug resistance (MDR)
1995,Rahman (2005),"Rahman MM, Haq JA, Morshed MA, Rahman MA. Salmonella enterica serovar Typhi with decreased susceptibility to ciprofloxacin--an emerging problem in Bangladesh. Int J Antimicrob Agents 2005; 25(4): 345-6.",Systematic review,BGD,Bangladesh,"Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders (BIRDEM)",823,Dhaka,2005,23,44,52.3,0,Salmonella Typhi,Multidrug resistance (MDR)
5115,Tanmoy (2018),"Tanmoy AM, Westeel E, Bruyne KD, et al. Salmonella enterica serovar Typhi in Bangladesh: exploration of genomic diversity and antimicrobial resistance.mBio 2018;9(6):02112-18",Systematic review,BGD,Bangladesh,Dhaka Shishu Hospital,823,Dhaka,2005,26,50,52,0,Salmonella Typhi,Multidrug resistance (MDR)
5115,Tanmoy (2018),"Tanmoy AM, Westeel E, Bruyne KD, et al. Salmonella enterica serovar Typhi in Bangladesh: exploration of genomic diversity and antimicrobial resistance.mBio 2018;9(6):02112-18",Systematic review,BGD,Bangladesh,Dhaka Shishu Hospital,823,Dhaka,2006,28,55,50.9,0,Salmonella Typhi,Multidrug resistance (MDR)
1088,Das(2014),"Das SK, Chisti MJ, Afrad MH, et al. Gastroenteritis due to typhoidal Salmonella: a decade of observation at an urban and a rural diarrheal disease hospital in Bangladesh. BMC Infect Dis 2014; 14: 435.",Systematic review,BGD,Bangladesh,ICDDR;Matlab Hospital (ICDDR),823,Dhaka,2006,5,12,41.7,0,Salmonella Typhi,Multidrug resistance (MDR)
1088,Das(2014),"Das SK, Chisti MJ, Afrad MH, et al. Gastroenteritis due to typhoidal Salmonella: a decade of observation at an urban and a rural diarrheal disease hospital in Bangladesh. BMC Infect Dis 2014; 14: 435.",Systematic review,BGD,Bangladesh,Unknown urban Dhaka hospital,823,Dhaka,2006,21,44,47.7,0,Salmonella Typhi,Multidrug resistance (MDR)
4229,Chiou(2014),"Chiou CS, Lauderdale TL, Phung DC, et al. Antimicrobial resistance in Salmonella enterica serovar Typhi isolates from Bangladesh, Indonesia, Taiwan, and Vietnam. Antimicrob Agents Chemother 2014; 58(11): 6501-7.",Systematic review,BGD,Bangladesh,Dhaka Hospital (ICCDR),823,Dhaka,2007,22,38,57.9,0,Salmonella Typhi,Multidrug resistance (MDR)
5115,Tanmoy (2018),"Tanmoy AM, Westeel E, Bruyne KD, et al. Salmonella enterica serovar Typhi in Bangladesh: exploration of genomic diversity and antimicrobial resistance.mBio 2018;9(6):02112-18",Systematic review,BGD,Bangladesh,Dhaka Shishu Hospital,823,Dhaka,2007,20,54,37,0,Salmonella Typhi,Multidrug resistance (MDR)
1130,Chisti(2009),"Chisti MJ, Bardhan PK, Huq S, et al. High-dose intravenous dexamethasone in the management of diarrheal patients with enteric fever and encephalopathy. Southeast Asian J Trop Med Public Health 2009; 40(5): 1065-73.",Systematic review,BGD,Bangladesh,Dhaka Hospital (ICCDR);ICDDR,823,Dhaka,2007,15,15,100,1,Salmonella Typhi,Multidrug resistance (MDR)
5115,Tanmoy (2018),"Tanmoy AM, Westeel E, Bruyne KD, et al. Salmonella enterica serovar Typhi in Bangladesh: exploration of genomic diversity and antimicrobial resistance.mBio 2018;9(6):02112-18",Systematic review,BGD,Bangladesh,Dhaka Shishu Hospital,823,Dhaka,2008,16,56,28.6,0,Salmonella Typhi,Multidrug resistance (MDR)
5115,Tanmoy (2018),"Tanmoy AM, Westeel E, Bruyne KD, et al. Salmonella enterica serovar Typhi in Bangladesh: exploration of genomic diversity and antimicrobial resistance.mBio 2018;9(6):02112-18",Systematic review,BGD,Bangladesh,Dhaka Shishu Hospital,823,Dhaka,2009,15,52,28.8,0,Salmonella Typhi,Multidrug resistance (MDR)
2847,"ICDDR,B(2009)<U+1D48>",International Centre for Diarrhoeal Disease Research Bangladesh. Surveillance updates. Health and Science Bulletin 2009; 7(4).,Surveillance report,BGD,Bangladesh,Kamalapur,823,Dhaka,2009,19,49,38.8,0,Salmonella Typhi,Multidrug resistance (MDR)
2848,"ICDDR,B(2009)<U+1D9C>",International Centre for Diarrhoeal Disease Research Bangladesh. Surveillance updates. Health and Science Bulletin 2009; 7(3).,Surveillance report,BGD,Bangladesh,Kamalapur,823,Dhaka,2009,14,26,53.8,0,Salmonella Typhi,Multidrug resistance (MDR)
2849,"ICDDR,B(2009)<U+1D47>",International Centre for Diarrhoeal Disease Research Bangladesh. Surveillance updates. Health and Science Bulletin 2009; 7(2).,Surveillance report,BGD,Bangladesh,Kamalapur,823,Dhaka,2009,28,46,60.9,0,Salmonella Typhi,Multidrug resistance (MDR)
1028,Leung (2012),"Leung DT, Bogetz J, Itoh M, et al. Factors associated with encephalopathy in patients with Salmonella enterica serotype Typhi bacteremia presenting to a diarrheal hospital in Dhaka, Bangladesh. Am J Trop Med Hyg 2012; 86(4): 698-702.",Systematic review,BGD,Bangladesh,Dhaka Hospital (ICCDR);ICDDR,823,Dhaka,2010,71,207,34.3,0,Salmonella Typhi,Multidrug resistance (MDR)
5062,Yu (2017),"Yu AT, Amin N, Rahman MW and Luby S. Typhoid fever case fatality rate in patients presenting to a laboratory network in Dhaka, Bangladesh.American Journal of Tropical Medicine and Hygiene 2017;97 (5 Supplement 1):352",Systematic review,BGD,Bangladesh,Unknown hospitals and clinics in Dhaka,823,Dhaka,2010,371,1425,26,0,Salmonella Typhi,Multidrug resistance (MDR)
5115,Tanmoy (2018),"Tanmoy AM, Westeel E, Bruyne KD, et al. Salmonella enterica serovar Typhi in Bangladesh: exploration of genomic diversity and antimicrobial resistance.mBio 2018;9(6):02112-18",Systematic review,BGD,Bangladesh,Dhaka Shishu Hospital,823,Dhaka,2010,13,44,29.5,0,Salmonella Typhi,Multidrug resistance (MDR)
2843,"ICDDR,B(2010)<U+1D9C>",International Centre for Diarrhoeal Disease Research Bangladesh. Surveillance updates. Health and Science Bulletin 2010; 8(4).,Surveillance report,BGD,Bangladesh,Kamalapur,823,Dhaka,2010,9,23,39.1,0,Salmonella Typhi,Multidrug resistance (MDR)
2844,"ICDDR,B(2010)<U+1D47>",International Centre for Diarrhoeal Disease Research Bangladesh. Surveillance updates. Health and Science Bulletin 2010; 8(3).,Surveillance report,BGD,Bangladesh,Kamalapur,823,Dhaka,2010,7,17,41.2,0,Salmonella Typhi,Multidrug resistance (MDR)
2845,"ICDDR,B(2010)<U+1D43>",International Centre for Diarrhoeal Disease Research Bangladesh. Surveillance updates. Health and Science Bulletin 2010; 8(2).,Surveillance report,BGD,Bangladesh,Kamalapur,823,Dhaka,2010,16,29,55.2,0,Salmonella Typhi,Multidrug resistance (MDR)
1680,Afroze (2014),"Afroze SR, Rahim MA, Hasan MM, et al. Pattern of antibiotic sensitivity in enteric fever: A tertiary care hospital experience. Journal of Medicine (Bangladesh) 2014; 15(2): 122-4.",Systematic review,BGD,Bangladesh,"Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders (BIRDEM)",823,Dhaka,2011,23,71,32.4,0,Salmonella Typhi,Multidrug resistance (MDR)
2392,Farhana (2015),"Farhana K, Sayeed MA, Feroza Kaneez C, et al. Typhoid fever in young children in Bangladesh: clinical findings, antibiotic susceptibility pattern and immune responses. PLoS Negl Trop Dis 2015; 9(4).",Systematic review,BGD,Bangladesh,Dhaka Hospital (ICCDR);ICDDR,823,Dhaka,2011,10,72,13.9,0,Salmonella Typhi,Multidrug resistance (MDR)
5115,Tanmoy (2018),"Tanmoy AM, Westeel E, Bruyne KD, et al. Salmonella enterica serovar Typhi in Bangladesh: exploration of genomic diversity and antimicrobial resistance.mBio 2018;9(6):02112-18",Systematic review,BGD,Bangladesh,Dhaka Shishu Hospital,823,Dhaka,2011,14,43,32.6,0,Salmonella Typhi,Multidrug resistance (MDR)
2195,"ICDDR,B(2011)<U+1D9C>",International Centre for Diarrhoeal Disease Research Bangladesh. Surveillance updates. Health and Science Bulletin 2011; 9(3): 22-5.,Surveillance report,BGD,Bangladesh,Kamalapur,823,Dhaka,2011,9,23,39.1,0,Salmonella Typhi,Multidrug resistance (MDR)
2839,"ICDDR,B(2011)<U+1D48>",International Centre for Diarrhoeal Disease Research Bangladesh. Surveillance updates. Health and Science Bulletin 2011; 9(4).,Surveillance report,BGD,Bangladesh,Kamalapur,823,Dhaka,2011,8,22,36.4,0,Salmonella Typhi,Multidrug resistance (MDR)
2841,"ICDDR,B(2011)<U+1D43>",International Centre for Diarrhoeal Disease Research Bangladesh. Surveillance updates. Health and Science Bulletin 2011; 2(1).,Surveillance report,BGD,Bangladesh,Kamalapur,823,Dhaka,2011,16,44,36.4,0,Salmonella Typhi,Multidrug resistance (MDR)
2842,"ICDDR,B(2011)<U+1D47>",International Centre for Diarrhoeal Disease Research Bangladesh. Surveillance updates. Health and Science Bulletin 2011; 9(1).,Surveillance report,BGD,Bangladesh,Kamalapur,823,Dhaka,2011,3,8,37.5,0,Salmonella Typhi,Multidrug resistance (MDR)
4451,Shahunja(2015),"Shahunja KM, Leung DT, Tahmeed A, et al. Factors associated with non-typhoidal Salmonella bacteremia versus typhoidal Salmonella bacteremia in patients presenting for care in an urban diarrheal disease hospital in Bangladesh. PLoS Negl Trop Dis 2015; 9(9).",Systematic review,BGD,Bangladesh,Dhaka Hospital (ICCDR),823,Dhaka,2011,16,60,26.7,0,Salmonella Typhi,Multidrug resistance (MDR)
5115,Tanmoy (2018),"Tanmoy AM, Westeel E, Bruyne KD, et al. Salmonella enterica serovar Typhi in Bangladesh: exploration of genomic diversity and antimicrobial resistance.mBio 2018;9(6):02112-18",Systematic review,BGD,Bangladesh,Dhaka Shishu Hospital,823,Dhaka,2012,11,44,25,0,Salmonella Typhi,Multidrug resistance (MDR)
2835,"ICDDR,B(2012)<U+1D48>",International Centre for Diarrhoeal Disease Research Bangladesh. Surveillance updates. Health and Science Bulletin 2012; 10(4).,Surveillance report,BGD,Bangladesh,Kamalapur,823,Dhaka,2012,1,31,3.2,0,Salmonella Typhi,Multidrug resistance (MDR)
2836,"ICDDR,B(2012)<U+1D9C>",International Centre for Diarrhoeal Disease Research Bangladesh. Surveillance updates. Health and Science Bulletin 2012; 10(3).,Surveillance report,BGD,Bangladesh,Kamalapur,823,Dhaka,2012,6.86,51,13.5,0,Salmonella Typhi,Multidrug resistance (MDR)
2837,"ICDDR,B(2012)<U+1D47>",International Centre for Diarrhoeal Disease Research Bangladesh. Surveillance updates. Health and Science Bulletin 2012; 10(2).,Surveillance report,BGD,Bangladesh,Kamalapur,823,Dhaka,2012,4,33,12.1,0,Salmonella Typhi,Multidrug resistance (MDR)
2838,"ICDDR,B(2012)<U+1D43>",International Centre for Diarrhoeal Disease Research Bangladesh. Surveillance updates. Health and Science Bulletin 2012; 10(1).,Surveillance report,BGD,Bangladesh,Kamalapur,823,Dhaka,2012,4,14,28.6,0,Salmonella Typhi,Multidrug resistance (MDR)
5115,Tanmoy (2018),"Tanmoy AM, Westeel E, Bruyne KD, et al. Salmonella enterica serovar Typhi in Bangladesh: exploration of genomic diversity and antimicrobial resistance.mBio 2018;9(6):02112-18",Systematic review,BGD,Bangladesh,Dhaka Shishu Hospital,823,Dhaka,2013,12,47,25.5,0,Salmonella Typhi,Multidrug resistance (MDR)
2831,"ICDDR,B(2013)<U+1D48>",International Centre for Diarrhoeal Disease Research Bangladesh. Surveillance updates. Health and Science Bulletin 2013; 11(4).,Surveillance report,BGD,Bangladesh,Kamalapur,823,Dhaka,2013,4,18,22.2,0,Salmonella Typhi,Multidrug resistance (MDR)
2832,"ICDDR,B(2013)<U+1D9C>",International Centre for Diarrhoeal Disease Research Bangladesh. Surveillance updates. Health and Science Bulletin 2013; 11(3).,Surveillance report,BGD,Bangladesh,Kamalapur,823,Dhaka,2013,12,41,29.3,0,Salmonella Typhi,Multidrug resistance (MDR)
2833,"ICDDR,B(2013)<U+1D47>",International Centre for Diarrhoeal Disease Research Bangladesh. Surveillance updates. Health and Science Bulletin 2013; 11(2).,Surveillance report,BGD,Bangladesh,Kamalapur,823,Dhaka,2013,9,22,40.9,0,Salmonella Typhi,Multidrug resistance (MDR)
2834,"ICDDR,B(2013)<U+1D43>",International Centre for Diarrhoeal Disease Research Bangladesh. Surveillance updates. Health and Science Bulletin 2013; 11(1).,Surveillance report,BGD,Bangladesh,Kamalapur,823,Dhaka,2013,3,17,17.6,0,Salmonella Typhi,Multidrug resistance (MDR)
2825,"ICDDR,B(2014)<U+1D47>",International Centre for Diarrhoeal Disease Research Bangladesh. Surveillance updates. Health and Science Bulletin 2014; 12(2).,Surveillance report,BGD,Bangladesh,Kamalapur,823,Dhaka,2014,1,43,2.3,0,Salmonella Typhi,Multidrug resistance (MDR)
2826,"ICDDR,B(2014)<U+1D43>",International Centre for Diarrhoeal Disease Research Bangladesh. Surveillance updates. Health and Science Bulletin 2014; 12(1).,Surveillance report,BGD,Bangladesh,Kamalapur,823,Dhaka,2014,2,15,13.3,0,Salmonella Typhi,Multidrug resistance (MDR)
2829,"ICDDR,B(2014)<U+1D48>",International Centre for Diarrhoeal Disease Research Bangladesh. Surveillance updates. Health and Science Bulletin 2014; 12(4).,Surveillance report,BGD,Bangladesh,Kamalapur,823,Dhaka,2014,6,30,20,0,Salmonella Typhi,Multidrug resistance (MDR)
2830,"ICDDR,B(2014)<U+1D9C>",International Centre for Diarrhoeal Disease Research Bangladesh. Surveillance updates. Health and Science Bulletin 2014; 12(3).,Surveillance report,BGD,Bangladesh,Kamalapur,823,Dhaka,2014,4,29,13.8,0,Salmonella Typhi,Multidrug resistance (MDR)
4490,Ali (2016),"Ali MK, Sultana S. Antimicrobial sensitivity patterns of Salmonella Typhi in children. Bangladesh J Med Sci 2016; 15(3): 416-8.",Systematic review,BGD,Bangladesh,Ibn Sina Medical College and Hospital,823,Dhaka,2014,20,181,11,0,Salmonella Typhi,Multidrug resistance (MDR)
5131,Saha (2018),"Saha S, Saha S, Das RC, et al. Enteric Fever and Related Contextual Factors in Bangladesh.American Journal of Tropical Medicine & Hygiene 2018;99(3_Suppl):20-25",Systematic review,BGD,Bangladesh,Dhaka Shishu Hospital;Shishu Sasthya Foundation Hospital,823,Dhaka,2014,62.01,241,25.7,0,Salmonella Typhi,Multidrug resistance (MDR)
5102,Okanda (2018),"Okanda T, Haque A, Ehara T, et al. Characteristics of resistance mechanisms and molecular epidemiology of fluoroquinolone-nonsusceptible Salmonella enterica serovar Typhi and Paratyphi a isolates from a tertiary hospital in Dhaka, Bangladesh.Microbial Drug Resistance 2018;24(10):1460-1465",Systematic review,BGD,Bangladesh,Bangabandhu Sheikh Mujib Medical University Hospital,823,Dhaka,2015,7,18,38.9,0,Salmonella Typhi,Multidrug resistance (MDR)
2827,"ICDDR,B(2016)",International Centre for Diarrhoeal Disease Research Bangladesh. Surveillance updates. Health and Science Bulletin 2016; 14(1).,Surveillance report,BGD,Bangladesh,Kamalapur,823,Dhaka,2016,1,6,16.7,0,Salmonella Typhi,Multidrug resistance (MDR)
539,Sen (1991),"Sen S, Goyal RS, Dev R. Ciprofloxacin in the management of multiple drug resistant typhoid fever. Indian Pediatr 1991; 28(4): 417-9.",Systematic review,IND,India,Charak Palika Hospital (Moti Bagh),850,Delhi,1990,5,12,41.7,0,Salmonella Typhi,Multidrug resistance (MDR)
1462,Koul (1991),"Koul PB, Murali MV, Sharma PP, Ghai OP, Ramchandran VG, Talwar V. Multi drug resistant Salmonella Typhi infection: clinical profile and therapy. Indian Pediatr 1991; 28(4): 357-61.",Systematic review,IND,India,Guru Teg Bahadur Hospital,850,Delhi,1990,11,26,42.3,0,Salmonella Typhi,Multidrug resistance (MDR)
1482,Dar (1992),"Dar L, Gupta BL, Rattan A, Bhujwala RA, Shriniwas. Multidrug resistant Salmonella Typhi in Delhi. Indian J Pediatr 1992; 59(2): 221-4.",Systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,1990,79,158,50,0,Salmonella Typhi,Multidrug resistance (MDR)
1488,Mishra (1992),"Mishra S, Patwari AK, Anand VK, et al. Multidrug resistant typhoid fever: therapeutic considerations. Indian Pediatr 1992; 29(4): 443-8.",Systematic review,IND,India,Kalawati Saran Children's Hospital,850,Delhi,1990,33,50,66,0,Salmonella Typhi,Multidrug resistance (MDR)
1761,Chopra(1992),"Chopra GS, Basu SK, Bhattacharya SR. Present phage types and antibiotic susceptibility of Salmonellae. Indian J Pathol Microbiol 1992; 35(4): 345-50.",Systematic review,IND,India,Command Pathology Laboratory,850,Delhi,1990,112,143,78.3,0,Salmonella Typhi,Multidrug resistance (MDR)
1802,Agarwal (1991),"Agarwal S, Madhu SV, Guleria JS, Talwar V. The problem of emerging chloramphenicol resistance in typhoid fever - A preliminary report. J Assoc Physicians India 1991; 39(6): 443-4.",Systematic review,IND,India,Guru Teg Bahadur Hospital,850,Delhi,1990,21,25,84,1,Salmonella Typhi,Multidrug resistance (MDR)
1495,Sabherwal (1992),"Sabherwal U, Chaudhary U, Saini S. Multidrug-resistant Salmonella Typhi in Haryana in 1989-90. Indian J Med Res 1992; 95: 12-3.",Systematic review,IND,India,Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences,853,Haryana,1990,218,730,29.9,0,Salmonella Typhi,Multidrug resistance (MDR)
594,Raghu Raman(1994),"Raghu Raman TS, Krishnamurthy L, Menon PK, Singh D, Jayaprakash DG. Clinical profile and therapy in enteric fever. Indian Pediatr 1994; 31(2): 196-9.",Systematic review,IND,India,Command Hospital (Bengaluru),855,Karnataka,1990,50,90,55.6,0,Salmonella Typhi,Multidrug resistance (MDR)
792,Pais (1991),"Pais N, Ravindranath S, Kesavamurthy. Drug resistant typhoid in Bangalore. J Assoc Physicians India 1991; 39(8): 654.",Systematic review,IND,India,Saint Martha's Hospital,855,Karnataka,1990,18.86,41,46,0,Salmonella Typhi,Multidrug resistance (MDR)
1876,Sridhar (1995),"Sridhar CB, Kulkarni RD. Reassessment of frequency of occurrence of typhoid fever and cost efficacy analysis of antibiotic therapy. J Assoc Physicians India 1995; 43(10): 679-84.",Systematic review,IND,India,St. John Medical College and Hospital,855,Karnataka,1990,29,135,21.5,0,Salmonella Typhi,Multidrug resistance (MDR)
2426,Ramanan(1992),"Ramanan A, Pandit N, Yeshwanth M. Unusual complications in a multidrug resistant Salmonella Typhi outbreak. Indian Pediatr 1992; 29(1): 118-20.",Systematic review,IND,India,St. John Medical College and Hospital,855,Karnataka,1990,4,9,44.4,0,Salmonella Typhi,Multidrug resistance (MDR)
540,Bavdekar (1991),"Bavdekar A, Chaudhari M, Bhave S, Pandit A. Ciprofloxacin in typhoid fever. Indian J Pediatr 1991; 58(3): 335-9.",Systematic review,IND,India,KEM Hospital,858,Maharashtra,1990,27,30,90,1,Salmonella Typhi,Multidrug resistance (MDR)
514,Rodrigues (1992),"Rodrigues C, Mehta A, Mehtar S, et al. Chloramphenicol resistance in Salmonella Typhi. Report from Bombay. J Assoc Physicians India 1992; 40(11): 729-32.",Systematic review,IND,India,P.D. Hinduja National Hospital and Medical Research Center,858,Maharashtra,1990,60,74,81.1,0,Salmonella Typhi,Multidrug resistance (MDR)
2049,Rodrigues(2002),"Rodrigues C, Mehta A, Joshi VR. Salmonella Typhiin the past decade: learning to live with resistance. Clin Infect Dis 2002; 34(1): 126.",Systematic review,IND,India,P.D. Hinduja National Hospital and Medical Research Center,858,Maharashtra,1990,75,101,74.3,0,Salmonella Typhi,Multidrug resistance (MDR)
1460,Sheorey(1993),"Sheorey HS, Kaundinya DV, Hulyalkar VS, Deshpande AK. Multi drug resistant Salmonella Typhi in Bombay. Indian J Pathol Microbiol 1993; 36(1): 8-12.",Systematic review,IND,India,Grant Medical College and Sir Jamshedjee Jeejeebhoy Group of Hospitals,858,Maharashtra,1990,156.99,215,73,0,Salmonella Typhi,Multidrug resistance (MDR)
997,Kumar (2002),"Kumar R, Aneja KR, Roy P, Sharma M, Gupta R, Ram S. Evaluation of minimum inhibitory concentration of quinolones and third generation cephalosporins to Salmonella Typhi isolates. Indian J Med Sci 2002; 56(1): 1-8.",Systematic review,IND,India,Postgraduate Institute of Medical Education and Research (PGIMER; Nehru Hospital),864,Punjab,1990,10,62,16.1,0,Salmonella Typhi,Multidrug resistance (MDR)
1641,Pal (1991),"Pal N, Ayyagari A, Panigrahi D. Outbreak of multidrug resistant S. Typhi infection. Bull Postgrad Inst Med Educ Res Chandigarh 1991; 25(4): 186-90.",Systematic review,IND,India,Postgraduate Institute of Medical Education and Research (PGIMER; Nehru Hospital),864,Punjab,1990,34,62,54.8,0,Salmonella Typhi,Multidrug resistance (MDR)
538,Panigrahi(1991),"Panigrahi D, Roy P, Sehgal R. Ciprofloxacin for typhoid fever? [28]. Lancet 1991; 338(8782-8783): 1601.",Systematic review,IND,India,Postgraduate Institute of Medical Education and Research (PGIMER; Nehru Hospital),864,Punjab,1990,36.99,109,33.9,0,Salmonella Typhi,Multidrug resistance (MDR)
458,Kumar (2001),"Kumar R, Aneja KR, Punia AK, et al. Changing pattern of biotypes, phage types & drug resistance of Salmonella Typhi in Ludhiana during 1980-1999. Indian J Med Res 2001; 113: 175-80.",Systematic review,IND,India,Dayanand Medical College and Hospital,864,Punjab,1990,117,411,28.5,0,Salmonella Typhi,Multidrug resistance (MDR)
475,Dhar (1993),"Dhar KL, Thomas MS, Abraham G. Changing trends in the treatment of Salmonella Typhi infections in north-western India. J Assoc Physicians India 1993; 41(9): 616-7.",Systematic review,IND,India,Christian Medical College and Hospital (Ludhiana),864,Punjab,1990,276,486,56.8,0,Salmonella Typhi,Multidrug resistance (MDR)
1519,Jesudasan(1990),"Jesudasan MV, John TJ. Multiresistant Salmonella Typhi in India. Lancet 1990; 336(8709): 252.",Systematic review,IND,India,Christian Medical College (Vellore),867,Tamil Nadu,1990,9,53,17,0,Salmonella Typhi,Multidrug resistance (MDR)
1724,Jesudason (1992),"Jesudason MV, John TJ. Plasmid mediated multidrug resistance in Salmonella Typhi. Indian J Med Res 1992; 95: 66-7.",Systematic review,IND,India,Christian Medical College (Vellore),867,Tamil Nadu,1990,44,283,15.5,0,Salmonella Typhi,Multidrug resistance (MDR)
520,Halder (1992),"Halder KK, Saha Dalal B, Ghose E, Sanyal S. Chloramphenicol resistant Salmonella Typhi: The cause of recent outbreak of enteric fever in Calcutta. Indian J Pathol Microbiol 1992; 35(1): 11-7.",Systematic review,IND,India,Medical College Hospital (Kolkata),869,West Bengal,1990,40,51,78.4,0,Salmonella Typhi,Multidrug resistance (MDR)
716,Saha (2002),"Saha MR, Dutta P, Niyogi SK, et al. Decreasing trend in the occurrence of Salmonella enterica serotype Typhi amongst hospitalised children in Kolkata, India during 1990-2000. Indian J Med Res 2002; 115(FEB.): 46-8.",Systematic review,IND,India,Dr B. C. Roy Memorial Hospital for Children,869,West Bengal,1990,189,189,100,1,Salmonella Typhi,Multidrug resistance (MDR)
1487,Arora(1992),"Arora RK, Gupta A, Joshi NM, Kataria VK, Lall P, Anand AC. Multidrug resistant typhoid fever: Study of an outbreak in Calcutta. Indian Pediatr 1992; 29(1): 61-6.",Systematic review,IND,India,Command Hospital (Kolkata),869,West Bengal,1990,85,103,82.5,0,Salmonella Typhi,Multidrug resistance (MDR)
1618,Saha (1992),"Saha MR, Dutta P, Bhattacharya SK, et al. Occurrence of multi-drug resistant Salmonella Typhi in Calcutta. Indian J Med Res 1992; 95(JULY): 179-80.",Systematic review,IND,India,Dr B. C. Roy Memorial Hospital for Children,869,West Bengal,1990,47,47,100,1,Salmonella Typhi,Multidrug resistance (MDR)
2143,Mukherjee(1991),"Mukherjee P, Mukherjee S, Dalal BK, Haldar KK, Ghosh E, Pal TK. Some prospective observations on recent outbreak of typhoid fever in West Bengal.[Erratum appears in J Assoc Physicians India. 1992 Apr;40(4):285-6; PMID: 1452554]. J Assoc Physicians India 1991; 39(6): 445-8.",Systematic review,IND,India,Medical College Hospital (Kolkata),869,West Bengal,1990,31,46,67.4,0,Salmonella Typhi,Multidrug resistance (MDR)
2293,Paul(1991),"Paul K, De PK. Transferable chloramphenicol resistance in Salmonella Typhi isolated during an outbreak of enteric fever in Calcutta, West Bengal. Indian J Med Microbiol 1991; 9(1): 10-2.",Systematic review,IND,India,Institute of Post-Graduate Medical Education and Research and Seth Sukhlal Karnani Memorial Hospital,869,West Bengal,1990,84,84,100,1,Salmonella Typhi,Multidrug resistance (MDR)
2296,Haldar (1995),"Haldar KK, Basak S, Chakraborty AK, Das S. Transferable drug resistance in Salmonella Typhi strains isolated from an outbreak at Calcutta in the recent past. J Indian Med Assoc 1995; 93(8): 299-300, 15.",Systematic review,IND,India,Unkown Hospital in Kolkata,869,West Bengal,1990,28,50,56,0,Salmonella Typhi,Multidrug resistance (MDR)
57,Anand (1993),Anand AC. The anatomy of an epidemic (the final report on an epidemic of multidrug resistant enteric fever in eastern India). Trop Gastroenterol 1993; 14(1): 21-7.,Systematic review,IND,India,Command Hospital (Kolkata),869,West Bengal,1990,179,216,82.9,0,Salmonella Typhi,Multidrug resistance (MDR)
1944,Karmaker(1991),"Karmaker S, Biswas D, Shaikh NM, Chatterjee SK, Kataria VK, Kumar R. Role of a large plasmid of Salmonella Typhi encoding multiple drug resistance. J Med Microbiol 1991; 34(3): 149-51.",Systematic review,IND,India,Command Hospital (Kolkata),869,West Bengal,1990,17,20,85,1,Salmonella Typhi,Multidrug resistance (MDR)
913,Buch (1994),"Buch NA, Hassan MU, Kakroo DK. Enteric fever--a changing sensitivity pattern, clinical profile and outcome. Indian Pediatr 1994; 31(8): 981-5.",Systematic review,IND,India,Sher-I-Kashmir Institute of Medical Sciences (SKIMS),875,Administrative unit not available,1990,25,71,35.2,0,Salmonella Typhi,Multidrug resistance (MDR)
436,Harish(1994),"Harish R, Sharma DB. Cefotaxime in multi drug resistant typhoid fever. Indian Pediatr 1994; 31(2): 193-6.",Systematic review,IND,India,Government Medical College (Jammu),877,Administrative unit not available,1990,8,8,100,1,Salmonella Typhi,Multidrug resistance (MDR)
1471,Chandra(1992),"Chandra R, Srinivasan S, Nalini P, Rao RS. Multidrug resistant enteric fever. J Trop Med Hyg 1992; 95(4): 284-7.",Systematic review,IND,India,Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER),889,Puducherry,1990,9,21,42.9,0,Salmonella Typhi,Multidrug resistance (MDR)
1650,Rao(1992),"Rao RS, Amarnath SK, Sujatha S. An outbreak of typhoid due to multidrug resistant Salmonella Typhi in Pondicherry. Trans R Soc Trop Med Hyg 1992; 86(2): 204-5.",Systematic review,IND,India,Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER),889,Puducherry,1990,36,91,39.6,0,Salmonella Typhi,Multidrug resistance (MDR)
1482,Dar (1992),"Dar L, Gupta BL, Rattan A, Bhujwala RA, Shriniwas. Multidrug resistant Salmonella Typhi in Delhi. Indian J Pediatr 1992; 59(2): 221-4.",Systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,1991,118,168,70.2,0,Salmonella Typhi,Multidrug resistance (MDR)
464,Gupta (1992),"Gupta S, Meena HS. Changing profile of enteric fever--in summer-91. J Assoc Physicians India 1992; 40(11): 726-9.",Systematic review,IND,India,Lady Hardinge Medical College,850,Delhi,1991,2.33,8,29.1,0,Salmonella Typhi,Multidrug resistance (MDR)
1483,Bhadoria(1993),"Bhadoria DP, Agarwal MP, Dwivedi S. Multidrug resistant Salmonella Typhi in India. Indian J Pathol Microbiol 1993; 36(2): 190-1.",Systematic review,IND,India,Guru Teg Bahadur Hospital,850,Delhi,1991,41,41,100,1,Salmonella Typhi,Multidrug resistance (MDR)
1480,Rathish (1994),"Rathish KC, Chandrashekar MR, Nagesha CN. Multidrug resistant Salmonella Typhi in Bangalore, south India. Indian J Med Sci 1994; 48(4): 85-8.",Systematic review,IND,India,Dr. B.R. Ambedkar Medical College,855,Karnataka,1991,180,190,94.7,1,Salmonella Typhi,Multidrug resistance (MDR)
1876,Sridhar (1995),"Sridhar CB, Kulkarni RD. Reassessment of frequency of occurrence of typhoid fever and cost efficacy analysis of antibiotic therapy. J Assoc Physicians India 1995; 43(10): 679-84.",Systematic review,IND,India,St. John Medical College and Hospital,855,Karnataka,1991,133,178,74.7,0,Salmonella Typhi,Multidrug resistance (MDR)
4668,Ranju (1998),"Ranju C, Pais P, Ravindran GD, Singh G. Changing pattern of antibiotic sensitivity of Salmonella Typhi. Natl Med J India 1998; 11(6): 266-7.",Systematic review,IND,India,St. John Medical College and Hospital,855,Karnataka,1991,35,100,35,0,Salmonella Typhi,Multidrug resistance (MDR)
856,Rao (1993),"Rao PS, Rajashekar V, Varghese GK, Shivananda PG. Emergence of multidrug-resistant Salmonella Typhi in rural southern India. Am J Trop Med Hyg 1993; 48(1): 108-11.",Systematic review,IND,India,Kasturba Medical College and Hospital (Manipal),855,Karnataka,1991,80,102,78.4,0,Salmonella Typhi,Multidrug resistance (MDR)
1726,Agrawal(1995),"Agrawal V, Thakar AK, Kurhade AK, Pathak AA, Saoji AM. Plasmid mediated resistance to chloramphenicol, ampicillin, sulphame thoxazole and trimethoprim in Salmonella Typhi. Indian J Pathol Microbiol 1995; 38(2): 223.",Systematic review,IND,India,Government Medical College and Hospital (Nagpur),858,Maharashtra,1991,472,632,74.7,0,Salmonella Typhi,Multidrug resistance (MDR)
1645,Agarwal(1992),"Agarwal V, Jalgaonkar PD, Pathak AA, Saoji AM. An outbreak of multidrug resistant typhoid fever in Nagpur. J Assoc Physicians India 1992; 40(6): 416.",Systematic review,IND,India,Government Medical College and Hospital (Nagpur),858,Maharashtra,1991,65.28,120,54.4,0,Salmonella Typhi,Multidrug resistance (MDR)
1464,Kulkarni(1992),"Kulkarni SA, Kulkarni AG. Multi resistant Salmonella Typhi from rural southern Maharashtra. J Assoc Physicians India 1992; 40(9): 636-7.",Systematic review,IND,India,Krishna Hospital and Medical Research Centre (Karad),858,Maharashtra,1991,39,43,90.7,1,Salmonella Typhi,Multidrug resistance (MDR)
3250,Mehta (1992),"Mehta A, Rodriques C, Joshi VR. Multiresistant Salmonella organisms in India. JAMA 1992; 267(12): 1614.",Systematic review,IND,India,P.D. Hinduja National Hospital and Medical Research Center,858,Maharashtra,1991,141,190,74.2,0,Salmonella Typhi,Multidrug resistance (MDR)
538,Panigrahi(1991),"Panigrahi D, Roy P, Sehgal R. Ciprofloxacin for typhoid fever? [28]. Lancet 1991; 338(8782-8783): 1601.",Systematic review,IND,India,Postgraduate Institute of Medical Education and Research (PGIMER; Nehru Hospital),864,Punjab,1991,144,180,80,0,Salmonella Typhi,Multidrug resistance (MDR)
458,Kumar (2001),"Kumar R, Aneja KR, Punia AK, et al. Changing pattern of biotypes, phage types & drug resistance of Salmonella Typhi in Ludhiana during 1980-1999. Indian J Med Res 2001; 113: 175-80.",Systematic review,IND,India,Dayanand Medical College and Hospital,864,Punjab,1991,116,322,36,0,Salmonella Typhi,Multidrug resistance (MDR)
648,Takkar (1994),"Takkar VP, Kumar R, Khurana S, Takkar R. Comparison of ciprofloxacin versus cephelexin and gentamicin in the treatment of multi-drug resistant typhoid fever. Indian Pediatr 1994; 31(2): 200-1.",Systematic review,IND,India,Takkar's Children Hospital,864,Punjab,1991,46,84,54.8,0,Salmonella Typhi,Multidrug resistance (MDR)
1925,Takkar (1995),"Takkar VP, Kumar R, Takkar R, Khurana S. Resurgence of chloramphenicol sensitive Salmonella Typhi. Indian Pediatr 1995; 32(5): 586-7.",Systematic review,IND,India,Takkar's Children Hospital,864,Punjab,1991,56,84,66.7,0,Salmonella Typhi,Multidrug resistance (MDR)
595,Garg (1994),"Garg K, Mangal N, Mathur HC. Clinical profile of multi drug resistant typhoid fever in Jaipur City. Indian Pediatr 1994; 31(2): 191-3.",Systematic review,IND,India,Sir Padampat Mother and Child Health Institute (SPCHI) Sawai Man Singh Medical College,865,Rajasthan,1991,46,69,66.7,0,Salmonella Typhi,Multidrug resistance (MDR)
2470,Threlfall (1992),"Threlfall EJ, Ward LR, Rowe B, et al. Widespread occurrence of multiple drug-resistant Salmonella Typhi in India. Eur J Clin Microbiol Infect Dis 1992; 11(11): 990-3.",Systematic review,IND,India,St. Joseph Hospital (Kattu Hospital),867,Tamil Nadu,1991,14,16,87.5,1,Salmonella Typhi,Multidrug resistance (MDR)
237,Mandal (2002),"Mandal S, Mandal MD, Pal NK. Antimicrobial resistance pattern of Salmonella Typhi isolates in Kolkata, India during 1991-2001: a retrospective study. Jpn J Infect Dis 2002; 55(2): 58-9.",Systematic review,IND,India,Calcutta School of Tropical Medicine,869,West Bengal,1991,64,64,100,1,Salmonella Typhi,Multidrug resistance (MDR)
716,Saha (2002),"Saha MR, Dutta P, Niyogi SK, et al. Decreasing trend in the occurrence of Salmonella enterica serotype Typhi amongst hospitalised children in Kolkata, India during 1990-2000. Indian J Med Res 2002; 115(FEB.): 46-8.",Systematic review,IND,India,Dr B. C. Roy Memorial Hospital for Children,869,West Bengal,1991,71,71,100,1,Salmonella Typhi,Multidrug resistance (MDR)
1522,Bhattacharya (1992),"Bhattacharya SK, Dutta D, Bhattacharya MK, et al. Multi-resistant typhoid fever. Natl Med J India 1992; 5(1): 41.",Systematic review,IND,India,Infectious Diseases Hospital (Kolkata),869,West Bengal,1991,16,16,100,1,Salmonella Typhi,Multidrug resistance (MDR)
548,Chitnis(2006),"Chitnis S, Chitnis V, Hemvani N, Chitnis DS. Ciprofloxacin therapy for typhoid fever needs reconsideration. J Infect Chemother 2006; 12(6): 402-4.",Systematic review,IND,India,Choithram Hospital and Research Centre,888,Madhya Pradesh,1991,391,421,92.9,1,Salmonella Typhi,Multidrug resistance (MDR)
579,Mathur (1996),"Mathur YC, Mathur NC, Lal HM. Clinical efficacy of Cefuroxime axetil in S. Typhi. Indian Pediatr 1996; 33(12): 1033-7.",Systematic review,IND,India,Aditya Children Hospital;CDR Hospital;Hari Prasad Memorial Hospital,848,Andhra Pradesh,1992,54.42,76,71.6,0,Salmonella Typhi,Multidrug resistance (MDR)
788,Khosla(1998),"Khosla SN, Saman A, Khosla P, Sabharwal U, Khosla A. Drug resistant typhoid fever. Trop Doct 1998; 28(4): 235-7.",Systematic review,IND,India,Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences,853,Haryana,1992,18,180,10,0,Salmonella Typhi,Multidrug resistance (MDR)
1644,Rathish (1995),"Rathish KC, Chandrashekar MR, Nagesha CN. An outbreak of multidrug resistant typhoid fever in Bangalore. Indian J Pediatr 1995; 62(4): 445-8.",Systematic review,IND,India,Dr. B.R. Ambedkar Medical College,855,Karnataka,1992,156,164,95.1,1,Salmonella Typhi,Multidrug resistance (MDR)
1876,Sridhar (1995),"Sridhar CB, Kulkarni RD. Reassessment of frequency of occurrence of typhoid fever and cost efficacy analysis of antibiotic therapy. J Assoc Physicians India 1995; 43(10): 679-84.",Systematic review,IND,India,St. John Medical College and Hospital,855,Karnataka,1992,64.01,143,44.8,0,Salmonella Typhi,Multidrug resistance (MDR)
1085,Sethuraman (1994),"Sethuraman S, Mahamood M, Kareem S. Furazolidone in multi-resistant childhood typhoid fever. Ann Trop Paediatr 1994; 14(4): 321-4.",Systematic review,IND,India,Government Medical College (Kozhikode),856,Kerala,1992,37.71,48,78.6,0,Salmonella Typhi,Multidrug resistance (MDR)
2049,Rodrigues(2002),"Rodrigues C, Mehta A, Joshi VR. Salmonella Typhiin the past decade: learning to live with resistance. Clin Infect Dis 2002; 34(1): 126.",Systematic review,IND,India,P.D. Hinduja National Hospital and Medical Research Center,858,Maharashtra,1992,63,96,65.6,0,Salmonella Typhi,Multidrug resistance (MDR)
458,Kumar (2001),"Kumar R, Aneja KR, Punia AK, et al. Changing pattern of biotypes, phage types & drug resistance of Salmonella Typhi in Ludhiana during 1980-1999. Indian J Med Res 2001; 113: 175-80.",Systematic review,IND,India,Dayanand Medical College and Hospital,864,Punjab,1992,90,166,54.2,0,Salmonella Typhi,Multidrug resistance (MDR)
882,Verma (1996),"Verma M, Chhatwal J, Saini V, Singh T. Enteric fever below 2 years of age. Indian Pediatr 1996; 33(3): 229-30.",Systematic review,IND,India,Christian Medical College and Hospital (Ludhiana),864,Punjab,1992,11,18,61.1,0,Salmonella Typhi,Multidrug resistance (MDR)
1925,Takkar (1995),"Takkar VP, Kumar R, Takkar R, Khurana S. Resurgence of chloramphenicol sensitive Salmonella Typhi. Indian Pediatr 1995; 32(5): 586-7.",Systematic review,IND,India,Takkar's Children Hospital,864,Punjab,1992,10,50,20,0,Salmonella Typhi,Multidrug resistance (MDR)
1685,Rajajee(1995),"Rajajee S, Anandi TB, Subha S, Vatsala BR. Patterns of resistant Salmonella Typhi infection in infants. J Trop Pediatr 1995; 41(1): 52-4.",Systematic review,IND,India,Kanchi Kamakoti CHILDS Trust Hospital,867,Tamil Nadu,1992,34,71,47.9,0,Salmonella Typhi,Multidrug resistance (MDR)
237,Mandal (2002),"Mandal S, Mandal MD, Pal NK. Antimicrobial resistance pattern of Salmonella Typhi isolates in Kolkata, India during 1991-2001: a retrospective study. Jpn J Infect Dis 2002; 55(2): 58-9.",Systematic review,IND,India,Calcutta School of Tropical Medicine,869,West Bengal,1992,4,44,9.1,0,Salmonella Typhi,Multidrug resistance (MDR)
716,Saha (2002),"Saha MR, Dutta P, Niyogi SK, et al. Decreasing trend in the occurrence of Salmonella enterica serotype Typhi amongst hospitalised children in Kolkata, India during 1990-2000. Indian J Med Res 2002; 115(FEB.): 46-8.",Systematic review,IND,India,Dr B. C. Roy Memorial Hospital for Children,869,West Bengal,1992,16,16,100,1,Salmonella Typhi,Multidrug resistance (MDR)
913,Buch (1994),"Buch NA, Hassan MU, Kakroo DK. Enteric fever--a changing sensitivity pattern, clinical profile and outcome. Indian Pediatr 1994; 31(8): 981-5.",Systematic review,IND,India,Sher-I-Kashmir Institute of Medical Sciences (SKIMS),875,Administrative unit not available,1992,77,112,68.8,0,Salmonella Typhi,Multidrug resistance (MDR)
2317,Mishra (1996),"Mishra OP, Gupta BL, Nath G, Prakash J. Treatment of multidrug-resistant typhoid fever. J Trop Pediatr 1996; 42(5): 310-1.",Systematic review,IND,India,Sir Sunderlal Hospital,890,Uttar Pradesh,1992,16,35,45.7,0,Salmonella Typhi,Multidrug resistance (MDR)
1474,Gandhi(1999),"Gandhi R, Banker DD. Multidrug resistant Salmonella. Indian J Med Sci 1999; 53(6): 259-66.",Systematic review,IND,India,BYL Nair Charitable Hospital;Jagjivan Ram Hospital;Nanavati Hospital;P.D. Hinduja National Hospital and Medical Research Center;Sir Hurkisondas Nurrotumdas Hospital,858,Maharashtra,1993,161.01,246,65.5,0,Salmonella Typhi,Multidrug resistance (MDR)
458,Kumar (2001),"Kumar R, Aneja KR, Punia AK, et al. Changing pattern of biotypes, phage types & drug resistance of Salmonella Typhi in Ludhiana during 1980-1999. Indian J Med Res 2001; 113: 175-80.",Systematic review,IND,India,Dayanand Medical College and Hospital,864,Punjab,1993,14,38,36.8,0,Salmonella Typhi,Multidrug resistance (MDR)
1421,Shanahan (1998),"Shanahan PM, Jesudason MV, Thomson CJ, Amyes SG. Molecular analysis of and identification of antibiotic resistance genes in clinical isolates of Salmonella Typhi from India. J Clin Microbiol 1998; 36(6): 1595-600.",Systematic review,IND,India,Christian Medical College (Vellore),867,Tamil Nadu,1993,11,21,52.4,0,Salmonella Typhi,Multidrug resistance (MDR)
237,Mandal (2002),"Mandal S, Mandal MD, Pal NK. Antimicrobial resistance pattern of Salmonella Typhi isolates in Kolkata, India during 1991-2001: a retrospective study. Jpn J Infect Dis 2002; 55(2): 58-9.",Systematic review,IND,India,Calcutta School of Tropical Medicine,869,West Bengal,1993,0,31,0,0,Salmonella Typhi,Multidrug resistance (MDR)
548,Chitnis(2006),"Chitnis S, Chitnis V, Hemvani N, Chitnis DS. Ciprofloxacin therapy for typhoid fever needs reconsideration. J Infect Chemother 2006; 12(6): 402-4.",Systematic review,IND,India,Choithram Hospital and Research Centre,888,Madhya Pradesh,1993,63,75,84,1,Salmonella Typhi,Multidrug resistance (MDR)
2049,Rodrigues(2002),"Rodrigues C, Mehta A, Joshi VR. Salmonella Typhiin the past decade: learning to live with resistance. Clin Infect Dis 2002; 34(1): 126.",Systematic review,IND,India,P.D. Hinduja National Hospital and Medical Research Center,858,Maharashtra,1994,44,110,40,0,Salmonella Typhi,Multidrug resistance (MDR)
458,Kumar (2001),"Kumar R, Aneja KR, Punia AK, et al. Changing pattern of biotypes, phage types & drug resistance of Salmonella Typhi in Ludhiana during 1980-1999. Indian J Med Res 2001; 113: 175-80.",Systematic review,IND,India,Dayanand Medical College and Hospital,864,Punjab,1994,20,68,29.4,0,Salmonella Typhi,Multidrug resistance (MDR)
1762,Maheshwari (1996),"Maheshwari VD, Agarwal SK. Present status of drug resistance in cases of enteric fever in Rajasthan. J Assoc Physicians India 1996; 44(9): 618-9.",Systematic review,IND,India,Sawai Man Singh Hospital,865,Rajasthan,1994,10,30,33.3,0,Salmonella Typhi,Multidrug resistance (MDR)
237,Mandal (2002),"Mandal S, Mandal MD, Pal NK. Antimicrobial resistance pattern of Salmonella Typhi isolates in Kolkata, India during 1991-2001: a retrospective study. Jpn J Infect Dis 2002; 55(2): 58-9.",Systematic review,IND,India,Calcutta School of Tropical Medicine,869,West Bengal,1994,0,44,0,0,Salmonella Typhi,Multidrug resistance (MDR)
452,Beig (2009),"Beig FK, Ahmad F, Abqari S. Changing antibiotic sensitivity pattern and scope of chloramphenicol in the management of hospitalised patients of typhoid fever. J Indian Med Assoc 2009; 107(12): 862-5.",Systematic review,IND,India,Jawaharlal Nehru Medical College (Aligarh),890,Uttar Pradesh,1994,9,25,36,0,Salmonella Typhi,Multidrug resistance (MDR)
787,Nath(2010),"Nath G, Maurya P. Drug resistance patterns in Salmonella enterica subspecies enterica serotype Typhi strains isolated over a period of two decades, with special reference to ciprofloxacin and ceftriaxone. Int J Antimicrob Agents 2010; 35(5): 482-5.",Systematic review,IND,India,Sir Sunderlal Hospital,890,Uttar Pradesh,1994,2,16,12.5,0,Salmonella Typhi,Multidrug resistance (MDR)
786,Ciraj (1999),"Ciraj AM, Seetha KS, Gopalkrishna BK, Shivananda PG. Drug resistance pattern and phage types of Salmonella Typhi isolates in Manipal, South Karnataka. Indian J Med Sci 1999; 53(11): 486-9.",Systematic review,IND,India,Kasturba Medical College and Hospital (Manipal),855,Karnataka,1995,131,226,58,0,Salmonella Typhi,Multidrug resistance (MDR)
458,Kumar (2001),"Kumar R, Aneja KR, Punia AK, et al. Changing pattern of biotypes, phage types & drug resistance of Salmonella Typhi in Ludhiana during 1980-1999. Indian J Med Res 2001; 113: 175-80.",Systematic review,IND,India,Dayanand Medical College and Hospital,864,Punjab,1995,3,46,6.5,0,Salmonella Typhi,Multidrug resistance (MDR)
997,Kumar (2002),"Kumar R, Aneja KR, Roy P, Sharma M, Gupta R, Ram S. Evaluation of minimum inhibitory concentration of quinolones and third generation cephalosporins to Salmonella Typhi isolates. Indian J Med Sci 2002; 56(1): 1-8.",Systematic review,IND,India,Dayanand Medical College and Hospital,864,Punjab,1995,9,46,19.6,0,Salmonella Typhi,Multidrug resistance (MDR)
237,Mandal (2002),"Mandal S, Mandal MD, Pal NK. Antimicrobial resistance pattern of Salmonella Typhi isolates in Kolkata, India during 1991-2001: a retrospective study. Jpn J Infect Dis 2002; 55(2): 58-9.",Systematic review,IND,India,Calcutta School of Tropical Medicine,869,West Bengal,1995,0,38,0,0,Salmonella Typhi,Multidrug resistance (MDR)
716,Saha (2002),"Saha MR, Dutta P, Niyogi SK, et al. Decreasing trend in the occurrence of Salmonella enterica serotype Typhi amongst hospitalised children in Kolkata, India during 1990-2000. Indian J Med Res 2002; 115(FEB.): 46-8.",Systematic review,IND,India,Dr B. C. Roy Memorial Hospital for Children,869,West Bengal,1995,22,34,64.7,0,Salmonella Typhi,Multidrug resistance (MDR)
548,Chitnis(2006),"Chitnis S, Chitnis V, Hemvani N, Chitnis DS. Ciprofloxacin therapy for typhoid fever needs reconsideration. J Infect Chemother 2006; 12(6): 402-4.",Systematic review,IND,India,Choithram Hospital and Research Centre,888,Madhya Pradesh,1995,19,34,55.9,0,Salmonella Typhi,Multidrug resistance (MDR)
1725,Khan(1999),"Khan JA, Shukla I, Malik A. Plasmid mediated multidrug resistance in Salmonella Typhi. Biomedicine 1999; 19(2): 107-11.",Systematic review,IND,India,Jawaharlal Nehru Medical College (Aligarh),890,Uttar Pradesh,1995,22,100,22,0,Salmonella Typhi,Multidrug resistance (MDR)
1498,Kabra (2000),"Kabra SK, Madhulika, Talati A, Soni N, Patel S, Modi RR. Multidrug-resistant typhoid fever. Trop Doct 2000; 30(4): 195-7.",Systematic review,IND,India,V S General Hospital (Ellis Bridge),852,Gujarat,1996,80,100,80,1,Salmonella Typhi,Multidrug resistance (MDR)
675,Ciraj (2000),"Ciraj AM, Mohammed M, Bhat KG, Shivananda PG. Copper resistance and its correlation to multiple drug resistance in Salmonella Typhi isolates from south Karnataka. Indian J Med Res 2000; 110(DEC.): 181-2.",Systematic review,IND,India,Kasturba Medical College and Hospital (Manipal);Kasturba Medical College Hospital (Mangaluru),855,Karnataka,1996,99.01,186,53.2,0,Salmonella Typhi,Multidrug resistance (MDR)
2049,Rodrigues(2002),"Rodrigues C, Mehta A, Joshi VR. Salmonella Typhiin the past decade: learning to live with resistance. Clin Infect Dis 2002; 34(1): 126.",Systematic review,IND,India,P.D. Hinduja National Hospital and Medical Research Center,858,Maharashtra,1996,53,98,54.1,0,Salmonella Typhi,Multidrug resistance (MDR)
458,Kumar (2001),"Kumar R, Aneja KR, Punia AK, et al. Changing pattern of biotypes, phage types & drug resistance of Salmonella Typhi in Ludhiana during 1980-1999. Indian J Med Res 2001; 113: 175-80.",Systematic review,IND,India,Dayanand Medical College and Hospital,864,Punjab,1996,2,46,4.3,0,Salmonella Typhi,Multidrug resistance (MDR)
997,Kumar (2002),"Kumar R, Aneja KR, Roy P, Sharma M, Gupta R, Ram S. Evaluation of minimum inhibitory concentration of quinolones and third generation cephalosporins to Salmonella Typhi isolates. Indian J Med Sci 2002; 56(1): 1-8.",Systematic review,IND,India,Dayanand Medical College and Hospital,864,Punjab,1996,0,46,0,0,Salmonella Typhi,Multidrug resistance (MDR)
237,Mandal (2002),"Mandal S, Mandal MD, Pal NK. Antimicrobial resistance pattern of Salmonella Typhi isolates in Kolkata, India during 1991-2001: a retrospective study. Jpn J Infect Dis 2002; 55(2): 58-9.",Systematic review,IND,India,Calcutta School of Tropical Medicine,869,West Bengal,1996,0,30,0,0,Salmonella Typhi,Multidrug resistance (MDR)
2093,Gautam (2002),"Gautam V, Gupta NK, Chaudhary U, Arora DR. Sensitivity pattern of Salmonella serotypes in Northern India. Braz J Infect Dis 2002; 6(6): 281-7.",Systematic review,IND,India,Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences,853,Haryana,1997,15,56,26.8,0,Salmonella Typhi,Multidrug resistance (MDR)
4668,Ranju (1998),"Ranju C, Pais P, Ravindran GD, Singh G. Changing pattern of antibiotic sensitivity of Salmonella Typhi. Natl Med J India 1998; 11(6): 266-7.",Systematic review,IND,India,St. John Medical College and Hospital,855,Karnataka,1997,20,100,20,0,Salmonella Typhi,Multidrug resistance (MDR)
458,Kumar (2001),"Kumar R, Aneja KR, Punia AK, et al. Changing pattern of biotypes, phage types & drug resistance of Salmonella Typhi in Ludhiana during 1980-1999. Indian J Med Res 2001; 113: 175-80.",Systematic review,IND,India,Dayanand Medical College and Hospital,864,Punjab,1997,4,14,28.6,0,Salmonella Typhi,Multidrug resistance (MDR)
997,Kumar (2002),"Kumar R, Aneja KR, Roy P, Sharma M, Gupta R, Ram S. Evaluation of minimum inhibitory concentration of quinolones and third generation cephalosporins to Salmonella Typhi isolates. Indian J Med Sci 2002; 56(1): 1-8.",Systematic review,IND,India,Dayanand Medical College and Hospital,864,Punjab,1997,8,18,44.4,0,Salmonella Typhi,Multidrug resistance (MDR)
237,Mandal (2002),"Mandal S, Mandal MD, Pal NK. Antimicrobial resistance pattern of Salmonella Typhi isolates in Kolkata, India during 1991-2001: a retrospective study. Jpn J Infect Dis 2002; 55(2): 58-9.",Systematic review,IND,India,Calcutta School of Tropical Medicine,869,West Bengal,1997,0,26,0,0,Salmonella Typhi,Multidrug resistance (MDR)
548,Chitnis(2006),"Chitnis S, Chitnis V, Hemvani N, Chitnis DS. Ciprofloxacin therapy for typhoid fever needs reconsideration. J Infect Chemother 2006; 12(6): 402-4.",Systematic review,IND,India,Choithram Hospital and Research Centre,888,Madhya Pradesh,1997,22,48,45.8,0,Salmonella Typhi,Multidrug resistance (MDR)
308,Dutta(2001),"Dutta TK, Beeresha A, Ghotekar LH. Atypical manifestations of typhoid fever. J Postgrad Med 2001; 47(4): 248-51.",Systematic review,IND,India,Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER),889,Puducherry,1997,10,32,31.3,0,Salmonella Typhi,Multidrug resistance (MDR)
1533,Kapil (2002),"Kapil A, Renuka, Das B. Nalidixic acid susceptibility test to screen ciprofloxacin resistance in Salmonella Typhi. Indian J Med Res 2002; 115(February): 49-54.",Systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,1998,25,94,26.6,0,Salmonella Typhi,Multidrug resistance (MDR)
2093,Gautam (2002),"Gautam V, Gupta NK, Chaudhary U, Arora DR. Sensitivity pattern of Salmonella serotypes in Northern India. Braz J Infect Dis 2002; 6(6): 281-7.",Systematic review,IND,India,Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences,853,Haryana,1998,20,38,52.6,0,Salmonella Typhi,Multidrug resistance (MDR)
558,Baliga (1999),"Baliga S, Shenoy S, Vidyalaxmi, Pereira P. Ciprofloxacin-resistant Salmonella Typhi. Natl Med J India 1999; 12(3): 138.",Systematic review,IND,India,Kasturba Medical College Hospital (Mangaluru),855,Karnataka,1998,21,44,47.7,0,Salmonella Typhi,Multidrug resistance (MDR)
2032,Sanghavi(2000),"Sanghavi SK, Mane MP, Niphadkar KB. Salmonella types and antibiotic susceptibility: a six months survey. Indian J Pathol Microbiol 2000; 43(1): 31-4.",Systematic review,IND,India,KEM Hospital,858,Maharashtra,1998,14,41,34.1,0,Salmonella Typhi,Multidrug resistance (MDR)
2049,Rodrigues(2002),"Rodrigues C, Mehta A, Joshi VR. Salmonella Typhiin the past decade: learning to live with resistance. Clin Infect Dis 2002; 34(1): 126.",Systematic review,IND,India,P.D. Hinduja National Hospital and Medical Research Center,858,Maharashtra,1998,55,106,51.9,0,Salmonella Typhi,Multidrug resistance (MDR)
1484,Das (2000),"Das U, Bhattacharya SS. Multidrug resistant Salmonella Typhi in Rourkela, Orissa. Indian J Pathol Microbiol 2000; 43(2): 135-8.",Systematic review,IND,India,Ispat General Hospital (Rourkela),863,Orissa,1998,51.26,380,13.5,0,Salmonella Typhi,Multidrug resistance (MDR)
458,Kumar (2001),"Kumar R, Aneja KR, Punia AK, et al. Changing pattern of biotypes, phage types & drug resistance of Salmonella Typhi in Ludhiana during 1980-1999. Indian J Med Res 2001; 113: 175-80.",Systematic review,IND,India,Dayanand Medical College and Hospital,864,Punjab,1998,22,96,22.9,0,Salmonella Typhi,Multidrug resistance (MDR)
997,Kumar (2002),"Kumar R, Aneja KR, Roy P, Sharma M, Gupta R, Ram S. Evaluation of minimum inhibitory concentration of quinolones and third generation cephalosporins to Salmonella Typhi isolates. Indian J Med Sci 2002; 56(1): 1-8.",Systematic review,IND,India,Dayanand Medical College and Hospital,864,Punjab,1998,43,96,44.8,0,Salmonella Typhi,Multidrug resistance (MDR)
237,Mandal (2002),"Mandal S, Mandal MD, Pal NK. Antimicrobial resistance pattern of Salmonella Typhi isolates in Kolkata, India during 1991-2001: a retrospective study. Jpn J Infect Dis 2002; 55(2): 58-9.",Systematic review,IND,India,Calcutta School of Tropical Medicine,869,West Bengal,1998,0,32,0,0,Salmonella Typhi,Multidrug resistance (MDR)
4278,Sudhaharan(2014),"Sudhaharan S, Padmaja K, Solanki R, Lakshmi V, Umabala P, Aparna B. Extra-intestinal salmonellosis in a tertiary care center in South India. J Infect Dev Ctries 2014; 8(7): 831-7.",Systematic review,IND,India,Nizam's Institute of Medical Sciences,848,Andhra Pradesh,1999,6,12,50,0,Salmonella Typhi,Multidrug resistance (MDR)
118,Mohanty (2006),"Mohanty S, Renuka K, Sood S, Das BK, Kapil A. Antibiogram pattern and seasonality of Salmonella serotypes in a North Indian tertiary care hospital. Epidemiol Infect 2006; 134(5): 961-6.",Systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,1999,27,110,24.5,0,Salmonella Typhi,Multidrug resistance (MDR)
1933,Kumar (2008),"Kumar S, Rizvi M, Berry N. Rising prevalence of enteric fever due to multidrug-resistant Salmonella: an epidemiological study. J Med Microbiol 2008; 57(Pt 10): 1247-50.",Systematic review,IND,India,Lok Nayak Jai Prakash Narayan Hospital,850,Delhi,1999,17,47,36.2,0,Salmonella Typhi,Multidrug resistance (MDR)
2093,Gautam (2002),"Gautam V, Gupta NK, Chaudhary U, Arora DR. Sensitivity pattern of Salmonella serotypes in Northern India. Braz J Infect Dis 2002; 6(6): 281-7.",Systematic review,IND,India,Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences,853,Haryana,1999,24,42,57.1,0,Salmonella Typhi,Multidrug resistance (MDR)
458,Kumar (2001),"Kumar R, Aneja KR, Punia AK, et al. Changing pattern of biotypes, phage types & drug resistance of Salmonella Typhi in Ludhiana during 1980-1999. Indian J Med Res 2001; 113: 175-80.",Systematic review,IND,India,Dayanand Medical College and Hospital,864,Punjab,1999,24,55,43.6,0,Salmonella Typhi,Multidrug resistance (MDR)
997,Kumar (2002),"Kumar R, Aneja KR, Roy P, Sharma M, Gupta R, Ram S. Evaluation of minimum inhibitory concentration of quinolones and third generation cephalosporins to Salmonella Typhi isolates. Indian J Med Sci 2002; 56(1): 1-8.",Systematic review,IND,India,Dayanand Medical College and Hospital,864,Punjab,1999,18,55,32.7,0,Salmonella Typhi,Multidrug resistance (MDR)
237,Mandal (2002),"Mandal S, Mandal MD, Pal NK. Antimicrobial resistance pattern of Salmonella Typhi isolates in Kolkata, India during 1991-2001: a retrospective study. Jpn J Infect Dis 2002; 55(2): 58-9.",Systematic review,IND,India,Calcutta School of Tropical Medicine,869,West Bengal,1999,0,42,0,0,Salmonella Typhi,Multidrug resistance (MDR)
716,Saha (2002),"Saha MR, Dutta P, Niyogi SK, et al. Decreasing trend in the occurrence of Salmonella enterica serotype Typhi amongst hospitalised children in Kolkata, India during 1990-2000. Indian J Med Res 2002; 115(FEB.): 46-8.",Systematic review,IND,India,Dr B. C. Roy Memorial Hospital for Children,869,West Bengal,1999,13,26,50,0,Salmonella Typhi,Multidrug resistance (MDR)
4526,Das (2016),"Das S, Samajpati S, Ray U, Roy I, Dutta S. Antimicrobial resistance and molecular subtypes of Salmonella enterica serovar Typhi isolates from Kolkata, India over a 15 years period 1998-2012. Int J Med Microbiol 2016; 25: 25.",Systematic review,IND,India,Two Kolkata Hospitals & two urban slums in Kolkata,869,West Bengal,1999,13,28,46.4,0,Salmonella Typhi,Multidrug resistance (MDR)
547,Dutta (2001)<U+1D47>,"Dutta P, Mitra U, Datta S, et al. Ciprofloxacin susceptible Salmonella Typhi with treatment failure. J Trop Pediatr 2001b; 47(4): 252-3.",Systematic review,IND,India,National Institute of Cholera and Enteric Diseases,869,West Bengal,1999,13,26,50,0,Salmonella Typhi,Multidrug resistance (MDR)
548,Chitnis(2006),"Chitnis S, Chitnis V, Hemvani N, Chitnis DS. Ciprofloxacin therapy for typhoid fever needs reconsideration. J Infect Chemother 2006; 12(6): 402-4.",Systematic review,IND,India,Choithram Hospital and Research Centre,888,Madhya Pradesh,1999,26,74,35.1,0,Salmonella Typhi,Multidrug resistance (MDR)
787,Nath(2010),"Nath G, Maurya P. Drug resistance patterns in Salmonella enterica subspecies enterica serotype Typhi strains isolated over a period of two decades, with special reference to ciprofloxacin and ceftriaxone. Int J Antimicrob Agents 2010; 35(5): 482-5.",Systematic review,IND,India,Sir Sunderlal Hospital,890,Uttar Pradesh,1999,11,61,18,0,Salmonella Typhi,Multidrug resistance (MDR)
118,Mohanty (2006),"Mohanty S, Renuka K, Sood S, Das BK, Kapil A. Antibiogram pattern and seasonality of Salmonella serotypes in a North Indian tertiary care hospital. Epidemiol Infect 2006; 134(5): 961-6.",Systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,2000,38,103,36.9,0,Salmonella Typhi,Multidrug resistance (MDR)
2093,Gautam (2002),"Gautam V, Gupta NK, Chaudhary U, Arora DR. Sensitivity pattern of Salmonella serotypes in Northern India. Braz J Infect Dis 2002; 6(6): 281-7.",Systematic review,IND,India,Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences,853,Haryana,2000,70,134,52.2,0,Salmonella Typhi,Multidrug resistance (MDR)
2169,Chowta (2005),"Chowta MN, Chowta NK. Study of clinical profile and antibiotic response in typhoid fever. Indian J Med Microbiol 2005; 23(2): 125-7.",Systematic review,IND,India,Kasturba Medical College Hospital (Mangaluru),855,Karnataka,2000,6,11,54.5,0,Salmonella Typhi,Multidrug resistance (MDR)
1683,Kadappu (2003),"Kadappu KK, Bhat R, Kurian B. Pattern of multiple drug resistance in enteric fever in Manipal, India. Trop Doct 2003; 33(3): 189-91.",Systematic review,IND,India,Kasturba Medical College and Hospital (Manipal),855,Karnataka,2000,21,40,52.5,0,Salmonella Typhi,Multidrug resistance (MDR)
1642,Misra (2005),"Misra RN, Bawa KS, Magu SK, Bhandari S, Nagendra A, Menon PK. Outbreak of multi-drug resistant Salmonella Typhi enteric fever in Mumbai garrison. Med J Armed Forces India 2005; 61(2): 148-50.",Systematic review,IND,India,Mumbai Garrison,858,Maharashtra,2000,93,93,100,1,Salmonella Typhi,Multidrug resistance (MDR)
899,Rodrigues (2003),"Rodrigues C, Shenai S, Mehta A. Enteric fever in Mumbai, India: the good news and the bad news. Clin Infect Dis 2003; 36(4): 535.",Systematic review,IND,India,P.D. Hinduja National Hospital and Medical Research Center,858,Maharashtra,2000,110,240,45.8,0,Salmonella Typhi,Multidrug resistance (MDR)
2049,Rodrigues(2002),"Rodrigues C, Mehta A, Joshi VR. Salmonella Typhiin the past decade: learning to live with resistance. Clin Infect Dis 2002; 34(1): 126.",Systematic review,IND,India,P.D. Hinduja National Hospital and Medical Research Center,858,Maharashtra,2000,110,240,45.8,0,Salmonella Typhi,Multidrug resistance (MDR)
2157,Bhattacharya (2003),"Bhattacharya SS, Das U. A steady decrease in occurrence of Salmonella Typhi infection in Rourkela, Orissa. Indian J Pathol Microbiol 2003; 46(3): 498-500.",Systematic review,IND,India,Ispat General Hospital (Rourkela),863,Orissa,2000,78,254,30.7,0,Salmonella Typhi,Multidrug resistance (MDR)
260,Safdar(2004),"Safdar A, Harjit K, Elting L, Rolston KVI. Antimicrobial susceptibility of 128 Salmonella enterica serovar Typhi and Paratyphi A isolates from Northern India. Chemotherapy 2004; 50(2): 88-91.",Systematic review,IND,India,Christian Medical College and Hospital (Ludhiana),864,Punjab,2000,20,101,19.8,0,Salmonella Typhi,Multidrug resistance (MDR)
2303,Rupali (2004),"Rupali P, Abraham OC, Jesudason MV, et al. Treatment failure in typhoid fever with ciprofloxacin susceptible Salmonella enterica serotype Typhi. Diagn Microbiol Infect Dis 2004; 49(1): 1-3.",Systematic review,IND,India,Christian Medical College (Vellore),867,Tamil Nadu,2000,54,109,49.5,0,Salmonella Typhi,Multidrug resistance (MDR)
237,Mandal (2002),"Mandal S, Mandal MD, Pal NK. Antimicrobial resistance pattern of Salmonella Typhi isolates in Kolkata, India during 1991-2001: a retrospective study. Jpn J Infect Dis 2002; 55(2): 58-9.",Systematic review,IND,India,Calcutta School of Tropical Medicine,869,West Bengal,2000,2,28,7.1,0,Salmonella Typhi,Multidrug resistance (MDR)
36,Mandeep (2006),"Mandeep W, Rajni G, Premila P, Rajesh M, Pushpa A, Mani K. Age-related clinical and microbiological characteristics of enteric fever in India. Trans R Soc Trop Med Hyg 2006; 100(10): 942-8.",Systematic review,IND,India,Safdarjung Hospital,850,Delhi,2001,60,304,19.7,0,Salmonella Typhi,Multidrug resistance (MDR)
118,Mohanty (2006),"Mohanty S, Renuka K, Sood S, Das BK, Kapil A. Antibiogram pattern and seasonality of Salmonella serotypes in a North Indian tertiary care hospital. Epidemiol Infect 2006; 134(5): 961-6.",Systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,2001,61,125,48.8,0,Salmonella Typhi,Multidrug resistance (MDR)
2090,Achla (2005),"Achla P, Grover SS, Bhatia R, Khare S. Sensitivity index of antimicrobial agents as a simple solution for multidrug resistance in Salmonella Typhi. Indian J Med Res 2005; 121(3): 185-93.",Systematic review,IND,India,Dr Lal PathLabs;Lady Hardinge Medical College;Majeedia Hospital;Ram Manohar Lohia Hospital,850,Delhi,2001,43,205,21,0,Salmonella Typhi,Multidrug resistance (MDR)
904,Capoor(2007),"Capoor MR, Nair D, Deb M, Aggarwal P. Enteric fever perspective in India: emergence of high-level ciprofloxacin resistance and rising MIC to cephalosporins. J Med Microbiol 2007; 56(Pt 8): 1131-2.",Systematic review,IND,India,Safdarjung Hospital,850,Delhi,2001,56,175,32,0,Salmonella Typhi,Multidrug resistance (MDR)
2093,Gautam (2002),"Gautam V, Gupta NK, Chaudhary U, Arora DR. Sensitivity pattern of Salmonella serotypes in Northern India. Braz J Infect Dis 2002; 6(6): 281-7.",Systematic review,IND,India,Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences,853,Haryana,2001,80,166,48.2,0,Salmonella Typhi,Multidrug resistance (MDR)
448,Chande (2002),"Chande C, Shrikhande S, Kapale S, Agrawal S, Fule RP. Change in antimicrobial resistance pattern of Salmonella Typhi in central India. Indian J Med Res 2002; 115: 248-50.",Systematic review,IND,India,Indira Gandhi Government Medical College (Mayo Hospital),858,Maharashtra,2001,11,51,21.6,0,Salmonella Typhi,Multidrug resistance (MDR)
119,Mehta (2002),"Mehta M, Joshi RM. Antibiogram pattern of Salmonella species causing bacteraemia/septicaemia in a teaching hospital. J Infect 2002; 45(2): 133.",Systematic review,IND,India,Government Medical College Hospital (Chandigarh),864,Punjab,2001,0,46,0,0,Salmonella Typhi,Multidrug resistance (MDR)
991,Saharan (2008),"Saharan G, Gupta A, Gupta BK, Sharma BP, Kochar DK, Purohit VP. Evaluation of antibiotic sensitivity pattern in cases of enteric fever in north west Rajasthan. J Indian Med Assoc 2008; 106(8): 528-30, 32.",Systematic review,IND,India,Sardar Patel Medical College (PBM and AG Hospital),865,Rajasthan,2001,23,37,62.2,0,Salmonella Typhi,Multidrug resistance (MDR)
1479,Senthilkumar(2005),"Senthilkumar B, Prabakaran G. Multidrug resistant Salmonella Typhi in asymptomatic typhoid carriers among food handlers in Namakkal district, Tamil Nadu. Indian J Med Microbiol 2005; 23(2): 92-4.",Systematic review,IND,India,Namakkal,867,Tamil Nadu,2001,2,6,33.3,0,Salmonella Typhi,Multidrug resistance (MDR)
237,Mandal (2002),"Mandal S, Mandal MD, Pal NK. Antimicrobial resistance pattern of Salmonella Typhi isolates in Kolkata, India during 1991-2001: a retrospective study. Jpn J Infect Dis 2002; 55(2): 58-9.",Systematic review,IND,India,Calcutta School of Tropical Medicine,869,West Bengal,2001,0,42,0,0,Salmonella Typhi,Multidrug resistance (MDR)
548,Chitnis(2006),"Chitnis S, Chitnis V, Hemvani N, Chitnis DS. Ciprofloxacin therapy for typhoid fever needs reconsideration. J Infect Chemother 2006; 12(6): 402-4.",Systematic review,IND,India,Choithram Hospital and Research Centre,888,Madhya Pradesh,2001,31,103,30.1,0,Salmonella Typhi,Multidrug resistance (MDR)
471,Lakshmi (2006),"Lakshmi V, Ashok R, Susmita J, Shailaja VV. Changing trends in the antibiograms of Salmonella isolates at a tertiary care hospital in Hyderabad. Indian J Med Microbiol 2006; 24(1): 45-8.",Systematic review,IND,India,Nizam's Institute of Medical Sciences,848,Andhra Pradesh,2002,14,26,53.8,0,Salmonella Typhi,Multidrug resistance (MDR)
118,Mohanty (2006),"Mohanty S, Renuka K, Sood S, Das BK, Kapil A. Antibiogram pattern and seasonality of Salmonella serotypes in a North Indian tertiary care hospital. Epidemiol Infect 2006; 134(5): 961-6.",Systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,2002,16,85,18.8,0,Salmonella Typhi,Multidrug resistance (MDR)
1933,Kumar (2008),"Kumar S, Rizvi M, Berry N. Rising prevalence of enteric fever due to multidrug-resistant Salmonella: an epidemiological study. J Med Microbiol 2008; 57(Pt 10): 1247-50.",Systematic review,IND,India,Lok Nayak Jai Prakash Narayan Hospital,850,Delhi,2002,27.77,48,57.9,0,Salmonella Typhi,Multidrug resistance (MDR)
1933,Kumar (2008),"Kumar S, Rizvi M, Berry N. Rising prevalence of enteric fever due to multidrug-resistant Salmonella: an epidemiological study. J Med Microbiol 2008; 57(Pt 10): 1247-50.",Systematic review,IND,India,Lok Nayak Jai Prakash Narayan Hospital,850,Delhi,2002,27.77,48,57.9,0,Salmonella Typhi,Multidrug resistance (MDR)
5124,Joshi (2019),"Joshi S, Adhikary R, Beena HB, et al. Trends in antibiotic susceptibility of enteric fever isolates from South India, 2002–2013.Medical Journal Armed Forces India 2019;75(1):81-85",Systematic review,IND,India,Manipal Hospital (Airport road),855,Karnataka,2002,2,64,3.1,0,Salmonella Typhi,Multidrug resistance (MDR)
465,Arora(2009),"Arora D, Seetha KS, Kumar R. The changing scenario of the Salmonella serotype and its drug resistance pattern. J Clin Diagn Res 2009; 3(5): 1754-9.",Systematic review,IND,India,Kasturba Medical College and Hospital (Manipal),855,Karnataka,2002,32,58,55.2,0,Salmonella Typhi,Multidrug resistance (MDR)
1757,Tankhiwale (2003)<U+1D43>,"Tankhiwale SS, Agrawal G, Jalgaonkar SV. A preliminary report on current antibiogram of Salmonella enterica serotype Typhi in Nagpur. Indian J Med Microbiol 2003a; 21(4): 292.",Systematic review,IND,India,Indira Gandhi Government Medical College (Mayo Hospital),858,Maharashtra,2002,7,23,30.4,0,Salmonella Typhi,Multidrug resistance (MDR)
899,Rodrigues (2003),"Rodrigues C, Shenai S, Mehta A. Enteric fever in Mumbai, India: the good news and the bad news. Clin Infect Dis 2003; 36(4): 535.",Systematic review,IND,India,P.D. Hinduja National Hospital and Medical Research Center,858,Maharashtra,2002,18,106,17,0,Salmonella Typhi,Multidrug resistance (MDR)
2807,Arora(2010),"Arora D, Singh R, Kaur M, Ahi RS. A changing pattern in antimicrobial susceptibility of Salmonella enterica serotype isolated in North India. African Journal of Microbiology Research 2010; 4(3): 197-203.",Systematic review,IND,India,Adesh Institute of Medical Sciences and Research,864,Punjab,2002,31,58,53.4,0,Salmonella Typhi,Multidrug resistance (MDR)
149,Reddy(2005),"Reddy KR, Rajesh PK, Krishnan M, Sekar U. Antibiotic susceptibility pattern and plasmid profile of multidrug resistant Salmonella Typhi. Indian J Med Microbiol 2005; 23(3): 208.",Systematic review,IND,India,Sri Ramachandra Medical College and Research Institute,867,Tamil Nadu,2002,35,63,55.6,0,Salmonella Typhi,Multidrug resistance (MDR)
4526,Das (2016),"Das S, Samajpati S, Ray U, Roy I, Dutta S. Antimicrobial resistance and molecular subtypes of Salmonella enterica serovar Typhi isolates from Kolkata, India over a 15 years period 1998-2012. Int J Med Microbiol 2016; 25: 25.",Systematic review,IND,India,Two Kolkata Hospitals & two urban slums in Kolkata,869,West Bengal,2002,12,36,33.3,0,Salmonella Typhi,Multidrug resistance (MDR)
1887,Mandal (2004),"Mandal S, Mandal MD, Pal NK. Reduced minimum inhibitory concentration of chloramphenicol for Salmonella enterica serovar Typhi. Indian J Med Sci 2004; 58(1): 16-23.",Systematic review,IND,India,Calcutta School of Tropical Medicine,869,West Bengal,2002,3,20,15,0,Salmonella Typhi,Multidrug resistance (MDR)
471,Lakshmi (2006),"Lakshmi V, Ashok R, Susmita J, Shailaja VV. Changing trends in the antibiograms of Salmonella isolates at a tertiary care hospital in Hyderabad. Indian J Med Microbiol 2006; 24(1): 45-8.",Systematic review,IND,India,Nizam's Institute of Medical Sciences,848,Andhra Pradesh,2003,7,22,31.8,0,Salmonella Typhi,Multidrug resistance (MDR)
118,Mohanty (2006),"Mohanty S, Renuka K, Sood S, Das BK, Kapil A. Antibiogram pattern and seasonality of Salmonella serotypes in a North Indian tertiary care hospital. Epidemiol Infect 2006; 134(5): 961-6.",Systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,2003,26,107,24.3,0,Salmonella Typhi,Multidrug resistance (MDR)
1499,Kumar (2007),"Kumar R, Gupta N, Shalini. Multidrug-resistant typhoid fever. Indian J Pediatr 2007; 74(1): 39-42.",Systematic review,IND,India,Batra Hospital and Medical Research Centre,850,Delhi,2003,62,93,66.7,1,Salmonella Typhi,Multidrug resistance (MDR)
870,Verma(2010),"Verma S, Thakur S, Kanga A, Singh G, Gupta P. Emerging Salmonella ParaTyphi A enteric fever and changing trends in antimicrobial resistance pattern of Salmonella in Shimla. Indian J Med Microbiol 2010; 28(1): 51-3.",Systematic review,IND,India,Indira Gandhi Medical College,854,Himachal Pradesh,2003,17,159,10.7,0,Salmonella Typhi,Multidrug resistance (MDR)
5124,Joshi (2019),"Joshi S, Adhikary R, Beena HB, et al. Trends in antibiotic susceptibility of enteric fever isolates from South India, 2002–2013.Medical Journal Armed Forces India 2019;75(1):81-85",Systematic review,IND,India,Manipal Hospital (Airport road),855,Karnataka,2003,2,47,4.3,0,Salmonella Typhi,Multidrug resistance (MDR)
465,Arora(2009),"Arora D, Seetha KS, Kumar R. The changing scenario of the Salmonella serotype and its drug resistance pattern. J Clin Diagn Res 2009; 3(5): 1754-9.",Systematic review,IND,India,Kasturba Medical College and Hospital (Manipal),855,Karnataka,2003,22,45,48.9,0,Salmonella Typhi,Multidrug resistance (MDR)
900,Jog (2008),"Jog S, Soman R, Singhal T, Rodrigues C, Mehta A, Dastur FD. Enteric fever in Mumbai--clinical profile, sensitivity patterns and response to antimicrobials. J Assoc Physicians India 2008; 56: 237-40.",Systematic review,IND,India,P.D. Hinduja National Hospital and Medical Research Center,858,Maharashtra,2003,1,29,3.4,0,Salmonella Typhi,Multidrug resistance (MDR)
2807,Arora(2010),"Arora D, Singh R, Kaur M, Ahi RS. A changing pattern in antimicrobial susceptibility of Salmonella enterica serotype isolated in North India. African Journal of Microbiology Research 2010; 4(3): 197-203.",Systematic review,IND,India,Adesh Institute of Medical Sciences and Research,864,Punjab,2003,20,45,44.4,0,Salmonella Typhi,Multidrug resistance (MDR)
1753,Pallab (2006),"Pallab R, Jyoti S, Marak RSK, Garg RK. Predictive efficacy of nalidixic acid resistance as a marker of fluoroquinolone resistance in Salmonella enterica var Typhi. Indian J Med Res 2006; 124(1): 105-8.",Systematic review,IND,India,Postgraduate Institute of Medical Education and Research (PGIMER; Nehru Hospital),864,Punjab,2003,13,70,18.6,0,Salmonella Typhi,Multidrug resistance (MDR)
2284,Aggarwal (2007),"Aggarwal A, Vij AS, Oberoi A. A three-year retrospective study on the prevalence, drug susceptibility pattern, and phage types of Salmonella enterica subspecies Typhi and ParaTyphi in Christian Medical College and Hospital, Ludhiana, Punjab. J Indian Acad Clin Med 2007; 8(1): 32-5.",Systematic review,IND,India,Christian Medical College and Hospital (Ludhiana),864,Punjab,2003,24,80,30,0,Salmonella Typhi,Multidrug resistance (MDR)
858,Kownhar(2007),"Kownhar H, Shankar EM, Rajan R, Rao UA. Emergence of nalidixic acid-resistant Salmonella enterica serovar Typhi resistant to ciprofloxacin in India. J Med Microbiol 2007; 56(Pt 1): 136-7.",Systematic review,IND,India,Rajiv Gandhi Government General Hospital,867,Tamil Nadu,2003,6,14,42.9,0,Salmonella Typhi,Multidrug resistance (MDR)
1887,Mandal (2004),"Mandal S, Mandal MD, Pal NK. Reduced minimum inhibitory concentration of chloramphenicol for Salmonella enterica serovar Typhi. Indian J Med Sci 2004; 58(1): 16-23.",Systematic review,IND,India,Calcutta School of Tropical Medicine,869,West Bengal,2003,2,23,8.7,0,Salmonella Typhi,Multidrug resistance (MDR)
548,Chitnis(2006),"Chitnis S, Chitnis V, Hemvani N, Chitnis DS. Ciprofloxacin therapy for typhoid fever needs reconsideration. J Infect Chemother 2006; 12(6): 402-4.",Systematic review,IND,India,Choithram Hospital and Research Centre,888,Madhya Pradesh,2003,10,124,8.1,0,Salmonella Typhi,Multidrug resistance (MDR)
690,Madhulika (2004),"Madhulika U, Harish BN, Parija SC. Current pattern in antimicrobial susceptibility of Salmonella Typhi isolates in Pondicherry. Indian J Med Res 2004; 120(2): 111-4.",Systematic review,IND,India,Government Hospital (Pondicherry);Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER),889,Puducherry,2003,61,157,38.9,0,Salmonella Typhi,Multidrug resistance (MDR)
362,Garg (2007),"Garg A, Anupurba S, Garg J, Goyal RK, Sen MR. Bacteriological profile and antimicrobial resistance of blood culture isolates from a university hospital. J Indian Acad Clin Med 2007; 8(2): 139-43.",Systematic review,IND,India,Sir Sunderlal Hospital,890,Uttar Pradesh,2003,36,66,54.5,0,Salmonella Typhi,Multidrug resistance (MDR)
471,Lakshmi (2006),"Lakshmi V, Ashok R, Susmita J, Shailaja VV. Changing trends in the antibiograms of Salmonella isolates at a tertiary care hospital in Hyderabad. Indian J Med Microbiol 2006; 24(1): 45-8.",Systematic review,IND,India,Nizam's Institute of Medical Sciences,848,Andhra Pradesh,2004,4,12,33.3,0,Salmonella Typhi,Multidrug resistance (MDR)
118,Mohanty (2006),"Mohanty S, Renuka K, Sood S, Das BK, Kapil A. Antibiogram pattern and seasonality of Salmonella serotypes in a North Indian tertiary care hospital. Epidemiol Infect 2006; 134(5): 961-6.",Systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,2004,13,99,13.1,0,Salmonella Typhi,Multidrug resistance (MDR)
152,Dhanashree (2007),Dhanashree B. Antibiotic susceptibility profile of Salmonella enterica serovars: trend over three years showing re-emergence of chloramphenicol sensitivity and rare serovars. Indian J Med Sci 2007; 61(10): 576-9.,Systematic review,IND,India,Kasturba Medical College Hospital (Mangaluru),855,Karnataka,2004,5,23,21.7,0,Salmonella Typhi,Multidrug resistance (MDR)
1064,Joshi (2007),"Joshi S, Amarnath SK. Fluoroquinolone resistance in Salmonella Typhi and S. ParaTyphi A in Bangalore, India. Trans R Soc Trop Med Hyg 2007; 101(3): 308-10.",Systematic review,IND,India,Manipal Hospital (Airport road),855,Karnataka,2004,0,25,0,0,Salmonella Typhi,Multidrug resistance (MDR)
5124,Joshi (2019),"Joshi S, Adhikary R, Beena HB, et al. Trends in antibiotic susceptibility of enteric fever isolates from South India, 2002–2013.Medical Journal Armed Forces India 2019;75(1):81-85",Systematic review,IND,India,Manipal Hospital (Airport road),855,Karnataka,2004,5,79,6.3,0,Salmonella Typhi,Multidrug resistance (MDR)
465,Arora(2009),"Arora D, Seetha KS, Kumar R. The changing scenario of the Salmonella serotype and its drug resistance pattern. J Clin Diagn Res 2009; 3(5): 1754-9.",Systematic review,IND,India,Kasturba Medical College and Hospital (Manipal),855,Karnataka,2004,16,45,35.6,0,Salmonella Typhi,Multidrug resistance (MDR)
900,Jog (2008),"Jog S, Soman R, Singhal T, Rodrigues C, Mehta A, Dastur FD. Enteric fever in Mumbai--clinical profile, sensitivity patterns and response to antimicrobials. J Assoc Physicians India 2008; 56: 237-40.",Systematic review,IND,India,P.D. Hinduja National Hospital and Medical Research Center,858,Maharashtra,2004,1,24,4.2,0,Salmonella Typhi,Multidrug resistance (MDR)
121,Das (2006),"Das U, Bhattacharya SS. Antibiogram, phage typing and biotyping of Salmonella Typhi and Salmonella ParaTyphi A from Rourkela, Orissa. Indian J Med Res 2006; 124(1): 109-11.",Systematic review,IND,India,Ispat General Hospital (Rourkela),863,Orissa,2004,11,105,10.5,0,Salmonella Typhi,Multidrug resistance (MDR)
2807,Arora(2010),"Arora D, Singh R, Kaur M, Ahi RS. A changing pattern in antimicrobial susceptibility of Salmonella enterica serotype isolated in North India. African Journal of Microbiology Research 2010; 4(3): 197-203.",Systematic review,IND,India,Adesh Institute of Medical Sciences and Research,864,Punjab,2004,15,45,33.3,0,Salmonella Typhi,Multidrug resistance (MDR)
2284,Aggarwal (2007),"Aggarwal A, Vij AS, Oberoi A. A three-year retrospective study on the prevalence, drug susceptibility pattern, and phage types of Salmonella enterica subspecies Typhi and ParaTyphi in Christian Medical College and Hospital, Ludhiana, Punjab. J Indian Acad Clin Med 2007; 8(1): 32-5.",Systematic review,IND,India,Christian Medical College and Hospital (Ludhiana),864,Punjab,2004,31,97,32,0,Salmonella Typhi,Multidrug resistance (MDR)
1698,Bhaswati (2007),"Bhaswati S, Shanta D, Dipika S, et al. Phage typing, biotyping & antimicrobial resistance profile of Salmonella enterica serotype Typhi from Kolkata. Indian J Med Res 2007; 125(5): 685-8.",Systematic review,IND,India,"Wards 29 & 30, Kolkata",869,West Bengal,2004,28,195,14.4,0,Salmonella Typhi,Multidrug resistance (MDR)
1955,Dutta (2005),"Dutta S, Sur D, Manna B, Bhattacharya SK, Deen JL, Clemens JD. Rollback of Salmonella enterica serotype Typhi resistance to chloramphenicol and other antimicrobials in Kolkata, India. Antimicrob Agents Chemother 2005; 49(4): 1662-3.",Systematic review,IND,India,Kolkata,869,West Bengal,2004,16.74,130,12.9,0,Salmonella Typhi,Multidrug resistance (MDR)
787,Nath(2010),"Nath G, Maurya P. Drug resistance patterns in Salmonella enterica subspecies enterica serotype Typhi strains isolated over a period of two decades, with special reference to ciprofloxacin and ceftriaxone. Int J Antimicrob Agents 2010; 35(5): 482-5.",Systematic review,IND,India,Sir Sunderlal Hospital,890,Uttar Pradesh,2004,7,32,21.9,0,Salmonella Typhi,Multidrug resistance (MDR)
2309,Manchanda (2006),"Manchanda V, Bhalla P, Sethi M, Sharma VK. Treatment of enteric fever in children on the basis of current trends of antimicrobial susceptibility of Salmonella enterica serovar Typhi and ParaTyphi A. Indian J Med Microbiol 2006; 24(2): 101-6.",Systematic review,IND,India,Chacha Nehru Bal Chikitsalaya Hospital,850,Delhi,2005,0,56,0,0,Salmonella Typhi,Multidrug resistance (MDR)
1933,Kumar (2008),"Kumar S, Rizvi M, Berry N. Rising prevalence of enteric fever due to multidrug-resistant Salmonella: an epidemiological study. J Med Microbiol 2008; 57(Pt 10): 1247-50.",Systematic review,IND,India,Lok Nayak Jai Prakash Narayan Hospital,850,Delhi,2005,33,45,73.3,1,Salmonella Typhi,Multidrug resistance (MDR)
5110,Sharma (2018),"Sharma P, Dahiya S, Manral N, et al. Changing trends of culture-positive typhoid fever and antimicrobial susceptibility in a tertiary care North Indian Hospital over the last decade.Indian Journal of Medical Microbiology 2018;36(1):70-76",Systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,2005,17,84,20.2,0,Salmonella Typhi,Multidrug resistance (MDR)
152,Dhanashree (2007),Dhanashree B. Antibiotic susceptibility profile of Salmonella enterica serovars: trend over three years showing re-emergence of chloramphenicol sensitivity and rare serovars. Indian J Med Sci 2007; 61(10): 576-9.,Systematic review,IND,India,Kasturba Medical College Hospital (Mangaluru),855,Karnataka,2005,2,26,7.7,0,Salmonella Typhi,Multidrug resistance (MDR)
1807,Gupta(2009),"Gupta S, Handa A, Chadha DS, Ganjoo RK, Panda RC. Profile of culture positive enteric fever from Bangalore. Med J Armed Forces India 2009; 65(4): 328-31.",Systematic review,IND,India,Command Hospital (Bengaluru),855,Karnataka,2005,0,65,0,0,Salmonella Typhi,Multidrug resistance (MDR)
5124,Joshi (2019),"Joshi S, Adhikary R, Beena HB, et al. Trends in antibiotic susceptibility of enteric fever isolates from South India, 2002–2013.Medical Journal Armed Forces India 2019;75(1):81-85",Systematic review,IND,India,Manipal Hospital (Airport road),855,Karnataka,2005,4,138,2.9,0,Salmonella Typhi,Multidrug resistance (MDR)
465,Arora(2009),"Arora D, Seetha KS, Kumar R. The changing scenario of the Salmonella serotype and its drug resistance pattern. J Clin Diagn Res 2009; 3(5): 1754-9.",Systematic review,IND,India,Kasturba Medical College and Hospital (Manipal),855,Karnataka,2005,17,38,44.7,0,Salmonella Typhi,Multidrug resistance (MDR)
900,Jog (2008),"Jog S, Soman R, Singhal T, Rodrigues C, Mehta A, Dastur FD. Enteric fever in Mumbai--clinical profile, sensitivity patterns and response to antimicrobials. J Assoc Physicians India 2008; 56: 237-40.",Systematic review,IND,India,P.D. Hinduja National Hospital and Medical Research Center,858,Maharashtra,2005,3,20,15,0,Salmonella Typhi,Multidrug resistance (MDR)
2807,Arora(2010),"Arora D, Singh R, Kaur M, Ahi RS. A changing pattern in antimicrobial susceptibility of Salmonella enterica serotype isolated in North India. African Journal of Microbiology Research 2010; 4(3): 197-203.",Systematic review,IND,India,Adesh Institute of Medical Sciences and Research,864,Punjab,2005,16,38,42.1,0,Salmonella Typhi,Multidrug resistance (MDR)
2284,Aggarwal (2007),"Aggarwal A, Vij AS, Oberoi A. A three-year retrospective study on the prevalence, drug susceptibility pattern, and phage types of Salmonella enterica subspecies Typhi and ParaTyphi in Christian Medical College and Hospital, Ludhiana, Punjab. J Indian Acad Clin Med 2007; 8(1): 32-5.",Systematic review,IND,India,Christian Medical College and Hospital (Ludhiana),864,Punjab,2005,22,80,27.5,0,Salmonella Typhi,Multidrug resistance (MDR)
1137,Holt (2012),"Holt KE, Dutta S, Manna B, et al. High-resolution genotyping of the endemic Salmonella Typhi population during a Vi (typhoid) vaccination trial in Kolkata. PLoS Negl Trop Dis 2012; 6(1): e1490.",Systematic review,IND,India,Kolkata outbreak site,869,West Bengal,2005,43,372,11.6,0,Salmonella Typhi,Multidrug resistance (MDR)
4526,Das (2016),"Das S, Samajpati S, Ray U, Roy I, Dutta S. Antimicrobial resistance and molecular subtypes of Salmonella enterica serovar Typhi isolates from Kolkata, India over a 15 years period 1998-2012. Int J Med Microbiol 2016; 25: 25.",Systematic review,IND,India,Two Kolkata Hospitals & two urban slums in Kolkata,869,West Bengal,2005,12,36,33.3,0,Salmonella Typhi,Multidrug resistance (MDR)
4672,Sur  (2009),"Sur  D, Ochiai  RL, Bhattacharya  SK, et al. A cluster-randomized effectiveness trial of Vi typhoid vaccine in India. N Engl J Med 2009; 361(4): 335-44.",Systematic review,IND,India,"Wards 29 & 30, Kolkata",869,West Bengal,2005,0,130,0,0,Salmonella Typhi,Multidrug resistance (MDR)
548,Chitnis(2006),"Chitnis S, Chitnis V, Hemvani N, Chitnis DS. Ciprofloxacin therapy for typhoid fever needs reconsideration. J Infect Chemother 2006; 12(6): 402-4.",Systematic review,IND,India,Choithram Hospital and Research Centre,888,Madhya Pradesh,2005,7,107,6.5,0,Salmonella Typhi,Multidrug resistance (MDR)
246,Menezes (2012),"Menezes GA, Harish BN, Khan MA, Goessens WHF, Hays JP. Antimicrobial resistance trends in blood culture positive Salmonella Typhi isolates from Pondicherry, India, 2005-2009. Clin Microbiol Infect 2012; 18(3): 239-45.",Systematic review,IND,India,Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER);Indira Gandhi Government General Hospital,889,Puducherry,2005,31,70,44.3,0,Salmonella Typhi,Multidrug resistance (MDR)
1126,Raveendran (2008),"Raveendran R, Wattal C, Sharma A, Oberoi J, Prasad K, Datta S. High level ciprofloxacin resistance in Salmonella enterica isolated from blood. Indian J Med Microbiol 2008; 26(1): 50-3.",Systematic review,IND,India,Sir Ganga Ram Hospital,850,Delhi,2006,64,431,14.8,0,Salmonella Typhi,Multidrug resistance (MDR)
904,Capoor(2007),"Capoor MR, Nair D, Deb M, Aggarwal P. Enteric fever perspective in India: emergence of high-level ciprofloxacin resistance and rising MIC to cephalosporins. J Med Microbiol 2007; 56(Pt 8): 1131-2.",Systematic review,IND,India,Safdarjung Hospital,850,Delhi,2006,10,142,7,0,Salmonella Typhi,Multidrug resistance (MDR)
5110,Sharma (2018),"Sharma P, Dahiya S, Manral N, et al. Changing trends of culture-positive typhoid fever and antimicrobial susceptibility in a tertiary care North Indian Hospital over the last decade.Indian Journal of Medical Microbiology 2018;36(1):70-76",Systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,2006,27,86,31.4,0,Salmonella Typhi,Multidrug resistance (MDR)
152,Dhanashree (2007),Dhanashree B. Antibiotic susceptibility profile of Salmonella enterica serovars: trend over three years showing re-emergence of chloramphenicol sensitivity and rare serovars. Indian J Med Sci 2007; 61(10): 576-9.,Systematic review,IND,India,Kasturba Medical College Hospital (Mangaluru),855,Karnataka,2006,2,22,9.1,0,Salmonella Typhi,Multidrug resistance (MDR)
934,Vidyalakshmi (2008),"Vidyalakshmi K, Yashavanth R, Chakrapani M, et al. Epidemiological shift, seasonal variation and antimicrobial susceptibility patterns among enteric fever pathogens in South India. Trop Doct 2008; 38(2): 89-91.",Systematic review,IND,India,Kasturba Medical College Hospital (Mangaluru),855,Karnataka,2006,1,71,1.4,0,Salmonella Typhi,Multidrug resistance (MDR)
1893,Yashavanth (2010),"Yashavanth R, Vidyalakshmi K. The Re-Emergence of chloramphenicol sensitivity among enteric fever pathogens in Mangalore. J Clin Diagn Res 2010; 4(5): 3016-108.",Systematic review,IND,India,Kasturba Medical College Hospital (Mangaluru),855,Karnataka,2006,1,77,1.3,0,Salmonella Typhi,Multidrug resistance (MDR)
5124,Joshi (2019),"Joshi S, Adhikary R, Beena HB, et al. Trends in antibiotic susceptibility of enteric fever isolates from South India, 2002–2013.Medical Journal Armed Forces India 2019;75(1):81-85",Systematic review,IND,India,Manipal Hospital (Airport road),855,Karnataka,2006,2,169,1.2,0,Salmonella Typhi,Multidrug resistance (MDR)
465,Arora(2009),"Arora D, Seetha KS, Kumar R. The changing scenario of the Salmonella serotype and its drug resistance pattern. J Clin Diagn Res 2009; 3(5): 1754-9.",Systematic review,IND,India,Kasturba Medical College and Hospital (Manipal),855,Karnataka,2006,5,25,20,0,Salmonella Typhi,Multidrug resistance (MDR)
2807,Arora(2010),"Arora D, Singh R, Kaur M, Ahi RS. A changing pattern in antimicrobial susceptibility of Salmonella enterica serotype isolated in North India. African Journal of Microbiology Research 2010; 4(3): 197-203.",Systematic review,IND,India,Adesh Institute of Medical Sciences and Research,864,Punjab,2006,4,25,16,0,Salmonella Typhi,Multidrug resistance (MDR)
246,Menezes (2012),"Menezes GA, Harish BN, Khan MA, Goessens WHF, Hays JP. Antimicrobial resistance trends in blood culture positive Salmonella Typhi isolates from Pondicherry, India, 2005-2009. Clin Microbiol Infect 2012; 18(3): 239-45.",Systematic review,IND,India,Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER);Indira Gandhi Government General Hospital,889,Puducherry,2006,26,76,34.2,0,Salmonella Typhi,Multidrug resistance (MDR)
452,Beig (2009),"Beig FK, Ahmad F, Abqari S. Changing antibiotic sensitivity pattern and scope of chloramphenicol in the management of hospitalised patients of typhoid fever. J Indian Med Assoc 2009; 107(12): 862-5.",Systematic review,IND,India,Jawaharlal Nehru Medical College (Aligarh),890,Uttar Pradesh,2006,15,35,42.9,0,Salmonella Typhi,Multidrug resistance (MDR)
2967,Iyer (2017),"Iyer RN, Jangam RR, Jacinth A, Venkatalakshmi A, Nahdi FB. Prevalence and trends in the antimicrobial susceptibility pattern of Salmonella enterica serovars Typhi and ParaTyphi A among children in a pediatric tertiary care hospital in South India over a period of ten years: a retrospective study. Eur J Clin Microbiol Infect Dis 2017; 07: 07.",Systematic review,IND,India,Rainbow Hospital for Women and Children,848,Andhra Pradesh,2007,0,7,0,0,Salmonella Typhi,Multidrug resistance (MDR)
1412,Capoor (2009),"Capoor MR, Deepthi N, Jitendra P, et al. Minimum inhibitory concentration of carbapenems and tigecycline against Salmonella spp. J Med Microbiol 2009; 58(3): 337-41.",Systematic review,IND,India,Majeedia Hospital;Safdarjung Hospital,850,Delhi,2007,6,149,4,0,Salmonella Typhi,Multidrug resistance (MDR)
5110,Sharma (2018),"Sharma P, Dahiya S, Manral N, et al. Changing trends of culture-positive typhoid fever and antimicrobial susceptibility in a tertiary care North Indian Hospital over the last decade.Indian Journal of Medical Microbiology 2018;36(1):70-76",Systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,2007,9,88,10.2,0,Salmonella Typhi,Multidrug resistance (MDR)
266,Kavita (2010),"Kavita N, Channappa ST, Gaddad SM. Antimicrobial susceptibility of Salmonella Typhi in India. J Infect Dev Ctries 2010; 4(2): 70-3.",Systematic review,IND,India,Unknown clinics private and public hospitals in Gulbarga region,855,Karnataka,2007,9,84,10.7,0,Salmonella Typhi,Multidrug resistance (MDR)
5124,Joshi (2019),"Joshi S, Adhikary R, Beena HB, et al. Trends in antibiotic susceptibility of enteric fever isolates from South India, 2002–2013.Medical Journal Armed Forces India 2019;75(1):81-85",Systematic review,IND,India,Manipal Hospital (Airport road),855,Karnataka,2007,10,184,5.4,0,Salmonella Typhi,Multidrug resistance (MDR)
465,Arora(2009),"Arora D, Seetha KS, Kumar R. The changing scenario of the Salmonella serotype and its drug resistance pattern. J Clin Diagn Res 2009; 3(5): 1754-9.",Systematic review,IND,India,Kasturba Medical College and Hospital (Manipal),855,Karnataka,2007,0,11,0,0,Salmonella Typhi,Multidrug resistance (MDR)
641,Ammini(2011),"Ammini P, Jasna V, Greeshma M, Preethi C. Comparative virulence genotyping and antimicrobial susceptibility profiling of environmental and clinical Salmonella enterica from Cochin, India. Current Microbiology 2011; 62(1): 21-6.",Systematic review,IND,India,General Hospital and private laboratories in Cochin,856,Kerala,2007,0,30,0,0,Salmonella Typhi,Multidrug resistance (MDR)
1617,Bhattacharya (2011),"Bhattacharya SS, Das U, Choudhury BK. Occurrence & antibiogram of Salmonella Typhi & S. ParaTyphi A isolated from Rourkela, Orissa. Indian J Med Res 2011; 133: 431-3.",Systematic review,IND,India,Ispat General Hospital (Rourkela),863,Orissa,2007,20.99,234,9,0,Salmonella Typhi,Multidrug resistance (MDR)
2807,Arora(2010),"Arora D, Singh R, Kaur M, Ahi RS. A changing pattern in antimicrobial susceptibility of Salmonella enterica serotype isolated in North India. African Journal of Microbiology Research 2010; 4(3): 197-203.",Systematic review,IND,India,Adesh Institute of Medical Sciences and Research,864,Punjab,2007,0,11,0,0,Salmonella Typhi,Multidrug resistance (MDR)
1897,Gupta (2009)<U+1D47>,"Gupta V, Kaur J, Kaistha N. Re-emerging chloramphenicol sensitivity and emerging low level ciprofloxacin resistance among Salmonella enterica serotype Typhi isolates in North India. Trop Doct 2009; 39(1): 28-30.",Systematic review,IND,India,Government Medical College Hospital (Chandigarh),864,Punjab,2007,3,87,3.4,0,Salmonella Typhi,Multidrug resistance (MDR)
246,Menezes (2012),"Menezes GA, Harish BN, Khan MA, Goessens WHF, Hays JP. Antimicrobial resistance trends in blood culture positive Salmonella Typhi isolates from Pondicherry, India, 2005-2009. Clin Microbiol Infect 2012; 18(3): 239-45.",Systematic review,IND,India,Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER);Indira Gandhi Government General Hospital,889,Puducherry,2007,17,63,27,0,Salmonella Typhi,Multidrug resistance (MDR)
2967,Iyer (2017),"Iyer RN, Jangam RR, Jacinth A, Venkatalakshmi A, Nahdi FB. Prevalence and trends in the antimicrobial susceptibility pattern of Salmonella enterica serovars Typhi and ParaTyphi A among children in a pediatric tertiary care hospital in South India over a period of ten years: a retrospective study. Eur J Clin Microbiol Infect Dis 2017; 07: 07.",Systematic review,IND,India,Rainbow Hospital for Women and Children,848,Andhra Pradesh,2008,1,16,6.3,0,Salmonella Typhi,Multidrug resistance (MDR)
4278,Sudhaharan(2014),"Sudhaharan S, Padmaja K, Solanki R, Lakshmi V, Umabala P, Aparna B. Extra-intestinal salmonellosis in a tertiary care center in South India. J Infect Dev Ctries 2014; 8(7): 831-7.",Systematic review,IND,India,Nizam's Institute of Medical Sciences,848,Andhra Pradesh,2008,9,16,56.3,1,Salmonella Typhi,Multidrug resistance (MDR)
439,Sabharwal (2010),Sabharwal ER. Ceftriaxone resistance in Salmonella Typhi - myth or a reality! Indian J Pathol Microbiol 2010; 53(2): 389.,Systematic review,IND,India,Dr Lal PathLabs,850,Delhi,2008,8,83,9.6,0,Salmonella Typhi,Multidrug resistance (MDR)
5110,Sharma (2018),"Sharma P, Dahiya S, Manral N, et al. Changing trends of culture-positive typhoid fever and antimicrobial susceptibility in a tertiary care North Indian Hospital over the last decade.Indian Journal of Medical Microbiology 2018;36(1):70-76",Systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,2008,16,92,17.4,0,Salmonella Typhi,Multidrug resistance (MDR)
262,Kumar (2013)<U+1D47>,"Kumar MS, Kumar GSV, Prashanth HV, Prakash R, Veena K, Chandrashekar SC. Antimicrobial susceptibility of enteric fever Salmonellae isolated from blood culture. Res J Pharm Biol Chem Sci 2013b; 4(3): 318-24.",Systematic review,IND,India,Sri Siddhartha Medical College,855,Karnataka,2008,2,160,1.3,0,Salmonella Typhi,Multidrug resistance (MDR)
5124,Joshi (2019),"Joshi S, Adhikary R, Beena HB, et al. Trends in antibiotic susceptibility of enteric fever isolates from South India, 2002–2013.Medical Journal Armed Forces India 2019;75(1):81-85",Systematic review,IND,India,Manipal Hospital (Airport road),855,Karnataka,2008,13,255,5.1,0,Salmonella Typhi,Multidrug resistance (MDR)
465,Arora(2009),"Arora D, Seetha KS, Kumar R. The changing scenario of the Salmonella serotype and its drug resistance pattern. J Clin Diagn Res 2009; 3(5): 1754-9.",Systematic review,IND,India,Kasturba Medical College and Hospital (Manipal),855,Karnataka,2008,0,18,0,0,Salmonella Typhi,Multidrug resistance (MDR)
1697,Sabiha(2012),"Sabiha ST, Nilekar SL. Phage types of multidrug resistant Salmonella species in a rural area of Maharashtra, India. Bangladesh J Med Sci 2012; 11(1): 37-9.",Systematic review,IND,India,Unknown rural medical college in Maharashtra,858,Maharashtra,2008,5,20,25,0,Salmonella Typhi,Multidrug resistance (MDR)
2807,Arora(2010),"Arora D, Singh R, Kaur M, Ahi RS. A changing pattern in antimicrobial susceptibility of Salmonella enterica serotype isolated in North India. African Journal of Microbiology Research 2010; 4(3): 197-203.",Systematic review,IND,India,Adesh Institute of Medical Sciences and Research,864,Punjab,2008,0,18,0,0,Salmonella Typhi,Multidrug resistance (MDR)
2334,Gupta (2013),"Gupta V, Singla N, Bansal N, Kaistha N, Chander J. Trends in the antibiotic resistance patterns of enteric fever isolates - a three year report from a tertiary care centre. Malays J Med Sci 2013; 20(4): 71-5.",Systematic review,IND,India,Government Medical College Hospital (Chandigarh),864,Punjab,2008,1,41,2.4,0,Salmonella Typhi,Multidrug resistance (MDR)
2334,Gupta (2013),"Gupta V, Singla N, Bansal N, Kaistha N, Chander J. Trends in the antibiotic resistance patterns of enteric fever isolates - a three year report from a tertiary care centre. Malays J Med Sci 2013; 20(4): 71-5.",Systematic review,IND,India,Government Medical College Hospital (Chandigarh),864,Punjab,2008,1,41,2.4,0,Salmonella Typhi,Multidrug resistance (MDR)
2165,Gopal(2011),"Gopal M, Arumugam S, Gnadesikan S, Ramesh S. Studies on antimicrobial susceptibility pattern of Salmonella isolates from Chennai, India. Int J Pharma Bio Sci 2011; 2(2).",Systematic review,IND,India,Rajiv Gandhi Government General Hospital;Other clinical laboratories Chennai,867,Tamil Nadu,2008,3,133,2.3,0,Salmonella Typhi,Multidrug resistance (MDR)
5069,Bandyopadhyay(2018),"Bandyopadhyay R, Balaji V, Yadav B, Jasmine S, Sathyendra S, Rupali P. Effectiveness of treatment regimens for Typhoid fever in the nalidixic acid-resistant S. Typhi (NARST) era in South India. Trop Doct 2018; 48(3): 182-8.",Systematic review,IND,India,Christian Medical College (Vellore),867,Tamil Nadu,2008,2,32,6.3,0,Salmonella Typhi,Multidrug resistance (MDR)
4526,Das (2016),"Das S, Samajpati S, Ray U, Roy I, Dutta S. Antimicrobial resistance and molecular subtypes of Salmonella enterica serovar Typhi isolates from Kolkata, India over a 15 years period 1998-2012. Int J Med Microbiol 2016; 25: 25.",Systematic review,IND,India,Two Kolkata Hospitals & two urban slums in Kolkata,869,West Bengal,2008,9,32,28.1,0,Salmonella Typhi,Multidrug resistance (MDR)
1128,Pathak (2012),"Pathak A, Marothi Y, Kekre V, Mahadik K, Macaden R, Lundborg CS. High prevalence of extended-spectrum beta-lactamase-producing pathogens: results of a surveillance study in two hospitals in Ujjain, India. Infect Drug Resist 2012; 5: 65-73.",Systematic review,IND,India,Ruxmaniben Deepchand Gardi Medical College Hospital;Ujjain Charitable Trust Hospital,888,Madhya Pradesh,2008,0,21,0,0,Salmonella Typhi,Multidrug resistance (MDR)
246,Menezes (2012),"Menezes GA, Harish BN, Khan MA, Goessens WHF, Hays JP. Antimicrobial resistance trends in blood culture positive Salmonella Typhi isolates from Pondicherry, India, 2005-2009. Clin Microbiol Infect 2012; 18(3): 239-45.",Systematic review,IND,India,Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER);Indira Gandhi Government General Hospital,889,Puducherry,2008,0,69,0,0,Salmonella Typhi,Multidrug resistance (MDR)
2967,Iyer (2017),"Iyer RN, Jangam RR, Jacinth A, Venkatalakshmi A, Nahdi FB. Prevalence and trends in the antimicrobial susceptibility pattern of Salmonella enterica serovars Typhi and ParaTyphi A among children in a pediatric tertiary care hospital in South India over a period of ten years: a retrospective study. Eur J Clin Microbiol Infect Dis 2017; 07: 07.",Systematic review,IND,India,Rainbow Hospital for Women and Children,848,Andhra Pradesh,2009,0,45,0,0,Salmonella Typhi,Multidrug resistance (MDR)
1923,Alam (2011),"Alam MS, Pillai PK, Kapur P, Pillai KK. Resistant patterns of bacteria isolated from bloodstream infections at a university hospital in Delhi. J Pharm Bioallied Sci 2011; 3(4): 525-30.",Systematic review,IND,India,Majeedia Hospital,850,Delhi,2009,1,11,9.1,0,Salmonella Typhi,Multidrug resistance (MDR)
5110,Sharma (2018),"Sharma P, Dahiya S, Manral N, et al. Changing trends of culture-positive typhoid fever and antimicrobial susceptibility in a tertiary care North Indian Hospital over the last decade.Indian Journal of Medical Microbiology 2018;36(1):70-76",Systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,2009,5,101,5,0,Salmonella Typhi,Multidrug resistance (MDR)
425,Trivedi (2010),"Trivedi ND, Trivedi UN. Case report and pathological result based study on typhoid patients. Int J Pharm Sci Rev Res 2010; 2(2): 22-3.",Systematic review,IND,India,Unknown hositals in Banaskantha District,852,Gujarat,2009,29,46,63,1,Salmonella Typhi,Multidrug resistance (MDR)
5124,Joshi (2019),"Joshi S, Adhikary R, Beena HB, et al. Trends in antibiotic susceptibility of enteric fever isolates from South India, 2002–2013.Medical Journal Armed Forces India 2019;75(1):81-85",Systematic review,IND,India,Manipal Hospital (Airport road),855,Karnataka,2009,8,197,4.1,0,Salmonella Typhi,Multidrug resistance (MDR)
1896,Kumar(2011),"Kumar Y, Sharma A, Mani KR. Re-emergence of susceptibility to conventionally used drugs among strains of Salmonella Typhi in central west India. J Infect Dev Ctries 2011; 5(3): 227-30.",Systematic review,IND,India,Unknown hospitals in Maharashtra state,858,Maharashtra,2009,6,128,4.7,0,Salmonella Typhi,Multidrug resistance (MDR)
2334,Gupta (2013),"Gupta V, Singla N, Bansal N, Kaistha N, Chander J. Trends in the antibiotic resistance patterns of enteric fever isolates - a three year report from a tertiary care centre. Malays J Med Sci 2013; 20(4): 71-5.",Systematic review,IND,India,Government Medical College Hospital (Chandigarh),864,Punjab,2009,0,91,0,0,Salmonella Typhi,Multidrug resistance (MDR)
2334,Gupta (2013),"Gupta V, Singla N, Bansal N, Kaistha N, Chander J. Trends in the antibiotic resistance patterns of enteric fever isolates - a three year report from a tertiary care centre. Malays J Med Sci 2013; 20(4): 71-5.",Systematic review,IND,India,Government Medical College Hospital (Chandigarh),864,Punjab,2009,0,91,0,0,Salmonella Typhi,Multidrug resistance (MDR)
5069,Bandyopadhyay(2018),"Bandyopadhyay R, Balaji V, Yadav B, Jasmine S, Sathyendra S, Rupali P. Effectiveness of treatment regimens for Typhoid fever in the nalidixic acid-resistant S. Typhi (NARST) era in South India. Trop Doct 2018; 48(3): 182-8.",Systematic review,IND,India,Christian Medical College (Vellore),867,Tamil Nadu,2009,2,29,6.9,0,Salmonella Typhi,Multidrug resistance (MDR)
246,Menezes (2012),"Menezes GA, Harish BN, Khan MA, Goessens WHF, Hays JP. Antimicrobial resistance trends in blood culture positive Salmonella Typhi isolates from Pondicherry, India, 2005-2009. Clin Microbiol Infect 2012; 18(3): 239-45.",Systematic review,IND,India,Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER);Indira Gandhi Government General Hospital,889,Puducherry,2009,0,59,0,0,Salmonella Typhi,Multidrug resistance (MDR)
842,Thamizhmani(2012),"Thamizhmani R, Bhattacharya D, Sayi DS, et al. Emergence of fluoroquinolone resistance in Salmonella enterica serovar Typhi in Andaman and Nicobar Islands, India. Indian J Med Res 2012; 136(1): 98-101.",Systematic review,IND,India,Govind Ballabh Pant Hospital;INHS Dhanwantari,847,Andaman and Nicobar,2010,0,6,0,0,Salmonella Typhi,Multidrug resistance (MDR)
2967,Iyer (2017),"Iyer RN, Jangam RR, Jacinth A, Venkatalakshmi A, Nahdi FB. Prevalence and trends in the antimicrobial susceptibility pattern of Salmonella enterica serovars Typhi and ParaTyphi A among children in a pediatric tertiary care hospital in South India over a period of ten years: a retrospective study. Eur J Clin Microbiol Infect Dis 2017; 07: 07.",Systematic review,IND,India,Rainbow Hospital for Women and Children,848,Andhra Pradesh,2010,0,36,0,0,Salmonella Typhi,Multidrug resistance (MDR)
3082,Duggal (2016),"Duggal S, Banerjee P, Chugh TD. Review of fifty culture proven Salmonella cases. Indian J Med Sci 2016; 68(1): 67-72.",Systematic review,IND,India,Unknown Hospital(s) in Delhi,850,Delhi,2010,2,36,5.6,0,Salmonella Typhi,Multidrug resistance (MDR)
207,Jain (2013),"Jain S, Chugh TD. Antimicrobial resistance among blood culture isolates of Salmonella enterica in New Delhi. J Infect Dev Ctries 2013; 7(11): 788-95.",Systematic review,IND,India,BLK Super speciality Hospital,850,Delhi,2010,0,108,0,0,Salmonella Typhi,Multidrug resistance (MDR)
5110,Sharma (2018),"Sharma P, Dahiya S, Manral N, et al. Changing trends of culture-positive typhoid fever and antimicrobial susceptibility in a tertiary care North Indian Hospital over the last decade.Indian Journal of Medical Microbiology 2018;36(1):70-76",Systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,2010,4,96,4.2,0,Salmonella Typhi,Multidrug resistance (MDR)
151,Suruchi (2014),"Suruchi B, Anil K, Ganju SA, Atal S. Antibiotic susceptibility pattern of Salmonella enterica serovar Typhi and ParaTyphi a from North India: the changing scenario. Int J Pharma Bio Sci 2014; 5(4).",Systematic review,IND,India,Indira Gandhi Medical College,854,Himachal Pradesh,2010,0,22,0,0,Salmonella Typhi,Multidrug resistance (MDR)
2820,Shetty (2012),"Shetty AK, Shetty IN, Furtado ZV, Antony B, Boloor R. Antibiogram of Salmonella isolates from blood with an emphasis on nalidixic acid and chloramphenicol susceptibility in a tertiary care hospital in coastal karnataka: a prospective study. J Lab Physicians 2012; 4(2): 74-7.",Systematic review,IND,India,Father Muller Medical College Hospital,855,Karnataka,2010,2,85,2.4,0,Salmonella Typhi,Multidrug resistance (MDR)
5124,Joshi (2019),"Joshi S, Adhikary R, Beena HB, et al. Trends in antibiotic susceptibility of enteric fever isolates from South India, 2002–2013.Medical Journal Armed Forces India 2019;75(1):81-85",Systematic review,IND,India,Manipal Hospital (Airport road),855,Karnataka,2010,8,164,4.9,0,Salmonella Typhi,Multidrug resistance (MDR)
2334,Gupta (2013),"Gupta V, Singla N, Bansal N, Kaistha N, Chander J. Trends in the antibiotic resistance patterns of enteric fever isolates - a three year report from a tertiary care centre. Malays J Med Sci 2013; 20(4): 71-5.",Systematic review,IND,India,Government Medical College Hospital (Chandigarh),864,Punjab,2010,0,125,0,0,Salmonella Typhi,Multidrug resistance (MDR)
2334,Gupta (2013),"Gupta V, Singla N, Bansal N, Kaistha N, Chander J. Trends in the antibiotic resistance patterns of enteric fever isolates - a three year report from a tertiary care centre. Malays J Med Sci 2013; 20(4): 71-5.",Systematic review,IND,India,Government Medical College Hospital (Chandigarh),864,Punjab,2010,0,125,0,0,Salmonella Typhi,Multidrug resistance (MDR)
264,Choudhary(2013),"Choudhary A, Gopalakrishnan R, Nambi PS, Ramasubramanian V, Ghafur KA, Thirunarayan MA. Antimicrobial susceptibility of Salmonella enterica serovars in a tertiary care hospital in southern India. Indian J Med Res 2013; 137(4): 800-2.",Systematic review,IND,India,Apollo Hospital (Gream Road),867,Tamil Nadu,2010,0,186,0,0,Salmonella Typhi,Multidrug resistance (MDR)
744,Elumalai (2014),"Elumalai S, Muthu G, Selvam RE, Ramesh S. Detection of TEM-, SHV- and CTX-M-type beta-lactamase production among clinical isolates of Salmonella species. J Med Microbiol 2014; 63(Pt 7): 962-7.",Systematic review,IND,India,Unknown hospitals and laboratories in Chennai,867,Tamil Nadu,2010,5,101,5,0,Salmonella Typhi,Multidrug resistance (MDR)
5069,Bandyopadhyay(2018),"Bandyopadhyay R, Balaji V, Yadav B, Jasmine S, Sathyendra S, Rupali P. Effectiveness of treatment regimens for Typhoid fever in the nalidixic acid-resistant S. Typhi (NARST) era in South India. Trop Doct 2018; 48(3): 182-8.",Systematic review,IND,India,Christian Medical College (Vellore),867,Tamil Nadu,2010,1,32,3.1,0,Salmonella Typhi,Multidrug resistance (MDR)
1649,Singla (2013),"Singla N, Bansal N, Gupta V, Chander J. Outbreak of Salmonella Typhi enteric fever in sub-urban area of North India: a public health perspective. Asian Pac J Trop Med 2013; 6(2): 167-8.",Systematic review,IND,India,Ram Darbar,883,Chandigarh,2010,0,18,0,0,Salmonella Typhi,Multidrug resistance (MDR)
4650,Yadav (2016),"Yadav VC, Kiran VR, Sharma R. Enteric fever in Bastar tribal region-prevalence and sensitivity patterns. J Evol Med Dent Sci 2016; 5(53): 3526-30.",Systematic review,IND,India,Late Baliram Kashyap Memorial Government Medical College Jagdalpur,884,Chhattisgarh,2010,66,122,54.1,1,Salmonella Typhi,Multidrug resistance (MDR)
781,Pratap(2012),"Pratap CB, Patel SK, Shukla VK, Tripathi SK, Singh TB, Nath G. Drug resistance in Salmonella enterica serotype Typhi isolated from chronic typhoid carriers. Int J Antimicrob Agents 2012; 40(3): 279-80.",Systematic review,IND,India,Sir Sunderlal Hospital,890,Uttar Pradesh,2010,7,36,19.4,0,Salmonella Typhi,Multidrug resistance (MDR)
2967,Iyer (2017),"Iyer RN, Jangam RR, Jacinth A, Venkatalakshmi A, Nahdi FB. Prevalence and trends in the antimicrobial susceptibility pattern of Salmonella enterica serovars Typhi and ParaTyphi A among children in a pediatric tertiary care hospital in South India over a period of ten years: a retrospective study. Eur J Clin Microbiol Infect Dis 2017; 07: 07.",Systematic review,IND,India,Rainbow Hospital for Women and Children,848,Andhra Pradesh,2011,1,51,2,0,Salmonella Typhi,Multidrug resistance (MDR)
207,Jain (2013),"Jain S, Chugh TD. Antimicrobial resistance among blood culture isolates of Salmonella enterica in New Delhi. J Infect Dev Ctries 2013; 7(11): 788-95.",Systematic review,IND,India,BLK Super speciality Hospital,850,Delhi,2011,9,266,3.4,0,Salmonella Typhi,Multidrug resistance (MDR)
5097,Makkar (2018),"Makkar A, Gupta S, Khan ID, et al. Epidemiological Profile and Antimicrobial Resistance Pattern of Enteric Fever in a Tertiary Care Hospital of North India - a Seven Year Ambispective Study.Acta Medica (Hradec Kralove) 2018;61(4):125-130",Systematic review,IND,India,Unknown Hospital(s) in Delhi,850,Delhi,2011,2,64,3.1,0,Salmonella Typhi,Multidrug resistance (MDR)
5110,Sharma (2018),"Sharma P, Dahiya S, Manral N, et al. Changing trends of culture-positive typhoid fever and antimicrobial susceptibility in a tertiary care North Indian Hospital over the last decade.Indian Journal of Medical Microbiology 2018;36(1):70-76",Systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,2011,3,55,5.5,0,Salmonella Typhi,Multidrug resistance (MDR)
4642,Vala (2016),"Vala S, Shah U, Ahmad SA, Scolnik D, Glatstein M. Resistance patterns of typhoid fever in children: A longitudinal community-based study. Am J Ther 2016; 23(5): E1151-E4.",Systematic review,IND,India,The Synergy Neonatal and Pediatric Hospital (Maninagar);The Synergy Neonatal and Pediatric Hospital (Vasna);Unknown private clinics in Ahmedabad;Unknown community hospitals in Ahmedabad;Unknown private clinics in Vadodara;Unknown community hospitals in Vadodara;Unknown private clinics in Bhavangar;Unknown community hospitals in Bhavangar,852,Gujarat,2011,10,61,16.4,0,Salmonella Typhi,Multidrug resistance (MDR)
352,Kaur(2014),"Kaur A, Singh VA. Bacterial isolates and their antibiotic sensitivity pattern in clinically suspected cases of fever of unknown origin. JK Science 2014; 16(3): 105-9.",Systematic review,IND,India,Maharishi Markandeshwar Institute of Medical Sciences and Research,853,Haryana,2011,3,5,60,1,Salmonella Typhi,Multidrug resistance (MDR)
151,Suruchi (2014),"Suruchi B, Anil K, Ganju SA, Atal S. Antibiotic susceptibility pattern of Salmonella enterica serovar Typhi and ParaTyphi a from North India: the changing scenario. Int J Pharma Bio Sci 2014; 5(4).",Systematic review,IND,India,Indira Gandhi Medical College,854,Himachal Pradesh,2011,0,7,0,0,Salmonella Typhi,Multidrug resistance (MDR)
5124,Joshi (2019),"Joshi S, Adhikary R, Beena HB, et al. Trends in antibiotic susceptibility of enteric fever isolates from South India, 2002–2013.Medical Journal Armed Forces India 2019;75(1):81-85",Systematic review,IND,India,Manipal Hospital (Airport road),855,Karnataka,2011,6,224,2.7,0,Salmonella Typhi,Multidrug resistance (MDR)
4515,Chande (2016),"Chande CA, Chopdekar KA, Pradnya V, et al. Current trend of antibiotic sensitivity of Salmonella Typhi and other Salmonellae in Mumbai: A 5 years study. Indian J Med Microbiol 2016; 34(1): 115-6.",Systematic review,IND,India,Grant Medical College and Sir Jamshedjee Jeejeebhoy Group of Hospitals,858,Maharashtra,2011,0,108,0,0,Salmonella Typhi,Multidrug resistance (MDR)
5069,Bandyopadhyay(2018),"Bandyopadhyay R, Balaji V, Yadav B, Jasmine S, Sathyendra S, Rupali P. Effectiveness of treatment regimens for Typhoid fever in the nalidixic acid-resistant S. Typhi (NARST) era in South India. Trop Doct 2018; 48(3): 182-8.",Systematic review,IND,India,Christian Medical College (Vellore),867,Tamil Nadu,2011,2,34,5.9,0,Salmonella Typhi,Multidrug resistance (MDR)
4526,Das (2016),"Das S, Samajpati S, Ray U, Roy I, Dutta S. Antimicrobial resistance and molecular subtypes of Salmonella enterica serovar Typhi isolates from Kolkata, India over a 15 years period 1998-2012. Int J Med Microbiol 2016; 25: 25.",Systematic review,IND,India,Two Kolkata Hospitals & two urban slums in Kolkata,869,West Bengal,2011,5,32,15.6,0,Salmonella Typhi,Multidrug resistance (MDR)
4650,Yadav (2016),"Yadav VC, Kiran VR, Sharma R. Enteric fever in Bastar tribal region-prevalence and sensitivity patterns. J Evol Med Dent Sci 2016; 5(53): 3526-30.",Systematic review,IND,India,Late Baliram Kashyap Memorial Government Medical College Jagdalpur,884,Chhattisgarh,2011,60,103,58.3,1,Salmonella Typhi,Multidrug resistance (MDR)
1730,Geetha (2014),"Geetha VK, Yugendran T, Srinivasan R, Harish BN. Plasmid-mediated quinolone resistance in typhoidal Salmonellae: a preliminary report from South India. Indian J Med Microbiol 2014; 32(1): 31-4.",Systematic review,IND,India,Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER),889,Puducherry,2011,2,36,5.6,0,Salmonella Typhi,Multidrug resistance (MDR)
4411,Narain (2015),"Narain U, Gupta R. Emergence of resistance in community-acquired enteric fever. Indian Pediatr 2015; 52(8): 709-.",Systematic review,IND,India,"Priti Hospital, Medical Research and Charitable Trust",890,Uttar Pradesh,2011,15,220,6.8,0,Salmonella Typhi,Multidrug resistance (MDR)
2967,Iyer (2017),"Iyer RN, Jangam RR, Jacinth A, Venkatalakshmi A, Nahdi FB. Prevalence and trends in the antimicrobial susceptibility pattern of Salmonella enterica serovars Typhi and ParaTyphi A among children in a pediatric tertiary care hospital in South India over a period of ten years: a retrospective study. Eur J Clin Microbiol Infect Dis 2017; 07: 07.",Systematic review,IND,India,Rainbow Hospital for Women and Children,848,Andhra Pradesh,2012,2,49,4.1,0,Salmonella Typhi,Multidrug resistance (MDR)
5097,Makkar (2018),"Makkar A, Gupta S, Khan ID, et al. Epidemiological Profile and Antimicrobial Resistance Pattern of Enteric Fever in a Tertiary Care Hospital of North India - a Seven Year Ambispective Study.Acta Medica (Hradec Kralove) 2018;61(4):125-130",Systematic review,IND,India,Unknown Hospital(s) in Delhi,850,Delhi,2012,3,79,3.8,0,Salmonella Typhi,Multidrug resistance (MDR)
207,Jain (2013),"Jain S, Chugh TD. Antimicrobial resistance among blood culture isolates of Salmonella enterica in New Delhi. J Infect Dev Ctries 2013; 7(11): 788-95.",Systematic review,IND,India,BLK Super speciality Hospital,850,Delhi,2012,1,51,2,0,Salmonella Typhi,Multidrug resistance (MDR)
4627,Sharma (2016),"Sharma P, Dahiya S, Balaji V, et al. Typhoidal Salmonellae: Use of multi-locus sequence typing to determine population structure. PLoS ONE 2016; 11(9).",Systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,2012,3,263,1.1,0,Salmonella Typhi,Multidrug resistance (MDR)
5110,Sharma (2018),"Sharma P, Dahiya S, Manral N, et al. Changing trends of culture-positive typhoid fever and antimicrobial susceptibility in a tertiary care North Indian Hospital over the last decade.Indian Journal of Medical Microbiology 2018;36(1):70-76",Systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,2012,1,43,2.3,0,Salmonella Typhi,Multidrug resistance (MDR)
151,Suruchi (2014),"Suruchi B, Anil K, Ganju SA, Atal S. Antibiotic susceptibility pattern of Salmonella enterica serovar Typhi and ParaTyphi a from North India: the changing scenario. Int J Pharma Bio Sci 2014; 5(4).",Systematic review,IND,India,Indira Gandhi Medical College,854,Himachal Pradesh,2012,0,22,0,0,Salmonella Typhi,Multidrug resistance (MDR)
4627,Sharma (2016),"Sharma P, Dahiya S, Balaji V, et al. Typhoidal Salmonellae: Use of multi-locus sequence typing to determine population structure. PLoS ONE 2016; 11(9).",Systematic review,IND,India,Indira Gandhi Medical College,854,Himachal Pradesh,2012,0,20,0,0,Salmonella Typhi,Multidrug resistance (MDR)
117,Venkatesh (2013),"Venkatesh BM, Joshi S, Adhikary R, Bhaskar BH. Antibiogram of Salmonella Typhi and Salmonella ParaTyphi A in a tertiary care hospital in 2012. Indian J Pathol Microbiol 2013; 56(4): 484-5.",Systematic review,IND,India,Manipal Hospital (Airport road),855,Karnataka,2012,0,251,0,0,Salmonella Typhi,Multidrug resistance (MDR)
5124,Joshi (2019),"Joshi S, Adhikary R, Beena HB, et al. Trends in antibiotic susceptibility of enteric fever isolates from South India, 2002–2013.Medical Journal Armed Forces India 2019;75(1):81-85",Systematic review,IND,India,Manipal Hospital (Airport road),855,Karnataka,2012,5,253,2,0,Salmonella Typhi,Multidrug resistance (MDR)
4519,Chatterjee(2016),"Chatterjee S, Eshwara VK, Tellapragada C, Mukhopadhyay C. Azithromycin susceptibility among clinical isolates of Salmonella: Interfacing guidelines with routine practices. Indian J Med Microbiol 2016; 34(3): 397-8.",Systematic review,IND,India,Kasturba Medical College and Hospital (Manipal),855,Karnataka,2012,0,95,0,0,Salmonella Typhi,Multidrug resistance (MDR)
2977,Harichandran (2017),"Harichandran D, Dinesh KR. Antimicrobial susceptibility profile, treatment outcome and serotype distribution of clinical isolates of Salmonella enterica subspecies enterica: a 2-year study from Kerala, South India. Infect Drug Resist 2017; 10: 97-101.",Systematic review,IND,India,Amrita Institute of Medical Sciences and Research Centre,856,Kerala,2012,0,79,0,0,Salmonella Typhi,Multidrug resistance (MDR)
4627,Sharma (2016),"Sharma P, Dahiya S, Balaji V, et al. Typhoidal Salmonellae: Use of multi-locus sequence typing to determine population structure. PLoS ONE 2016; 11(9).",Systematic review,IND,India,Mahatma Gandhi Institute of Medical Sciences (Sevagram),858,Maharashtra,2012,0,5,0,0,Salmonella Typhi,Multidrug resistance (MDR)
4625,Sania (2016),"Sania KM, Shyamasakhi PD, Krishna Pramodini KD, Sulochana KD. Evaluation of minimum inhibitory concentration of chloramphenicol for Salmonella spp. isolated from enteric fever cases in a tertiary hospital in Imphal. Int J Pharm Sci Res 2016; 7(9): 3815-9.",Systematic review,IND,India,Regional Institute of Medical Sciences,859,Manipur,2012,0,16,0,0,Salmonella Typhi,Multidrug resistance (MDR)
4627,Sharma (2016),"Sharma P, Dahiya S, Balaji V, et al. Typhoidal Salmonellae: Use of multi-locus sequence typing to determine population structure. PLoS ONE 2016; 11(9).",Systematic review,IND,India,North Eastern Indira Gandhi Regional Institute of Health and Medical Sciences,860,Meghalaya,2012,0,15,0,0,Salmonella Typhi,Multidrug resistance (MDR)
4627,Sharma (2016),"Sharma P, Dahiya S, Balaji V, et al. Typhoidal Salmonellae: Use of multi-locus sequence typing to determine population structure. PLoS ONE 2016; 11(9).",Systematic review,IND,India,Maharaja Krishna Chandra Gajapati Medical College & Hospital,863,Orissa,2012,0,15,0,0,Salmonella Typhi,Multidrug resistance (MDR)
3012,Behl(2017),"Behl P, Gupta V, Sachdev A, Guglani V, Chander J. Patterns in antimicrobial susceptibility of Salmonellae isolated at a tertiary care hospital in northern India. Indian J Med Res 2017; 145(1): 124-8.",Systematic review,IND,India,Government Medical College Hospital (Chandigarh),864,Punjab,2012,2,78,2.6,0,Salmonella Typhi,Multidrug resistance (MDR)
4440,Riyaz (2015),"Riyaz C, Jayavardhana A. Current pattern of Salmonella Typhi antimicrobial susceptibility in the era of antibiotic abuse. Indian J Basic Appl Med Res 2015; 5(1): 400-4.",Systematic review,IND,India,PSG Institute of Medical Sciences and Research,867,Tamil Nadu,2012,2,50,4,0,Salmonella Typhi,Multidrug resistance (MDR)
4627,Sharma (2016),"Sharma P, Dahiya S, Balaji V, et al. Typhoidal Salmonellae: Use of multi-locus sequence typing to determine population structure. PLoS ONE 2016; 11(9).",Systematic review,IND,India,Sri Ramachandra Medical College and Research Institute,867,Tamil Nadu,2012,0,7,0,0,Salmonella Typhi,Multidrug resistance (MDR)
696,Mathew (2014),"Mathew R, Jobin SR. Current trends of antimicrobial susceptibility of Salmonella enterica serovar Typhi and ParaTyphi a from blood cultures in a tertiary care center of Chennai, Tamil Nadu, India. Res J Pharm Biol Chem Sci 2014; 5(2): 1167-74.",Systematic review,IND,India,Saveetha Medical College (Thandalam),867,Tamil Nadu,2012,0,29,0,0,Salmonella Typhi,Multidrug resistance (MDR)
5069,Bandyopadhyay(2018),"Bandyopadhyay R, Balaji V, Yadav B, Jasmine S, Sathyendra S, Rupali P. Effectiveness of treatment regimens for Typhoid fever in the nalidixic acid-resistant S. Typhi (NARST) era in South India. Trop Doct 2018; 48(3): 182-8.",Systematic review,IND,India,Christian Medical College (Vellore),867,Tamil Nadu,2012,1,19,5.3,0,Salmonella Typhi,Multidrug resistance (MDR)
4627,Sharma (2016),"Sharma P, Dahiya S, Balaji V, et al. Typhoidal Salmonellae: Use of multi-locus sequence typing to determine population structure. PLoS ONE 2016; 11(9).",Systematic review,IND,India,Christian Medical College (Vellore),867,Tamil Nadu,2012,11.99,267,4.5,0,Salmonella Typhi,Multidrug resistance (MDR)
4650,Yadav (2016),"Yadav VC, Kiran VR, Sharma R. Enteric fever in Bastar tribal region-prevalence and sensitivity patterns. J Evol Med Dent Sci 2016; 5(53): 3526-30.",Systematic review,IND,India,Late Baliram Kashyap Memorial Government Medical College Jagdalpur,884,Chhattisgarh,2012,60.99,111,54.9,1,Salmonella Typhi,Multidrug resistance (MDR)
2967,Iyer (2017),"Iyer RN, Jangam RR, Jacinth A, Venkatalakshmi A, Nahdi FB. Prevalence and trends in the antimicrobial susceptibility pattern of Salmonella enterica serovars Typhi and ParaTyphi A among children in a pediatric tertiary care hospital in South India over a period of ten years: a retrospective study. Eur J Clin Microbiol Infect Dis 2017; 07: 07.",Systematic review,IND,India,Rainbow Hospital for Women and Children,848,Andhra Pradesh,2013,0,36,0,0,Salmonella Typhi,Multidrug resistance (MDR)
5097,Makkar (2018),"Makkar A, Gupta S, Khan ID, et al. Epidemiological Profile and Antimicrobial Resistance Pattern of Enteric Fever in a Tertiary Care Hospital of North India - a Seven Year Ambispective Study.Acta Medica (Hradec Kralove) 2018;61(4):125-130",Systematic review,IND,India,Unknown Hospital(s) in Delhi,850,Delhi,2013,4,73,5.5,0,Salmonella Typhi,Multidrug resistance (MDR)
5110,Sharma (2018),"Sharma P, Dahiya S, Manral N, et al. Changing trends of culture-positive typhoid fever and antimicrobial susceptibility in a tertiary care North Indian Hospital over the last decade.Indian Journal of Medical Microbiology 2018;36(1):70-76",Systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,2013,2,21,9.5,0,Salmonella Typhi,Multidrug resistance (MDR)
5100,Narasanna (2018),"Narasanna R, Chavadi M and Chandrakanth K. Prevalence of multidrug-resistant Salmonella Typhi in typhoid patients and detection of blaCTX-M2 and blaCTX-M9 genes in cefetoxime-mediated extended spectrum beta-lactamase-producing Salmonella Typhi isolates.Biomedical Research (India) 2018;29(14):3015-3021",Systematic review,IND,India,"Government Hospital Kalaburagi;Pooja Diagnostic Centre, Kalaburagi",855,Karnataka,2013,0,66,0,0,Salmonella Typhi,Multidrug resistance (MDR)
3039,Sharvani (2016),"Sharvani R, Hemavathi, Dayanand DK, Shenoy P, Sarmah P. Antibiogram of Salmonella isolates: time to consider antibiotic salvage. J Clin Diagn Res 2016; 10(5): DC6-DC8.",Systematic review,IND,India,Sapthagiri Hospital,855,Karnataka,2013,3,167,1.8,0,Salmonella Typhi,Multidrug resistance (MDR)
5124,Joshi (2019),"Joshi S, Adhikary R, Beena HB, et al. Trends in antibiotic susceptibility of enteric fever isolates from South India, 2002–2013.Medical Journal Armed Forces India 2019;75(1):81-85",Systematic review,IND,India,Manipal Hospital (Airport road),855,Karnataka,2013,1,131,0.8,0,Salmonella Typhi,Multidrug resistance (MDR)
5060,Rajashri (2017),Rajashri P and Amar P. Study of antibiotic sensitivity pattern of Salmonella Typhi in tertiary care centre.International Journal of Healthcare & Biomedical Research 2017;6(1):75-80,Systematic review,IND,India,Dr D Y Patil Vidyapeeth,858,Maharashtra,2013,0,21,0,0,Salmonella Typhi,Multidrug resistance (MDR)
3016,Bakthavatchalam(2017),"Bakthavatchalam YD, Kumar DT, Tayubi IA, et al. In vitro efficacy and in silico analysis of cefixime-ofloxacin combination for Salmonella Typhi from bloodstream infection. J Appl Microbiol 2017; 123(3): 615-24.",Systematic review,IND,India,Christian Medical College (Vellore),867,Tamil Nadu,2013,15,283,5.3,0,Salmonella Typhi,Multidrug resistance (MDR)
4650,Yadav (2016),"Yadav VC, Kiran VR, Sharma R. Enteric fever in Bastar tribal region-prevalence and sensitivity patterns. J Evol Med Dent Sci 2016; 5(53): 3526-30.",Systematic review,IND,India,Late Baliram Kashyap Memorial Government Medical College Jagdalpur,884,Chhattisgarh,2013,93.99,193,48.7,0,Salmonella Typhi,Multidrug resistance (MDR)
2166,Srirangaraj (2014),"Srirangaraj S, Kali A, Charles MV. A study of antibiogram of Salmonella enterica serovar Typhi isolates from Pondicherry, India. Australas Med J 2014; 7(4): 185-90.",Systematic review,IND,India,Mahatma Gandhi Medical College and Research Institute,889,Puducherry,2013,1,16,6.3,0,Salmonella Typhi,Multidrug resistance (MDR)
4301,Anees (2015),"Anees A, Indu S, Fatima K, Anjum P. Multi-drug resistant Salmonella enterica subspecies enterica serotype Typhi: A diagnostic and therapeutic challenge. Int J Curr Microbiol Appl Sci 2015; 4(Special Issue 1): 19-25.",Systematic review,IND,India,Jawaharlal Nehru Medical College (Aligarh),890,Uttar Pradesh,2013,8,12,66.7,1,Salmonella Typhi,Multidrug resistance (MDR)
4597,Misra (2016),"Misra R, Thakare R, Amrin N, Prasad KN, Chopra S, Dhole TN. Antimicrobial susceptibility pattern and sequence analysis of DNA gyrase and DNA topoisomerase IV in Salmonella enterica serovars Typhi and ParaTyphi A isolates with decreased susceptibility to ciprofloxacin. Trans R Soc Trop Med Hyg 2016; 110(8): 472-9.",Systematic review,IND,India,Sanjay Gandhi Postgraduate Institute of Medical Sciences,890,Uttar Pradesh,2013,0,20,0,0,Salmonella Typhi,Multidrug resistance (MDR)
2967,Iyer (2017),"Iyer RN, Jangam RR, Jacinth A, Venkatalakshmi A, Nahdi FB. Prevalence and trends in the antimicrobial susceptibility pattern of Salmonella enterica serovars Typhi and ParaTyphi A among children in a pediatric tertiary care hospital in South India over a period of ten years: a retrospective study. Eur J Clin Microbiol Infect Dis 2017; 07: 07.",Systematic review,IND,India,Rainbow Hospital for Women and Children,848,Andhra Pradesh,2014,0,41,0,0,Salmonella Typhi,Multidrug resistance (MDR)
3043,Roy(2016),"Roy JS, Lahari S, Mithu M, Dipak T. Epidemiological investigation of an outbreak of typhoid fever in Jorhat town of Assam, India. Indian J Med Res 2016; 144(4): 592-6.",Systematic review,IND,India,Jorhat Town,849,Assam,2014,0,6,0,0,Salmonella Typhi,Multidrug resistance (MDR)
5097,Makkar (2018),"Makkar A, Gupta S, Khan ID, et al. Epidemiological Profile and Antimicrobial Resistance Pattern of Enteric Fever in a Tertiary Care Hospital of North India - a Seven Year Ambispective Study.Acta Medica (Hradec Kralove) 2018;61(4):125-130",Systematic review,IND,India,Unknown Hospital(s) in Delhi,850,Delhi,2014,3,120,2.5,0,Salmonella Typhi,Multidrug resistance (MDR)
5110,Sharma (2018),"Sharma P, Dahiya S, Manral N, et al. Changing trends of culture-positive typhoid fever and antimicrobial susceptibility in a tertiary care North Indian Hospital over the last decade.Indian Journal of Medical Microbiology 2018;36(1):70-76",Systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,2014,0,11,0,0,Salmonella Typhi,Multidrug resistance (MDR)
4650,Yadav (2016),"Yadav VC, Kiran VR, Sharma R. Enteric fever in Bastar tribal region-prevalence and sensitivity patterns. J Evol Med Dent Sci 2016; 5(53): 3526-30.",Systematic review,IND,India,Late Baliram Kashyap Memorial Government Medical College Jagdalpur,884,Chhattisgarh,2014,40,101,39.6,0,Salmonella Typhi,Multidrug resistance (MDR)
4597,Misra (2016),"Misra R, Thakare R, Amrin N, Prasad KN, Chopra S, Dhole TN. Antimicrobial susceptibility pattern and sequence analysis of DNA gyrase and DNA topoisomerase IV in Salmonella enterica serovars Typhi and ParaTyphi A isolates with decreased susceptibility to ciprofloxacin. Trans R Soc Trop Med Hyg 2016; 110(8): 472-9.",Systematic review,IND,India,Sanjay Gandhi Postgraduate Institute of Medical Sciences,890,Uttar Pradesh,2014,3,29,10.3,0,Salmonella Typhi,Multidrug resistance (MDR)
2967,Iyer (2017),"Iyer RN, Jangam RR, Jacinth A, Venkatalakshmi A, Nahdi FB. Prevalence and trends in the antimicrobial susceptibility pattern of Salmonella enterica serovars Typhi and ParaTyphi A among children in a pediatric tertiary care hospital in South India over a period of ten years: a retrospective study. Eur J Clin Microbiol Infect Dis 2017; 07: 07.",Systematic review,IND,India,Rainbow Hospital for Women and Children,848,Andhra Pradesh,2015,0,37,0,0,Salmonella Typhi,Multidrug resistance (MDR)
5097,Makkar (2018),"Makkar A, Gupta S, Khan ID, et al. Epidemiological Profile and Antimicrobial Resistance Pattern of Enteric Fever in a Tertiary Care Hospital of North India - a Seven Year Ambispective Study.Acta Medica (Hradec Kralove) 2018;61(4):125-130",Systematic review,IND,India,Unknown Hospital(s) in Delhi,850,Delhi,2015,0,79,0,0,Salmonella Typhi,Multidrug resistance (MDR)
5110,Sharma (2018),"Sharma P, Dahiya S, Manral N, et al. Changing trends of culture-positive typhoid fever and antimicrobial susceptibility in a tertiary care North Indian Hospital over the last decade.Indian Journal of Medical Microbiology 2018;36(1):70-76",Systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,2015,4,23,17.4,0,Salmonella Typhi,Multidrug resistance (MDR)
4597,Misra (2016),"Misra R, Thakare R, Amrin N, Prasad KN, Chopra S, Dhole TN. Antimicrobial susceptibility pattern and sequence analysis of DNA gyrase and DNA topoisomerase IV in Salmonella enterica serovars Typhi and ParaTyphi A isolates with decreased susceptibility to ciprofloxacin. Trans R Soc Trop Med Hyg 2016; 110(8): 472-9.",Systematic review,IND,India,Sanjay Gandhi Postgraduate Institute of Medical Sciences,890,Uttar Pradesh,2015,2,31,6.5,0,Salmonella Typhi,Multidrug resistance (MDR)
2967,Iyer (2017),"Iyer RN, Jangam RR, Jacinth A, Venkatalakshmi A, Nahdi FB. Prevalence and trends in the antimicrobial susceptibility pattern of Salmonella enterica serovars Typhi and ParaTyphi A among children in a pediatric tertiary care hospital in South India over a period of ten years: a retrospective study. Eur J Clin Microbiol Infect Dis 2017; 07: 07.",Systematic review,IND,India,Rainbow Hospital for Women and Children,848,Andhra Pradesh,2016,0,90,0,0,Salmonella Typhi,Multidrug resistance (MDR)
5097,Makkar (2018),"Makkar A, Gupta S, Khan ID, et al. Epidemiological Profile and Antimicrobial Resistance Pattern of Enteric Fever in a Tertiary Care Hospital of North India - a Seven Year Ambispective Study.Acta Medica (Hradec Kralove) 2018;61(4):125-130",Systematic review,IND,India,Unknown Hospital(s) in Delhi,850,Delhi,2016,2,109,1.8,0,Salmonella Typhi,Multidrug resistance (MDR)
5110,Sharma (2018),"Sharma P, Dahiya S, Manral N, et al. Changing trends of culture-positive typhoid fever and antimicrobial susceptibility in a tertiary care North Indian Hospital over the last decade.Indian Journal of Medical Microbiology 2018;36(1):70-76",Systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,2016,5,72,6.9,0,Salmonella Typhi,Multidrug resistance (MDR)
5058,Purighalla (2017),"Purighalla S, Esakimuthu S, Reddy M, et al. Investigation into a community outbreak of Salmonella Typhi in Bengaluru, India.Indian Journal of Medical Research 2017;146(July Supplement):15-22",Systematic review,IND,India,Unknown hospitals in Bengaluru,855,Karnataka,2016,0,42,0,0,Salmonella Typhi,Multidrug resistance (MDR)
5097,Makkar (2018),"Makkar A, Gupta S, Khan ID, et al. Epidemiological Profile and Antimicrobial Resistance Pattern of Enteric Fever in a Tertiary Care Hospital of North India - a Seven Year Ambispective Study.Acta Medica (Hradec Kralove) 2018;61(4):125-130",Systematic review,IND,India,Unknown Hospital(s) in Delhi,850,Delhi,2017,2,99,2,0,Salmonella Typhi,Multidrug resistance (MDR)
5119,Wankhede (2018),Wankhede SV and Apurva. Prevalence and antibiogram of Salmonella Typhi and Paratyphi A isolates from a tertiary care hospital.Indian Journal of Basic and Applied Medical Research 2018;7(Diagnostic):31-38,Systematic review,IND,India,Smt. Kashibai Navale Medical College and General Hospital,858,Maharashtra,2017,0,27,0,0,Salmonella Typhi,Multidrug resistance (MDR)
5064,Zellweger (2017),"Zellweger RM, Basnyat B, Shrestha P, et al. A 23-year retrospective investigation of Salmonella Typhi and Salmonella ParaTyphi isolated in a tertiary Kathmandu hospital.PLoS Neglected Tropical Diseases [electronic resource] 2017;11(11):e0006051",Systematic review,NPL,Nepal,Patan Hospital (Lalitpur),892,Central,1992,146,579,25.2,0,Salmonella Typhi,Multidrug resistance (MDR)
3341,Acharya(1997),"Acharya G, Davis T, Ho M, et al. Factors affecting the pharmacokinetics of parenteral chloramphenicol in enteric fever. The Journal of antimicrobial chemotherapy, 1997. http://onlinelibrary.wiley.com/o/cochrane/clcentral/articles/216/CN-00142216/frame.html (accessed.",Systematic review,NPL,Nepal,Tribhuvan University Teaching Hospital (Kathmandu),892,Central,1993,0,13,0,0,Salmonella Typhi,Multidrug resistance (MDR)
5064,Zellweger (2017),"Zellweger RM, Basnyat B, Shrestha P, et al. A 23-year retrospective investigation of Salmonella Typhi and Salmonella ParaTyphi isolated in a tertiary Kathmandu hospital.PLoS Neglected Tropical Diseases [electronic resource] 2017;11(11):e0006051",Systematic review,NPL,Nepal,Patan Hospital (Lalitpur),892,Central,1993,180,717,25.1,0,Salmonella Typhi,Multidrug resistance (MDR)
5064,Zellweger (2017),"Zellweger RM, Basnyat B, Shrestha P, et al. A 23-year retrospective investigation of Salmonella Typhi and Salmonella ParaTyphi isolated in a tertiary Kathmandu hospital.PLoS Neglected Tropical Diseases [electronic resource] 2017;11(11):e0006051",Systematic review,NPL,Nepal,Patan Hospital (Lalitpur),892,Central,1994,129,580,22.2,0,Salmonella Typhi,Multidrug resistance (MDR)
5064,Zellweger (2017),"Zellweger RM, Basnyat B, Shrestha P, et al. A 23-year retrospective investigation of Salmonella Typhi and Salmonella ParaTyphi isolated in a tertiary Kathmandu hospital.PLoS Neglected Tropical Diseases [electronic resource] 2017;11(11):e0006051",Systematic review,NPL,Nepal,Patan Hospital (Lalitpur),892,Central,1995,87,436,20,0,Salmonella Typhi,Multidrug resistance (MDR)
5064,Zellweger (2017),"Zellweger RM, Basnyat B, Shrestha P, et al. A 23-year retrospective investigation of Salmonella Typhi and Salmonella ParaTyphi isolated in a tertiary Kathmandu hospital.PLoS Neglected Tropical Diseases [electronic resource] 2017;11(11):e0006051",Systematic review,NPL,Nepal,Patan Hospital (Lalitpur),892,Central,1996,14,241,5.8,0,Salmonella Typhi,Multidrug resistance (MDR)
5064,Zellweger (2017),"Zellweger RM, Basnyat B, Shrestha P, et al. A 23-year retrospective investigation of Salmonella Typhi and Salmonella ParaTyphi isolated in a tertiary Kathmandu hospital.PLoS Neglected Tropical Diseases [electronic resource] 2017;11(11):e0006051",Systematic review,NPL,Nepal,Patan Hospital (Lalitpur),892,Central,1997,2,258,0.8,0,Salmonella Typhi,Multidrug resistance (MDR)
5064,Zellweger (2017),"Zellweger RM, Basnyat B, Shrestha P, et al. A 23-year retrospective investigation of Salmonella Typhi and Salmonella ParaTyphi isolated in a tertiary Kathmandu hospital.PLoS Neglected Tropical Diseases [electronic resource] 2017;11(11):e0006051",Systematic review,NPL,Nepal,Patan Hospital (Lalitpur),892,Central,1998,11,265,4.2,0,Salmonella Typhi,Multidrug resistance (MDR)
5064,Zellweger (2017),"Zellweger RM, Basnyat B, Shrestha P, et al. A 23-year retrospective investigation of Salmonella Typhi and Salmonella ParaTyphi isolated in a tertiary Kathmandu hospital.PLoS Neglected Tropical Diseases [electronic resource] 2017;11(11):e0006051",Systematic review,NPL,Nepal,Patan Hospital (Lalitpur),892,Central,1999,13,240,5.4,0,Salmonella Typhi,Multidrug resistance (MDR)
5064,Zellweger (2017),"Zellweger RM, Basnyat B, Shrestha P, et al. A 23-year retrospective investigation of Salmonella Typhi and Salmonella ParaTyphi isolated in a tertiary Kathmandu hospital.PLoS Neglected Tropical Diseases [electronic resource] 2017;11(11):e0006051",Systematic review,NPL,Nepal,Patan Hospital (Lalitpur),892,Central,2000,10,445,2.2,0,Salmonella Typhi,Multidrug resistance (MDR)
274,Khanal (2007),"Khanal B, Sharma SK, Bhattacharya SK, Bhattarai NR, Deb M, Kanungo R. Antimicrobial susceptibility patterns of Salmonella enterica serotype Typhi in eastern Nepal. J Health Popul Nutr 2007; 25(1): 82-7.",Systematic review,NPL,Nepal,B.P. Koirala Institute of Health Sciences (Koshi),893,Eastern,2000,7,20,35,1,Salmonella Typhi,Multidrug resistance (MDR)
5064,Zellweger (2017),"Zellweger RM, Basnyat B, Shrestha P, et al. A 23-year retrospective investigation of Salmonella Typhi and Salmonella ParaTyphi isolated in a tertiary Kathmandu hospital.PLoS Neglected Tropical Diseases [electronic resource] 2017;11(11):e0006051",Systematic review,NPL,Nepal,Patan Hospital (Lalitpur),892,Central,2001,9,583,1.5,0,Salmonella Typhi,Multidrug resistance (MDR)
274,Khanal (2007),"Khanal B, Sharma SK, Bhattacharya SK, Bhattarai NR, Deb M, Kanungo R. Antimicrobial susceptibility patterns of Salmonella enterica serotype Typhi in eastern Nepal. J Health Popul Nutr 2007; 25(1): 82-7.",Systematic review,NPL,Nepal,B.P. Koirala Institute of Health Sciences (Koshi),893,Eastern,2001,10,30,33.3,1,Salmonella Typhi,Multidrug resistance (MDR)
1967,Guha (2005),"Guha S, Jalan BY, Dey S, Easow JM, Wilson G, Shivananda PG. Salmonella bacteraemia in Pokhara: emergence of antibiotic resistance. Nepal Med Coll J 2005; 7(1): 23-5.",Systematic review,NPL,Nepal,Manipal Teaching Hospital (Pokhara),896,Western,2001,0,10,0,0,Salmonella Typhi,Multidrug resistance (MDR)
912,Ansari(2005),"Ansari I, Adhikari N, Pandey R, Dangal MM, Karanjit R, Acharya A. Enteric fever: is ciprofloxacin failing in Nepal? Trop Doct 2005; 35(1): 57-8.",Systematic review,NPL,Nepal,Patan Hospital (Lalitpur),892,Central,2002,12,38,31.6,1,Salmonella Typhi,Multidrug resistance (MDR)
953,Malla (2005),"Malla S, Kansakar P, Serichantalergs, Rahman M, Basnet S. Epidemiology of typhoid and paratyphoid fever in Kathmandu: two years study and trends of antimicrobial resistance. JNMA J Nepal Med Assoc 2005; 44(157): 18-22.",Systematic review,NPL,Nepal,Bir Hospital (Kathmandu);Maternity Hospital (Kathmandu);National Public Health Laboratory (Kathmandu);Tribhuvan University Teaching Hospital (Kathmandu),892,Central,2002,19,106,17.9,0,Salmonella Typhi,Multidrug resistance (MDR)
5064,Zellweger (2017),"Zellweger RM, Basnyat B, Shrestha P, et al. A 23-year retrospective investigation of Salmonella Typhi and Salmonella ParaTyphi isolated in a tertiary Kathmandu hospital.PLoS Neglected Tropical Diseases [electronic resource] 2017;11(11):e0006051",Systematic review,NPL,Nepal,Patan Hospital (Lalitpur),892,Central,2002,333,1669,20,0,Salmonella Typhi,Multidrug resistance (MDR)
2401,Lewis (2005),"Lewis MD, Serichantalergs O, Pitarangsi C, et al. Typhoid fever: a massive, single-point source, multidrug-resistant outbreak in Nepal. Clin Infect Dis 2005; 40(4): 554-61.",Systematic review,NPL,Nepal,Bharatpur College of Medical Sciences Hospital;Bharatpur Zonal Hospital,892,Central,2002,51,60,85,1,Salmonella Typhi,Multidrug resistance (MDR)
274,Khanal (2007),"Khanal B, Sharma SK, Bhattacharya SK, Bhattarai NR, Deb M, Kanungo R. Antimicrobial susceptibility patterns of Salmonella enterica serotype Typhi in eastern Nepal. J Health Popul Nutr 2007; 25(1): 82-7.",Systematic review,NPL,Nepal,B.P. Koirala Institute of Health Sciences (Koshi),893,Eastern,2002,6,25,24,0,Salmonella Typhi,Multidrug resistance (MDR)
1967,Guha (2005),"Guha S, Jalan BY, Dey S, Easow JM, Wilson G, Shivananda PG. Salmonella bacteraemia in Pokhara: emergence of antibiotic resistance. Nepal Med Coll J 2005; 7(1): 23-5.",Systematic review,NPL,Nepal,Manipal Teaching Hospital (Pokhara),896,Western,2002,11,29,37.9,1,Salmonella Typhi,Multidrug resistance (MDR)
833,Nobthai(2010),"Nobthai P, Serichantalergs O, Wongstitwilairoong B, et al. Emergence and properties of fluoroquinolone resistant Salmonella enterica serovar Typhi strains isolated from Nepal in 2002 and 2003. Southeast Asian J Trop Med Public Health 2010; 41(6): 1416-22.",Systematic review,NPL,Nepal,Unknown healthcare facilities in Kathmandu and Bharatpur,892,Central,2003,98.99,171,57.9,1,Salmonella Typhi,Multidrug resistance (MDR)
712,Shirakawa (2006),"Shirakawa T, Acharya B, Kinoshita S, Kumagai S, Gotoh A, Kawabata M. Decreased susceptibility to fluoroquinolones and gyrA gene mutation in the Salmonella enterica serovar Typhi and ParaTyphi A isolated in Katmandu, Nepal, in 2003. Diagn Microbiol Infect Dis 2006; 54(4): 299-303.",Systematic review,NPL,Nepal,Unknown Hospital in Kathmandu,892,Central,2003,7,30,23.3,0,Salmonella Typhi,Multidrug resistance (MDR)
953,Malla (2005),"Malla S, Kansakar P, Serichantalergs, Rahman M, Basnet S. Epidemiology of typhoid and paratyphoid fever in Kathmandu: two years study and trends of antimicrobial resistance. JNMA J Nepal Med Assoc 2005; 44(157): 18-22.",Systematic review,NPL,Nepal,Bir Hospital (Kathmandu);Maternity Hospital (Kathmandu);National Public Health Laboratory (Kathmandu);Tribhuvan University Teaching Hospital (Kathmandu),892,Central,2003,73,746,9.8,0,Salmonella Typhi,Multidrug resistance (MDR)
5064,Zellweger (2017),"Zellweger RM, Basnyat B, Shrestha P, et al. A 23-year retrospective investigation of Salmonella Typhi and Salmonella ParaTyphi isolated in a tertiary Kathmandu hospital.PLoS Neglected Tropical Diseases [electronic resource] 2017;11(11):e0006051",Systematic review,NPL,Nepal,Patan Hospital (Lalitpur),892,Central,2003,101,1157,8.7,0,Salmonella Typhi,Multidrug resistance (MDR)
274,Khanal (2007),"Khanal B, Sharma SK, Bhattacharya SK, Bhattarai NR, Deb M, Kanungo R. Antimicrobial susceptibility patterns of Salmonella enterica serotype Typhi in eastern Nepal. J Health Popul Nutr 2007; 25(1): 82-7.",Systematic review,NPL,Nepal,B.P. Koirala Institute of Health Sciences (Koshi),893,Eastern,2003,11,34,32.4,1,Salmonella Typhi,Multidrug resistance (MDR)
908,Malla(2007),"Malla T, Malla KK, Thapalial A, Shaw C. Enteric fever: a retrospective 6-year analysis of 82 paediatric cases in a teaching hospital. Kathmandu Univ Med J (KUMJ) 2007; 5(2): 181-7.",Systematic review,NPL,Nepal,Manipal Teaching Hospital (Pokhara),896,Western,2003,6.52,21,31,1,Salmonella Typhi,Multidrug resistance (MDR)
1967,Guha (2005),"Guha S, Jalan BY, Dey S, Easow JM, Wilson G, Shivananda PG. Salmonella bacteraemia in Pokhara: emergence of antibiotic resistance. Nepal Med Coll J 2005; 7(1): 23-5.",Systematic review,NPL,Nepal,Manipal Teaching Hospital (Pokhara),896,Western,2003,12,37,32.4,1,Salmonella Typhi,Multidrug resistance (MDR)
953,Malla (2005),"Malla S, Kansakar P, Serichantalergs, Rahman M, Basnet S. Epidemiology of typhoid and paratyphoid fever in Kathmandu: two years study and trends of antimicrobial resistance. JNMA J Nepal Med Assoc 2005; 44(157): 18-22.",Systematic review,NPL,Nepal,Bir Hospital (Kathmandu);Maternity Hospital (Kathmandu);National Public Health Laboratory (Kathmandu);Tribhuvan University Teaching Hospital (Kathmandu),892,Central,2004,9,187,4.8,0,Salmonella Typhi,Multidrug resistance (MDR)
5064,Zellweger (2017),"Zellweger RM, Basnyat B, Shrestha P, et al. A 23-year retrospective investigation of Salmonella Typhi and Salmonella ParaTyphi isolated in a tertiary Kathmandu hospital.PLoS Neglected Tropical Diseases [electronic resource] 2017;11(11):e0006051",Systematic review,NPL,Nepal,Patan Hospital (Lalitpur),892,Central,2004,14,847,1.7,0,Salmonella Typhi,Multidrug resistance (MDR)
1988,Maskey (2006),"Maskey AP, Day JN, Phung QT, et al. Salmonella enterica serovar ParaTyphi A and S. enterica serovar Typhi cause indistinguishable clinical syndromes in Kathmandu, Nepal. Clin Infect Dis 2006; 42(9): 1247-53.",Systematic review,NPL,Nepal,Patan Hospital (Lalitpur),892,Central,2004,8.02,409,2,0,Salmonella Typhi,Multidrug resistance (MDR)
274,Khanal (2007),"Khanal B, Sharma SK, Bhattacharya SK, Bhattarai NR, Deb M, Kanungo R. Antimicrobial susceptibility patterns of Salmonella enterica serotype Typhi in eastern Nepal. J Health Popul Nutr 2007; 25(1): 82-7.",Systematic review,NPL,Nepal,B.P. Koirala Institute of Health Sciences (Koshi),893,Eastern,2004,1,23,4.3,0,Salmonella Typhi,Multidrug resistance (MDR)
850,Tamang (2007),"Tamang MD, Oh J, Seol S, et al. Emergence of multidrug-resistant Salmonella enterica serovar Typhi associated with a class 1 integron carrying the dfrA7 gene cassette in Nepal. Int J Antimicrob Agents 2007; 30(4): 330-5.",Systematic review,NPL,Nepal,Dhulikhel Hospital (Kathmandu),892,Central,2005,7,93,7.5,0,Salmonella Typhi,Multidrug resistance (MDR)
5064,Zellweger (2017),"Zellweger RM, Basnyat B, Shrestha P, et al. A 23-year retrospective investigation of Salmonella Typhi and Salmonella ParaTyphi isolated in a tertiary Kathmandu hospital.PLoS Neglected Tropical Diseases [electronic resource] 2017;11(11):e0006051",Systematic review,NPL,Nepal,Patan Hospital (Lalitpur),892,Central,2005,6,1138,0.5,0,Salmonella Typhi,Multidrug resistance (MDR)
971,Amatya (2007),"Amatya NM, Shrestha B, Lekhak B. Etiological agents of bacteraemia and antibiotic susceptibility pattern in Kathmandu Model Hospital. JNMA J Nepal Med Assoc 2007; 46(167): 112-8.",Systematic review,NPL,Nepal,Kathmandu Model Hospital (Kathmandu),892,Central,2005,2,78,2.6,0,Salmonella Typhi,Multidrug resistance (MDR)
2171,Mathura (2005),"Mathura KC, Chaudhary D, Simkhada R, Pradhan M, Shrestha P, Gurubacharya DL. Study of clinical profile and antibiotic sensitivity pattern in culture positive typhoid fever cases. Kathmandu Univ Med J (KUMJ) 2005; 3(4): 376-9.",Systematic review,NPL,Nepal,Kathmandu Medical College (Kathmandu),892,Central,2005,29,46,63,1,Salmonella Typhi,Multidrug resistance (MDR)
1139,Holt (2009),"Holt KE, Baker S, Dongol S, et al. High-throughput bacterial SNP typing identifies distinct clusters of Salmonella Typhi causing typhoid in Nepalese children. BMC Infect Dis 2009; 10(144).",Systematic review,NPL,Nepal,Patan Hospital (Lalitpur),892,Central,2006,0,62,0,0,Salmonella Typhi,Multidrug resistance (MDR)
5064,Zellweger (2017),"Zellweger RM, Basnyat B, Shrestha P, et al. A 23-year retrospective investigation of Salmonella Typhi and Salmonella ParaTyphi isolated in a tertiary Kathmandu hospital.PLoS Neglected Tropical Diseases [electronic resource] 2017;11(11):e0006051",Systematic review,NPL,Nepal,Patan Hospital (Lalitpur),892,Central,2006,2,736,0.3,0,Salmonella Typhi,Multidrug resistance (MDR)
466,Neopane (2008),"Neopane A, Singh SB, Bhatta R, Dhital B, Karki DB. Changing spectrum of antibiotic sensitivity in enteric fever. Kathmandu Univ Med J (KUMJ) 2008; 6(1): 12-5.",Systematic review,NPL,Nepal,Kathmandu Medical College (Kathmandu),892,Central,2006,0,25,0,0,Salmonella Typhi,Multidrug resistance (MDR)
1092,Arjyal (2011),"Arjyal A, Basnyat B, Koirala S, et al. Gatifloxacin versus chloramphenicol for uncomplicated enteric fever: an open-label, randomised, controlled trial. Lancet Infect Dis 2011; 11(6): 445-54.",Systematic review,NPL,Nepal,Patan Hospital (Lalitpur),892,Central,2007,2,243,0.8,0,Salmonella Typhi,Multidrug resistance (MDR)
5064,Zellweger (2017),"Zellweger RM, Basnyat B, Shrestha P, et al. A 23-year retrospective investigation of Salmonella Typhi and Salmonella ParaTyphi isolated in a tertiary Kathmandu hospital.PLoS Neglected Tropical Diseases [electronic resource] 2017;11(11):e0006051",Systematic review,NPL,Nepal,Patan Hospital (Lalitpur),892,Central,2007,6,595,1,0,Salmonella Typhi,Multidrug resistance (MDR)
5064,Zellweger (2017),"Zellweger RM, Basnyat B, Shrestha P, et al. A 23-year retrospective investigation of Salmonella Typhi and Salmonella ParaTyphi isolated in a tertiary Kathmandu hospital.PLoS Neglected Tropical Diseases [electronic resource] 2017;11(11):e0006051",Systematic review,NPL,Nepal,Patan Hospital (Lalitpur),892,Central,2008,2,511,0.4,0,Salmonella Typhi,Multidrug resistance (MDR)
1791,Prajapati (2008),"Prajapati B, Rai GK, Rai SK, et al. Prevalence of Salmonella Typhi and ParaTyphi infection in children: a hospital based study. Nepal Med Coll J 2008; 10(4): 238-41.",Systematic review,NPL,Nepal,Kanti Children's Hospital (Kathmandu),892,Central,2008,11,169,6.5,0,Salmonella Typhi,Multidrug resistance (MDR)
1132,Karki (2013),"Karki AB, Bhatta DR, Shrestha B, et al. Higher nalidixic acid resistance pattern of Salmonella isolates from enteric fever patients in kathmandu model hospital Nepal. Res J Pharm Biol Chem Sci 2013; 4(2): 1687-93.",Systematic review,NPL,Nepal,Kathmandu Model Hospital (Kathmandu),892,Central,2009,1,55,1.8,0,Salmonella Typhi,Multidrug resistance (MDR)
5064,Zellweger (2017),"Zellweger RM, Basnyat B, Shrestha P, et al. A 23-year retrospective investigation of Salmonella Typhi and Salmonella ParaTyphi isolated in a tertiary Kathmandu hospital.PLoS Neglected Tropical Diseases [electronic resource] 2017;11(11):e0006051",Systematic review,NPL,Nepal,Patan Hospital (Lalitpur),892,Central,2009,9,411,2.2,0,Salmonella Typhi,Multidrug resistance (MDR)
1402,Dongol(2012),"Dongol S, Thompson CN, Clare S, et al. The microbiological and clinical characteristics of invasive Salmonella in gallbladders from cholecystectomy patients in kathmandu, Nepal. PLoS ONE 2012; 7(10): e47342.",Systematic review,NPL,Nepal,Patan Hospital (Lalitpur),892,Central,2009,0,22,0,0,Salmonella Typhi,Multidrug resistance (MDR)
1093,Koirala (2013),"Koirala S, Basnyat B, Arjyal A, et al. Gatifloxacin versus ofloxacin for the treatment of uncomplicated enteric fever in Nepal: an open-label, randomized, controlled trial. PLoS Negl Trop Dis 2013; 7(10): e2523.",Systematic review,NPL,Nepal,Patan (Lalitpur),892,Central,2010,0,132,0,0,Salmonella Typhi,Multidrug resistance (MDR)
5064,Zellweger (2017),"Zellweger RM, Basnyat B, Shrestha P, et al. A 23-year retrospective investigation of Salmonella Typhi and Salmonella ParaTyphi isolated in a tertiary Kathmandu hospital.PLoS Neglected Tropical Diseases [electronic resource] 2017;11(11):e0006051",Systematic review,NPL,Nepal,Patan Hospital (Lalitpur),892,Central,2010,1,564,0.2,0,Salmonella Typhi,Multidrug resistance (MDR)
150,Acharya (2012),"Acharya D, Trakulsomboon S, Madhup SK, Korbsrisate S. Antibiotic susceptibility pattern and the indicator of decreased ciprofloxacin susceptibility of Salmonella enterica serovar Typhi isolated from Dhulikhel Hospital, Nepal. Jpn J Infect Dis 2012; 65(3): 264-7.",Systematic review,NPL,Nepal,Dhulikhel Hospital (Kathmandu),892,Central,2010,2,114,1.8,0,Salmonella Typhi,Multidrug resistance (MDR)
2821,Singh (2011),"Singh U, Neopane A, Thapa M, Aryal N, Agrawal K. Salmonella Typhi infections and effect of fluroquinolones and third generation cephalosporins in clinical outcome. Journal of Nepal Paediatric Society 2011; 31(3): 216-21.",Systematic review,NPL,Nepal,Shree Birendra Hospital (Kathmandu),892,Central,2010,4,21,19,0,Salmonella Typhi,Multidrug resistance (MDR)
275,Raza (2012),"Raza S, Tamrakar R, Bhatt CP, Joshi SK. Antimicrobial susceptibility patterns of Salmonella Typhi and Salmonella ParaTyphi A in a tertiary care hospital. J Nepal Health Res Counc 2012; 10(22): 214-7.",Systematic review,NPL,Nepal,Kathmandu Medical College (Kathmandu),892,Central,2011,3,47,6.4,0,Salmonella Typhi,Multidrug resistance (MDR)
5064,Zellweger (2017),"Zellweger RM, Basnyat B, Shrestha P, et al. A 23-year retrospective investigation of Salmonella Typhi and Salmonella ParaTyphi isolated in a tertiary Kathmandu hospital.PLoS Neglected Tropical Diseases [electronic resource] 2017;11(11):e0006051",Systematic review,NPL,Nepal,Patan Hospital (Lalitpur),892,Central,2011,4,406,1,0,Salmonella Typhi,Multidrug resistance (MDR)
593,Joshi (2011),"Joshi BG, Keyal K, Pandey R, Shrestha BM. Clinical profile and sensitivity pattern of Salmonella serotypes in children: A hospital based study. Journal of Nepal Paediatric Society 2011; 31(3): 180-3.",Systematic review,NPL,Nepal,Civil Service Hospital (Kathmandu),892,Central,2011,0,25,0,0,Salmonella Typhi,Multidrug resistance (MDR)
2806,Adhikari (2012),"Adhikari D, Acharya D, Shrestha P, Amatya R. Ciprofloxacin susceptibility of Salmonella enteric serovar Typhi and ParaTyphi A from blood samples of suspected enteric fever patients. International Journal of Infection and Microbiology 2012; 1(1): 9-13.",Systematic review,NPL,Nepal,KIST Medical College (Kathmandu),892,Central,2011,1,41,2.4,0,Salmonella Typhi,Multidrug resistance (MDR)
1895,Chand (2014),"Chand HJ, Rijal KR, Neupane B, Sharma VK, Jha B. Re-emergence of susceptibility to conventional first line drugs in Salmonella isolates from enteric fever patients in Nepal. J Infect Dev Ctries 2014; 8(11): 1483-7.",Systematic review,NPL,Nepal,"Alka Hospital (Jawalakhel, Lalitpur)",892,Central,2012,0,56,0,0,Salmonella Typhi,Multidrug resistance (MDR)
5064,Zellweger (2017),"Zellweger RM, Basnyat B, Shrestha P, et al. A 23-year retrospective investigation of Salmonella Typhi and Salmonella ParaTyphi isolated in a tertiary Kathmandu hospital.PLoS Neglected Tropical Diseases [electronic resource] 2017;11(11):e0006051",Systematic review,NPL,Nepal,Patan Hospital (Lalitpur),892,Central,2012,23,281,8.2,0,Salmonella Typhi,Multidrug resistance (MDR)
1323,Rai (2012)<U+1D43>,"Rai GK, Karki S, Prajapati B. Is antimicrobial resistance pattern of enteric fever changing in Kathmandu valley? Journal of Nepal Paediatric Society 2012a; 32(3): 221-8.",Systematic review,NPL,Nepal,Kanti Children's Hospital (Kathmandu),892,Central,2012,0.12,5,2.4,0,Salmonella Typhi,Multidrug resistance (MDR)
5064,Zellweger (2017),"Zellweger RM, Basnyat B, Shrestha P, et al. A 23-year retrospective investigation of Salmonella Typhi and Salmonella ParaTyphi isolated in a tertiary Kathmandu hospital.PLoS Neglected Tropical Diseases [electronic resource] 2017;11(11):e0006051",Systematic review,NPL,Nepal,Patan Hospital (Lalitpur),892,Central,2013,4,495,0.8,0,Salmonella Typhi,Multidrug resistance (MDR)
5104,Petersiel (2018),"Petersiel N, Shresta S, Tamrakar R, et al. The epidemiology of typhoid fever in the Dhulikhel area, Nepal: A prospective cohort study.PLoS ONE 2018;13 (9) (no pagination)(e0204479):",Systematic review,NPL,Nepal,Dhulikhel Hospital (Kathmandu),892,Central,2013,0.99,62,1.6,0,Salmonella Typhi,Multidrug resistance (MDR)
5064,Zellweger (2017),"Zellweger RM, Basnyat B, Shrestha P, et al. A 23-year retrospective investigation of Salmonella Typhi and Salmonella ParaTyphi isolated in a tertiary Kathmandu hospital.PLoS Neglected Tropical Diseases [electronic resource] 2017;11(11):e0006051",Systematic review,NPL,Nepal,Patan Hospital (Lalitpur),892,Central,2014,4,187,2.1,0,Salmonella Typhi,Multidrug resistance (MDR)
5073,Britto (2018),"Britto CD, Dyson ZA, Duchene S, et al. Laboratory and molecular surveillance of paediatric typhoidal Salmonella in Nepal: Antimicrobial resistance and implications for vaccine policy.PLoS Neglected Tropical Diseases [electronic resource] 2018;12(4):e0006408",Systematic review,NPL,Nepal,Patan Hospital (Lalitpur),892,Central,2015,2,10,20,0,Salmonella Typhi,Multidrug resistance (MDR)
2979,Gurung (2017),"Gurung B, Pandey S, Shah DK, et al. Antibiogram pattern of Salmonella in blood samples of enteric fever patients at lalitpur, nepal. Asian Pac J Trop Dis 2017; 7(1): 21-4.",Systematic review,NPL,Nepal,KIST Medical College (Kathmandu),892,Central,2015,9,41,22,0,Salmonella Typhi,Multidrug resistance (MDR)
2958,Khanal (2017),"Khanal PR, Satyal D, Bhetwal A, et al. Renaissance of conventional first-line antibiotics in Salmonella enterica clinical isolates: Assessment of MICs for therapeutic antimicrobials in enteric fever cases from Nepal. Biomed Res Int 2017; 2017: 2868143.",Systematic review,NPL,Nepal,Manmohan Memorial Community Hospital (Kathmandu),892,Central,2016,0,74,0,0,Salmonella Typhi,Multidrug resistance (MDR)
5073,Britto (2018),"Britto CD, Dyson ZA, Duchene S, et al. Laboratory and molecular surveillance of paediatric typhoidal Salmonella in Nepal: Antimicrobial resistance and implications for vaccine policy.PLoS Neglected Tropical Diseases [electronic resource] 2018;12(4):e0006408",Systematic review,NPL,Nepal,Patan Hospital (Lalitpur),892,Central,2016,0,59,0,0,Salmonella Typhi,Multidrug resistance (MDR)
5049,Bhetwal (2017),"Bhetwal A, Maharjan A, Khanal PR and Parajuli NP. Enteric Fever Caused by Salmonella enterica Serovars with Reduced Susceptibility of Fluoroquinolones at a Community Based Teaching Hospital of Nepal.International Journal of Microbiology 2017;2017(2869458",Systematic review,NPL,Nepal,Manmohan Memorial Teaching Hospital (Kathmandu),892,Central,2016,4,162,2.5,0,Salmonella Typhi,Multidrug resistance (MDR)
1496,Rathore (1996),"Rathore MH, Bux D, Hasan M. Multidrug-resistant Salmonella Typhi in Pakistani children: clinical features and treatment. South Med J 1996; 89(2): 235-7.",Systematic review,PAK,Pakistan,Children's Hospital (PIMS),899,Islamabad,1990,79,109,72.5,0,Salmonella Typhi,Multidrug resistance (MDR)
2787,Karamat (1996),"Karamat K, Butt T, Hannan A, et al. Problem of multi-drug resistant typhoid fever in Rawalpindi/Islamabad area. Pak Armed Forces Med J 1996; 46(2): 48-54.",Systematic review,PAK,Pakistan,Military Hospital (Rawalpindi);Armed Force Institute of Pathology,901,Punjab,1990,152,323,47.1,0,Salmonella Typhi,Multidrug resistance (MDR)
461,Hannan (1991),Hannan A. Changing pattern of Salmonella Typhi isolates in Pakistan and their unchanged response to ofloxacin. International Journal of Experimental and Clinical Chemotherapy 1991; 4(4): 225-9.,Systematic review,PAK,Pakistan,Armed Force Institute of Pathology,901,Punjab,1990,77,126,61.1,0,Salmonella Typhi,Multidrug resistance (MDR)
2787,Karamat (1996),"Karamat K, Butt T, Hannan A, et al. Problem of multi-drug resistant typhoid fever in Rawalpindi/Islamabad area. Pak Armed Forces Med J 1996; 46(2): 48-54.",Systematic review,PAK,Pakistan,Military Hospital (Rawalpindi);Armed Force Institute of Pathology,901,Punjab,1991,65,190,34.2,0,Salmonella Typhi,Multidrug resistance (MDR)
2794,Bhutta(1996),Bhutta ZA. Impact of age and drug resistance on mortality in typhoid fever. Arch Dis Child 1996; 75(3): 214-7.,Systematic review,PAK,Pakistan,Aga Khan University Hospital (Karachi),902,Sind,1991,261,1158,22.5,0,Salmonella Typhi,Multidrug resistance (MDR)
2276,Hazir (2002),"Hazir T, Qazi SA, Abbas KA, Khan MA. Therapeutic re-appraisal of multiple drug resistant Salmonella Typhi (MDRST) in Pakistani children. J Pak Med Assoc 2002; 52(3): 123-7.",Systematic review,PAK,Pakistan,Children's Hospital (PIMS),899,Islamabad,1992,80,119,67.2,0,Salmonella Typhi,Multidrug resistance (MDR)
2787,Karamat (1996),"Karamat K, Butt T, Hannan A, et al. Problem of multi-drug resistant typhoid fever in Rawalpindi/Islamabad area. Pak Armed Forces Med J 1996; 46(2): 48-54.",Systematic review,PAK,Pakistan,Military Hospital (Rawalpindi);Armed Force Institute of Pathology,901,Punjab,1992,71,172,41.3,0,Salmonella Typhi,Multidrug resistance (MDR)
2787,Karamat (1996),"Karamat K, Butt T, Hannan A, et al. Problem of multi-drug resistant typhoid fever in Rawalpindi/Islamabad area. Pak Armed Forces Med J 1996; 46(2): 48-54.",Systematic review,PAK,Pakistan,Military Hospital (Rawalpindi);Armed Force Institute of Pathology,901,Punjab,1993,113,239,47.3,0,Salmonella Typhi,Multidrug resistance (MDR)
1771,Mirza (1995),"Mirza SH, Beeching NJ, Hart CA. The prevalence and clinical features of multi-drug resistant Salmonella Typhi infections in Baluchistan, Pakistan. Ann Trop Med Parasitol 1995; 89(5): 515-9.",Systematic review,PAK,Pakistan,Combined Military Hospital (Quetta),897,Balochistan,1994,43,62,69.4,0,Salmonella Typhi,Multidrug resistance (MDR)
2787,Karamat (1996),"Karamat K, Butt T, Hannan A, et al. Problem of multi-drug resistant typhoid fever in Rawalpindi/Islamabad area. Pak Armed Forces Med J 1996; 46(2): 48-54.",Systematic review,PAK,Pakistan,Military Hospital (Rawalpindi);Armed Force Institute of Pathology,901,Punjab,1994,165,255,64.7,0,Salmonella Typhi,Multidrug resistance (MDR)
2787,Karamat (1996),"Karamat K, Butt T, Hannan A, et al. Problem of multi-drug resistant typhoid fever in Rawalpindi/Islamabad area. Pak Armed Forces Med J 1996; 46(2): 48-54.",Systematic review,PAK,Pakistan,Military Hospital (Rawalpindi);Armed Force Institute of Pathology,901,Punjab,1995,183,244,75,0,Salmonella Typhi,Multidrug resistance (MDR)
470,Butt (2005),"Butt T, Ahmad RN, Salman M, Kazmi SY. Changing trends in drug resistance among typhoid Salmonellae in Rawalpindi, Pakistan. East Mediterr Health J 2005; 11(5-6): 1038-44.",Systematic review,PAK,Pakistan,Armed Force Institute of Pathology,901,Punjab,1996,78,97,80.4,0,Salmonella Typhi,Multidrug resistance (MDR)
1673,Khichi(2001),"Khichi QK, Channer MS. Parenteral chloramphenicol versus chloramphenicol plus dexamethasone in the treatment of typhoid fever. Pak Paed J, 2001.",Systematic review,PAK,Pakistan,Quaid-e-Azam Medical College,901,Punjab,1997,47,84,56,0,Salmonella Typhi,Multidrug resistance (MDR)
470,Butt (2005),"Butt T, Ahmad RN, Salman M, Kazmi SY. Changing trends in drug resistance among typhoid Salmonellae in Rawalpindi, Pakistan. East Mediterr Health J 2005; 11(5-6): 1038-44.",Systematic review,PAK,Pakistan,Armed Force Institute of Pathology,901,Punjab,1997,26,60,43.3,0,Salmonella Typhi,Multidrug resistance (MDR)
470,Butt (2005),"Butt T, Ahmad RN, Salman M, Kazmi SY. Changing trends in drug resistance among typhoid Salmonellae in Rawalpindi, Pakistan. East Mediterr Health J 2005; 11(5-6): 1038-44.",Systematic review,PAK,Pakistan,Armed Force Institute of Pathology,901,Punjab,1998,27,77,35.1,0,Salmonella Typhi,Multidrug resistance (MDR)
470,Butt (2005),"Butt T, Ahmad RN, Salman M, Kazmi SY. Changing trends in drug resistance among typhoid Salmonellae in Rawalpindi, Pakistan. East Mediterr Health J 2005; 11(5-6): 1038-44.",Systematic review,PAK,Pakistan,Armed Force Institute of Pathology,901,Punjab,1999,16,65,24.6,0,Salmonella Typhi,Multidrug resistance (MDR)
461,Hannan (1991),Hannan A. Changing pattern of Salmonella Typhi isolates in Pakistan and their unchanged response to ofloxacin. International Journal of Experimental and Clinical Chemotherapy 1991; 4(4): 225-9.,Systematic review,PAK,Pakistan,Armed Force Institute of Pathology,901,Punjab,1999,5,132,3.8,0,Salmonella Typhi,Multidrug resistance (MDR)
470,Butt (2005),"Butt T, Ahmad RN, Salman M, Kazmi SY. Changing trends in drug resistance among typhoid Salmonellae in Rawalpindi, Pakistan. East Mediterr Health J 2005; 11(5-6): 1038-44.",Systematic review,PAK,Pakistan,Armed Force Institute of Pathology,901,Punjab,2000,10,52,19.2,0,Salmonella Typhi,Multidrug resistance (MDR)
4674,Siddiqui (2006),"Siddiqui FJ, Rabbani F, Hasan R, Nizami SQ, Bhutta ZA. Typhoid fever in children: some epidemiological considerations from Karachi, Pakistan. Int J Infect Dis 2006; 10(3): 215-22.",Systematic review,PAK,Pakistan,Hijrat Colony & Sultanabad,902,Sind,2000,6,42,14.3,0,Salmonella Typhi,Multidrug resistance (MDR)
470,Butt (2005),"Butt T, Ahmad RN, Salman M, Kazmi SY. Changing trends in drug resistance among typhoid Salmonellae in Rawalpindi, Pakistan. East Mediterr Health J 2005; 11(5-6): 1038-44.",Systematic review,PAK,Pakistan,Armed Force Institute of Pathology,901,Punjab,2001,10,68,14.7,0,Salmonella Typhi,Multidrug resistance (MDR)
2463,Mushtaq (2006),Mushtaq MA. What after ciprofloxacin and ceftriaxone in treatment of Salmonella Typhi. Pak J Med Sci 2006; 22(1): 51-4.,Systematic review,PAK,Pakistan,Fatima Memorial Hospital,901,Punjab,2002,18,24,75,0,Salmonella Typhi,Multidrug resistance (MDR)
470,Butt (2005),"Butt T, Ahmad RN, Salman M, Kazmi SY. Changing trends in drug resistance among typhoid Salmonellae in Rawalpindi, Pakistan. East Mediterr Health J 2005; 11(5-6): 1038-44.",Systematic review,PAK,Pakistan,Armed Force Institute of Pathology,901,Punjab,2002,6,34,17.6,0,Salmonella Typhi,Multidrug resistance (MDR)
470,Butt (2005),"Butt T, Ahmad RN, Salman M, Kazmi SY. Changing trends in drug resistance among typhoid Salmonellae in Rawalpindi, Pakistan. East Mediterr Health J 2005; 11(5-6): 1038-44.",Systematic review,PAK,Pakistan,Armed Force Institute of Pathology,901,Punjab,2003,3,24,12.5,0,Salmonella Typhi,Multidrug resistance (MDR)
2180,Ochiai (2008),"Ochiai RL, Acosta CJ, Danovaro-Holliday MC, et al. A study of typhoid fever in five Asian countries: Disease burden and implications for controls. Bull World Health Organ 2008; 86(4): 260-8.",Systematic review,PAK,Pakistan,"Hijrat Colony, Sultanabad and Bilal Colony, Karachi",902,Sind,2003,83,127,65.4,0,Salmonella Typhi,Multidrug resistance (MDR)
1363,Mirza (2008),"Mirza SH, Khan MA. Low-level quinolone-resistance in multi-drug resistant typhoid. J Coll Physicians Surg Pak 2008; 18(1): 13-6.",Systematic review,PAK,Pakistan,Armed Force Institute of Pathology,901,Punjab,2005,24,29,82.8,0,Salmonella Typhi,Multidrug resistance (MDR)
5146,PARN(2018),Pakistan Antimicrobial Resistance Network. Antimicrobial data. 2018. https://parn.org.pk/antimicrobial-data/.,Surveillance report,PAK,Pakistan,Dr. Ziauddin Hospital (branch not specified),901,Punjab,2006,22,84,26.2,0,Salmonella Typhi,Multidrug resistance (MDR)
4363,Ikram (2015),"Ikram S, Hussain S, Aslam A, Khan MD, Ahmed I. Evaluation of the current trends in the antimicrobial susceptibility patterns of typhoid Salmonellae. Pak J Med Health Sci 2015; 9(4): 1247-50.",Systematic review,PAK,Pakistan,Islamabad Hospital (PIMS),899,Islamabad,2007,30,71,42.3,0,Salmonella Typhi,Multidrug resistance (MDR)
1238,Aatekah (2010),"Aatekah O, Shazia S, Umber Z, Arjumand R, Zaidi AKM. Incidence of typhoid bacteremia in infants and young children in southern coastal Pakistan. Pediatr Infect Dis J 2010; 29(11): 1035-9.",Systematic review,PAK,Pakistan,Karachi,902,Sind,2008,3,16,18.8,0,Salmonella Typhi,Multidrug resistance (MDR)
896,Abdullah (2012),"Abdullah FE, Faryal H, Kanwal F, Saboohi I, Iqbal MS. Enteric fever in Karachi: current antibiotic susceptibility of Salmonellae isolates. J Coll Physicians Surg Pak 2012; 22(3): 147-50.",Systematic review,PAK,Pakistan,Laboratory and Diagnostic Centre,902,Sind,2009,60.06,129,46.6,0,Salmonella Typhi,Multidrug resistance (MDR)
142,Muhammad (2013),"Muhammad R, Ali Z, Mehmood K, Ziauddin, Afridi AR, Bari F. Antibiotic sensitivity pattern of Salmonella serotypes in patients with enteric fever in a teaching hospital. Journal of Postgraduate Medical Institute 2013; 27(4): 397-402.",Systematic review,PAK,Pakistan,Lady Reading Hospital,900,Nwfp,2010,51,58,87.9,0,Salmonella Typhi,Multidrug resistance (MDR)
5146,PARN(2018),Pakistan Antimicrobial Resistance Network. Antimicrobial data. 2018. https://parn.org.pk/antimicrobial-data/.,Surveillance report,PAK,Pakistan,Dr. Ziauddin Hospital (branch not specified),901,Punjab,2011,93.01,273,34.1,0,Salmonella Typhi,Multidrug resistance (MDR)
1444,Afzal (2013),"Afzal A, Sarwar Y, Ali A, et al. Molecular evaluation of drug resistance in clinical isolates of Salmonella enterica serovar Typhi from Pakistan. J Infect Dev Ctries 2013; 7(12): 929-40.",Systematic review,PAK,Pakistan,Unknown public hospitals in Faisalabad,901,Punjab,2011,21,80,26.3,0,Salmonella Typhi,Multidrug resistance (MDR)
4588,Malik(2016),"Malik N, Ahmed M. In vitro effect of new antibiotics against clinical isolates of Salmonella Typhi. J Coll Physicians Surg Pak 2016; 26(4): 288-92.",Systematic review,PAK,Pakistan,Armed Force Institute of Pathology,901,Punjab,2012,49,128,38.3,0,Salmonella Typhi,Multidrug resistance (MDR)
5106,Qamar (2018),"Qamar FN, Yousafzai MT, Sultana S, et al. A Retrospective Study of Laboratory-Based Enteric Fever Surveillance, Pakistan, 2012-2014.Journal of Infectious Diseases 2018;218(suppl_4):S201-S205",Systematic review,PAK,Pakistan,Aga Khan University Hospital (Karachi);Aga Khan Hospital for Women and Children;Aga Khan Hospital (Hyderadad),902,Sind,2012,365,584,62.5,0,Salmonella Typhi,Multidrug resistance (MDR)
3023,Ali (2017),"Ali A, Ali HA, Shah FH, Zahid A, Aslam H, Javed B. Pattern of antimicrobial drug resistance of Salmonella Typhi and ParaTyphi a in a teaching hospital in Islamabad. J Pak Med Assoc 2017; 67(3): 375-9.",Systematic review,PAK,Pakistan,Khan Research Laboratories (KRL) Hospital,899,Islamabad,2013,69,155,44.5,0,Salmonella Typhi,Multidrug resistance (MDR)
4102,Abdullah (2013),"Abdullah MA, Adnan Z, Sattar NY. Susceptibility of Salmonella enterica serotype Typhi, to the usual line of antimicrobial treatment in Rawalpindi. Pakistan Journal of Public Health 2013; 3(2): 14-8.",Systematic review,PAK,Pakistan,District Headquarters (DHQ) Teaching Hospital,901,Punjab,2013,59,96,61.5,0,Salmonella Typhi,Multidrug resistance (MDR)
5106,Qamar (2018),"Qamar FN, Yousafzai MT, Sultana S, et al. A Retrospective Study of Laboratory-Based Enteric Fever Surveillance, Pakistan, 2012-2014.Journal of Infectious Diseases 2018;218(suppl_4):S201-S205",Systematic review,PAK,Pakistan,Aga Khan University Hospital (Karachi);Aga Khan Hospital for Women and Children;Aga Khan Hospital (Hyderadad),902,Sind,2013,332,675,49.2,0,Salmonella Typhi,Multidrug resistance (MDR)
5106,Qamar (2018),"Qamar FN, Yousafzai MT, Sultana S, et al. A Retrospective Study of Laboratory-Based Enteric Fever Surveillance, Pakistan, 2012-2014.Journal of Infectious Diseases 2018;218(suppl_4):S201-S205",Systematic review,PAK,Pakistan,Aga Khan University Hospital (Karachi);Aga Khan Hospital for Women and Children;Aga Khan Hospital (Hyderadad),902,Sind,2014,338,702,48.1,0,Salmonella Typhi,Multidrug resistance (MDR)
5063,Zehra (2017),"Zehra NM, Irfan F, Mirza IA, et al. Current Trends of Antimicrobial Susceptibility of Typhoidal Salmonellae Isolated at Tertiary Care Hospital.Jcpsp, Journal of the College of Physicians & Surgeons - Pakistan 2017;27(11):690-692",Systematic review,PAK,Pakistan,PNS Shifa Hospital,902,Sind,2015,154,270,57,0,Salmonella Typhi,Multidrug resistance (MDR)
5083,Imran (2018),"Imran M, Dost S and Saleem M. Pattern of antibiotic resistance among patients with enteric fever.Indo American Journal of Pharmaceutical Sciences 2018;5(8):7797-7801",Systematic review,PAK,Pakistan,Bahawal-Victoria Hospital,901,Punjab,2017,121.01,161,75.2,1,Salmonella Typhi,Multidrug resistance (MDR)
5146,PARN(2018),Pakistan Antimicrobial Resistance Network. Antimicrobial data. 2018. https://parn.org.pk/antimicrobial-data/.,Surveillance report,PAK,Pakistan,Aga Khan University Hospital (Karachi),902,Sind,2018,572.92,3583,16,1,Salmonella Typhi,Multidrug resistance (MDR)
294,Abbas(1997),"Abbas EHE, Albawab IM, Abdallah MZ, Al-Hassan R, Sahool EM, Bener A. Are new antibiotics essential in the treatment of Salmonella Typhi enteric fever? A comparison between enteric fever due to sensitive and resistant Salmonella in Ras Al-Kaimah, United Arab Emirates. Saudi Med J 1997; 18(2): 161-5.",Systematic review,ARE,United Arab Emirates,Saif Bin Ghobash Hospital,456,Ras Al Khaymah,1990,6,18,33.3,0,Salmonella Typhi,Multidrug resistance (MDR)
148,Bouzenoune (2011),"Bouzenoune F, Debbih KK, Boudersa F, Kouhil S, Nezzar N. Antibiotic susceptibility of Salmonella enterica serovar Typhi isolated from blood cultures at the Ain M'lila hospital (Algeria), between 2005 and 2008. [French]. Med Mal Infect 2011; 41(4): 181-5.",Systematic review,DZA,Algeria,Fourchi,492,Oum El Bouaghi,2005,0,90,0,0,Salmonella Typhi,Multidrug resistance (MDR)
148,Bouzenoune (2011),"Bouzenoune F, Debbih KK, Boudersa F, Kouhil S, Nezzar N. Antibiotic susceptibility of Salmonella enterica serovar Typhi isolated from blood cultures at the Ain M'lila hospital (Algeria), between 2005 and 2008. [French]. Med Mal Infect 2011; 41(4): 181-5.",Systematic review,DZA,Algeria,Fourchi,492,Oum El Bouaghi,2006,0,60,0,0,Salmonella Typhi,Multidrug resistance (MDR)
148,Bouzenoune (2011),"Bouzenoune F, Debbih KK, Boudersa F, Kouhil S, Nezzar N. Antibiotic susceptibility of Salmonella enterica serovar Typhi isolated from blood cultures at the Ain M'lila hospital (Algeria), between 2005 and 2008. [French]. Med Mal Infect 2011; 41(4): 181-5.",Systematic review,DZA,Algeria,Ain Kercha,492,Oum El Bouaghi,2007,0,14,0,0,Salmonella Typhi,Multidrug resistance (MDR)
148,Bouzenoune (2011),"Bouzenoune F, Debbih KK, Boudersa F, Kouhil S, Nezzar N. Antibiotic susceptibility of Salmonella enterica serovar Typhi isolated from blood cultures at the Ain M'lila hospital (Algeria), between 2005 and 2008. [French]. Med Mal Infect 2011; 41(4): 181-5.",Systematic review,DZA,Algeria,Ain Kercha,492,Oum El Bouaghi,2008,0,14,0,0,Salmonella Typhi,Multidrug resistance (MDR)
1774,Wasfy(1996),"Wasfy MO, Moustafa DA, El-Gendy AM, et al. Prevalence of antibiotic resistance among Egyptian Salmonella Typhi strains. J Egypt Public Health Assoc 1996; 71(1-2): 149-60.",Systematic review,EGY,Egypt,Abbassia Fever Hospital,516,Al Qahirah (cairo),1990,14,41,34.1,0,Salmonella Typhi,Multidrug resistance (MDR)
2339,Wasfy (2002),"Wasfy MO, Frenck R, Ismail TF, Mansour H, Malone JL, Mahoney FJ. Trends of multiple-drug resistance among Salmonella serotype Typhi isolates during a 14-year period in Egypt. Clin Infect Dis 2002; 35(10): 1265-8.",Systematic review,EGY,Egypt,Abbassia Fever Hospital,516,Al Qahirah (cairo),1990,14,48,29.2,0,Salmonella Typhi,Multidrug resistance (MDR)
652,Girgis (1995),"Girgis NI, Sultan Y, Hammad O, Farid Z. Comparison of the efficacy, safety and cost of cefixime, ceftriaxone and aztreonam in the treatment of multidrug-resistant Salmonella Typhi septicemia in children. Pediatr Infect Dis J 1995; 14(7): 603-5.",Systematic review,EGY,Egypt,Abbassia Fever Hospital,516,Al Qahirah (cairo),1991,124,165,75.2,0,Salmonella Typhi,Multidrug resistance (MDR)
1774,Wasfy(1996),"Wasfy MO, Moustafa DA, El-Gendy AM, et al. Prevalence of antibiotic resistance among Egyptian Salmonella Typhi strains. J Egypt Public Health Assoc 1996; 71(1-2): 149-60.",Systematic review,EGY,Egypt,Abbassia Fever Hospital,516,Al Qahirah (cairo),1991,68,126,54,0,Salmonella Typhi,Multidrug resistance (MDR)
2339,Wasfy (2002),"Wasfy MO, Frenck R, Ismail TF, Mansour H, Malone JL, Mahoney FJ. Trends of multiple-drug resistance among Salmonella serotype Typhi isolates during a 14-year period in Egypt. Clin Infect Dis 2002; 35(10): 1265-8.",Systematic review,EGY,Egypt,Abbassia Fever Hospital,516,Al Qahirah (cairo),1991,51.1,93,54.9,0,Salmonella Typhi,Multidrug resistance (MDR)
2804,Mourad(1993),"Mourad AS, Metwally M, el Deen AN, et al. Multiple-drug-resistant Salmonella Typhi. Clin Infect Dis 1993; 17(1): 135-6.",Systematic review,EGY,Egypt,Alexandria Fever Hospital,512,Al Iskandariyah (alex.),1992,15,35,42.9,0,Salmonella Typhi,Multidrug resistance (MDR)
435,Girgis(1993),"Girgis NI, Kilpatrick ME, Farid Z, Sultan Y, Podgore JK. Cefixime in the treatment of enteric fever in children. Drugs Exp Clin Res 1993; 19(1): 47-9.",Systematic review,EGY,Egypt,Abbassia Fever Hospital,516,Al Qahirah (cairo),1992,44,50,88,0,Salmonella Typhi,Multidrug resistance (MDR)
1774,Wasfy(1996),"Wasfy MO, Moustafa DA, El-Gendy AM, et al. Prevalence of antibiotic resistance among Egyptian Salmonella Typhi strains. J Egypt Public Health Assoc 1996; 71(1-2): 149-60.",Systematic review,EGY,Egypt,Abbassia Fever Hospital,516,Al Qahirah (cairo),1992,107,151,70.9,0,Salmonella Typhi,Multidrug resistance (MDR)
2339,Wasfy (2002),"Wasfy MO, Frenck R, Ismail TF, Mansour H, Malone JL, Mahoney FJ. Trends of multiple-drug resistance among Salmonella serotype Typhi isolates during a 14-year period in Egypt. Clin Infect Dis 2002; 35(10): 1265-8.",Systematic review,EGY,Egypt,Abbassia Fever Hospital,516,Al Qahirah (cairo),1992,32,114,28.1,0,Salmonella Typhi,Multidrug resistance (MDR)
1774,Wasfy(1996),"Wasfy MO, Moustafa DA, El-Gendy AM, et al. Prevalence of antibiotic resistance among Egyptian Salmonella Typhi strains. J Egypt Public Health Assoc 1996; 71(1-2): 149-60.",Systematic review,EGY,Egypt,Abbassia Fever Hospital,516,Al Qahirah (cairo),1993,100,104,96.2,1,Salmonella Typhi,Multidrug resistance (MDR)
2339,Wasfy (2002),"Wasfy MO, Frenck R, Ismail TF, Mansour H, Malone JL, Mahoney FJ. Trends of multiple-drug resistance among Salmonella serotype Typhi isolates during a 14-year period in Egypt. Clin Infect Dis 2002; 35(10): 1265-8.",Systematic review,EGY,Egypt,Abbassia Fever Hospital,516,Al Qahirah (cairo),1993,27,27,100,1,Salmonella Typhi,Multidrug resistance (MDR)
1774,Wasfy(1996),"Wasfy MO, Moustafa DA, El-Gendy AM, et al. Prevalence of antibiotic resistance among Egyptian Salmonella Typhi strains. J Egypt Public Health Assoc 1996; 71(1-2): 149-60.",Systematic review,EGY,Egypt,Abbassia Fever Hospital,516,Al Qahirah (cairo),1994,64,115,55.7,0,Salmonella Typhi,Multidrug resistance (MDR)
2339,Wasfy (2002),"Wasfy MO, Frenck R, Ismail TF, Mansour H, Malone JL, Mahoney FJ. Trends of multiple-drug resistance among Salmonella serotype Typhi isolates during a 14-year period in Egypt. Clin Infect Dis 2002; 35(10): 1265-8.",Systematic review,EGY,Egypt,Abbassia Fever Hospital,516,Al Qahirah (cairo),1994,9,20,45,0,Salmonella Typhi,Multidrug resistance (MDR)
319,Girgis(1999),"Girgis NI, Butler T, Frenck RW, et al. Azithromycin versus ciprofloxacin for treatment of uncomplicated typhoid fever in a randomized trial in Egypt that included patients with multidrug resistance. Antimicrob Agents Chemother 1999; 43(6): 1441-4.",Systematic review,EGY,Egypt,Abbassia Fever Hospital,516,Al Qahirah (cairo),1995,21,61,34.4,0,Salmonella Typhi,Multidrug resistance (MDR)
2339,Wasfy (2002),"Wasfy MO, Frenck R, Ismail TF, Mansour H, Malone JL, Mahoney FJ. Trends of multiple-drug resistance among Salmonella serotype Typhi isolates during a 14-year period in Egypt. Clin Infect Dis 2002; 35(10): 1265-8.",Systematic review,EGY,Egypt,Abbassia Fever Hospital,516,Al Qahirah (cairo),1995,31,50,62,0,Salmonella Typhi,Multidrug resistance (MDR)
3411,Frenck(2000),"Frenck R, Nakhla I, Sultan Y, et al. Azithromycin versus ceftriaxone for the treatment of uncomplicated typhoid fever in children. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2000. http://onlinelibrary.wiley.com/o/cochrane/clcentral/articles/607/CN-00328607/frame.html",Systematic review,EGY,Egypt,Abbassia Fever Hospital,516,Al Qahirah (cairo),1996,11,64,17.2,0,Salmonella Typhi,Multidrug resistance (MDR)
2339,Wasfy (2002),"Wasfy MO, Frenck R, Ismail TF, Mansour H, Malone JL, Mahoney FJ. Trends of multiple-drug resistance among Salmonella serotype Typhi isolates during a 14-year period in Egypt. Clin Infect Dis 2002; 35(10): 1265-8.",Systematic review,EGY,Egypt,Abbassia Fever Hospital,516,Al Qahirah (cairo),1996,1,29,3.4,0,Salmonella Typhi,Multidrug resistance (MDR)
2339,Wasfy (2002),"Wasfy MO, Frenck R, Ismail TF, Mansour H, Malone JL, Mahoney FJ. Trends of multiple-drug resistance among Salmonella serotype Typhi isolates during a 14-year period in Egypt. Clin Infect Dis 2002; 35(10): 1265-8.",Systematic review,EGY,Egypt,Abbassia Fever Hospital,516,Al Qahirah (cairo),1997,12.69,83,15.3,0,Salmonella Typhi,Multidrug resistance (MDR)
638,Abdel Wahab (1999),"Abdel Wahab MF, el-Gindy IM, Sultan Y, el-Naby HM. Comparative study on different recent diagnostic and therapeutic regimens in acute typhoid fever. J Egypt Public Health Assoc 1999; 74(1-2): 193-205.",Systematic review,EGY,Egypt,Abbassia Fever Hospital,516,Al Qahirah (cairo),1998,30,45,66.7,0,Salmonella Typhi,Multidrug resistance (MDR)
2339,Wasfy (2002),"Wasfy MO, Frenck R, Ismail TF, Mansour H, Malone JL, Mahoney FJ. Trends of multiple-drug resistance among Salmonella serotype Typhi isolates during a 14-year period in Egypt. Clin Infect Dis 2002; 35(10): 1265-8.",Systematic review,EGY,Egypt,Abbassia Fever Hospital,516,Al Qahirah (cairo),1998,6,41,14.6,0,Salmonella Typhi,Multidrug resistance (MDR)
2339,Wasfy (2002),"Wasfy MO, Frenck R, Ismail TF, Mansour H, Malone JL, Mahoney FJ. Trends of multiple-drug resistance among Salmonella serotype Typhi isolates during a 14-year period in Egypt. Clin Infect Dis 2002; 35(10): 1265-8.",Systematic review,EGY,Egypt,Abbassia Fever Hospital,516,Al Qahirah (cairo),1999,9,100,9,0,Salmonella Typhi,Multidrug resistance (MDR)
2128,Frenck Jr(2004),"Frenck Jr RW, Mansour A, Nakhla I, et al. Short-course azithromycin for the treatment of uncomplicated typhoid fever in children and adolescents. Clin Infect Dis 2004; 38(7): 951-7.",Systematic review,EGY,Egypt,Abbassia Fever Hospital,516,Al Qahirah (cairo),2000,1,68,1.5,0,Salmonella Typhi,Multidrug resistance (MDR)
2339,Wasfy (2002),"Wasfy MO, Frenck R, Ismail TF, Mansour H, Malone JL, Mahoney FJ. Trends of multiple-drug resistance among Salmonella serotype Typhi isolates during a 14-year period in Egypt. Clin Infect Dis 2002; 35(10): 1265-8.",Systematic review,EGY,Egypt,Abbassia Fever Hospital,516,Al Qahirah (cairo),2000,2,41,4.9,0,Salmonella Typhi,Multidrug resistance (MDR)
1744,Srikantiah (2006),"Srikantiah P, Girgis FY, Luby SP, et al. Population-based surveillance of typhoid fever in Egypt. Am J Trop Med Hyg 2006; 74(1): 114-9.",Systematic review,EGY,Egypt,Unknown hospitals and primary care providers in Fayoum governornate,510,Al Fayyum (fayoum),2002,26,89,29.2,1,Salmonella Typhi,Multidrug resistance (MDR)
1466,Rahman (2014),"Rahman BA, Wasfy MO, Maksoud MA, Hanna N, Dueger E, House B. Multi-drug resistance and reduced susceptibility to ciprofloxacin among Salmonella enterica serovar Typhi isolates from the Middle East and Central Asia. New microbes new infect 2014; 2(4): 88-92.",Systematic review,EGY,Egypt,Fayoum Fever/Infectious Diseases Hospital,510,Al Fayyum (fayoum),2005,77,270,28.5,1,Salmonella Typhi,Multidrug resistance (MDR)
1466,Rahman (2014),"Rahman BA, Wasfy MO, Maksoud MA, Hanna N, Dueger E, House B. Multi-drug resistance and reduced susceptibility to ciprofloxacin among Salmonella enterica serovar Typhi isolates from the Middle East and Central Asia. New microbes new infect 2014; 2(4): 88-92.",Systematic review,EGY,Egypt,Gharbiya Fever/Infectious Diseases Hospital,511,Al Gharbiyah (gharbia),2005,3,40,7.5,0,Salmonella Typhi,Multidrug resistance (MDR)
1466,Rahman (2014),"Rahman BA, Wasfy MO, Maksoud MA, Hanna N, Dueger E, House B. Multi-drug resistance and reduced susceptibility to ciprofloxacin among Salmonella enterica serovar Typhi isolates from the Middle East and Central Asia. New microbes new infect 2014; 2(4): 88-92.",Systematic review,EGY,Egypt,Alexandria Fever Hospital,512,Al Iskandariyah (alex.),2005,1,40,2.5,0,Salmonella Typhi,Multidrug resistance (MDR)
1466,Rahman (2014),"Rahman BA, Wasfy MO, Maksoud MA, Hanna N, Dueger E, House B. Multi-drug resistance and reduced susceptibility to ciprofloxacin among Salmonella enterica serovar Typhi isolates from the Middle East and Central Asia. New microbes new infect 2014; 2(4): 88-92.",Systematic review,EGY,Egypt,Menofiya Fever/Infectious Diseases Hospital,514,Al Minufiyah (menoufia),2005,0,12,0,0,Salmonella Typhi,Multidrug resistance (MDR)
1466,Rahman (2014),"Rahman BA, Wasfy MO, Maksoud MA, Hanna N, Dueger E, House B. Multi-drug resistance and reduced susceptibility to ciprofloxacin among Salmonella enterica serovar Typhi isolates from the Middle East and Central Asia. New microbes new infect 2014; 2(4): 88-92.",Systematic review,EGY,Egypt,Abbassia Fever Hospital,516,Al Qahirah (cairo),2005,12,166,7.2,0,Salmonella Typhi,Multidrug resistance (MDR)
1466,Rahman (2014),"Rahman BA, Wasfy MO, Maksoud MA, Hanna N, Dueger E, House B. Multi-drug resistance and reduced susceptibility to ciprofloxacin among Salmonella enterica serovar Typhi isolates from the Middle East and Central Asia. New microbes new infect 2014; 2(4): 88-92.",Systematic review,EGY,Egypt,Aswan Fever/Infectious Diseases Hospital,522,Aswan,2005,1,66,1.5,0,Salmonella Typhi,Multidrug resistance (MDR)
1466,Rahman (2014),"Rahman BA, Wasfy MO, Maksoud MA, Hanna N, Dueger E, House B. Multi-drug resistance and reduced susceptibility to ciprofloxacin among Salmonella enterica serovar Typhi isolates from the Middle East and Central Asia. New microbes new infect 2014; 2(4): 88-92.",Systematic review,EGY,Egypt,Asuit Fever/Infectious Diseases Hospital,523,Asyiut,2005,0,26,0,0,Salmonella Typhi,Multidrug resistance (MDR)
236,Bahrmand(1997),"Bahrmand AR, Velayati AA. Antimicrobial resistance pattern and plasmid profile of Salmonella Typhi isolated from an outbreak in Tehran province. Scandinavian Journal of Infectious Diseases 1997; 29(3): 265-9.",Systematic review,IRN,Iran,Four unknown hospitals in Tehran,553,Tehran,1994,16,33,48.5,0,Salmonella Typhi,Multidrug resistance (MDR)
236,Bahrmand(1997),"Bahrmand AR, Velayati AA. Antimicrobial resistance pattern and plasmid profile of Salmonella Typhi isolated from an outbreak in Tehran province. Scandinavian Journal of Infectious Diseases 1997; 29(3): 265-9.",Systematic review,IRN,Iran,Four unknown hospitals in Tehran,553,Tehran,1995,36,48,75,1,Salmonella Typhi,Multidrug resistance (MDR)
1187,Lari(1997),"Lari AR, Validi N, Ghaffarzadeh K, Shamshiri AR. In vitro activity of cefixime versus ceftizoxime against Salmonella Typhi. Pathologie Biologie 1997; 45(5): 415-9.",Systematic review,IRN,Iran,Labadi-nejad hospital,553,Tehran,1996,18,52,34.6,0,Salmonella Typhi,Multidrug resistance (MDR)
4670,Yousefi-Mashouf(2007),"Yousefi-Mashouf R, Moshtaghi A. Frequency of typhoidal and non-typhoidal Salmonella species and detection of their drugs resistance patterns. Journal of research in health sciences 2007; 7(1): 49-56.",Systematic review,IRN,Iran,Bu-Ali Sina Hospital;Ekbatan Hospital,540,Hamedan,2003,18,135,13.3,0,Salmonella Typhi,Multidrug resistance (MDR)
602,Pourshafie(2008),"Pourshafie MR, Saifi M, Mousavi SF, Sedaghat M, Nikbakht GH, Rubino S. Clonal diversity of Salmonella enterica serotype Typhi isolated from patients with typhoid fever in Tehran. Scandinavian Journal of Infectious Diseases 2008; 40(1): 18-23.",Systematic review,IRN,Iran,Three unknown hospitals in Tehran,553,Tehran,2004,0,15,0,1,Salmonella Typhi,Multidrug resistance (MDR)
4087,Tajbakhsh(2012),"Tajbakhsh M, Hendriksen RS, Nochi Z, Zali MR, Aarestrup FM, Garcia-Migura L. Antimicrobial resistance in Salmonella spp. recovered from patients admitted to six different hospitals in Tehran, Iran from 2007 to 2008. Folia Microbiol (Praha) 2012; 57(2): 91-7.",Systematic review,IRN,Iran,Six major hospitals in Tehran,553,Tehran,2008,2,17,11.8,0,Salmonella Typhi,Multidrug resistance (MDR)
1684,Soltan Dallal(2014),"Soltan Dallal MM, Rastegar Lari A, Sharifi Yazdi MK. Pattern of serotyping and antibiotic resistance of Salmonella in children with diarrhea. [Persian]. Journal of Gorgan University of Medical Sciences 2014; 16(1): e100-Pe4.",Systematic review,IRN,Iran,Unknown public health centers in Robat-Karim,553,Tehran,2010,1,7,14.3,0,Salmonella Typhi,Multidrug resistance (MDR)
3022,Aljanaby (2017),"Aljanaby AAJ, Medhat AR. Prevalence of some antimicrobials resistance associated-genes in Salmonella Typhi isolated from patients infected with typhoid fever. J Bio Sci 2017; 17(4): 171-84.",Systematic review,IRQ,Iraq,Al-Najaf Hospital,565,Najaf,2017,20,39,51.3,0,Salmonella Typhi,Multidrug resistance (MDR)
3585,Dimitrov (2005),"Dimitrov TS, Panigrahi D, Emara M, Al-Nakkas A, Awni F, Passadilla R. Incidence of bloodstream infections in a speciality hospital in Kuwait: 8-Year experience. Med Princ Pract 2005; 14(6): 417-21.",Systematic review,KWT,Kuwait,Infectious Diseases Hospital (Al Farwaniyah),592,Al Farwaniyah,1995,15,45,33.3,0,Salmonella Typhi,Multidrug resistance (MDR)
3585,Dimitrov (2005),"Dimitrov TS, Panigrahi D, Emara M, Al-Nakkas A, Awni F, Passadilla R. Incidence of bloodstream infections in a speciality hospital in Kuwait: 8-Year experience. Med Princ Pract 2005; 14(6): 417-21.",Systematic review,KWT,Kuwait,Infectious Diseases Hospital (Al Farwaniyah),592,Al Farwaniyah,1996,26,95,27.4,0,Salmonella Typhi,Multidrug resistance (MDR)
3585,Dimitrov (2005),"Dimitrov TS, Panigrahi D, Emara M, Al-Nakkas A, Awni F, Passadilla R. Incidence of bloodstream infections in a speciality hospital in Kuwait: 8-Year experience. Med Princ Pract 2005; 14(6): 417-21.",Systematic review,KWT,Kuwait,Infectious Diseases Hospital (Al Farwaniyah),592,Al Farwaniyah,1997,35,80,43.8,0,Salmonella Typhi,Multidrug resistance (MDR)
3585,Dimitrov (2005),"Dimitrov TS, Panigrahi D, Emara M, Al-Nakkas A, Awni F, Passadilla R. Incidence of bloodstream infections in a speciality hospital in Kuwait: 8-Year experience. Med Princ Pract 2005; 14(6): 417-21.",Systematic review,KWT,Kuwait,Infectious Diseases Hospital (Al Farwaniyah),592,Al Farwaniyah,1998,18,60,30,0,Salmonella Typhi,Multidrug resistance (MDR)
1981,Dashti (2008),"Dashti AA, Jadaon MM, Habeeb F, West PW, Panigrahi D, Amyes SG. Salmonella enterica Serotype Typhi in Kuwait and its reduced susceptibility to ciprofloxacin. J Chemother 2008; 20(3): 297-302.",Systematic review,KWT,Kuwait,Farwania Hospital;Infectious Diseases Hospital (Al Farwaniyah),592,Al Farwaniyah,1999,3,25,12,0,Salmonella Typhi,Multidrug resistance (MDR)
3585,Dimitrov (2005),"Dimitrov TS, Panigrahi D, Emara M, Al-Nakkas A, Awni F, Passadilla R. Incidence of bloodstream infections in a speciality hospital in Kuwait: 8-Year experience. Med Princ Pract 2005; 14(6): 417-21.",Systematic review,KWT,Kuwait,Infectious Diseases Hospital (Al Farwaniyah),592,Al Farwaniyah,1999,20,62,32.3,0,Salmonella Typhi,Multidrug resistance (MDR)
3585,Dimitrov (2005),"Dimitrov TS, Panigrahi D, Emara M, Al-Nakkas A, Awni F, Passadilla R. Incidence of bloodstream infections in a speciality hospital in Kuwait: 8-Year experience. Med Princ Pract 2005; 14(6): 417-21.",Systematic review,KWT,Kuwait,Infectious Diseases Hospital (Al Farwaniyah),592,Al Farwaniyah,2000,10,30,33.3,0,Salmonella Typhi,Multidrug resistance (MDR)
3585,Dimitrov (2005),"Dimitrov TS, Panigrahi D, Emara M, Al-Nakkas A, Awni F, Passadilla R. Incidence of bloodstream infections in a speciality hospital in Kuwait: 8-Year experience. Med Princ Pract 2005; 14(6): 417-21.",Systematic review,KWT,Kuwait,Infectious Diseases Hospital (Al Farwaniyah),592,Al Farwaniyah,2001,5,20,25,0,Salmonella Typhi,Multidrug resistance (MDR)
737,Dimitrov (2010),"Dimitrov T, Dashti AA, Albaksami O, Jadaon MM. Detection of mutations in the gyrA gene in fluoroquinolone resistance Salmonella enterica serotypes Typhi and ParaTyphi A isolated from the Infectious Diseases Hospital, Kuwait. J Clin Pathol 2010; 63(1): 83-7.",Systematic review,KWT,Kuwait,Infectious Diseases Hospital (Al Farwaniyah),592,Al Farwaniyah,2002,10,23,43.5,0,Salmonella Typhi,Multidrug resistance (MDR)
3585,Dimitrov (2005),"Dimitrov TS, Panigrahi D, Emara M, Al-Nakkas A, Awni F, Passadilla R. Incidence of bloodstream infections in a speciality hospital in Kuwait: 8-Year experience. Med Princ Pract 2005; 14(6): 417-21.",Systematic review,KWT,Kuwait,Infectious Diseases Hospital (Al Farwaniyah),592,Al Farwaniyah,2002,11,22,50,0,Salmonella Typhi,Multidrug resistance (MDR)
737,Dimitrov (2010),"Dimitrov T, Dashti AA, Albaksami O, Jadaon MM. Detection of mutations in the gyrA gene in fluoroquinolone resistance Salmonella enterica serotypes Typhi and ParaTyphi A isolated from the Infectious Diseases Hospital, Kuwait. J Clin Pathol 2010; 63(1): 83-7.",Systematic review,KWT,Kuwait,Infectious Diseases Hospital (Al Farwaniyah),592,Al Farwaniyah,2003,7,22,31.8,0,Salmonella Typhi,Multidrug resistance (MDR)
737,Dimitrov (2010),"Dimitrov T, Dashti AA, Albaksami O, Jadaon MM. Detection of mutations in the gyrA gene in fluoroquinolone resistance Salmonella enterica serotypes Typhi and ParaTyphi A isolated from the Infectious Diseases Hospital, Kuwait. J Clin Pathol 2010; 63(1): 83-7.",Systematic review,KWT,Kuwait,Infectious Diseases Hospital (Al Farwaniyah),592,Al Farwaniyah,2004,16,30,53.3,0,Salmonella Typhi,Multidrug resistance (MDR)
855,Rotimi(2008),"Rotimi VO, Jamal W, Pal T, Sonnevend A, Dimitrov TS, Albert MJ. Emergence of multidrug-resistant Salmonella spp. and isolates with reduced susceptibility to ciprofloxacin in Kuwait and the United Arab Emirates. Diagn Microbiol Infect Dis 2008; 60(1): 71-7.",Systematic review,KWT,Kuwait,Mubarak Al-Kabeer Hospital,596,Hawalli,2004,8,25,32,0,Salmonella Typhi,Multidrug resistance (MDR)
737,Dimitrov (2010),"Dimitrov T, Dashti AA, Albaksami O, Jadaon MM. Detection of mutations in the gyrA gene in fluoroquinolone resistance Salmonella enterica serotypes Typhi and ParaTyphi A isolated from the Infectious Diseases Hospital, Kuwait. J Clin Pathol 2010; 63(1): 83-7.",Systematic review,KWT,Kuwait,Infectious Diseases Hospital (Al Farwaniyah),592,Al Farwaniyah,2005,10,26,38.5,0,Salmonella Typhi,Multidrug resistance (MDR)
737,Dimitrov (2010),"Dimitrov T, Dashti AA, Albaksami O, Jadaon MM. Detection of mutations in the gyrA gene in fluoroquinolone resistance Salmonella enterica serotypes Typhi and ParaTyphi A isolated from the Infectious Diseases Hospital, Kuwait. J Clin Pathol 2010; 63(1): 83-7.",Systematic review,KWT,Kuwait,Infectious Diseases Hospital (Al Farwaniyah),592,Al Farwaniyah,2006,14,35,40,0,Salmonella Typhi,Multidrug resistance (MDR)
273,Araj(1994),"Araj GF, Uwaydah MM, Alami SY. Antimicrobial susceptibility patterns of bacterial isolates at the American University Medical Center in Lebanon. Diagn Microbiol Infect Dis 1994; 20(3): 151-8.",Systematic review,LBN,Lebanon,American University of Beirut Medical Center,598,Beyrouth,1993,1,39,2.6,0,Salmonella Typhi,Multidrug resistance (MDR)
3515,Hamze(2003),"Hamze M, Dabboussi F, Izard D. Enterobacterial susceptibility to antibiotics in northern Lebanon (1998-2001). Cahiers Sante 2003; 13(2): 107-12.",Systematic review,LBN,Lebanon,Islamic Charity Hospital (Tripoli),599,Liban Nord,2000,0,127,0,0,Salmonella Typhi,Multidrug resistance (MDR)
3098,Rouahi(2015),"Rouahi N, Zouhdi M. Antibioresistance of Moroccan strains of Salmonella Typhi: a need for updating the standardized treatment of typhoid fever set on 1994. Ann Biol Clin (Paris) 2015; 73(6): 749-50.",Systematic review,MAR,Morocco,Hopital Ibnou Sina (Ibn Sina);Institut National d'Hygiene,631,Nord Ouest,2000,0,18,0,0,Salmonella Typhi,Multidrug resistance (MDR)
1193,Qadri(1997),"Qadri SM, Ueno Y, Almodovar E. In vitro activity of sparfloxacin against Salmonella Typhi. Chemotherapy 1997; 43(1): 6-9.",Systematic review,SAU,Saudi Arabia,King Faisal Specialist Hospital and Research Centre,664,Riyad,1993,11,104,10.6,0,Salmonella Typhi,Multidrug resistance (MDR)
2376,Panhotra (2004),"Panhotra BR, Saxena AK, Al-Ghamdi AM. Typhoid fever due to multiresistant Salmonella enterica serovar Typhi having reduced susceptibility to ciprofloxacin and nalidixic acid resistance. Saudi Med J 2004; 25(10): 1509-11.",Systematic review,SAU,Saudi Arabia,King Fahd Hospital (Al-Hofif),655,Eastern Province,2003,12,12,100,1,Salmonella Typhi,Multidrug resistance (MDR)
2042,Secmeer (1995),"Secmeer G, Kanra G, Cemeroglu AP, Ozen H, Ceyhan M, Ecevit Z. Salmonella Typhi infections. A 10-year retrospective study. Turk J Pediatr 1995; 37(4): 339-41.",Systematic review,TUR,Turkey,Hacettepe Children's Hospital,728,Ankara,1990,2,11,18.2,0,Salmonella Typhi,Multidrug resistance (MDR)
145,Kuzucu(2001),"Kuzucu C, Baktr E, Acar N. Antibiotic susceptibilities of Salmonella and Shigella strains isolated between 1998-1999. [Turkish]. Turk Hijyen ve Deneysel Biyoloji Dergisi 2001; 58(1): 11-4.",Systematic review,TUR,Turkey,S.B. Ankara Hospital,728,Ankara,1994,0,17,0,0,Salmonella Typhi,Multidrug resistance (MDR)
147,Akan(1997),"Akan O, Kanra G, Secmeer G, Ceyhan M, Ecevit Z, Berkman E. Antibiotic susceptibilities of Salmonella serogroups isolated from Turkish children. Turk J Pediatr 1997; 39(1): 7-11.",Systematic review,TUR,Turkey,Hacettepe Children's Hospital,728,Ankara,1995,0,20,0,0,Salmonella Typhi,Multidrug resistance (MDR)
146,Cesur(2004),"Cesur S, Albayrak F, Birengel S, Sozen TH. Antibiotic susceptibilities of Salmonella and Shigella strains isolated from stool samples in the 1997-1999 period against ampicillin, cotrimoxazole, chloramphenicol and ciprofloxacin. [Turkish]. Infeksiyon Dergisi = Turkish Journal of Infection 2004; 18(1): 65-8.",Systematic review,TUR,Turkey,Ankara University Medical School,728,Ankara,1998,13,31,41.9,0,Salmonella Typhi,Multidrug resistance (MDR)
1443,Hosoglu (2003),"Hosoglu S, Loeb M, Geyik MF, Ucmak H, Jayaratne P. Molecular epidemiology of invasive Salmonella Typhi in southeast Turkey. Clin Microbiol Infect 2003; 9(7): 727-30.",Systematic review,TUR,Turkey,Dicle University Hospital,747,Diyarbakir,1999,0,65,0,0,Salmonella Typhi,Multidrug resistance (MDR)
929,Bayram(2011),"Bayram Y, Guducuoglu H, Otlu B, et al. Epidemiological characteristics and molecular typing of Salmonella enterica serovar Typhi during a waterborne outbreak in Eastern Anatolia. Ann Trop Med Parasitol 2011; 105(5): 359-65.",Systematic review,TUR,Turkey,Ercek town,798,Van,2008,91,91,100,1,Salmonella Typhi,Multidrug resistance (MDR)
2980,Gundogdu(2017),"Gundogdu A, Kilic H, Ulu-Kilic A, Parkan OM, Ture Z. Distribution and Antimicrobial Resistance of Salmonella Serovars Isolated in Kayseri Region. Klimik Journal 2017; 30(1): 22-6.",Systematic review,TUR,Turkey,Erciyes University Hospital,768,Kayseri,2015,0,25,0,0,Salmonella Typhi,Multidrug resistance (MDR)
2030,Taha(2013),"Taha RR, Alghalibi SM, Saeed Saleh MG. Salmonella spp. in patients suffering from enteric fever and food poisoning in Thamar city, Yemen. East Mediterr Health J 2013; 19(1): 88-93.",Systematic review,YEM,Yemen,Dar Alshafaa Hospital;Dhamar General Hospital,811,Dhamar,2008,6,41,14.6,0,Salmonella Typhi,Multidrug resistance (MDR)
5149,KEMRI (2020),"Bigogo G, Verani JR, Munywoki P, Audi A. KEMRI CDC Gram_project_pbids30July2020. Nairobi, Kenya; 2020",Dataset,KEN,Kenya,CDC Tabitha clinic,1106,Nairobi,2007,22,30,73.3,0,Salmonella Typhi,Multidrug resistance (MDR)
5149,KEMRI (2020),"Bigogo G, Verani JR, Munywoki P, Audi A. KEMRI CDC Gram_project_pbids30July2020. Nairobi, Kenya; 2020",Dataset,KEN,Kenya,CDC Tabitha clinic,1106,Nairobi,2008,34,43,79.1,0,Salmonella Typhi,Multidrug resistance (MDR)
5149,KEMRI (2020),"Bigogo G, Verani JR, Munywoki P, Audi A. KEMRI CDC Gram_project_pbids30July2020. Nairobi, Kenya; 2020",Dataset,KEN,Kenya,CDC Tabitha clinic,1106,Nairobi,2009,12,16,75,0,Salmonella Typhi,Multidrug resistance (MDR)
5149,KEMRI (2020),"Bigogo G, Verani JR, Munywoki P, Audi A. KEMRI CDC Gram_project_pbids30July2020. Nairobi, Kenya; 2020",Dataset,KEN,Kenya,CDC Tabitha clinic,1106,Nairobi,2010,28,50,56,0,Salmonella Typhi,Multidrug resistance (MDR)
5149,KEMRI (2020),"Bigogo G, Verani JR, Munywoki P, Audi A. KEMRI CDC Gram_project_pbids30July2020. Nairobi, Kenya; 2020",Dataset,KEN,Kenya,CDC Tabitha clinic,1106,Nairobi,2011,28,32,87.5,0,Salmonella Typhi,Multidrug resistance (MDR)
5149,KEMRI (2020),"Bigogo G, Verani JR, Munywoki P, Audi A. KEMRI CDC Gram_project_pbids30July2020. Nairobi, Kenya; 2020",Dataset,KEN,Kenya,CDC Tabitha clinic,1106,Nairobi,2012,40,50,80,0,Salmonella Typhi,Multidrug resistance (MDR)
5149,KEMRI (2020),"Bigogo G, Verani JR, Munywoki P, Audi A. KEMRI CDC Gram_project_pbids30July2020. Nairobi, Kenya; 2020",Dataset,KEN,Kenya,CDC Tabitha clinic,1106,Nairobi,2013,5,8,62.5,0,Salmonella Typhi,Multidrug resistance (MDR)
5149,KEMRI (2020),"Bigogo G, Verani JR, Munywoki P, Audi A. KEMRI CDC Gram_project_pbids30July2020. Nairobi, Kenya; 2020",Dataset,KEN,Kenya,CDC Tabitha clinic,1106,Nairobi,2014,9,11,81.8,0,Salmonella Typhi,Multidrug resistance (MDR)
5149,KEMRI (2020),"Bigogo G, Verani JR, Munywoki P, Audi A. KEMRI CDC Gram_project_pbids30July2020. Nairobi, Kenya; 2020",Dataset,KEN,Kenya,CDC Tabitha clinic,1106,Nairobi,2015,11,13,84.6,0,Salmonella Typhi,Multidrug resistance (MDR)
5149,KEMRI (2020),"Bigogo G, Verani JR, Munywoki P, Audi A. KEMRI CDC Gram_project_pbids30July2020. Nairobi, Kenya; 2020",Dataset,KEN,Kenya,CDC Tabitha clinic,1106,Nairobi,2017,6,8,75,0,Salmonella Typhi,Multidrug resistance (MDR)
5149,KEMRI (2020),"Bigogo G, Verani JR, Munywoki P, Audi A. KEMRI CDC Gram_project_pbids30July2020. Nairobi, Kenya; 2020",Dataset,KEN,Kenya,CDC Tabitha clinic,1106,Nairobi,2019,26,31,83.9,0,Salmonella Typhi,Multidrug resistance (MDR)
5150,Sharkoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Balochistan,897,Balochistan,2012,3,5,60,0,Salmonella Typhi,Multidrug resistance (MDR)
5150,Sharkoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Balochistan,897,Balochistan,2014,0,6,0,1,Salmonella Typhi,Multidrug resistance (MDR)
5150,Sharkoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Balochistan,897,Balochistan,2019,291,310,93.9,0,Salmonella Typhi,Multidrug resistance (MDR)
5150,Sharkoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Gilgit–Baltistan,904,Administrative unit not available,2007,6,9,66.7,0,Salmonella Typhi,Multidrug resistance (MDR)
5150,Sharkoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Gilgit–Baltistan,904,Administrative unit not available,2008,9,17,52.9,0,Salmonella Typhi,Multidrug resistance (MDR)
5150,Sharkoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Gilgit–Baltistan,904,Administrative unit not available,2009,4,9,44.4,0,Salmonella Typhi,Multidrug resistance (MDR)
5150,Sharkoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Gilgit–Baltistan,904,Administrative unit not available,2010,3,9,33.3,0,Salmonella Typhi,Multidrug resistance (MDR)
5150,Sharkoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Gilgit–Baltistan,904,Administrative unit not available,2012,8,10,80,0,Salmonella Typhi,Multidrug resistance (MDR)
5150,Sharkoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Gilgit–Baltistan,904,Administrative unit not available,2013,8,15,53.3,0,Salmonella Typhi,Multidrug resistance (MDR)
5150,Sharkoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Gilgit–Baltistan,904,Administrative unit not available,2019,102,124,82.3,0,Salmonella Typhi,Multidrug resistance (MDR)
5150,Sharkoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Islamabad,899,Islamabad,2019,12,16,75,0,Salmonella Typhi,Multidrug resistance (MDR)
5150,Sharkoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Khyber Pakhtunkhwa,900,Nwfp,2011,9,13,69.2,0,Salmonella Typhi,Multidrug resistance (MDR)
5150,Sharkoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Khyber Pakhtunkhwa,900,Nwfp,2012,6,7,85.7,0,Salmonella Typhi,Multidrug resistance (MDR)
5150,Sharkoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Khyber Pakhtunkhwa,900,Nwfp,2013,11,15,73.3,0,Salmonella Typhi,Multidrug resistance (MDR)
5150,Sharkoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Khyber Pakhtunkhwa,900,Nwfp,2014,7,10,70,0,Salmonella Typhi,Multidrug resistance (MDR)
5150,Sharkoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Khyber Pakhtunkhwa,900,Nwfp,2015,9,11,81.8,0,Salmonella Typhi,Multidrug resistance (MDR)
5150,Sharkoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Khyber Pakhtunkhwa,900,Nwfp,2019,30,42,71.4,0,Salmonella Typhi,Multidrug resistance (MDR)
5150,Sharkoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Punjab,901,Punjab,2007,18,26,69.2,0,Salmonella Typhi,Multidrug resistance (MDR)
5150,Sharkoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Punjab,901,Punjab,2008,18,31,58.1,0,Salmonella Typhi,Multidrug resistance (MDR)
5150,Sharkoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Punjab,901,Punjab,2009,14,20,70,0,Salmonella Typhi,Multidrug resistance (MDR)
5150,Sharkoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Punjab,901,Punjab,2010,16,19,84.2,0,Salmonella Typhi,Multidrug resistance (MDR)
5150,Sharkoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Punjab,901,Punjab,2011,29,47,61.7,0,Salmonella Typhi,Multidrug resistance (MDR)
5150,Sharkoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Punjab,901,Punjab,2012,25,42,59.5,0,Salmonella Typhi,Multidrug resistance (MDR)
5150,Sharkoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Punjab,901,Punjab,2013,19,34,55.9,0,Salmonella Typhi,Multidrug resistance (MDR)
5150,Sharkoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Punjab,901,Punjab,2014,18,20,90,0,Salmonella Typhi,Multidrug resistance (MDR)
5150,Sharkoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Punjab,901,Punjab,2015,20,32,62.5,0,Salmonella Typhi,Multidrug resistance (MDR)
5150,Sharkoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Punjab,901,Punjab,2019,579,747,77.5,0,Salmonella Typhi,Multidrug resistance (MDR)
5150,Sharkoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Sindh,902,Sind,2007,478,824,58,0,Salmonella Typhi,Multidrug resistance (MDR)
5150,Sharkoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Sindh,902,Sind,2008,434,707,61.4,0,Salmonella Typhi,Multidrug resistance (MDR)
5150,Sharkoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Sindh,902,Sind,2009,648,999,64.9,0,Salmonella Typhi,Multidrug resistance (MDR)
5150,Sharkoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Sindh,902,Sind,2010,458,696,65.8,0,Salmonella Typhi,Multidrug resistance (MDR)
5150,Sharkoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Sindh,902,Sind,2011,567,861,65.9,0,Salmonella Typhi,Multidrug resistance (MDR)
5150,Sharkoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Sindh,902,Sind,2012,349,558,62.5,0,Salmonella Typhi,Multidrug resistance (MDR)
5150,Sharkoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Sindh,902,Sind,2013,311,621,50.1,0,Salmonella Typhi,Multidrug resistance (MDR)
5150,Sharkoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Sindh,902,Sind,2014,327,684,47.8,0,Salmonella Typhi,Multidrug resistance (MDR)
5150,Sharkoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Sindh,902,Sind,2015,436,848,51.4,0,Salmonella Typhi,Multidrug resistance (MDR)
5150,Sharkoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Sindh,902,Sind,2019,5374,6450,83.3,0,Salmonella Typhi,Multidrug resistance (MDR)
5151,SEAP (2021),Sabine Vaccine Institute. Surveillance for Enteric Fever in Asia Project (SEAP) dataset. 2021,Dataset,BGD,Bangladesh,Dhaka,823,Dhaka,2017,54,310,17.4,0,Salmonella Typhi,Multidrug resistance (MDR)
5151,SEAP (2021),Sabine Vaccine Institute. Surveillance for Enteric Fever in Asia Project (SEAP) dataset. 2021,Dataset,BGD,Bangladesh,Dhaka,823,Dhaka,2018,70,339,20.6,0,Salmonella Typhi,Multidrug resistance (MDR)
5151,SEAP (2021),Sabine Vaccine Institute. Surveillance for Enteric Fever in Asia Project (SEAP) dataset. 2021,Dataset,BGD,Bangladesh,Dhaka,823,Dhaka,2019,50,267,18.7,0,Salmonella Typhi,Multidrug resistance (MDR)
5151,SEAP (2021),Sabine Vaccine Institute. Surveillance for Enteric Fever in Asia Project (SEAP) dataset. 2021,Dataset,BGD,Bangladesh,Dhaka,823,Dhaka,2020,12,48,25,0,Salmonella Typhi,Multidrug resistance (MDR)
5151,SEAP (2021),Sabine Vaccine Institute. Surveillance for Enteric Fever in Asia Project (SEAP) dataset. 2021,Dataset,BGD,Bangladesh,Dhaka,823,Dhaka,2016,8,27,29.6,0,Salmonella Typhi,Multidrug resistance (MDR)
5151,SEAP (2021),Sabine Vaccine Institute. Surveillance for Enteric Fever in Asia Project (SEAP) dataset. 2021,Dataset,NPL,Nepal,Kathmandu,892,Central,2017,0,25,0,0,Salmonella Typhi,Multidrug resistance (MDR)
5151,SEAP (2021),Sabine Vaccine Institute. Surveillance for Enteric Fever in Asia Project (SEAP) dataset. 2021,Dataset,NPL,Nepal,Kathmandu,892,Central,2018,0,71,0,0,Salmonella Typhi,Multidrug resistance (MDR)
5151,SEAP (2021),Sabine Vaccine Institute. Surveillance for Enteric Fever in Asia Project (SEAP) dataset. 2021,Dataset,NPL,Nepal,Kathmandu,892,Central,2019,1,29,3.4,0,Salmonella Typhi,Multidrug resistance (MDR)
5151,SEAP (2021),Sabine Vaccine Institute. Surveillance for Enteric Fever in Asia Project (SEAP) dataset. 2021,Dataset,PAK,Pakistan,Karachi,902,Sind,2016,9,11,81.8,0,Salmonella Typhi,Multidrug resistance (MDR)
5151,SEAP (2021),Sabine Vaccine Institute. Surveillance for Enteric Fever in Asia Project (SEAP) dataset. 2021,Dataset,PAK,Pakistan,Karachi,902,Sind,2017,68,115,59.1,0,Salmonella Typhi,Multidrug resistance (MDR)
5151,SEAP (2021),Sabine Vaccine Institute. Surveillance for Enteric Fever in Asia Project (SEAP) dataset. 2021,Dataset,PAK,Pakistan,Karachi,902,Sind,2018,298,346,86.1,0,Salmonella Typhi,Multidrug resistance (MDR)
5151,SEAP (2021),Sabine Vaccine Institute. Surveillance for Enteric Fever in Asia Project (SEAP) dataset. 2021,Dataset,PAK,Pakistan,Karachi,902,Sind,2019,452,518,87.3,0,Salmonella Typhi,Multidrug resistance (MDR)
5151,SEAP (2021),Sabine Vaccine Institute. Surveillance for Enteric Fever in Asia Project (SEAP) dataset. 2021,Dataset,PAK,Pakistan,Karachi,902,Sind,2020,50,58,86.2,0,Salmonella Typhi,Multidrug resistance (MDR)
405,Aliya (2010),"Aliya N, Ram PK, Brooks WA, et al. Burden of typhoid and paratyphoid fever in a densely populated urban community, Dhaka, Bangladesh. Int J Infect Dis 2010; 14(Suppl. 3): e93-e9.",Systematic review,BGD,Bangladesh,Kamalapur,823,Dhaka,2004,0,8,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
3026,Ahmed (2017),"Ahmed D, Nahid MA, Sami AB, et al. Bacterial etiology of bloodstream infections and antimicrobial resistance in Dhaka, Bangladesh, 2005-2014. Antimicrob Resist Infect Control 2017; 6.",Systematic review,BGD,Bangladesh,Dhaka Hospital (ICCDR);ICDDR,823,Dhaka,2006,0,133,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
1088,Das(2014),"Das SK, Chisti MJ, Afrad MH, et al. Gastroenteritis due to typhoidal Salmonella: a decade of observation at an urban and a rural diarrheal disease hospital in Bangladesh. BMC Infect Dis 2014; 14: 435.",Systematic review,BGD,Bangladesh,ICDDR;Matlab Hospital (ICDDR),823,Dhaka,2006,8,278,2.9,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
1088,Das(2014),"Das SK, Chisti MJ, Afrad MH, et al. Gastroenteritis due to typhoidal Salmonella: a decade of observation at an urban and a rural diarrheal disease hospital in Bangladesh. BMC Infect Dis 2014; 14: 435.",Systematic review,BGD,Bangladesh,Unknown urban Dhaka hospital,823,Dhaka,2006,1,33,3,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
3026,Ahmed (2017),"Ahmed D, Nahid MA, Sami AB, et al. Bacterial etiology of bloodstream infections and antimicrobial resistance in Dhaka, Bangladesh, 2005-2014. Antimicrob Resist Infect Control 2017; 6.",Systematic review,BGD,Bangladesh,Dhaka Hospital (ICCDR);ICDDR,823,Dhaka,2007,0,127,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
1130,Chisti(2009),"Chisti MJ, Bardhan PK, Huq S, et al. High-dose intravenous dexamethasone in the management of diarrheal patients with enteric fever and encephalopathy. Southeast Asian J Trop Med Public Health 2009; 40(5): 1065-73.",Systematic review,BGD,Bangladesh,Dhaka Hospital (ICCDR);ICDDR,823,Dhaka,2007,7,7,100,1,Salmonella Paratyphi A,Multidrug resistance (MDR)
3026,Ahmed (2017),"Ahmed D, Nahid MA, Sami AB, et al. Bacterial etiology of bloodstream infections and antimicrobial resistance in Dhaka, Bangladesh, 2005-2014. Antimicrob Resist Infect Control 2017; 6.",Systematic review,BGD,Bangladesh,Dhaka Hospital (ICCDR);ICDDR,823,Dhaka,2008,0,146,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
3026,Ahmed (2017),"Ahmed D, Nahid MA, Sami AB, et al. Bacterial etiology of bloodstream infections and antimicrobial resistance in Dhaka, Bangladesh, 2005-2014. Antimicrob Resist Infect Control 2017; 6.",Systematic review,BGD,Bangladesh,Dhaka Hospital (ICCDR);ICDDR,823,Dhaka,2009,0,102,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
3026,Ahmed (2017),"Ahmed D, Nahid MA, Sami AB, et al. Bacterial etiology of bloodstream infections and antimicrobial resistance in Dhaka, Bangladesh, 2005-2014. Antimicrob Resist Infect Control 2017; 6.",Systematic review,BGD,Bangladesh,Dhaka Hospital (ICCDR);ICDDR,823,Dhaka,2010,0,179,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
1680,Afroze (2014),"Afroze SR, Rahim MA, Hasan MM, et al. Pattern of antibiotic sensitivity in enteric fever: A tertiary care hospital experience. Journal of Medicine (Bangladesh) 2014; 15(2): 122-4.",Systematic review,BGD,Bangladesh,"Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders (BIRDEM)",823,Dhaka,2011,3,26,11.5,1,Salmonella Paratyphi A,Multidrug resistance (MDR)
3026,Ahmed (2017),"Ahmed D, Nahid MA, Sami AB, et al. Bacterial etiology of bloodstream infections and antimicrobial resistance in Dhaka, Bangladesh, 2005-2014. Antimicrob Resist Infect Control 2017; 6.",Systematic review,BGD,Bangladesh,Dhaka Hospital (ICCDR);ICDDR,823,Dhaka,2011,0,135,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
3026,Ahmed (2017),"Ahmed D, Nahid MA, Sami AB, et al. Bacterial etiology of bloodstream infections and antimicrobial resistance in Dhaka, Bangladesh, 2005-2014. Antimicrob Resist Infect Control 2017; 6.",Systematic review,BGD,Bangladesh,Dhaka Hospital (ICCDR);ICDDR,823,Dhaka,2012,0,129,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
3026,Ahmed (2017),"Ahmed D, Nahid MA, Sami AB, et al. Bacterial etiology of bloodstream infections and antimicrobial resistance in Dhaka, Bangladesh, 2005-2014. Antimicrob Resist Infect Control 2017; 6.",Systematic review,BGD,Bangladesh,Dhaka Hospital (ICCDR);ICDDR,823,Dhaka,2014,0,110,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
5131,Saha (2018),"Saha S, Saha S, Das RC, et al. Enteric Fever and Related Contextual Factors in Bangladesh.American Journal of Tropical Medicine & Hygiene 2018;99(3_Suppl):20-25",Systematic review,BGD,Bangladesh,Dhaka Shishu Hospital;Shishu Sasthya Foundation Hospital,823,Dhaka,2014,1,38,2.6,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
5102,Okanda (2018),"Okanda T, Haque A, Ehara T, et al. Characteristics of resistance mechanisms and molecular epidemiology of fluoroquinolone-nonsusceptible Salmonella enterica serovar Typhi and Paratyphi a isolates from a tertiary hospital in Dhaka, Bangladesh.Microbial Drug Resistance 2018;24(10):1460-1465",Systematic review,BGD,Bangladesh,Bangabandhu Sheikh Mujib Medical University Hospital,823,Dhaka,2015,0,6,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
1761,Chopra(1992),"Chopra GS, Basu SK, Bhattacharya SR. Present phage types and antibiotic susceptibility of Salmonellae. Indian J Pathol Microbiol 1992; 35(4): 345-50.",Systematic review,IND,India,Command Pathology Laboratory,850,Delhi,1990,14,17,82.4,1,Salmonella Paratyphi A,Multidrug resistance (MDR)
793,Mahanta(1994),Mahanta J. Drug sensitivity of Salmonella Paratyphi A isolated from a suspected outbreak of enteric fever in Duliajan. J Indian Med Assoc 1994; 92(2): 49-50.,Systematic review,IND,India,Oil India Hospital (Duliajan),849,Assam,1991,3,30,10,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
856,Rao (1993),"Rao PS, Rajashekar V, Varghese GK, Shivananda PG. Emergence of multidrug-resistant Salmonella Typhi in rural southern India. Am J Trop Med Hyg 1993; 48(1): 108-11.",Systematic review,IND,India,Kasturba Medical College and Hospital (Manipal),855,Karnataka,1991,0,27,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
135,Mandal (2006),"Mandal S, Mandal M, Pal N. Antibiotic resistance of Salmonella enterica serovar ParaTyphi A in India: Emerging and reemerging problem. J Postgrad Med 2006; 52(3): 163-6.",Systematic review,IND,India,Calcutta School of Tropical Medicine,869,West Bengal,1991,9,13,69.2,1,Salmonella Paratyphi A,Multidrug resistance (MDR)
1474,Gandhi(1999),"Gandhi R, Banker DD. Multidrug resistant Salmonella. Indian J Med Sci 1999; 53(6): 259-66.",Systematic review,IND,India,BYL Nair Charitable Hospital;Jagjivan Ram Hospital;Nanavati Hospital;P.D. Hinduja National Hospital and Medical Research Center;Sir Hurkisondas Nurrotumdas Hospital,858,Maharashtra,1993,4,31,12.9,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
135,Mandal (2006),"Mandal S, Mandal M, Pal N. Antibiotic resistance of Salmonella enterica serovar ParaTyphi A in India: Emerging and reemerging problem. J Postgrad Med 2006; 52(3): 163-6.",Systematic review,IND,India,Calcutta School of Tropical Medicine,869,West Bengal,1994,0,9,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
135,Mandal (2006),"Mandal S, Mandal M, Pal N. Antibiotic resistance of Salmonella enterica serovar ParaTyphi A in India: Emerging and reemerging problem. J Postgrad Med 2006; 52(3): 163-6.",Systematic review,IND,India,Calcutta School of Tropical Medicine,869,West Bengal,1995,0,12,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
797,Chandel(2000)<U+1D43>,"Chandel DS, Chaudhry R, Dhawan B, Pandey A, Dey AB. Drug-resistant Salmonella enterica serotype Paratyphi A in India. Emerg Infect Dis 2000; 6(4): 420-1.",Systematic review,IND,India,All India Institute of Medical Sciences;Safdarjung Hospital,850,Delhi,1996,0,10,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
2785,Kapil (1997),"Kapil A, Sood S, Reddaiah VP, Das B, Seth P. Paratyphoid fever due to Salmonella enterica serotype ParaTyphi A. Emerg Infect Dis 1997; 3(3): 407.",Systematic review,IND,India,New Delhi,850,Delhi,1996,0,36,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
1947,Chandel(2000)<U+1D47>,"Chandel DS, Nisar N, Thong KL, Pang T, Chaudhry R. Role of molecular typing in an outbreak of Salmonella Paratyphi A. Trop Gastroenterol 2000; 21(3): 121-3.",Systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,1996,0,36,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
135,Mandal (2006),"Mandal S, Mandal M, Pal N. Antibiotic resistance of Salmonella enterica serovar ParaTyphi A in India: Emerging and reemerging problem. J Postgrad Med 2006; 52(3): 163-6.",Systematic review,IND,India,Calcutta School of Tropical Medicine,869,West Bengal,1996,0,9,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
797,Chandel(2000)<U+1D43>,"Chandel DS, Chaudhry R, Dhawan B, Pandey A, Dey AB. Drug-resistant Salmonella enterica serotype Paratyphi A in India. Emerg Infect Dis 2000; 6(4): 420-1.",Systematic review,IND,India,All India Institute of Medical Sciences;Safdarjung Hospital,850,Delhi,1997,0,16,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
2093,Gautam (2002),"Gautam V, Gupta NK, Chaudhary U, Arora DR. Sensitivity pattern of Salmonella serotypes in Northern India. Braz J Infect Dis 2002; 6(6): 281-7.",Systematic review,IND,India,Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences,853,Haryana,1997,8,16,50,1,Salmonella Paratyphi A,Multidrug resistance (MDR)
135,Mandal (2006),"Mandal S, Mandal M, Pal N. Antibiotic resistance of Salmonella enterica serovar ParaTyphi A in India: Emerging and reemerging problem. J Postgrad Med 2006; 52(3): 163-6.",Systematic review,IND,India,Calcutta School of Tropical Medicine,869,West Bengal,1997,0,10,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
797,Chandel(2000)<U+1D43>,"Chandel DS, Chaudhry R, Dhawan B, Pandey A, Dey AB. Drug-resistant Salmonella enterica serotype Paratyphi A in India. Emerg Infect Dis 2000; 6(4): 420-1.",Systematic review,IND,India,All India Institute of Medical Sciences;Safdarjung Hospital,850,Delhi,1998,3,57,5.3,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
2093,Gautam (2002),"Gautam V, Gupta NK, Chaudhary U, Arora DR. Sensitivity pattern of Salmonella serotypes in Northern India. Braz J Infect Dis 2002; 6(6): 281-7.",Systematic review,IND,India,Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences,853,Haryana,1998,6,14,42.9,1,Salmonella Paratyphi A,Multidrug resistance (MDR)
135,Mandal (2006),"Mandal S, Mandal M, Pal N. Antibiotic resistance of Salmonella enterica serovar ParaTyphi A in India: Emerging and reemerging problem. J Postgrad Med 2006; 52(3): 163-6.",Systematic review,IND,India,Calcutta School of Tropical Medicine,869,West Bengal,1998,3,10,30,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
118,Mohanty (2006),"Mohanty S, Renuka K, Sood S, Das BK, Kapil A. Antibiogram pattern and seasonality of Salmonella serotypes in a North Indian tertiary care hospital. Epidemiol Infect 2006; 134(5): 961-6.",Systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,1999,1,28,3.6,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
797,Chandel(2000)<U+1D43>,"Chandel DS, Chaudhry R, Dhawan B, Pandey A, Dey AB. Drug-resistant Salmonella enterica serotype Paratyphi A in India. Emerg Infect Dis 2000; 6(4): 420-1.",Systematic review,IND,India,All India Institute of Medical Sciences;Safdarjung Hospital,850,Delhi,1999,3,22,13.6,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
2093,Gautam (2002),"Gautam V, Gupta NK, Chaudhary U, Arora DR. Sensitivity pattern of Salmonella serotypes in Northern India. Braz J Infect Dis 2002; 6(6): 281-7.",Systematic review,IND,India,Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences,853,Haryana,1999,6,12,50,1,Salmonella Paratyphi A,Multidrug resistance (MDR)
118,Mohanty (2006),"Mohanty S, Renuka K, Sood S, Das BK, Kapil A. Antibiogram pattern and seasonality of Salmonella serotypes in a North Indian tertiary care hospital. Epidemiol Infect 2006; 134(5): 961-6.",Systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,2000,0,21,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
2093,Gautam (2002),"Gautam V, Gupta NK, Chaudhary U, Arora DR. Sensitivity pattern of Salmonella serotypes in Northern India. Braz J Infect Dis 2002; 6(6): 281-7.",Systematic review,IND,India,Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences,853,Haryana,2000,1,5,20,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
1683,Kadappu (2003),"Kadappu KK, Bhat R, Kurian B. Pattern of multiple drug resistance in enteric fever in Manipal, India. Trop Doct 2003; 33(3): 189-91.",Systematic review,IND,India,Kasturba Medical College and Hospital (Manipal),855,Karnataka,2000,1,10,10,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
260,Safdar(2004),"Safdar A, Harjit K, Elting L, Rolston KVI. Antimicrobial susceptibility of 128 Salmonella enterica serovar Typhi and Paratyphi A isolates from Northern India. Chemotherapy 2004; 50(2): 88-91.",Systematic review,IND,India,Christian Medical College and Hospital (Ludhiana),864,Punjab,2000,7,27,25.9,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
135,Mandal (2006),"Mandal S, Mandal M, Pal N. Antibiotic resistance of Salmonella enterica serovar ParaTyphi A in India: Emerging and reemerging problem. J Postgrad Med 2006; 52(3): 163-6.",Systematic review,IND,India,Calcutta School of Tropical Medicine,869,West Bengal,2000,2,8,25,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
36,Mandeep (2006),"Mandeep W, Rajni G, Premila P, Rajesh M, Pushpa A, Mani K. Age-related clinical and microbiological characteristics of enteric fever in India. Trans R Soc Trop Med Hyg 2006; 100(10): 942-8.",Systematic review,IND,India,Safdarjung Hospital,850,Delhi,2001,0,73,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
118,Mohanty (2006),"Mohanty S, Renuka K, Sood S, Das BK, Kapil A. Antibiogram pattern and seasonality of Salmonella serotypes in a North Indian tertiary care hospital. Epidemiol Infect 2006; 134(5): 961-6.",Systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,2001,1,28,3.6,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
2093,Gautam (2002),"Gautam V, Gupta NK, Chaudhary U, Arora DR. Sensitivity pattern of Salmonella serotypes in Northern India. Braz J Infect Dis 2002; 6(6): 281-7.",Systematic review,IND,India,Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences,853,Haryana,2001,13,47,27.7,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
119,Mehta (2002),"Mehta M, Joshi RM. Antibiogram pattern of Salmonella species causing bacteraemia/septicaemia in a teaching hospital. J Infect 2002; 45(2): 133.",Systematic review,IND,India,Government Medical College Hospital (Chandigarh),864,Punjab,2001,0,10,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
991,Saharan (2008),"Saharan G, Gupta A, Gupta BK, Sharma BP, Kochar DK, Purohit VP. Evaluation of antibiotic sensitivity pattern in cases of enteric fever in north west Rajasthan. J Indian Med Assoc 2008; 106(8): 528-30, 32.",Systematic review,IND,India,Sardar Patel Medical College (PBM and AG Hospital),865,Rajasthan,2001,0,13,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
135,Mandal (2006),"Mandal S, Mandal M, Pal N. Antibiotic resistance of Salmonella enterica serovar ParaTyphi A in India: Emerging and reemerging problem. J Postgrad Med 2006; 52(3): 163-6.",Systematic review,IND,India,Calcutta School of Tropical Medicine,869,West Bengal,2001,1,6,16.7,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
471,Lakshmi (2006),"Lakshmi V, Ashok R, Susmita J, Shailaja VV. Changing trends in the antibiograms of Salmonella isolates at a tertiary care hospital in Hyderabad. Indian J Med Microbiol 2006; 24(1): 45-8.",Systematic review,IND,India,Nizam's Institute of Medical Sciences,848,Andhra Pradesh,2002,3,13,23.1,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
118,Mohanty (2006),"Mohanty S, Renuka K, Sood S, Das BK, Kapil A. Antibiogram pattern and seasonality of Salmonella serotypes in a North Indian tertiary care hospital. Epidemiol Infect 2006; 134(5): 961-6.",Systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,2002,3,28,10.7,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
1933,Kumar (2008),"Kumar S, Rizvi M, Berry N. Rising prevalence of enteric fever due to multidrug-resistant Salmonella: an epidemiological study. J Med Microbiol 2008; 57(Pt 10): 1247-50.",Systematic review,IND,India,Lok Nayak Jai Prakash Narayan Hospital,850,Delhi,2002,0,16,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
5124,Joshi (2019),"Joshi S, Adhikary R, Beena HB, et al. Trends in antibiotic susceptibility of enteric fever isolates from South India, 2002–2013.Medical Journal Armed Forces India 2019;75(1):81-85",Systematic review,IND,India,Manipal Hospital (Airport road),855,Karnataka,2002,0,46,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
465,Arora(2009),"Arora D, Seetha KS, Kumar R. The changing scenario of the Salmonella serotype and its drug resistance pattern. J Clin Diagn Res 2009; 3(5): 1754-9.",Systematic review,IND,India,Kasturba Medical College and Hospital (Manipal),855,Karnataka,2002,0,6,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
2429,Tankhiwale (2003)<U+1D47>,"Tankhiwale SS, Agrawal G, Jalgaonkar SV. An unusually high occurrence of Salmonella enterica serotype ParaTyphi A in patients with enteric fever. Indian J Med Res 2003b; 117: 10-2.",Systematic review,IND,India,Indira Gandhi Government Medical College (Mayo Hospital),858,Maharashtra,2002,2,18,11.1,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
2807,Arora(2010),"Arora D, Singh R, Kaur M, Ahi RS. A changing pattern in antimicrobial susceptibility of Salmonella enterica serotype isolated in North India. African Journal of Microbiology Research 2010; 4(3): 197-203.",Systematic review,IND,India,Adesh Institute of Medical Sciences and Research,864,Punjab,2002,0,6,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
118,Mohanty (2006),"Mohanty S, Renuka K, Sood S, Das BK, Kapil A. Antibiogram pattern and seasonality of Salmonella serotypes in a North Indian tertiary care hospital. Epidemiol Infect 2006; 134(5): 961-6.",Systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,2003,5,50,10,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
5124,Joshi (2019),"Joshi S, Adhikary R, Beena HB, et al. Trends in antibiotic susceptibility of enteric fever isolates from South India, 2002–2013.Medical Journal Armed Forces India 2019;75(1):81-85",Systematic review,IND,India,Manipal Hospital (Airport road),855,Karnataka,2003,0,48,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
465,Arora(2009),"Arora D, Seetha KS, Kumar R. The changing scenario of the Salmonella serotype and its drug resistance pattern. J Clin Diagn Res 2009; 3(5): 1754-9.",Systematic review,IND,India,Kasturba Medical College and Hospital (Manipal),855,Karnataka,2003,6,15,40,1,Salmonella Paratyphi A,Multidrug resistance (MDR)
900,Jog (2008),"Jog S, Soman R, Singhal T, Rodrigues C, Mehta A, Dastur FD. Enteric fever in Mumbai--clinical profile, sensitivity patterns and response to antimicrobials. J Assoc Physicians India 2008; 56: 237-40.",Systematic review,IND,India,P.D. Hinduja National Hospital and Medical Research Center,858,Maharashtra,2003,0,15,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
2807,Arora(2010),"Arora D, Singh R, Kaur M, Ahi RS. A changing pattern in antimicrobial susceptibility of Salmonella enterica serotype isolated in North India. African Journal of Microbiology Research 2010; 4(3): 197-203.",Systematic review,IND,India,Adesh Institute of Medical Sciences and Research,864,Punjab,2003,2,15,13.3,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
1241,Gupta (2009)<U+1D43>,"Gupta V, Kaur J, Chander J. An increase in enteric fever cases due to Salmonella ParaTyphi A in & around Chandigarh. Indian J Med Res 2009a; 129(1): 95-8.",Systematic review,IND,India,Government Medical College Hospital (Chandigarh),864,Punjab,2003,0,7,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
2284,Aggarwal (2007),"Aggarwal A, Vij AS, Oberoi A. A three-year retrospective study on the prevalence, drug susceptibility pattern, and phage types of Salmonella enterica subspecies Typhi and ParaTyphi in Christian Medical College and Hospital, Ludhiana, Punjab. J Indian Acad Clin Med 2007; 8(1): 32-5.",Systematic review,IND,India,Christian Medical College and Hospital (Ludhiana),864,Punjab,2003,4,28,14.3,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
471,Lakshmi (2006),"Lakshmi V, Ashok R, Susmita J, Shailaja VV. Changing trends in the antibiograms of Salmonella isolates at a tertiary care hospital in Hyderabad. Indian J Med Microbiol 2006; 24(1): 45-8.",Systematic review,IND,India,Nizam's Institute of Medical Sciences,848,Andhra Pradesh,2004,0,7,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
118,Mohanty (2006),"Mohanty S, Renuka K, Sood S, Das BK, Kapil A. Antibiogram pattern and seasonality of Salmonella serotypes in a North Indian tertiary care hospital. Epidemiol Infect 2006; 134(5): 961-6.",Systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,2004,5,43,11.6,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
870,Verma(2010),"Verma S, Thakur S, Kanga A, Singh G, Gupta P. Emerging Salmonella ParaTyphi A enteric fever and changing trends in antimicrobial resistance pattern of Salmonella in Shimla. Indian J Med Microbiol 2010; 28(1): 51-3.",Systematic review,IND,India,Indira Gandhi Medical College,854,Himachal Pradesh,2004,13,99,13.1,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
152,Dhanashree (2007),Dhanashree B. Antibiotic susceptibility profile of Salmonella enterica serovars: trend over three years showing re-emergence of chloramphenicol sensitivity and rare serovars. Indian J Med Sci 2007; 61(10): 576-9.,Systematic review,IND,India,Kasturba Medical College Hospital (Mangaluru),855,Karnataka,2004,0,8,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
5124,Joshi (2019),"Joshi S, Adhikary R, Beena HB, et al. Trends in antibiotic susceptibility of enteric fever isolates from South India, 2002–2013.Medical Journal Armed Forces India 2019;75(1):81-85",Systematic review,IND,India,Manipal Hospital (Airport road),855,Karnataka,2004,0,156,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
465,Arora(2009),"Arora D, Seetha KS, Kumar R. The changing scenario of the Salmonella serotype and its drug resistance pattern. J Clin Diagn Res 2009; 3(5): 1754-9.",Systematic review,IND,India,Kasturba Medical College and Hospital (Manipal),855,Karnataka,2004,0,7,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
900,Jog (2008),"Jog S, Soman R, Singhal T, Rodrigues C, Mehta A, Dastur FD. Enteric fever in Mumbai--clinical profile, sensitivity patterns and response to antimicrobials. J Assoc Physicians India 2008; 56: 237-40.",Systematic review,IND,India,P.D. Hinduja National Hospital and Medical Research Center,858,Maharashtra,2004,0,15,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
121,Das (2006),"Das U, Bhattacharya SS. Antibiogram, phage typing and biotyping of Salmonella Typhi and Salmonella ParaTyphi A from Rourkela, Orissa. Indian J Med Res 2006; 124(1): 109-11.",Systematic review,IND,India,Ispat General Hospital (Rourkela),863,Orissa,2004,1,31,3.2,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
2807,Arora(2010),"Arora D, Singh R, Kaur M, Ahi RS. A changing pattern in antimicrobial susceptibility of Salmonella enterica serotype isolated in North India. African Journal of Microbiology Research 2010; 4(3): 197-203.",Systematic review,IND,India,Adesh Institute of Medical Sciences and Research,864,Punjab,2004,0,7,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
1241,Gupta (2009)<U+1D43>,"Gupta V, Kaur J, Chander J. An increase in enteric fever cases due to Salmonella ParaTyphi A in & around Chandigarh. Indian J Med Res 2009a; 129(1): 95-8.",Systematic review,IND,India,Government Medical College Hospital (Chandigarh),864,Punjab,2004,1,14,7.1,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
1241,Gupta (2009)<U+1D43>,"Gupta V, Kaur J, Chander J. An increase in enteric fever cases due to Salmonella ParaTyphi A in & around Chandigarh. Indian J Med Res 2009a; 129(1): 95-8.",Systematic review,IND,India,Government Medical College Hospital (Chandigarh),864,Punjab,2004,1,14,7.1,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
2284,Aggarwal (2007),"Aggarwal A, Vij AS, Oberoi A. A three-year retrospective study on the prevalence, drug susceptibility pattern, and phage types of Salmonella enterica subspecies Typhi and ParaTyphi in Christian Medical College and Hospital, Ludhiana, Punjab. J Indian Acad Clin Med 2007; 8(1): 32-5.",Systematic review,IND,India,Christian Medical College and Hospital (Ludhiana),864,Punjab,2004,6,36,16.7,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
2309,Manchanda (2006),"Manchanda V, Bhalla P, Sethi M, Sharma VK. Treatment of enteric fever in children on the basis of current trends of antimicrobial susceptibility of Salmonella enterica serovar Typhi and ParaTyphi A. Indian J Med Microbiol 2006; 24(2): 101-6.",Systematic review,IND,India,Chacha Nehru Bal Chikitsalaya Hospital,850,Delhi,2005,0,5,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
5110,Sharma (2018),"Sharma P, Dahiya S, Manral N, et al. Changing trends of culture-positive typhoid fever and antimicrobial susceptibility in a tertiary care North Indian Hospital over the last decade.Indian Journal of Medical Microbiology 2018;36(1):70-76",Systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,2005,1,21,4.8,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
152,Dhanashree (2007),Dhanashree B. Antibiotic susceptibility profile of Salmonella enterica serovars: trend over three years showing re-emergence of chloramphenicol sensitivity and rare serovars. Indian J Med Sci 2007; 61(10): 576-9.,Systematic review,IND,India,Kasturba Medical College Hospital (Mangaluru),855,Karnataka,2005,0,11,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
1807,Gupta(2009),"Gupta S, Handa A, Chadha DS, Ganjoo RK, Panda RC. Profile of culture positive enteric fever from Bangalore. Med J Armed Forces India 2009; 65(4): 328-31.",Systematic review,IND,India,Command Hospital (Bengaluru),855,Karnataka,2005,0,16,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
5124,Joshi (2019),"Joshi S, Adhikary R, Beena HB, et al. Trends in antibiotic susceptibility of enteric fever isolates from South India, 2002–2013.Medical Journal Armed Forces India 2019;75(1):81-85",Systematic review,IND,India,Manipal Hospital (Airport road),855,Karnataka,2005,0,135,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
465,Arora(2009),"Arora D, Seetha KS, Kumar R. The changing scenario of the Salmonella serotype and its drug resistance pattern. J Clin Diagn Res 2009; 3(5): 1754-9.",Systematic review,IND,India,Kasturba Medical College and Hospital (Manipal),855,Karnataka,2005,0,12,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
900,Jog (2008),"Jog S, Soman R, Singhal T, Rodrigues C, Mehta A, Dastur FD. Enteric fever in Mumbai--clinical profile, sensitivity patterns and response to antimicrobials. J Assoc Physicians India 2008; 56: 237-40.",Systematic review,IND,India,P.D. Hinduja National Hospital and Medical Research Center,858,Maharashtra,2005,0,16,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
2807,Arora(2010),"Arora D, Singh R, Kaur M, Ahi RS. A changing pattern in antimicrobial susceptibility of Salmonella enterica serotype isolated in North India. African Journal of Microbiology Research 2010; 4(3): 197-203.",Systematic review,IND,India,Adesh Institute of Medical Sciences and Research,864,Punjab,2005,0,12,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
1241,Gupta (2009)<U+1D43>,"Gupta V, Kaur J, Chander J. An increase in enteric fever cases due to Salmonella ParaTyphi A in & around Chandigarh. Indian J Med Res 2009a; 129(1): 95-8.",Systematic review,IND,India,Government Medical College Hospital (Chandigarh),864,Punjab,2005,0,13,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
1241,Gupta (2009)<U+1D43>,"Gupta V, Kaur J, Chander J. An increase in enteric fever cases due to Salmonella ParaTyphi A in & around Chandigarh. Indian J Med Res 2009a; 129(1): 95-8.",Systematic review,IND,India,Government Medical College Hospital (Chandigarh),864,Punjab,2005,0,13,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
2284,Aggarwal (2007),"Aggarwal A, Vij AS, Oberoi A. A three-year retrospective study on the prevalence, drug susceptibility pattern, and phage types of Salmonella enterica subspecies Typhi and ParaTyphi in Christian Medical College and Hospital, Ludhiana, Punjab. J Indian Acad Clin Med 2007; 8(1): 32-5.",Systematic review,IND,India,Christian Medical College and Hospital (Ludhiana),864,Punjab,2005,9,90,10,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
4593,Menezes (2016),"Menezes GA, Harish BN, Khan MA, Goessens W, Hays JP. Antimicrobial resistance trends in blood culture positive Salmonella ParaTyphi A isolates from Pondicherry, India. Indian J Med Microbiol 2016; 34(2): 222-7.",Systematic review,IND,India,Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER);Government Hospital (Pondicherry),889,Puducherry,2005,3,59,5.1,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
1126,Raveendran (2008),"Raveendran R, Wattal C, Sharma A, Oberoi J, Prasad K, Datta S. High level ciprofloxacin resistance in Salmonella enterica isolated from blood. Indian J Med Microbiol 2008; 26(1): 50-3.",Systematic review,IND,India,Sir Ganga Ram Hospital,850,Delhi,2006,0,198,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
904,Capoor(2007),"Capoor MR, Nair D, Deb M, Aggarwal P. Enteric fever perspective in India: emergence of high-level ciprofloxacin resistance and rising MIC to cephalosporins. J Med Microbiol 2007; 56(Pt 8): 1131-2.",Systematic review,IND,India,Safdarjung Hospital,850,Delhi,2006,3,56,5.4,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
5110,Sharma (2018),"Sharma P, Dahiya S, Manral N, et al. Changing trends of culture-positive typhoid fever and antimicrobial susceptibility in a tertiary care North Indian Hospital over the last decade.Indian Journal of Medical Microbiology 2018;36(1):70-76",Systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,2006,1,24,4.2,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
152,Dhanashree (2007),Dhanashree B. Antibiotic susceptibility profile of Salmonella enterica serovars: trend over three years showing re-emergence of chloramphenicol sensitivity and rare serovars. Indian J Med Sci 2007; 61(10): 576-9.,Systematic review,IND,India,Kasturba Medical College Hospital (Mangaluru),855,Karnataka,2006,0,18,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
934,Vidyalakshmi (2008),"Vidyalakshmi K, Yashavanth R, Chakrapani M, et al. Epidemiological shift, seasonal variation and antimicrobial susceptibility patterns among enteric fever pathogens in South India. Trop Doct 2008; 38(2): 89-91.",Systematic review,IND,India,Kasturba Medical College Hospital (Mangaluru),855,Karnataka,2006,0,85,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
1893,Yashavanth (2010),"Yashavanth R, Vidyalakshmi K. The Re-Emergence of chloramphenicol sensitivity among enteric fever pathogens in Mangalore. J Clin Diagn Res 2010; 4(5): 3016-108.",Systematic review,IND,India,Kasturba Medical College Hospital (Mangaluru),855,Karnataka,2006,0,111,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
5124,Joshi (2019),"Joshi S, Adhikary R, Beena HB, et al. Trends in antibiotic susceptibility of enteric fever isolates from South India, 2002–2013.Medical Journal Armed Forces India 2019;75(1):81-85",Systematic review,IND,India,Manipal Hospital (Airport road),855,Karnataka,2006,0,231,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
465,Arora(2009),"Arora D, Seetha KS, Kumar R. The changing scenario of the Salmonella serotype and its drug resistance pattern. J Clin Diagn Res 2009; 3(5): 1754-9.",Systematic review,IND,India,Kasturba Medical College and Hospital (Manipal),855,Karnataka,2006,2,12,16.7,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
1669,Bekur (2010),"Bekur R, Vandana KE, Shivashankara KN, Valsalan R, Sathyanarayanan V. Paratyphoid fever- Emerging problem in South India. Asian Pac J Trop Med 2010; 3(10): 815-7.",Systematic review,IND,India,Kasturba Medical College and Hospital (Manipal),855,Karnataka,2006,1,37,2.7,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
2807,Arora(2010),"Arora D, Singh R, Kaur M, Ahi RS. A changing pattern in antimicrobial susceptibility of Salmonella enterica serotype isolated in North India. African Journal of Microbiology Research 2010; 4(3): 197-203.",Systematic review,IND,India,Adesh Institute of Medical Sciences and Research,864,Punjab,2006,0,12,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
1241,Gupta (2009)<U+1D43>,"Gupta V, Kaur J, Chander J. An increase in enteric fever cases due to Salmonella ParaTyphi A in & around Chandigarh. Indian J Med Res 2009a; 129(1): 95-8.",Systematic review,IND,India,Government Medical College Hospital (Chandigarh),864,Punjab,2006,3,27,11.1,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
1241,Gupta (2009)<U+1D43>,"Gupta V, Kaur J, Chander J. An increase in enteric fever cases due to Salmonella ParaTyphi A in & around Chandigarh. Indian J Med Res 2009a; 129(1): 95-8.",Systematic review,IND,India,Government Medical College Hospital (Chandigarh),864,Punjab,2006,3,27,11.1,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
4593,Menezes (2016),"Menezes GA, Harish BN, Khan MA, Goessens W, Hays JP. Antimicrobial resistance trends in blood culture positive Salmonella ParaTyphi A isolates from Pondicherry, India. Indian J Med Microbiol 2016; 34(2): 222-7.",Systematic review,IND,India,Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER);Government Hospital (Pondicherry),889,Puducherry,2006,2,57,3.5,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
1412,Capoor (2009),"Capoor MR, Deepthi N, Jitendra P, et al. Minimum inhibitory concentration of carbapenems and tigecycline against Salmonella spp. J Med Microbiol 2009; 58(3): 337-41.",Systematic review,IND,India,Majeedia Hospital;Safdarjung Hospital,850,Delhi,2007,2,43,4.7,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
5110,Sharma (2018),"Sharma P, Dahiya S, Manral N, et al. Changing trends of culture-positive typhoid fever and antimicrobial susceptibility in a tertiary care North Indian Hospital over the last decade.Indian Journal of Medical Microbiology 2018;36(1):70-76",Systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,2007,1,42,2.4,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
5124,Joshi (2019),"Joshi S, Adhikary R, Beena HB, et al. Trends in antibiotic susceptibility of enteric fever isolates from South India, 2002–2013.Medical Journal Armed Forces India 2019;75(1):81-85",Systematic review,IND,India,Manipal Hospital (Airport road),855,Karnataka,2007,0,132,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
465,Arora(2009),"Arora D, Seetha KS, Kumar R. The changing scenario of the Salmonella serotype and its drug resistance pattern. J Clin Diagn Res 2009; 3(5): 1754-9.",Systematic review,IND,India,Kasturba Medical College and Hospital (Manipal),855,Karnataka,2007,0,13,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
1669,Bekur (2010),"Bekur R, Vandana KE, Shivashankara KN, Valsalan R, Sathyanarayanan V. Paratyphoid fever- Emerging problem in South India. Asian Pac J Trop Med 2010; 3(10): 815-7.",Systematic review,IND,India,Kasturba Medical College and Hospital (Manipal),855,Karnataka,2007,0,35,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
1617,Bhattacharya (2011),"Bhattacharya SS, Das U, Choudhury BK. Occurrence & antibiogram of Salmonella Typhi & S. ParaTyphi A isolated from Rourkela, Orissa. Indian J Med Res 2011; 133: 431-3.",Systematic review,IND,India,Ispat General Hospital (Rourkela),863,Orissa,2007,15,64,23.4,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
2807,Arora(2010),"Arora D, Singh R, Kaur M, Ahi RS. A changing pattern in antimicrobial susceptibility of Salmonella enterica serotype isolated in North India. African Journal of Microbiology Research 2010; 4(3): 197-203.",Systematic review,IND,India,Adesh Institute of Medical Sciences and Research,864,Punjab,2007,0,13,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
1241,Gupta (2009)<U+1D43>,"Gupta V, Kaur J, Chander J. An increase in enteric fever cases due to Salmonella ParaTyphi A in & around Chandigarh. Indian J Med Res 2009a; 129(1): 95-8.",Systematic review,IND,India,Government Medical College Hospital (Chandigarh),864,Punjab,2007,1,40,2.5,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
4593,Menezes (2016),"Menezes GA, Harish BN, Khan MA, Goessens W, Hays JP. Antimicrobial resistance trends in blood culture positive Salmonella ParaTyphi A isolates from Pondicherry, India. Indian J Med Microbiol 2016; 34(2): 222-7.",Systematic review,IND,India,Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER);Government Hospital (Pondicherry),889,Puducherry,2007,0,65,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
2967,Iyer (2017),"Iyer RN, Jangam RR, Jacinth A, Venkatalakshmi A, Nahdi FB. Prevalence and trends in the antimicrobial susceptibility pattern of Salmonella enterica serovars Typhi and ParaTyphi A among children in a pediatric tertiary care hospital in South India over a period of ten years: a retrospective study. Eur J Clin Microbiol Infect Dis 2017; 07: 07.",Systematic review,IND,India,Rainbow Hospital for Women and Children,848,Andhra Pradesh,2008,0,6,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
5110,Sharma (2018),"Sharma P, Dahiya S, Manral N, et al. Changing trends of culture-positive typhoid fever and antimicrobial susceptibility in a tertiary care North Indian Hospital over the last decade.Indian Journal of Medical Microbiology 2018;36(1):70-76",Systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,2008,1,48,2.1,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
262,Kumar (2013)<U+1D47>,"Kumar MS, Kumar GSV, Prashanth HV, Prakash R, Veena K, Chandrashekar SC. Antimicrobial susceptibility of enteric fever Salmonellae isolated from blood culture. Res J Pharm Biol Chem Sci 2013b; 4(3): 318-24.",Systematic review,IND,India,Sri Siddhartha Medical College,855,Karnataka,2008,2,132,1.5,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
5124,Joshi (2019),"Joshi S, Adhikary R, Beena HB, et al. Trends in antibiotic susceptibility of enteric fever isolates from South India, 2002–2013.Medical Journal Armed Forces India 2019;75(1):81-85",Systematic review,IND,India,Manipal Hospital (Airport road),855,Karnataka,2008,0,204,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
1669,Bekur (2010),"Bekur R, Vandana KE, Shivashankara KN, Valsalan R, Sathyanarayanan V. Paratyphoid fever- Emerging problem in South India. Asian Pac J Trop Med 2010; 3(10): 815-7.",Systematic review,IND,India,Kasturba Medical College and Hospital (Manipal),855,Karnataka,2008,0,29,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
2170,Pandit (2012),"Pandit V, Kumar A, Kulkarni MM, Pattanshetty SM, Samarasinghe C, Kamath S. Study of clinical profile and antibiotic sensitivity in paratyphoid fever cases admitted at teaching hospital in South India. J Family Med Prim Care 2012; 1(2): 118-21.",Systematic review,IND,India,Kasturba Medical College and Hospital (Manipal),855,Karnataka,2008,7,110,6.4,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
1697,Sabiha(2012),"Sabiha ST, Nilekar SL. Phage types of multidrug resistant Salmonella species in a rural area of Maharashtra, India. Bangladesh J Med Sci 2012; 11(1): 37-9.",Systematic review,IND,India,Unknown rural medical college in Maharashtra,858,Maharashtra,2008,3,12,25,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
2334,Gupta (2013),"Gupta V, Singla N, Bansal N, Kaistha N, Chander J. Trends in the antibiotic resistance patterns of enteric fever isolates - a three year report from a tertiary care centre. Malays J Med Sci 2013; 20(4): 71-5.",Systematic review,IND,India,Government Medical College Hospital (Chandigarh),864,Punjab,2008,1,18,5.6,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
2334,Gupta (2013),"Gupta V, Singla N, Bansal N, Kaistha N, Chander J. Trends in the antibiotic resistance patterns of enteric fever isolates - a three year report from a tertiary care centre. Malays J Med Sci 2013; 20(4): 71-5.",Systematic review,IND,India,Government Medical College Hospital (Chandigarh),864,Punjab,2008,1,18,5.6,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
1424,Muthu(2014),"Muthu G, Suresh A, Elumalaisathishkumar, et al. Molecular analysis of gyramutations in Salmonella Paratyphi ABY PCR-RFLP and sequencing method. International Journal of Pharmacy and Pharmaceutical Sciences 2014; 6(4): 658-60.",Systematic review,IND,India,Unknown hospitals and laboratories in Chennai,867,Tamil Nadu,2008,2,41,4.9,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
2165,Gopal(2011),"Gopal M, Arumugam S, Gnadesikan S, Ramesh S. Studies on antimicrobial susceptibility pattern of Salmonella isolates from Chennai, India. Int J Pharma Bio Sci 2011; 2(2).",Systematic review,IND,India,Rajiv Gandhi Government General Hospital;Other clinical laboratories Chennai,867,Tamil Nadu,2008,2,41,4.9,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
4593,Menezes (2016),"Menezes GA, Harish BN, Khan MA, Goessens W, Hays JP. Antimicrobial resistance trends in blood culture positive Salmonella ParaTyphi A isolates from Pondicherry, India. Indian J Med Microbiol 2016; 34(2): 222-7.",Systematic review,IND,India,Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER);Government Hospital (Pondicherry),889,Puducherry,2008,0,59,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
2967,Iyer (2017),"Iyer RN, Jangam RR, Jacinth A, Venkatalakshmi A, Nahdi FB. Prevalence and trends in the antimicrobial susceptibility pattern of Salmonella enterica serovars Typhi and ParaTyphi A among children in a pediatric tertiary care hospital in South India over a period of ten years: a retrospective study. Eur J Clin Microbiol Infect Dis 2017; 07: 07.",Systematic review,IND,India,Rainbow Hospital for Women and Children,848,Andhra Pradesh,2009,0,23,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
5110,Sharma (2018),"Sharma P, Dahiya S, Manral N, et al. Changing trends of culture-positive typhoid fever and antimicrobial susceptibility in a tertiary care North Indian Hospital over the last decade.Indian Journal of Medical Microbiology 2018;36(1):70-76",Systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,2009,2,64,3.1,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
5124,Joshi (2019),"Joshi S, Adhikary R, Beena HB, et al. Trends in antibiotic susceptibility of enteric fever isolates from South India, 2002–2013.Medical Journal Armed Forces India 2019;75(1):81-85",Systematic review,IND,India,Manipal Hospital (Airport road),855,Karnataka,2009,0,106,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
4585,Mahapatra (2016),"Mahapatra A, Patro S, Choudhury S, Padhee A, Das R. Emerging enteric fever due to switching biotype of Salmonella (ParaTyphi A) in Eastern Odisha. Indian J Pathol Microbiol 2016; 59(3): 327-9.",Systematic review,IND,India,SRL Diagnostics (Bhubaneswar),863,Orissa,2009,0,140,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
2334,Gupta (2013),"Gupta V, Singla N, Bansal N, Kaistha N, Chander J. Trends in the antibiotic resistance patterns of enteric fever isolates - a three year report from a tertiary care centre. Malays J Med Sci 2013; 20(4): 71-5.",Systematic review,IND,India,Government Medical College Hospital (Chandigarh),864,Punjab,2009,0,16,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
2334,Gupta (2013),"Gupta V, Singla N, Bansal N, Kaistha N, Chander J. Trends in the antibiotic resistance patterns of enteric fever isolates - a three year report from a tertiary care centre. Malays J Med Sci 2013; 20(4): 71-5.",Systematic review,IND,India,Government Medical College Hospital (Chandigarh),864,Punjab,2009,0,16,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
4593,Menezes (2016),"Menezes GA, Harish BN, Khan MA, Goessens W, Hays JP. Antimicrobial resistance trends in blood culture positive Salmonella ParaTyphi A isolates from Pondicherry, India. Indian J Med Microbiol 2016; 34(2): 222-7.",Systematic review,IND,India,Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER);Government Hospital (Pondicherry),889,Puducherry,2009,0,44,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
2967,Iyer (2017),"Iyer RN, Jangam RR, Jacinth A, Venkatalakshmi A, Nahdi FB. Prevalence and trends in the antimicrobial susceptibility pattern of Salmonella enterica serovars Typhi and ParaTyphi A among children in a pediatric tertiary care hospital in South India over a period of ten years: a retrospective study. Eur J Clin Microbiol Infect Dis 2017; 07: 07.",Systematic review,IND,India,Rainbow Hospital for Women and Children,848,Andhra Pradesh,2010,0,7,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
207,Jain (2013),"Jain S, Chugh TD. Antimicrobial resistance among blood culture isolates of Salmonella enterica in New Delhi. J Infect Dev Ctries 2013; 7(11): 788-95.",Systematic review,IND,India,BLK Super speciality Hospital,850,Delhi,2010,0,28,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
3082,Duggal (2016),"Duggal S, Banerjee P, Chugh TD. Review of fifty culture proven Salmonella cases. Indian J Med Sci 2016; 68(1): 67-72.",Systematic review,IND,India,Unknown Hospital(s) in Delhi,850,Delhi,2010,0,12,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
5110,Sharma (2018),"Sharma P, Dahiya S, Manral N, et al. Changing trends of culture-positive typhoid fever and antimicrobial susceptibility in a tertiary care North Indian Hospital over the last decade.Indian Journal of Medical Microbiology 2018;36(1):70-76",Systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,2010,0,13,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
2820,Shetty (2012),"Shetty AK, Shetty IN, Furtado ZV, Antony B, Boloor R. Antibiogram of Salmonella isolates from blood with an emphasis on nalidixic acid and chloramphenicol susceptibility in a tertiary care hospital in coastal karnataka: a prospective study. J Lab Physicians 2012; 4(2): 74-7.",Systematic review,IND,India,Father Muller Medical College Hospital,855,Karnataka,2010,0,16,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
5124,Joshi (2019),"Joshi S, Adhikary R, Beena HB, et al. Trends in antibiotic susceptibility of enteric fever isolates from South India, 2002–2013.Medical Journal Armed Forces India 2019;75(1):81-85",Systematic review,IND,India,Manipal Hospital (Airport road),855,Karnataka,2010,0,60,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
2334,Gupta (2013),"Gupta V, Singla N, Bansal N, Kaistha N, Chander J. Trends in the antibiotic resistance patterns of enteric fever isolates - a three year report from a tertiary care centre. Malays J Med Sci 2013; 20(4): 71-5.",Systematic review,IND,India,Government Medical College Hospital (Chandigarh),864,Punjab,2010,0,11,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
2334,Gupta (2013),"Gupta V, Singla N, Bansal N, Kaistha N, Chander J. Trends in the antibiotic resistance patterns of enteric fever isolates - a three year report from a tertiary care centre. Malays J Med Sci 2013; 20(4): 71-5.",Systematic review,IND,India,Government Medical College Hospital (Chandigarh),864,Punjab,2010,0,11,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
264,Choudhary(2013),"Choudhary A, Gopalakrishnan R, Nambi PS, Ramasubramanian V, Ghafur KA, Thirunarayan MA. Antimicrobial susceptibility of Salmonella enterica serovars in a tertiary care hospital in southern India. Indian J Med Res 2013; 137(4): 800-2.",Systematic review,IND,India,Apollo Hospital (Gream Road),867,Tamil Nadu,2010,0,134,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
744,Elumalai (2014),"Elumalai S, Muthu G, Selvam RE, Ramesh S. Detection of TEM-, SHV- and CTX-M-type beta-lactamase production among clinical isolates of Salmonella species. J Med Microbiol 2014; 63(Pt 7): 962-7.",Systematic review,IND,India,Unknown hospitals and laboratories in Chennai,867,Tamil Nadu,2010,0,31,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
5069,Bandyopadhyay(2018),"Bandyopadhyay R, Balaji V, Yadav B, Jasmine S, Sathyendra S, Rupali P. Effectiveness of treatment regimens for Typhoid fever in the nalidixic acid-resistant S. Typhi (NARST) era in South India. Trop Doct 2018; 48(3): 182-8.",Systematic review,IND,India,Christian Medical College (Vellore),867,Tamil Nadu,2010,0,18,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
4650,Yadav (2016),"Yadav VC, Kiran VR, Sharma R. Enteric fever in Bastar tribal region-prevalence and sensitivity patterns. J Evol Med Dent Sci 2016; 5(53): 3526-30.",Systematic review,IND,India,Late Baliram Kashyap Memorial Government Medical College Jagdalpur,884,Chhattisgarh,2010,10,16,62.5,1,Salmonella Paratyphi A,Multidrug resistance (MDR)
2967,Iyer (2017),"Iyer RN, Jangam RR, Jacinth A, Venkatalakshmi A, Nahdi FB. Prevalence and trends in the antimicrobial susceptibility pattern of Salmonella enterica serovars Typhi and ParaTyphi A among children in a pediatric tertiary care hospital in South India over a period of ten years: a retrospective study. Eur J Clin Microbiol Infect Dis 2017; 07: 07.",Systematic review,IND,India,Rainbow Hospital for Women and Children,848,Andhra Pradesh,2011,0,5,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
207,Jain (2013),"Jain S, Chugh TD. Antimicrobial resistance among blood culture isolates of Salmonella enterica in New Delhi. J Infect Dev Ctries 2013; 7(11): 788-95.",Systematic review,IND,India,BLK Super speciality Hospital,850,Delhi,2011,0,33,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
5097,Makkar (2018),"Makkar A, Gupta S, Khan ID, et al. Epidemiological Profile and Antimicrobial Resistance Pattern of Enteric Fever in a Tertiary Care Hospital of North India - a Seven Year Ambispective Study.Acta Medica (Hradec Kralove) 2018;61(4):125-130",Systematic review,IND,India,Unknown Hospital(s) in Delhi,850,Delhi,2011,0,9,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
5110,Sharma (2018),"Sharma P, Dahiya S, Manral N, et al. Changing trends of culture-positive typhoid fever and antimicrobial susceptibility in a tertiary care North Indian Hospital over the last decade.Indian Journal of Medical Microbiology 2018;36(1):70-76",Systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,2011,0,17,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
5124,Joshi (2019),"Joshi S, Adhikary R, Beena HB, et al. Trends in antibiotic susceptibility of enteric fever isolates from South India, 2002–2013.Medical Journal Armed Forces India 2019;75(1):81-85",Systematic review,IND,India,Manipal Hospital (Airport road),855,Karnataka,2011,0,73,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
4650,Yadav (2016),"Yadav VC, Kiran VR, Sharma R. Enteric fever in Bastar tribal region-prevalence and sensitivity patterns. J Evol Med Dent Sci 2016; 5(53): 3526-30.",Systematic review,IND,India,Late Baliram Kashyap Memorial Government Medical College Jagdalpur,884,Chhattisgarh,2011,8,11,72.7,1,Salmonella Paratyphi A,Multidrug resistance (MDR)
1730,Geetha (2014),"Geetha VK, Yugendran T, Srinivasan R, Harish BN. Plasmid-mediated quinolone resistance in typhoidal Salmonellae: a preliminary report from South India. Indian J Med Microbiol 2014; 32(1): 31-4.",Systematic review,IND,India,Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER),889,Puducherry,2011,0,27,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
2967,Iyer (2017),"Iyer RN, Jangam RR, Jacinth A, Venkatalakshmi A, Nahdi FB. Prevalence and trends in the antimicrobial susceptibility pattern of Salmonella enterica serovars Typhi and ParaTyphi A among children in a pediatric tertiary care hospital in South India over a period of ten years: a retrospective study. Eur J Clin Microbiol Infect Dis 2017; 07: 07.",Systematic review,IND,India,Rainbow Hospital for Women and Children,848,Andhra Pradesh,2012,0,9,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
207,Jain (2013),"Jain S, Chugh TD. Antimicrobial resistance among blood culture isolates of Salmonella enterica in New Delhi. J Infect Dev Ctries 2013; 7(11): 788-95.",Systematic review,IND,India,BLK Super speciality Hospital,850,Delhi,2012,0,16,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
5097,Makkar (2018),"Makkar A, Gupta S, Khan ID, et al. Epidemiological Profile and Antimicrobial Resistance Pattern of Enteric Fever in a Tertiary Care Hospital of North India - a Seven Year Ambispective Study.Acta Medica (Hradec Kralove) 2018;61(4):125-130",Systematic review,IND,India,Unknown Hospital(s) in Delhi,850,Delhi,2012,1,13,7.7,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
4627,Sharma (2016),"Sharma P, Dahiya S, Balaji V, et al. Typhoidal Salmonellae: Use of multi-locus sequence typing to determine population structure. PLoS ONE 2016; 11(9).",Systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,2012,1,10,10,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
5110,Sharma (2018),"Sharma P, Dahiya S, Manral N, et al. Changing trends of culture-positive typhoid fever and antimicrobial susceptibility in a tertiary care North Indian Hospital over the last decade.Indian Journal of Medical Microbiology 2018;36(1):70-76",Systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,2012,11,17,64.7,1,Salmonella Paratyphi A,Multidrug resistance (MDR)
151,Suruchi (2014),"Suruchi B, Anil K, Ganju SA, Atal S. Antibiotic susceptibility pattern of Salmonella enterica serovar Typhi and ParaTyphi a from North India: the changing scenario. Int J Pharma Bio Sci 2014; 5(4).",Systematic review,IND,India,Indira Gandhi Medical College,854,Himachal Pradesh,2012,0,25,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
117,Venkatesh (2013),"Venkatesh BM, Joshi S, Adhikary R, Bhaskar BH. Antibiogram of Salmonella Typhi and Salmonella ParaTyphi A in a tertiary care hospital in 2012. Indian J Pathol Microbiol 2013; 56(4): 484-5.",Systematic review,IND,India,Manipal Hospital (Airport road),855,Karnataka,2012,0,92,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
5124,Joshi (2019),"Joshi S, Adhikary R, Beena HB, et al. Trends in antibiotic susceptibility of enteric fever isolates from South India, 2002–2013.Medical Journal Armed Forces India 2019;75(1):81-85",Systematic review,IND,India,Manipal Hospital (Airport road),855,Karnataka,2012,0,91,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
4519,Chatterjee(2016),"Chatterjee S, Eshwara VK, Tellapragada C, Mukhopadhyay C. Azithromycin susceptibility among clinical isolates of Salmonella: Interfacing guidelines with routine practices. Indian J Med Microbiol 2016; 34(3): 397-8.",Systematic review,IND,India,Kasturba Medical College and Hospital (Manipal),855,Karnataka,2012,0,53,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
2977,Harichandran (2017),"Harichandran D, Dinesh KR. Antimicrobial susceptibility profile, treatment outcome and serotype distribution of clinical isolates of Salmonella enterica subspecies enterica: a 2-year study from Kerala, South India. Infect Drug Resist 2017; 10: 97-101.",Systematic review,IND,India,Amrita Institute of Medical Sciences and Research Centre,856,Kerala,2012,0,22,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
3012,Behl(2017),"Behl P, Gupta V, Sachdev A, Guglani V, Chander J. Patterns in antimicrobial susceptibility of Salmonellae isolated at a tertiary care hospital in northern India. Indian J Med Res 2017; 145(1): 124-8.",Systematic review,IND,India,Government Medical College Hospital (Chandigarh),864,Punjab,2012,0,16,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
696,Mathew (2014),"Mathew R, Jobin SR. Current trends of antimicrobial susceptibility of Salmonella enterica serovar Typhi and ParaTyphi a from blood cultures in a tertiary care center of Chennai, Tamil Nadu, India. Res J Pharm Biol Chem Sci 2014; 5(2): 1167-74.",Systematic review,IND,India,Saveetha Medical College (Thandalam),867,Tamil Nadu,2012,0,11,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
4650,Yadav (2016),"Yadav VC, Kiran VR, Sharma R. Enteric fever in Bastar tribal region-prevalence and sensitivity patterns. J Evol Med Dent Sci 2016; 5(53): 3526-30.",Systematic review,IND,India,Late Baliram Kashyap Memorial Government Medical College Jagdalpur,884,Chhattisgarh,2012,7,14,50,1,Salmonella Paratyphi A,Multidrug resistance (MDR)
2967,Iyer (2017),"Iyer RN, Jangam RR, Jacinth A, Venkatalakshmi A, Nahdi FB. Prevalence and trends in the antimicrobial susceptibility pattern of Salmonella enterica serovars Typhi and ParaTyphi A among children in a pediatric tertiary care hospital in South India over a period of ten years: a retrospective study. Eur J Clin Microbiol Infect Dis 2017; 07: 07.",Systematic review,IND,India,Rainbow Hospital for Women and Children,848,Andhra Pradesh,2013,0,6,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
5097,Makkar (2018),"Makkar A, Gupta S, Khan ID, et al. Epidemiological Profile and Antimicrobial Resistance Pattern of Enteric Fever in a Tertiary Care Hospital of North India - a Seven Year Ambispective Study.Acta Medica (Hradec Kralove) 2018;61(4):125-130",Systematic review,IND,India,Unknown Hospital(s) in Delhi,850,Delhi,2013,1,11,9.1,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
5110,Sharma (2018),"Sharma P, Dahiya S, Manral N, et al. Changing trends of culture-positive typhoid fever and antimicrobial susceptibility in a tertiary care North Indian Hospital over the last decade.Indian Journal of Medical Microbiology 2018;36(1):70-76",Systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,2013,0,6,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
3039,Sharvani (2016),"Sharvani R, Hemavathi, Dayanand DK, Shenoy P, Sarmah P. Antibiogram of Salmonella isolates: time to consider antibiotic salvage. J Clin Diagn Res 2016; 10(5): DC6-DC8.",Systematic review,IND,India,Sapthagiri Hospital,855,Karnataka,2013,0,117,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
5124,Joshi (2019),"Joshi S, Adhikary R, Beena HB, et al. Trends in antibiotic susceptibility of enteric fever isolates from South India, 2002–2013.Medical Journal Armed Forces India 2019;75(1):81-85",Systematic review,IND,India,Manipal Hospital (Airport road),855,Karnataka,2013,0,111,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
4650,Yadav (2016),"Yadav VC, Kiran VR, Sharma R. Enteric fever in Bastar tribal region-prevalence and sensitivity patterns. J Evol Med Dent Sci 2016; 5(53): 3526-30.",Systematic review,IND,India,Late Baliram Kashyap Memorial Government Medical College Jagdalpur,884,Chhattisgarh,2013,8,14,57.1,1,Salmonella Paratyphi A,Multidrug resistance (MDR)
4597,Misra (2016),"Misra R, Thakare R, Amrin N, Prasad KN, Chopra S, Dhole TN. Antimicrobial susceptibility pattern and sequence analysis of DNA gyrase and DNA topoisomerase IV in Salmonella enterica serovars Typhi and ParaTyphi A isolates with decreased susceptibility to ciprofloxacin. Trans R Soc Trop Med Hyg 2016; 110(8): 472-9.",Systematic review,IND,India,Sanjay Gandhi Postgraduate Institute of Medical Sciences,890,Uttar Pradesh,2013,0,8,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
5097,Makkar (2018),"Makkar A, Gupta S, Khan ID, et al. Epidemiological Profile and Antimicrobial Resistance Pattern of Enteric Fever in a Tertiary Care Hospital of North India - a Seven Year Ambispective Study.Acta Medica (Hradec Kralove) 2018;61(4):125-130",Systematic review,IND,India,Unknown Hospital(s) in Delhi,850,Delhi,2014,0,35,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
5110,Sharma (2018),"Sharma P, Dahiya S, Manral N, et al. Changing trends of culture-positive typhoid fever and antimicrobial susceptibility in a tertiary care North Indian Hospital over the last decade.Indian Journal of Medical Microbiology 2018;36(1):70-76",Systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,2014,0,5,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
4650,Yadav (2016),"Yadav VC, Kiran VR, Sharma R. Enteric fever in Bastar tribal region-prevalence and sensitivity patterns. J Evol Med Dent Sci 2016; 5(53): 3526-30.",Systematic review,IND,India,Late Baliram Kashyap Memorial Government Medical College Jagdalpur,884,Chhattisgarh,2014,3,5,60,1,Salmonella Paratyphi A,Multidrug resistance (MDR)
4597,Misra (2016),"Misra R, Thakare R, Amrin N, Prasad KN, Chopra S, Dhole TN. Antimicrobial susceptibility pattern and sequence analysis of DNA gyrase and DNA topoisomerase IV in Salmonella enterica serovars Typhi and ParaTyphi A isolates with decreased susceptibility to ciprofloxacin. Trans R Soc Trop Med Hyg 2016; 110(8): 472-9.",Systematic review,IND,India,Sanjay Gandhi Postgraduate Institute of Medical Sciences,890,Uttar Pradesh,2014,0,6,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
5097,Makkar (2018),"Makkar A, Gupta S, Khan ID, et al. Epidemiological Profile and Antimicrobial Resistance Pattern of Enteric Fever in a Tertiary Care Hospital of North India - a Seven Year Ambispective Study.Acta Medica (Hradec Kralove) 2018;61(4):125-130",Systematic review,IND,India,Unknown Hospital(s) in Delhi,850,Delhi,2015,0,18,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
5110,Sharma (2018),"Sharma P, Dahiya S, Manral N, et al. Changing trends of culture-positive typhoid fever and antimicrobial susceptibility in a tertiary care North Indian Hospital over the last decade.Indian Journal of Medical Microbiology 2018;36(1):70-76",Systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,2015,0,13,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
2967,Iyer (2017),"Iyer RN, Jangam RR, Jacinth A, Venkatalakshmi A, Nahdi FB. Prevalence and trends in the antimicrobial susceptibility pattern of Salmonella enterica serovars Typhi and ParaTyphi A among children in a pediatric tertiary care hospital in South India over a period of ten years: a retrospective study. Eur J Clin Microbiol Infect Dis 2017; 07: 07.",Systematic review,IND,India,Rainbow Hospital for Women and Children,848,Andhra Pradesh,2016,0,10,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
5097,Makkar (2018),"Makkar A, Gupta S, Khan ID, et al. Epidemiological Profile and Antimicrobial Resistance Pattern of Enteric Fever in a Tertiary Care Hospital of North India - a Seven Year Ambispective Study.Acta Medica (Hradec Kralove) 2018;61(4):125-130",Systematic review,IND,India,Unknown Hospital(s) in Delhi,850,Delhi,2016,0,33,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
5110,Sharma (2018),"Sharma P, Dahiya S, Manral N, et al. Changing trends of culture-positive typhoid fever and antimicrobial susceptibility in a tertiary care North Indian Hospital over the last decade.Indian Journal of Medical Microbiology 2018;36(1):70-76",Systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,2016,0,24,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
5097,Makkar (2018),"Makkar A, Gupta S, Khan ID, et al. Epidemiological Profile and Antimicrobial Resistance Pattern of Enteric Fever in a Tertiary Care Hospital of North India - a Seven Year Ambispective Study.Acta Medica (Hradec Kralove) 2018;61(4):125-130",Systematic review,IND,India,Unknown Hospital(s) in Delhi,850,Delhi,2017,0,38,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
5119,Wankhede (2018),Wankhede SV and Apurva. Prevalence and antibiogram of Salmonella Typhi and Paratyphi A isolates from a tertiary care hospital.Indian Journal of Basic and Applied Medical Research 2018;7(Diagnostic):31-38,Systematic review,IND,India,Smt. Kashibai Navale Medical College and General Hospital,858,Maharashtra,2017,0,6,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
5064,Zellweger (2017),"Zellweger RM, Basnyat B, Shrestha P, et al. A 23-year retrospective investigation of Salmonella Typhi and Salmonella ParaTyphi isolated in a tertiary Kathmandu hospital.PLoS Neglected Tropical Diseases [electronic resource] 2017;11(11):e0006051",Systematic review,NPL,Nepal,Patan Hospital (Lalitpur),892,Central,1992,7,131,5.3,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
5064,Zellweger (2017),"Zellweger RM, Basnyat B, Shrestha P, et al. A 23-year retrospective investigation of Salmonella Typhi and Salmonella ParaTyphi isolated in a tertiary Kathmandu hospital.PLoS Neglected Tropical Diseases [electronic resource] 2017;11(11):e0006051",Systematic review,NPL,Nepal,Patan Hospital (Lalitpur),892,Central,1993,5,90,5.6,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
5064,Zellweger (2017),"Zellweger RM, Basnyat B, Shrestha P, et al. A 23-year retrospective investigation of Salmonella Typhi and Salmonella ParaTyphi isolated in a tertiary Kathmandu hospital.PLoS Neglected Tropical Diseases [electronic resource] 2017;11(11):e0006051",Systematic review,NPL,Nepal,Patan Hospital (Lalitpur),892,Central,1994,2,224,0.9,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
5064,Zellweger (2017),"Zellweger RM, Basnyat B, Shrestha P, et al. A 23-year retrospective investigation of Salmonella Typhi and Salmonella ParaTyphi isolated in a tertiary Kathmandu hospital.PLoS Neglected Tropical Diseases [electronic resource] 2017;11(11):e0006051",Systematic review,NPL,Nepal,Patan Hospital (Lalitpur),892,Central,1995,6,166,3.6,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
5064,Zellweger (2017),"Zellweger RM, Basnyat B, Shrestha P, et al. A 23-year retrospective investigation of Salmonella Typhi and Salmonella ParaTyphi isolated in a tertiary Kathmandu hospital.PLoS Neglected Tropical Diseases [electronic resource] 2017;11(11):e0006051",Systematic review,NPL,Nepal,Patan Hospital (Lalitpur),892,Central,1996,0,95,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
871,Maskey (2008),"Maskey AP, Basnyat B, Thwaites GE, Campbell JI, Farrar JJ, Zimmerman MD. Emerging trends in enteric fever in Nepal: 9124 cases confirmed by blood culture 1993-2003. Trans R Soc Trop Med Hyg 2008; 102(1): 91-5.",Systematic review,NPL,Nepal,Patan Hospital (Lalitpur),892,Central,1996,42,875,4.8,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
5064,Zellweger (2017),"Zellweger RM, Basnyat B, Shrestha P, et al. A 23-year retrospective investigation of Salmonella Typhi and Salmonella ParaTyphi isolated in a tertiary Kathmandu hospital.PLoS Neglected Tropical Diseases [electronic resource] 2017;11(11):e0006051",Systematic review,NPL,Nepal,Patan Hospital (Lalitpur),892,Central,1997,2,100,2,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
5064,Zellweger (2017),"Zellweger RM, Basnyat B, Shrestha P, et al. A 23-year retrospective investigation of Salmonella Typhi and Salmonella ParaTyphi isolated in a tertiary Kathmandu hospital.PLoS Neglected Tropical Diseases [electronic resource] 2017;11(11):e0006051",Systematic review,NPL,Nepal,Patan Hospital (Lalitpur),892,Central,1998,1,146,0.7,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
5064,Zellweger (2017),"Zellweger RM, Basnyat B, Shrestha P, et al. A 23-year retrospective investigation of Salmonella Typhi and Salmonella ParaTyphi isolated in a tertiary Kathmandu hospital.PLoS Neglected Tropical Diseases [electronic resource] 2017;11(11):e0006051",Systematic review,NPL,Nepal,Patan Hospital (Lalitpur),892,Central,1999,1,57,1.8,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
5064,Zellweger (2017),"Zellweger RM, Basnyat B, Shrestha P, et al. A 23-year retrospective investigation of Salmonella Typhi and Salmonella ParaTyphi isolated in a tertiary Kathmandu hospital.PLoS Neglected Tropical Diseases [electronic resource] 2017;11(11):e0006051",Systematic review,NPL,Nepal,Patan Hospital (Lalitpur),892,Central,2000,2,262,0.8,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
3669,Woods (2006),"Woods CW, Murdoch DR, Zimmerman MD, et al. Emergence of Salmonella enterica serotype ParaTyphi A as a major cause of enteric fever in Kathmandu, Nepal. Trans R Soc Trop Med Hyg 2006; 100(11): 1063-7.",Systematic review,NPL,Nepal,Patan Hospital (Lalitpur),892,Central,2001,0,57,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
5064,Zellweger (2017),"Zellweger RM, Basnyat B, Shrestha P, et al. A 23-year retrospective investigation of Salmonella Typhi and Salmonella ParaTyphi isolated in a tertiary Kathmandu hospital.PLoS Neglected Tropical Diseases [electronic resource] 2017;11(11):e0006051",Systematic review,NPL,Nepal,Patan Hospital (Lalitpur),892,Central,2001,0,345,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
871,Maskey (2008),"Maskey AP, Basnyat B, Thwaites GE, Campbell JI, Farrar JJ, Zimmerman MD. Emerging trends in enteric fever in Nepal: 9124 cases confirmed by blood culture 1993-2003. Trans R Soc Trop Med Hyg 2008; 102(1): 91-5.",Systematic review,NPL,Nepal,Patan Hospital (Lalitpur),892,Central,2001,30,1809,1.7,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
1967,Guha (2005),"Guha S, Jalan BY, Dey S, Easow JM, Wilson G, Shivananda PG. Salmonella bacteraemia in Pokhara: emergence of antibiotic resistance. Nepal Med Coll J 2005; 7(1): 23-5.",Systematic review,NPL,Nepal,Manipal Teaching Hospital (Pokhara),896,Western,2001,0,8,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
953,Malla (2005),"Malla S, Kansakar P, Serichantalergs, Rahman M, Basnet S. Epidemiology of typhoid and paratyphoid fever in Kathmandu: two years study and trends of antimicrobial resistance. JNMA J Nepal Med Assoc 2005; 44(157): 18-22.",Systematic review,NPL,Nepal,Bir Hospital (Kathmandu);Maternity Hospital (Kathmandu);National Public Health Laboratory (Kathmandu);Tribhuvan University Teaching Hospital (Kathmandu),892,Central,2002,1,23,4.3,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
5064,Zellweger (2017),"Zellweger RM, Basnyat B, Shrestha P, et al. A 23-year retrospective investigation of Salmonella Typhi and Salmonella ParaTyphi isolated in a tertiary Kathmandu hospital.PLoS Neglected Tropical Diseases [electronic resource] 2017;11(11):e0006051",Systematic review,NPL,Nepal,Patan Hospital (Lalitpur),892,Central,2002,9,883,1,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
1967,Guha (2005),"Guha S, Jalan BY, Dey S, Easow JM, Wilson G, Shivananda PG. Salmonella bacteraemia in Pokhara: emergence of antibiotic resistance. Nepal Med Coll J 2005; 7(1): 23-5.",Systematic review,NPL,Nepal,Manipal Teaching Hospital (Pokhara),896,Western,2002,0,10,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
712,Shirakawa (2006),"Shirakawa T, Acharya B, Kinoshita S, Kumagai S, Gotoh A, Kawabata M. Decreased susceptibility to fluoroquinolones and gyrA gene mutation in the Salmonella enterica serovar Typhi and ParaTyphi A isolated in Katmandu, Nepal, in 2003. Diagn Microbiol Infect Dis 2006; 54(4): 299-303.",Systematic review,NPL,Nepal,Unknown Hospital in Kathmandu,892,Central,2003,0,39,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
953,Malla (2005),"Malla S, Kansakar P, Serichantalergs, Rahman M, Basnet S. Epidemiology of typhoid and paratyphoid fever in Kathmandu: two years study and trends of antimicrobial resistance. JNMA J Nepal Med Assoc 2005; 44(157): 18-22.",Systematic review,NPL,Nepal,Bir Hospital (Kathmandu);Maternity Hospital (Kathmandu);National Public Health Laboratory (Kathmandu);Tribhuvan University Teaching Hospital (Kathmandu),892,Central,2003,5,302,1.7,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
5064,Zellweger (2017),"Zellweger RM, Basnyat B, Shrestha P, et al. A 23-year retrospective investigation of Salmonella Typhi and Salmonella ParaTyphi isolated in a tertiary Kathmandu hospital.PLoS Neglected Tropical Diseases [electronic resource] 2017;11(11):e0006051",Systematic review,NPL,Nepal,Patan Hospital (Lalitpur),892,Central,2003,3,415,0.7,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
1967,Guha (2005),"Guha S, Jalan BY, Dey S, Easow JM, Wilson G, Shivananda PG. Salmonella bacteraemia in Pokhara: emergence of antibiotic resistance. Nepal Med Coll J 2005; 7(1): 23-5.",Systematic review,NPL,Nepal,Manipal Teaching Hospital (Pokhara),896,Western,2003,1,20,5,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
953,Malla (2005),"Malla S, Kansakar P, Serichantalergs, Rahman M, Basnet S. Epidemiology of typhoid and paratyphoid fever in Kathmandu: two years study and trends of antimicrobial resistance. JNMA J Nepal Med Assoc 2005; 44(157): 18-22.",Systematic review,NPL,Nepal,Bir Hospital (Kathmandu);Maternity Hospital (Kathmandu);National Public Health Laboratory (Kathmandu);Tribhuvan University Teaching Hospital (Kathmandu),892,Central,2004,1,105,1,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
5064,Zellweger (2017),"Zellweger RM, Basnyat B, Shrestha P, et al. A 23-year retrospective investigation of Salmonella Typhi and Salmonella ParaTyphi isolated in a tertiary Kathmandu hospital.PLoS Neglected Tropical Diseases [electronic resource] 2017;11(11):e0006051",Systematic review,NPL,Nepal,Patan Hospital (Lalitpur),892,Central,2004,2,385,0.5,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
1988,Maskey (2006),"Maskey AP, Day JN, Phung QT, et al. Salmonella enterica serovar ParaTyphi A and S. enterica serovar Typhi cause indistinguishable clinical syndromes in Kathmandu, Nepal. Clin Infect Dis 2006; 42(9): 1247-53.",Systematic review,NPL,Nepal,Patan Hospital (Lalitpur),892,Central,2004,3,200,1.5,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
850,Tamang (2007),"Tamang MD, Oh J, Seol S, et al. Emergence of multidrug-resistant Salmonella enterica serovar Typhi associated with a class 1 integron carrying the dfrA7 gene cassette in Nepal. Int J Antimicrob Agents 2007; 30(4): 330-5.",Systematic review,NPL,Nepal,Dhulikhel Hospital (Kathmandu),892,Central,2005,0,28,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
971,Amatya (2007),"Amatya NM, Shrestha B, Lekhak B. Etiological agents of bacteraemia and antibiotic susceptibility pattern in Kathmandu Model Hospital. JNMA J Nepal Med Assoc 2007; 46(167): 112-8.",Systematic review,NPL,Nepal,Kathmandu Model Hospital (Kathmandu),892,Central,2005,0,44,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
5064,Zellweger (2017),"Zellweger RM, Basnyat B, Shrestha P, et al. A 23-year retrospective investigation of Salmonella Typhi and Salmonella ParaTyphi isolated in a tertiary Kathmandu hospital.PLoS Neglected Tropical Diseases [electronic resource] 2017;11(11):e0006051",Systematic review,NPL,Nepal,Patan Hospital (Lalitpur),892,Central,2005,1,334,0.3,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
5064,Zellweger (2017),"Zellweger RM, Basnyat B, Shrestha P, et al. A 23-year retrospective investigation of Salmonella Typhi and Salmonella ParaTyphi isolated in a tertiary Kathmandu hospital.PLoS Neglected Tropical Diseases [electronic resource] 2017;11(11):e0006051",Systematic review,NPL,Nepal,Patan Hospital (Lalitpur),892,Central,2006,0,325,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
406,Kelly(2011),"Kelly DF, Thorson S, Maskey M, et al. The burden of vaccine-preventable invasive bacterial infections and pneumonia in children admitted to hospital in urban Nepal. Int J Infect Dis 2011; 15(1): e17-23.",Systematic review,NPL,Nepal,Patan Hospital (Lalitpur),892,Central,2006,0,6,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
1092,Arjyal (2011),"Arjyal A, Basnyat B, Koirala S, et al. Gatifloxacin versus chloramphenicol for uncomplicated enteric fever: an open-label, randomised, controlled trial. Lancet Infect Dis 2011; 11(6): 445-54.",Systematic review,NPL,Nepal,Patan Hospital (Lalitpur),892,Central,2007,0,102,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
5064,Zellweger (2017),"Zellweger RM, Basnyat B, Shrestha P, et al. A 23-year retrospective investigation of Salmonella Typhi and Salmonella ParaTyphi isolated in a tertiary Kathmandu hospital.PLoS Neglected Tropical Diseases [electronic resource] 2017;11(11):e0006051",Systematic review,NPL,Nepal,Patan Hospital (Lalitpur),892,Central,2007,2,195,1,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
393,Easow(2010),"Easow JM, Joseph NM, Dhungel BA, Chapagain B, Shivananda PG. Blood stream infections among febrile patients attending a teaching hospital in Western Region of Nepal. Australasian Medical Journal 2010; 3(10): 633-7.",Systematic review,NPL,Nepal,Manipal Teaching Hospital (Pokhara),896,Western,2007,1,6,16.7,1,Salmonella Paratyphi A,Multidrug resistance (MDR)
5064,Zellweger (2017),"Zellweger RM, Basnyat B, Shrestha P, et al. A 23-year retrospective investigation of Salmonella Typhi and Salmonella ParaTyphi isolated in a tertiary Kathmandu hospital.PLoS Neglected Tropical Diseases [electronic resource] 2017;11(11):e0006051",Systematic review,NPL,Nepal,Patan Hospital (Lalitpur),892,Central,2008,0,285,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
1791,Prajapati (2008),"Prajapati B, Rai GK, Rai SK, et al. Prevalence of Salmonella Typhi and ParaTyphi infection in children: a hospital based study. Nepal Med Coll J 2008; 10(4): 238-41.",Systematic review,NPL,Nepal,Kanti Children's Hospital (Kathmandu),892,Central,2008,1,34,2.9,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
5064,Zellweger (2017),"Zellweger RM, Basnyat B, Shrestha P, et al. A 23-year retrospective investigation of Salmonella Typhi and Salmonella ParaTyphi isolated in a tertiary Kathmandu hospital.PLoS Neglected Tropical Diseases [electronic resource] 2017;11(11):e0006051",Systematic review,NPL,Nepal,Patan Hospital (Lalitpur),892,Central,2009,1,242,0.4,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
1132,Karki (2013),"Karki AB, Bhatta DR, Shrestha B, et al. Higher nalidixic acid resistance pattern of Salmonella isolates from enteric fever patients in kathmandu model hospital Nepal. Res J Pharm Biol Chem Sci 2013; 4(2): 1687-93.",Systematic review,NPL,Nepal,Kathmandu Model Hospital (Kathmandu),892,Central,2009,0,47,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
1402,Dongol(2012),"Dongol S, Thompson CN, Clare S, et al. The microbiological and clinical characteristics of invasive Salmonella in gallbladders from cholecystectomy patients in kathmandu, Nepal. PLoS ONE 2012; 7(10): e47342.",Systematic review,NPL,Nepal,Patan Hospital (Lalitpur),892,Central,2009,0,22,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
1093,Koirala (2013),"Koirala S, Basnyat B, Arjyal A, et al. Gatifloxacin versus ofloxacin for the treatment of uncomplicated enteric fever in Nepal: an open-label, randomized, controlled trial. PLoS Negl Trop Dis 2013; 7(10): e2523.",Systematic review,NPL,Nepal,Patan (Lalitpur),892,Central,2010,0,86,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
5064,Zellweger (2017),"Zellweger RM, Basnyat B, Shrestha P, et al. A 23-year retrospective investigation of Salmonella Typhi and Salmonella ParaTyphi isolated in a tertiary Kathmandu hospital.PLoS Neglected Tropical Diseases [electronic resource] 2017;11(11):e0006051",Systematic review,NPL,Nepal,Patan Hospital (Lalitpur),892,Central,2010,0,394,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
275,Raza (2012),"Raza S, Tamrakar R, Bhatt CP, Joshi SK. Antimicrobial susceptibility patterns of Salmonella Typhi and Salmonella ParaTyphi A in a tertiary care hospital. J Nepal Health Res Counc 2012; 10(22): 214-7.",Systematic review,NPL,Nepal,Kathmandu Medical College (Kathmandu),892,Central,2011,0,31,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
5064,Zellweger (2017),"Zellweger RM, Basnyat B, Shrestha P, et al. A 23-year retrospective investigation of Salmonella Typhi and Salmonella ParaTyphi isolated in a tertiary Kathmandu hospital.PLoS Neglected Tropical Diseases [electronic resource] 2017;11(11):e0006051",Systematic review,NPL,Nepal,Patan Hospital (Lalitpur),892,Central,2011,0,328,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
593,Joshi (2011),"Joshi BG, Keyal K, Pandey R, Shrestha BM. Clinical profile and sensitivity pattern of Salmonella serotypes in children: A hospital based study. Journal of Nepal Paediatric Society 2011; 31(3): 180-3.",Systematic review,NPL,Nepal,Civil Service Hospital (Kathmandu),892,Central,2011,0,15,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
2806,Adhikari (2012),"Adhikari D, Acharya D, Shrestha P, Amatya R. Ciprofloxacin susceptibility of Salmonella enteric serovar Typhi and ParaTyphi A from blood samples of suspected enteric fever patients. International Journal of Infection and Microbiology 2012; 1(1): 9-13.",Systematic review,NPL,Nepal,KIST Medical College (Kathmandu),892,Central,2011,1,23,4.3,1,Salmonella Paratyphi A,Multidrug resistance (MDR)
1895,Chand (2014),"Chand HJ, Rijal KR, Neupane B, Sharma VK, Jha B. Re-emergence of susceptibility to conventional first line drugs in Salmonella isolates from enteric fever patients in Nepal. J Infect Dev Ctries 2014; 8(11): 1483-7.",Systematic review,NPL,Nepal,"Alka Hospital (Jawalakhel, Lalitpur)",892,Central,2012,0,30,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
5064,Zellweger (2017),"Zellweger RM, Basnyat B, Shrestha P, et al. A 23-year retrospective investigation of Salmonella Typhi and Salmonella ParaTyphi isolated in a tertiary Kathmandu hospital.PLoS Neglected Tropical Diseases [electronic resource] 2017;11(11):e0006051",Systematic review,NPL,Nepal,Patan Hospital (Lalitpur),892,Central,2012,0,256,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
5064,Zellweger (2017),"Zellweger RM, Basnyat B, Shrestha P, et al. A 23-year retrospective investigation of Salmonella Typhi and Salmonella ParaTyphi isolated in a tertiary Kathmandu hospital.PLoS Neglected Tropical Diseases [electronic resource] 2017;11(11):e0006051",Systematic review,NPL,Nepal,Patan Hospital (Lalitpur),892,Central,2013,0,142,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
5104,Petersiel (2018),"Petersiel N, Shresta S, Tamrakar R, et al. The epidemiology of typhoid fever in the Dhulikhel area, Nepal: A prospective cohort study.PLoS ONE 2018;13 (9) (no pagination)(e0204479):",Systematic review,NPL,Nepal,Dhulikhel Hospital (Kathmandu),892,Central,2013,0,42,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
5064,Zellweger (2017),"Zellweger RM, Basnyat B, Shrestha P, et al. A 23-year retrospective investigation of Salmonella Typhi and Salmonella ParaTyphi isolated in a tertiary Kathmandu hospital.PLoS Neglected Tropical Diseases [electronic resource] 2017;11(11):e0006051",Systematic review,NPL,Nepal,Patan Hospital (Lalitpur),892,Central,2014,0,127,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
2913,Sherchan(2017),"Sherchan JB, Morita M, Matono T, et al. Molecular and Clinical Epidemiology of Salmonella ParaTyphi A Isolated from Patients with Bacteremia in Nepal. Am J Trop Med Hyg 2017; 09: 09.",Systematic review,NPL,Nepal,Tribhuvan University Teaching Hospital (Kathmandu),892,Central,2015,0,23,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
2979,Gurung (2017),"Gurung B, Pandey S, Shah DK, et al. Antibiogram pattern of Salmonella in blood samples of enteric fever patients at lalitpur, nepal. Asian Pac J Trop Dis 2017; 7(1): 21-4.",Systematic review,NPL,Nepal,KIST Medical College (Kathmandu),892,Central,2015,0,35,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
2958,Khanal (2017),"Khanal PR, Satyal D, Bhetwal A, et al. Renaissance of conventional first-line antibiotics in Salmonella enterica clinical isolates: Assessment of MICs for therapeutic antimicrobials in enteric fever cases from Nepal. Biomed Res Int 2017; 2017: 2868143.",Systematic review,NPL,Nepal,Manmohan Memorial Community Hospital (Kathmandu),892,Central,2016,0,14,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
5049,Bhetwal (2017),"Bhetwal A, Maharjan A, Khanal PR and Parajuli NP. Enteric Fever Caused by Salmonella enterica Serovars with Reduced Susceptibility of Fluoroquinolones at a Community Based Teaching Hospital of Nepal.International Journal of Microbiology 2017;2017(2869458",Systematic review,NPL,Nepal,Manmohan Memorial Teaching Hospital (Kathmandu),892,Central,2016,0,83,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
5073,Britto (2018),"Britto CD, Dyson ZA, Duchene S, et al. Laboratory and molecular surveillance of paediatric typhoidal Salmonella in Nepal: Antimicrobial resistance and implications for vaccine policy.PLoS Neglected Tropical Diseases [electronic resource] 2018;12(4):e0006408",Systematic review,NPL,Nepal,Patan Hospital (Lalitpur),892,Central,2016,0,5,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
2787,Karamat (1996),"Karamat K, Butt T, Hannan A, et al. Problem of multi-drug resistant typhoid fever in Rawalpindi/Islamabad area. Pak Armed Forces Med J 1996; 46(2): 48-54.",Systematic review,PAK,Pakistan,Military Hospital (Rawalpindi);Armed Force Institute of Pathology,901,Punjab,1990,0,30,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
2787,Karamat (1996),"Karamat K, Butt T, Hannan A, et al. Problem of multi-drug resistant typhoid fever in Rawalpindi/Islamabad area. Pak Armed Forces Med J 1996; 46(2): 48-54.",Systematic review,PAK,Pakistan,Military Hospital (Rawalpindi);Armed Force Institute of Pathology,901,Punjab,1991,0,39,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
2787,Karamat (1996),"Karamat K, Butt T, Hannan A, et al. Problem of multi-drug resistant typhoid fever in Rawalpindi/Islamabad area. Pak Armed Forces Med J 1996; 46(2): 48-54.",Systematic review,PAK,Pakistan,Military Hospital (Rawalpindi);Armed Force Institute of Pathology,901,Punjab,1992,0,44,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
2787,Karamat (1996),"Karamat K, Butt T, Hannan A, et al. Problem of multi-drug resistant typhoid fever in Rawalpindi/Islamabad area. Pak Armed Forces Med J 1996; 46(2): 48-54.",Systematic review,PAK,Pakistan,Military Hospital (Rawalpindi);Armed Force Institute of Pathology,901,Punjab,1993,0,82,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
1771,Mirza (1995),"Mirza SH, Beeching NJ, Hart CA. The prevalence and clinical features of multi-drug resistant Salmonella Typhi infections in Baluchistan, Pakistan. Ann Trop Med Parasitol 1995; 89(5): 515-9.",Systematic review,PAK,Pakistan,Combined Military Hospital (Quetta),897,Balochistan,1994,0,14,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
2787,Karamat (1996),"Karamat K, Butt T, Hannan A, et al. Problem of multi-drug resistant typhoid fever in Rawalpindi/Islamabad area. Pak Armed Forces Med J 1996; 46(2): 48-54.",Systematic review,PAK,Pakistan,Military Hospital (Rawalpindi);Armed Force Institute of Pathology,901,Punjab,1994,0,61,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
2787,Karamat (1996),"Karamat K, Butt T, Hannan A, et al. Problem of multi-drug resistant typhoid fever in Rawalpindi/Islamabad area. Pak Armed Forces Med J 1996; 46(2): 48-54.",Systematic review,PAK,Pakistan,Military Hospital (Rawalpindi);Armed Force Institute of Pathology,901,Punjab,1995,0,52,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
455,Qureshi (2001),"Qureshi AH, Mushahid N, Ijaz A, et al. Changing drug susceptibility pattern of Salmonellae ParaTyphi A. J Coll Physicians Surg Pak 2001; 11(7): 449-51.",Systematic review,PAK,Pakistan,Combined Military Hospital (Quetta),897,Balochistan,1996,8,43,18.6,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
470,Butt (2005),"Butt T, Ahmad RN, Salman M, Kazmi SY. Changing trends in drug resistance among typhoid Salmonellae in Rawalpindi, Pakistan. East Mediterr Health J 2005; 11(5-6): 1038-44.",Systematic review,PAK,Pakistan,Armed Force Institute of Pathology,901,Punjab,1996,7,50,14,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
455,Qureshi (2001),"Qureshi AH, Mushahid N, Ijaz A, et al. Changing drug susceptibility pattern of Salmonellae ParaTyphi A. J Coll Physicians Surg Pak 2001; 11(7): 449-51.",Systematic review,PAK,Pakistan,Combined Military Hospital (Quetta),897,Balochistan,1997,10,25,40,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
470,Butt (2005),"Butt T, Ahmad RN, Salman M, Kazmi SY. Changing trends in drug resistance among typhoid Salmonellae in Rawalpindi, Pakistan. East Mediterr Health J 2005; 11(5-6): 1038-44.",Systematic review,PAK,Pakistan,Armed Force Institute of Pathology,901,Punjab,1997,12,41,29.3,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
455,Qureshi (2001),"Qureshi AH, Mushahid N, Ijaz A, et al. Changing drug susceptibility pattern of Salmonellae ParaTyphi A. J Coll Physicians Surg Pak 2001; 11(7): 449-51.",Systematic review,PAK,Pakistan,Combined Military Hospital (Quetta),897,Balochistan,1998,1,11,9.1,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
470,Butt (2005),"Butt T, Ahmad RN, Salman M, Kazmi SY. Changing trends in drug resistance among typhoid Salmonellae in Rawalpindi, Pakistan. East Mediterr Health J 2005; 11(5-6): 1038-44.",Systematic review,PAK,Pakistan,Armed Force Institute of Pathology,901,Punjab,1998,18,102,17.6,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
455,Qureshi (2001),"Qureshi AH, Mushahid N, Ijaz A, et al. Changing drug susceptibility pattern of Salmonellae ParaTyphi A. J Coll Physicians Surg Pak 2001; 11(7): 449-51.",Systematic review,PAK,Pakistan,Combined Military Hospital (Quetta),897,Balochistan,1999,14,38,36.8,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
470,Butt (2005),"Butt T, Ahmad RN, Salman M, Kazmi SY. Changing trends in drug resistance among typhoid Salmonellae in Rawalpindi, Pakistan. East Mediterr Health J 2005; 11(5-6): 1038-44.",Systematic review,PAK,Pakistan,Armed Force Institute of Pathology,901,Punjab,1999,11,61,18,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
455,Qureshi (2001),"Qureshi AH, Mushahid N, Ijaz A, et al. Changing drug susceptibility pattern of Salmonellae ParaTyphi A. J Coll Physicians Surg Pak 2001; 11(7): 449-51.",Systematic review,PAK,Pakistan,Combined Military Hospital (Quetta),897,Balochistan,2000,33,44,75,1,Salmonella Paratyphi A,Multidrug resistance (MDR)
470,Butt (2005),"Butt T, Ahmad RN, Salman M, Kazmi SY. Changing trends in drug resistance among typhoid Salmonellae in Rawalpindi, Pakistan. East Mediterr Health J 2005; 11(5-6): 1038-44.",Systematic review,PAK,Pakistan,Armed Force Institute of Pathology,901,Punjab,2000,12,49,24.5,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
4674,Siddiqui (2006),"Siddiqui FJ, Rabbani F, Hasan R, Nizami SQ, Bhutta ZA. Typhoid fever in children: some epidemiological considerations from Karachi, Pakistan. Int J Infect Dis 2006; 10(3): 215-22.",Systematic review,PAK,Pakistan,Hijrat Colony & Sultanabad,902,Sind,2000,4,7,57.1,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
470,Butt (2005),"Butt T, Ahmad RN, Salman M, Kazmi SY. Changing trends in drug resistance among typhoid Salmonellae in Rawalpindi, Pakistan. East Mediterr Health J 2005; 11(5-6): 1038-44.",Systematic review,PAK,Pakistan,Armed Force Institute of Pathology,901,Punjab,2001,10,41,24.4,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
470,Butt (2005),"Butt T, Ahmad RN, Salman M, Kazmi SY. Changing trends in drug resistance among typhoid Salmonellae in Rawalpindi, Pakistan. East Mediterr Health J 2005; 11(5-6): 1038-44.",Systematic review,PAK,Pakistan,Armed Force Institute of Pathology,901,Punjab,2002,19,41,46.3,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
470,Butt (2005),"Butt T, Ahmad RN, Salman M, Kazmi SY. Changing trends in drug resistance among typhoid Salmonellae in Rawalpindi, Pakistan. East Mediterr Health J 2005; 11(5-6): 1038-44.",Systematic review,PAK,Pakistan,Armed Force Institute of Pathology,901,Punjab,2003,11,25,44,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
959,Khan (2012),"Khan MI, Soofi SB, Ochiai Leon R, et al. Epidemiology, clinical presentation, and patterns of drug resistance of Salmonella Typhi in Karachi, Pakistan. J Infect Dev Ctries 2012; 6(10): 704-14.",Systematic review,PAK,Pakistan,"Hijrat Colony, Sultanabad and Bilal Colony, Karachi",902,Sind,2003,1,32,3.1,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
4363,Ikram (2015),"Ikram S, Hussain S, Aslam A, Khan MD, Ahmed I. Evaluation of the current trends in the antimicrobial susceptibility patterns of typhoid Salmonellae. Pak J Med Health Sci 2015; 9(4): 1247-50.",Systematic review,PAK,Pakistan,Islamabad Hospital (PIMS),899,Islamabad,2007,0,70,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
896,Abdullah (2012),"Abdullah FE, Faryal H, Kanwal F, Saboohi I, Iqbal MS. Enteric fever in Karachi: current antibiotic susceptibility of Salmonellae isolates. J Coll Physicians Surg Pak 2012; 22(3): 147-50.",Systematic review,PAK,Pakistan,Laboratory and Diagnostic Centre,902,Sind,2009,9,65,13.8,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
142,Muhammad (2013),"Muhammad R, Ali Z, Mehmood K, Ziauddin, Afridi AR, Bari F. Antibiotic sensitivity pattern of Salmonella serotypes in patients with enteric fever in a teaching hospital. Journal of Postgraduate Medical Institute 2013; 27(4): 397-402.",Systematic review,PAK,Pakistan,Lady Reading Hospital,900,Nwfp,2010,21,34,61.8,1,Salmonella Paratyphi A,Multidrug resistance (MDR)
5106,Qamar (2018),"Qamar FN, Yousafzai MT, Sultana S, et al. A Retrospective Study of Laboratory-Based Enteric Fever Surveillance, Pakistan, 2012-2014.Journal of Infectious Diseases 2018;218(suppl_4):S201-S205",Systematic review,PAK,Pakistan,Aga Khan University Hospital (Karachi);Aga Khan Hospital for Women and Children;Aga Khan Hospital (Hyderadad),902,Sind,2012,4,301,1.3,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
3023,Ali (2017),"Ali A, Ali HA, Shah FH, Zahid A, Aslam H, Javed B. Pattern of antimicrobial drug resistance of Salmonella Typhi and ParaTyphi a in a teaching hospital in Islamabad. J Pak Med Assoc 2017; 67(3): 375-9.",Systematic review,PAK,Pakistan,Khan Research Laboratories (KRL) Hospital,899,Islamabad,2013,5,42,11.9,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
5106,Qamar (2018),"Qamar FN, Yousafzai MT, Sultana S, et al. A Retrospective Study of Laboratory-Based Enteric Fever Surveillance, Pakistan, 2012-2014.Journal of Infectious Diseases 2018;218(suppl_4):S201-S205",Systematic review,PAK,Pakistan,Aga Khan University Hospital (Karachi);Aga Khan Hospital for Women and Children;Aga Khan Hospital (Hyderadad),902,Sind,2013,5,311,1.6,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
5106,Qamar (2018),"Qamar FN, Yousafzai MT, Sultana S, et al. A Retrospective Study of Laboratory-Based Enteric Fever Surveillance, Pakistan, 2012-2014.Journal of Infectious Diseases 2018;218(suppl_4):S201-S205",Systematic review,PAK,Pakistan,Aga Khan University Hospital (Karachi);Aga Khan Hospital for Women and Children;Aga Khan Hospital (Hyderadad),902,Sind,2014,5,274,1.8,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
5063,Zehra (2017),"Zehra NM, Irfan F, Mirza IA, et al. Current Trends of Antimicrobial Susceptibility of Typhoidal Salmonellae Isolated at Tertiary Care Hospital.Jcpsp, Journal of the College of Physicians & Surgeons - Pakistan 2017;27(11):690-692",Systematic review,PAK,Pakistan,PNS Shifa Hospital,902,Sind,2015,80,190,42.1,1,Salmonella Paratyphi A,Multidrug resistance (MDR)
5146,PARN(2018),Pakistan Antimicrobial Resistance Network. Antimicrobial data. 2018. https://parn.org.pk/antimicrobial-data/.,Surveillance report,PAK,Pakistan,Aga Khan University Hospital (Karachi),902,Sind,2018,228,237,96.2,1,Salmonella Paratyphi A,Multidrug resistance (MDR)
1514,Yu(2003),"Yu ZB, Yao C, Xiao YH, Cai SF. Multiple-antibiotic-resistant active efflux gene acrB and its expression in Salmonella Paratyphi A. [Chinese]. Chinese Journal of Antibiotics 2003; 28(12): 737-40+67.",Systematic review,CHN,China,First Affiliated Hospital of Chongqing Medical University (Yu Zhong District),6,Chongqing Shi,1999,0,12,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
2327,Dong(2010),"Dong BQ, Yang J, Wang XY, et al. Trends and disease burden of enteric fever in Guangxi province, China, 1994-2004. Bull World Health Organ 2010; 88(9): 689-96.",Systematic review,CHN,China,Center for Disease Control and Prevention Guangxi,10,Guangxi Zhuangzu Zizhiqu,1999,4,1107,0.4,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
2191,Zhang(2004),"Zhang ZK, Huang YN, Guo BC, Deng ML, Yuan RZ, Wang QS. Surveillance of the antibiotic resistance and plasmid of Salmonella paratyphoid. [Chinese]. Chinese Journal of Antibiotics 2004; 29(10): 610-3.",Systematic review,CHN,China,Centre for Disease Control and Prevention Guilin,10,Guangxi Zhuangzu Zizhiqu,1999,1,292,0.3,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
2824,Shukun (2010),"Shukun W, Congjia C, Yunbo Y, Biao K, Baowei D. Nalidixic acid resistance and clonal expansion of Salmonella enterica serotype ParaTyphi A in Yuxi city, China. J Med Med Sci 2010; 17: 320-6.",Systematic review,CHN,China,Unknown hospitals in Yuxi,34,Yunnan Sheng,1999,0,8,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
570,Chen(2006),"Chen M, Wu J, Jiang J. Clinical and laboratory analysis of 79 cases of typhoid fever and paratyphoid fever. [Chinese]. Journal of Tropical Medicine 2006; 6(5): 570-2.",Systematic review,CHN,China,First Affiliated Hospital of Guangxi Medical University,10,Guangxi Zhuangzu Zizhiqu,2000,2,19,10.5,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
2824,Shukun (2010),"Shukun W, Congjia C, Yunbo Y, Biao K, Baowei D. Nalidixic acid resistance and clonal expansion of Salmonella enterica serotype ParaTyphi A in Yuxi city, China. J Med Med Sci 2010; 17: 320-6.",Systematic review,CHN,China,Unknown hospitals in Yuxi,34,Yunnan Sheng,2000,0,73,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
569,Wan(2008),"Wan L, Xiao K, Ye X. Clinical analysis of typhoid fever and paratyphoid fever. [Chinese]. China Tropical Medicine 2008; 8(2): 225-6.",Systematic review,CHN,China,The Second Affiliated Hospital of Guangzhou Medical College,9,Guangdong Sheng,2002,1,11,9.1,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
5118,Wang (2018),"Wang H, Yu H, Zheng W, et al. Genomic epidemiology of Salmonella Paratyphi A strains isolated in Hangzhou area. [Chinese].Chinese Journal of Microbiology and Immunology (China) 2018;38(2):116-123",Systematic review,CHN,China,Centre for Disease Control and Prevention Hangzhou,35,Zhejiang Sheng,2002,0,5,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
2824,Shukun (2010),"Shukun W, Congjia C, Yunbo Y, Biao K, Baowei D. Nalidixic acid resistance and clonal expansion of Salmonella enterica serotype ParaTyphi A in Yuxi city, China. J Med Med Sci 2010; 17: 320-6.",Systematic review,CHN,China,Unknown hospitals in Yuxi,34,Yunnan Sheng,2004,0,3878,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
47,Yu (2011),"Yu F, Fan S, Fan X, et al. Analysis of characteristics of paratyphoid A in 157 Chinese inpatients between 1998 and 2009. Eur J Clin Microbiol Infect Dis 2011; 30(1): 71-5.",Systematic review,CHN,China,First Afilliated Hospital of Wenzhou Medical College,35,Zhejiang Sheng,2004,1,157,0.6,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
1095,Wu (2010),"Wu W, Wang H, Lu J, et al. Genetic diversity of Salmonella enteric serovar Typhi and ParaTyphi in Shenzhen, China from 2002 through 2007. BMC Microbiol 2010; 10: 32.",Systematic review,CHN,China,Shenzhen People's Hospital,9,Guangdong Sheng,2005,0,64,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
244,Jiang(2015),"Jiang Y, Zuo H, Niu H, et al. Antimicrobial resistance surveillance of Salmonella isolates from the First People's Hospital of Yunnan Province, China. J Infect Dev Ctries 2015; 9(4): 333-7.",Systematic review,CHN,China,First People’s Hospital of Yunnan Province,34,Yunnan Sheng,2006,0,784,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
5118,Wang (2018),"Wang H, Yu H, Zheng W, et al. Genomic epidemiology of Salmonella Paratyphi A strains isolated in Hangzhou area. [Chinese].Chinese Journal of Microbiology and Immunology (China) 2018;38(2):116-123",Systematic review,CHN,China,Centre for Disease Control and Prevention Hangzhou,35,Zhejiang Sheng,2006,0,15,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
5118,Wang (2018),"Wang H, Yu H, Zheng W, et al. Genomic epidemiology of Salmonella Paratyphi A strains isolated in Hangzhou area. [Chinese].Chinese Journal of Microbiology and Immunology (China) 2018;38(2):116-123",Systematic review,CHN,China,Centre for Disease Control and Prevention Hangzhou,35,Zhejiang Sheng,2007,0,23,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
2824,Shukun (2010),"Shukun W, Congjia C, Yunbo Y, Biao K, Baowei D. Nalidixic acid resistance and clonal expansion of Salmonella enterica serotype ParaTyphi A in Yuxi city, China. J Med Med Sci 2010; 17: 320-6.",Systematic review,CHN,China,Unknown hospitals in Yuxi,34,Yunnan Sheng,2008,0,182,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
4658,Zhao (2016),"Zhao JY, Zhang SY, Mu YJ, et al. Drug tolerance and PFGE molecular typing of Salmonella ParaTyphi A isolated in Dengfeng, Henan province, 2009-2015 [Chinese]. Chung Hua Liu Hsing Ping Hsueh Tsa Chih 2016; 37(5): 714-7.",Systematic review,CHN,China,Unknown hospitals in Denfeng,15,Henan Sheng,2012,16,126,12.7,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
5053,Kong(2017),"Kong X, Dong C, Ji H, et al. Antimicrobial resistance and molecular subtypes of Salmonella Typhi and Salmonella paratyphoid isolates from Jiangsu province, 2012-2015. [Chinese]. Chinese Journal of Endemiology 2017; 38(11): 1546-50.",Systematic review,CHN,China,Center for Disease Control and Prevention Jiangsu,18,Jiangsu Sheng,2014,0,5,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
3151,Amdani (1998),"Amdani SK. Antibiotic resistance pattern of pediatric typhoid fever patients at Harapan Kita Children and Maternity Hospital Jakarta, 1996. Med J Indones 1998; 7: 253-6.",Systematic review,IDN,Indonesia,Harapan Kita Children's and Maternity Hospital,57,DKI JAKARTA,1996,0,19,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
3143,Parwati(1998),"Parwati I, Samaun E. Multidrug resistance Salmonella in dr. Hasan Sadikin general hospital, Bandung. Med J Indones 1998; 7: 194.",Systematic review,IDN,Indonesia,Dr. Hasan Sadikin General Hospital,61,JAWA BARAT,1996,0,58,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
1694,Gasem(2003),"Gasem MH, Keuter M, Dolmans WM, Van Der Ven-Jongekrijg J, Djokomoeljanto R, Van Der Meer JW. Persistence of Salmonellae in blood and bone marrow: randomized controlled trial comparing ciprofloxacin and chloramphenicol treatments against enteric fever. Antimicrob Agents Chemother 2003; 47(5): 1727-31.",Systematic review,IDN,Indonesia,Dr Kariadi Hospital,67,JAWA TENGAH,1997,0,5,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
1940,Vollaard (2004),"Vollaard AM, Ali S, van Asten HA, et al. Risk factors for typhoid and paratyphoid fever in Jakarta, Indonesia. JAMA 2004; 291(21): 2607-15.",Systematic review,IDN,Indonesia,Four unknown hospitals in Jatinegara and eight private outpatient clinics in the surrounding area,57,DKI JAKARTA,2002,0,26,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
883,Punjabi (2013),"Punjabi NH, Agtini MD, Ochiai RL, et al. Enteric fever burden in North Jakarta, Indonesia: a prospective, community-based study. J Infect Dev Ctries 2013; 7(11): 781-7.",Systematic review,IDN,Indonesia,Tanjung Priok & Koja,57,DKI JAKARTA,2002,0,41,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
2955,Kuijpers (2017),"Kuijpers LMF, Phe T, Veng CH, et al. The clinical and microbiological characteristics of enteric fever in Cambodia, 2008-2015. PLoS Negl Trop Dis 2017; 11(9): e0005964.",Systematic review,KHM,Cambodia,Sihanouk Hospital Center of Hope,92,Phnom Penh,2010,0,12,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
2955,Kuijpers (2017),"Kuijpers LMF, Phe T, Veng CH, et al. The clinical and microbiological characteristics of enteric fever in Cambodia, 2008-2015. PLoS Negl Trop Dis 2017; 11(9): e0005964.",Systematic review,KHM,Cambodia,Sihanouk Hospital Center of Hope,92,Phnom Penh,2014,0,171,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
5148,Roberts (2019),"Roberts T. LOMRU blood culture database. Vientiene, Laos; 2019",Dataset,LAO,Laos,Mahosot Hospital,117,Vientiane capital,2009,0,6,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
5148,Roberts (2019),"Roberts T. LOMRU blood culture database. Vientiene, Laos; 2019",Dataset,LAO,Laos,Mahosot Hospital,117,Vientiane capital,2014,1,6,16.7,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
3394,Komolpis (1999),"Komolpis P, Srifuengfung S, Dhiraputra C, Pingwang B. Salmonella bacteremia: serotype distribution and antimicrobial susceptibility during 1991-1995. Journal of Infectious Diseases and Antimicrobial Agents 1999; 16(2): 49-52.",Systematic review,THA,Thailand,Siriraj Hospital,236,Bangkok,1993,2,107,1.9,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
2385,Nguyen(1993),"Nguyen TA, Ha Ba K, Nguyen TD. Typhoid fever in South Vietnam, 1990-1993. [French]. Bulletin de la Societe de pathologie exotique (1990) 1993; 86(5 Pt 2): 476-8.",Systematic review,VNM,Vietnam,Centre for Tropical Diseases,328,Ho Chi Minh,1992,0,6,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
651,Smith(1994),"Smith MD, Duong NM, Hoa NTT, et al. Comparison of ofloxacin and ceftriaxone for short-course treatment of enteric fever. Antimicrob Agents Chemother 1994; 38(8): 1716-20.",Systematic review,VNM,Vietnam,Centre for Tropical Diseases,328,Ho Chi Minh,1993,0,6,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
2124,Hien (1995),"Hien TT, Bethell DB, Hoa NTT, et al. Short course of ofloxacin for treatment of multidrug-resistant typhoid. Clin Infect Dis 1995; 20(4): 917-23.",Systematic review,VNM,Vietnam,Dong Hoa & Dong Thanh,369,Kien Giang,1993,0,19,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
621,Hoa (1998),"Hoa NTT, Diep TS, Wain J, et al. Community-acquired septicaemia in southern Viet Nam: The importance of multidrug-resistant Salmonella Typhi. Trans R Soc Trop Med Hyg 1998; 92(5): 503-8.",Systematic review,VNM,Vietnam,Centre for Tropical Diseases,328,Ho Chi Minh,1994,0,15,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
5150,Sharkoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Balochistan,897,Balochistan,2019,0,7,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
5150,Sharkoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Gilgit–Baltistan,904,Administrative unit not available,2009,0,9,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
5150,Sharkoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Khyber Pakhtunkhwa,900,Nwfp,2015,0,5,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
5150,Sharkoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Punjab,901,Punjab,2007,1,15,6.7,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
5150,Sharkoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Punjab,901,Punjab,2008,2,10,20,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
5150,Sharkoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Punjab,901,Punjab,2009,0,12,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
5150,Sharkoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Punjab,901,Punjab,2010,0,8,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
5150,Sharkoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Punjab,901,Punjab,2011,0,12,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
5150,Sharkoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Punjab,901,Punjab,2012,0,16,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
5150,Sharkoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Punjab,901,Punjab,2013,0,10,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
5150,Sharkoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Punjab,901,Punjab,2014,0,11,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
5150,Sharkoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Punjab,901,Punjab,2015,1,8,12.5,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
5150,Sharkoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Punjab,901,Punjab,2019,0,98,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
5150,Sharkoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Sindh,902,Sind,2007,29,549,5.3,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
5150,Sharkoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Sindh,902,Sind,2008,28,535,5.2,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
5150,Sharkoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Sindh,902,Sind,2009,32,682,4.7,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
5150,Sharkoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Sindh,902,Sind,2010,4,416,1,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
5150,Sharkoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Sindh,902,Sind,2011,4,626,0.6,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
5150,Sharkoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Sindh,902,Sind,2012,4,286,1.4,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
5150,Sharkoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Sindh,902,Sind,2013,4,293,1.4,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
5150,Sharkoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Sindh,902,Sind,2014,5,258,1.9,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
5150,Sharkoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Sindh,902,Sind,2015,6,215,2.8,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
5150,Sharkoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Sindh,902,Sind,2019,0,351,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
5151,SEAP (2021),Sabine Vaccine Institute. Surveillance for Enteric Fever in Asia Project (SEAP) dataset. 2021,Dataset,BGD,Bangladesh,Dhaka,823,Dhaka,2017,0,41,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
5151,SEAP (2021),Sabine Vaccine Institute. Surveillance for Enteric Fever in Asia Project (SEAP) dataset. 2021,Dataset,BGD,Bangladesh,Dhaka,823,Dhaka,2018,0,32,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
5151,SEAP (2021),Sabine Vaccine Institute. Surveillance for Enteric Fever in Asia Project (SEAP) dataset. 2021,Dataset,BGD,Bangladesh,Dhaka,823,Dhaka,2019,0,16,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
5151,SEAP (2021),Sabine Vaccine Institute. Surveillance for Enteric Fever in Asia Project (SEAP) dataset. 2021,Dataset,BGD,Bangladesh,Dhaka,823,Dhaka,2016,0,6,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
5151,SEAP (2021),Sabine Vaccine Institute. Surveillance for Enteric Fever in Asia Project (SEAP) dataset. 2021,Dataset,NPL,Nepal,Kathmandu,892,Central,2017,0,5,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
5151,SEAP (2021),Sabine Vaccine Institute. Surveillance for Enteric Fever in Asia Project (SEAP) dataset. 2021,Dataset,NPL,Nepal,Kathmandu,892,Central,2019,0,10,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
5151,SEAP (2021),Sabine Vaccine Institute. Surveillance for Enteric Fever in Asia Project (SEAP) dataset. 2021,Dataset,NPL,Nepal,Kathmandu,892,Central,2018,0,6,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
5151,SEAP (2021),Sabine Vaccine Institute. Surveillance for Enteric Fever in Asia Project (SEAP) dataset. 2021,Dataset,PAK,Pakistan,Karachi,902,Sind,2017,0,20,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
5151,SEAP (2021),Sabine Vaccine Institute. Surveillance for Enteric Fever in Asia Project (SEAP) dataset. 2021,Dataset,PAK,Pakistan,Karachi,902,Sind,2018,1,7,14.3,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
5151,SEAP (2021),Sabine Vaccine Institute. Surveillance for Enteric Fever in Asia Project (SEAP) dataset. 2021,Dataset,PAK,Pakistan,Karachi,902,Sind,2019,0,7,0,0,Salmonella Paratyphi A,Multidrug resistance (MDR)
148,Bouzenoune (2011),"Bouzenoune F, Debbih KK, Boudersa F, Kouhil S, Nezzar N. Antibiotic susceptibility of Salmonella enterica serovar Typhi isolated from blood cultures at the Ain M'lila hospital (Algeria), between 2005 and 2008. [French]. Med Mal Infect 2011; 41(4): 181-5.",Systematic review,DZA,Algeria,Fourchi,492,Oum El Bouaghi,2005,0,90,0,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
148,Bouzenoune (2011),"Bouzenoune F, Debbih KK, Boudersa F, Kouhil S, Nezzar N. Antibiotic susceptibility of Salmonella enterica serovar Typhi isolated from blood cultures at the Ain M'lila hospital (Algeria), between 2005 and 2008. [French]. Med Mal Infect 2011; 41(4): 181-5.",Systematic review,DZA,Algeria,Fourchi,492,Oum El Bouaghi,2006,0,60,0,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
148,Bouzenoune (2011),"Bouzenoune F, Debbih KK, Boudersa F, Kouhil S, Nezzar N. Antibiotic susceptibility of Salmonella enterica serovar Typhi isolated from blood cultures at the Ain M'lila hospital (Algeria), between 2005 and 2008. [French]. Med Mal Infect 2011; 41(4): 181-5.",Systematic review,DZA,Algeria,Ain Kercha,492,Oum El Bouaghi,2007,0,14,0,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
148,Bouzenoune (2011),"Bouzenoune F, Debbih KK, Boudersa F, Kouhil S, Nezzar N. Antibiotic susceptibility of Salmonella enterica serovar Typhi isolated from blood cultures at the Ain M'lila hospital (Algeria), between 2005 and 2008. [French]. Med Mal Infect 2011; 41(4): 181-5.",Systematic review,DZA,Algeria,Ain Kercha,492,Oum El Bouaghi,2008,0,14,0,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
1774,Wasfy(1996),"Wasfy MO, Moustafa DA, El-Gendy AM, et al. Prevalence of antibiotic resistance among Egyptian Salmonella Typhi strains. J Egypt Public Health Assoc 1996; 71(1-2): 149-60.",Systematic review,EGY,Egypt,Abbassia Fever Hospital,516,Al Qahirah (cairo),1990,0,41,0,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
1774,Wasfy(1996),"Wasfy MO, Moustafa DA, El-Gendy AM, et al. Prevalence of antibiotic resistance among Egyptian Salmonella Typhi strains. J Egypt Public Health Assoc 1996; 71(1-2): 149-60.",Systematic review,EGY,Egypt,Abbassia Fever Hospital,516,Al Qahirah (cairo),1991,0,126,0,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
1774,Wasfy(1996),"Wasfy MO, Moustafa DA, El-Gendy AM, et al. Prevalence of antibiotic resistance among Egyptian Salmonella Typhi strains. J Egypt Public Health Assoc 1996; 71(1-2): 149-60.",Systematic review,EGY,Egypt,Abbassia Fever Hospital,516,Al Qahirah (cairo),1992,0,151,0,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
1774,Wasfy(1996),"Wasfy MO, Moustafa DA, El-Gendy AM, et al. Prevalence of antibiotic resistance among Egyptian Salmonella Typhi strains. J Egypt Public Health Assoc 1996; 71(1-2): 149-60.",Systematic review,EGY,Egypt,Abbassia Fever Hospital,516,Al Qahirah (cairo),1993,0,104,0,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
1774,Wasfy(1996),"Wasfy MO, Moustafa DA, El-Gendy AM, et al. Prevalence of antibiotic resistance among Egyptian Salmonella Typhi strains. J Egypt Public Health Assoc 1996; 71(1-2): 149-60.",Systematic review,EGY,Egypt,Abbassia Fever Hospital,516,Al Qahirah (cairo),1994,0,115,0,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
1466,Rahman (2014),"Rahman BA, Wasfy MO, Maksoud MA, Hanna N, Dueger E, House B. Multi-drug resistance and reduced susceptibility to ciprofloxacin among Salmonella enterica serovar Typhi isolates from the Middle East and Central Asia. New microbes new infect 2014; 2(4): 88-92.",Systematic review,EGY,Egypt,Fayoum Fever/Infectious Diseases Hospital,510,Al Fayyum (fayoum),2005,118,270,43.7,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
1466,Rahman (2014),"Rahman BA, Wasfy MO, Maksoud MA, Hanna N, Dueger E, House B. Multi-drug resistance and reduced susceptibility to ciprofloxacin among Salmonella enterica serovar Typhi isolates from the Middle East and Central Asia. New microbes new infect 2014; 2(4): 88-92.",Systematic review,EGY,Egypt,Gharbiya Fever/Infectious Diseases Hospital,511,Al Gharbiyah (gharbia),2005,19,40,47.5,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
1466,Rahman (2014),"Rahman BA, Wasfy MO, Maksoud MA, Hanna N, Dueger E, House B. Multi-drug resistance and reduced susceptibility to ciprofloxacin among Salmonella enterica serovar Typhi isolates from the Middle East and Central Asia. New microbes new infect 2014; 2(4): 88-92.",Systematic review,EGY,Egypt,Alexandria Fever Hospital,512,Al Iskandariyah (alex.),2005,14,46,30.4,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
1466,Rahman (2014),"Rahman BA, Wasfy MO, Maksoud MA, Hanna N, Dueger E, House B. Multi-drug resistance and reduced susceptibility to ciprofloxacin among Salmonella enterica serovar Typhi isolates from the Middle East and Central Asia. New microbes new infect 2014; 2(4): 88-92.",Systematic review,EGY,Egypt,Menofiya Fever/Infectious Diseases Hospital,514,Al Minufiyah (menoufia),2005,2,12,16.7,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
1466,Rahman (2014),"Rahman BA, Wasfy MO, Maksoud MA, Hanna N, Dueger E, House B. Multi-drug resistance and reduced susceptibility to ciprofloxacin among Salmonella enterica serovar Typhi isolates from the Middle East and Central Asia. New microbes new infect 2014; 2(4): 88-92.",Systematic review,EGY,Egypt,Abbassia Fever Hospital,516,Al Qahirah (cairo),2005,49,166,29.5,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
1466,Rahman (2014),"Rahman BA, Wasfy MO, Maksoud MA, Hanna N, Dueger E, House B. Multi-drug resistance and reduced susceptibility to ciprofloxacin among Salmonella enterica serovar Typhi isolates from the Middle East and Central Asia. New microbes new infect 2014; 2(4): 88-92.",Systematic review,EGY,Egypt,Aswan Fever/Infectious Diseases Hospital,522,Aswan,2005,19,66,28.8,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
1466,Rahman (2014),"Rahman BA, Wasfy MO, Maksoud MA, Hanna N, Dueger E, House B. Multi-drug resistance and reduced susceptibility to ciprofloxacin among Salmonella enterica serovar Typhi isolates from the Middle East and Central Asia. New microbes new infect 2014; 2(4): 88-92.",Systematic review,EGY,Egypt,Asuit Fever/Infectious Diseases Hospital,523,Asyiut,2005,3,26,11.5,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
602,Pourshafie(2008),"Pourshafie MR, Saifi M, Mousavi SF, Sedaghat M, Nikbakht GH, Rubino S. Clonal diversity of Salmonella enterica serotype Typhi isolated from patients with typhoid fever in Tehran. Scandinavian Journal of Infectious Diseases 2008; 40(1): 18-23.",Systematic review,IRN,Iran,Three unknown hospitals in Tehran,553,Tehran,2004,0,15,0,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
4087,Tajbakhsh(2012),"Tajbakhsh M, Hendriksen RS, Nochi Z, Zali MR, Aarestrup FM, Garcia-Migura L. Antimicrobial resistance in Salmonella spp. recovered from patients admitted to six different hospitals in Tehran, Iran from 2007 to 2008. Folia Microbiol (Praha) 2012; 57(2): 91-7.",Systematic review,IRN,Iran,Six major hospitals in Tehran,553,Tehran,2008,1,17,5.9,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
1684,Soltan Dallal(2014),"Soltan Dallal MM, Rastegar Lari A, Sharifi Yazdi MK. Pattern of serotyping and antibiotic resistance of Salmonella in children with diarrhea. [Persian]. Journal of Gorgan University of Medical Sciences 2014; 16(1): e100-Pe4.",Systematic review,IRN,Iran,Unknown public health centers in Robat-Karim,553,Tehran,2010,1,7,14.3,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
3022,Aljanaby (2017),"Aljanaby AAJ, Medhat AR. Prevalence of some antimicrobials resistance associated-genes in Salmonella Typhi isolated from patients infected with typhoid fever. J Bio Sci 2017; 17(4): 171-84.",Systematic review,IRQ,Iraq,Al-Najaf Hospital,565,Najaf,2017,20,39,51.3,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5066,Al-Abbasy (2018),Al-Abbasy AJ. Molecular study of antibiotic resistance gene in Salmonella enterica serovar Typhi isolates.International Journal of Pharmaceutical Research 2018;10(3):378-384,Systematic review,IRQ,Iraq,Al-Hakim Hospital,565,Najaf,2018,1,30,3.3,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
737,Dimitrov (2010),"Dimitrov T, Dashti AA, Albaksami O, Jadaon MM. Detection of mutations in the gyrA gene in fluoroquinolone resistance Salmonella enterica serotypes Typhi and ParaTyphi A isolated from the Infectious Diseases Hospital, Kuwait. J Clin Pathol 2010; 63(1): 83-7.",Systematic review,KWT,Kuwait,Infectious Diseases Hospital (Al Farwaniyah),592,Al Farwaniyah,2002,16,23,69.6,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
737,Dimitrov (2010),"Dimitrov T, Dashti AA, Albaksami O, Jadaon MM. Detection of mutations in the gyrA gene in fluoroquinolone resistance Salmonella enterica serotypes Typhi and ParaTyphi A isolated from the Infectious Diseases Hospital, Kuwait. J Clin Pathol 2010; 63(1): 83-7.",Systematic review,KWT,Kuwait,Infectious Diseases Hospital (Al Farwaniyah),592,Al Farwaniyah,2003,14,22,63.6,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
737,Dimitrov (2010),"Dimitrov T, Dashti AA, Albaksami O, Jadaon MM. Detection of mutations in the gyrA gene in fluoroquinolone resistance Salmonella enterica serotypes Typhi and ParaTyphi A isolated from the Infectious Diseases Hospital, Kuwait. J Clin Pathol 2010; 63(1): 83-7.",Systematic review,KWT,Kuwait,Infectious Diseases Hospital (Al Farwaniyah),592,Al Farwaniyah,2004,28,30,93.3,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
855,Rotimi(2008),"Rotimi VO, Jamal W, Pal T, Sonnevend A, Dimitrov TS, Albert MJ. Emergence of multidrug-resistant Salmonella spp. and isolates with reduced susceptibility to ciprofloxacin in Kuwait and the United Arab Emirates. Diagn Microbiol Infect Dis 2008; 60(1): 71-7.",Systematic review,KWT,Kuwait,Mubarak Al-Kabeer Hospital,596,Hawalli,2004,11,25,44,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
737,Dimitrov (2010),"Dimitrov T, Dashti AA, Albaksami O, Jadaon MM. Detection of mutations in the gyrA gene in fluoroquinolone resistance Salmonella enterica serotypes Typhi and ParaTyphi A isolated from the Infectious Diseases Hospital, Kuwait. J Clin Pathol 2010; 63(1): 83-7.",Systematic review,KWT,Kuwait,Infectious Diseases Hospital (Al Farwaniyah),592,Al Farwaniyah,2005,19,26,73.1,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
737,Dimitrov (2010),"Dimitrov T, Dashti AA, Albaksami O, Jadaon MM. Detection of mutations in the gyrA gene in fluoroquinolone resistance Salmonella enterica serotypes Typhi and ParaTyphi A isolated from the Infectious Diseases Hospital, Kuwait. J Clin Pathol 2010; 63(1): 83-7.",Systematic review,KWT,Kuwait,Infectious Diseases Hospital (Al Farwaniyah),592,Al Farwaniyah,2006,28,35,80,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
2376,Panhotra (2004),"Panhotra BR, Saxena AK, Al-Ghamdi AM. Typhoid fever due to multiresistant Salmonella enterica serovar Typhi having reduced susceptibility to ciprofloxacin and nalidixic acid resistance. Saudi Med J 2004; 25(10): 1509-11.",Systematic review,SAU,Saudi Arabia,King Fahd Hospital (Al-Hofif),655,Eastern Province,2003,12,12,100,1,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
2822,Somily(2012),"Somily AM, Sayyed SB, Habib HA, et al. Salmonella isolates serotypes and susceptibility to commonly used drugs at a tertiary care hospital in Riyadh, Saudi Arabia. J Infect Dev Ctries 2012; 6(6): 478-82.",Systematic review,SAU,Saudi Arabia,King Khalid University Hospital,664,Riyad,2008,3,5,60,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
929,Bayram(2011),"Bayram Y, Guducuoglu H, Otlu B, et al. Epidemiological characteristics and molecular typing of Salmonella enterica serovar Typhi during a waterborne outbreak in Eastern Anatolia. Ann Trop Med Parasitol 2011; 105(5): 359-65.",Systematic review,TUR,Turkey,Ercek town,798,Van,2008,91,91,100,1,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
2980,Gundogdu(2017),"Gundogdu A, Kilic H, Ulu-Kilic A, Parkan OM, Ture Z. Distribution and Antimicrobial Resistance of Salmonella Serovars Isolated in Kayseri Region. Klimik Journal 2017; 30(1): 22-6.",Systematic review,TUR,Turkey,Erciyes University Hospital,768,Kayseri,2015,3,25,12,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
2030,Taha(2013),"Taha RR, Alghalibi SM, Saeed Saleh MG. Salmonella spp. in patients suffering from enteric fever and food poisoning in Thamar city, Yemen. East Mediterr Health J 2013; 19(1): 88-93.",Systematic review,YEM,Yemen,Dar Alshafaa Hospital;Dhamar General Hospital,811,Dhamar,2008,15,41,36.6,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
137,Saha (1994),Saha SK. Antibiotic resistance of Salmonella Typhi in Bangladesh. J Antimicrob Chemother 1994; 33(1): 190-1.,Systematic review,BGD,Bangladesh,Dhaka Shishu Hospital,823,Dhaka,1991,0,236,0,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
1878,Islam (1993),"Islam MN, Afroza A, Hasan Z, Majumder B, Hossain A. Recent antibiogram pattern and clinical profile of typhoid fever in children - A study of 36 cases. Bangladesh J Child Health 1993; 17(3): 93-6.",Systematic review,BGD,Bangladesh,Institute of Postgraduate Medicine and Research,823,Dhaka,1993,0,29,0,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
849,Rahman (2006),"Rahman M, Siddique AK, Shoma S, et al. Emergence of multidrug-resistant Salmonella enterica serotype Typhi with decreased ciprofloxacin susceptibility in Bangladesh. Epidemiol Infect 2006; 134(2): 433-8.",Systematic review,BGD,Bangladesh,ICDDR,823,Dhaka,1996,25,132,18.9,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
1427,Mamun (2004),"Mamun KZ, Tabassum S, Ashna SM, Hart CA. Molecular analysis of multi-drug resistant Salmonella Typhi from urban paediatric population of Bangladesh. Bangladesh Med Res Counc Bull 2004; 30(3): 81-6.",Systematic review,BGD,Bangladesh,Unknown clinics in Narayanganj district,823,Dhaka,2000,0,30,0,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
1768,Mahmud (2014),"Mahmud ASM, Hakim MA. Prevalence and antimicrobial resistance of Salmonella strains isolated from blood cultures in Dhaka Division, Bangladesh. J Pure Appl Microbiol 2014; 8(3): 2315-23.",Systematic review,BGD,Bangladesh,Dhaka Shishu Hospital;Popular Diagnostic Center,823,Dhaka,2003,358,411,87.1,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
405,Aliya (2010),"Aliya N, Ram PK, Brooks WA, et al. Burden of typhoid and paratyphoid fever in a densely populated urban community, Dhaka, Bangladesh. Int J Infect Dis 2010; 14(Suppl. 3): e93-e9.",Systematic review,BGD,Bangladesh,Kamalapur,823,Dhaka,2004,8,40,20,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
1502,Kato(2007),"Kato Y, Fukayama M, Adachi T, et al. Multidrug-resistant typhoid fever outbreak in travelers returning from Bangladesh. Emerg Infect Dis 2007; 13(12): 1954-5.",Systematic review,BGD,Bangladesh,Dhaka,823,Dhaka,2004,6,6,100,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
1493,Dilruba (2006),"Dilruba A, D'Costa LT, Khorshed A, Nair GB, Hossain MA. Multidrug-resistant Salmonella enterica serovar Typhi isolates with high-level resistance to ciprofloxacin in Dhaka, Bangladesh. Antimicrob Agents Chemother 2006; 50(10): 3516-7.",Systematic review,BGD,Bangladesh,ICDDR,823,Dhaka,2005,388,428,90.7,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
1995,Rahman (2005),"Rahman MM, Haq JA, Morshed MA, Rahman MA. Salmonella enterica serovar Typhi with decreased susceptibility to ciprofloxacin--an emerging problem in Bangladesh. Int J Antimicrob Agents 2005; 25(4): 345-6.",Systematic review,BGD,Bangladesh,"Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders (BIRDEM)",823,Dhaka,2005,33,44,75,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
1998,Alaullah (2009),"Alaullah S, Bhuiyan MS, Farhana K, et al. Salmonella enterica serovar Typhi-specific immunoglobulin A antibody responses in plasma and antibody in lymphocyte supernatant specimens in Bangladeshi patients with suspected typhoid fever. Clin Vaccine Immunol 2009; 16(11): 1587-94.",Systematic review,BGD,Bangladesh,Dhaka Hospital (ICCDR);Dhaka Medical College Hospital;ICDDR,823,Dhaka,2005,24,26,92.3,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
3026,Ahmed (2017),"Ahmed D, Nahid MA, Sami AB, et al. Bacterial etiology of bloodstream infections and antimicrobial resistance in Dhaka, Bangladesh, 2005-2014. Antimicrob Resist Infect Control 2017; 6.",Systematic review,BGD,Bangladesh,Dhaka Hospital (ICCDR);ICDDR,823,Dhaka,2005,411,457,89.9,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
1088,Das(2014),"Das SK, Chisti MJ, Afrad MH, et al. Gastroenteritis due to typhoidal Salmonella: a decade of observation at an urban and a rural diarrheal disease hospital in Bangladesh. BMC Infect Dis 2014; 14: 435.",Systematic review,BGD,Bangladesh,Unknown urban Dhaka hospital,823,Dhaka,2006,40,44,90.9,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
3026,Ahmed (2017),"Ahmed D, Nahid MA, Sami AB, et al. Bacterial etiology of bloodstream infections and antimicrobial resistance in Dhaka, Bangladesh, 2005-2014. Antimicrob Resist Infect Control 2017; 6.",Systematic review,BGD,Bangladesh,Dhaka Hospital (ICCDR);ICDDR,823,Dhaka,2006,553,595,92.9,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
3026,Ahmed (2017),"Ahmed D, Nahid MA, Sami AB, et al. Bacterial etiology of bloodstream infections and antimicrobial resistance in Dhaka, Bangladesh, 2005-2014. Antimicrob Resist Infect Control 2017; 6.",Systematic review,BGD,Bangladesh,Dhaka Hospital (ICCDR);ICDDR,823,Dhaka,2007,514,571,90,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
4229,Chiou(2014),"Chiou CS, Lauderdale TL, Phung DC, et al. Antimicrobial resistance in Salmonella enterica serovar Typhi isolates from Bangladesh, Indonesia, Taiwan, and Vietnam. Antimicrob Agents Chemother 2014; 58(11): 6501-7.",Systematic review,BGD,Bangladesh,Dhaka Hospital (ICCDR),823,Dhaka,2007,0,38,0,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
3026,Ahmed (2017),"Ahmed D, Nahid MA, Sami AB, et al. Bacterial etiology of bloodstream infections and antimicrobial resistance in Dhaka, Bangladesh, 2005-2014. Antimicrob Resist Infect Control 2017; 6.",Systematic review,BGD,Bangladesh,Dhaka Hospital (ICCDR);ICDDR,823,Dhaka,2008,564,600,94,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
2847,"ICDDR,B(2009)<U+1D48>",International Centre for Diarrhoeal Disease Research Bangladesh. Surveillance updates. Health and Science Bulletin 2009; 7(4).,Surveillance report,BGD,Bangladesh,Kamalapur,823,Dhaka,2009,48,49,98,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
2848,"ICDDR,B(2009)<U+1D9C>",International Centre for Diarrhoeal Disease Research Bangladesh. Surveillance updates. Health and Science Bulletin 2009; 7(3).,Surveillance report,BGD,Bangladesh,Kamalapur,823,Dhaka,2009,25,26,96.2,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
2849,"ICDDR,B(2009)<U+1D47>",International Centre for Diarrhoeal Disease Research Bangladesh. Surveillance updates. Health and Science Bulletin 2009; 7(2).,Surveillance report,BGD,Bangladesh,Kamalapur,823,Dhaka,2009,41,46,89.1,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
3026,Ahmed (2017),"Ahmed D, Nahid MA, Sami AB, et al. Bacterial etiology of bloodstream infections and antimicrobial resistance in Dhaka, Bangladesh, 2005-2014. Antimicrob Resist Infect Control 2017; 6.",Systematic review,BGD,Bangladesh,Dhaka Hospital (ICCDR);ICDDR,823,Dhaka,2009,454,483,94,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
2843,"ICDDR,B(2010)<U+1D9C>",International Centre for Diarrhoeal Disease Research Bangladesh. Surveillance updates. Health and Science Bulletin 2010; 8(4).,Surveillance report,BGD,Bangladesh,Kamalapur,823,Dhaka,2010,22,23,95.7,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
2844,"ICDDR,B(2010)<U+1D47>",International Centre for Diarrhoeal Disease Research Bangladesh. Surveillance updates. Health and Science Bulletin 2010; 8(3).,Surveillance report,BGD,Bangladesh,Kamalapur,823,Dhaka,2010,17,17,100,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
2845,"ICDDR,B(2010)<U+1D43>",International Centre for Diarrhoeal Disease Research Bangladesh. Surveillance updates. Health and Science Bulletin 2010; 8(2).,Surveillance report,BGD,Bangladesh,Kamalapur,823,Dhaka,2010,29,29,100,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
3026,Ahmed (2017),"Ahmed D, Nahid MA, Sami AB, et al. Bacterial etiology of bloodstream infections and antimicrobial resistance in Dhaka, Bangladesh, 2005-2014. Antimicrob Resist Infect Control 2017; 6.",Systematic review,BGD,Bangladesh,Dhaka Hospital (ICCDR);ICDDR,823,Dhaka,2010,617,643,96,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
1680,Afroze (2014),"Afroze SR, Rahim MA, Hasan MM, et al. Pattern of antibiotic sensitivity in enteric fever: A tertiary care hospital experience. Journal of Medicine (Bangladesh) 2014; 15(2): 122-4.",Systematic review,BGD,Bangladesh,"Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders (BIRDEM)",823,Dhaka,2011,30,64,46.9,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
2195,"ICDDR,B(2011)<U+1D9C>",International Centre for Diarrhoeal Disease Research Bangladesh. Surveillance updates. Health and Science Bulletin 2011; 9(3): 22-5.,Surveillance report,BGD,Bangladesh,Kamalapur,823,Dhaka,2011,22,23,95.7,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
2392,Farhana (2015),"Farhana K, Sayeed MA, Feroza Kaneez C, et al. Typhoid fever in young children in Bangladesh: clinical findings, antibiotic susceptibility pattern and immune responses. PLoS Negl Trop Dis 2015; 9(4).",Systematic review,BGD,Bangladesh,Dhaka Hospital (ICCDR);ICDDR,823,Dhaka,2011,70,72,97.2,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
2839,"ICDDR,B(2011)<U+1D48>",International Centre for Diarrhoeal Disease Research Bangladesh. Surveillance updates. Health and Science Bulletin 2011; 9(4).,Surveillance report,BGD,Bangladesh,Kamalapur,823,Dhaka,2011,22,22,100,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
2841,"ICDDR,B(2011)<U+1D43>",International Centre for Diarrhoeal Disease Research Bangladesh. Surveillance updates. Health and Science Bulletin 2011; 2(1).,Surveillance report,BGD,Bangladesh,Kamalapur,823,Dhaka,2011,42,44,95.5,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
2842,"ICDDR,B(2011)<U+1D47>",International Centre for Diarrhoeal Disease Research Bangladesh. Surveillance updates. Health and Science Bulletin 2011; 9(1).,Surveillance report,BGD,Bangladesh,Kamalapur,823,Dhaka,2011,7,8,87.5,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
3026,Ahmed (2017),"Ahmed D, Nahid MA, Sami AB, et al. Bacterial etiology of bloodstream infections and antimicrobial resistance in Dhaka, Bangladesh, 2005-2014. Antimicrob Resist Infect Control 2017; 6.",Systematic review,BGD,Bangladesh,Dhaka Hospital (ICCDR);ICDDR,823,Dhaka,2011,424,451,94,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
2835,"ICDDR,B(2012)<U+1D48>",International Centre for Diarrhoeal Disease Research Bangladesh. Surveillance updates. Health and Science Bulletin 2012; 10(4).,Surveillance report,BGD,Bangladesh,Kamalapur,823,Dhaka,2012,31,31,100,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
2836,"ICDDR,B(2012)<U+1D9C>",International Centre for Diarrhoeal Disease Research Bangladesh. Surveillance updates. Health and Science Bulletin 2012; 10(3).,Surveillance report,BGD,Bangladesh,Kamalapur,823,Dhaka,2012,49,52,94.2,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
2837,"ICDDR,B(2012)<U+1D47>",International Centre for Diarrhoeal Disease Research Bangladesh. Surveillance updates. Health and Science Bulletin 2012; 10(2).,Surveillance report,BGD,Bangladesh,Kamalapur,823,Dhaka,2012,33,33,100,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
2838,"ICDDR,B(2012)<U+1D43>",International Centre for Diarrhoeal Disease Research Bangladesh. Surveillance updates. Health and Science Bulletin 2012; 10(1).,Surveillance report,BGD,Bangladesh,Kamalapur,823,Dhaka,2012,15,15,100,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
3026,Ahmed (2017),"Ahmed D, Nahid MA, Sami AB, et al. Bacterial etiology of bloodstream infections and antimicrobial resistance in Dhaka, Bangladesh, 2005-2014. Antimicrob Resist Infect Control 2017; 6.",Systematic review,BGD,Bangladesh,Dhaka Hospital (ICCDR);ICDDR,823,Dhaka,2012,511,527,97,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
2831,"ICDDR,B(2013)<U+1D48>",International Centre for Diarrhoeal Disease Research Bangladesh. Surveillance updates. Health and Science Bulletin 2013; 11(4).,Surveillance report,BGD,Bangladesh,Kamalapur,823,Dhaka,2013,18,18,100,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
2832,"ICDDR,B(2013)<U+1D9C>",International Centre for Diarrhoeal Disease Research Bangladesh. Surveillance updates. Health and Science Bulletin 2013; 11(3).,Surveillance report,BGD,Bangladesh,Kamalapur,823,Dhaka,2013,39,41,95.1,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
2833,"ICDDR,B(2013)<U+1D47>",International Centre for Diarrhoeal Disease Research Bangladesh. Surveillance updates. Health and Science Bulletin 2013; 11(2).,Surveillance report,BGD,Bangladesh,Kamalapur,823,Dhaka,2013,20,22,90.9,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
2834,"ICDDR,B(2013)<U+1D43>",International Centre for Diarrhoeal Disease Research Bangladesh. Surveillance updates. Health and Science Bulletin 2013; 11(1).,Surveillance report,BGD,Bangladesh,Kamalapur,823,Dhaka,2013,17,17,100,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
3026,Ahmed (2017),"Ahmed D, Nahid MA, Sami AB, et al. Bacterial etiology of bloodstream infections and antimicrobial resistance in Dhaka, Bangladesh, 2005-2014. Antimicrob Resist Infect Control 2017; 6.",Systematic review,BGD,Bangladesh,Dhaka Hospital (ICCDR);ICDDR,823,Dhaka,2013,329,354,92.9,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
2825,"ICDDR,B(2014)<U+1D47>",International Centre for Diarrhoeal Disease Research Bangladesh. Surveillance updates. Health and Science Bulletin 2014; 12(2).,Surveillance report,BGD,Bangladesh,Kamalapur,823,Dhaka,2014,39,43,90.7,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
2826,"ICDDR,B(2014)<U+1D43>",International Centre for Diarrhoeal Disease Research Bangladesh. Surveillance updates. Health and Science Bulletin 2014; 12(1).,Surveillance report,BGD,Bangladesh,Kamalapur,823,Dhaka,2014,14,15,93.3,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
2829,"ICDDR,B(2014)<U+1D48>",International Centre for Diarrhoeal Disease Research Bangladesh. Surveillance updates. Health and Science Bulletin 2014; 12(4).,Surveillance report,BGD,Bangladesh,Kamalapur,823,Dhaka,2014,27,30,90,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
2830,"ICDDR,B(2014)<U+1D9C>",International Centre for Diarrhoeal Disease Research Bangladesh. Surveillance updates. Health and Science Bulletin 2014; 12(3).,Surveillance report,BGD,Bangladesh,Kamalapur,823,Dhaka,2014,28,30,93.3,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
3026,Ahmed (2017),"Ahmed D, Nahid MA, Sami AB, et al. Bacterial etiology of bloodstream infections and antimicrobial resistance in Dhaka, Bangladesh, 2005-2014. Antimicrob Resist Infect Control 2017; 6.",Systematic review,BGD,Bangladesh,Dhaka Hospital (ICCDR);ICDDR,823,Dhaka,2014,499,509,98,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
4490,Ali (2016),"Ali MK, Sultana S. Antimicrobial sensitivity patterns of Salmonella Typhi in children. Bangladesh J Med Sci 2016; 15(3): 416-8.",Systematic review,BGD,Bangladesh,Ibn Sina Medical College and Hospital,823,Dhaka,2014,172,181,95,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5102,Okanda (2018),"Okanda T, Haque A, Ehara T, et al. Characteristics of resistance mechanisms and molecular epidemiology of fluoroquinolone-nonsusceptible Salmonella enterica serovar Typhi and Paratyphi a isolates from a tertiary hospital in Dhaka, Bangladesh.Microbial Drug Resistance 2018;24(10):1460-1465",Systematic review,BGD,Bangladesh,Bangabandhu Sheikh Mujib Medical University Hospital,823,Dhaka,2015,18,18,100,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
2827,"ICDDR,B(2016)",International Centre for Diarrhoeal Disease Research Bangladesh. Surveillance updates. Health and Science Bulletin 2016; 14(1).,Surveillance report,BGD,Bangladesh,Kamalapur,823,Dhaka,2016,5,6,83.3,1,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5151,SEAP (2021),Sabine Vaccine Institute. Surveillance for Enteric Fever in Asia Project (SEAP) dataset. 2021,Dataset,BGD,Bangladesh,Dhaka,823,Dhaka,2016,27,27,100,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5151,SEAP (2021),Sabine Vaccine Institute. Surveillance for Enteric Fever in Asia Project (SEAP) dataset. 2021,Dataset,BGD,Bangladesh,Dhaka,823,Dhaka,2017,302,310,97.4,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5151,SEAP (2021),Sabine Vaccine Institute. Surveillance for Enteric Fever in Asia Project (SEAP) dataset. 2021,Dataset,BGD,Bangladesh,Dhaka,823,Dhaka,2018,338,339,99.7,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5151,SEAP (2021),Sabine Vaccine Institute. Surveillance for Enteric Fever in Asia Project (SEAP) dataset. 2021,Dataset,BGD,Bangladesh,Dhaka,823,Dhaka,2019,267,267,100,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5151,SEAP (2021),Sabine Vaccine Institute. Surveillance for Enteric Fever in Asia Project (SEAP) dataset. 2021,Dataset,BGD,Bangladesh,Dhaka,823,Dhaka,2020,48,48,100,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
539,Sen (1991),"Sen S, Goyal RS, Dev R. Ciprofloxacin in the management of multiple drug resistant typhoid fever. Indian Pediatr 1991; 28(4): 417-9.",Systematic review,IND,India,Charak Palika Hospital (Moti Bagh),850,Delhi,1990,6,12,50,1,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
1761,Chopra(1992),"Chopra GS, Basu SK, Bhattacharya SR. Present phage types and antibiotic susceptibility of Salmonellae. Indian J Pathol Microbiol 1992; 35(4): 345-50.",Systematic review,IND,India,Command Pathology Laboratory,850,Delhi,1990,9,143,6.3,1,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
2049,Rodrigues(2002),"Rodrigues C, Mehta A, Joshi VR. Salmonella Typhiin the past decade: learning to live with resistance. Clin Infect Dis 2002; 34(1): 126.",Systematic review,IND,India,P.D. Hinduja National Hospital and Medical Research Center,858,Maharashtra,1990,0,101,0,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
1944,Karmaker(1991),"Karmaker S, Biswas D, Shaikh NM, Chatterjee SK, Kataria VK, Kumar R. Role of a large plasmid of Salmonella Typhi encoding multiple drug resistance. J Med Microbiol 1991; 34(3): 149-51.",Systematic review,IND,India,Command Hospital (Kolkata),869,West Bengal,1990,0,20,0,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
2470,Threlfall (1992),"Threlfall EJ, Ward LR, Rowe B, et al. Widespread occurrence of multiple drug-resistant Salmonella Typhi in India. Eur J Clin Microbiol Infect Dis 1992; 11(11): 990-3.",Systematic review,IND,India,St. Joseph Hospital (Kattu Hospital),867,Tamil Nadu,1991,0,16,0,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
2789,Jesudason(1996),"Jesudason M, Malathy B, John T. Trend of increasing levels of minimum inhibitory concentration of ciprofloxacin to Salmonella Typhi. The Indian journal of medical research 1996; 103: 247-9.",Systematic review,IND,India,Christian Medical College (Vellore),867,Tamil Nadu,1991,0,36,0,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
1485,Rasaily (1994),"Rasaily R, Dutta P, Saha MR, Mitra U, Lahiri M, Pal SC. Multi-drug resistant typhoid fever in hospitalised children. Clinical, bacteriological and epidemiological profiles. Eur J Epidemiol 1994; 10(1): 41-6.",Systematic review,IND,India,Dr B. C. Roy Memorial Hospital for Children,869,West Bengal,1991,4,172,2.3,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
1522,Bhattacharya (1992),"Bhattacharya SK, Dutta D, Bhattacharya MK, et al. Multi-resistant typhoid fever. Natl Med J India 1992; 5(1): 41.",Systematic review,IND,India,Infectious Diseases Hospital (Kolkata),869,West Bengal,1991,0,16,0,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
2049,Rodrigues(2002),"Rodrigues C, Mehta A, Joshi VR. Salmonella Typhiin the past decade: learning to live with resistance. Clin Infect Dis 2002; 34(1): 126.",Systematic review,IND,India,P.D. Hinduja National Hospital and Medical Research Center,858,Maharashtra,1992,0,96,0,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
1527,Brown(1996),"Brown JC, Shanahan PM, Jesudason MV, Thomson CJ, Amyes SG. Mutations responsible for reduced susceptibility to 4-quinolones in clinical isolates of multi-resistant Salmonella Typhi in India. J Antimicrob Chemother 1996; 37(5): 891-900.",Systematic review,IND,India,Christian Medical College (Vellore),867,Tamil Nadu,1993,12,15,80,1,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
267,Bhat (1998),"Bhat KG, Andrade AT, Karadesai SG, Hemashettar BM, Patil CS. Antimicrobial susceptibility of Salmonella Typhi to quinolones & cephalosporins. Indian J Med Res 1998; 107: 247-51.",Systematic review,IND,India,Jawaharlal Nehru Medical College (Belgaum),855,Karnataka,1994,38,85,44.7,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
2049,Rodrigues(2002),"Rodrigues C, Mehta A, Joshi VR. Salmonella Typhiin the past decade: learning to live with resistance. Clin Infect Dis 2002; 34(1): 126.",Systematic review,IND,India,P.D. Hinduja National Hospital and Medical Research Center,858,Maharashtra,1994,0,110,0,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
2789,Jesudason(1996),"Jesudason M, Malathy B, John T. Trend of increasing levels of minimum inhibitory concentration of ciprofloxacin to Salmonella Typhi. The Indian journal of medical research 1996; 103: 247-9.",Systematic review,IND,India,Christian Medical College (Vellore),867,Tamil Nadu,1994,0,39,0,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
2789,Jesudason(1996),"Jesudason M, Malathy B, John T. Trend of increasing levels of minimum inhibitory concentration of ciprofloxacin to Salmonella Typhi. The Indian journal of medical research 1996; 103: 247-9.",Systematic review,IND,India,Christian Medical College (Vellore),867,Tamil Nadu,1994,3,40,7.5,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
787,Nath(2010),"Nath G, Maurya P. Drug resistance patterns in Salmonella enterica subspecies enterica serotype Typhi strains isolated over a period of two decades, with special reference to ciprofloxacin and ceftriaxone. Int J Antimicrob Agents 2010; 35(5): 482-5.",Systematic review,IND,India,Sir Sunderlal Hospital,890,Uttar Pradesh,1994,9,16,56.3,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
2789,Jesudason(1996),"Jesudason M, Malathy B, John T. Trend of increasing levels of minimum inhibitory concentration of ciprofloxacin to Salmonella Typhi. The Indian journal of medical research 1996; 103: 247-9.",Systematic review,IND,India,Christian Medical College (Vellore),867,Tamil Nadu,1995,14,40,35,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
2789,Jesudason(1996),"Jesudason M, Malathy B, John T. Trend of increasing levels of minimum inhibitory concentration of ciprofloxacin to Salmonella Typhi. The Indian journal of medical research 1996; 103: 247-9.",Systematic review,IND,India,Christian Medical College (Vellore),867,Tamil Nadu,1995,5,38,13.2,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
1725,Khan(1999),"Khan JA, Shukla I, Malik A. Plasmid mediated multidrug resistance in Salmonella Typhi. Biomedicine 1999; 19(2): 107-11.",Systematic review,IND,India,Jawaharlal Nehru Medical College (Aligarh),890,Uttar Pradesh,1995,10,100,10,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
136,Mandal (2012),"Mandal S, Debmandal M, Pal NK. Antibiotic resistance of Salmonella enterica serovar Typhi in Kolkata, India, and in vitro experiments on effect of combined chemotherapy. ScientificWorldJournal 2012; 2012(454059).",Systematic review,IND,India,Calcutta School of Tropical Medicine,869,West Bengal,1996,149,421,35.4,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
1531,Ciraj (2001),"Ciraj AM, Seema DS, Bhat GK, Shivananda PG. Nalidixic acid screening test for the detection of decreased susceptibility to ciprofloxacin in Salmonella Typhi. Indian J Pathol Microbiol 2001; 44(4): 407-8.",Systematic review,IND,India,Kasturba Medical College and Hospital (Manipal);Kasturba Medical College Hospital (Mangaluru),855,Karnataka,1997,43,121,35.5,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
541,Kapil(1999),"Kapil A, Sood S, Dash NR, Das BK, Seth P. Ciprofloxacin in typhoid fever.[Erratum appears in Lancet 1999 Sep 4;354(9181):870]. Lancet 1999; 354(9173): 164.",Systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,1998,20,60,33.3,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
1533,Kapil (2002),"Kapil A, Renuka, Das B. Nalidixic acid susceptibility test to screen ciprofloxacin resistance in Salmonella Typhi. Indian J Med Res 2002; 115(February): 49-54.",Systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,1998,23,94,24.5,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
558,Baliga (1999),"Baliga S, Shenoy S, Vidyalaxmi, Pereira P. Ciprofloxacin-resistant Salmonella Typhi. Natl Med J India 1999; 12(3): 138.",Systematic review,IND,India,Kasturba Medical College Hospital (Mangaluru),855,Karnataka,1998,44,44,100,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
2049,Rodrigues(2002),"Rodrigues C, Mehta A, Joshi VR. Salmonella Typhiin the past decade: learning to live with resistance. Clin Infect Dis 2002; 34(1): 126.",Systematic review,IND,India,P.D. Hinduja National Hospital and Medical Research Center,858,Maharashtra,1998,71,106,67,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
118,Mohanty (2006),"Mohanty S, Renuka K, Sood S, Das BK, Kapil A. Antibiogram pattern and seasonality of Salmonella serotypes in a North Indian tertiary care hospital. Epidemiol Infect 2006; 134(5): 961-6.",Systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,1999,59,110,53.6,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
1933,Kumar (2008),"Kumar S, Rizvi M, Berry N. Rising prevalence of enteric fever due to multidrug-resistant Salmonella: an epidemiological study. J Med Microbiol 2008; 57(Pt 10): 1247-50.",Systematic review,IND,India,Lok Nayak Jai Prakash Narayan Hospital,850,Delhi,1999,1,47,2.1,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
2093,Gautam (2002),"Gautam V, Gupta NK, Chaudhary U, Arora DR. Sensitivity pattern of Salmonella serotypes in Northern India. Braz J Infect Dis 2002; 6(6): 281-7.",Systematic review,IND,India,Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences,853,Haryana,1999,46,60,76.7,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
547,Dutta (2001)<U+1D47>,"Dutta P, Mitra U, Datta S, et al. Ciprofloxacin susceptible Salmonella Typhi with treatment failure. J Trop Pediatr 2001b; 47(4): 252-3.",Systematic review,IND,India,National Institute of Cholera and Enteric Diseases,869,West Bengal,1999,10,26,38.5,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
4526,Das (2016),"Das S, Samajpati S, Ray U, Roy I, Dutta S. Antimicrobial resistance and molecular subtypes of Salmonella enterica serovar Typhi isolates from Kolkata, India over a 15 years period 1998-2012. Int J Med Microbiol 2016; 25: 25.",Systematic review,IND,India,Two Kolkata Hospitals & two urban slums in Kolkata,869,West Bengal,1999,19,28,67.9,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
548,Chitnis(2006),"Chitnis S, Chitnis V, Hemvani N, Chitnis DS. Ciprofloxacin therapy for typhoid fever needs reconsideration. J Infect Chemother 2006; 12(6): 402-4.",Systematic review,IND,India,Choithram Hospital and Research Centre,888,Madhya Pradesh,1999,30,50,60,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
787,Nath(2010),"Nath G, Maurya P. Drug resistance patterns in Salmonella enterica subspecies enterica serotype Typhi strains isolated over a period of two decades, with special reference to ciprofloxacin and ceftriaxone. Int J Antimicrob Agents 2010; 35(5): 482-5.",Systematic review,IND,India,Sir Sunderlal Hospital,890,Uttar Pradesh,1999,46,61,75.4,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
118,Mohanty (2006),"Mohanty S, Renuka K, Sood S, Das BK, Kapil A. Antibiogram pattern and seasonality of Salmonella serotypes in a North Indian tertiary care hospital. Epidemiol Infect 2006; 134(5): 961-6.",Systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,2000,75,103,72.8,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
870,Verma(2010),"Verma S, Thakur S, Kanga A, Singh G, Gupta P. Emerging Salmonella ParaTyphi A enteric fever and changing trends in antimicrobial resistance pattern of Salmonella in Shimla. Indian J Med Microbiol 2010; 28(1): 51-3.",Systematic review,IND,India,Indira Gandhi Medical College,854,Himachal Pradesh,2000,14,28,50,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
1642,Misra (2005),"Misra RN, Bawa KS, Magu SK, Bhandari S, Nagendra A, Menon PK. Outbreak of multi-drug resistant Salmonella Typhi enteric fever in Mumbai garrison. Med J Armed Forces India 2005; 61(2): 148-50.",Systematic review,IND,India,Mumbai Garrison,858,Maharashtra,2000,93,93,100,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
899,Rodrigues (2003),"Rodrigues C, Shenai S, Mehta A. Enteric fever in Mumbai, India: the good news and the bad news. Clin Infect Dis 2003; 36(4): 535.",Systematic review,IND,India,P.D. Hinduja National Hospital and Medical Research Center,858,Maharashtra,2000,197,240,82.1,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
2049,Rodrigues(2002),"Rodrigues C, Mehta A, Joshi VR. Salmonella Typhiin the past decade: learning to live with resistance. Clin Infect Dis 2002; 34(1): 126.",Systematic review,IND,India,P.D. Hinduja National Hospital and Medical Research Center,858,Maharashtra,2000,197,240,82.1,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
1243,Sekar (2003),"Sekar U, Srikanth P, Kindo AJ, Babu VP, Ramasubramanian V. Increase in minimum inhibitory concentration to quinolones and ceftriaxone in Salmonellae causing enteric fever. J Commun Dis 2003; 35(3): 162-9.",Systematic review,IND,India,Sri Ramachandra Medical College and Research Institute,867,Tamil Nadu,2000,42,48,87.5,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
2303,Rupali (2004),"Rupali P, Abraham OC, Jesudason MV, et al. Treatment failure in typhoid fever with ciprofloxacin susceptible Salmonella enterica serotype Typhi. Diagn Microbiol Infect Dis 2004; 49(1): 1-3.",Systematic review,IND,India,Christian Medical College (Vellore),867,Tamil Nadu,2000,38,50,76,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
36,Mandeep (2006),"Mandeep W, Rajni G, Premila P, Rajesh M, Pushpa A, Mani K. Age-related clinical and microbiological characteristics of enteric fever in India. Trans R Soc Trop Med Hyg 2006; 100(10): 942-8.",Systematic review,IND,India,Safdarjung Hospital,850,Delhi,2001,226,304,74.3,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
118,Mohanty (2006),"Mohanty S, Renuka K, Sood S, Das BK, Kapil A. Antibiogram pattern and seasonality of Salmonella serotypes in a North Indian tertiary care hospital. Epidemiol Infect 2006; 134(5): 961-6.",Systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,2001,93,125,74.4,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
904,Capoor(2007),"Capoor MR, Nair D, Deb M, Aggarwal P. Enteric fever perspective in India: emergence of high-level ciprofloxacin resistance and rising MIC to cephalosporins. J Med Microbiol 2007; 56(Pt 8): 1131-2.",Systematic review,IND,India,Safdarjung Hospital,850,Delhi,2001,89,175,50.9,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
2090,Achla (2005),"Achla P, Grover SS, Bhatia R, Khare S. Sensitivity index of antimicrobial agents as a simple solution for multidrug resistance in Salmonella Typhi. Indian J Med Res 2005; 121(3): 185-93.",Systematic review,IND,India,Dr Lal PathLabs;Lady Hardinge Medical College;Majeedia Hospital;Ram Manohar Lohia Hospital,850,Delhi,2001,173,205,84.4,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
870,Verma(2010),"Verma S, Thakur S, Kanga A, Singh G, Gupta P. Emerging Salmonella ParaTyphi A enteric fever and changing trends in antimicrobial resistance pattern of Salmonella in Shimla. Indian J Med Microbiol 2010; 28(1): 51-3.",Systematic review,IND,India,Indira Gandhi Medical College,854,Himachal Pradesh,2001,13,18,72.2,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
1479,Senthilkumar(2005),"Senthilkumar B, Prabakaran G. Multidrug resistant Salmonella Typhi in asymptomatic typhoid carriers among food handlers in Namakkal district, Tamil Nadu. Indian J Med Microbiol 2005; 23(2): 92-4.",Systematic review,IND,India,Namakkal,867,Tamil Nadu,2001,1,6,16.7,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
548,Chitnis(2006),"Chitnis S, Chitnis V, Hemvani N, Chitnis DS. Ciprofloxacin therapy for typhoid fever needs reconsideration. J Infect Chemother 2006; 12(6): 402-4.",Systematic review,IND,India,Choithram Hospital and Research Centre,888,Madhya Pradesh,2001,28,40,70,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
471,Lakshmi (2006),"Lakshmi V, Ashok R, Susmita J, Shailaja VV. Changing trends in the antibiograms of Salmonella isolates at a tertiary care hospital in Hyderabad. Indian J Med Microbiol 2006; 24(1): 45-8.",Systematic review,IND,India,Nizam's Institute of Medical Sciences,848,Andhra Pradesh,2002,25,26,96.2,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
118,Mohanty (2006),"Mohanty S, Renuka K, Sood S, Das BK, Kapil A. Antibiogram pattern and seasonality of Salmonella serotypes in a North Indian tertiary care hospital. Epidemiol Infect 2006; 134(5): 961-6.",Systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,2002,64,85,75.3,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
1933,Kumar (2008),"Kumar S, Rizvi M, Berry N. Rising prevalence of enteric fever due to multidrug-resistant Salmonella: an epidemiological study. J Med Microbiol 2008; 57(Pt 10): 1247-50.",Systematic review,IND,India,Lok Nayak Jai Prakash Narayan Hospital,850,Delhi,2002,4,48,8.3,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
870,Verma(2010),"Verma S, Thakur S, Kanga A, Singh G, Gupta P. Emerging Salmonella ParaTyphi A enteric fever and changing trends in antimicrobial resistance pattern of Salmonella in Shimla. Indian J Med Microbiol 2010; 28(1): 51-3.",Systematic review,IND,India,Indira Gandhi Medical College,854,Himachal Pradesh,2002,12,18,66.7,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
899,Rodrigues (2003),"Rodrigues C, Shenai S, Mehta A. Enteric fever in Mumbai, India: the good news and the bad news. Clin Infect Dis 2003; 36(4): 535.",Systematic review,IND,India,P.D. Hinduja National Hospital and Medical Research Center,858,Maharashtra,2002,93,106,87.7,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
1887,Mandal (2004),"Mandal S, Mandal MD, Pal NK. Reduced minimum inhibitory concentration of chloramphenicol for Salmonella enterica serovar Typhi. Indian J Med Sci 2004; 58(1): 16-23.",Systematic review,IND,India,Calcutta School of Tropical Medicine,869,West Bengal,2002,20,20,100,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
4526,Das (2016),"Das S, Samajpati S, Ray U, Roy I, Dutta S. Antimicrobial resistance and molecular subtypes of Salmonella enterica serovar Typhi isolates from Kolkata, India over a 15 years period 1998-2012. Int J Med Microbiol 2016; 25: 25.",Systematic review,IND,India,Two Kolkata Hospitals & two urban slums in Kolkata,869,West Bengal,2002,24,36,66.7,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
471,Lakshmi (2006),"Lakshmi V, Ashok R, Susmita J, Shailaja VV. Changing trends in the antibiograms of Salmonella isolates at a tertiary care hospital in Hyderabad. Indian J Med Microbiol 2006; 24(1): 45-8.",Systematic review,IND,India,Nizam's Institute of Medical Sciences,848,Andhra Pradesh,2003,22,22,100,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
118,Mohanty (2006),"Mohanty S, Renuka K, Sood S, Das BK, Kapil A. Antibiogram pattern and seasonality of Salmonella serotypes in a North Indian tertiary care hospital. Epidemiol Infect 2006; 134(5): 961-6.",Systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,2003,88,107,82.2,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
1848,Joshi (2004),"Joshi S, Wattal C, Sharma A, Oberoi JK, Prasad KJ. Quinolones - Drug of choice for enteric fever? Indian J Med Microbiol 2004; 22(4): 271-2.",Systematic review,IND,India,Sir Ganga Ram Hospital,850,Delhi,2003,84,166,50.6,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
870,Verma(2010),"Verma S, Thakur S, Kanga A, Singh G, Gupta P. Emerging Salmonella ParaTyphi A enteric fever and changing trends in antimicrobial resistance pattern of Salmonella in Shimla. Indian J Med Microbiol 2010; 28(1): 51-3.",Systematic review,IND,India,Indira Gandhi Medical College,854,Himachal Pradesh,2003,22,22,100,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
900,Jog (2008),"Jog S, Soman R, Singhal T, Rodrigues C, Mehta A, Dastur FD. Enteric fever in Mumbai--clinical profile, sensitivity patterns and response to antimicrobials. J Assoc Physicians India 2008; 56: 237-40.",Systematic review,IND,India,P.D. Hinduja National Hospital and Medical Research Center,858,Maharashtra,2003,20,29,69,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
1753,Pallab (2006),"Pallab R, Jyoti S, Marak RSK, Garg RK. Predictive efficacy of nalidixic acid resistance as a marker of fluoroquinolone resistance in Salmonella enterica var Typhi. Indian J Med Res 2006; 124(1): 105-8.",Systematic review,IND,India,Postgraduate Institute of Medical Education and Research (PGIMER; Nehru Hospital),864,Punjab,2003,62,70,88.6,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
858,Kownhar(2007),"Kownhar H, Shankar EM, Rajan R, Rao UA. Emergence of nalidixic acid-resistant Salmonella enterica serovar Typhi resistant to ciprofloxacin in India. J Med Microbiol 2007; 56(Pt 1): 136-7.",Systematic review,IND,India,Rajiv Gandhi Government General Hospital,867,Tamil Nadu,2003,12,14,85.7,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
1887,Mandal (2004),"Mandal S, Mandal MD, Pal NK. Reduced minimum inhibitory concentration of chloramphenicol for Salmonella enterica serovar Typhi. Indian J Med Sci 2004; 58(1): 16-23.",Systematic review,IND,India,Calcutta School of Tropical Medicine,869,West Bengal,2003,23,23,100,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
548,Chitnis(2006),"Chitnis S, Chitnis V, Hemvani N, Chitnis DS. Ciprofloxacin therapy for typhoid fever needs reconsideration. J Infect Chemother 2006; 12(6): 402-4.",Systematic review,IND,India,Choithram Hospital and Research Centre,888,Madhya Pradesh,2003,81,97,83.5,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
690,Madhulika (2004),"Madhulika U, Harish BN, Parija SC. Current pattern in antimicrobial susceptibility of Salmonella Typhi isolates in Pondicherry. Indian J Med Res 2004; 120(2): 111-4.",Systematic review,IND,India,Government Hospital (Pondicherry);Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER),889,Puducherry,2003,131,143,91.6,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
471,Lakshmi (2006),"Lakshmi V, Ashok R, Susmita J, Shailaja VV. Changing trends in the antibiograms of Salmonella isolates at a tertiary care hospital in Hyderabad. Indian J Med Microbiol 2006; 24(1): 45-8.",Systematic review,IND,India,Nizam's Institute of Medical Sciences,848,Andhra Pradesh,2004,11,12,91.7,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
118,Mohanty (2006),"Mohanty S, Renuka K, Sood S, Das BK, Kapil A. Antibiogram pattern and seasonality of Salmonella serotypes in a North Indian tertiary care hospital. Epidemiol Infect 2006; 134(5): 961-6.",Systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,2004,87,99,87.9,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
1900,Arya(2008),"Arya SC, Agarwal N. Regarding ""Typhoid fever in travelers: time for re-assessment"". European Journal of Internal Medicine 2008; 19(2): 148-9.",Systematic review,IND,India,Sant Parmanand Hospital,850,Delhi,2004,8,15,53.3,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
870,Verma(2010),"Verma S, Thakur S, Kanga A, Singh G, Gupta P. Emerging Salmonella ParaTyphi A enteric fever and changing trends in antimicrobial resistance pattern of Salmonella in Shimla. Indian J Med Microbiol 2010; 28(1): 51-3.",Systematic review,IND,India,Indira Gandhi Medical College,854,Himachal Pradesh,2004,28,30,93.3,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
152,Dhanashree (2007),Dhanashree B. Antibiotic susceptibility profile of Salmonella enterica serovars: trend over three years showing re-emergence of chloramphenicol sensitivity and rare serovars. Indian J Med Sci 2007; 61(10): 576-9.,Systematic review,IND,India,Kasturba Medical College Hospital (Mangaluru),855,Karnataka,2004,12,23,52.2,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
1064,Joshi (2007),"Joshi S, Amarnath SK. Fluoroquinolone resistance in Salmonella Typhi and S. ParaTyphi A in Bangalore, India. Trans R Soc Trop Med Hyg 2007; 101(3): 308-10.",Systematic review,IND,India,Manipal Hospital (Airport road),855,Karnataka,2004,22,25,88,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
900,Jog (2008),"Jog S, Soman R, Singhal T, Rodrigues C, Mehta A, Dastur FD. Enteric fever in Mumbai--clinical profile, sensitivity patterns and response to antimicrobials. J Assoc Physicians India 2008; 56: 237-40.",Systematic review,IND,India,P.D. Hinduja National Hospital and Medical Research Center,858,Maharashtra,2004,17,24,70.8,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
1698,Bhaswati (2007),"Bhaswati S, Shanta D, Dipika S, et al. Phage typing, biotyping & antimicrobial resistance profile of Salmonella enterica serotype Typhi from Kolkata. Indian J Med Res 2007; 125(5): 685-8.",Systematic review,IND,India,"Wards 29 & 30, Kolkata",869,West Bengal,2004,10,195,5.1,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
1955,Dutta (2005),"Dutta S, Sur D, Manna B, Bhattacharya SK, Deen JL, Clemens JD. Rollback of Salmonella enterica serotype Typhi resistance to chloramphenicol and other antimicrobials in Kolkata, India. Antimicrob Agents Chemother 2005; 49(4): 1662-3.",Systematic review,IND,India,Kolkata,869,West Bengal,2004,13,131,9.9,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
787,Nath(2010),"Nath G, Maurya P. Drug resistance patterns in Salmonella enterica subspecies enterica serotype Typhi strains isolated over a period of two decades, with special reference to ciprofloxacin and ceftriaxone. Int J Antimicrob Agents 2010; 35(5): 482-5.",Systematic review,IND,India,Sir Sunderlal Hospital,890,Uttar Pradesh,2004,29,32,90.6,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
1425,Capoor(2009),"Capoor MR, Nair D, Walia NS, et al. Molecular analysis of high-level ciprofloxacin resistance in Salmonella enterica serovar Typhi and S. ParaTyphi A: need to expand the QRDR region. Epidemiol Infect 2009; 137(6): 871-8.",Systematic review,IND,India,Majeedia Hospital;Safdarjung Hospital,850,Delhi,2005,158,158,100,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
1933,Kumar (2008),"Kumar S, Rizvi M, Berry N. Rising prevalence of enteric fever due to multidrug-resistant Salmonella: an epidemiological study. J Med Microbiol 2008; 57(Pt 10): 1247-50.",Systematic review,IND,India,Lok Nayak Jai Prakash Narayan Hospital,850,Delhi,2005,10,45,22.2,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
2309,Manchanda (2006),"Manchanda V, Bhalla P, Sethi M, Sharma VK. Treatment of enteric fever in children on the basis of current trends of antimicrobial susceptibility of Salmonella enterica serovar Typhi and ParaTyphi A. Indian J Med Microbiol 2006; 24(2): 101-6.",Systematic review,IND,India,Chacha Nehru Bal Chikitsalaya Hospital,850,Delhi,2005,48,56,85.7,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
870,Verma(2010),"Verma S, Thakur S, Kanga A, Singh G, Gupta P. Emerging Salmonella ParaTyphi A enteric fever and changing trends in antimicrobial resistance pattern of Salmonella in Shimla. Indian J Med Microbiol 2010; 28(1): 51-3.",Systematic review,IND,India,Indira Gandhi Medical College,854,Himachal Pradesh,2005,29,33,87.9,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
152,Dhanashree (2007),Dhanashree B. Antibiotic susceptibility profile of Salmonella enterica serovars: trend over three years showing re-emergence of chloramphenicol sensitivity and rare serovars. Indian J Med Sci 2007; 61(10): 576-9.,Systematic review,IND,India,Kasturba Medical College Hospital (Mangaluru),855,Karnataka,2005,24,26,92.3,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
1807,Gupta(2009),"Gupta S, Handa A, Chadha DS, Ganjoo RK, Panda RC. Profile of culture positive enteric fever from Bangalore. Med J Armed Forces India 2009; 65(4): 328-31.",Systematic review,IND,India,Command Hospital (Bengaluru),855,Karnataka,2005,56,65,86.2,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
900,Jog (2008),"Jog S, Soman R, Singhal T, Rodrigues C, Mehta A, Dastur FD. Enteric fever in Mumbai--clinical profile, sensitivity patterns and response to antimicrobials. J Assoc Physicians India 2008; 56: 237-40.",Systematic review,IND,India,P.D. Hinduja National Hospital and Medical Research Center,858,Maharashtra,2005,15,20,75,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
1137,Holt (2012),"Holt KE, Dutta S, Manna B, et al. High-resolution genotyping of the endemic Salmonella Typhi population during a Vi (typhoid) vaccination trial in Kolkata. PLoS Negl Trop Dis 2012; 6(1): e1490.",Systematic review,IND,India,Kolkata outbreak site,869,West Bengal,2005,54,372,14.5,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
4526,Das (2016),"Das S, Samajpati S, Ray U, Roy I, Dutta S. Antimicrobial resistance and molecular subtypes of Salmonella enterica serovar Typhi isolates from Kolkata, India over a 15 years period 1998-2012. Int J Med Microbiol 2016; 25: 25.",Systematic review,IND,India,Two Kolkata Hospitals & two urban slums in Kolkata,869,West Bengal,2005,32,36,88.9,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
4672,Sur  (2009),"Sur  D, Ochiai  RL, Bhattacharya  SK, et al. A cluster-randomized effectiveness trial of Vi typhoid vaccine in India. N Engl J Med 2009; 361(4): 335-44.",Systematic review,IND,India,"Wards 29 & 30, Kolkata",869,West Bengal,2005,64,130,49.2,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
548,Chitnis(2006),"Chitnis S, Chitnis V, Hemvani N, Chitnis DS. Ciprofloxacin therapy for typhoid fever needs reconsideration. J Infect Chemother 2006; 12(6): 402-4.",Systematic review,IND,India,Choithram Hospital and Research Centre,888,Madhya Pradesh,2005,68,77,88.3,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
246,Menezes (2012),"Menezes GA, Harish BN, Khan MA, Goessens WHF, Hays JP. Antimicrobial resistance trends in blood culture positive Salmonella Typhi isolates from Pondicherry, India, 2005-2009. Clin Microbiol Infect 2012; 18(3): 239-45.",Systematic review,IND,India,Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER);Indira Gandhi Government General Hospital,889,Puducherry,2005,51,70,72.9,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
1062,Harish (2006),"Harish BN, Menezes GA, Sarangapani K, Parija SC. Fluoroquinolone resistance among Salmonella enterica serovar ParaTyphi A in Pondicherry [2]. Indian J Med Res 2006; 124: 585-7.",Systematic review,IND,India,Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER);Indira Gandhi Government General Hospital,889,Puducherry,2005,25,27,92.6,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
904,Capoor(2007),"Capoor MR, Nair D, Deb M, Aggarwal P. Enteric fever perspective in India: emergence of high-level ciprofloxacin resistance and rising MIC to cephalosporins. J Med Microbiol 2007; 56(Pt 8): 1131-2.",Systematic review,IND,India,Safdarjung Hospital,850,Delhi,2006,131,142,92.3,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
1126,Raveendran (2008),"Raveendran R, Wattal C, Sharma A, Oberoi J, Prasad K, Datta S. High level ciprofloxacin resistance in Salmonella enterica isolated from blood. Indian J Med Microbiol 2008; 26(1): 50-3.",Systematic review,IND,India,Sir Ganga Ram Hospital,850,Delhi,2006,396,431,91.9,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
1900,Arya(2008),"Arya SC, Agarwal N. Regarding ""Typhoid fever in travelers: time for re-assessment"". European Journal of Internal Medicine 2008; 19(2): 148-9.",Systematic review,IND,India,Sant Parmanand Hospital,850,Delhi,2006,35,68,51.5,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
4371,Kapil(2015),"Kapil A, Sharma P, Dahiya S, Sood S, Das B. Trends of Increasing Antimicrobial Resistance in Community Acquired infections- a Case Study of Enteric Fever and Health Implications. International Journal of Epidemiology 2015; 44: 99-100.",Systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,2006,181,236,76.7,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
870,Verma(2010),"Verma S, Thakur S, Kanga A, Singh G, Gupta P. Emerging Salmonella ParaTyphi A enteric fever and changing trends in antimicrobial resistance pattern of Salmonella in Shimla. Indian J Med Microbiol 2010; 28(1): 51-3.",Systematic review,IND,India,Indira Gandhi Medical College,854,Himachal Pradesh,2006,0,10,0,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
152,Dhanashree (2007),Dhanashree B. Antibiotic susceptibility profile of Salmonella enterica serovars: trend over three years showing re-emergence of chloramphenicol sensitivity and rare serovars. Indian J Med Sci 2007; 61(10): 576-9.,Systematic review,IND,India,Kasturba Medical College Hospital (Mangaluru),855,Karnataka,2006,20,22,90.9,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
934,Vidyalakshmi (2008),"Vidyalakshmi K, Yashavanth R, Chakrapani M, et al. Epidemiological shift, seasonal variation and antimicrobial susceptibility patterns among enteric fever pathogens in South India. Trop Doct 2008; 38(2): 89-91.",Systematic review,IND,India,Kasturba Medical College Hospital (Mangaluru),855,Karnataka,2006,33,71,46.5,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
1893,Yashavanth (2010),"Yashavanth R, Vidyalakshmi K. The Re-Emergence of chloramphenicol sensitivity among enteric fever pathogens in Mangalore. J Clin Diagn Res 2010; 4(5): 3016-108.",Systematic review,IND,India,Kasturba Medical College Hospital (Mangaluru),855,Karnataka,2006,59,77,76.6,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
4525,Das(2016),"Das S, Ray U, Dutta S. Revisit of fluoroquinolone and azithromycin susceptibility breakpoints for Salmonella enterica serovar Typhi. J Med Microbiol 2016; 65(7): 632-40.",Systematic review,IND,India,National Institute of Cholera and Enteric Diseases,869,West Bengal,2006,110,146,75.3,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
246,Menezes (2012),"Menezes GA, Harish BN, Khan MA, Goessens WHF, Hays JP. Antimicrobial resistance trends in blood culture positive Salmonella Typhi isolates from Pondicherry, India, 2005-2009. Clin Microbiol Infect 2012; 18(3): 239-45.",Systematic review,IND,India,Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER);Indira Gandhi Government General Hospital,889,Puducherry,2006,57,76,75,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
452,Beig (2009),"Beig FK, Ahmad F, Abqari S. Changing antibiotic sensitivity pattern and scope of chloramphenicol in the management of hospitalised patients of typhoid fever. J Indian Med Assoc 2009; 107(12): 862-5.",Systematic review,IND,India,Jawaharlal Nehru Medical College (Aligarh),890,Uttar Pradesh,2006,14,35,40,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
1412,Capoor (2009),"Capoor MR, Deepthi N, Jitendra P, et al. Minimum inhibitory concentration of carbapenems and tigecycline against Salmonella spp. J Med Microbiol 2009; 58(3): 337-41.",Systematic review,IND,India,Majeedia Hospital;Safdarjung Hospital,850,Delhi,2007,144,149,96.6,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
266,Kavita (2010),"Kavita N, Channappa ST, Gaddad SM. Antimicrobial susceptibility of Salmonella Typhi in India. J Infect Dev Ctries 2010; 4(2): 70-3.",Systematic review,IND,India,Unknown clinics private and public hospitals in Gulbarga region,855,Karnataka,2007,30,84,35.7,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5124,Joshi (2019),"Joshi S, Adhikary R, Beena HB, et al. Trends in antibiotic susceptibility of enteric fever isolates from South India, 2002–2013.Medical Journal Armed Forces India 2019;75(1):81-85",Systematic review,IND,India,Manipal Hospital (Airport road),855,Karnataka,2007,124,184,67.4,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
1897,Gupta (2009)<U+1D47>,"Gupta V, Kaur J, Kaistha N. Re-emerging chloramphenicol sensitivity and emerging low level ciprofloxacin resistance among Salmonella enterica serotype Typhi isolates in North India. Trop Doct 2009; 39(1): 28-30.",Systematic review,IND,India,Government Medical College Hospital (Chandigarh),864,Punjab,2007,83,87,95.4,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
1808,Ganesh (2010),"Ganesh R, Janakiraman L, Vasanthi T, Sathiyasekeran M. Profile of typhoid fever in children from a tertiary care hospital in Chennai-South India. Indian J Pediatr 2010; 77(10): 1089-92.",Systematic review,IND,India,Kanchi Kamakoti CHILDS Trust Hospital,867,Tamil Nadu,2007,56,100,56,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
246,Menezes (2012),"Menezes GA, Harish BN, Khan MA, Goessens WHF, Hays JP. Antimicrobial resistance trends in blood culture positive Salmonella Typhi isolates from Pondicherry, India, 2005-2009. Clin Microbiol Infect 2012; 18(3): 239-45.",Systematic review,IND,India,Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER);Indira Gandhi Government General Hospital,889,Puducherry,2007,48,63,76.2,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
2967,Iyer (2017),"Iyer RN, Jangam RR, Jacinth A, Venkatalakshmi A, Nahdi FB. Prevalence and trends in the antimicrobial susceptibility pattern of Salmonella enterica serovars Typhi and ParaTyphi A among children in a pediatric tertiary care hospital in South India over a period of ten years: a retrospective study. Eur J Clin Microbiol Infect Dis 2017; 07: 07.",Systematic review,IND,India,Rainbow Hospital for Women and Children,848,Andhra Pradesh,2008,8,8,100,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
262,Kumar (2013)<U+1D47>,"Kumar MS, Kumar GSV, Prashanth HV, Prakash R, Veena K, Chandrashekar SC. Antimicrobial susceptibility of enteric fever Salmonellae isolated from blood culture. Res J Pharm Biol Chem Sci 2013b; 4(3): 318-24.",Systematic review,IND,India,Sri Siddhartha Medical College,855,Karnataka,2008,141,160,88.1,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5124,Joshi (2019),"Joshi S, Adhikary R, Beena HB, et al. Trends in antibiotic susceptibility of enteric fever isolates from South India, 2002–2013.Medical Journal Armed Forces India 2019;75(1):81-85",Systematic review,IND,India,Manipal Hospital (Airport road),855,Karnataka,2008,220,255,86.3,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
1127,Kumar (2009),"Kumar Y, Sharma A, Mani KR. High level of resistance to nalidixic acid in Salmonella enterica serovar Typhi in Central India. J Infect Dev Ctries 2009; 3(6): 467-9.",Systematic review,IND,India,Unknown hospitals in Maharashtra state,858,Maharashtra,2008,48,50,96,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
2334,Gupta (2013),"Gupta V, Singla N, Bansal N, Kaistha N, Chander J. Trends in the antibiotic resistance patterns of enteric fever isolates - a three year report from a tertiary care centre. Malays J Med Sci 2013; 20(4): 71-5.",Systematic review,IND,India,Government Medical College Hospital (Chandigarh),864,Punjab,2008,41,41,100,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
467,Dheer (2013),"Dheer G, Kundra S, Goel A, Singh T, Berry V. Changing spectrum of antibiotic sensitivity in enteric fever- a six year retrospective study in north india. Res J Pharm Biol Chem Sci 2013; 4(4): 492-8.",Systematic review,IND,India,Christian Medical College and Hospital (Ludhiana),864,Punjab,2008,32,37,86.5,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
1808,Ganesh (2010),"Ganesh R, Janakiraman L, Vasanthi T, Sathiyasekeran M. Profile of typhoid fever in children from a tertiary care hospital in Chennai-South India. Indian J Pediatr 2010; 77(10): 1089-92.",Systematic review,IND,India,Kanchi Kamakoti CHILDS Trust Hospital,867,Tamil Nadu,2008,62,85,72.9,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
2165,Gopal(2011),"Gopal M, Arumugam S, Gnadesikan S, Ramesh S. Studies on antimicrobial susceptibility pattern of Salmonella isolates from Chennai, India. Int J Pharma Bio Sci 2011; 2(2).",Systematic review,IND,India,Rajiv Gandhi Government General Hospital;Other clinical laboratories Chennai,867,Tamil Nadu,2008,127,133,95.5,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5069,Bandyopadhyay(2018),"Bandyopadhyay R, Balaji V, Yadav B, Jasmine S, Sathyendra S, Rupali P. Effectiveness of treatment regimens for Typhoid fever in the nalidixic acid-resistant S. Typhi (NARST) era in South India. Trop Doct 2018; 48(3): 182-8.",Systematic review,IND,India,Christian Medical College (Vellore),867,Tamil Nadu,2008,28,32,87.5,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
4526,Das (2016),"Das S, Samajpati S, Ray U, Roy I, Dutta S. Antimicrobial resistance and molecular subtypes of Salmonella enterica serovar Typhi isolates from Kolkata, India over a 15 years period 1998-2012. Int J Med Microbiol 2016; 25: 25.",Systematic review,IND,India,Two Kolkata Hospitals & two urban slums in Kolkata,869,West Bengal,2008,32,32,100,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
1128,Pathak (2012),"Pathak A, Marothi Y, Kekre V, Mahadik K, Macaden R, Lundborg CS. High prevalence of extended-spectrum beta-lactamase-producing pathogens: results of a surveillance study in two hospitals in Ujjain, India. Infect Drug Resist 2012; 5: 65-73.",Systematic review,IND,India,Ruxmaniben Deepchand Gardi Medical College Hospital;Ujjain Charitable Trust Hospital,888,Madhya Pradesh,2008,17,21,81,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
246,Menezes (2012),"Menezes GA, Harish BN, Khan MA, Goessens WHF, Hays JP. Antimicrobial resistance trends in blood culture positive Salmonella Typhi isolates from Pondicherry, India, 2005-2009. Clin Microbiol Infect 2012; 18(3): 239-45.",Systematic review,IND,India,Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER);Indira Gandhi Government General Hospital,889,Puducherry,2008,58,69,84.1,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
2967,Iyer (2017),"Iyer RN, Jangam RR, Jacinth A, Venkatalakshmi A, Nahdi FB. Prevalence and trends in the antimicrobial susceptibility pattern of Salmonella enterica serovars Typhi and ParaTyphi A among children in a pediatric tertiary care hospital in South India over a period of ten years: a retrospective study. Eur J Clin Microbiol Infect Dis 2017; 07: 07.",Systematic review,IND,India,Rainbow Hospital for Women and Children,848,Andhra Pradesh,2009,29,38,76.3,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5124,Joshi (2019),"Joshi S, Adhikary R, Beena HB, et al. Trends in antibiotic susceptibility of enteric fever isolates from South India, 2002–2013.Medical Journal Armed Forces India 2019;75(1):81-85",Systematic review,IND,India,Manipal Hospital (Airport road),855,Karnataka,2009,167,197,84.8,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
2334,Gupta (2013),"Gupta V, Singla N, Bansal N, Kaistha N, Chander J. Trends in the antibiotic resistance patterns of enteric fever isolates - a three year report from a tertiary care centre. Malays J Med Sci 2013; 20(4): 71-5.",Systematic review,IND,India,Government Medical College Hospital (Chandigarh),864,Punjab,2009,91,91,100,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5069,Bandyopadhyay(2018),"Bandyopadhyay R, Balaji V, Yadav B, Jasmine S, Sathyendra S, Rupali P. Effectiveness of treatment regimens for Typhoid fever in the nalidixic acid-resistant S. Typhi (NARST) era in South India. Trop Doct 2018; 48(3): 182-8.",Systematic review,IND,India,Christian Medical College (Vellore),867,Tamil Nadu,2009,27,29,93.1,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
246,Menezes (2012),"Menezes GA, Harish BN, Khan MA, Goessens WHF, Hays JP. Antimicrobial resistance trends in blood culture positive Salmonella Typhi isolates from Pondicherry, India, 2005-2009. Clin Microbiol Infect 2012; 18(3): 239-45.",Systematic review,IND,India,Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER);Indira Gandhi Government General Hospital,889,Puducherry,2009,50,59,84.7,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
842,Thamizhmani(2012),"Thamizhmani R, Bhattacharya D, Sayi DS, et al. Emergence of fluoroquinolone resistance in Salmonella enterica serovar Typhi in Andaman and Nicobar Islands, India. Indian J Med Res 2012; 136(1): 98-101.",Systematic review,IND,India,Govind Ballabh Pant Hospital;INHS Dhanwantari,847,Andaman and Nicobar,2010,6,6,100,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
2967,Iyer (2017),"Iyer RN, Jangam RR, Jacinth A, Venkatalakshmi A, Nahdi FB. Prevalence and trends in the antimicrobial susceptibility pattern of Salmonella enterica serovars Typhi and ParaTyphi A among children in a pediatric tertiary care hospital in South India over a period of ten years: a retrospective study. Eur J Clin Microbiol Infect Dis 2017; 07: 07.",Systematic review,IND,India,Rainbow Hospital for Women and Children,848,Andhra Pradesh,2010,18,30,60,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
207,Jain (2013),"Jain S, Chugh TD. Antimicrobial resistance among blood culture isolates of Salmonella enterica in New Delhi. J Infect Dev Ctries 2013; 7(11): 788-95.",Systematic review,IND,India,BLK Super speciality Hospital,850,Delhi,2010,101,108,93.5,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
3082,Duggal (2016),"Duggal S, Banerjee P, Chugh TD. Review of fifty culture proven Salmonella cases. Indian J Med Sci 2016; 68(1): 67-72.",Systematic review,IND,India,Unknown Hospital(s) in Delhi,850,Delhi,2010,34,36,94.4,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
151,Suruchi (2014),"Suruchi B, Anil K, Ganju SA, Atal S. Antibiotic susceptibility pattern of Salmonella enterica serovar Typhi and ParaTyphi a from North India: the changing scenario. Int J Pharma Bio Sci 2014; 5(4).",Systematic review,IND,India,Indira Gandhi Medical College,854,Himachal Pradesh,2010,15,22,68.2,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
2820,Shetty (2012),"Shetty AK, Shetty IN, Furtado ZV, Antony B, Boloor R. Antibiogram of Salmonella isolates from blood with an emphasis on nalidixic acid and chloramphenicol susceptibility in a tertiary care hospital in coastal karnataka: a prospective study. J Lab Physicians 2012; 4(2): 74-7.",Systematic review,IND,India,Father Muller Medical College Hospital,855,Karnataka,2010,69,85,81.2,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5124,Joshi (2019),"Joshi S, Adhikary R, Beena HB, et al. Trends in antibiotic susceptibility of enteric fever isolates from South India, 2002–2013.Medical Journal Armed Forces India 2019;75(1):81-85",Systematic review,IND,India,Manipal Hospital (Airport road),855,Karnataka,2010,146,164,89,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
2334,Gupta (2013),"Gupta V, Singla N, Bansal N, Kaistha N, Chander J. Trends in the antibiotic resistance patterns of enteric fever isolates - a three year report from a tertiary care centre. Malays J Med Sci 2013; 20(4): 71-5.",Systematic review,IND,India,Government Medical College Hospital (Chandigarh),864,Punjab,2010,125,125,100,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
744,Elumalai (2014),"Elumalai S, Muthu G, Selvam RE, Ramesh S. Detection of TEM-, SHV- and CTX-M-type beta-lactamase production among clinical isolates of Salmonella species. J Med Microbiol 2014; 63(Pt 7): 962-7.",Systematic review,IND,India,Unknown hospitals and laboratories in Chennai,867,Tamil Nadu,2010,100,101,99,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5069,Bandyopadhyay(2018),"Bandyopadhyay R, Balaji V, Yadav B, Jasmine S, Sathyendra S, Rupali P. Effectiveness of treatment regimens for Typhoid fever in the nalidixic acid-resistant S. Typhi (NARST) era in South India. Trop Doct 2018; 48(3): 182-8.",Systematic review,IND,India,Christian Medical College (Vellore),867,Tamil Nadu,2010,31,32,96.9,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
1649,Singla (2013),"Singla N, Bansal N, Gupta V, Chander J. Outbreak of Salmonella Typhi enteric fever in sub-urban area of North India: a public health perspective. Asian Pac J Trop Med 2013; 6(2): 167-8.",Systematic review,IND,India,Ram Darbar,883,Chandigarh,2010,18,18,100,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
4650,Yadav (2016),"Yadav VC, Kiran VR, Sharma R. Enteric fever in Bastar tribal region-prevalence and sensitivity patterns. J Evol Med Dent Sci 2016; 5(53): 3526-30.",Systematic review,IND,India,Late Baliram Kashyap Memorial Government Medical College Jagdalpur,884,Chhattisgarh,2010,0,122,0,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
781,Pratap(2012),"Pratap CB, Patel SK, Shukla VK, Tripathi SK, Singh TB, Nath G. Drug resistance in Salmonella enterica serotype Typhi isolated from chronic typhoid carriers. Int J Antimicrob Agents 2012; 40(3): 279-80.",Systematic review,IND,India,Sir Sunderlal Hospital,890,Uttar Pradesh,2010,36,36,100,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
2967,Iyer (2017),"Iyer RN, Jangam RR, Jacinth A, Venkatalakshmi A, Nahdi FB. Prevalence and trends in the antimicrobial susceptibility pattern of Salmonella enterica serovars Typhi and ParaTyphi A among children in a pediatric tertiary care hospital in South India over a period of ten years: a retrospective study. Eur J Clin Microbiol Infect Dis 2017; 07: 07.",Systematic review,IND,India,Rainbow Hospital for Women and Children,848,Andhra Pradesh,2011,43,44,97.7,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
207,Jain (2013),"Jain S, Chugh TD. Antimicrobial resistance among blood culture isolates of Salmonella enterica in New Delhi. J Infect Dev Ctries 2013; 7(11): 788-95.",Systematic review,IND,India,BLK Super speciality Hospital,850,Delhi,2011,103,107,96.3,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5097,Makkar (2018),"Makkar A, Gupta S, Khan ID, et al. Epidemiological Profile and Antimicrobial Resistance Pattern of Enteric Fever in a Tertiary Care Hospital of North India - a Seven Year Ambispective Study.Acta Medica (Hradec Kralove) 2018;61(4):125-130",Systematic review,IND,India,Unknown Hospital(s) in Delhi,850,Delhi,2011,61,64,95.3,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
4642,Vala (2016),"Vala S, Shah U, Ahmad SA, Scolnik D, Glatstein M. Resistance patterns of typhoid fever in children: A longitudinal community-based study. Am J Ther 2016; 23(5): E1151-E4.",Systematic review,IND,India,The Synergy Neonatal and Pediatric Hospital (Maninagar);The Synergy Neonatal and Pediatric Hospital (Vasna);Unknown private clinics in Ahmedabad;Unknown community hospitals in Ahmedabad;Unknown private clinics in Vadodara;Unknown community hospitals in Vadodara;Unknown private clinics in Bhavangar;Unknown community hospitals in Bhavangar,852,Gujarat,2011,4,61,6.6,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5124,Joshi (2019),"Joshi S, Adhikary R, Beena HB, et al. Trends in antibiotic susceptibility of enteric fever isolates from South India, 2002–2013.Medical Journal Armed Forces India 2019;75(1):81-85",Systematic review,IND,India,Manipal Hospital (Airport road),855,Karnataka,2011,214,224,95.5,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
4515,Chande (2016),"Chande CA, Chopdekar KA, Pradnya V, et al. Current trend of antibiotic sensitivity of Salmonella Typhi and other Salmonellae in Mumbai: A 5 years study. Indian J Med Microbiol 2016; 34(1): 115-6.",Systematic review,IND,India,Grant Medical College and Sir Jamshedjee Jeejeebhoy Group of Hospitals,858,Maharashtra,2011,48,49,98,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5069,Bandyopadhyay(2018),"Bandyopadhyay R, Balaji V, Yadav B, Jasmine S, Sathyendra S, Rupali P. Effectiveness of treatment regimens for Typhoid fever in the nalidixic acid-resistant S. Typhi (NARST) era in South India. Trop Doct 2018; 48(3): 182-8.",Systematic review,IND,India,Christian Medical College (Vellore),867,Tamil Nadu,2011,30,34,88.2,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
4526,Das (2016),"Das S, Samajpati S, Ray U, Roy I, Dutta S. Antimicrobial resistance and molecular subtypes of Salmonella enterica serovar Typhi isolates from Kolkata, India over a 15 years period 1998-2012. Int J Med Microbiol 2016; 25: 25.",Systematic review,IND,India,Two Kolkata Hospitals & two urban slums in Kolkata,869,West Bengal,2011,31,32,96.9,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
4650,Yadav (2016),"Yadav VC, Kiran VR, Sharma R. Enteric fever in Bastar tribal region-prevalence and sensitivity patterns. J Evol Med Dent Sci 2016; 5(53): 3526-30.",Systematic review,IND,India,Late Baliram Kashyap Memorial Government Medical College Jagdalpur,884,Chhattisgarh,2011,0,103,0,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
1730,Geetha (2014),"Geetha VK, Yugendran T, Srinivasan R, Harish BN. Plasmid-mediated quinolone resistance in typhoidal Salmonellae: a preliminary report from South India. Indian J Med Microbiol 2014; 32(1): 31-4.",Systematic review,IND,India,Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER),889,Puducherry,2011,36,36,100,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
2967,Iyer (2017),"Iyer RN, Jangam RR, Jacinth A, Venkatalakshmi A, Nahdi FB. Prevalence and trends in the antimicrobial susceptibility pattern of Salmonella enterica serovars Typhi and ParaTyphi A among children in a pediatric tertiary care hospital in South India over a period of ten years: a retrospective study. Eur J Clin Microbiol Infect Dis 2017; 07: 07.",Systematic review,IND,India,Rainbow Hospital for Women and Children,848,Andhra Pradesh,2012,45,46,97.8,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
207,Jain (2013),"Jain S, Chugh TD. Antimicrobial resistance among blood culture isolates of Salmonella enterica in New Delhi. J Infect Dev Ctries 2013; 7(11): 788-95.",Systematic review,IND,India,BLK Super speciality Hospital,850,Delhi,2012,51,51,100,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
4627,Sharma (2016),"Sharma P, Dahiya S, Balaji V, et al. Typhoidal Salmonellae: Use of multi-locus sequence typing to determine population structure. PLoS ONE 2016; 11(9).",Systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,2012,165,263,62.7,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5097,Makkar (2018),"Makkar A, Gupta S, Khan ID, et al. Epidemiological Profile and Antimicrobial Resistance Pattern of Enteric Fever in a Tertiary Care Hospital of North India - a Seven Year Ambispective Study.Acta Medica (Hradec Kralove) 2018;61(4):125-130",Systematic review,IND,India,Unknown Hospital(s) in Delhi,850,Delhi,2012,77,79,97.5,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5110,Sharma (2018),"Sharma P, Dahiya S, Manral N, et al. Changing trends of culture-positive typhoid fever and antimicrobial susceptibility in a tertiary care North Indian Hospital over the last decade.Indian Journal of Medical Microbiology 2018;36(1):70-76",Systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,2012,41,43,95.3,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
151,Suruchi (2014),"Suruchi B, Anil K, Ganju SA, Atal S. Antibiotic susceptibility pattern of Salmonella enterica serovar Typhi and ParaTyphi a from North India: the changing scenario. Int J Pharma Bio Sci 2014; 5(4).",Systematic review,IND,India,Indira Gandhi Medical College,854,Himachal Pradesh,2012,17,22,77.3,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
4627,Sharma (2016),"Sharma P, Dahiya S, Balaji V, et al. Typhoidal Salmonellae: Use of multi-locus sequence typing to determine population structure. PLoS ONE 2016; 11(9).",Systematic review,IND,India,Indira Gandhi Medical College,854,Himachal Pradesh,2012,13,20,65,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
117,Venkatesh (2013),"Venkatesh BM, Joshi S, Adhikary R, Bhaskar BH. Antibiogram of Salmonella Typhi and Salmonella ParaTyphi A in a tertiary care hospital in 2012. Indian J Pathol Microbiol 2013; 56(4): 484-5.",Systematic review,IND,India,Manipal Hospital (Airport road),855,Karnataka,2012,113,119,95,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5124,Joshi (2019),"Joshi S, Adhikary R, Beena HB, et al. Trends in antibiotic susceptibility of enteric fever isolates from South India, 2002–2013.Medical Journal Armed Forces India 2019;75(1):81-85",Systematic review,IND,India,Manipal Hospital (Airport road),855,Karnataka,2012,245,253,96.8,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
4519,Chatterjee(2016),"Chatterjee S, Eshwara VK, Tellapragada C, Mukhopadhyay C. Azithromycin susceptibility among clinical isolates of Salmonella: Interfacing guidelines with routine practices. Indian J Med Microbiol 2016; 34(3): 397-8.",Systematic review,IND,India,Kasturba Medical College and Hospital (Manipal),855,Karnataka,2012,91,95,95.8,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
2977,Harichandran (2017),"Harichandran D, Dinesh KR. Antimicrobial susceptibility profile, treatment outcome and serotype distribution of clinical isolates of Salmonella enterica subspecies enterica: a 2-year study from Kerala, South India. Infect Drug Resist 2017; 10: 97-101.",Systematic review,IND,India,Amrita Institute of Medical Sciences and Research Centre,856,Kerala,2012,53,79,67.1,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
4625,Sania (2016),"Sania KM, Shyamasakhi PD, Krishna Pramodini KD, Sulochana KD. Evaluation of minimum inhibitory concentration of chloramphenicol for Salmonella spp. isolated from enteric fever cases in a tertiary hospital in Imphal. Int J Pharm Sci Res 2016; 7(9): 3815-9.",Systematic review,IND,India,Regional Institute of Medical Sciences,859,Manipur,2012,16,16,100,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
4627,Sharma (2016),"Sharma P, Dahiya S, Balaji V, et al. Typhoidal Salmonellae: Use of multi-locus sequence typing to determine population structure. PLoS ONE 2016; 11(9).",Systematic review,IND,India,North Eastern Indira Gandhi Regional Institute of Health and Medical Sciences,860,Meghalaya,2012,10,15,66.7,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
4627,Sharma (2016),"Sharma P, Dahiya S, Balaji V, et al. Typhoidal Salmonellae: Use of multi-locus sequence typing to determine population structure. PLoS ONE 2016; 11(9).",Systematic review,IND,India,Maharaja Krishna Chandra Gajapati Medical College & Hospital,863,Orissa,2012,10,15,66.7,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
3012,Behl(2017),"Behl P, Gupta V, Sachdev A, Guglani V, Chander J. Patterns in antimicrobial susceptibility of Salmonellae isolated at a tertiary care hospital in northern India. Indian J Med Res 2017; 145(1): 124-8.",Systematic review,IND,India,Government Medical College Hospital (Chandigarh),864,Punjab,2012,75,78,96.2,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
4440,Riyaz (2015),"Riyaz C, Jayavardhana A. Current pattern of Salmonella Typhi antimicrobial susceptibility in the era of antibiotic abuse. Indian J Basic Appl Med Res 2015; 5(1): 400-4.",Systematic review,IND,India,PSG Institute of Medical Sciences and Research,867,Tamil Nadu,2012,46,50,92,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
696,Mathew (2014),"Mathew R, Jobin SR. Current trends of antimicrobial susceptibility of Salmonella enterica serovar Typhi and ParaTyphi a from blood cultures in a tertiary care center of Chennai, Tamil Nadu, India. Res J Pharm Biol Chem Sci 2014; 5(2): 1167-74.",Systematic review,IND,India,Saveetha Medical College (Thandalam),867,Tamil Nadu,2012,29,29,100,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
4627,Sharma (2016),"Sharma P, Dahiya S, Balaji V, et al. Typhoidal Salmonellae: Use of multi-locus sequence typing to determine population structure. PLoS ONE 2016; 11(9).",Systematic review,IND,India,Christian Medical College (Vellore),867,Tamil Nadu,2012,180,267,67.4,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5069,Bandyopadhyay(2018),"Bandyopadhyay R, Balaji V, Yadav B, Jasmine S, Sathyendra S, Rupali P. Effectiveness of treatment regimens for Typhoid fever in the nalidixic acid-resistant S. Typhi (NARST) era in South India. Trop Doct 2018; 48(3): 182-8.",Systematic review,IND,India,Christian Medical College (Vellore),867,Tamil Nadu,2012,18,19,94.7,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
4650,Yadav (2016),"Yadav VC, Kiran VR, Sharma R. Enteric fever in Bastar tribal region-prevalence and sensitivity patterns. J Evol Med Dent Sci 2016; 5(53): 3526-30.",Systematic review,IND,India,Late Baliram Kashyap Memorial Government Medical College Jagdalpur,884,Chhattisgarh,2012,17,111,15.3,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
2967,Iyer (2017),"Iyer RN, Jangam RR, Jacinth A, Venkatalakshmi A, Nahdi FB. Prevalence and trends in the antimicrobial susceptibility pattern of Salmonella enterica serovars Typhi and ParaTyphi A among children in a pediatric tertiary care hospital in South India over a period of ten years: a retrospective study. Eur J Clin Microbiol Infect Dis 2017; 07: 07.",Systematic review,IND,India,Rainbow Hospital for Women and Children,848,Andhra Pradesh,2013,34,35,97.1,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
634,Uppal(2015),"Uppal B, Perween N, Aggarwal P, Kumar SK. A comparative study of bacterial and parasitic intestinal infections in India. J Clin Diagn Res 2015; 9(3): DC01-4.",Systematic review,IND,India,Lok Nayak Jai Prakash Narayan Hospital,850,Delhi,2013,4,7,57.1,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5097,Makkar (2018),"Makkar A, Gupta S, Khan ID, et al. Epidemiological Profile and Antimicrobial Resistance Pattern of Enteric Fever in a Tertiary Care Hospital of North India - a Seven Year Ambispective Study.Acta Medica (Hradec Kralove) 2018;61(4):125-130",Systematic review,IND,India,Unknown Hospital(s) in Delhi,850,Delhi,2013,70,73,95.9,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5110,Sharma (2018),"Sharma P, Dahiya S, Manral N, et al. Changing trends of culture-positive typhoid fever and antimicrobial susceptibility in a tertiary care North Indian Hospital over the last decade.Indian Journal of Medical Microbiology 2018;36(1):70-76",Systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,2013,19,21,90.5,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5100,Narasanna (2018),"Narasanna R, Chavadi M and Chandrakanth K. Prevalence of multidrug-resistant Salmonella Typhi in typhoid patients and detection of blaCTX-M2 and blaCTX-M9 genes in cefetoxime-mediated extended spectrum beta-lactamase-producing Salmonella Typhi isolates.Biomedical Research (India) 2018;29(14):3015-3021",Systematic review,IND,India,"Government Hospital Kalaburagi;Pooja Diagnostic Centre, Kalaburagi",855,Karnataka,2013,31,66,47,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
3039,Sharvani (2016),"Sharvani R, Hemavathi, Dayanand DK, Shenoy P, Sarmah P. Antibiogram of Salmonella isolates: time to consider antibiotic salvage. J Clin Diagn Res 2016; 10(5): DC6-DC8.",Systematic review,IND,India,Sapthagiri Hospital,855,Karnataka,2013,123,136,90.4,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5124,Joshi (2019),"Joshi S, Adhikary R, Beena HB, et al. Trends in antibiotic susceptibility of enteric fever isolates from South India, 2002–2013.Medical Journal Armed Forces India 2019;75(1):81-85",Systematic review,IND,India,Manipal Hospital (Airport road),855,Karnataka,2013,108,131,82.4,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5060,Rajashri (2017),Rajashri P and Amar P. Study of antibiotic sensitivity pattern of Salmonella Typhi in tertiary care centre.International Journal of Healthcare & Biomedical Research 2017;6(1):75-80,Systematic review,IND,India,Dr D Y Patil Vidyapeeth,858,Maharashtra,2013,21,21,100,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
3006,Chandane (2017),"Chandane P, Gandhi A, Bowalekar S. Study of antibiotic susceptibility pattern of Salmonella Typhi in children suffering from enteric fever. Ann Trop Med Public Health 2017; 10(2): 440-3.",Systematic review,IND,India,B J Wadia Hospital for Children,858,Maharashtra,2013,18,43,41.9,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
3016,Bakthavatchalam(2017),"Bakthavatchalam YD, Kumar DT, Tayubi IA, et al. In vitro efficacy and in silico analysis of cefixime-ofloxacin combination for Salmonella Typhi from bloodstream infection. J Appl Microbiol 2017; 123(3): 615-24.",Systematic review,IND,India,Christian Medical College (Vellore),867,Tamil Nadu,2013,269,283,95.1,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
4650,Yadav (2016),"Yadav VC, Kiran VR, Sharma R. Enteric fever in Bastar tribal region-prevalence and sensitivity patterns. J Evol Med Dent Sci 2016; 5(53): 3526-30.",Systematic review,IND,India,Late Baliram Kashyap Memorial Government Medical College Jagdalpur,884,Chhattisgarh,2013,34,193,17.6,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
2166,Srirangaraj (2014),"Srirangaraj S, Kali A, Charles MV. A study of antibiogram of Salmonella enterica serovar Typhi isolates from Pondicherry, India. Australas Med J 2014; 7(4): 185-90.",Systematic review,IND,India,Mahatma Gandhi Medical College and Research Institute,889,Puducherry,2013,16,16,100,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
4301,Anees (2015),"Anees A, Indu S, Fatima K, Anjum P. Multi-drug resistant Salmonella enterica subspecies enterica serotype Typhi: A diagnostic and therapeutic challenge. Int J Curr Microbiol Appl Sci 2015; 4(Special Issue 1): 19-25.",Systematic review,IND,India,Jawaharlal Nehru Medical College (Aligarh),890,Uttar Pradesh,2013,2,12,16.7,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
4597,Misra (2016),"Misra R, Thakare R, Amrin N, Prasad KN, Chopra S, Dhole TN. Antimicrobial susceptibility pattern and sequence analysis of DNA gyrase and DNA topoisomerase IV in Salmonella enterica serovars Typhi and ParaTyphi A isolates with decreased susceptibility to ciprofloxacin. Trans R Soc Trop Med Hyg 2016; 110(8): 472-9.",Systematic review,IND,India,Sanjay Gandhi Postgraduate Institute of Medical Sciences,890,Uttar Pradesh,2013,20,20,100,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
2967,Iyer (2017),"Iyer RN, Jangam RR, Jacinth A, Venkatalakshmi A, Nahdi FB. Prevalence and trends in the antimicrobial susceptibility pattern of Salmonella enterica serovars Typhi and ParaTyphi A among children in a pediatric tertiary care hospital in South India over a period of ten years: a retrospective study. Eur J Clin Microbiol Infect Dis 2017; 07: 07.",Systematic review,IND,India,Rainbow Hospital for Women and Children,848,Andhra Pradesh,2014,38,41,92.7,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5097,Makkar (2018),"Makkar A, Gupta S, Khan ID, et al. Epidemiological Profile and Antimicrobial Resistance Pattern of Enteric Fever in a Tertiary Care Hospital of North India - a Seven Year Ambispective Study.Acta Medica (Hradec Kralove) 2018;61(4):125-130",Systematic review,IND,India,Unknown Hospital(s) in Delhi,850,Delhi,2014,118,120,98.3,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5110,Sharma (2018),"Sharma P, Dahiya S, Manral N, et al. Changing trends of culture-positive typhoid fever and antimicrobial susceptibility in a tertiary care North Indian Hospital over the last decade.Indian Journal of Medical Microbiology 2018;36(1):70-76",Systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,2014,10,11,90.9,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
4452,Sharma (2015),"Sharma, Sharma R, Gupta S. Bacteriological analysis of blood culture isolates with their antibiogram from a tertiary care hospital. Int J Pharm Sci Res 2015; 6(11): 4847-51.",Systematic review,IND,India,Mahatma Gandhi Medical College and Hospital (Jaipur),865,Rajasthan,2014,3,20,15,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
4650,Yadav (2016),"Yadav VC, Kiran VR, Sharma R. Enteric fever in Bastar tribal region-prevalence and sensitivity patterns. J Evol Med Dent Sci 2016; 5(53): 3526-30.",Systematic review,IND,India,Late Baliram Kashyap Memorial Government Medical College Jagdalpur,884,Chhattisgarh,2014,19,101,18.8,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
4597,Misra (2016),"Misra R, Thakare R, Amrin N, Prasad KN, Chopra S, Dhole TN. Antimicrobial susceptibility pattern and sequence analysis of DNA gyrase and DNA topoisomerase IV in Salmonella enterica serovars Typhi and ParaTyphi A isolates with decreased susceptibility to ciprofloxacin. Trans R Soc Trop Med Hyg 2016; 110(8): 472-9.",Systematic review,IND,India,Sanjay Gandhi Postgraduate Institute of Medical Sciences,890,Uttar Pradesh,2014,27,29,93.1,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
2967,Iyer (2017),"Iyer RN, Jangam RR, Jacinth A, Venkatalakshmi A, Nahdi FB. Prevalence and trends in the antimicrobial susceptibility pattern of Salmonella enterica serovars Typhi and ParaTyphi A among children in a pediatric tertiary care hospital in South India over a period of ten years: a retrospective study. Eur J Clin Microbiol Infect Dis 2017; 07: 07.",Systematic review,IND,India,Rainbow Hospital for Women and Children,848,Andhra Pradesh,2015,34,37,91.9,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5097,Makkar (2018),"Makkar A, Gupta S, Khan ID, et al. Epidemiological Profile and Antimicrobial Resistance Pattern of Enteric Fever in a Tertiary Care Hospital of North India - a Seven Year Ambispective Study.Acta Medica (Hradec Kralove) 2018;61(4):125-130",Systematic review,IND,India,Unknown Hospital(s) in Delhi,850,Delhi,2015,71,79,89.9,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5110,Sharma (2018),"Sharma P, Dahiya S, Manral N, et al. Changing trends of culture-positive typhoid fever and antimicrobial susceptibility in a tertiary care North Indian Hospital over the last decade.Indian Journal of Medical Microbiology 2018;36(1):70-76",Systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,2015,21,23,91.3,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
4597,Misra (2016),"Misra R, Thakare R, Amrin N, Prasad KN, Chopra S, Dhole TN. Antimicrobial susceptibility pattern and sequence analysis of DNA gyrase and DNA topoisomerase IV in Salmonella enterica serovars Typhi and ParaTyphi A isolates with decreased susceptibility to ciprofloxacin. Trans R Soc Trop Med Hyg 2016; 110(8): 472-9.",Systematic review,IND,India,Sanjay Gandhi Postgraduate Institute of Medical Sciences,890,Uttar Pradesh,2015,31,31,100,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
2967,Iyer (2017),"Iyer RN, Jangam RR, Jacinth A, Venkatalakshmi A, Nahdi FB. Prevalence and trends in the antimicrobial susceptibility pattern of Salmonella enterica serovars Typhi and ParaTyphi A among children in a pediatric tertiary care hospital in South India over a period of ten years: a retrospective study. Eur J Clin Microbiol Infect Dis 2017; 07: 07.",Systematic review,IND,India,Rainbow Hospital for Women and Children,848,Andhra Pradesh,2016,90,90,100,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5097,Makkar (2018),"Makkar A, Gupta S, Khan ID, et al. Epidemiological Profile and Antimicrobial Resistance Pattern of Enteric Fever in a Tertiary Care Hospital of North India - a Seven Year Ambispective Study.Acta Medica (Hradec Kralove) 2018;61(4):125-130",Systematic review,IND,India,Unknown Hospital(s) in Delhi,850,Delhi,2016,103,109,94.5,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5110,Sharma (2018),"Sharma P, Dahiya S, Manral N, et al. Changing trends of culture-positive typhoid fever and antimicrobial susceptibility in a tertiary care North Indian Hospital over the last decade.Indian Journal of Medical Microbiology 2018;36(1):70-76",Systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,2016,66,72,91.7,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5058,Purighalla (2017),"Purighalla S, Esakimuthu S, Reddy M, et al. Investigation into a community outbreak of Salmonella Typhi in Bengaluru, India.Indian Journal of Medical Research 2017;146(July Supplement):15-22",Systematic review,IND,India,Unknown hospitals in Bengaluru,855,Karnataka,2016,19,42,45.2,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5097,Makkar (2018),"Makkar A, Gupta S, Khan ID, et al. Epidemiological Profile and Antimicrobial Resistance Pattern of Enteric Fever in a Tertiary Care Hospital of North India - a Seven Year Ambispective Study.Acta Medica (Hradec Kralove) 2018;61(4):125-130",Systematic review,IND,India,Unknown Hospital(s) in Delhi,850,Delhi,2017,89,99,89.9,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5061,Sucindar (2017),Sucindar M and Kumaran SS. Profile of culture positive enteric fever in children admitted in a tertiary care hospital.Journal of Evolution of Medical and Dental Sciences-Jemds 2017;6(88):6112-6117,Systematic review,IND,India,Sri Lakshmi Narayana Institute of Medical Sciences,889,Puducherry,2017,49,49,100,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
3669,Woods (2006),"Woods CW, Murdoch DR, Zimmerman MD, et al. Emergence of Salmonella enterica serotype ParaTyphi A as a major cause of enteric fever in Kathmandu, Nepal. Trans R Soc Trop Med Hyg 2006; 100(11): 1063-7.",Systematic review,NPL,Nepal,Patan Hospital (Lalitpur),892,Central,2001,22,60,36.7,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
274,Khanal (2007),"Khanal B, Sharma SK, Bhattacharya SK, Bhattarai NR, Deb M, Kanungo R. Antimicrobial susceptibility patterns of Salmonella enterica serotype Typhi in eastern Nepal. J Health Popul Nutr 2007; 25(1): 82-7.",Systematic review,NPL,Nepal,B.P. Koirala Institute of Health Sciences (Koshi),893,Eastern,2001,23,30,76.7,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
833,Nobthai(2010),"Nobthai P, Serichantalergs O, Wongstitwilairoong B, et al. Emergence and properties of fluoroquinolone resistant Salmonella enterica serovar Typhi strains isolated from Nepal in 2002 and 2003. Southeast Asian J Trop Med Public Health 2010; 41(6): 1416-22.",Systematic review,NPL,Nepal,Unknown healthcare facilities in Kathmandu and Bharatpur,892,Central,2002,67,90,74.4,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
274,Khanal (2007),"Khanal B, Sharma SK, Bhattacharya SK, Bhattarai NR, Deb M, Kanungo R. Antimicrobial susceptibility patterns of Salmonella enterica serotype Typhi in eastern Nepal. J Health Popul Nutr 2007; 25(1): 82-7.",Systematic review,NPL,Nepal,B.P. Koirala Institute of Health Sciences (Koshi),893,Eastern,2002,19,25,76,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
2401,Lewis (2005),"Lewis MD, Serichantalergs O, Pitarangsi C, et al. Typhoid fever: a massive, single-point source, multidrug-resistant outbreak in Nepal. Clin Infect Dis 2005; 40(4): 554-61.",Systematic review,NPL,Nepal,Bharatpur College of Medical Sciences Hospital;Bharatpur Zonal Hospital,892,Central,2002,60,60,100,1,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
4673,Blacksell (2007),"Blacksell SD, Sharma NP, Phumratanaprapin W, et al. Serological and blood culture investigations of Nepalese fever patients. Trans R Soc Trop Med Hyg 2007; 101(7): 686-90.",Systematic review,NPL,Nepal,Dhulikhel Hospital (Kathmandu),892,Central,2003,10,15,66.7,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
712,Shirakawa (2006),"Shirakawa T, Acharya B, Kinoshita S, Kumagai S, Gotoh A, Kawabata M. Decreased susceptibility to fluoroquinolones and gyrA gene mutation in the Salmonella enterica serovar Typhi and ParaTyphi A isolated in Katmandu, Nepal, in 2003. Diagn Microbiol Infect Dis 2006; 54(4): 299-303.",Systematic review,NPL,Nepal,Unknown Hospital in Kathmandu,892,Central,2003,22,30,73.3,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
274,Khanal (2007),"Khanal B, Sharma SK, Bhattacharya SK, Bhattarai NR, Deb M, Kanungo R. Antimicrobial susceptibility patterns of Salmonella enterica serotype Typhi in eastern Nepal. J Health Popul Nutr 2007; 25(1): 82-7.",Systematic review,NPL,Nepal,B.P. Koirala Institute of Health Sciences (Koshi),893,Eastern,2003,28,34,82.4,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
1988,Maskey (2006),"Maskey AP, Day JN, Phung QT, et al. Salmonella enterica serovar ParaTyphi A and S. enterica serovar Typhi cause indistinguishable clinical syndromes in Kathmandu, Nepal. Clin Infect Dis 2006; 42(9): 1247-53.",Systematic review,NPL,Nepal,Patan Hospital (Lalitpur),892,Central,2004,205,406,50.5,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
274,Khanal (2007),"Khanal B, Sharma SK, Bhattacharya SK, Bhattarai NR, Deb M, Kanungo R. Antimicrobial susceptibility patterns of Salmonella enterica serotype Typhi in eastern Nepal. J Health Popul Nutr 2007; 25(1): 82-7.",Systematic review,NPL,Nepal,B.P. Koirala Institute of Health Sciences (Koshi),893,Eastern,2004,16,23,69.6,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
850,Tamang (2007),"Tamang MD, Oh J, Seol S, et al. Emergence of multidrug-resistant Salmonella enterica serovar Typhi associated with a class 1 integron carrying the dfrA7 gene cassette in Nepal. Int J Antimicrob Agents 2007; 30(4): 330-5.",Systematic review,NPL,Nepal,Dhulikhel Hospital (Kathmandu),892,Central,2005,50,93,53.8,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
971,Amatya (2007),"Amatya NM, Shrestha B, Lekhak B. Etiological agents of bacteraemia and antibiotic susceptibility pattern in Kathmandu Model Hospital. JNMA J Nepal Med Assoc 2007; 46(167): 112-8.",Systematic review,NPL,Nepal,Kathmandu Model Hospital (Kathmandu),892,Central,2005,10,16,62.5,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
1139,Holt (2009),"Holt KE, Baker S, Dongol S, et al. High-throughput bacterial SNP typing identifies distinct clusters of Salmonella Typhi causing typhoid in Nepalese children. BMC Infect Dis 2009; 10(144).",Systematic review,NPL,Nepal,Patan Hospital (Lalitpur),892,Central,2006,42,62,67.7,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
466,Neopane (2008),"Neopane A, Singh SB, Bhatta R, Dhital B, Karki DB. Changing spectrum of antibiotic sensitivity in enteric fever. Kathmandu Univ Med J (KUMJ) 2008; 6(1): 12-5.",Systematic review,NPL,Nepal,Kathmandu Medical College (Kathmandu),892,Central,2006,37,46,80.4,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
396,Pradhan (2012),"Pradhan R, Shrestha U, Gautam SC, et al. Bloodstream infection among children presenting to a general hospital outpatient clinic in urban Nepal. PLoS ONE 2012; 7(10): e47531.",Systematic review,NPL,Nepal,Patan Hospital (Lalitpur),892,Central,2007,60,107,56.1,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
1092,Arjyal (2011),"Arjyal A, Basnyat B, Koirala S, et al. Gatifloxacin versus chloramphenicol for uncomplicated enteric fever: an open-label, randomised, controlled trial. Lancet Infect Dis 2011; 11(6): 445-54.",Systematic review,NPL,Nepal,Patan Hospital (Lalitpur),892,Central,2007,159,243,65.4,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
1402,Dongol(2012),"Dongol S, Thompson CN, Clare S, et al. The microbiological and clinical characteristics of invasive Salmonella in gallbladders from cholecystectomy patients in kathmandu, Nepal. PLoS ONE 2012; 7(10): e47342.",Systematic review,NPL,Nepal,Patan Hospital (Lalitpur),892,Central,2009,11,22,50,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
1132,Karki (2013),"Karki AB, Bhatta DR, Shrestha B, et al. Higher nalidixic acid resistance pattern of Salmonella isolates from enteric fever patients in kathmandu model hospital Nepal. Res J Pharm Biol Chem Sci 2013; 4(2): 1687-93.",Systematic review,NPL,Nepal,Kathmandu Model Hospital (Kathmandu),892,Central,2009,34,55,61.8,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
2821,Singh (2011),"Singh U, Neopane A, Thapa M, Aryal N, Agrawal K. Salmonella Typhi infections and effect of fluroquinolones and third generation cephalosporins in clinical outcome. Journal of Nepal Paediatric Society 2011; 31(3): 216-21.",Systematic review,NPL,Nepal,Shree Birendra Hospital (Kathmandu),892,Central,2010,15,21,71.4,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
150,Acharya (2012),"Acharya D, Trakulsomboon S, Madhup SK, Korbsrisate S. Antibiotic susceptibility pattern and the indicator of decreased ciprofloxacin susceptibility of Salmonella enterica serovar Typhi isolated from Dhulikhel Hospital, Nepal. Jpn J Infect Dis 2012; 65(3): 264-7.",Systematic review,NPL,Nepal,Dhulikhel Hospital (Kathmandu),892,Central,2010,35,40,87.5,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
2808,Chaudhary (2011),"Chaudhary R, Sijapati K, Singh SK. A study on nalidixic acid resistant Salmonella among the patients attending Shree Birendra Hospital. Med J Shree Birendra Hosp 2011; 10(2): 1-3.",Systematic review,NPL,Nepal,Shree Birendra Hospital (Kathmandu),892,Central,2011,62,114,54.4,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
593,Joshi (2011),"Joshi BG, Keyal K, Pandey R, Shrestha BM. Clinical profile and sensitivity pattern of Salmonella serotypes in children: A hospital based study. Journal of Nepal Paediatric Society 2011; 31(3): 180-3.",Systematic review,NPL,Nepal,Civil Service Hospital (Kathmandu),892,Central,2011,14,25,56,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
2806,Adhikari (2012),"Adhikari D, Acharya D, Shrestha P, Amatya R. Ciprofloxacin susceptibility of Salmonella enteric serovar Typhi and ParaTyphi A from blood samples of suspected enteric fever patients. International Journal of Infection and Microbiology 2012; 1(1): 9-13.",Systematic review,NPL,Nepal,KIST Medical College (Kathmandu),892,Central,2011,41,41,100,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
1323,Rai (2012)<U+1D43>,"Rai GK, Karki S, Prajapati B. Is antimicrobial resistance pattern of enteric fever changing in Kathmandu valley? Journal of Nepal Paediatric Society 2012a; 32(3): 221-8.",Systematic review,NPL,Nepal,Kanti Children's Hospital (Kathmandu),892,Central,2012,20,32,62.5,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5064,Zellweger (2017),"Zellweger RM, Basnyat B, Shrestha P, et al. A 23-year retrospective investigation of Salmonella Typhi and Salmonella ParaTyphi isolated in a tertiary Kathmandu hospital.PLoS Neglected Tropical Diseases [electronic resource] 2017;11(11):e0006051",Systematic review,NPL,Nepal,Patan Hospital (Lalitpur),892,Central,2012,197,280,70.4,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
1895,Chand (2014),"Chand HJ, Rijal KR, Neupane B, Sharma VK, Jha B. Re-emergence of susceptibility to conventional first line drugs in Salmonella isolates from enteric fever patients in Nepal. J Infect Dev Ctries 2014; 8(11): 1483-7.",Systematic review,NPL,Nepal,"Alka Hospital (Jawalakhel, Lalitpur)",892,Central,2012,51,56,91.1,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5104,Petersiel (2018),"Petersiel N, Shresta S, Tamrakar R, et al. The epidemiology of typhoid fever in the Dhulikhel area, Nepal: A prospective cohort study.PLoS ONE 2018;13 (9) (no pagination)(e0204479):",Systematic review,NPL,Nepal,Dhulikhel Hospital (Kathmandu),892,Central,2013,54,63,85.7,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
3182,Arjyal (2016),"Arjyal A, Basnyat B, Nhan HT, et al. Gatifloxacin versus ceftriaxone for uncomplicated enteric fever in Nepal: an open-label, two-centre, randomised controlled trial. Lancet Infect Dis 2016; 16(5): 535-45.",Systematic review,NPL,Nepal,Civil Service Hospital (Kathmandu);Patan Hospital (Lalitpur),892,Central,2013,71,78,91,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5064,Zellweger (2017),"Zellweger RM, Basnyat B, Shrestha P, et al. A 23-year retrospective investigation of Salmonella Typhi and Salmonella ParaTyphi isolated in a tertiary Kathmandu hospital.PLoS Neglected Tropical Diseases [electronic resource] 2017;11(11):e0006051",Systematic review,NPL,Nepal,Patan Hospital (Lalitpur),892,Central,2013,477,515,92.6,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5064,Zellweger (2017),"Zellweger RM, Basnyat B, Shrestha P, et al. A 23-year retrospective investigation of Salmonella Typhi and Salmonella ParaTyphi isolated in a tertiary Kathmandu hospital.PLoS Neglected Tropical Diseases [electronic resource] 2017;11(11):e0006051",Systematic review,NPL,Nepal,Patan Hospital (Lalitpur),892,Central,2014,183,191,95.8,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
2979,Gurung (2017),"Gurung B, Pandey S, Shah DK, et al. Antibiogram pattern of Salmonella in blood samples of enteric fever patients at lalitpur, nepal. Asian Pac J Trop Dis 2017; 7(1): 21-4.",Systematic review,NPL,Nepal,KIST Medical College (Kathmandu),892,Central,2015,22,41,53.7,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5073,Britto (2018),"Britto CD, Dyson ZA, Duchene S, et al. Laboratory and molecular surveillance of paediatric typhoidal Salmonella in Nepal: Antimicrobial resistance and implications for vaccine policy.PLoS Neglected Tropical Diseases [electronic resource] 2018;12(4):e0006408",Systematic review,NPL,Nepal,Patan Hospital (Lalitpur),892,Central,2015,9,10,90,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
2958,Khanal (2017),"Khanal PR, Satyal D, Bhetwal A, et al. Renaissance of conventional first-line antibiotics in Salmonella enterica clinical isolates: Assessment of MICs for therapeutic antimicrobials in enteric fever cases from Nepal. Biomed Res Int 2017; 2017: 2868143.",Systematic review,NPL,Nepal,Manmohan Memorial Community Hospital (Kathmandu),892,Central,2016,6,74,8.1,1,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5049,Bhetwal (2017),"Bhetwal A, Maharjan A, Khanal PR and Parajuli NP. Enteric Fever Caused by Salmonella enterica Serovars with Reduced Susceptibility of Fluoroquinolones at a Community Based Teaching Hospital of Nepal.International Journal of Microbiology 2017;2017(2869458",Systematic review,NPL,Nepal,Manmohan Memorial Teaching Hospital (Kathmandu),892,Central,2016,99,162,61.1,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5073,Britto (2018),"Britto CD, Dyson ZA, Duchene S, et al. Laboratory and molecular surveillance of paediatric typhoidal Salmonella in Nepal: Antimicrobial resistance and implications for vaccine policy.PLoS Neglected Tropical Diseases [electronic resource] 2018;12(4):e0006408",Systematic review,NPL,Nepal,Patan Hospital (Lalitpur),892,Central,2016,53,59,89.8,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5151,SEAP (2021),Sabine Vaccine Institute. Surveillance for Enteric Fever in Asia Project (SEAP) dataset. 2021,Dataset,NPL,Nepal,Kathmandu,892,Central,2017,23,25,92,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5151,SEAP (2021),Sabine Vaccine Institute. Surveillance for Enteric Fever in Asia Project (SEAP) dataset. 2021,Dataset,NPL,Nepal,Kathmandu,892,Central,2018,64,71,90.1,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5151,SEAP (2021),Sabine Vaccine Institute. Surveillance for Enteric Fever in Asia Project (SEAP) dataset. 2021,Dataset,NPL,Nepal,Kathmandu,892,Central,2019,24,29,82.8,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
1532,Afia (2005),"Afia Z, Ibrahim NG, Tanwir A, Zohair A, Zaidi A, Rumina H. Nalidixic acid screening test in detection of decreased fluoroquinolone susceptibility in Salmonella Typhi isolated from blood. J Coll Physicians Surg Pak 2005; 15(7): 413-7.",Systematic review,PAK,Pakistan,Aga Khan University Hospital (Karachi),902,Sind,2002,102,200,51,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
2446,Butt (2006),"Butt T, Khan MY, Ahmad RN, Salman M, Afzal RK. Validity of nalidixic acid screening in fluoroquinolone-resistant typhoid Salmonellae. J Coll Physicians Surg Pak 2006; 16(1): 31-4.",Systematic review,PAK,Pakistan,Armed Force Institute of Pathology,901,Punjab,2003,18,126,14.3,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
2180,Ochiai (2008),"Ochiai RL, Acosta CJ, Danovaro-Holliday MC, et al. A study of typhoid fever in five Asian countries: Disease burden and implications for controls. Bull World Health Organ 2008; 86(4): 260-8.",Systematic review,PAK,Pakistan,"Hijrat Colony, Sultanabad and Bilal Colony, Karachi",902,Sind,2003,75,127,59.1,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
1363,Mirza (2008),"Mirza SH, Khan MA. Low-level quinolone-resistance in multi-drug resistant typhoid. J Coll Physicians Surg Pak 2008; 18(1): 13-6.",Systematic review,PAK,Pakistan,Armed Force Institute of Pathology,901,Punjab,2005,19,29,65.5,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
4363,Ikram (2015),"Ikram S, Hussain S, Aslam A, Khan MD, Ahmed I. Evaluation of the current trends in the antimicrobial susceptibility patterns of typhoid Salmonellae. Pak J Med Health Sci 2015; 9(4): 1247-50.",Systematic review,PAK,Pakistan,Islamabad Hospital (PIMS),899,Islamabad,2007,36,71,50.7,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
463,Javaid (2012),"Javaid H, Zafar A, Ahmed JM, Ejaz H, Zubair M. Changing patterns of antimicrobial susceptibility of Salmonella Typhi at the children's hospital Lahore. Pak J Med Health Sci 2012; 6(1): 201-4.",Systematic review,PAK,Pakistan,The Children's Hospital (Lahore),901,Punjab,2010,9,60,15,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
693,Afzal(2012),"Afzal A, Sarwar Y, Ali A, Haque A. Current status of fluoroquinolone and cephalosporin resistance in Salmonella enterica serovar Typhi isolates from Faisalabad, Pakistan. Pak J Med Sci 2012; 28(4).",Systematic review,PAK,Pakistan,National Institute for Biotechnology and Genetic Engineering,901,Punjab,2011,24,30,80,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
1444,Afzal (2013),"Afzal A, Sarwar Y, Ali A, et al. Molecular evaluation of drug resistance in clinical isolates of Salmonella enterica serovar Typhi from Pakistan. J Infect Dev Ctries 2013; 7(12): 929-40.",Systematic review,PAK,Pakistan,Unknown public hospitals in Faisalabad,901,Punjab,2011,63,70,90,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5150,Sharkoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Khyber Pakhtunkhwa,900,Nwfp,2011,13,13,100,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5150,Sharkoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Punjab,901,Punjab,2011,36,39,92.3,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5150,Sharkoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Sindh,902,Sind,2011,654,726,90.1,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
4588,Malik(2016),"Malik N, Ahmed M. In vitro effect of new antibiotics against clinical isolates of Salmonella Typhi. J Coll Physicians Surg Pak 2016; 26(4): 288-92.",Systematic review,PAK,Pakistan,Armed Force Institute of Pathology,901,Punjab,2012,94,128,73.4,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5150,Sharkoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Balochistan,897,Balochistan,2012,5,5,100,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5150,Sharkoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Gilgit–Baltistan,904,Administrative unit not available,2012,9,10,90,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5150,Sharkoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Khyber Pakhtunkhwa,900,Nwfp,2012,8,8,100,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5150,Sharkoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Punjab,901,Punjab,2012,43,43,100,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5150,Sharkoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Sindh,902,Sind,2012,526,572,92,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
3023,Ali (2017),"Ali A, Ali HA, Shah FH, Zahid A, Aslam H, Javed B. Pattern of antimicrobial drug resistance of Salmonella Typhi and ParaTyphi a in a teaching hospital in Islamabad. J Pak Med Assoc 2017; 67(3): 375-9.",Systematic review,PAK,Pakistan,Khan Research Laboratories (KRL) Hospital,899,Islamabad,2013,146,155,94.2,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5150,Sharkoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Gilgit–Baltistan,904,Administrative unit not available,2013,15,16,93.8,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5150,Sharkoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Khyber Pakhtunkhwa,900,Nwfp,2013,15,15,100,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5150,Sharkoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Punjab,901,Punjab,2013,33,36,91.7,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5150,Sharkoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Sindh,902,Sind,2013,572,631,90.6,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5150,Sharkoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Balochistan,897,Balochistan,2014,5,6,83.3,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5150,Sharkoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Khyber Pakhtunkhwa,900,Nwfp,2014,10,10,100,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5150,Sharkoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Punjab,901,Punjab,2014,22,23,95.7,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5150,Sharkoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Sindh,902,Sind,2014,623,695,89.6,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5150,Sharkoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Khyber Pakhtunkhwa,900,Nwfp,2015,11,12,91.7,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5150,Sharkoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Punjab,901,Punjab,2015,32,32,100,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5150,Sharkoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Sindh,902,Sind,2015,827,869,95.2,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5151,SEAP (2021),Sabine Vaccine Institute. Surveillance for Enteric Fever in Asia Project (SEAP) dataset. 2021,Dataset,PAK,Pakistan,Karachi,902,Sind,2016,11,11,100,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5151,SEAP (2021),Sabine Vaccine Institute. Surveillance for Enteric Fever in Asia Project (SEAP) dataset. 2021,Dataset,PAK,Pakistan,Karachi,902,Sind,2017,107,117,91.5,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5151,SEAP (2021),Sabine Vaccine Institute. Surveillance for Enteric Fever in Asia Project (SEAP) dataset. 2021,Dataset,PAK,Pakistan,Karachi,902,Sind,2018,329,344,95.6,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5150,Sharkoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Balochistan,897,Balochistan,2019,311,311,100,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5150,Sharkoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Gilgit–Baltistan,904,Administrative unit not available,2019,124,124,100,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5150,Sharkoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Islamabad,899,Islamabad,2019,16,16,100,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5150,Sharkoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Khyber Pakhtunkhwa,900,Nwfp,2019,43,43,100,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5150,Sharkoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Punjab,901,Punjab,2019,747,748,99.9,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5150,Sharkoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Sindh,902,Sind,2019,6442,6457,99.8,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5151,SEAP (2021),Sabine Vaccine Institute. Surveillance for Enteric Fever in Asia Project (SEAP) dataset. 2021,Dataset,PAK,Pakistan,Karachi,902,Sind,2019,516,516,100,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5151,SEAP (2021),Sabine Vaccine Institute. Surveillance for Enteric Fever in Asia Project (SEAP) dataset. 2021,Dataset,PAK,Pakistan,Karachi,902,Sind,2020,58,59,98.3,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
2327,Dong(2010),"Dong BQ, Yang J, Wang XY, et al. Trends and disease burden of enteric fever in Guangxi province, China, 1994-2004. Bull World Health Organ 2010; 88(9): 689-96.",Systematic review,CHN,China,Center for Disease Control and Prevention Guangxi,10,Guangxi Zhuangzu Zizhiqu,1999,5,46,10.9,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
2882,Wang(2005),"Wang JL, Kao JH, Tseng SP, Teng LJ, Ho SW, Hsueh PR. Typhoid fever and typhoid hepatitis in Taiwan. Epidemiol Infect 2005; 133(6): 1073-9.",Systematic review,CHN,China,National Taiwan University Hospital,30,Taiwan Sheng,1999,0,27,0,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
2180,Ochiai (2008),"Ochiai RL, Acosta CJ, Danovaro-Holliday MC, et al. A study of typhoid fever in five Asian countries: Disease burden and implications for controls. Bull World Health Organ 2008; 86(4): 260-8.",Systematic review,CHN,China,Hechi,10,Guangxi Zhuangzu Zizhiqu,2002,0,15,0,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
2188,Chuang(2009),"Chuang CH, Su LH, Perera J, et al. Surveillance of antimicrobial resistance of Salmonella enterica serotype Typhi in seven Asian countries. Epidemiol Infect 2009; 137(2): 266-9.",Systematic review,CHN,China,Chang Gung Memorial Hospital;National Taiwan University Hospital,30,Taiwan Sheng,2003,6,15,40,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
930,Wang (2014),"Wang M, Kan B, Yang J, et al. Epidemiological characteristics of typhoid fever and antibiotic susceptibility testing of Salmonella Typhi isolates in Guangxi, 1994-2013 [Chinese]. Chung Hua Liu Hsing Ping Hsueh Tsa Chih 2014; 35(8): 930-4.",Systematic review,CHN,China,Guangxi,10,Guangxi Zhuangzu Zizhiqu,2004,69,475,14.5,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
1095,Wu (2010),"Wu W, Wang H, Lu J, et al. Genetic diversity of Salmonella enteric serovar Typhi and ParaTyphi in Shenzhen, China from 2002 through 2007. BMC Microbiol 2010; 10: 32.",Systematic review,CHN,China,Shenzhen People's Hospital,9,Guangdong Sheng,2005,6,25,24,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
244,Jiang(2015),"Jiang Y, Zuo H, Niu H, et al. Antimicrobial resistance surveillance of Salmonella isolates from the First People's Hospital of Yunnan Province, China. J Infect Dev Ctries 2015; 9(4): 333-7.",Systematic review,CHN,China,First People’s Hospital of Yunnan Province,34,Yunnan Sheng,2006,5,37,13.5,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5112,Song(2018),"Song Q, Xu Z, Gao H, Zhang D. Overview of the development of quinolone resistance in Salmonella species in China, 2005-2016. Infect Drug Resist 2018; 11: 267-74.",Systematic review,CHN,China,Ningbo,35,Zhejiang Sheng,2007,5,54,9.3,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
4229,Chiou(2014),"Chiou CS, Lauderdale TL, Phung DC, et al. Antimicrobial resistance in Salmonella enterica serovar Typhi isolates from Bangladesh, Indonesia, Taiwan, and Vietnam. Antimicrob Agents Chemother 2014; 58(11): 6501-7.",Systematic review,CHN,China,"Centers for Disease Control, Taiwan",30,Taiwan Sheng,2008,0,36,0,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
926,Zhuang (2012),"Zhuang L, Zhang YJ, Tang Z, et al. Epidemiologic characteristics of typhoid and paratyphoid fever on related drug resistance and molecular types regarding Salmonella Typhi and S. ParaTyphi, in Jiangsu province [Chinese]. Chung Hua Liu Hsing Ping Hsueh Tsa Chih 2012; 33(12): 1269-72.",Systematic review,CHN,China,Jiangsu,18,Jiangsu Sheng,2009,87,139,62.6,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
2909,Song(2017),"Song Q, Yang Y, Lin W, Yi B, Xu G. Epidemiological characteristics and clinical treatment outcome of typhoid fever in Ningbo, China, 2005-2014: Pulsed-field gel electorophoresis results revealing great proportion of common transmission sources. Jpn J Infect Dis 2017; 70(5): 513-7.",Systematic review,CHN,China,Ningbo Municipal Centre for Disease Control and Prevention,35,Zhejiang Sheng,2011,4,32,12.5,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5112,Song(2018),"Song Q, Xu Z, Gao H, Zhang D. Overview of the development of quinolone resistance in Salmonella species in China, 2005-2016. Infect Drug Resist 2018; 11: 267-74.",Systematic review,CHN,China,Ningbo,35,Zhejiang Sheng,2011,21,60,35,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5053,Kong(2017),"Kong X, Dong C, Ji H, et al. Antimicrobial resistance and molecular subtypes of Salmonella Typhi and Salmonella paratyphoid isolates from Jiangsu province, 2012-2015. [Chinese]. Chinese Journal of Endemiology 2017; 38(11): 1546-50.",Systematic review,CHN,China,Center for Disease Control and Prevention Jiangsu,18,Jiangsu Sheng,2012,32,40,80,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
2909,Song(2017),"Song Q, Yang Y, Lin W, Yi B, Xu G. Epidemiological characteristics and clinical treatment outcome of typhoid fever in Ningbo, China, 2005-2014: Pulsed-field gel electorophoresis results revealing great proportion of common transmission sources. Jpn J Infect Dis 2017; 70(5): 513-7.",Systematic review,CHN,China,Ningbo Municipal Centre for Disease Control and Prevention,35,Zhejiang Sheng,2012,42,56,75,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5053,Kong(2017),"Kong X, Dong C, Ji H, et al. Antimicrobial resistance and molecular subtypes of Salmonella Typhi and Salmonella paratyphoid isolates from Jiangsu province, 2012-2015. [Chinese]. Chinese Journal of Endemiology 2017; 38(11): 1546-50.",Systematic review,CHN,China,Center for Disease Control and Prevention Jiangsu,18,Jiangsu Sheng,2013,16,26,61.5,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5053,Kong(2017),"Kong X, Dong C, Ji H, et al. Antimicrobial resistance and molecular subtypes of Salmonella Typhi and Salmonella paratyphoid isolates from Jiangsu province, 2012-2015. [Chinese]. Chinese Journal of Endemiology 2017; 38(11): 1546-50.",Systematic review,CHN,China,Center for Disease Control and Prevention Jiangsu,18,Jiangsu Sheng,2014,12,23,52.2,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5053,Kong(2017),"Kong X, Dong C, Ji H, et al. Antimicrobial resistance and molecular subtypes of Salmonella Typhi and Salmonella paratyphoid isolates from Jiangsu province, 2012-2015. [Chinese]. Chinese Journal of Endemiology 2017; 38(11): 1546-50.",Systematic review,CHN,China,Center for Disease Control and Prevention Jiangsu,18,Jiangsu Sheng,2015,11,27,40.7,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5112,Song(2018),"Song Q, Xu Z, Gao H, Zhang D. Overview of the development of quinolone resistance in Salmonella species in China, 2005-2016. Infect Drug Resist 2018; 11: 267-74.",Systematic review,CHN,China,Ningbo,35,Zhejiang Sheng,2015,66,74,89.2,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
623,Isbandrio(1994),"Isbandrio BB, Gasem MH, Dolmans WMV, Hoogkamp-Korstanje JAA. Comparative activities of three quinolones and seven comparison standard drugs against Salmonella Typhi from Indonesia [1]. J Antimicrob Chemother 1994; 33(5): 1055-6.",Systematic review,IDN,Indonesia,Dr Kariadi Hospital,67,JAWA TENGAH,1991,0,218,0,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
883,Punjabi (2013),"Punjabi NH, Agtini MD, Ochiai RL, et al. Enteric fever burden in North Jakarta, Indonesia: a prospective, community-based study. J Infect Dev Ctries 2013; 7(11): 781-7.",Systematic review,IDN,Indonesia,Tanjung Priok & Koja,57,DKI JAKARTA,2002,0,221,0,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
843,Yanagi (2009),"Yanagi D, de Vries GC, Rahardjo D, et al. Emergence of fluoroquinolone-resistant strains of Salmonella enterica in Surabaya, Indonesia. Diagn Microbiol Infect Dis 2009; 64(4): 422-6.",Systematic review,IDN,Indonesia,Dr. Soetomo General Hospital,44,JAWA TIMUR,2006,0,9,0,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
843,Yanagi (2009),"Yanagi D, de Vries GC, Rahardjo D, et al. Emergence of fluoroquinolone-resistant strains of Salmonella enterica in Surabaya, Indonesia. Diagn Microbiol Infect Dis 2009; 64(4): 422-6.",Systematic review,IDN,Indonesia,Dr. Soetomo General Hospital,44,JAWA TIMUR,2008,8,8,100,1,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
2978,Hardjo Lugito (2017),"Hardjo Lugito NP, Cucunawangsih. Antimicrobial resistance of Salmonella enterica serovars Typhi and ParaTyphi isolates from a general hospital in Karawaci, Tangerang, Indonesia: A five-year review. Int J Microbiol 2017; 2017: 6215136.",Systematic review,IDN,Indonesia,Siloam Hospital (Karawaci),69,BANTEN,2011,0,14,0,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
2978,Hardjo Lugito (2017),"Hardjo Lugito NP, Cucunawangsih. Antimicrobial resistance of Salmonella enterica serovars Typhi and ParaTyphi isolates from a general hospital in Karawaci, Tangerang, Indonesia: A five-year review. Int J Microbiol 2017; 2017: 6215136.",Systematic review,IDN,Indonesia,Siloam Hospital (Karawaci),69,BANTEN,2012,1,16,6.3,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
2978,Hardjo Lugito (2017),"Hardjo Lugito NP, Cucunawangsih. Antimicrobial resistance of Salmonella enterica serovars Typhi and ParaTyphi isolates from a general hospital in Karawaci, Tangerang, Indonesia: A five-year review. Int J Microbiol 2017; 2017: 6215136.",Systematic review,IDN,Indonesia,Siloam Hospital (Karawaci),69,BANTEN,2013,0,17,0,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
2978,Hardjo Lugito (2017),"Hardjo Lugito NP, Cucunawangsih. Antimicrobial resistance of Salmonella enterica serovars Typhi and ParaTyphi isolates from a general hospital in Karawaci, Tangerang, Indonesia: A five-year review. Int J Microbiol 2017; 2017: 6215136.",Systematic review,IDN,Indonesia,Siloam Hospital (Karawaci),69,BANTEN,2014,0,27,0,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
2978,Hardjo Lugito (2017),"Hardjo Lugito NP, Cucunawangsih. Antimicrobial resistance of Salmonella enterica serovars Typhi and ParaTyphi isolates from a general hospital in Karawaci, Tangerang, Indonesia: A five-year review. Int J Microbiol 2017; 2017: 6215136.",Systematic review,IDN,Indonesia,Siloam Hospital (Karawaci),69,BANTEN,2015,0,19,0,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
852,Kasper (2010),"Kasper MR, Sokhal B, Blair PJ, Wierzba TF, Putnam SD. Emergence of multidrug-resistant Salmonella enterica serovar Typhi with reduced susceptibility to fluoroquinolones in Cambodia. Diagn Microbiol Infect Dis 2010; 66(2): 207-9.",Systematic review,KHM,Cambodia,Unknown healthcare facilities in Kandal district;Unknown healthcare facilities in Oudong district,84,Kandal,2008,36,41,87.8,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
316,Vlieghe (2012),"Vlieghe ER, Phe T, De Smet B, et al. Azithromycin and ciprofloxacin resistance in Salmonella bloodstream infections in Cambodian adults. PLoS Negl Trop Dis 2012; 6(12): e1933.",Systematic review,KHM,Cambodia,Sihanouk Hospital Center of Hope,92,Phnom Penh,2009,18,20,90,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
891,Ngoun (2012),"Ngoun C, Emary K, Khun PA, et al. Enteric fever in Cambodian children is dominated by multidrug resistant H58 Salmonella enterica serovar Typhi with decreased susceptibility to ciprofloxacin. Int J Infect Dis 2012; 16: e427.",Systematic review,KHM,Cambodia,Angkor Hospital for Children;Angkor Hospital for Children Satellite Clinic,97,Siemreap,2009,133,148,89.9,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
2955,Kuijpers (2017),"Kuijpers LMF, Phe T, Veng CH, et al. The clinical and microbiological characteristics of enteric fever in Cambodia, 2008-2015. PLoS Negl Trop Dis 2017; 11(9): e0005964.",Systematic review,KHM,Cambodia,Sihanouk Hospital Center of Hope,92,Phnom Penh,2010,35,35,100,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
2809,Chheng (2013),"Chheng K, Carter MJ, Emary K, et al. A prospective study of the causes of febrile illness requiring hospitalization in children in Cambodia. PLoS ONE 2013; 8(4): e60634.",Systematic review,KHM,Cambodia,Angkor Hospital for Children,97,Siemreap,2010,19,21,90.5,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
2955,Kuijpers (2017),"Kuijpers LMF, Phe T, Veng CH, et al. The clinical and microbiological characteristics of enteric fever in Cambodia, 2008-2015. PLoS Negl Trop Dis 2017; 11(9): e0005964.",Systematic review,KHM,Cambodia,Sihanouk Hospital Center of Hope,92,Phnom Penh,2014,27,29,93.1,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5134,Turner(2019),Turner P. GRAM_data_AHC-COMRU_2015. Cambodia; 2019.,Dataset,KHM,Cambodia,Angkor Hospital for Children,97,Siemreap,2015,34,34,100,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5134,Turner(2019),Turner P. GRAM_data_AHC-COMRU_2015. Cambodia; 2019.,Dataset,KHM,Cambodia,Angkor Hospital for Children Satellite Clinic,97,Siemreap,2015,7,7,100,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
434,Mayxay (2013),"Mayxay M, Castonguay-Vanier J, Chansamouth V, et al. Causes of non-malarial fever in Laos: a prospective study. Lancet Glob Health 2013; 1(1): e46-54.",Systematic review,LAO,Laos,Luang Namtha Provincial Hospital,110,Louang-Namtha,2009,1,30,3.3,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5148,Roberts (2019),"Roberts T. LOMRU blood culture database. Vientiene, Laos; 2019",Dataset,LAO,Laos,Mahosot Hospital,117,Vientiane capital,2013,2,28,7.1,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5148,Roberts (2019),"Roberts T. LOMRU blood culture database. Vientiene, Laos; 2019",Dataset,LAO,Laos,Setthathirath Hospital,117,Vientiane capital,2013,1,5,20,1,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5148,Roberts (2019),"Roberts T. LOMRU blood culture database. Vientiene, Laos; 2019",Dataset,LAO,Laos,Mahosot Hospital,117,Vientiane capital,2014,0,28,0,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5148,Roberts (2019),"Roberts T. LOMRU blood culture database. Vientiene, Laos; 2019",Dataset,LAO,Laos,Mahosot Hospital,117,Vientiane capital,2015,1,9,11.1,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5148,Roberts (2019),"Roberts T. LOMRU blood culture database. Vientiene, Laos; 2019",Dataset,LAO,Laos,Mahosot Hospital,117,Vientiane capital,2016,2,21,9.5,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5148,Roberts (2019),"Roberts T. LOMRU blood culture database. Vientiene, Laos; 2019",Dataset,LAO,Laos,Mahosot Hospital,117,Vientiane capital,2017,0,9,0,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5148,Roberts (2019),"Roberts T. LOMRU blood culture database. Vientiene, Laos; 2019",Dataset,LAO,Laos,Mahosot Hospital,117,Vientiane capital,2018,2,21,9.5,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
2188,Chuang(2009),"Chuang CH, Su LH, Perera J, et al. Surveillance of antimicrobial resistance of Salmonella enterica serotype Typhi in seven Asian countries. Epidemiol Infect 2009; 137(2): 266-9.",Systematic review,LKA,Sri Lanka,National Hospital of Sri Lanka,128,Western,2003,3,17,17.6,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
390,Shwe (2002),"Shwe TN, Nyein MM, Yi W, Mon A. Blood culture isolates from children admitted to Medical Unit III, Yangon Children's Hospital, 1998. Southeast Asian J Trop Med Public Health 2002; 33(4): 764-71.",Systematic review,MMR,Myanmar,Yangon Children's Hospital,134,Yangon Division,1999,0,28,0,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
3715,Tunung(2007),"Tunung R, Chai LC, Usha MR, et al. Incidence and characterization of Salmonella species in street food and clinical samples. Journal of Food Safety 2007; 27(4): 345-61.",Systematic review,MYS,Malaysia,Unknown hospital in Klang,170,Selangor,2004,1,8,12.5,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
2188,Chuang(2009),"Chuang CH, Su LH, Perera J, et al. Surveillance of antimicrobial resistance of Salmonella enterica serotype Typhi in seven Asian countries. Epidemiol Infect 2009; 137(2): 266-9.",Systematic review,PHL,Philippines,Research Institute for Tropical Medicine,176,National Capital region (NCR),2003,24,28,85.7,1,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
1845,Parry (1998),"Parry C, Wain J, Chinh NT, Vinh H, Farrar JJ. Quinolone-resistant Salmonella Typhi in Vietnam. Lancet 1998; 351(9111): 1289.",Systematic review,VNM,Vietnam,Centre for Tropical Diseases,328,Ho Chi Minh,1993,10,246,4.1,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
3145,Ly (1998),"Ly N, Chinh N, Parry C, Diep T, Wain J, White N. Randomised trial of azithromycin versus ofloxacin for the treatment of typhoid fever in adult. Med J Indones 1998; 7: 202-6.",Systematic review,VNM,Vietnam,Centre for Tropical Diseases,328,Ho Chi Minh,1994,1,26,3.8,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
4065,Nga (2012),"Nga TVT, Parry CM, Le T, et al. The decline of typhoid and the rise of non-typhoid Salmonellae and fungal infections in a changing HIV landscape: Bloodstream infection trends over 15 years in southern Vietnam. Trans R Soc Trop Med Hyg 2012; 106(1): 26-34.",Systematic review,VNM,Vietnam,Centre for Tropical Diseases,328,Ho Chi Minh,1995,14,716,2,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
640,Vinh (2005),"Vinh H, Duong NM, Phuong le T, et al. Comparative trial of short-course ofloxacin for uncomplicated typhoid fever in Vietnamese children. Ann Trop Paediatr 2005; 25(1): 17-22.",Systematic review,VNM,Vietnam,Dong Thap Provincial Hospital,360,Dong Thap,1995,5,166,3,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
272,Nguyen Dac(2007),"Nguyen Dac T, Suthisarnsuntorn U, Kalambaheti T, Wonglumsom W, Tunyong W. Antimicrobial susceptibility patterns and phage types of Salmonella Typhi from Vietnam. Southeast Asian J Trop Med Public Health 2007; 38(3): 487-92.",Systematic review,VNM,Vietnam,National Hospital (HCMC),328,Ho Chi Minh,1996,2,14,14.3,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
1832,Wain (2001),"Wain J, Bay PVB, Vinh H, et al. Quantitation of bacteria in bone marrow from patients with typhoid fever: Relationship between counts and clinical features. J Clin Microbiol 2001; 39(4): 1571-6.",Systematic review,VNM,Vietnam,Dong Thap Provincial Hospital,360,Dong Thap,1996,14,89,15.7,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
272,Nguyen Dac(2007),"Nguyen Dac T, Suthisarnsuntorn U, Kalambaheti T, Wonglumsom W, Tunyong W. Antimicrobial susceptibility patterns and phage types of Salmonella Typhi from Vietnam. Southeast Asian J Trop Med Public Health 2007; 38(3): 487-92.",Systematic review,VNM,Vietnam,National Hospital (Hanoi),368,Ha Noi,1996,0,52,0,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
272,Nguyen Dac(2007),"Nguyen Dac T, Suthisarnsuntorn U, Kalambaheti T, Wonglumsom W, Tunyong W. Antimicrobial susceptibility patterns and phage types of Salmonella Typhi from Vietnam. Southeast Asian J Trop Med Public Health 2007; 38(3): 487-92.",Systematic review,VNM,Vietnam,National Hospital (Hue),373,Thua Thien Hue,1996,0,45,0,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
636,Phuong (1999),"Phuong CXT, Kneen R, Anh NT, Luat TD, White NJ, Parry CM. A comparative study of ofloxacin and cefixime for treatment of typhoid fever in children. Pediatr Infect Dis J 1999; 18(3): 245-8.",Systematic review,VNM,Vietnam,Dong Nai Pediatric Centre,374,Dong Nai,1996,0,82,0,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
1845,Parry (1998),"Parry C, Wain J, Chinh NT, Vinh H, Farrar JJ. Quinolone-resistant Salmonella Typhi in Vietnam. Lancet 1998; 351(9111): 1289.",Systematic review,VNM,Vietnam,Centre for Tropical Diseases,328,Ho Chi Minh,1997,27,228,11.8,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
1845,Parry (1998),"Parry C, Wain J, Chinh NT, Vinh H, Farrar JJ. Quinolone-resistant Salmonella Typhi in Vietnam. Lancet 1998; 351(9111): 1289.",Systematic review,VNM,Vietnam,Centre for Tropical Diseases,328,Ho Chi Minh,1998,161,213,75.6,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
4065,Nga (2012),"Nga TVT, Parry CM, Le T, et al. The decline of typhoid and the rise of non-typhoid Salmonellae and fungal infections in a changing HIV landscape: Bloodstream infection trends over 15 years in southern Vietnam. Trans R Soc Trop Med Hyg 2012; 106(1): 26-34.",Systematic review,VNM,Vietnam,Centre for Tropical Diseases,328,Ho Chi Minh,1998,264,599,44.1,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
1862,Parry(2007),"Parry CM, Ho VA, Phuong le T, et al. Randomized controlled comparison of ofloxacin, azithromycin, and an ofloxacin-azithromycin combination for treatment of multidrug-resistant and nalidixic acid-resistant typhoid fever. Antimicrob Agents Chemother 2007; 51(3): 819-25.",Systematic review,VNM,Vietnam,Dong Thap Provincial Hospital,360,Dong Thap,2000,173,187,92.5,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
2188,Chuang(2009),"Chuang CH, Su LH, Perera J, et al. Surveillance of antimicrobial resistance of Salmonella enterica serotype Typhi in seven Asian countries. Epidemiol Infect 2009; 137(2): 266-9.",Systematic review,VNM,Vietnam,University Hospital (HCMC),328,Ho Chi Minh,2003,92,102,90.2,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
2180,Ochiai (2008),"Ochiai RL, Acosta CJ, Danovaro-Holliday MC, et al. A study of typhoid fever in five Asian countries: Disease burden and implications for controls. Bull World Health Organ 2008; 86(4): 260-8.",Systematic review,VNM,Vietnam,Hue,373,Thua Thien Hue,2003,8,18,44.4,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
4065,Nga (2012),"Nga TVT, Parry CM, Le T, et al. The decline of typhoid and the rise of non-typhoid Salmonellae and fungal infections in a changing HIV landscape: Bloodstream infection trends over 15 years in southern Vietnam. Trans R Soc Trop Med Hyg 2012; 106(1): 26-34.",Systematic review,VNM,Vietnam,Centre for Tropical Diseases,328,Ho Chi Minh,2008,17,34,50,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5079,Francisco(2018),"Francisco M, Costa SS, Belas A, et al. First report on antimicrobial resistance and molecular characterisation of Salmonella enterica serotype Typhi isolated from human specimens in Luanda, Angola. Journal of Global Antimicrobial Resistance 2018; 13: 246-9.",Systematic review,AGO,Angola,Clínica Sagrada Esperança,915,Luanda,2014,2,10,20,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
3907,Vandenberg (2010),"Vandenberg O, Nyarukweba DZ, Ndeba PM, et al. Microbiologic and clinical features of Salmonella species isolated from bacteremic children in eastern Democratic Republic of Congo. Pediatr Infect Dis J 2010; 29(6): 504-10.",Systematic review,COD,Democratic Republic of the Congo,Children’s Hospital of Lwiro (Lwiro Pediatric Hospital),1016,Sud-Kivu,2004,2,29,6.9,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
1647,Muyembe-Tamfum (2009),"Muyembe-Tamfum JJ, Veyi J, Kaswa M, Lunguya O, Verhaegen J, Boelaert M. An outbreak of peritonitis caused by multidrug-resistant Salmonella Typhi in Kinshasa, Democratic Republic of Congo. Travel Med Infect Dis 2009; 7(1): 40-3.",Systematic review,COD,Democratic Republic of the Congo,General Reference Hospital Kinshasa;General Reference Hospital Ndjili;Hôpital Roi Baudouin;University Hospital Kinshasa (UNIKIN),1012,Kinshasa,2005,0,11,0,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
1494,Phoba (2012),"Phoba MF, Lunguya O, Mayimon DV, et al. Multidrug-resistant Salmonella enterica, Democratic Republic of the Congo. Emerg Infect Dis 2012; 18(10): 1693-4.",Systematic review,COD,Democratic Republic of the Congo,Hospital of Saint Luc (Kisantu),1007,Bas-Congo,2010,7,17,41.2,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
4370,Kalonji (2015),"Kalonji LM, Post A, Phoba MF, et al. Invasive Salmonella infections at multiple aurveillance aites in the Democratic Republic of the Congo, 2011-2014. Clin Infect Dis 2015; 61: S346-S53.",Systematic review,COD,Democratic Republic of the Congo,Unknown healthcare facilities in Bas Congo,1007,Bas-Congo,2011,9,25,36,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
4370,Kalonji (2015),"Kalonji LM, Post A, Phoba MF, et al. Invasive Salmonella infections at multiple aurveillance aites in the Democratic Republic of the Congo, 2011-2014. Clin Infect Dis 2015; 61: S346-S53.",Systematic review,COD,Democratic Republic of the Congo,Unknown healthcare facilities in Bas Congo,1007,Bas-Congo,2012,14,32,43.8,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
4370,Kalonji (2015),"Kalonji LM, Post A, Phoba MF, et al. Invasive Salmonella infections at multiple aurveillance aites in the Democratic Republic of the Congo, 2011-2014. Clin Infect Dis 2015; 61: S346-S53.",Systematic review,COD,Democratic Republic of the Congo,Unknown healthcare facilities in Equateur,1008,Equateur,2012,0,18,0,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
4370,Kalonji (2015),"Kalonji LM, Post A, Phoba MF, et al. Invasive Salmonella infections at multiple aurveillance aites in the Democratic Republic of the Congo, 2011-2014. Clin Infect Dis 2015; 61: S346-S53.",Systematic review,COD,Democratic Republic of the Congo,Unknown healthcare facilities in Bas Congo,1007,Bas-Congo,2013,6,12,50,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
4370,Kalonji (2015),"Kalonji LM, Post A, Phoba MF, et al. Invasive Salmonella infections at multiple aurveillance aites in the Democratic Republic of the Congo, 2011-2014. Clin Infect Dis 2015; 61: S346-S53.",Systematic review,COD,Democratic Republic of the Congo,Unknown healthcare facilities in Orientale,1015,Province Orientale,2013,1,5,20,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
4370,Kalonji (2015),"Kalonji LM, Post A, Phoba MF, et al. Invasive Salmonella infections at multiple aurveillance aites in the Democratic Republic of the Congo, 2011-2014. Clin Infect Dis 2015; 61: S346-S53.",Systematic review,COD,Democratic Republic of the Congo,Unknown healthcare facilities in Bas Congo,1007,Bas-Congo,2014,11,29,37.9,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
4370,Kalonji (2015),"Kalonji LM, Post A, Phoba MF, et al. Invasive Salmonella infections at multiple aurveillance aites in the Democratic Republic of the Congo, 2011-2014. Clin Infect Dis 2015; 61: S346-S53.",Systematic review,COD,Democratic Republic of the Congo,Unknown healthcare facilities in Kinshasa,1012,Kinshasa,2014,13,17,76.5,1,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
4370,Kalonji (2015),"Kalonji LM, Post A, Phoba MF, et al. Invasive Salmonella infections at multiple aurveillance aites in the Democratic Republic of the Congo, 2011-2014. Clin Infect Dis 2015; 61: S346-S53.",Systematic review,COD,Democratic Republic of the Congo,Unknown healthcare facilities in Orientale,1015,Province Orientale,2014,0,5,0,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
2410,Kariuki (2010),"Kariuki S, Revathi G, Kiiru J, et al. Typhoid in Kenya is associated with a dominant multidrug-resistant Salmonella enterica serovar Typhi haplotype that is also widespread in Southeast Asia. J Clin Microbiol 2010; 48(6): 2171-6.",Systematic review,KEN,Kenya,Unknown hospitals in Nairobi province,1106,Nairobi,1991,2,45,4.4,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
2796,Kariuki (2000),"Kariuki S, Gilks C, Revathi G, Hart CA. Genotypic analysis of multidrug-resistant Salmonella enterica Serovar Typhi, Kenya. Emerg Infect Dis 2000; 6(6): 649-51.",Systematic review,KEN,Kenya,Kenyatta National Hospital,1106,Nairobi,1991,0,16,0,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
2796,Kariuki (2000),"Kariuki S, Gilks C, Revathi G, Hart CA. Genotypic analysis of multidrug-resistant Salmonella enterica Serovar Typhi, Kenya. Emerg Infect Dis 2000; 6(6): 649-51.",Systematic review,KEN,Kenya,Kenyatta National Hospital,1106,Nairobi,1991,0,16,0,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
2410,Kariuki (2010),"Kariuki S, Revathi G, Kiiru J, et al. Typhoid in Kenya is associated with a dominant multidrug-resistant Salmonella enterica serovar Typhi haplotype that is also widespread in Southeast Asia. J Clin Microbiol 2010; 48(6): 2171-6.",Systematic review,KEN,Kenya,Unknown hospitals in Nairobi province,1106,Nairobi,1997,8,142,5.6,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
2796,Kariuki (2000),"Kariuki S, Gilks C, Revathi G, Hart CA. Genotypic analysis of multidrug-resistant Salmonella enterica Serovar Typhi, Kenya. Emerg Infect Dis 2000; 6(6): 649-51.",Systematic review,KEN,Kenya,Kenyatta National Hospital,1106,Nairobi,1998,0,22,0,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
3627,Brooks(2006),"Brooks JT, Ochieng JB, Kumar L, et al. Surveillance for bacterial diarrhea and antimicrobial resistance in rural western Kenya, 1997-2003. Clin Infect Dis 2006; 43(4): 393-401.",Systematic review,KEN,Kenya,Unknown hospitals and clinics in Asembo Bay,1108,Nyanza,2000,1,8,12.5,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
496,Kariuki (2004),"Kariuki S, Revathi G, Muyodi J, et al. Characterization of multidrug-resistant typhoid outbreaks in Kenya. J Clin Microbiol 2004; 42(4): 1477-82.",Systematic review,KEN,Kenya,Embu,1105,Eastern,2002,7,14,50,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
496,Kariuki (2004),"Kariuki S, Revathi G, Muyodi J, et al. Characterization of multidrug-resistant typhoid outbreaks in Kenya. J Clin Microbiol 2004; 42(4): 1477-82.",Systematic review,KEN,Kenya,Nairobi,1106,Nairobi,2002,38,85,44.7,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
2332,Mengo (2010),"Mengo DM, Kariuki S, Muigai A, Revathi G. Trends in Salmonella enteric serovar Typhi in Nairobi, Kenya from 2004 to 2006. J Infect Dev Ctries 2010; 4(6): 393-6.",Systematic review,KEN,Kenya,Aga Khan University Hospital (Nairobi);Kenyatta National Hospital,1106,Nairobi,2004,10,32,31.3,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
2410,Kariuki (2010),"Kariuki S, Revathi G, Kiiru J, et al. Typhoid in Kenya is associated with a dominant multidrug-resistant Salmonella enterica serovar Typhi haplotype that is also widespread in Southeast Asia. J Clin Microbiol 2010; 48(6): 2171-6.",Systematic review,KEN,Kenya,Unknown hospitals in Nairobi province,1106,Nairobi,2005,25,136,18.4,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
2332,Mengo (2010),"Mengo DM, Kariuki S, Muigai A, Revathi G. Trends in Salmonella enteric serovar Typhi in Nairobi, Kenya from 2004 to 2006. J Infect Dev Ctries 2010; 4(6): 393-6.",Systematic review,KEN,Kenya,Aga Khan University Hospital (Nairobi);Kenyatta National Hospital,1106,Nairobi,2005,15,39,38.5,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
2332,Mengo (2010),"Mengo DM, Kariuki S, Muigai A, Revathi G. Trends in Salmonella enteric serovar Typhi in Nairobi, Kenya from 2004 to 2006. J Infect Dev Ctries 2010; 4(6): 393-6.",Systematic review,KEN,Kenya,Aga Khan University Hospital (Nairobi);Kenyatta National Hospital,1106,Nairobi,2006,10,29,34.5,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5099,Mutai (2018),"Mutai WC, Muigai AWT, Waiyaki P and Kariuki S. Multi-drug resistant Salmonella enterica serovar Typhi isolates with reduced susceptibility to ciprofloxacin in Kenya.BMC Microbiology 2018;18(1):187",Systematic review,KEN,Kenya,Aga Khan University Hospital (Nairobi);Kenyatta National Hospital,1106,Nairobi,2006,109,144,75.7,1,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5149,KEMRI (2020),"Bigogo G, Verani JR, Munywoki P, Audi A. KEMRI CDC Gram_project_pbids30July2020. Nairobi, Kenya; 2020",Dataset,KEN,Kenya,CDC Tabitha clinic,1106,Nairobi,2007,5,62,8.1,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
1743,Breiman (2012),"Breiman RF, Cosmas L, Njuguna H, et al. Population-based incidence of typhoid fever in an urban informal settlement and a rural area in Kenya: implications for typhoid vaccine use in Africa. PLoS ONE 2012; 7(1): e29119.",Systematic review,KEN,Kenya,Kibera,1106,Nairobi,2008,9,132,6.8,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
1743,Breiman (2012),"Breiman RF, Cosmas L, Njuguna H, et al. Population-based incidence of typhoid fever in an urban informal settlement and a rural area in Kenya: implications for typhoid vaccine use in Africa. PLoS ONE 2012; 7(1): e29119.",Systematic review,KEN,Kenya,Lwak,1108,Nyanza,2008,1,22,4.5,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5149,KEMRI (2020),"Bigogo G, Verani JR, Munywoki P, Audi A. KEMRI CDC Gram_project_pbids30July2020. Nairobi, Kenya; 2020",Dataset,KEN,Kenya,CDC Tabitha clinic,1106,Nairobi,2008,3,86,3.5,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5149,KEMRI (2020),"Bigogo G, Verani JR, Munywoki P, Audi A. KEMRI CDC Gram_project_pbids30July2020. Nairobi, Kenya; 2020",Dataset,KEN,Kenya,CDC Tabitha clinic,1106,Nairobi,2009,2,30,6.7,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5149,KEMRI (2020),"Bigogo G, Verani JR, Munywoki P, Audi A. KEMRI CDC Gram_project_pbids30July2020. Nairobi, Kenya; 2020",Dataset,KEN,Kenya,CDC Tabitha clinic,1106,Nairobi,2010,7,99,7.1,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5149,KEMRI (2020),"Bigogo G, Verani JR, Munywoki P, Audi A. KEMRI CDC Gram_project_pbids30July2020. Nairobi, Kenya; 2020",Dataset,KEN,Kenya,CDC Tabitha clinic,1106,Nairobi,2011,7,64,10.9,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5149,KEMRI (2020),"Bigogo G, Verani JR, Munywoki P, Audi A. KEMRI CDC Gram_project_pbids30July2020. Nairobi, Kenya; 2020",Dataset,KEN,Kenya,CDC Tabitha clinic,1106,Nairobi,2012,5,94,5.3,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
2946,Marks (2017),"Marks F, Kalckreuth V, Aaby P, et al. Incidence of invasive Salmonella disease in sub-Saharan Africa: A multicentre population-based surveillance study. Lancet Glob Health 2017; 5(3): e310-e23.",Systematic review,KEN,Kenya,Unkown Hospitals in Kibera,1106,Nairobi,2013,22,61,36.1,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5149,KEMRI (2020),"Bigogo G, Verani JR, Munywoki P, Audi A. KEMRI CDC Gram_project_pbids30July2020. Nairobi, Kenya; 2020",Dataset,KEN,Kenya,CDC Tabitha clinic,1106,Nairobi,2013,1,16,6.3,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5086,Kavai(2018),"Kavai SM, Kangogo M, Muigai AWT, Kariuki S. Analysis of Trends in Resistance to Fluoroquinolones and Extended Spectrum Beta-Lactams among Salmonella Typhi Isolates Obtained from Patients at Four Outpatient Clinics in Nairobi County, Kenya. Advances in Microbiology 2018; 8(7): 578-88.",Systematic review,KEN,Kenya,Mbagathi District Hospital;Unkown faciltlies in Mukuru Kwa Njenga;Unkown faciltlies in Mukuru Reuben,1106,Nairobi,2014,2,287,0.7,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5149,KEMRI (2020),"Bigogo G, Verani JR, Munywoki P, Audi A. KEMRI CDC Gram_project_pbids30July2020. Nairobi, Kenya; 2020",Dataset,KEN,Kenya,CDC Tabitha clinic,1106,Nairobi,2014,7,22,31.8,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5149,KEMRI (2020),"Bigogo G, Verani JR, Munywoki P, Audi A. KEMRI CDC Gram_project_pbids30July2020. Nairobi, Kenya; 2020",Dataset,KEN,Kenya,CDC Tabitha clinic,1106,Nairobi,2015,10,26,38.5,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5149,KEMRI (2020),"Bigogo G, Verani JR, Munywoki P, Audi A. KEMRI CDC Gram_project_pbids30July2020. Nairobi, Kenya; 2020",Dataset,KEN,Kenya,CDC Tabitha clinic,1106,Nairobi,2016,6,8,75,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5149,KEMRI (2020),"Bigogo G, Verani JR, Munywoki P, Audi A. KEMRI CDC Gram_project_pbids30July2020. Nairobi, Kenya; 2020",Dataset,KEN,Kenya,CDC Tabitha clinic,1106,Nairobi,2018,6,8,75,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5149,KEMRI (2020),"Bigogo G, Verani JR, Munywoki P, Audi A. KEMRI CDC Gram_project_pbids30July2020. Nairobi, Kenya; 2020",Dataset,KEN,Kenya,CDC Tabitha clinic,1106,Nairobi,2019,39,69,56.5,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
276,Ashok(2010),"Ashok R, Peter K, Joselyne N, Emma N. Antimicrobial susceptibility patterns of Salmonella Typhi from Kigali, Rwanda. Shiraz E Medical Journal 2010; 11(3): 117-21.",Systematic review,RWA,Rwanda,King Faisal Hospital,1233,Kigali City/Umujyi wa Kigali,2007,1,33,3,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
276,Ashok(2010),"Ashok R, Peter K, Joselyne N, Emma N. Antimicrobial susceptibility patterns of Salmonella Typhi from Kigali, Rwanda. Shiraz E Medical Journal 2010; 11(3): 117-21.",Systematic review,RWA,Rwanda,King Faisal Hospital,1233,Kigali City/Umujyi wa Kigali,2008,7,36,19.4,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
394,Mahende (2015),"Mahende C, Ngasala B, Lusingu J, et al. Bloodstream bacterial infection among outpatient children with acute febrile illness in north-eastern Tanzania. BMC Res Notes 2015; 8: 289.",Systematic review,TZA,Tanzania,Korogwe District Hospital,1342,Tanga,2013,0,17,0,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
1352,Neil(2012),"Neil KP, Sodha SV, Lukwago L, et al. A large outbreak of typhoid fever associated with a high rate of intestinal perforation in Kasese District, Uganda, 2008-2009. Clin Infect Dis 2012; 54(8): 1091-9.",Systematic review,UGA,Uganda,Kasese District,1422,Kasese,2009,0,21,0,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
1103,Hendriksen(2015),"Hendriksen RS, Leekitcharoenphon P, Lukjancenko O, et al. Genomic signature of multidrug-resistant Salmonella enterica serovar Typhi isolates related to a massive outbreak in Zambia between 2010 and 2012. J Clin Microbiol 2015; 53(1): 262-72.",Systematic review,ZMB,Zambia,University Teaching Hospital (Lusaka),1460,Lusaka,2010,2,35,5.7,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
1103,Hendriksen(2015),"Hendriksen RS, Leekitcharoenphon P, Lukjancenko O, et al. Genomic signature of multidrug-resistant Salmonella enterica serovar Typhi isolates related to a massive outbreak in Zambia between 2010 and 2012. J Clin Microbiol 2015; 53(1): 262-72.",Systematic review,ZMB,Zambia,University Teaching Hospital (Lusaka),1460,Lusaka,2011,2,33,6.1,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
1103,Hendriksen(2015),"Hendriksen RS, Leekitcharoenphon P, Lukjancenko O, et al. Genomic signature of multidrug-resistant Salmonella enterica serovar Typhi isolates related to a massive outbreak in Zambia between 2010 and 2012. J Clin Microbiol 2015; 53(1): 262-72.",Systematic review,ZMB,Zambia,University Teaching Hospital (Lusaka),1460,Lusaka,2012,0,26,0,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
1643,Clarke(2012),"Clarke KR, Kanyanga MK, Musenga E, et al. Outbreak of multi-drug resistant Salmonella Typhi, lusaka, zambia 2011-2012. American Journal of Tropical Medicine and Hygiene 2012; 1: 318.",Systematic review,ZMB,Zambia,Two unknown city hospitals in Lusaka,1460,Lusaka,2012,9,27,33.3,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
2946,Marks (2017),"Marks F, Kalckreuth V, Aaby P, et al. Incidence of invasive Salmonella disease in sub-Saharan Africa: A multicentre population-based surveillance study. Lancet Glob Health 2017; 5(3): e310-e23.",Systematic review,BFA,Burkina Faso,Unkown Hospitals in Nioko II and Polesgo,954,Centre,2013,0,18,0,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
1082,Maltha (2014),"Maltha J, Guiraud I, Kabore B, et al. Frequency of severe malaria and invasive bacterial infections among children admitted to a rural hospital in Burkina Faso. PLoS ONE 2014; 9(2).",Systematic review,BFA,Burkina Faso,Centre Medical avec Antenne chirurgicale (CMA) Saint Camille of Nanoro;The Health Center Urbain (Nanoro),957,Centre-ouest,2013,0,12,0,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
4536,Eibacha (2016),"Eibacha D, Al-Emrana HM, Dekker DM, et al. The emergence of reduced ciprofloxacin susceptibility in Salmonella enterica causing bloodstream infections in rural Ghana. Clin Infect Dis 2016; 62(Suppl. 1): S32-S6.",Systematic review,GHA,Ghana,Agogo Presbyterian Hospital,1062,Ashanti,2008,0,89,0,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
2946,Marks (2017),"Marks F, Kalckreuth V, Aaby P, et al. Incidence of invasive Salmonella disease in sub-Saharan Africa: A multicentre population-based surveillance study. Lancet Glob Health 2017; 5(3): e310-e23.",Systematic review,GHA,Ghana,Agogo Presbyterian Hospital,1062,Ashanti,2011,0,66,0,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5065,Akinyemi (2018),"Akinyemi KO, Oyefolu AOB, Mutiu WB, et al. Typhoid fever: tracking the trend in Nigeria. (Special Issue: Tackling typhoid - what do global and country trends teach us?).American Journal of Tropical Medicine and Hygiene 2018;99(3 Suppl):41-47",Systematic review,NGA,Nigeria,Lagos University Teaching Hospital;General Hospital Lagos,1212,Lagos,1993,0,11,0,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5065,Akinyemi (2018),"Akinyemi KO, Oyefolu AOB, Mutiu WB, et al. Typhoid fever: tracking the trend in Nigeria. (Special Issue: Tackling typhoid - what do global and country trends teach us?).American Journal of Tropical Medicine and Hygiene 2018;99(3 Suppl):41-47",Systematic review,NGA,Nigeria,Lagos University Teaching Hospital;General Hospital Lagos,1212,Lagos,1994,0,8,0,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5065,Akinyemi (2018),"Akinyemi KO, Oyefolu AOB, Mutiu WB, et al. Typhoid fever: tracking the trend in Nigeria. (Special Issue: Tackling typhoid - what do global and country trends teach us?).American Journal of Tropical Medicine and Hygiene 2018;99(3 Suppl):41-47",Systematic review,NGA,Nigeria,Lagos University Teaching Hospital;General Hospital Lagos,1212,Lagos,1995,0,16,0,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
270,Olasupo(1999),"Olasupo NA, Alabi SA, Akinyemi KA, Omonigbehin EA. The antimicrobial susceptibility pattern of bacterial agents isolated from patients with diarrhoea. Biomedical Letters 1999; 60(235): 77-82.",Systematic review,NGA,Nigeria,Unknown healthcare facilities in Lagos metropolis,1212,Lagos,1996,0,44,0,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5065,Akinyemi (2018),"Akinyemi KO, Oyefolu AOB, Mutiu WB, et al. Typhoid fever: tracking the trend in Nigeria. (Special Issue: Tackling typhoid - what do global and country trends teach us?).American Journal of Tropical Medicine and Hygiene 2018;99(3 Suppl):41-47",Systematic review,NGA,Nigeria,Lagos University Teaching Hospital;General Hospital Lagos,1212,Lagos,1996,0,11,0,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5065,Akinyemi (2018),"Akinyemi KO, Oyefolu AOB, Mutiu WB, et al. Typhoid fever: tracking the trend in Nigeria. (Special Issue: Tackling typhoid - what do global and country trends teach us?).American Journal of Tropical Medicine and Hygiene 2018;99(3 Suppl):41-47",Systematic review,NGA,Nigeria,Lagos University Teaching Hospital;General Hospital Lagos,1212,Lagos,1997,0,12,0,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
2338,Akinyemi(2007)<U+1D47>,"Akinyemi KO, Smith SI, Oyefolu AO, Fasure KA, Coker AO. Trends of multiple drug resistance in Salmonella enterica serovar Typhi in Lagos, Nigeria. East and Central African Journal of Surgery 2007; 12(1): 83-8.",Systematic review,NGA,Nigeria,Central Public Health Laboratories (Yaba),1212,Lagos,1997,14,29,48.3,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
1783,Akinyemi (2000),"Akinyemi KO, Coker AO, Olukoya DK, Oyefolu AO, Amorighoye EP, Omonigbehin EO. Prevalence of multi-drug resistant Salmonella Typhi among clinically diagnosed typhoid fever patients in Lagos, Nigeria. Z Naturforsch [C] 2000; 55(5-6): 489-93.",Systematic review,NGA,Nigeria,Central Bank of Nigeria Health Clinics (Satellite Town);Central Public Health Laboratories (Yaba);Infectious Diseases Hospital (Lagos),1212,Lagos,1998,9,68,13.2,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5065,Akinyemi (2018),"Akinyemi KO, Oyefolu AOB, Mutiu WB, et al. Typhoid fever: tracking the trend in Nigeria. (Special Issue: Tackling typhoid - what do global and country trends teach us?).American Journal of Tropical Medicine and Hygiene 2018;99(3 Suppl):41-47",Systematic review,NGA,Nigeria,Lagos University Teaching Hospital;General Hospital Lagos,1212,Lagos,1998,0,34,0,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
2338,Akinyemi(2007)<U+1D47>,"Akinyemi KO, Smith SI, Oyefolu AO, Fasure KA, Coker AO. Trends of multiple drug resistance in Salmonella enterica serovar Typhi in Lagos, Nigeria. East and Central African Journal of Surgery 2007; 12(1): 83-8.",Systematic review,NGA,Nigeria,Central Public Health Laboratories (Yaba),1212,Lagos,1998,16,37,43.2,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5065,Akinyemi (2018),"Akinyemi KO, Oyefolu AOB, Mutiu WB, et al. Typhoid fever: tracking the trend in Nigeria. (Special Issue: Tackling typhoid - what do global and country trends teach us?).American Journal of Tropical Medicine and Hygiene 2018;99(3 Suppl):41-47",Systematic review,NGA,Nigeria,Lagos University Teaching Hospital;General Hospital Lagos,1212,Lagos,1999,0,33,0,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
2338,Akinyemi(2007)<U+1D47>,"Akinyemi KO, Smith SI, Oyefolu AO, Fasure KA, Coker AO. Trends of multiple drug resistance in Salmonella enterica serovar Typhi in Lagos, Nigeria. East and Central African Journal of Surgery 2007; 12(1): 83-8.",Systematic review,NGA,Nigeria,Central Public Health Laboratories (Yaba),1212,Lagos,1999,11,26,42.3,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5065,Akinyemi (2018),"Akinyemi KO, Oyefolu AOB, Mutiu WB, et al. Typhoid fever: tracking the trend in Nigeria. (Special Issue: Tackling typhoid - what do global and country trends teach us?).American Journal of Tropical Medicine and Hygiene 2018;99(3 Suppl):41-47",Systematic review,NGA,Nigeria,Lagos University Teaching Hospital;General Hospital Lagos,1212,Lagos,2000,0,18,0,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
2338,Akinyemi(2007)<U+1D47>,"Akinyemi KO, Smith SI, Oyefolu AO, Fasure KA, Coker AO. Trends of multiple drug resistance in Salmonella enterica serovar Typhi in Lagos, Nigeria. East and Central African Journal of Surgery 2007; 12(1): 83-8.",Systematic review,NGA,Nigeria,Central Public Health Laboratories (Yaba),1212,Lagos,2000,17,38,44.7,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
1467,Akinyemi (2005),"Akinyemi KO, Smith SI, Bola Oyefolu AO, Coker AO. Multidrug resistance in Salmonella enterica serovar Typhi isolated from patients with typhoid fever complications in Lagos, Nigeria. Public Health 2005; 119(4): 321-7.",Systematic review,NGA,Nigeria,Central Bank of Nigeria Health Clinics (Satellite Town);Ikeja General Hospital;Infectious Diseases Hospital (Lagos);Lagos University Teaching Hospital,1212,Lagos,2001,0,41,0,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5065,Akinyemi (2018),"Akinyemi KO, Oyefolu AOB, Mutiu WB, et al. Typhoid fever: tracking the trend in Nigeria. (Special Issue: Tackling typhoid - what do global and country trends teach us?).American Journal of Tropical Medicine and Hygiene 2018;99(3 Suppl):41-47",Systematic review,NGA,Nigeria,Lagos University Teaching Hospital;General Hospital Lagos,1212,Lagos,2001,0,8,0,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
2338,Akinyemi(2007)<U+1D47>,"Akinyemi KO, Smith SI, Oyefolu AO, Fasure KA, Coker AO. Trends of multiple drug resistance in Salmonella enterica serovar Typhi in Lagos, Nigeria. East and Central African Journal of Surgery 2007; 12(1): 83-8.",Systematic review,NGA,Nigeria,Central Public Health Laboratories (Yaba),1212,Lagos,2001,17,33,51.5,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5065,Akinyemi (2018),"Akinyemi KO, Oyefolu AOB, Mutiu WB, et al. Typhoid fever: tracking the trend in Nigeria. (Special Issue: Tackling typhoid - what do global and country trends teach us?).American Journal of Tropical Medicine and Hygiene 2018;99(3 Suppl):41-47",Systematic review,NGA,Nigeria,Lagos University Teaching Hospital;General Hospital Lagos,1212,Lagos,2002,0,18,0,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
2338,Akinyemi(2007)<U+1D47>,"Akinyemi KO, Smith SI, Oyefolu AO, Fasure KA, Coker AO. Trends of multiple drug resistance in Salmonella enterica serovar Typhi in Lagos, Nigeria. East and Central African Journal of Surgery 2007; 12(1): 83-8.",Systematic review,NGA,Nigeria,Central Public Health Laboratories (Yaba),1212,Lagos,2002,20,35,57.1,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
869,Enabulele(2006),"Enabulele IO, Yah SC, Yusuf EO, Eghafona NO. Emerging quinolones resistant transfer genes among gram-negative bacteria, isolated from faeces of HIV/AIDS patients attending some Clinics and Hospitals in the City of Benin, Edo State, Nigeria. Online Journal of Health and Allied Sciences 2006; 5(3).",Systematic review,NGA,Nigeria,Unknown clinics and hospitals in Benin city,1202,Edo,2003,28,39,71.8,1,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5065,Akinyemi (2018),"Akinyemi KO, Oyefolu AOB, Mutiu WB, et al. Typhoid fever: tracking the trend in Nigeria. (Special Issue: Tackling typhoid - what do global and country trends teach us?).American Journal of Tropical Medicine and Hygiene 2018;99(3 Suppl):41-47",Systematic review,NGA,Nigeria,Lagos University Teaching Hospital;General Hospital Lagos,1212,Lagos,2003,2,22,9.1,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
2338,Akinyemi(2007)<U+1D47>,"Akinyemi KO, Smith SI, Oyefolu AO, Fasure KA, Coker AO. Trends of multiple drug resistance in Salmonella enterica serovar Typhi in Lagos, Nigeria. East and Central African Journal of Surgery 2007; 12(1): 83-8.",Systematic review,NGA,Nigeria,Central Public Health Laboratories (Yaba),1212,Lagos,2003,20,37,54.1,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5065,Akinyemi (2018),"Akinyemi KO, Oyefolu AOB, Mutiu WB, et al. Typhoid fever: tracking the trend in Nigeria. (Special Issue: Tackling typhoid - what do global and country trends teach us?).American Journal of Tropical Medicine and Hygiene 2018;99(3 Suppl):41-47",Systematic review,NGA,Nigeria,Lagos University Teaching Hospital;General Hospital Lagos,1212,Lagos,2004,2,26,7.7,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
2338,Akinyemi(2007)<U+1D47>,"Akinyemi KO, Smith SI, Oyefolu AO, Fasure KA, Coker AO. Trends of multiple drug resistance in Salmonella enterica serovar Typhi in Lagos, Nigeria. East and Central African Journal of Surgery 2007; 12(1): 83-8.",Systematic review,NGA,Nigeria,Central Public Health Laboratories (Yaba),1212,Lagos,2004,23,39,59,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
2069,Akinyemi(2007)<U+1D43>,"Akinyemi KO, Bamiro BS, Coker AO. Salmonellosis in Lagos, Nigeria: incidence of Plasmodium falciparum-associated co-infection, patterns of antimicrobial resistance, and emergence of reduced susceptibility to fluoroquinolones. J Health Popul Nutr 2007; 25(3): 351-8.",Systematic review,NGA,Nigeria,Central Bank of Nigeria Health Clinics (Satellite Town);Central Medical Laboratory Health Centre;Ikeja General Hospital;Infectious Diseases Hospital (Lagos),1212,Lagos,2005,3,21,14.3,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5065,Akinyemi (2018),"Akinyemi KO, Oyefolu AOB, Mutiu WB, et al. Typhoid fever: tracking the trend in Nigeria. (Special Issue: Tackling typhoid - what do global and country trends teach us?).American Journal of Tropical Medicine and Hygiene 2018;99(3 Suppl):41-47",Systematic review,NGA,Nigeria,Lagos University Teaching Hospital;General Hospital Lagos,1212,Lagos,2005,3,28,10.7,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
258,Fashae(2010),"Fashae K, Ogunsola F, Aarestrup FM, Hendriksen RS. Antimicrobial susceptibility and serovars of Salmonella from chickens and humans in Ibadan, Nigeria. J Infect Dev Ctries 2010; 4(8): 484-94.",Systematic review,NGA,Nigeria,Unknown hospitals and diagnostic laboratory in Ibadan province,1216,Oyo,2005,0,7,0,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
1232,Abdullahi(2010),"Abdullahi M. Incidence and antimicrobial susceptibility pattern of Salmonella species in children attending some hospitals in Kano Metropolis, Kano State-Nigeria. Bayero Journal of Pure and Applied Sciences 2010; 3(1): 202-6.",Systematic review,NGA,Nigeria,Five unkown hospitals in Kano Metropolis,1207,Kano,2006,9,12,75,1,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5065,Akinyemi (2018),"Akinyemi KO, Oyefolu AOB, Mutiu WB, et al. Typhoid fever: tracking the trend in Nigeria. (Special Issue: Tackling typhoid - what do global and country trends teach us?).American Journal of Tropical Medicine and Hygiene 2018;99(3 Suppl):41-47",Systematic review,NGA,Nigeria,Lagos University Teaching Hospital;General Hospital Lagos,1212,Lagos,2006,2,16,12.5,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5065,Akinyemi (2018),"Akinyemi KO, Oyefolu AOB, Mutiu WB, et al. Typhoid fever: tracking the trend in Nigeria. (Special Issue: Tackling typhoid - what do global and country trends teach us?).American Journal of Tropical Medicine and Hygiene 2018;99(3 Suppl):41-47",Systematic review,NGA,Nigeria,Lagos University Teaching Hospital;General Hospital Lagos,1212,Lagos,2007,3,23,13,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
1773,Adeshina (2009),"Adeshina GO, Osuagwu NO, Okeke CLE, Ehinmidu JO, Bolaji RO. Prevalence and susceptibility of Salmonella Typhi and Salmonella ParaTyphi in Zaria, Nigeria. International Journal of Health Research 2009; 2(4): 355-60.",Systematic review,NGA,Nigeria,Ahmadu Bello University Sick Bay Clinic;Federal College of Education;Salama Clinics;Savanna Polyclinics,1206,Kaduna,2008,29,71,40.8,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5065,Akinyemi (2018),"Akinyemi KO, Oyefolu AOB, Mutiu WB, et al. Typhoid fever: tracking the trend in Nigeria. (Special Issue: Tackling typhoid - what do global and country trends teach us?).American Journal of Tropical Medicine and Hygiene 2018;99(3 Suppl):41-47",Systematic review,NGA,Nigeria,Lagos University Teaching Hospital;General Hospital Lagos,1212,Lagos,2008,4,30,13.3,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5065,Akinyemi (2018),"Akinyemi KO, Oyefolu AOB, Mutiu WB, et al. Typhoid fever: tracking the trend in Nigeria. (Special Issue: Tackling typhoid - what do global and country trends teach us?).American Journal of Tropical Medicine and Hygiene 2018;99(3 Suppl):41-47",Systematic review,NGA,Nigeria,Lagos University Teaching Hospital;General Hospital Lagos,1212,Lagos,2009,2,25,8,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5065,Akinyemi (2018),"Akinyemi KO, Oyefolu AOB, Mutiu WB, et al. Typhoid fever: tracking the trend in Nigeria. (Special Issue: Tackling typhoid - what do global and country trends teach us?).American Journal of Tropical Medicine and Hygiene 2018;99(3 Suppl):41-47",Systematic review,NGA,Nigeria,Lagos University Teaching Hospital;General Hospital Lagos,1212,Lagos,2010,0,18,0,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
158,Abdullahi(2014),"Abdullahi B, Abdulfatai K, Wartu JR, Mzungu I, Muhammad HID, Abdulsalam AO. Antibiotics susceptibility patterns and characterization of clinical Salmonella serotypes in Katsina State, Nigeria. African Journal of Microbiology Research 2014; 8(9): 915-21.",Systematic review,NGA,Nigeria,General Hospital Funtua;General Hospital Katsina;Turai Umaru Yar’adua Maternity and Children Hospital,1208,Katsina,2011,4,44,9.1,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5065,Akinyemi (2018),"Akinyemi KO, Oyefolu AOB, Mutiu WB, et al. Typhoid fever: tracking the trend in Nigeria. (Special Issue: Tackling typhoid - what do global and country trends teach us?).American Journal of Tropical Medicine and Hygiene 2018;99(3 Suppl):41-47",Systematic review,NGA,Nigeria,Lagos University Teaching Hospital;General Hospital Lagos,1212,Lagos,2011,0,25,0,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
109,Abdullahi (2015),"Abdullahi M, Olonitola SO, Umoh VJ, Inabo IH. Antibacterial resistance profile and PCR detection of antibiotic resistance genes in Salmonella serovars isolated from blood samples of hospitalized subjects in Kano, North-West, Nigeria. Br Microbiol Res J 2015; 5(3): 245-56.",Systematic review,NGA,Nigeria,Aminu Kano Teaching Hospital;Khadijat Memorial Private Hospital;Mohammed Abdullahi Wase Specialist Hospital;Murtala Mohammed Specialist Hospital;Sheik Waziru Gidado General Hospital;Sir Sunusi Specialist Hospital,1207,Kano,2012,32,39,82.1,1,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5065,Akinyemi (2018),"Akinyemi KO, Oyefolu AOB, Mutiu WB, et al. Typhoid fever: tracking the trend in Nigeria. (Special Issue: Tackling typhoid - what do global and country trends teach us?).American Journal of Tropical Medicine and Hygiene 2018;99(3 Suppl):41-47",Systematic review,NGA,Nigeria,Lagos University Teaching Hospital;General Hospital Lagos,1212,Lagos,2012,5,20,25,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5065,Akinyemi (2018),"Akinyemi KO, Oyefolu AOB, Mutiu WB, et al. Typhoid fever: tracking the trend in Nigeria. (Special Issue: Tackling typhoid - what do global and country trends teach us?).American Journal of Tropical Medicine and Hygiene 2018;99(3 Suppl):41-47",Systematic review,NGA,Nigeria,Lagos University Teaching Hospital;General Hospital Lagos,1212,Lagos,2013,5,20,25,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5065,Akinyemi (2018),"Akinyemi KO, Oyefolu AOB, Mutiu WB, et al. Typhoid fever: tracking the trend in Nigeria. (Special Issue: Tackling typhoid - what do global and country trends teach us?).American Journal of Tropical Medicine and Hygiene 2018;99(3 Suppl):41-47",Systematic review,NGA,Nigeria,Lagos University Teaching Hospital;General Hospital Lagos,1212,Lagos,2014,1,7,14.3,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
5065,Akinyemi (2018),"Akinyemi KO, Oyefolu AOB, Mutiu WB, et al. Typhoid fever: tracking the trend in Nigeria. (Special Issue: Tackling typhoid - what do global and country trends teach us?).American Journal of Tropical Medicine and Hygiene 2018;99(3 Suppl):41-47",Systematic review,NGA,Nigeria,Lagos University Teaching Hospital;General Hospital Lagos,1212,Lagos,2015,3,11,27.3,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
233,Dromigny(2003),"Dromigny JA, Perrier-Gros-Claude JD. Antimicrobial resistance of Salmonella enterica serotype Typhi in Dakar, Senegal. Clin Infect Dis 2003; 37(3): 465-6.",Systematic review,SEN,Senegal,Unkown healthcare facilities in Dakar,1243,Dakar,1995,0,232,0,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
1769,Harrois(2014),"Harrois D, Breurec S, Seck A, et al. Prevalence and characterization of extended-spectrum beta-lactamase-producing clinical Salmonella enterica isolates in Dakar, Senegal, from 1999 to 2009. Clin Microbiol Infect 2014; 20(2): O109-16.",Systematic review,SEN,Senegal,Bio24 Laboratory;Hopital Aristide Le Dantec;Hopital Principal;Institut Pasteur,1243,Dakar,1999,0,17,0,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
3599,Lefebvre (2005),"Lefebvre N, Gning SB, Nabeth P, et al. Clinical and laboratory features of typhoid fever in Senegal. A 70-case study [French]. Med Trop 2005; 65(6): 543-8.",Systematic review,SEN,Senegal,Hopital Principal,1243,Dakar,1999,1,38,2.6,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
1769,Harrois(2014),"Harrois D, Breurec S, Seck A, et al. Prevalence and characterization of extended-spectrum beta-lactamase-producing clinical Salmonella enterica isolates in Dakar, Senegal, from 1999 to 2009. Clin Microbiol Infect 2014; 20(2): O109-16.",Systematic review,SEN,Senegal,Bio24 Laboratory;Hopital Aristide Le Dantec;Hopital Principal;Institut Pasteur,1243,Dakar,2000,0,10,0,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
1769,Harrois(2014),"Harrois D, Breurec S, Seck A, et al. Prevalence and characterization of extended-spectrum beta-lactamase-producing clinical Salmonella enterica isolates in Dakar, Senegal, from 1999 to 2009. Clin Microbiol Infect 2014; 20(2): O109-16.",Systematic review,SEN,Senegal,Bio24 Laboratory;Hopital Aristide Le Dantec;Hopital Principal;Institut Pasteur,1243,Dakar,2001,0,8,0,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
1769,Harrois(2014),"Harrois D, Breurec S, Seck A, et al. Prevalence and characterization of extended-spectrum beta-lactamase-producing clinical Salmonella enterica isolates in Dakar, Senegal, from 1999 to 2009. Clin Microbiol Infect 2014; 20(2): O109-16.",Systematic review,SEN,Senegal,Bio24 Laboratory;Hopital Aristide Le Dantec;Hopital Principal;Institut Pasteur,1243,Dakar,2002,0,12,0,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
1769,Harrois(2014),"Harrois D, Breurec S, Seck A, et al. Prevalence and characterization of extended-spectrum beta-lactamase-producing clinical Salmonella enterica isolates in Dakar, Senegal, from 1999 to 2009. Clin Microbiol Infect 2014; 20(2): O109-16.",Systematic review,SEN,Senegal,Bio24 Laboratory;Hopital Aristide Le Dantec;Hopital Principal;Institut Pasteur,1243,Dakar,2003,0,10,0,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
1769,Harrois(2014),"Harrois D, Breurec S, Seck A, et al. Prevalence and characterization of extended-spectrum beta-lactamase-producing clinical Salmonella enterica isolates in Dakar, Senegal, from 1999 to 2009. Clin Microbiol Infect 2014; 20(2): O109-16.",Systematic review,SEN,Senegal,Bio24 Laboratory;Hopital Aristide Le Dantec;Hopital Principal;Institut Pasteur,1243,Dakar,2007,0,5,0,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
1769,Harrois(2014),"Harrois D, Breurec S, Seck A, et al. Prevalence and characterization of extended-spectrum beta-lactamase-producing clinical Salmonella enterica isolates in Dakar, Senegal, from 1999 to 2009. Clin Microbiol Infect 2014; 20(2): O109-16.",Systematic review,SEN,Senegal,Bio24 Laboratory;Hopital Aristide Le Dantec;Hopital Principal;Institut Pasteur,1243,Dakar,2008,0,15,0,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
848,Dagnra(2007),"Dagnra AY, Akolly K, Gbadoe A, Aho K, David M. Emergence of multidrug resistant Salmonella strains in Lome (Togo). [French]. Med Mal Infect 2007; 37(5): 266-9.",Systematic review,TGO,Togo,Centre Hospitalier et Universitaire Tokoin (Lome),1315,Maritime,2000,0,65,0,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
848,Dagnra(2007),"Dagnra AY, Akolly K, Gbadoe A, Aho K, David M. Emergence of multidrug resistant Salmonella strains in Lome (Togo). [French]. Med Mal Infect 2007; 37(5): 266-9.",Systematic review,TGO,Togo,Centre Hospitalier et Universitaire Tokoin (Lome),1315,Maritime,2004,3,82,3.7,0,Salmonella Typhi,Fluoroquinolone non-susceptibility (FQNS)
2327,Dong(2010),"Dong BQ, Yang J, Wang XY, et al. Trends and disease burden of enteric fever in Guangxi province, China, 1994-2004. Bull World Health Organ 2010; 88(9): 689-96.",Systematic review,CHN,China,Center for Disease Control and Prevention Guangxi,10,Guangxi Zhuangzu Zizhiqu,1999,861,1292,66.6,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
2824,Shukun (2010),"Shukun W, Congjia C, Yunbo Y, Biao K, Baowei D. Nalidixic acid resistance and clonal expansion of Salmonella enterica serotype ParaTyphi A in Yuxi city, China. J Med Med Sci 2010; 17: 320-6.",Systematic review,CHN,China,Unknown hospitals in Yuxi,34,Yunnan Sheng,2004,166,186,89.2,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
1095,Wu (2010),"Wu W, Wang H, Lu J, et al. Genetic diversity of Salmonella enteric serovar Typhi and ParaTyphi in Shenzhen, China from 2002 through 2007. BMC Microbiol 2010; 10: 32.",Systematic review,CHN,China,Shenzhen People's Hospital,9,Guangdong Sheng,2005,60,64,93.8,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
1431,Gu (2015),"Gu W, Yang Z, Chen Y, et al. Molecular characteristics of Salmonella enterica ParaTyphi A in Yunnan Province, southwest China. Infect Genet Evol 2015; 30: 181-5.",Systematic review,CHN,China,Yuxi,34,Yunnan Sheng,2005,5,5,100,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
244,Jiang(2015),"Jiang Y, Zuo H, Niu H, et al. Antimicrobial resistance surveillance of Salmonella isolates from the First People's Hospital of Yunnan Province, China. J Infect Dev Ctries 2015; 9(4): 333-7.",Systematic review,CHN,China,First People’s Hospital of Yunnan Province,34,Yunnan Sheng,2006,46,784,5.9,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
1431,Gu (2015),"Gu W, Yang Z, Chen Y, et al. Molecular characteristics of Salmonella enterica ParaTyphi A in Yunnan Province, southwest China. Infect Genet Evol 2015; 30: 181-5.",Systematic review,CHN,China,Yuxi,34,Yunnan Sheng,2006,14,14,100,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
1431,Gu (2015),"Gu W, Yang Z, Chen Y, et al. Molecular characteristics of Salmonella enterica ParaTyphi A in Yunnan Province, southwest China. Infect Genet Evol 2015; 30: 181-5.",Systematic review,CHN,China,Yuxi,34,Yunnan Sheng,2007,25,25,100,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
1431,Gu (2015),"Gu W, Yang Z, Chen Y, et al. Molecular characteristics of Salmonella enterica ParaTyphi A in Yunnan Province, southwest China. Infect Genet Evol 2015; 30: 181-5.",Systematic review,CHN,China,Yuxi,34,Yunnan Sheng,2008,20,20,100,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
926,Zhuang (2012),"Zhuang L, Zhang YJ, Tang Z, et al. Epidemiologic characteristics of typhoid and paratyphoid fever on related drug resistance and molecular types regarding Salmonella Typhi and S. ParaTyphi, in Jiangsu province [Chinese]. Chung Hua Liu Hsing Ping Hsueh Tsa Chih 2012; 33(12): 1269-72.",Systematic review,CHN,China,Jiangsu,18,Jiangsu Sheng,2009,44,50,88,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
1431,Gu (2015),"Gu W, Yang Z, Chen Y, et al. Molecular characteristics of Salmonella enterica ParaTyphi A in Yunnan Province, southwest China. Infect Genet Evol 2015; 30: 181-5.",Systematic review,CHN,China,Yuxi,34,Yunnan Sheng,2010,38,38,100,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
1431,Gu (2015),"Gu W, Yang Z, Chen Y, et al. Molecular characteristics of Salmonella enterica ParaTyphi A in Yunnan Province, southwest China. Infect Genet Evol 2015; 30: 181-5.",Systematic review,CHN,China,Honghe,34,Yunnan Sheng,2010,29,29,100,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
1431,Gu (2015),"Gu W, Yang Z, Chen Y, et al. Molecular characteristics of Salmonella enterica ParaTyphi A in Yunnan Province, southwest China. Infect Genet Evol 2015; 30: 181-5.",Systematic review,CHN,China,Yuxi,34,Yunnan Sheng,2011,36,36,100,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
4658,Zhao (2016),"Zhao JY, Zhang SY, Mu YJ, et al. Drug tolerance and PFGE molecular typing of Salmonella ParaTyphi A isolated in Dengfeng, Henan province, 2009-2015 [Chinese]. Chung Hua Liu Hsing Ping Hsueh Tsa Chih 2016; 37(5): 714-7.",Systematic review,CHN,China,Unknown hospitals in Denfeng,15,Henan Sheng,2012,79,126,62.7,1,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
1431,Gu (2015),"Gu W, Yang Z, Chen Y, et al. Molecular characteristics of Salmonella enterica ParaTyphi A in Yunnan Province, southwest China. Infect Genet Evol 2015; 30: 181-5.",Systematic review,CHN,China,Yuxi,34,Yunnan Sheng,2012,85,85,100,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
5053,Kong(2017),"Kong X, Dong C, Ji H, et al. Antimicrobial resistance and molecular subtypes of Salmonella Typhi and Salmonella paratyphoid isolates from Jiangsu province, 2012-2015. [Chinese]. Chinese Journal of Endemiology 2017; 38(11): 1546-50.",Systematic review,CHN,China,Center for Disease Control and Prevention Jiangsu,18,Jiangsu Sheng,2013,7,8,87.5,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
1431,Gu (2015),"Gu W, Yang Z, Chen Y, et al. Molecular characteristics of Salmonella enterica ParaTyphi A in Yunnan Province, southwest China. Infect Genet Evol 2015; 30: 181-5.",Systematic review,CHN,China,Yuxi,34,Yunnan Sheng,2013,56,56,100,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
1431,Gu (2015),"Gu W, Yang Z, Chen Y, et al. Molecular characteristics of Salmonella enterica ParaTyphi A in Yunnan Province, southwest China. Infect Genet Evol 2015; 30: 181-5.",Systematic review,CHN,China,Honghe,34,Yunnan Sheng,2013,34,34,100,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
5053,Kong(2017),"Kong X, Dong C, Ji H, et al. Antimicrobial resistance and molecular subtypes of Salmonella Typhi and Salmonella paratyphoid isolates from Jiangsu province, 2012-2015. [Chinese]. Chinese Journal of Endemiology 2017; 38(11): 1546-50.",Systematic review,CHN,China,Center for Disease Control and Prevention Jiangsu,18,Jiangsu Sheng,2014,4,5,80,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
883,Punjabi (2013),"Punjabi NH, Agtini MD, Ochiai RL, et al. Enteric fever burden in North Jakarta, Indonesia: a prospective, community-based study. J Infect Dev Ctries 2013; 7(11): 781-7.",Systematic review,IDN,Indonesia,Tanjung Priok & Koja,57,DKI JAKARTA,2002,0,41,0,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
2978,Hardjo Lugito (2017),"Hardjo Lugito NP, Cucunawangsih. Antimicrobial resistance of Salmonella enterica serovars Typhi and ParaTyphi isolates from a general hospital in Karawaci, Tangerang, Indonesia: A five-year review. Int J Microbiol 2017; 2017: 6215136.",Systematic review,IDN,Indonesia,Siloam Hospital (Karawaci),69,BANTEN,2011,0,14,0,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
2978,Hardjo Lugito (2017),"Hardjo Lugito NP, Cucunawangsih. Antimicrobial resistance of Salmonella enterica serovars Typhi and ParaTyphi isolates from a general hospital in Karawaci, Tangerang, Indonesia: A five-year review. Int J Microbiol 2017; 2017: 6215136.",Systematic review,IDN,Indonesia,Siloam Hospital (Karawaci),69,BANTEN,2012,0,22,0,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
2978,Hardjo Lugito (2017),"Hardjo Lugito NP, Cucunawangsih. Antimicrobial resistance of Salmonella enterica serovars Typhi and ParaTyphi isolates from a general hospital in Karawaci, Tangerang, Indonesia: A five-year review. Int J Microbiol 2017; 2017: 6215136.",Systematic review,IDN,Indonesia,Siloam Hospital (Karawaci),69,BANTEN,2013,0,17,0,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
2978,Hardjo Lugito (2017),"Hardjo Lugito NP, Cucunawangsih. Antimicrobial resistance of Salmonella enterica serovars Typhi and ParaTyphi isolates from a general hospital in Karawaci, Tangerang, Indonesia: A five-year review. Int J Microbiol 2017; 2017: 6215136.",Systematic review,IDN,Indonesia,Siloam Hospital (Karawaci),69,BANTEN,2014,0,18,0,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
2955,Kuijpers (2017),"Kuijpers LMF, Phe T, Veng CH, et al. The clinical and microbiological characteristics of enteric fever in Cambodia, 2008-2015. PLoS Negl Trop Dis 2017; 11(9): e0005964.",Systematic review,KHM,Cambodia,Sihanouk Hospital Center of Hope,92,Phnom Penh,2010,0,12,0,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
2955,Kuijpers (2017),"Kuijpers LMF, Phe T, Veng CH, et al. The clinical and microbiological characteristics of enteric fever in Cambodia, 2008-2015. PLoS Negl Trop Dis 2017; 11(9): e0005964.",Systematic review,KHM,Cambodia,Sihanouk Hospital Center of Hope,92,Phnom Penh,2014,21,171,12.3,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
5148,Roberts (2019),"Roberts T. LOMRU blood culture database. Vientiene, Laos; 2019",Dataset,LAO,Laos,Mahosot Hospital,117,Vientiane capital,2014,1,6,16.7,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
1878,Islam (1993),"Islam MN, Afroza A, Hasan Z, Majumder B, Hossain A. Recent antibiogram pattern and clinical profile of typhoid fever in children - A study of 36 cases. Bangladesh J Child Health 1993; 17(3): 93-6.",Systematic review,BGD,Bangladesh,Institute of Postgraduate Medicine and Research,823,Dhaka,1993,0,7,0,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
3026,Ahmed (2017),"Ahmed D, Nahid MA, Sami AB, et al. Bacterial etiology of bloodstream infections and antimicrobial resistance in Dhaka, Bangladesh, 2005-2014. Antimicrob Resist Infect Control 2017; 6.",Systematic review,BGD,Bangladesh,Dhaka Hospital (ICCDR);ICDDR,823,Dhaka,2005,78,85,91.8,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
51,Sheikh(2010),"Sheikh A, Charles RC, Rollins SM, et al. Analysis of Salmonella enterica serotype Paratyphi A gene expression in the blood of bacteremic patients in Bangladesh. PLoS Negl Trop Dis 2010; 4(12): e908.",Systematic review,BGD,Bangladesh,ICDDR;Dhaka Medical College Hospital,823,Dhaka,2006,5,5,100,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
1088,Das(2014),"Das SK, Chisti MJ, Afrad MH, et al. Gastroenteritis due to typhoidal Salmonella: a decade of observation at an urban and a rural diarrheal disease hospital in Bangladesh. BMC Infect Dis 2014; 14: 435.",Systematic review,BGD,Bangladesh,ICDDR;Matlab Hospital (ICDDR),823,Dhaka,2006,0,278,0,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
1088,Das(2014),"Das SK, Chisti MJ, Afrad MH, et al. Gastroenteritis due to typhoidal Salmonella: a decade of observation at an urban and a rural diarrheal disease hospital in Bangladesh. BMC Infect Dis 2014; 14: 435.",Systematic review,BGD,Bangladesh,Unknown urban Dhaka hospital,823,Dhaka,2006,7,33,21.2,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
3026,Ahmed (2017),"Ahmed D, Nahid MA, Sami AB, et al. Bacterial etiology of bloodstream infections and antimicrobial resistance in Dhaka, Bangladesh, 2005-2014. Antimicrob Resist Infect Control 2017; 6.",Systematic review,BGD,Bangladesh,Dhaka Hospital (ICCDR);ICDDR,823,Dhaka,2006,124,133,93.2,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
3026,Ahmed (2017),"Ahmed D, Nahid MA, Sami AB, et al. Bacterial etiology of bloodstream infections and antimicrobial resistance in Dhaka, Bangladesh, 2005-2014. Antimicrob Resist Infect Control 2017; 6.",Systematic review,BGD,Bangladesh,Dhaka Hospital (ICCDR);ICDDR,823,Dhaka,2007,123,127,96.9,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
3026,Ahmed (2017),"Ahmed D, Nahid MA, Sami AB, et al. Bacterial etiology of bloodstream infections and antimicrobial resistance in Dhaka, Bangladesh, 2005-2014. Antimicrob Resist Infect Control 2017; 6.",Systematic review,BGD,Bangladesh,Dhaka Hospital (ICCDR);ICDDR,823,Dhaka,2008,145,146,99.3,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
3026,Ahmed (2017),"Ahmed D, Nahid MA, Sami AB, et al. Bacterial etiology of bloodstream infections and antimicrobial resistance in Dhaka, Bangladesh, 2005-2014. Antimicrob Resist Infect Control 2017; 6.",Systematic review,BGD,Bangladesh,Dhaka Hospital (ICCDR);ICDDR,823,Dhaka,2009,102,102,100,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
501,Khanam (2014),"Khanam F, Qadri F. Characterization of the induced immune responses, clinical presentation and antibiotic susceptibility pattern in Bangladeshi S. ParaTyphi A bacteremic patients. Int J Infect Dis 2014; 21: 343.",Systematic review,BGD,Bangladesh,ICDDR,823,Dhaka,2010,25,25,100,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
3026,Ahmed (2017),"Ahmed D, Nahid MA, Sami AB, et al. Bacterial etiology of bloodstream infections and antimicrobial resistance in Dhaka, Bangladesh, 2005-2014. Antimicrob Resist Infect Control 2017; 6.",Systematic review,BGD,Bangladesh,Dhaka Hospital (ICCDR);ICDDR,823,Dhaka,2010,177,179,98.9,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
1680,Afroze (2014),"Afroze SR, Rahim MA, Hasan MM, et al. Pattern of antibiotic sensitivity in enteric fever: A tertiary care hospital experience. Journal of Medicine (Bangladesh) 2014; 15(2): 122-4.",Systematic review,BGD,Bangladesh,"Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders (BIRDEM)",823,Dhaka,2011,8,25,32,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
3026,Ahmed (2017),"Ahmed D, Nahid MA, Sami AB, et al. Bacterial etiology of bloodstream infections and antimicrobial resistance in Dhaka, Bangladesh, 2005-2014. Antimicrob Resist Infect Control 2017; 6.",Systematic review,BGD,Bangladesh,Dhaka Hospital (ICCDR);ICDDR,823,Dhaka,2011,132,135,97.8,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
3026,Ahmed (2017),"Ahmed D, Nahid MA, Sami AB, et al. Bacterial etiology of bloodstream infections and antimicrobial resistance in Dhaka, Bangladesh, 2005-2014. Antimicrob Resist Infect Control 2017; 6.",Systematic review,BGD,Bangladesh,Dhaka Hospital (ICCDR);ICDDR,823,Dhaka,2012,129,129,100,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
3026,Ahmed (2017),"Ahmed D, Nahid MA, Sami AB, et al. Bacterial etiology of bloodstream infections and antimicrobial resistance in Dhaka, Bangladesh, 2005-2014. Antimicrob Resist Infect Control 2017; 6.",Systematic review,BGD,Bangladesh,Dhaka Hospital (ICCDR);ICDDR,823,Dhaka,2013,105,107,98.1,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
3026,Ahmed (2017),"Ahmed D, Nahid MA, Sami AB, et al. Bacterial etiology of bloodstream infections and antimicrobial resistance in Dhaka, Bangladesh, 2005-2014. Antimicrob Resist Infect Control 2017; 6.",Systematic review,BGD,Bangladesh,Dhaka Hospital (ICCDR);ICDDR,823,Dhaka,2014,110,110,100,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
5102,Okanda (2018),"Okanda T, Haque A, Ehara T, et al. Characteristics of resistance mechanisms and molecular epidemiology of fluoroquinolone-nonsusceptible Salmonella enterica serovar Typhi and Paratyphi a isolates from a tertiary hospital in Dhaka, Bangladesh.Microbial Drug Resistance 2018;24(10):1460-1465",Systematic review,BGD,Bangladesh,Bangabandhu Sheikh Mujib Medical University Hospital,823,Dhaka,2015,6,6,100,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
1761,Chopra(1992),"Chopra GS, Basu SK, Bhattacharya SR. Present phage types and antibiotic susceptibility of Salmonellae. Indian J Pathol Microbiol 1992; 35(4): 345-50.",Systematic review,IND,India,Command Pathology Laboratory,850,Delhi,1990,0,17,0,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
135,Mandal (2006),"Mandal S, Mandal M, Pal N. Antibiotic resistance of Salmonella enterica serovar ParaTyphi A in India: Emerging and reemerging problem. J Postgrad Med 2006; 52(3): 163-6.",Systematic review,IND,India,Calcutta School of Tropical Medicine,869,West Bengal,1991,0,13,0,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
135,Mandal (2006),"Mandal S, Mandal M, Pal N. Antibiotic resistance of Salmonella enterica serovar ParaTyphi A in India: Emerging and reemerging problem. J Postgrad Med 2006; 52(3): 163-6.",Systematic review,IND,India,Calcutta School of Tropical Medicine,869,West Bengal,1994,0,9,0,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
135,Mandal (2006),"Mandal S, Mandal M, Pal N. Antibiotic resistance of Salmonella enterica serovar ParaTyphi A in India: Emerging and reemerging problem. J Postgrad Med 2006; 52(3): 163-6.",Systematic review,IND,India,Calcutta School of Tropical Medicine,869,West Bengal,1995,3,12,25,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
135,Mandal (2006),"Mandal S, Mandal M, Pal N. Antibiotic resistance of Salmonella enterica serovar ParaTyphi A in India: Emerging and reemerging problem. J Postgrad Med 2006; 52(3): 163-6.",Systematic review,IND,India,Calcutta School of Tropical Medicine,869,West Bengal,1996,8,9,88.9,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
135,Mandal (2006),"Mandal S, Mandal M, Pal N. Antibiotic resistance of Salmonella enterica serovar ParaTyphi A in India: Emerging and reemerging problem. J Postgrad Med 2006; 52(3): 163-6.",Systematic review,IND,India,Calcutta School of Tropical Medicine,869,West Bengal,1997,10,10,100,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
797,Chandel(2000)<U+1D43>,"Chandel DS, Chaudhry R, Dhawan B, Pandey A, Dey AB. Drug-resistant Salmonella enterica serotype Paratyphi A in India. Emerg Infect Dis 2000; 6(4): 420-1.",Systematic review,IND,India,All India Institute of Medical Sciences;Safdarjung Hospital,850,Delhi,1998,12,57,21.1,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
135,Mandal (2006),"Mandal S, Mandal M, Pal N. Antibiotic resistance of Salmonella enterica serovar ParaTyphi A in India: Emerging and reemerging problem. J Postgrad Med 2006; 52(3): 163-6.",Systematic review,IND,India,Calcutta School of Tropical Medicine,869,West Bengal,1998,10,10,100,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
118,Mohanty (2006),"Mohanty S, Renuka K, Sood S, Das BK, Kapil A. Antibiogram pattern and seasonality of Salmonella serotypes in a North Indian tertiary care hospital. Epidemiol Infect 2006; 134(5): 961-6.",Systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,1999,14,28,50,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
797,Chandel(2000)<U+1D43>,"Chandel DS, Chaudhry R, Dhawan B, Pandey A, Dey AB. Drug-resistant Salmonella enterica serotype Paratyphi A in India. Emerg Infect Dis 2000; 6(4): 420-1.",Systematic review,IND,India,All India Institute of Medical Sciences;Safdarjung Hospital,850,Delhi,1999,7,22,31.8,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
118,Mohanty (2006),"Mohanty S, Renuka K, Sood S, Das BK, Kapil A. Antibiogram pattern and seasonality of Salmonella serotypes in a North Indian tertiary care hospital. Epidemiol Infect 2006; 134(5): 961-6.",Systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,2000,12,21,57.1,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
135,Mandal (2006),"Mandal S, Mandal M, Pal N. Antibiotic resistance of Salmonella enterica serovar ParaTyphi A in India: Emerging and reemerging problem. J Postgrad Med 2006; 52(3): 163-6.",Systematic review,IND,India,Calcutta School of Tropical Medicine,869,West Bengal,2000,8,8,100,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
36,Mandeep (2006),"Mandeep W, Rajni G, Premila P, Rajesh M, Pushpa A, Mani K. Age-related clinical and microbiological characteristics of enteric fever in India. Trans R Soc Trop Med Hyg 2006; 100(10): 942-8.",Systematic review,IND,India,Safdarjung Hospital,850,Delhi,2001,56,73,76.7,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
118,Mohanty (2006),"Mohanty S, Renuka K, Sood S, Das BK, Kapil A. Antibiogram pattern and seasonality of Salmonella serotypes in a North Indian tertiary care hospital. Epidemiol Infect 2006; 134(5): 961-6.",Systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,2001,22,28,78.6,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
135,Mandal (2006),"Mandal S, Mandal M, Pal N. Antibiotic resistance of Salmonella enterica serovar ParaTyphi A in India: Emerging and reemerging problem. J Postgrad Med 2006; 52(3): 163-6.",Systematic review,IND,India,Calcutta School of Tropical Medicine,869,West Bengal,2001,6,6,100,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
471,Lakshmi (2006),"Lakshmi V, Ashok R, Susmita J, Shailaja VV. Changing trends in the antibiograms of Salmonella isolates at a tertiary care hospital in Hyderabad. Indian J Med Microbiol 2006; 24(1): 45-8.",Systematic review,IND,India,Nizam's Institute of Medical Sciences,848,Andhra Pradesh,2002,13,13,100,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
118,Mohanty (2006),"Mohanty S, Renuka K, Sood S, Das BK, Kapil A. Antibiogram pattern and seasonality of Salmonella serotypes in a North Indian tertiary care hospital. Epidemiol Infect 2006; 134(5): 961-6.",Systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,2002,23,28,82.1,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
118,Mohanty (2006),"Mohanty S, Renuka K, Sood S, Das BK, Kapil A. Antibiogram pattern and seasonality of Salmonella serotypes in a North Indian tertiary care hospital. Epidemiol Infect 2006; 134(5): 961-6.",Systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,2003,45,50,90,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
1848,Joshi (2004),"Joshi S, Wattal C, Sharma A, Oberoi JK, Prasad KJ. Quinolones - Drug of choice for enteric fever? Indian J Med Microbiol 2004; 22(4): 271-2.",Systematic review,IND,India,Sir Ganga Ram Hospital,850,Delhi,2003,63,80,78.8,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
870,Verma(2010),"Verma S, Thakur S, Kanga A, Singh G, Gupta P. Emerging Salmonella ParaTyphi A enteric fever and changing trends in antimicrobial resistance pattern of Salmonella in Shimla. Indian J Med Microbiol 2010; 28(1): 51-3.",Systematic review,IND,India,Indira Gandhi Medical College,854,Himachal Pradesh,2003,23,27,85.2,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
900,Jog (2008),"Jog S, Soman R, Singhal T, Rodrigues C, Mehta A, Dastur FD. Enteric fever in Mumbai--clinical profile, sensitivity patterns and response to antimicrobials. J Assoc Physicians India 2008; 56: 237-40.",Systematic review,IND,India,P.D. Hinduja National Hospital and Medical Research Center,858,Maharashtra,2003,13,15,86.7,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
1241,Gupta (2009)<U+1D43>,"Gupta V, Kaur J, Chander J. An increase in enteric fever cases due to Salmonella ParaTyphi A in & around Chandigarh. Indian J Med Res 2009a; 129(1): 95-8.",Systematic review,IND,India,Government Medical College Hospital (Chandigarh),864,Punjab,2003,7,7,100,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
471,Lakshmi (2006),"Lakshmi V, Ashok R, Susmita J, Shailaja VV. Changing trends in the antibiograms of Salmonella isolates at a tertiary care hospital in Hyderabad. Indian J Med Microbiol 2006; 24(1): 45-8.",Systematic review,IND,India,Nizam's Institute of Medical Sciences,848,Andhra Pradesh,2004,6,7,85.7,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
118,Mohanty (2006),"Mohanty S, Renuka K, Sood S, Das BK, Kapil A. Antibiogram pattern and seasonality of Salmonella serotypes in a North Indian tertiary care hospital. Epidemiol Infect 2006; 134(5): 961-6.",Systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,2004,38,43,88.4,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
870,Verma(2010),"Verma S, Thakur S, Kanga A, Singh G, Gupta P. Emerging Salmonella ParaTyphi A enteric fever and changing trends in antimicrobial resistance pattern of Salmonella in Shimla. Indian J Med Microbiol 2010; 28(1): 51-3.",Systematic review,IND,India,Indira Gandhi Medical College,854,Himachal Pradesh,2004,33,37,89.2,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
152,Dhanashree (2007),Dhanashree B. Antibiotic susceptibility profile of Salmonella enterica serovars: trend over three years showing re-emergence of chloramphenicol sensitivity and rare serovars. Indian J Med Sci 2007; 61(10): 576-9.,Systematic review,IND,India,Kasturba Medical College Hospital (Mangaluru),855,Karnataka,2004,8,8,100,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
1064,Joshi (2007),"Joshi S, Amarnath SK. Fluoroquinolone resistance in Salmonella Typhi and S. ParaTyphi A in Bangalore, India. Trans R Soc Trop Med Hyg 2007; 101(3): 308-10.",Systematic review,IND,India,Manipal Hospital (Airport road),855,Karnataka,2004,25,25,100,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
900,Jog (2008),"Jog S, Soman R, Singhal T, Rodrigues C, Mehta A, Dastur FD. Enteric fever in Mumbai--clinical profile, sensitivity patterns and response to antimicrobials. J Assoc Physicians India 2008; 56: 237-40.",Systematic review,IND,India,P.D. Hinduja National Hospital and Medical Research Center,858,Maharashtra,2004,13,15,86.7,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
1241,Gupta (2009)<U+1D43>,"Gupta V, Kaur J, Chander J. An increase in enteric fever cases due to Salmonella ParaTyphi A in & around Chandigarh. Indian J Med Res 2009a; 129(1): 95-8.",Systematic review,IND,India,Government Medical College Hospital (Chandigarh),864,Punjab,2004,14,14,100,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
1425,Capoor(2009),"Capoor MR, Nair D, Walia NS, et al. Molecular analysis of high-level ciprofloxacin resistance in Salmonella enterica serovar Typhi and S. ParaTyphi A: need to expand the QRDR region. Epidemiol Infect 2009; 137(6): 871-8.",Systematic review,IND,India,Majeedia Hospital;Safdarjung Hospital,850,Delhi,2005,40,40,100,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
870,Verma(2010),"Verma S, Thakur S, Kanga A, Singh G, Gupta P. Emerging Salmonella ParaTyphi A enteric fever and changing trends in antimicrobial resistance pattern of Salmonella in Shimla. Indian J Med Microbiol 2010; 28(1): 51-3.",Systematic review,IND,India,Indira Gandhi Medical College,854,Himachal Pradesh,2005,16,16,100,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
152,Dhanashree (2007),Dhanashree B. Antibiotic susceptibility profile of Salmonella enterica serovars: trend over three years showing re-emergence of chloramphenicol sensitivity and rare serovars. Indian J Med Sci 2007; 61(10): 576-9.,Systematic review,IND,India,Kasturba Medical College Hospital (Mangaluru),855,Karnataka,2005,10,11,90.9,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
1807,Gupta(2009),"Gupta S, Handa A, Chadha DS, Ganjoo RK, Panda RC. Profile of culture positive enteric fever from Bangalore. Med J Armed Forces India 2009; 65(4): 328-31.",Systematic review,IND,India,Command Hospital (Bengaluru),855,Karnataka,2005,11,16,68.8,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
900,Jog (2008),"Jog S, Soman R, Singhal T, Rodrigues C, Mehta A, Dastur FD. Enteric fever in Mumbai--clinical profile, sensitivity patterns and response to antimicrobials. J Assoc Physicians India 2008; 56: 237-40.",Systematic review,IND,India,P.D. Hinduja National Hospital and Medical Research Center,858,Maharashtra,2005,16,16,100,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
1241,Gupta (2009)<U+1D43>,"Gupta V, Kaur J, Chander J. An increase in enteric fever cases due to Salmonella ParaTyphi A in & around Chandigarh. Indian J Med Res 2009a; 129(1): 95-8.",Systematic review,IND,India,Government Medical College Hospital (Chandigarh),864,Punjab,2005,13,13,100,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
1253,Anup(2006),"Anup P, Subrata G, Sanjucta D, Dipika S, Bhattacharya MK, Bhattacharya SK. Increasing prevalence of Salmonella enterica serotype ParaTyphi-A in patients with enteric fever in a periurban slum setting of Kolkata, India. International Journal of Environmental Health Research 2006; 16(6): 455-9.",Systematic review,IND,India,Kalikapur,869,West Bengal,2005,5,9,55.6,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
1062,Harish (2006),"Harish BN, Menezes GA, Sarangapani K, Parija SC. Fluoroquinolone resistance among Salmonella enterica serovar ParaTyphi A in Pondicherry [2]. Indian J Med Res 2006; 124: 585-7.",Systematic review,IND,India,Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER);Indira Gandhi Government General Hospital,889,Puducherry,2005,24,24,100,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
4593,Menezes (2016),"Menezes GA, Harish BN, Khan MA, Goessens W, Hays JP. Antimicrobial resistance trends in blood culture positive Salmonella ParaTyphi A isolates from Pondicherry, India. Indian J Med Microbiol 2016; 34(2): 222-7.",Systematic review,IND,India,Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER);Government Hospital (Pondicherry),889,Puducherry,2005,57,59,96.6,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
904,Capoor(2007),"Capoor MR, Nair D, Deb M, Aggarwal P. Enteric fever perspective in India: emergence of high-level ciprofloxacin resistance and rising MIC to cephalosporins. J Med Microbiol 2007; 56(Pt 8): 1131-2.",Systematic review,IND,India,Safdarjung Hospital,850,Delhi,2006,53,56,94.6,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
1126,Raveendran (2008),"Raveendran R, Wattal C, Sharma A, Oberoi J, Prasad K, Datta S. High level ciprofloxacin resistance in Salmonella enterica isolated from blood. Indian J Med Microbiol 2008; 26(1): 50-3.",Systematic review,IND,India,Sir Ganga Ram Hospital,850,Delhi,2006,193,198,97.5,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
4371,Kapil(2015),"Kapil A, Sharma P, Dahiya S, Sood S, Das B. Trends of Increasing Antimicrobial Resistance in Community Acquired infections- a Case Study of Enteric Fever and Health Implications. International Journal of Epidemiology 2015; 44: 99-100.",Systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,2006,27,28,96.4,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
870,Verma(2010),"Verma S, Thakur S, Kanga A, Singh G, Gupta P. Emerging Salmonella ParaTyphi A enteric fever and changing trends in antimicrobial resistance pattern of Salmonella in Shimla. Indian J Med Microbiol 2010; 28(1): 51-3.",Systematic review,IND,India,Indira Gandhi Medical College,854,Himachal Pradesh,2006,0,5,0,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
152,Dhanashree (2007),Dhanashree B. Antibiotic susceptibility profile of Salmonella enterica serovars: trend over three years showing re-emergence of chloramphenicol sensitivity and rare serovars. Indian J Med Sci 2007; 61(10): 576-9.,Systematic review,IND,India,Kasturba Medical College Hospital (Mangaluru),855,Karnataka,2006,16,18,88.9,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
934,Vidyalakshmi (2008),"Vidyalakshmi K, Yashavanth R, Chakrapani M, et al. Epidemiological shift, seasonal variation and antimicrobial susceptibility patterns among enteric fever pathogens in South India. Trop Doct 2008; 38(2): 89-91.",Systematic review,IND,India,Kasturba Medical College Hospital (Mangaluru),855,Karnataka,2006,84,85,98.8,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
1893,Yashavanth (2010),"Yashavanth R, Vidyalakshmi K. The Re-Emergence of chloramphenicol sensitivity among enteric fever pathogens in Mangalore. J Clin Diagn Res 2010; 4(5): 3016-108.",Systematic review,IND,India,Kasturba Medical College Hospital (Mangaluru),855,Karnataka,2006,111,111,100,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
1241,Gupta (2009)<U+1D43>,"Gupta V, Kaur J, Chander J. An increase in enteric fever cases due to Salmonella ParaTyphi A in & around Chandigarh. Indian J Med Res 2009a; 129(1): 95-8.",Systematic review,IND,India,Government Medical College Hospital (Chandigarh),864,Punjab,2006,27,27,100,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
4593,Menezes (2016),"Menezes GA, Harish BN, Khan MA, Goessens W, Hays JP. Antimicrobial resistance trends in blood culture positive Salmonella ParaTyphi A isolates from Pondicherry, India. Indian J Med Microbiol 2016; 34(2): 222-7.",Systematic review,IND,India,Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER);Government Hospital (Pondicherry),889,Puducherry,2006,56,57,98.2,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
1412,Capoor (2009),"Capoor MR, Deepthi N, Jitendra P, et al. Minimum inhibitory concentration of carbapenems and tigecycline against Salmonella spp. J Med Microbiol 2009; 58(3): 337-41.",Systematic review,IND,India,Majeedia Hospital;Safdarjung Hospital,850,Delhi,2007,38,43,88.4,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
5124,Joshi (2019),"Joshi S, Adhikary R, Beena HB, et al. Trends in antibiotic susceptibility of enteric fever isolates from South India, 2002–2013.Medical Journal Armed Forces India 2019;75(1):81-85",Systematic review,IND,India,Manipal Hospital (Airport road),855,Karnataka,2007,24,132,18.2,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
1241,Gupta (2009)<U+1D43>,"Gupta V, Kaur J, Chander J. An increase in enteric fever cases due to Salmonella ParaTyphi A in & around Chandigarh. Indian J Med Res 2009a; 129(1): 95-8.",Systematic review,IND,India,Government Medical College Hospital (Chandigarh),864,Punjab,2007,13,13,100,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
4593,Menezes (2016),"Menezes GA, Harish BN, Khan MA, Goessens W, Hays JP. Antimicrobial resistance trends in blood culture positive Salmonella ParaTyphi A isolates from Pondicherry, India. Indian J Med Microbiol 2016; 34(2): 222-7.",Systematic review,IND,India,Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER);Government Hospital (Pondicherry),889,Puducherry,2007,65,65,100,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
262,Kumar (2013)<U+1D47>,"Kumar MS, Kumar GSV, Prashanth HV, Prakash R, Veena K, Chandrashekar SC. Antimicrobial susceptibility of enteric fever Salmonellae isolated from blood culture. Res J Pharm Biol Chem Sci 2013b; 4(3): 318-24.",Systematic review,IND,India,Sri Siddhartha Medical College,855,Karnataka,2008,118,132,89.4,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
5124,Joshi (2019),"Joshi S, Adhikary R, Beena HB, et al. Trends in antibiotic susceptibility of enteric fever isolates from South India, 2002–2013.Medical Journal Armed Forces India 2019;75(1):81-85",Systematic review,IND,India,Manipal Hospital (Airport road),855,Karnataka,2008,183,204,89.7,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
2334,Gupta (2013),"Gupta V, Singla N, Bansal N, Kaistha N, Chander J. Trends in the antibiotic resistance patterns of enteric fever isolates - a three year report from a tertiary care centre. Malays J Med Sci 2013; 20(4): 71-5.",Systematic review,IND,India,Government Medical College Hospital (Chandigarh),864,Punjab,2008,18,18,100,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
1424,Muthu(2014),"Muthu G, Suresh A, Elumalaisathishkumar, et al. Molecular analysis of gyramutations in Salmonella Paratyphi ABY PCR-RFLP and sequencing method. International Journal of Pharmacy and Pharmaceutical Sciences 2014; 6(4): 658-60.",Systematic review,IND,India,Unknown hospitals and laboratories in Chennai,867,Tamil Nadu,2008,40,41,97.6,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
2165,Gopal(2011),"Gopal M, Arumugam S, Gnadesikan S, Ramesh S. Studies on antimicrobial susceptibility pattern of Salmonella isolates from Chennai, India. Int J Pharma Bio Sci 2011; 2(2).",Systematic review,IND,India,Rajiv Gandhi Government General Hospital;Other clinical laboratories Chennai,867,Tamil Nadu,2008,40,41,97.6,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
4593,Menezes (2016),"Menezes GA, Harish BN, Khan MA, Goessens W, Hays JP. Antimicrobial resistance trends in blood culture positive Salmonella ParaTyphi A isolates from Pondicherry, India. Indian J Med Microbiol 2016; 34(2): 222-7.",Systematic review,IND,India,Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER);Government Hospital (Pondicherry),889,Puducherry,2008,59,59,100,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
2967,Iyer (2017),"Iyer RN, Jangam RR, Jacinth A, Venkatalakshmi A, Nahdi FB. Prevalence and trends in the antimicrobial susceptibility pattern of Salmonella enterica serovars Typhi and ParaTyphi A among children in a pediatric tertiary care hospital in South India over a period of ten years: a retrospective study. Eur J Clin Microbiol Infect Dis 2017; 07: 07.",Systematic review,IND,India,Rainbow Hospital for Women and Children,848,Andhra Pradesh,2009,19,20,95,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
5124,Joshi (2019),"Joshi S, Adhikary R, Beena HB, et al. Trends in antibiotic susceptibility of enteric fever isolates from South India, 2002–2013.Medical Journal Armed Forces India 2019;75(1):81-85",Systematic review,IND,India,Manipal Hospital (Airport road),855,Karnataka,2009,105,106,99.1,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
4585,Mahapatra (2016),"Mahapatra A, Patro S, Choudhury S, Padhee A, Das R. Emerging enteric fever due to switching biotype of Salmonella (ParaTyphi A) in Eastern Odisha. Indian J Pathol Microbiol 2016; 59(3): 327-9.",Systematic review,IND,India,SRL Diagnostics (Bhubaneswar),863,Orissa,2009,137,140,97.9,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
2334,Gupta (2013),"Gupta V, Singla N, Bansal N, Kaistha N, Chander J. Trends in the antibiotic resistance patterns of enteric fever isolates - a three year report from a tertiary care centre. Malays J Med Sci 2013; 20(4): 71-5.",Systematic review,IND,India,Government Medical College Hospital (Chandigarh),864,Punjab,2009,16,16,100,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
4593,Menezes (2016),"Menezes GA, Harish BN, Khan MA, Goessens W, Hays JP. Antimicrobial resistance trends in blood culture positive Salmonella ParaTyphi A isolates from Pondicherry, India. Indian J Med Microbiol 2016; 34(2): 222-7.",Systematic review,IND,India,Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER);Government Hospital (Pondicherry),889,Puducherry,2009,44,44,100,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
2967,Iyer (2017),"Iyer RN, Jangam RR, Jacinth A, Venkatalakshmi A, Nahdi FB. Prevalence and trends in the antimicrobial susceptibility pattern of Salmonella enterica serovars Typhi and ParaTyphi A among children in a pediatric tertiary care hospital in South India over a period of ten years: a retrospective study. Eur J Clin Microbiol Infect Dis 2017; 07: 07.",Systematic review,IND,India,Rainbow Hospital for Women and Children,848,Andhra Pradesh,2010,4,5,80,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
207,Jain (2013),"Jain S, Chugh TD. Antimicrobial resistance among blood culture isolates of Salmonella enterica in New Delhi. J Infect Dev Ctries 2013; 7(11): 788-95.",Systematic review,IND,India,BLK Super speciality Hospital,850,Delhi,2010,28,28,100,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
3082,Duggal (2016),"Duggal S, Banerjee P, Chugh TD. Review of fifty culture proven Salmonella cases. Indian J Med Sci 2016; 68(1): 67-72.",Systematic review,IND,India,Unknown Hospital(s) in Delhi,850,Delhi,2010,12,12,100,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
2820,Shetty (2012),"Shetty AK, Shetty IN, Furtado ZV, Antony B, Boloor R. Antibiogram of Salmonella isolates from blood with an emphasis on nalidixic acid and chloramphenicol susceptibility in a tertiary care hospital in coastal karnataka: a prospective study. J Lab Physicians 2012; 4(2): 74-7.",Systematic review,IND,India,Father Muller Medical College Hospital,855,Karnataka,2010,10,16,62.5,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
5124,Joshi (2019),"Joshi S, Adhikary R, Beena HB, et al. Trends in antibiotic susceptibility of enteric fever isolates from South India, 2002–2013.Medical Journal Armed Forces India 2019;75(1):81-85",Systematic review,IND,India,Manipal Hospital (Airport road),855,Karnataka,2010,59,60,98.3,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
2334,Gupta (2013),"Gupta V, Singla N, Bansal N, Kaistha N, Chander J. Trends in the antibiotic resistance patterns of enteric fever isolates - a three year report from a tertiary care centre. Malays J Med Sci 2013; 20(4): 71-5.",Systematic review,IND,India,Government Medical College Hospital (Chandigarh),864,Punjab,2010,11,11,100,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
744,Elumalai (2014),"Elumalai S, Muthu G, Selvam RE, Ramesh S. Detection of TEM-, SHV- and CTX-M-type beta-lactamase production among clinical isolates of Salmonella species. J Med Microbiol 2014; 63(Pt 7): 962-7.",Systematic review,IND,India,Unknown hospitals and laboratories in Chennai,867,Tamil Nadu,2010,31,31,100,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
5069,Bandyopadhyay(2018),"Bandyopadhyay R, Balaji V, Yadav B, Jasmine S, Sathyendra S, Rupali P. Effectiveness of treatment regimens for Typhoid fever in the nalidixic acid-resistant S. Typhi (NARST) era in South India. Trop Doct 2018; 48(3): 182-8.",Systematic review,IND,India,Christian Medical College (Vellore),867,Tamil Nadu,2010,18,18,100,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
4650,Yadav (2016),"Yadav VC, Kiran VR, Sharma R. Enteric fever in Bastar tribal region-prevalence and sensitivity patterns. J Evol Med Dent Sci 2016; 5(53): 3526-30.",Systematic review,IND,India,Late Baliram Kashyap Memorial Government Medical College Jagdalpur,884,Chhattisgarh,2010,0,16,0,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
207,Jain (2013),"Jain S, Chugh TD. Antimicrobial resistance among blood culture isolates of Salmonella enterica in New Delhi. J Infect Dev Ctries 2013; 7(11): 788-95.",Systematic review,IND,India,BLK Super speciality Hospital,850,Delhi,2011,33,33,100,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
5097,Makkar (2018),"Makkar A, Gupta S, Khan ID, et al. Epidemiological Profile and Antimicrobial Resistance Pattern of Enteric Fever in a Tertiary Care Hospital of North India - a Seven Year Ambispective Study.Acta Medica (Hradec Kralove) 2018;61(4):125-130",Systematic review,IND,India,Unknown Hospital(s) in Delhi,850,Delhi,2011,9,9,100,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
5124,Joshi (2019),"Joshi S, Adhikary R, Beena HB, et al. Trends in antibiotic susceptibility of enteric fever isolates from South India, 2002–2013.Medical Journal Armed Forces India 2019;75(1):81-85",Systematic review,IND,India,Manipal Hospital (Airport road),855,Karnataka,2011,71,73,97.3,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
4650,Yadav (2016),"Yadav VC, Kiran VR, Sharma R. Enteric fever in Bastar tribal region-prevalence and sensitivity patterns. J Evol Med Dent Sci 2016; 5(53): 3526-30.",Systematic review,IND,India,Late Baliram Kashyap Memorial Government Medical College Jagdalpur,884,Chhattisgarh,2011,0,11,0,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
1730,Geetha (2014),"Geetha VK, Yugendran T, Srinivasan R, Harish BN. Plasmid-mediated quinolone resistance in typhoidal Salmonellae: a preliminary report from South India. Indian J Med Microbiol 2014; 32(1): 31-4.",Systematic review,IND,India,Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER),889,Puducherry,2011,27,27,100,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
2967,Iyer (2017),"Iyer RN, Jangam RR, Jacinth A, Venkatalakshmi A, Nahdi FB. Prevalence and trends in the antimicrobial susceptibility pattern of Salmonella enterica serovars Typhi and ParaTyphi A among children in a pediatric tertiary care hospital in South India over a period of ten years: a retrospective study. Eur J Clin Microbiol Infect Dis 2017; 07: 07.",Systematic review,IND,India,Rainbow Hospital for Women and Children,848,Andhra Pradesh,2012,8,8,100,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
207,Jain (2013),"Jain S, Chugh TD. Antimicrobial resistance among blood culture isolates of Salmonella enterica in New Delhi. J Infect Dev Ctries 2013; 7(11): 788-95.",Systematic review,IND,India,BLK Super speciality Hospital,850,Delhi,2012,16,16,100,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
4627,Sharma (2016),"Sharma P, Dahiya S, Balaji V, et al. Typhoidal Salmonellae: Use of multi-locus sequence typing to determine population structure. PLoS ONE 2016; 11(9).",Systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,2012,9,10,90,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
5097,Makkar (2018),"Makkar A, Gupta S, Khan ID, et al. Epidemiological Profile and Antimicrobial Resistance Pattern of Enteric Fever in a Tertiary Care Hospital of North India - a Seven Year Ambispective Study.Acta Medica (Hradec Kralove) 2018;61(4):125-130",Systematic review,IND,India,Unknown Hospital(s) in Delhi,850,Delhi,2012,12,13,92.3,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
5110,Sharma (2018),"Sharma P, Dahiya S, Manral N, et al. Changing trends of culture-positive typhoid fever and antimicrobial susceptibility in a tertiary care North Indian Hospital over the last decade.Indian Journal of Medical Microbiology 2018;36(1):70-76",Systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,2012,17,17,100,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
151,Suruchi (2014),"Suruchi B, Anil K, Ganju SA, Atal S. Antibiotic susceptibility pattern of Salmonella enterica serovar Typhi and ParaTyphi a from North India: the changing scenario. Int J Pharma Bio Sci 2014; 5(4).",Systematic review,IND,India,Indira Gandhi Medical College,854,Himachal Pradesh,2012,24,25,96,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
117,Venkatesh (2013),"Venkatesh BM, Joshi S, Adhikary R, Bhaskar BH. Antibiogram of Salmonella Typhi and Salmonella ParaTyphi A in a tertiary care hospital in 2012. Indian J Pathol Microbiol 2013; 56(4): 484-5.",Systematic review,IND,India,Manipal Hospital (Airport road),855,Karnataka,2012,64,64,100,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
5124,Joshi (2019),"Joshi S, Adhikary R, Beena HB, et al. Trends in antibiotic susceptibility of enteric fever isolates from South India, 2002–2013.Medical Journal Armed Forces India 2019;75(1):81-85",Systematic review,IND,India,Manipal Hospital (Airport road),855,Karnataka,2012,91,91,100,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
4519,Chatterjee(2016),"Chatterjee S, Eshwara VK, Tellapragada C, Mukhopadhyay C. Azithromycin susceptibility among clinical isolates of Salmonella: Interfacing guidelines with routine practices. Indian J Med Microbiol 2016; 34(3): 397-8.",Systematic review,IND,India,Kasturba Medical College and Hospital (Manipal),855,Karnataka,2012,48,53,90.6,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
2977,Harichandran (2017),"Harichandran D, Dinesh KR. Antimicrobial susceptibility profile, treatment outcome and serotype distribution of clinical isolates of Salmonella enterica subspecies enterica: a 2-year study from Kerala, South India. Infect Drug Resist 2017; 10: 97-101.",Systematic review,IND,India,Amrita Institute of Medical Sciences and Research Centre,856,Kerala,2012,13,22,59.1,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
3012,Behl(2017),"Behl P, Gupta V, Sachdev A, Guglani V, Chander J. Patterns in antimicrobial susceptibility of Salmonellae isolated at a tertiary care hospital in northern India. Indian J Med Res 2017; 145(1): 124-8.",Systematic review,IND,India,Government Medical College Hospital (Chandigarh),864,Punjab,2012,11,16,68.8,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
696,Mathew (2014),"Mathew R, Jobin SR. Current trends of antimicrobial susceptibility of Salmonella enterica serovar Typhi and ParaTyphi a from blood cultures in a tertiary care center of Chennai, Tamil Nadu, India. Res J Pharm Biol Chem Sci 2014; 5(2): 1167-74.",Systematic review,IND,India,Saveetha Medical College (Thandalam),867,Tamil Nadu,2012,11,11,100,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
4650,Yadav (2016),"Yadav VC, Kiran VR, Sharma R. Enteric fever in Bastar tribal region-prevalence and sensitivity patterns. J Evol Med Dent Sci 2016; 5(53): 3526-30.",Systematic review,IND,India,Late Baliram Kashyap Memorial Government Medical College Jagdalpur,884,Chhattisgarh,2012,1,14,7.1,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
2967,Iyer (2017),"Iyer RN, Jangam RR, Jacinth A, Venkatalakshmi A, Nahdi FB. Prevalence and trends in the antimicrobial susceptibility pattern of Salmonella enterica serovars Typhi and ParaTyphi A among children in a pediatric tertiary care hospital in South India over a period of ten years: a retrospective study. Eur J Clin Microbiol Infect Dis 2017; 07: 07.",Systematic review,IND,India,Rainbow Hospital for Women and Children,848,Andhra Pradesh,2013,6,6,100,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
5097,Makkar (2018),"Makkar A, Gupta S, Khan ID, et al. Epidemiological Profile and Antimicrobial Resistance Pattern of Enteric Fever in a Tertiary Care Hospital of North India - a Seven Year Ambispective Study.Acta Medica (Hradec Kralove) 2018;61(4):125-130",Systematic review,IND,India,Unknown Hospital(s) in Delhi,850,Delhi,2013,11,11,100,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
5110,Sharma (2018),"Sharma P, Dahiya S, Manral N, et al. Changing trends of culture-positive typhoid fever and antimicrobial susceptibility in a tertiary care North Indian Hospital over the last decade.Indian Journal of Medical Microbiology 2018;36(1):70-76",Systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,2013,6,6,100,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
3039,Sharvani (2016),"Sharvani R, Hemavathi, Dayanand DK, Shenoy P, Sarmah P. Antibiogram of Salmonella isolates: time to consider antibiotic salvage. J Clin Diagn Res 2016; 10(5): DC6-DC8.",Systematic review,IND,India,Sapthagiri Hospital,855,Karnataka,2013,117,117,100,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
5124,Joshi (2019),"Joshi S, Adhikary R, Beena HB, et al. Trends in antibiotic susceptibility of enteric fever isolates from South India, 2002–2013.Medical Journal Armed Forces India 2019;75(1):81-85",Systematic review,IND,India,Manipal Hospital (Airport road),855,Karnataka,2013,111,111,100,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
4650,Yadav (2016),"Yadav VC, Kiran VR, Sharma R. Enteric fever in Bastar tribal region-prevalence and sensitivity patterns. J Evol Med Dent Sci 2016; 5(53): 3526-30.",Systematic review,IND,India,Late Baliram Kashyap Memorial Government Medical College Jagdalpur,884,Chhattisgarh,2013,2,14,14.3,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
4597,Misra (2016),"Misra R, Thakare R, Amrin N, Prasad KN, Chopra S, Dhole TN. Antimicrobial susceptibility pattern and sequence analysis of DNA gyrase and DNA topoisomerase IV in Salmonella enterica serovars Typhi and ParaTyphi A isolates with decreased susceptibility to ciprofloxacin. Trans R Soc Trop Med Hyg 2016; 110(8): 472-9.",Systematic review,IND,India,Sanjay Gandhi Postgraduate Institute of Medical Sciences,890,Uttar Pradesh,2013,8,8,100,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
5097,Makkar (2018),"Makkar A, Gupta S, Khan ID, et al. Epidemiological Profile and Antimicrobial Resistance Pattern of Enteric Fever in a Tertiary Care Hospital of North India - a Seven Year Ambispective Study.Acta Medica (Hradec Kralove) 2018;61(4):125-130",Systematic review,IND,India,Unknown Hospital(s) in Delhi,850,Delhi,2014,33,35,94.3,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
5110,Sharma (2018),"Sharma P, Dahiya S, Manral N, et al. Changing trends of culture-positive typhoid fever and antimicrobial susceptibility in a tertiary care North Indian Hospital over the last decade.Indian Journal of Medical Microbiology 2018;36(1):70-76",Systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,2014,5,5,100,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
4597,Misra (2016),"Misra R, Thakare R, Amrin N, Prasad KN, Chopra S, Dhole TN. Antimicrobial susceptibility pattern and sequence analysis of DNA gyrase and DNA topoisomerase IV in Salmonella enterica serovars Typhi and ParaTyphi A isolates with decreased susceptibility to ciprofloxacin. Trans R Soc Trop Med Hyg 2016; 110(8): 472-9.",Systematic review,IND,India,Sanjay Gandhi Postgraduate Institute of Medical Sciences,890,Uttar Pradesh,2014,6,6,100,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
5097,Makkar (2018),"Makkar A, Gupta S, Khan ID, et al. Epidemiological Profile and Antimicrobial Resistance Pattern of Enteric Fever in a Tertiary Care Hospital of North India - a Seven Year Ambispective Study.Acta Medica (Hradec Kralove) 2018;61(4):125-130",Systematic review,IND,India,Unknown Hospital(s) in Delhi,850,Delhi,2015,16,18,88.9,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
5110,Sharma (2018),"Sharma P, Dahiya S, Manral N, et al. Changing trends of culture-positive typhoid fever and antimicrobial susceptibility in a tertiary care North Indian Hospital over the last decade.Indian Journal of Medical Microbiology 2018;36(1):70-76",Systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,2015,13,13,100,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
2967,Iyer (2017),"Iyer RN, Jangam RR, Jacinth A, Venkatalakshmi A, Nahdi FB. Prevalence and trends in the antimicrobial susceptibility pattern of Salmonella enterica serovars Typhi and ParaTyphi A among children in a pediatric tertiary care hospital in South India over a period of ten years: a retrospective study. Eur J Clin Microbiol Infect Dis 2017; 07: 07.",Systematic review,IND,India,Rainbow Hospital for Women and Children,848,Andhra Pradesh,2016,10,10,100,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
5097,Makkar (2018),"Makkar A, Gupta S, Khan ID, et al. Epidemiological Profile and Antimicrobial Resistance Pattern of Enteric Fever in a Tertiary Care Hospital of North India - a Seven Year Ambispective Study.Acta Medica (Hradec Kralove) 2018;61(4):125-130",Systematic review,IND,India,Unknown Hospital(s) in Delhi,850,Delhi,2016,27,33,81.8,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
5110,Sharma (2018),"Sharma P, Dahiya S, Manral N, et al. Changing trends of culture-positive typhoid fever and antimicrobial susceptibility in a tertiary care North Indian Hospital over the last decade.Indian Journal of Medical Microbiology 2018;36(1):70-76",Systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,2016,24,24,100,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
5097,Makkar (2018),"Makkar A, Gupta S, Khan ID, et al. Epidemiological Profile and Antimicrobial Resistance Pattern of Enteric Fever in a Tertiary Care Hospital of North India - a Seven Year Ambispective Study.Acta Medica (Hradec Kralove) 2018;61(4):125-130",Systematic review,IND,India,Unknown Hospital(s) in Delhi,850,Delhi,2017,29,38,76.3,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
3669,Woods (2006),"Woods CW, Murdoch DR, Zimmerman MD, et al. Emergence of Salmonella enterica serotype ParaTyphi A as a major cause of enteric fever in Kathmandu, Nepal. Trans R Soc Trop Med Hyg 2006; 100(11): 1063-7.",Systematic review,NPL,Nepal,Patan Hospital (Lalitpur),892,Central,2001,48,57,84.2,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
712,Shirakawa (2006),"Shirakawa T, Acharya B, Kinoshita S, Kumagai S, Gotoh A, Kawabata M. Decreased susceptibility to fluoroquinolones and gyrA gene mutation in the Salmonella enterica serovar Typhi and ParaTyphi A isolated in Katmandu, Nepal, in 2003. Diagn Microbiol Infect Dis 2006; 54(4): 299-303.",Systematic review,NPL,Nepal,Unknown Hospital in Kathmandu,892,Central,2003,37,39,94.9,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
4673,Blacksell (2007),"Blacksell SD, Sharma NP, Phumratanaprapin W, et al. Serological and blood culture investigations of Nepalese fever patients. Trans R Soc Trop Med Hyg 2007; 101(7): 686-90.",Systematic review,NPL,Nepal,Dhulikhel Hospital (Kathmandu),892,Central,2003,8,8,100,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
3745,Khanal (2008),"Khanal B, Sharma SK, Amatya R, Poudyal N. Salmonella Typhi and ParaTyphi A in Eastern Nepal-Trends in Antimicrobial Resistance. Int J Infect Dis 2008; 12: E109-E.",Systematic review,NPL,Nepal,B.P. Koirala Institute of Health Sciences (Koshi),893,Eastern,2003,71,134,53,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
1988,Maskey (2006),"Maskey AP, Day JN, Phung QT, et al. Salmonella enterica serovar ParaTyphi A and S. enterica serovar Typhi cause indistinguishable clinical syndromes in Kathmandu, Nepal. Clin Infect Dis 2006; 42(9): 1247-53.",Systematic review,NPL,Nepal,Patan Hospital (Lalitpur),892,Central,2004,149,198,75.3,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
850,Tamang (2007),"Tamang MD, Oh J, Seol S, et al. Emergence of multidrug-resistant Salmonella enterica serovar Typhi associated with a class 1 integron carrying the dfrA7 gene cassette in Nepal. Int J Antimicrob Agents 2007; 30(4): 330-5.",Systematic review,NPL,Nepal,Dhulikhel Hospital (Kathmandu),892,Central,2005,24,28,85.7,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
971,Amatya (2007),"Amatya NM, Shrestha B, Lekhak B. Etiological agents of bacteraemia and antibiotic susceptibility pattern in Kathmandu Model Hospital. JNMA J Nepal Med Assoc 2007; 46(167): 112-8.",Systematic review,NPL,Nepal,Kathmandu Model Hospital (Kathmandu),892,Central,2005,10,10,100,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
396,Pradhan (2012),"Pradhan R, Shrestha U, Gautam SC, et al. Bloodstream infection among children presenting to a general hospital outpatient clinic in urban Nepal. PLoS ONE 2012; 7(10): e47531.",Systematic review,NPL,Nepal,Patan Hospital (Lalitpur),892,Central,2007,27,30,90,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
1092,Arjyal (2011),"Arjyal A, Basnyat B, Koirala S, et al. Gatifloxacin versus chloramphenicol for uncomplicated enteric fever: an open-label, randomised, controlled trial. Lancet Infect Dis 2011; 11(6): 445-54.",Systematic review,NPL,Nepal,Patan Hospital (Lalitpur),892,Central,2007,92,102,90.2,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
1132,Karki (2013),"Karki AB, Bhatta DR, Shrestha B, et al. Higher nalidixic acid resistance pattern of Salmonella isolates from enteric fever patients in kathmandu model hospital Nepal. Res J Pharm Biol Chem Sci 2013; 4(2): 1687-93.",Systematic review,NPL,Nepal,Kathmandu Model Hospital (Kathmandu),892,Central,2009,44,47,93.6,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
1402,Dongol(2012),"Dongol S, Thompson CN, Clare S, et al. The microbiological and clinical characteristics of invasive Salmonella in gallbladders from cholecystectomy patients in kathmandu, Nepal. PLoS ONE 2012; 7(10): e47342.",Systematic review,NPL,Nepal,Patan Hospital (Lalitpur),892,Central,2009,16,19,84.2,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
1093,Koirala (2013),"Koirala S, Basnyat B, Arjyal A, et al. Gatifloxacin versus ofloxacin for the treatment of uncomplicated enteric fever in Nepal: an open-label, randomized, controlled trial. PLoS Negl Trop Dis 2013; 7(10): e2523.",Systematic review,NPL,Nepal,Patan (Lalitpur),892,Central,2010,86,86,100,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
593,Joshi (2011),"Joshi BG, Keyal K, Pandey R, Shrestha BM. Clinical profile and sensitivity pattern of Salmonella serotypes in children: A hospital based study. Journal of Nepal Paediatric Society 2011; 31(3): 180-3.",Systematic review,NPL,Nepal,Civil Service Hospital (Kathmandu),892,Central,2011,9,15,60,1,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
2806,Adhikari (2012),"Adhikari D, Acharya D, Shrestha P, Amatya R. Ciprofloxacin susceptibility of Salmonella enteric serovar Typhi and ParaTyphi A from blood samples of suspected enteric fever patients. International Journal of Infection and Microbiology 2012; 1(1): 9-13.",Systematic review,NPL,Nepal,KIST Medical College (Kathmandu),892,Central,2011,23,23,100,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
2808,Chaudhary (2011),"Chaudhary R, Sijapati K, Singh SK. A study on nalidixic acid resistant Salmonella among the patients attending Shree Birendra Hospital. Med J Shree Birendra Hosp 2011; 10(2): 1-3.",Systematic review,NPL,Nepal,Shree Birendra Hospital (Kathmandu),892,Central,2011,159,166,95.8,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
1323,Rai (2012)<U+1D43>,"Rai GK, Karki S, Prajapati B. Is antimicrobial resistance pattern of enteric fever changing in Kathmandu valley? Journal of Nepal Paediatric Society 2012a; 32(3): 221-8.",Systematic review,NPL,Nepal,Kanti Children's Hospital (Kathmandu),892,Central,2012,13,13,100,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
1895,Chand (2014),"Chand HJ, Rijal KR, Neupane B, Sharma VK, Jha B. Re-emergence of susceptibility to conventional first line drugs in Salmonella isolates from enteric fever patients in Nepal. J Infect Dev Ctries 2014; 8(11): 1483-7.",Systematic review,NPL,Nepal,"Alka Hospital (Jawalakhel, Lalitpur)",892,Central,2012,27,30,90,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
3182,Arjyal (2016),"Arjyal A, Basnyat B, Nhan HT, et al. Gatifloxacin versus ceftriaxone for uncomplicated enteric fever in Nepal: an open-label, two-centre, randomised controlled trial. Lancet Infect Dis 2016; 16(5): 535-45.",Systematic review,NPL,Nepal,Civil Service Hospital (Kathmandu);Patan Hospital (Lalitpur),892,Central,2013,34,34,100,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
5104,Petersiel (2018),"Petersiel N, Shresta S, Tamrakar R, et al. The epidemiology of typhoid fever in the Dhulikhel area, Nepal: A prospective cohort study.PLoS ONE 2018;13 (9) (no pagination)(e0204479):",Systematic review,NPL,Nepal,Dhulikhel Hospital (Kathmandu),892,Central,2013,38,42,90.5,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
2913,Sherchan(2017),"Sherchan JB, Morita M, Matono T, et al. Molecular and Clinical Epidemiology of Salmonella ParaTyphi A Isolated from Patients with Bacteremia in Nepal. Am J Trop Med Hyg 2017; 09: 09.",Systematic review,NPL,Nepal,Tribhuvan University Teaching Hospital (Kathmandu),892,Central,2015,23,23,100,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
2979,Gurung (2017),"Gurung B, Pandey S, Shah DK, et al. Antibiogram pattern of Salmonella in blood samples of enteric fever patients at lalitpur, nepal. Asian Pac J Trop Dis 2017; 7(1): 21-4.",Systematic review,NPL,Nepal,KIST Medical College (Kathmandu),892,Central,2015,35,35,100,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
2958,Khanal (2017),"Khanal PR, Satyal D, Bhetwal A, et al. Renaissance of conventional first-line antibiotics in Salmonella enterica clinical isolates: Assessment of MICs for therapeutic antimicrobials in enteric fever cases from Nepal. Biomed Res Int 2017; 2017: 2868143.",Systematic review,NPL,Nepal,Manmohan Memorial Community Hospital (Kathmandu),892,Central,2016,0,14,0,1,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
5049,Bhetwal (2017),"Bhetwal A, Maharjan A, Khanal PR and Parajuli NP. Enteric Fever Caused by Salmonella enterica Serovars with Reduced Susceptibility of Fluoroquinolones at a Community Based Teaching Hospital of Nepal.International Journal of Microbiology 2017;2017(2869458",Systematic review,NPL,Nepal,Manmohan Memorial Teaching Hospital (Kathmandu),892,Central,2016,44,83,53,1,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
5073,Britto (2018),"Britto CD, Dyson ZA, Duchene S, et al. Laboratory and molecular surveillance of paediatric typhoidal Salmonella in Nepal: Antimicrobial resistance and implications for vaccine policy.PLoS Neglected Tropical Diseases [electronic resource] 2018;12(4):e0006408",Systematic review,NPL,Nepal,Patan Hospital (Lalitpur),892,Central,2016,5,5,100,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
1071,Anjum (2004),"Anjum P, Qureshi AH, Rafi S. Fluroquinolone resistance in typhoidal Salmonella and its detection by nalidixic acid disc diffusion. J Pak Med Assoc 2004; 54(6): 295-301.",Systematic review,PAK,Pakistan,Army Medical College,901,Punjab,2001,11,100,11,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
2446,Butt (2006),"Butt T, Khan MY, Ahmad RN, Salman M, Afzal RK. Validity of nalidixic acid screening in fluoroquinolone-resistant typhoid Salmonellae. J Coll Physicians Surg Pak 2006; 16(1): 31-4.",Systematic review,PAK,Pakistan,Armed Force Institute of Pathology,901,Punjab,2003,12,99,12.1,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
4363,Ikram (2015),"Ikram S, Hussain S, Aslam A, Khan MD, Ahmed I. Evaluation of the current trends in the antimicrobial susceptibility patterns of typhoid Salmonellae. Pak J Med Health Sci 2015; 9(4): 1247-50.",Systematic review,PAK,Pakistan,Islamabad Hospital (PIMS),899,Islamabad,2007,38,70,54.3,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
3023,Ali (2017),"Ali A, Ali HA, Shah FH, Zahid A, Aslam H, Javed B. Pattern of antimicrobial drug resistance of Salmonella Typhi and ParaTyphi a in a teaching hospital in Islamabad. J Pak Med Assoc 2017; 67(3): 375-9.",Systematic review,PAK,Pakistan,Khan Research Laboratories (KRL) Hospital,899,Islamabad,2013,42,42,100,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
5150,Sharkoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Khyber Pakhtunkhwa,900,Nwfp,2015,5,5,100,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
5150,Sharkoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Punjab,901,Punjab,2019,97,98,99,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
5150,Sharkoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Sindh,902,Sind,2013,278,295,94.2,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
5150,Sharkoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Sindh,902,Sind,2019,350,352,99.4,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
5150,Sharkoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Sindh,902,Sind,2011,534,568,94,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
5150,Sharkoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Sindh,902,Sind,2014,252,271,93,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
5150,Sharkoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Sindh,902,Sind,2015,210,218,96.3,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
5150,Sharkoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Punjab,901,Punjab,2013,9,10,90,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
5150,Sharkoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Punjab,901,Punjab,2015,8,8,100,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
5150,Sharkoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Punjab,901,Punjab,2011,8,9,88.9,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
5150,Sharkoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Sindh,902,Sind,2012,281,299,94,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
5150,Sharkoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Punjab,901,Punjab,2014,10,11,90.9,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
5150,Sharkoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Balochistan,897,Balochistan,2019,7,7,100,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
5150,Sharkoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Punjab,901,Punjab,2012,16,16,100,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
5151,SEAP (2021),Sabine Vaccine Institute. Surveillance for Enteric Fever in Asia Project (SEAP) dataset. 2021,Dataset,BGD,Bangladesh,Dhaka,823,Dhaka,2017,41,41,100,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
5151,SEAP (2021),Sabine Vaccine Institute. Surveillance for Enteric Fever in Asia Project (SEAP) dataset. 2021,Dataset,BGD,Bangladesh,Dhaka,823,Dhaka,2018,32,32,100,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
5151,SEAP (2021),Sabine Vaccine Institute. Surveillance for Enteric Fever in Asia Project (SEAP) dataset. 2021,Dataset,BGD,Bangladesh,Dhaka,823,Dhaka,2019,16,16,100,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
5151,SEAP (2021),Sabine Vaccine Institute. Surveillance for Enteric Fever in Asia Project (SEAP) dataset. 2021,Dataset,BGD,Bangladesh,Dhaka,823,Dhaka,2016,5,6,83.3,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
5151,SEAP (2021),Sabine Vaccine Institute. Surveillance for Enteric Fever in Asia Project (SEAP) dataset. 2021,Dataset,NPL,Nepal,Kathmandu,892,Central,2017,2,5,40,1,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
5151,SEAP (2021),Sabine Vaccine Institute. Surveillance for Enteric Fever in Asia Project (SEAP) dataset. 2021,Dataset,NPL,Nepal,Kathmandu,892,Central,2018,6,6,100,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
5151,SEAP (2021),Sabine Vaccine Institute. Surveillance for Enteric Fever in Asia Project (SEAP) dataset. 2021,Dataset,NPL,Nepal,Kathmandu,892,Central,2019,10,10,100,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
5151,SEAP (2021),Sabine Vaccine Institute. Surveillance for Enteric Fever in Asia Project (SEAP) dataset. 2021,Dataset,PAK,Pakistan,Karachi,902,Sind,2017,19,20,95,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
5151,SEAP (2021),Sabine Vaccine Institute. Surveillance for Enteric Fever in Asia Project (SEAP) dataset. 2021,Dataset,PAK,Pakistan,Karachi,902,Sind,2018,7,7,100,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
5151,SEAP (2021),Sabine Vaccine Institute. Surveillance for Enteric Fever in Asia Project (SEAP) dataset. 2021,Dataset,PAK,Pakistan,Karachi,902,Sind,2019,7,7,100,0,Salmonella Paratyphi A,Fluoroquinolone non-susceptibility (FQNS)
2946,Marks (2017),"Marks F, Kalckreuth V, Aaby P, et al. Incidence of invasive Salmonella disease in sub-Saharan Africa: A multicentre population-based surveillance study. Lancet Glob Health 2017; 5(3): e310-e23.",Initial systematic review,BFA,Burkina Faso,Unkown Hospitals in Nioko II and Polesgo,954,Centre,2013,0,18,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
705,Rahman (2002),"Rahman M, Ahmad A, Shoma S. Decline in epidemic of multidrug resistant Salmonella Typhi is not associated with increased incidence of antibiotic-susceptible strain in Bangladesh. Epidemiol Infect 2002; 129(1): 29-34.",Initial systematic review,BGD,Bangladesh,ICDDR,823,Dhaka,1990,0,99,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
849,Rahman (2006),"Rahman M, Siddique AK, Shoma S, et al. Emergence of multidrug-resistant Salmonella enterica serotype Typhi with decreased ciprofloxacin susceptibility in Bangladesh. Epidemiol Infect 2006; 134(2): 433-8.",Initial systematic review,BGD,Bangladesh,ICDDR,823,Dhaka,1990,0,99,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
137,Saha (1994),Saha SK. Antibiotic resistance of Salmonella Typhi in Bangladesh. J Antimicrob Chemother 1994; 33(1): 190-1.,Initial systematic review,BGD,Bangladesh,Dhaka Shishu Hospital,823,Dhaka,1991,0,236,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
705,Rahman (2002),"Rahman M, Ahmad A, Shoma S. Decline in epidemic of multidrug resistant Salmonella Typhi is not associated with increased incidence of antibiotic-susceptible strain in Bangladesh. Epidemiol Infect 2002; 129(1): 29-34.",Initial systematic review,BGD,Bangladesh,ICDDR,823,Dhaka,1991,0,231,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
849,Rahman (2006),"Rahman M, Siddique AK, Shoma S, et al. Emergence of multidrug-resistant Salmonella enterica serotype Typhi with decreased ciprofloxacin susceptibility in Bangladesh. Epidemiol Infect 2006; 134(2): 433-8.",Initial systematic review,BGD,Bangladesh,ICDDR,823,Dhaka,1991,0,231,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
705,Rahman (2002),"Rahman M, Ahmad A, Shoma S. Decline in epidemic of multidrug resistant Salmonella Typhi is not associated with increased incidence of antibiotic-susceptible strain in Bangladesh. Epidemiol Infect 2002; 129(1): 29-34.",Initial systematic review,BGD,Bangladesh,ICDDR,823,Dhaka,1992,8,309,2.6,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
849,Rahman (2006),"Rahman M, Siddique AK, Shoma S, et al. Emergence of multidrug-resistant Salmonella enterica serotype Typhi with decreased ciprofloxacin susceptibility in Bangladesh. Epidemiol Infect 2006; 134(2): 433-8.",Initial systematic review,BGD,Bangladesh,ICDDR,823,Dhaka,1992,0,309,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
705,Rahman (2002),"Rahman M, Ahmad A, Shoma S. Decline in epidemic of multidrug resistant Salmonella Typhi is not associated with increased incidence of antibiotic-susceptible strain in Bangladesh. Epidemiol Infect 2002; 129(1): 29-34.",Initial systematic review,BGD,Bangladesh,ICDDR,823,Dhaka,1993,0,479,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
849,Rahman (2006),"Rahman M, Siddique AK, Shoma S, et al. Emergence of multidrug-resistant Salmonella enterica serotype Typhi with decreased ciprofloxacin susceptibility in Bangladesh. Epidemiol Infect 2006; 134(2): 433-8.",Initial systematic review,BGD,Bangladesh,ICDDR,823,Dhaka,1993,0,479,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
1878,Islam (1993),"Islam MN, Afroza A, Hasan Z, Majumder B, Hossain A. Recent antibiogram pattern and clinical profile of typhoid fever in children - A study of 36 cases. Bangladesh J Child Health 1993; 17(3): 93-6.",Initial systematic review,BGD,Bangladesh,Institute of Postgraduate Medicine and Research,823,Dhaka,1993,0,29,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
705,Rahman (2002),"Rahman M, Ahmad A, Shoma S. Decline in epidemic of multidrug resistant Salmonella Typhi is not associated with increased incidence of antibiotic-susceptible strain in Bangladesh. Epidemiol Infect 2002; 129(1): 29-34.",Initial systematic review,BGD,Bangladesh,ICDDR,823,Dhaka,1994,0,547,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
849,Rahman (2006),"Rahman M, Siddique AK, Shoma S, et al. Emergence of multidrug-resistant Salmonella enterica serotype Typhi with decreased ciprofloxacin susceptibility in Bangladesh. Epidemiol Infect 2006; 134(2): 433-8.",Initial systematic review,BGD,Bangladesh,ICDDR,823,Dhaka,1994,0,547,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
705,Rahman (2002),"Rahman M, Ahmad A, Shoma S. Decline in epidemic of multidrug resistant Salmonella Typhi is not associated with increased incidence of antibiotic-susceptible strain in Bangladesh. Epidemiol Infect 2002; 129(1): 29-34.",Initial systematic review,BGD,Bangladesh,ICDDR,823,Dhaka,1995,1,582,0.2,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
849,Rahman (2006),"Rahman M, Siddique AK, Shoma S, et al. Emergence of multidrug-resistant Salmonella enterica serotype Typhi with decreased ciprofloxacin susceptibility in Bangladesh. Epidemiol Infect 2006; 134(2): 433-8.",Initial systematic review,BGD,Bangladesh,ICDDR,823,Dhaka,1995,0,582,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
708,Asna (2000),"Asna SMZH, Ashraful Haq J. Decrease of antibiotic resistance in Salmonella Typhi isolated from patients attending hospitals of Dhaka City over a 3 year period. Int J Antimicrob Agents 2000; 16(3): 249-51.",Initial systematic review,BGD,Bangladesh,Unknown hospitals in Dhaka,823,Dhaka,1996,0,47,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
705,Rahman (2002),"Rahman M, Ahmad A, Shoma S. Decline in epidemic of multidrug resistant Salmonella Typhi is not associated with increased incidence of antibiotic-susceptible strain in Bangladesh. Epidemiol Infect 2002; 129(1): 29-34.",Initial systematic review,BGD,Bangladesh,ICDDR,823,Dhaka,1996,0,375,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
849,Rahman (2006),"Rahman M, Siddique AK, Shoma S, et al. Emergence of multidrug-resistant Salmonella enterica serotype Typhi with decreased ciprofloxacin susceptibility in Bangladesh. Epidemiol Infect 2006; 134(2): 433-8.",Initial systematic review,BGD,Bangladesh,ICDDR,823,Dhaka,1996,0,375,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
708,Asna (2000),"Asna SMZH, Ashraful Haq J. Decrease of antibiotic resistance in Salmonella Typhi isolated from patients attending hospitals of Dhaka City over a 3 year period. Int J Antimicrob Agents 2000; 16(3): 249-51.",Initial systematic review,BGD,Bangladesh,Unknown hospitals in Dhaka,823,Dhaka,1997,0,50,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
849,Rahman (2006),"Rahman M, Siddique AK, Shoma S, et al. Emergence of multidrug-resistant Salmonella enterica serotype Typhi with decreased ciprofloxacin susceptibility in Bangladesh. Epidemiol Infect 2006; 134(2): 433-8.",Initial systematic review,BGD,Bangladesh,ICDDR,823,Dhaka,1997,0,226,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
708,Asna (2000),"Asna SMZH, Ashraful Haq J. Decrease of antibiotic resistance in Salmonella Typhi isolated from patients attending hospitals of Dhaka City over a 3 year period. Int J Antimicrob Agents 2000; 16(3): 249-51.",Initial systematic review,BGD,Bangladesh,Unknown hospitals in Dhaka,823,Dhaka,1998,0,54,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
849,Rahman (2006),"Rahman M, Siddique AK, Shoma S, et al. Emergence of multidrug-resistant Salmonella enterica serotype Typhi with decreased ciprofloxacin susceptibility in Bangladesh. Epidemiol Infect 2006; 134(2): 433-8.",Initial systematic review,BGD,Bangladesh,ICDDR,823,Dhaka,1998,0,306,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
849,Rahman (2006),"Rahman M, Siddique AK, Shoma S, et al. Emergence of multidrug-resistant Salmonella enterica serotype Typhi with decreased ciprofloxacin susceptibility in Bangladesh. Epidemiol Infect 2006; 134(2): 433-8.",Initial systematic review,BGD,Bangladesh,ICDDR,823,Dhaka,1999,0,174,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5115,Tanmoy (2018),"Tanmoy AM, Westeel E, Bruyne KD, et al. Salmonella enterica serovar Typhi in Bangladesh: exploration of genomic diversity and antimicrobial resistance.mBio 2018;9(6):02112-18",Initial systematic review,BGD,Bangladesh,Dhaka Shishu Hospital,823,Dhaka,1999,0,16,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
849,Rahman (2006),"Rahman M, Siddique AK, Shoma S, et al. Emergence of multidrug-resistant Salmonella enterica serotype Typhi with decreased ciprofloxacin susceptibility in Bangladesh. Epidemiol Infect 2006; 134(2): 433-8.",Initial systematic review,BGD,Bangladesh,ICDDR,823,Dhaka,2000,0,153,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5115,Tanmoy (2018),"Tanmoy AM, Westeel E, Bruyne KD, et al. Salmonella enterica serovar Typhi in Bangladesh: exploration of genomic diversity and antimicrobial resistance.mBio 2018;9(6):02112-18",Initial systematic review,BGD,Bangladesh,Dhaka Shishu Hospital,823,Dhaka,2000,1,26,3.8,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
339,Brooks (2005),"Brooks WA, Hossain A, Goswami D, et al. Bacteremic typhoid fever in children in an urban slum, Bangladesh. Emerg Infect Dis 2005; 11(2): 326-9.",Initial systematic review,BGD,Bangladesh,Kamalapur,823,Dhaka,2001,1,49,2,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
849,Rahman (2006),"Rahman M, Siddique AK, Shoma S, et al. Emergence of multidrug-resistant Salmonella enterica serotype Typhi with decreased ciprofloxacin susceptibility in Bangladesh. Epidemiol Infect 2006; 134(2): 433-8.",Initial systematic review,BGD,Bangladesh,ICDDR,823,Dhaka,2001,0,212,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5115,Tanmoy (2018),"Tanmoy AM, Westeel E, Bruyne KD, et al. Salmonella enterica serovar Typhi in Bangladesh: exploration of genomic diversity and antimicrobial resistance.mBio 2018;9(6):02112-18",Initial systematic review,BGD,Bangladesh,Dhaka Shishu Hospital,823,Dhaka,2001,0,20,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
849,Rahman (2006),"Rahman M, Siddique AK, Shoma S, et al. Emergence of multidrug-resistant Salmonella enterica serotype Typhi with decreased ciprofloxacin susceptibility in Bangladesh. Epidemiol Infect 2006; 134(2): 433-8.",Initial systematic review,BGD,Bangladesh,ICDDR,823,Dhaka,2002,0,173,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5115,Tanmoy (2018),"Tanmoy AM, Westeel E, Bruyne KD, et al. Salmonella enterica serovar Typhi in Bangladesh: exploration of genomic diversity and antimicrobial resistance.mBio 2018;9(6):02112-18",Initial systematic review,BGD,Bangladesh,Dhaka Shishu Hospital,823,Dhaka,2002,0,14,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
405,Aliya (2010),"Aliya N, Ram PK, Brooks WA, et al. Burden of typhoid and paratyphoid fever in a densely populated urban community, Dhaka, Bangladesh. Int J Infect Dis 2010; 14(Suppl. 3): e93-e9.",Initial systematic review,BGD,Bangladesh,Kamalapur,823,Dhaka,2004,0,40,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5115,Tanmoy (2018),"Tanmoy AM, Westeel E, Bruyne KD, et al. Salmonella enterica serovar Typhi in Bangladesh: exploration of genomic diversity and antimicrobial resistance.mBio 2018;9(6):02112-18",Initial systematic review,BGD,Bangladesh,Dhaka Shishu Hospital,823,Dhaka,2004,0,15,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
1998,Alaullah (2009),"Alaullah S, Bhuiyan MS, Farhana K, et al. Salmonella enterica serovar Typhi-specific immunoglobulin A antibody responses in plasma and antibody in lymphocyte supernatant specimens in Bangladeshi patients with suspected typhoid fever. Clin Vaccine Immunol 2009; 16(11): 1587-94.",Initial systematic review,BGD,Bangladesh,Dhaka Hospital (ICCDR);Dhaka Medical College Hospital;ICDDR,823,Dhaka,2005,0,26,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
3026,Ahmed (2017),"Ahmed D, Nahid MA, Sami AB, et al. Bacterial etiology of bloodstream infections and antimicrobial resistance in Dhaka, Bangladesh, 2005-2014. Antimicrob Resist Infect Control 2017; 6.",Initial systematic review,BGD,Bangladesh,Dhaka Hospital (ICCDR);ICDDR,823,Dhaka,2005,0,457,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5115,Tanmoy (2018),"Tanmoy AM, Westeel E, Bruyne KD, et al. Salmonella enterica serovar Typhi in Bangladesh: exploration of genomic diversity and antimicrobial resistance.mBio 2018;9(6):02112-18",Initial systematic review,BGD,Bangladesh,Dhaka Shishu Hospital,823,Dhaka,2005,0,50,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
1088,Das(2014),"Das SK, Chisti MJ, Afrad MH, et al. Gastroenteritis due to typhoidal Salmonella: a decade of observation at an urban and a rural diarrheal disease hospital in Bangladesh. BMC Infect Dis 2014; 14: 435.",Extended systematic review,BGD,Bangladesh,ICDDR;Matlab Hospital (ICDDR),823,Dhaka,2006,0,12,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
1088,Das(2014),"Das SK, Chisti MJ, Afrad MH, et al. Gastroenteritis due to typhoidal Salmonella: a decade of observation at an urban and a rural diarrheal disease hospital in Bangladesh. BMC Infect Dis 2014; 14: 435.",Extended systematic review,BGD,Bangladesh,Unknown urban Dhaka hospital,823,Dhaka,2006,0,44,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
3026,Ahmed (2017),"Ahmed D, Nahid MA, Sami AB, et al. Bacterial etiology of bloodstream infections and antimicrobial resistance in Dhaka, Bangladesh, 2005-2014. Antimicrob Resist Infect Control 2017; 6.",Initial systematic review,BGD,Bangladesh,Dhaka Hospital (ICCDR);ICDDR,823,Dhaka,2006,0,595,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5115,Tanmoy (2018),"Tanmoy AM, Westeel E, Bruyne KD, et al. Salmonella enterica serovar Typhi in Bangladesh: exploration of genomic diversity and antimicrobial resistance.mBio 2018;9(6):02112-18",Initial systematic review,BGD,Bangladesh,Dhaka Shishu Hospital,823,Dhaka,2006,0,55,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
3026,Ahmed (2017),"Ahmed D, Nahid MA, Sami AB, et al. Bacterial etiology of bloodstream infections and antimicrobial resistance in Dhaka, Bangladesh, 2005-2014. Antimicrob Resist Infect Control 2017; 6.",Initial systematic review,BGD,Bangladesh,Dhaka Hospital (ICCDR);ICDDR,823,Dhaka,2007,0,571,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5115,Tanmoy (2018),"Tanmoy AM, Westeel E, Bruyne KD, et al. Salmonella enterica serovar Typhi in Bangladesh: exploration of genomic diversity and antimicrobial resistance.mBio 2018;9(6):02112-18",Initial systematic review,BGD,Bangladesh,Dhaka Shishu Hospital,823,Dhaka,2007,0,54,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
3026,Ahmed (2017),"Ahmed D, Nahid MA, Sami AB, et al. Bacterial etiology of bloodstream infections and antimicrobial resistance in Dhaka, Bangladesh, 2005-2014. Antimicrob Resist Infect Control 2017; 6.",Initial systematic review,BGD,Bangladesh,Dhaka Hospital (ICCDR);ICDDR,823,Dhaka,2008,0,600,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5115,Tanmoy (2018),"Tanmoy AM, Westeel E, Bruyne KD, et al. Salmonella enterica serovar Typhi in Bangladesh: exploration of genomic diversity and antimicrobial resistance.mBio 2018;9(6):02112-18",Initial systematic review,BGD,Bangladesh,Dhaka Shishu Hospital,823,Dhaka,2008,0,56,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
2847,"ICDDR,B(2009)<U+1D48>",International Centre for Diarrhoeal Disease Research Bangladesh. Surveillance updates. Health and Science Bulletin 2009; 7(4).,Surveillance report,BGD,Bangladesh,Kamalapur,823,Dhaka,2009,0,49,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
2848,"ICDDR,B(2009)<U+1D9C>",International Centre for Diarrhoeal Disease Research Bangladesh. Surveillance updates. Health and Science Bulletin 2009; 7(3).,Surveillance report,BGD,Bangladesh,Kamalapur,823,Dhaka,2009,0,26,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
2849,"ICDDR,B(2009)<U+1D47>",International Centre for Diarrhoeal Disease Research Bangladesh. Surveillance updates. Health and Science Bulletin 2009; 7(2).,Surveillance report,BGD,Bangladesh,Kamalapur,823,Dhaka,2009,0,46,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
3026,Ahmed (2017),"Ahmed D, Nahid MA, Sami AB, et al. Bacterial etiology of bloodstream infections and antimicrobial resistance in Dhaka, Bangladesh, 2005-2014. Antimicrob Resist Infect Control 2017; 6.",Initial systematic review,BGD,Bangladesh,Dhaka Hospital (ICCDR);ICDDR,823,Dhaka,2009,0,483,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5115,Tanmoy (2018),"Tanmoy AM, Westeel E, Bruyne KD, et al. Salmonella enterica serovar Typhi in Bangladesh: exploration of genomic diversity and antimicrobial resistance.mBio 2018;9(6):02112-18",Initial systematic review,BGD,Bangladesh,Dhaka Shishu Hospital,823,Dhaka,2009,0,52,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
2843,"ICDDR,B(2010)<U+1D9C>",International Centre for Diarrhoeal Disease Research Bangladesh. Surveillance updates. Health and Science Bulletin 2010; 8(4).,Surveillance report,BGD,Bangladesh,Kamalapur,823,Dhaka,2010,0,23,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
2844,"ICDDR,B(2010)<U+1D47>",International Centre for Diarrhoeal Disease Research Bangladesh. Surveillance updates. Health and Science Bulletin 2010; 8(3).,Surveillance report,BGD,Bangladesh,Kamalapur,823,Dhaka,2010,0,17,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
2845,"ICDDR,B(2010)<U+1D43>",International Centre for Diarrhoeal Disease Research Bangladesh. Surveillance updates. Health and Science Bulletin 2010; 8(2).,Surveillance report,BGD,Bangladesh,Kamalapur,823,Dhaka,2010,0,29,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
3026,Ahmed (2017),"Ahmed D, Nahid MA, Sami AB, et al. Bacterial etiology of bloodstream infections and antimicrobial resistance in Dhaka, Bangladesh, 2005-2014. Antimicrob Resist Infect Control 2017; 6.",Initial systematic review,BGD,Bangladesh,Dhaka Hospital (ICCDR);ICDDR,823,Dhaka,2010,0,643,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5115,Tanmoy (2018),"Tanmoy AM, Westeel E, Bruyne KD, et al. Salmonella enterica serovar Typhi in Bangladesh: exploration of genomic diversity and antimicrobial resistance.mBio 2018;9(6):02112-18",Initial systematic review,BGD,Bangladesh,Dhaka Shishu Hospital,823,Dhaka,2010,0,44,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
1680,Afroze (2014),"Afroze SR, Rahim MA, Hasan MM, et al. Pattern of antibiotic sensitivity in enteric fever: A tertiary care hospital experience. Journal of Medicine (Bangladesh) 2014; 15(2): 122-4.",Initial systematic review,BGD,Bangladesh,"Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders (BIRDEM)",823,Dhaka,2011,0,71,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
2195,"ICDDR,B(2011)<U+1D9C>",International Centre for Diarrhoeal Disease Research Bangladesh. Surveillance updates. Health and Science Bulletin 2011; 9(3): 22-5.,Surveillance report,BGD,Bangladesh,Kamalapur,823,Dhaka,2011,0,23,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
2392,Farhana (2015),"Farhana K, Sayeed MA, Feroza Kaneez C, et al. Typhoid fever in young children in Bangladesh: clinical findings, antibiotic susceptibility pattern and immune responses. PLoS Negl Trop Dis 2015; 9(4).",Initial systematic review,BGD,Bangladesh,Dhaka Hospital (ICCDR);ICDDR,823,Dhaka,2011,0,72,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
2839,"ICDDR,B(2011)<U+1D48>",International Centre for Diarrhoeal Disease Research Bangladesh. Surveillance updates. Health and Science Bulletin 2011; 9(4).,Surveillance report,BGD,Bangladesh,Kamalapur,823,Dhaka,2011,0,22,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
2841,"ICDDR,B(2011)<U+1D43>",International Centre for Diarrhoeal Disease Research Bangladesh. Surveillance updates. Health and Science Bulletin 2011; 2(1).,Surveillance report,BGD,Bangladesh,Kamalapur,823,Dhaka,2011,0,44,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
2842,"ICDDR,B(2011)<U+1D47>",International Centre for Diarrhoeal Disease Research Bangladesh. Surveillance updates. Health and Science Bulletin 2011; 9(1).,Surveillance report,BGD,Bangladesh,Kamalapur,823,Dhaka,2011,0,8,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
3026,Ahmed (2017),"Ahmed D, Nahid MA, Sami AB, et al. Bacterial etiology of bloodstream infections and antimicrobial resistance in Dhaka, Bangladesh, 2005-2014. Antimicrob Resist Infect Control 2017; 6.",Initial systematic review,BGD,Bangladesh,Dhaka Hospital (ICCDR);ICDDR,823,Dhaka,2011,0,451,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
4451,Shahunja(2015),"Shahunja KM, Leung DT, Tahmeed A, et al. Factors associated with non-typhoidal Salmonella bacteremia versus typhoidal Salmonella bacteremia in patients presenting for care in an urban diarrheal disease hospital in Bangladesh. PLoS Negl Trop Dis 2015; 9(9).",Extended systematic review,BGD,Bangladesh,Dhaka Hospital (ICCDR),823,Dhaka,2011,0,60,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5115,Tanmoy (2018),"Tanmoy AM, Westeel E, Bruyne KD, et al. Salmonella enterica serovar Typhi in Bangladesh: exploration of genomic diversity and antimicrobial resistance.mBio 2018;9(6):02112-18",Initial systematic review,BGD,Bangladesh,Dhaka Shishu Hospital,823,Dhaka,2011,0,43,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
2835,"ICDDR,B(2012)<U+1D48>",International Centre for Diarrhoeal Disease Research Bangladesh. Surveillance updates. Health and Science Bulletin 2012; 10(4).,Surveillance report,BGD,Bangladesh,Kamalapur,823,Dhaka,2012,0,31,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
2836,"ICDDR,B(2012)<U+1D9C>",International Centre for Diarrhoeal Disease Research Bangladesh. Surveillance updates. Health and Science Bulletin 2012; 10(3).,Surveillance report,BGD,Bangladesh,Kamalapur,823,Dhaka,2012,0,52,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
2837,"ICDDR,B(2012)<U+1D47>",International Centre for Diarrhoeal Disease Research Bangladesh. Surveillance updates. Health and Science Bulletin 2012; 10(2).,Surveillance report,BGD,Bangladesh,Kamalapur,823,Dhaka,2012,0,33,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
2838,"ICDDR,B(2012)<U+1D43>",International Centre for Diarrhoeal Disease Research Bangladesh. Surveillance updates. Health and Science Bulletin 2012; 10(1).,Surveillance report,BGD,Bangladesh,Kamalapur,823,Dhaka,2012,0,14,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
3026,Ahmed (2017),"Ahmed D, Nahid MA, Sami AB, et al. Bacterial etiology of bloodstream infections and antimicrobial resistance in Dhaka, Bangladesh, 2005-2014. Antimicrob Resist Infect Control 2017; 6.",Initial systematic review,BGD,Bangladesh,Dhaka Hospital (ICCDR);ICDDR,823,Dhaka,2012,0,527,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5115,Tanmoy (2018),"Tanmoy AM, Westeel E, Bruyne KD, et al. Salmonella enterica serovar Typhi in Bangladesh: exploration of genomic diversity and antimicrobial resistance.mBio 2018;9(6):02112-18",Initial systematic review,BGD,Bangladesh,Dhaka Shishu Hospital,823,Dhaka,2012,0,44,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
2831,"ICDDR,B(2013)<U+1D48>",International Centre for Diarrhoeal Disease Research Bangladesh. Surveillance updates. Health and Science Bulletin 2013; 11(4).,Surveillance report,BGD,Bangladesh,Kamalapur,823,Dhaka,2013,0,18,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
2832,"ICDDR,B(2013)<U+1D9C>",International Centre for Diarrhoeal Disease Research Bangladesh. Surveillance updates. Health and Science Bulletin 2013; 11(3).,Surveillance report,BGD,Bangladesh,Kamalapur,823,Dhaka,2013,0,41,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
2833,"ICDDR,B(2013)<U+1D47>",International Centre for Diarrhoeal Disease Research Bangladesh. Surveillance updates. Health and Science Bulletin 2013; 11(2).,Surveillance report,BGD,Bangladesh,Kamalapur,823,Dhaka,2013,0,22,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
2834,"ICDDR,B(2013)<U+1D43>",International Centre for Diarrhoeal Disease Research Bangladesh. Surveillance updates. Health and Science Bulletin 2013; 11(1).,Surveillance report,BGD,Bangladesh,Kamalapur,823,Dhaka,2013,0,17,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
3026,Ahmed (2017),"Ahmed D, Nahid MA, Sami AB, et al. Bacterial etiology of bloodstream infections and antimicrobial resistance in Dhaka, Bangladesh, 2005-2014. Antimicrob Resist Infect Control 2017; 6.",Initial systematic review,BGD,Bangladesh,Dhaka Hospital (ICCDR);ICDDR,823,Dhaka,2013,0,354,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5115,Tanmoy (2018),"Tanmoy AM, Westeel E, Bruyne KD, et al. Salmonella enterica serovar Typhi in Bangladesh: exploration of genomic diversity and antimicrobial resistance.mBio 2018;9(6):02112-18",Initial systematic review,BGD,Bangladesh,Dhaka Shishu Hospital,823,Dhaka,2013,0,47,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
2825,"ICDDR,B(2014)<U+1D47>",International Centre for Diarrhoeal Disease Research Bangladesh. Surveillance updates. Health and Science Bulletin 2014; 12(2).,Surveillance report,BGD,Bangladesh,Kamalapur,823,Dhaka,2014,0,43,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
2826,"ICDDR,B(2014)<U+1D43>",International Centre for Diarrhoeal Disease Research Bangladesh. Surveillance updates. Health and Science Bulletin 2014; 12(1).,Surveillance report,BGD,Bangladesh,Kamalapur,823,Dhaka,2014,0,15,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
2829,"ICDDR,B(2014)<U+1D48>",International Centre for Diarrhoeal Disease Research Bangladesh. Surveillance updates. Health and Science Bulletin 2014; 12(4).,Surveillance report,BGD,Bangladesh,Kamalapur,823,Dhaka,2014,0,30,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
2830,"ICDDR,B(2014)<U+1D9C>",International Centre for Diarrhoeal Disease Research Bangladesh. Surveillance updates. Health and Science Bulletin 2014; 12(3).,Surveillance report,BGD,Bangladesh,Kamalapur,823,Dhaka,2014,0,30,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
3026,Ahmed (2017),"Ahmed D, Nahid MA, Sami AB, et al. Bacterial etiology of bloodstream infections and antimicrobial resistance in Dhaka, Bangladesh, 2005-2014. Antimicrob Resist Infect Control 2017; 6.",Initial systematic review,BGD,Bangladesh,Dhaka Hospital (ICCDR);ICDDR,823,Dhaka,2014,0,509,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
4490,Ali (2016),"Ali MK, Sultana S. Antimicrobial sensitivity patterns of Salmonella Typhi in children. Bangladesh J Med Sci 2016; 15(3): 416-8.",Initial systematic review,BGD,Bangladesh,Ibn Sina Medical College and Hospital,823,Dhaka,2014,0,181,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5131,Saha (2018),"Saha S, Saha S, Das RC, et al. Enteric Fever and Related Contextual Factors in Bangladesh.American Journal of Tropical Medicine & Hygiene 2018;99(3_Suppl):20-25",Initial systematic review,BGD,Bangladesh,Dhaka Shishu Hospital;Shishu Sasthya Foundation Hospital,823,Dhaka,2014,1,241,0.4,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5102,Okanda (2018),"Okanda T, Haque A, Ehara T, et al. Characteristics of resistance mechanisms and molecular epidemiology of fluoroquinolone-nonsusceptible Salmonella enterica serovar Typhi and Paratyphi a isolates from a tertiary hospital in Dhaka, Bangladesh.Microbial Drug Resistance 2018;24(10):1460-1465",Initial systematic review,BGD,Bangladesh,Bangabandhu Sheikh Mujib Medical University Hospital,823,Dhaka,2015,0,18,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
2827,"ICDDR,B(2016)",International Centre for Diarrhoeal Disease Research Bangladesh. Surveillance updates. Health and Science Bulletin 2016; 14(1).,Surveillance report,BGD,Bangladesh,Kamalapur,823,Dhaka,2016,0,6,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5151,SEAP (2021),Sabine Vaccine Institute. Surveillance for Enteric Fever in Asia Project (SEAP) dataset. 2021,Dataset,BGD,Bangladesh,Dhaka,823,Dhaka,2016,0,27,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5151,SEAP (2021),Sabine Vaccine Institute. Surveillance for Enteric Fever in Asia Project (SEAP) dataset. 2021,Dataset,BGD,Bangladesh,Dhaka,823,Dhaka,2017,0,310,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5151,SEAP (2021),Sabine Vaccine Institute. Surveillance for Enteric Fever in Asia Project (SEAP) dataset. 2021,Dataset,BGD,Bangladesh,Dhaka,823,Dhaka,2018,0,339,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5151,SEAP (2021),Sabine Vaccine Institute. Surveillance for Enteric Fever in Asia Project (SEAP) dataset. 2021,Dataset,BGD,Bangladesh,Dhaka,823,Dhaka,2019,0,267,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
2086,Su(2001),"Su LH, Chiu CH, Kuo AJ, et al. Secular trends in incidence and antimicrobial resistance among clinical isolates of Salmonella at a university hospital in Taiwan, 1983-1999. Epidemiol Infect 2001; 127(2): 207-13.",Extended systematic review,CHN,China,Chang Gung Memorial Hospital,30,Taiwan Sheng,1991,0,94,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
2882,Wang(2005),"Wang JL, Kao JH, Tseng SP, Teng LJ, Ho SW, Hsueh PR. Typhoid fever and typhoid hepatitis in Taiwan. Epidemiol Infect 2005; 133(6): 1073-9.",Extended systematic review,CHN,China,National Taiwan University Hospital,30,Taiwan Sheng,1999,0,27,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
1248,Su(2005),"Su LH, Wu TL, Chia JH, Chu C, Kuo AJ, Chiu CH. Increasing ceftriaxone resistance in Salmonella isolates from a university hospital in Taiwan. J Antimicrob Chemother 2005; 55(6): 846-52.",Extended systematic review,CHN,China,Chang Gung Memorial Hospital,30,Taiwan Sheng,1999,0,16,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
647,Ling (2006),"Ling JH, Wang Y, Li JJ, Xu YC, Xie XL, Chen MJ. Comparison of antimicrobial susceptability of common gram-negative isolates from blood stream between Hong Kong and Beijing patients. [Chinese]. Chinese Journal of Infection and Chemotherapy 2006; 6(4): 251-4.",Initial systematic review,CHN,China,Peking Union Medical College Hospital,5,Beijing Shi,2001,0,23,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
567,Yu (2010),"Yu R, Liang J, Xu H. Clinical analysis of 125 children with typhoid fever from 1993 to 2008 in Chongqing area. [Chinese]. Chinese Journal of Practical Pediatrics 2010; 25(7): 539-42.",Initial systematic review,CHN,China,Chongqing Medical University (Children's Hospital),6,Chongqing Shi,2001,1,15,6.7,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
1248,Su(2005),"Su LH, Wu TL, Chia JH, Chu C, Kuo AJ, Chiu CH. Increasing ceftriaxone resistance in Salmonella isolates from a university hospital in Taiwan. J Antimicrob Chemother 2005; 55(6): 846-52.",Extended systematic review,CHN,China,Chang Gung Memorial Hospital,30,Taiwan Sheng,2001,0,6,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
2180,Ochiai (2008),"Ochiai RL, Acosta CJ, Danovaro-Holliday MC, et al. A study of typhoid fever in five Asian countries: Disease burden and implications for controls. Bull World Health Organ 2008; 86(4): 260-8.",Initial systematic review,CHN,China,Hechi,10,Guangxi Zhuangzu Zizhiqu,2002,0,15,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
1248,Su(2005),"Su LH, Wu TL, Chia JH, Chu C, Kuo AJ, Chiu CH. Increasing ceftriaxone resistance in Salmonella isolates from a university hospital in Taiwan. J Antimicrob Chemother 2005; 55(6): 846-52.",Extended systematic review,CHN,China,Chang Gung Memorial Hospital,30,Taiwan Sheng,2002,0,5,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
2188,Chuang(2009),"Chuang CH, Su LH, Perera J, et al. Surveillance of antimicrobial resistance of Salmonella enterica serotype Typhi in seven Asian countries. Epidemiol Infect 2009; 137(2): 266-9.",Extended systematic review,CHN,China,Chang Gung Memorial Hospital;National Taiwan University Hospital,30,Taiwan Sheng,2003,0,15,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
1095,Wu (2010),"Wu W, Wang H, Lu J, et al. Genetic diversity of Salmonella enteric serovar Typhi and ParaTyphi in Shenzhen, China from 2002 through 2007. BMC Microbiol 2010; 10: 32.",Initial systematic review,CHN,China,Shenzhen People's Hospital,9,Guangdong Sheng,2005,0,25,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
244,Jiang(2015),"Jiang Y, Zuo H, Niu H, et al. Antimicrobial resistance surveillance of Salmonella isolates from the First People's Hospital of Yunnan Province, China. J Infect Dev Ctries 2015; 9(4): 333-7.",Extended systematic review,CHN,China,First People’s Hospital of Yunnan Province,34,Yunnan Sheng,2006,2,37,5.4,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
1052,Lee(2013),"Lee C, Su L, Huang Y, Chiu C. First isolation of ciprofloxacin-resistant Salmonella enterica serovar Typhi in Taiwan. Journal of Microbiology, Immunology and Infection 2013; 46(6): 469-73.",Extended systematic review,CHN,China,Chang Gung Memorial Hospital,30,Taiwan Sheng,2011,0,8,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
4274,Shen(2014),"Shen M, Wu X, Wang L. Serotypes and drug resistance of Salmonella isolated from clinical infection cases in Pinghu, Zhejiang. [Chinese]. Disease Surveillance 2014; 29(7): 560-3.",Extended systematic review,CHN,China,First People's Hospital of Pinghu,35,Zhejiang Sheng,2011,1,8,12.5,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
3907,Vandenberg (2010),"Vandenberg O, Nyarukweba DZ, Ndeba PM, et al. Microbiologic and clinical features of Salmonella species isolated from bacteremic children in eastern Democratic Republic of Congo. Pediatr Infect Dis J 2010; 29(6): 504-10.",Initial systematic review,COD,Democratic Republic of the Congo,Children’s Hospital of Lwiro (Lwiro Pediatric Hospital),1016,Sud-Kivu,2004,1,29,3.4,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
4370,Kalonji (2015),"Kalonji LM, Post A, Phoba MF, et al. Invasive Salmonella infections at multiple aurveillance aites in the Democratic Republic of the Congo, 2011-2014. Clin Infect Dis 2015; 61: S346-S53.",Initial systematic review,COD,Democratic Republic of the Congo,Unknown healthcare facilities in Bas Congo,1007,Bas-Congo,2011,0,12,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
4370,Kalonji (2015),"Kalonji LM, Post A, Phoba MF, et al. Invasive Salmonella infections at multiple aurveillance aites in the Democratic Republic of the Congo, 2011-2014. Clin Infect Dis 2015; 61: S346-S53.",Initial systematic review,COD,Democratic Republic of the Congo,Unknown healthcare facilities in Bas Congo,1007,Bas-Congo,2012,0,32,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
4370,Kalonji (2015),"Kalonji LM, Post A, Phoba MF, et al. Invasive Salmonella infections at multiple aurveillance aites in the Democratic Republic of the Congo, 2011-2014. Clin Infect Dis 2015; 61: S346-S53.",Initial systematic review,COD,Democratic Republic of the Congo,Unknown healthcare facilities in Equateur,1008,Equateur,2012,0,18,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
4370,Kalonji (2015),"Kalonji LM, Post A, Phoba MF, et al. Invasive Salmonella infections at multiple aurveillance aites in the Democratic Republic of the Congo, 2011-2014. Clin Infect Dis 2015; 61: S346-S53.",Initial systematic review,COD,Democratic Republic of the Congo,Unknown healthcare facilities in Bas Congo,1007,Bas-Congo,2013,0,12,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
4370,Kalonji (2015),"Kalonji LM, Post A, Phoba MF, et al. Invasive Salmonella infections at multiple aurveillance aites in the Democratic Republic of the Congo, 2011-2014. Clin Infect Dis 2015; 61: S346-S53.",Initial systematic review,COD,Democratic Republic of the Congo,Unknown healthcare facilities in Orientale,1015,Province Orientale,2013,0,5,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
4370,Kalonji (2015),"Kalonji LM, Post A, Phoba MF, et al. Invasive Salmonella infections at multiple aurveillance aites in the Democratic Republic of the Congo, 2011-2014. Clin Infect Dis 2015; 61: S346-S53.",Initial systematic review,COD,Democratic Republic of the Congo,Unknown healthcare facilities in Bas Congo,1007,Bas-Congo,2014,0,29,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
4370,Kalonji (2015),"Kalonji LM, Post A, Phoba MF, et al. Invasive Salmonella infections at multiple aurveillance aites in the Democratic Republic of the Congo, 2011-2014. Clin Infect Dis 2015; 61: S346-S53.",Initial systematic review,COD,Democratic Republic of the Congo,Unknown healthcare facilities in Kinshasa,1012,Kinshasa,2014,0,17,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
4370,Kalonji (2015),"Kalonji LM, Post A, Phoba MF, et al. Invasive Salmonella infections at multiple aurveillance aites in the Democratic Republic of the Congo, 2011-2014. Clin Infect Dis 2015; 61: S346-S53.",Initial systematic review,COD,Democratic Republic of the Congo,Unknown healthcare facilities in Orientale,1015,Province Orientale,2014,0,5,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
1774,Wasfy(1996),"Wasfy MO, Moustafa DA, El-Gendy AM, et al. Prevalence of antibiotic resistance among Egyptian Salmonella Typhi strains. J Egypt Public Health Assoc 1996; 71(1-2): 149-60.",Extended systematic review,EGY,Egypt,Abbassia Fever Hospital,516,Al Qahirah (cairo),1990,0,41,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
2339,Wasfy (2002),"Wasfy MO, Frenck R, Ismail TF, Mansour H, Malone JL, Mahoney FJ. Trends of multiple-drug resistance among Salmonella serotype Typhi isolates during a 14-year period in Egypt. Clin Infect Dis 2002; 35(10): 1265-8.",Initial systematic review,EGY,Egypt,Abbassia Fever Hospital,516,Al Qahirah (cairo),1990,0,48,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
652,Girgis (1995),"Girgis NI, Sultan Y, Hammad O, Farid Z. Comparison of the efficacy, safety and cost of cefixime, ceftriaxone and aztreonam in the treatment of multidrug-resistant Salmonella Typhi septicemia in children. Pediatr Infect Dis J 1995; 14(7): 603-5.",Initial systematic review,EGY,Egypt,Abbassia Fever Hospital,516,Al Qahirah (cairo),1991,0,165,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
1774,Wasfy(1996),"Wasfy MO, Moustafa DA, El-Gendy AM, et al. Prevalence of antibiotic resistance among Egyptian Salmonella Typhi strains. J Egypt Public Health Assoc 1996; 71(1-2): 149-60.",Extended systematic review,EGY,Egypt,Abbassia Fever Hospital,516,Al Qahirah (cairo),1991,0,126,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
2339,Wasfy (2002),"Wasfy MO, Frenck R, Ismail TF, Mansour H, Malone JL, Mahoney FJ. Trends of multiple-drug resistance among Salmonella serotype Typhi isolates during a 14-year period in Egypt. Clin Infect Dis 2002; 35(10): 1265-8.",Initial systematic review,EGY,Egypt,Abbassia Fever Hospital,516,Al Qahirah (cairo),1991,0,114,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
2804,Mourad(1993),"Mourad AS, Metwally M, el Deen AN, et al. Multiple-drug-resistant Salmonella Typhi. Clin Infect Dis 1993; 17(1): 135-6.",Extended systematic review,EGY,Egypt,Alexandria Fever Hospital,512,Al Iskandariyah (alex.),1992,0,35,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
435,Girgis(1993),"Girgis NI, Kilpatrick ME, Farid Z, Sultan Y, Podgore JK. Cefixime in the treatment of enteric fever in children. Drugs Exp Clin Res 1993; 19(1): 47-9.",Extended systematic review,EGY,Egypt,Abbassia Fever Hospital,516,Al Qahirah (cairo),1992,0,50,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
1774,Wasfy(1996),"Wasfy MO, Moustafa DA, El-Gendy AM, et al. Prevalence of antibiotic resistance among Egyptian Salmonella Typhi strains. J Egypt Public Health Assoc 1996; 71(1-2): 149-60.",Extended systematic review,EGY,Egypt,Abbassia Fever Hospital,516,Al Qahirah (cairo),1992,0,151,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
2339,Wasfy (2002),"Wasfy MO, Frenck R, Ismail TF, Mansour H, Malone JL, Mahoney FJ. Trends of multiple-drug resistance among Salmonella serotype Typhi isolates during a 14-year period in Egypt. Clin Infect Dis 2002; 35(10): 1265-8.",Initial systematic review,EGY,Egypt,Abbassia Fever Hospital,516,Al Qahirah (cairo),1992,0,114,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
1774,Wasfy(1996),"Wasfy MO, Moustafa DA, El-Gendy AM, et al. Prevalence of antibiotic resistance among Egyptian Salmonella Typhi strains. J Egypt Public Health Assoc 1996; 71(1-2): 149-60.",Extended systematic review,EGY,Egypt,Abbassia Fever Hospital,516,Al Qahirah (cairo),1993,0,104,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
2339,Wasfy (2002),"Wasfy MO, Frenck R, Ismail TF, Mansour H, Malone JL, Mahoney FJ. Trends of multiple-drug resistance among Salmonella serotype Typhi isolates during a 14-year period in Egypt. Clin Infect Dis 2002; 35(10): 1265-8.",Initial systematic review,EGY,Egypt,Abbassia Fever Hospital,516,Al Qahirah (cairo),1993,0,27,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
1774,Wasfy(1996),"Wasfy MO, Moustafa DA, El-Gendy AM, et al. Prevalence of antibiotic resistance among Egyptian Salmonella Typhi strains. J Egypt Public Health Assoc 1996; 71(1-2): 149-60.",Extended systematic review,EGY,Egypt,Abbassia Fever Hospital,516,Al Qahirah (cairo),1994,0,115,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
2339,Wasfy (2002),"Wasfy MO, Frenck R, Ismail TF, Mansour H, Malone JL, Mahoney FJ. Trends of multiple-drug resistance among Salmonella serotype Typhi isolates during a 14-year period in Egypt. Clin Infect Dis 2002; 35(10): 1265-8.",Initial systematic review,EGY,Egypt,Abbassia Fever Hospital,516,Al Qahirah (cairo),1994,0,20,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
2339,Wasfy (2002),"Wasfy MO, Frenck R, Ismail TF, Mansour H, Malone JL, Mahoney FJ. Trends of multiple-drug resistance among Salmonella serotype Typhi isolates during a 14-year period in Egypt. Clin Infect Dis 2002; 35(10): 1265-8.",Initial systematic review,EGY,Egypt,Abbassia Fever Hospital,516,Al Qahirah (cairo),1995,0,50,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
2339,Wasfy (2002),"Wasfy MO, Frenck R, Ismail TF, Mansour H, Malone JL, Mahoney FJ. Trends of multiple-drug resistance among Salmonella serotype Typhi isolates during a 14-year period in Egypt. Clin Infect Dis 2002; 35(10): 1265-8.",Initial systematic review,EGY,Egypt,Abbassia Fever Hospital,516,Al Qahirah (cairo),1996,0,29,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
3411,Frenck(2000),"Frenck R, Nakhla I, Sultan Y, et al. Azithromycin versus ceftriaxone for the treatment of uncomplicated typhoid fever in children. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2000. http://onlinelibrary.wiley.com/o/cochrane/clcentral/articles/607/CN-00328607/frame.html",Extended systematic review,EGY,Egypt,Abbassia Fever Hospital,516,Al Qahirah (cairo),1996,0,64,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
2339,Wasfy (2002),"Wasfy MO, Frenck R, Ismail TF, Mansour H, Malone JL, Mahoney FJ. Trends of multiple-drug resistance among Salmonella serotype Typhi isolates during a 14-year period in Egypt. Clin Infect Dis 2002; 35(10): 1265-8.",Initial systematic review,EGY,Egypt,Abbassia Fever Hospital,516,Al Qahirah (cairo),1997,0,85,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
2339,Wasfy (2002),"Wasfy MO, Frenck R, Ismail TF, Mansour H, Malone JL, Mahoney FJ. Trends of multiple-drug resistance among Salmonella serotype Typhi isolates during a 14-year period in Egypt. Clin Infect Dis 2002; 35(10): 1265-8.",Initial systematic review,EGY,Egypt,Abbassia Fever Hospital,516,Al Qahirah (cairo),1998,0,41,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
2339,Wasfy (2002),"Wasfy MO, Frenck R, Ismail TF, Mansour H, Malone JL, Mahoney FJ. Trends of multiple-drug resistance among Salmonella serotype Typhi isolates during a 14-year period in Egypt. Clin Infect Dis 2002; 35(10): 1265-8.",Initial systematic review,EGY,Egypt,Abbassia Fever Hospital,516,Al Qahirah (cairo),1999,0,100,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
2128,Frenck Jr(2004),"Frenck Jr RW, Mansour A, Nakhla I, et al. Short-course azithromycin for the treatment of uncomplicated typhoid fever in children and adolescents. Clin Infect Dis 2004; 38(7): 951-7.",Extended systematic review,EGY,Egypt,Abbassia Fever Hospital,516,Al Qahirah (cairo),2000,0,68,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
2339,Wasfy (2002),"Wasfy MO, Frenck R, Ismail TF, Mansour H, Malone JL, Mahoney FJ. Trends of multiple-drug resistance among Salmonella serotype Typhi isolates during a 14-year period in Egypt. Clin Infect Dis 2002; 35(10): 1265-8.",Initial systematic review,EGY,Egypt,Abbassia Fever Hospital,516,Al Qahirah (cairo),2000,0,41,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
1744,Srikantiah (2006),"Srikantiah P, Girgis FY, Luby SP, et al. Population-based surveillance of typhoid fever in Egypt. Am J Trop Med Hyg 2006; 74(1): 114-9.",Initial systematic review,EGY,Egypt,Unknown hospitals and primary care providers in Fayoum governornate,510,Al Fayyum (fayoum),2002,2,89,2.2,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
1466,Rahman (2014),"Rahman BA, Wasfy MO, Maksoud MA, Hanna N, Dueger E, House B. Multi-drug resistance and reduced susceptibility to ciprofloxacin among Salmonella enterica serovar Typhi isolates from the Middle East and Central Asia. New microbes new infect 2014; 2(4): 88-92.",Initial systematic review,EGY,Egypt,Fayoum Fever/Infectious Diseases Hospital,510,Al Fayyum (fayoum),2005,0,270,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
1466,Rahman (2014),"Rahman BA, Wasfy MO, Maksoud MA, Hanna N, Dueger E, House B. Multi-drug resistance and reduced susceptibility to ciprofloxacin among Salmonella enterica serovar Typhi isolates from the Middle East and Central Asia. New microbes new infect 2014; 2(4): 88-92.",Initial systematic review,EGY,Egypt,Gharbiya Fever/Infectious Diseases Hospital,511,Al Gharbiyah (gharbia),2005,0,40,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
1466,Rahman (2014),"Rahman BA, Wasfy MO, Maksoud MA, Hanna N, Dueger E, House B. Multi-drug resistance and reduced susceptibility to ciprofloxacin among Salmonella enterica serovar Typhi isolates from the Middle East and Central Asia. New microbes new infect 2014; 2(4): 88-92.",Initial systematic review,EGY,Egypt,Alexandria Fever Hospital,512,Al Iskandariyah (alex.),2005,2,46,4.3,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
1466,Rahman (2014),"Rahman BA, Wasfy MO, Maksoud MA, Hanna N, Dueger E, House B. Multi-drug resistance and reduced susceptibility to ciprofloxacin among Salmonella enterica serovar Typhi isolates from the Middle East and Central Asia. New microbes new infect 2014; 2(4): 88-92.",Initial systematic review,EGY,Egypt,Menofiya Fever/Infectious Diseases Hospital,514,Al Minufiyah (menoufia),2005,0,12,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
1466,Rahman (2014),"Rahman BA, Wasfy MO, Maksoud MA, Hanna N, Dueger E, House B. Multi-drug resistance and reduced susceptibility to ciprofloxacin among Salmonella enterica serovar Typhi isolates from the Middle East and Central Asia. New microbes new infect 2014; 2(4): 88-92.",Initial systematic review,EGY,Egypt,Abbassia Fever Hospital,516,Al Qahirah (cairo),2005,0,166,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
1466,Rahman (2014),"Rahman BA, Wasfy MO, Maksoud MA, Hanna N, Dueger E, House B. Multi-drug resistance and reduced susceptibility to ciprofloxacin among Salmonella enterica serovar Typhi isolates from the Middle East and Central Asia. New microbes new infect 2014; 2(4): 88-92.",Initial systematic review,EGY,Egypt,Aswan Fever/Infectious Diseases Hospital,522,Aswan,2005,0,66,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
1466,Rahman (2014),"Rahman BA, Wasfy MO, Maksoud MA, Hanna N, Dueger E, House B. Multi-drug resistance and reduced susceptibility to ciprofloxacin among Salmonella enterica serovar Typhi isolates from the Middle East and Central Asia. New microbes new infect 2014; 2(4): 88-92.",Initial systematic review,EGY,Egypt,Asuit Fever/Infectious Diseases Hospital,523,Asyiut,2005,0,26,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
364,Wasihun(2015)<U+1D43>,"Wasihun AG, Wlekidan LN, Gebremariam SA, et al. Bacteriological profile and antimicrobial susceptibility patterns of blood culture isolates among febrile patients in Mekelle Hospital, Northern Ethiopia. Springerplus 2015; 4: 314.",Extended systematic review,ETH,Ethiopia,Mekelle Hospital,1050,Tigray,2014,3,8,37.5,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
751,Wasihun(2015)<U+1D47>,"Wasihun AG, Wlekidan LN, Gebremariam SA, et al. Diagnosis and Treatment of Typhoid Fever and Associated Prevailing Drug Resistance in Northern Ethiopia. Int J Infect Dis 2015; 35: 96-102.",Extended systematic review,ETH,Ethiopia,Mekelle Hospital,1050,Tigray,2014,2,8,25,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
1382,Huenger (2010),"Huenger F, Agyekum A, Nkrumah B, et al. Massive emergence of multidrug-resistant Enterobacteriaceae in blood culture isolates of children in Ghana. Clin Microbiol Infect 2010; 16: S88.",Initial systematic review,GHA,Ghana,Agogo Presbyterian Hospital,1062,Ashanti,2008,0,39,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
2369,Marks (2010),"Marks F, Adu-Sarkodie Y, Hunger F, et al. Typhoid fever among children, ghana. Emerg Infect Dis 2010; 16(11): 1796-7.",Initial systematic review,GHA,Ghana,Agogo Presbyterian Hospital,1062,Ashanti,2008,0,37,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
4666,Agyekum (2010),"Agyekum A. Prevalence of bacteria causing bacteraemia in children under five years in Agogo, Asante-Akyem and their antimicrobial susceptibility patterns: Kwame Nkrumha University of Science & Technology, Kumasi; 2010.",Initial systematic review,GHA,Ghana,Agogo Presbyterian Hospital,1062,Ashanti,2008,0,23,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
2946,Marks (2017),"Marks F, Kalckreuth V, Aaby P, et al. Incidence of invasive Salmonella disease in sub-Saharan Africa: A multicentre population-based surveillance study. Lancet Glob Health 2017; 5(3): e310-e23.",Initial systematic review,GHA,Ghana,Agogo Presbyterian Hospital,1062,Ashanti,2011,0,66,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
2199,Acquah(2013),"Acquah SE, Quaye L, Sagoe K, Ziem JB, Bromberger PI, Amponsem AA. Susceptibility of bacterial etiological agents to commonly-used antimicrobial agents in children with sepsis at the Tamale Teaching Hospital. BMC Infect Dis 2013; 13: 89.",Extended systematic review,GHA,Ghana,Tamale Teaching Hospital,1067,Northern,2012,0,6,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
3151,Amdani (1998),"Amdani SK. Antibiotic resistance pattern of pediatric typhoid fever patients at Harapan Kita Children and Maternity Hospital Jakarta, 1996. Med J Indones 1998; 7: 253-6.",Initial systematic review,IDN,Indonesia,Harapan Kita Children's and Maternity Hospital,57,DKI JAKARTA,1996,1,114,0.9,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
883,Punjabi (2013),"Punjabi NH, Agtini MD, Ochiai RL, et al. Enteric fever burden in North Jakarta, Indonesia: a prospective, community-based study. J Infect Dev Ctries 2013; 7(11): 781-7.",Initial systematic review,IDN,Indonesia,Tanjung Priok & Koja,57,DKI JAKARTA,2002,0,221,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
3126,Rosana(2007),"Rosana Y, Kiranasari A, Ningsih I, Tjampakasari C, Kadarsih R, Wahid MH. Patterns of bacterial resistance against Ceftriaxone from 2002 to 2005 in the clinical microbiology laboratory of the faculty of medicine, university of Indonesia. Med J Indones 2007; 16(1): 3-6.",Extended systematic review,IDN,Indonesia,Clinical Microbiology Laboratory of Medical Faculty University of Indonesia (CML-FMUI),57,DKI JAKARTA,2004,0,9,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
2330,Moehario (2009),"Moehario LH, Tjoa E, Kiranasari A, Ningsih I, Rosana Y, Karuniawati A. Trends in antimicrobial susceptibility of gram-negative bacteria isolated from blood in Jakarta from 2002 to 2008. J Infect Dev Ctries 2009; 3(11): 843-8.",Initial systematic review,IDN,Indonesia,Clinical Microbiology Laboratory of Medical Faculty University of Indonesia (CML-FMUI),57,DKI JAKARTA,2005,3,35,8.6,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
3126,Rosana(2007),"Rosana Y, Kiranasari A, Ningsih I, Tjampakasari C, Kadarsih R, Wahid MH. Patterns of bacterial resistance against Ceftriaxone from 2002 to 2005 in the clinical microbiology laboratory of the faculty of medicine, university of Indonesia. Med J Indones 2007; 16(1): 3-6.",Extended systematic review,IDN,Indonesia,Clinical Microbiology Laboratory of Medical Faculty University of Indonesia (CML-FMUI),57,DKI JAKARTA,2005,0,7,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
843,Yanagi (2009),"Yanagi D, de Vries GC, Rahardjo D, et al. Emergence of fluoroquinolone-resistant strains of Salmonella enterica in Surabaya, Indonesia. Diagn Microbiol Infect Dis 2009; 64(4): 422-6.",Initial systematic review,IDN,Indonesia,Dr. Soetomo General Hospital,44,JAWA TIMUR,2006,0,9,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5133,Alam(2016),"Alam A. Pola resistensi Salmonella enterica Serotipe Typhi, departemen Ilmu Kesehatan anak RSHS, Tahun 2006–2010. Sari Pediatri 2016; 12(5): 296-301.",Extended systematic review,IDN,Indonesia,Dr. Hasan Sadikin General Hospital,61,JAWA BARAT,2006,0,50,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5133,Alam(2016),"Alam A. Pola resistensi Salmonella enterica Serotipe Typhi, departemen Ilmu Kesehatan anak RSHS, Tahun 2006–2010. Sari Pediatri 2016; 12(5): 296-301.",Extended systematic review,IDN,Indonesia,Dr. Hasan Sadikin General Hospital,61,JAWA BARAT,2007,0,55,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
843,Yanagi (2009),"Yanagi D, de Vries GC, Rahardjo D, et al. Emergence of fluoroquinolone-resistant strains of Salmonella enterica in Surabaya, Indonesia. Diagn Microbiol Infect Dis 2009; 64(4): 422-6.",Initial systematic review,IDN,Indonesia,Dr. Soetomo General Hospital,44,JAWA TIMUR,2008,2,8,25,1,Salmonella Typhi,Third-generation cephalosporin (3GC)
5133,Alam(2016),"Alam A. Pola resistensi Salmonella enterica Serotipe Typhi, departemen Ilmu Kesehatan anak RSHS, Tahun 2006–2010. Sari Pediatri 2016; 12(5): 296-301.",Extended systematic review,IDN,Indonesia,Dr. Hasan Sadikin General Hospital,61,JAWA BARAT,2008,0,28,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5133,Alam(2016),"Alam A. Pola resistensi Salmonella enterica Serotipe Typhi, departemen Ilmu Kesehatan anak RSHS, Tahun 2006–2010. Sari Pediatri 2016; 12(5): 296-301.",Extended systematic review,IDN,Indonesia,Dr. Hasan Sadikin General Hospital,61,JAWA BARAT,2009,1,21,4.8,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5133,Alam(2016),"Alam A. Pola resistensi Salmonella enterica Serotipe Typhi, departemen Ilmu Kesehatan anak RSHS, Tahun 2006–2010. Sari Pediatri 2016; 12(5): 296-301.",Extended systematic review,IDN,Indonesia,Dr. Hasan Sadikin General Hospital,61,JAWA BARAT,2010,0,27,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
2978,Hardjo Lugito (2017),"Hardjo Lugito NP, Cucunawangsih. Antimicrobial resistance of Salmonella enterica serovars Typhi and ParaTyphi isolates from a general hospital in Karawaci, Tangerang, Indonesia: A five-year review. Int J Microbiol 2017; 2017: 6215136.",Initial systematic review,IDN,Indonesia,Siloam Hospital (Karawaci),69,BANTEN,2011,0,14,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
2978,Hardjo Lugito (2017),"Hardjo Lugito NP, Cucunawangsih. Antimicrobial resistance of Salmonella enterica serovars Typhi and ParaTyphi isolates from a general hospital in Karawaci, Tangerang, Indonesia: A five-year review. Int J Microbiol 2017; 2017: 6215136.",Initial systematic review,IDN,Indonesia,Siloam Hospital (Karawaci),69,BANTEN,2012,0,16,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
2978,Hardjo Lugito (2017),"Hardjo Lugito NP, Cucunawangsih. Antimicrobial resistance of Salmonella enterica serovars Typhi and ParaTyphi isolates from a general hospital in Karawaci, Tangerang, Indonesia: A five-year review. Int J Microbiol 2017; 2017: 6215136.",Initial systematic review,IDN,Indonesia,Siloam Hospital (Karawaci),69,BANTEN,2013,0,17,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
2978,Hardjo Lugito (2017),"Hardjo Lugito NP, Cucunawangsih. Antimicrobial resistance of Salmonella enterica serovars Typhi and ParaTyphi isolates from a general hospital in Karawaci, Tangerang, Indonesia: A five-year review. Int J Microbiol 2017; 2017: 6215136.",Initial systematic review,IDN,Indonesia,Siloam Hospital (Karawaci),69,BANTEN,2014,0,27,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
2978,Hardjo Lugito (2017),"Hardjo Lugito NP, Cucunawangsih. Antimicrobial resistance of Salmonella enterica serovars Typhi and ParaTyphi isolates from a general hospital in Karawaci, Tangerang, Indonesia: A five-year review. Int J Microbiol 2017; 2017: 6215136.",Initial systematic review,IDN,Indonesia,Siloam Hospital (Karawaci),69,BANTEN,2015,0,19,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
1488,Mishra (1992),"Mishra S, Patwari AK, Anand VK, et al. Multidrug resistant typhoid fever: therapeutic considerations. Indian Pediatr 1992; 29(4): 443-8.",Initial systematic review,IND,India,Kalawati Saran Children's Hospital,850,Delhi,1990,7,37,18.9,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
1685,Rajajee(1995),"Rajajee S, Anandi TB, Subha S, Vatsala BR. Patterns of resistant Salmonella Typhi infection in infants. J Trop Pediatr 1995; 41(1): 52-4.",Extended systematic review,IND,India,Kanchi Kamakoti CHILDS Trust Hospital,867,Tamil Nadu,1992,4,71,5.6,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
2317,Mishra (1996),"Mishra OP, Gupta BL, Nath G, Prakash J. Treatment of multidrug-resistant typhoid fever. J Trop Pediatr 1996; 42(5): 310-1.",Initial systematic review,IND,India,Sir Sunderlal Hospital,890,Uttar Pradesh,1992,4,35,11.4,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
2798,Sood (1999),"Sood S, Kapil A, Das B, Jain Y, Kabra SK. Re-emergence of chloramphenicol-sensitive Salmonella Typhi. Lancet 1999; 353(9160): 1241-2.",Initial systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,1994,0,54,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
1762,Maheshwari (1996),"Maheshwari VD, Agarwal SK. Present status of drug resistance in cases of enteric fever in Rajasthan. J Assoc Physicians India 1996; 44(9): 618-9.",Initial systematic review,IND,India,Sawai Man Singh Hospital,865,Rajasthan,1994,2,30,6.7,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
783,Nath(2000),"Nath G, Tikoo A, Manocha H, Tripathi AK, Gulati AK. Drug resistance in Salmonella Typhi in north India with special reference to ciprofloxacin. J Antimicrob Chemother 2000; 46(1): 149-50.",Extended systematic review,IND,India,Sir Sunderlal Hospital,890,Uttar Pradesh,1994,2,74,2.7,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
787,Nath(2010),"Nath G, Maurya P. Drug resistance patterns in Salmonella enterica subspecies enterica serotype Typhi strains isolated over a period of two decades, with special reference to ciprofloxacin and ceftriaxone. Int J Antimicrob Agents 2010; 35(5): 482-5.",Extended systematic review,IND,India,Sir Sunderlal Hospital,890,Uttar Pradesh,1994,0,16,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
2798,Sood (1999),"Sood S, Kapil A, Das B, Jain Y, Kabra SK. Re-emergence of chloramphenicol-sensitive Salmonella Typhi. Lancet 1999; 353(9160): 1241-2.",Initial systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,1995,0,37,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
786,Ciraj (1999),"Ciraj AM, Seetha KS, Gopalkrishna BK, Shivananda PG. Drug resistance pattern and phage types of Salmonella Typhi isolates in Manipal, South Karnataka. Indian J Med Sci 1999; 53(11): 486-9.",Initial systematic review,IND,India,Kasturba Medical College and Hospital (Manipal),855,Karnataka,1995,0,226,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
2798,Sood (1999),"Sood S, Kapil A, Das B, Jain Y, Kabra SK. Re-emergence of chloramphenicol-sensitive Salmonella Typhi. Lancet 1999; 353(9160): 1241-2.",Initial systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,1996,0,44,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
1498,Kabra (2000),"Kabra SK, Madhulika, Talati A, Soni N, Patel S, Modi RR. Multidrug-resistant typhoid fever. Trop Doct 2000; 30(4): 195-7.",Initial systematic review,IND,India,V S General Hospital (Ellis Bridge),852,Gujarat,1996,0,100,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
675,Ciraj (2000),"Ciraj AM, Mohammed M, Bhat KG, Shivananda PG. Copper resistance and its correlation to multiple drug resistance in Salmonella Typhi isolates from south Karnataka. Indian J Med Res 2000; 110(DEC.): 181-2.",Initial systematic review,IND,India,Kasturba Medical College and Hospital (Manipal);Kasturba Medical College Hospital (Mangaluru),855,Karnataka,1996,0,186,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
136,Mandal (2012),"Mandal S, Debmandal M, Pal NK. Antibiotic resistance of Salmonella enterica serovar Typhi in Kolkata, India, and in vitro experiments on effect of combined chemotherapy. ScientificWorldJournal 2012; 2012(454059).",Initial systematic review,IND,India,Calcutta School of Tropical Medicine,869,West Bengal,1996,0,421,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
2798,Sood (1999),"Sood S, Kapil A, Das B, Jain Y, Kabra SK. Re-emergence of chloramphenicol-sensitive Salmonella Typhi. Lancet 1999; 353(9160): 1241-2.",Initial systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,1997,0,54,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
3551,Ghatole(2004),"Ghatole M, Manthalkar P, Kandle S, Yemul V, Jahagirdar V. Correlation of extended spectrum beta lactamases production with cephalosporin resistance in gram negative bacilli. Indian J Pathol Microbiol 2004; 47(1): 82-4.",Extended systematic review,IND,India,Basaveshwar Hospital,858,Maharashtra,1997,6,16,37.5,1,Salmonella Typhi,Third-generation cephalosporin (3GC)
2798,Sood (1999),"Sood S, Kapil A, Das B, Jain Y, Kabra SK. Re-emergence of chloramphenicol-sensitive Salmonella Typhi. Lancet 1999; 353(9160): 1241-2.",Initial systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,1998,0,60,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
1484,Das (2000),"Das U, Bhattacharya SS. Multidrug resistant Salmonella Typhi in Rourkela, Orissa. Indian J Pathol Microbiol 2000; 43(2): 135-8.",Initial systematic review,IND,India,Ispat General Hospital (Rourkela),863,Orissa,1998,0,100,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
783,Nath(2000),"Nath G, Tikoo A, Manocha H, Tripathi AK, Gulati AK. Drug resistance in Salmonella Typhi in north India with special reference to ciprofloxacin. J Antimicrob Chemother 2000; 46(1): 149-50.",Extended systematic review,IND,India,Sir Sunderlal Hospital,890,Uttar Pradesh,1998,0,22,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
4278,Sudhaharan(2014),"Sudhaharan S, Padmaja K, Solanki R, Lakshmi V, Umabala P, Aparna B. Extra-intestinal salmonellosis in a tertiary care center in South India. J Infect Dev Ctries 2014; 8(7): 831-7.",Extended systematic review,IND,India,Nizam's Institute of Medical Sciences,848,Andhra Pradesh,1999,5,12,41.7,1,Salmonella Typhi,Third-generation cephalosporin (3GC)
118,Mohanty (2006),"Mohanty S, Renuka K, Sood S, Das BK, Kapil A. Antibiogram pattern and seasonality of Salmonella serotypes in a North Indian tertiary care hospital. Epidemiol Infect 2006; 134(5): 961-6.",Initial systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,1999,0,110,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
1933,Kumar (2008),"Kumar S, Rizvi M, Berry N. Rising prevalence of enteric fever due to multidrug-resistant Salmonella: an epidemiological study. J Med Microbiol 2008; 57(Pt 10): 1247-50.",Initial systematic review,IND,India,Lok Nayak Jai Prakash Narayan Hospital,850,Delhi,1999,1,47,2.1,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
440,Dutta (2001)<U+1D43>,"Dutta P, Mitra U, Dutta S, De A, Chatterjee MK, Bhattacharya SK. Ceftriaxone therapy in ciprofloxacin treatment failure typhoid fever in children. Indian J Med Res 2001a; 113: 210-3.",Initial systematic review,IND,India,Dr B. C. Roy Memorial Hospital for Children,869,West Bengal,1999,0,32,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
547,Dutta (2001)<U+1D47>,"Dutta P, Mitra U, Datta S, et al. Ciprofloxacin susceptible Salmonella Typhi with treatment failure. J Trop Pediatr 2001b; 47(4): 252-3.",Initial systematic review,IND,India,National Institute of Cholera and Enteric Diseases,869,West Bengal,1999,0,26,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
787,Nath(2010),"Nath G, Maurya P. Drug resistance patterns in Salmonella enterica subspecies enterica serotype Typhi strains isolated over a period of two decades, with special reference to ciprofloxacin and ceftriaxone. Int J Antimicrob Agents 2010; 35(5): 482-5.",Extended systematic review,IND,India,Sir Sunderlal Hospital,890,Uttar Pradesh,1999,0,61,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
118,Mohanty (2006),"Mohanty S, Renuka K, Sood S, Das BK, Kapil A. Antibiogram pattern and seasonality of Salmonella serotypes in a North Indian tertiary care hospital. Epidemiol Infect 2006; 134(5): 961-6.",Initial systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,2000,0,103,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
2093,Gautam (2002),"Gautam V, Gupta NK, Chaudhary U, Arora DR. Sensitivity pattern of Salmonella serotypes in Northern India. Braz J Infect Dis 2002; 6(6): 281-7.",Initial systematic review,IND,India,Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences,853,Haryana,2000,17,134,12.7,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
2169,Chowta (2005),"Chowta MN, Chowta NK. Study of clinical profile and antibiotic response in typhoid fever. Indian J Med Microbiol 2005; 23(2): 125-7.",Initial systematic review,IND,India,Kasturba Medical College Hospital (Mangaluru),855,Karnataka,2000,0,11,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
1683,Kadappu (2003),"Kadappu KK, Bhat R, Kurian B. Pattern of multiple drug resistance in enteric fever in Manipal, India. Trop Doct 2003; 33(3): 189-91.",Initial systematic review,IND,India,Kasturba Medical College and Hospital (Manipal),855,Karnataka,2000,6,40,15,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
1642,Misra (2005),"Misra RN, Bawa KS, Magu SK, Bhandari S, Nagendra A, Menon PK. Outbreak of multi-drug resistant Salmonella Typhi enteric fever in Mumbai garrison. Med J Armed Forces India 2005; 61(2): 148-50.",Initial systematic review,IND,India,Mumbai Garrison,858,Maharashtra,2000,0,93,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
2157,Bhattacharya (2003),"Bhattacharya SS, Das U. A steady decrease in occurrence of Salmonella Typhi infection in Rourkela, Orissa. Indian J Pathol Microbiol 2003; 46(3): 498-500.",Initial systematic review,IND,India,Ispat General Hospital (Rourkela),863,Orissa,2000,0,254,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
260,Safdar(2004),"Safdar A, Harjit K, Elting L, Rolston KVI. Antimicrobial susceptibility of 128 Salmonella enterica serovar Typhi and Paratyphi A isolates from Northern India. Chemotherapy 2004; 50(2): 88-91.",Extended systematic review,IND,India,Christian Medical College and Hospital (Ludhiana),864,Punjab,2000,0,101,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
118,Mohanty (2006),"Mohanty S, Renuka K, Sood S, Das BK, Kapil A. Antibiogram pattern and seasonality of Salmonella serotypes in a North Indian tertiary care hospital. Epidemiol Infect 2006; 134(5): 961-6.",Initial systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,2001,0,125,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
904,Capoor(2007),"Capoor MR, Nair D, Deb M, Aggarwal P. Enteric fever perspective in India: emergence of high-level ciprofloxacin resistance and rising MIC to cephalosporins. J Med Microbiol 2007; 56(Pt 8): 1131-2.",Extended systematic review,IND,India,Safdarjung Hospital,850,Delhi,2001,0,175,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
2093,Gautam (2002),"Gautam V, Gupta NK, Chaudhary U, Arora DR. Sensitivity pattern of Salmonella serotypes in Northern India. Braz J Infect Dis 2002; 6(6): 281-7.",Initial systematic review,IND,India,Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences,853,Haryana,2001,17,166,10.2,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
119,Mehta (2002),"Mehta M, Joshi RM. Antibiogram pattern of Salmonella species causing bacteraemia/septicaemia in a teaching hospital. J Infect 2002; 45(2): 133.",Initial systematic review,IND,India,Government Medical College Hospital (Chandigarh),864,Punjab,2001,0,46,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
991,Saharan (2008),"Saharan G, Gupta A, Gupta BK, Sharma BP, Kochar DK, Purohit VP. Evaluation of antibiotic sensitivity pattern in cases of enteric fever in north west Rajasthan. J Indian Med Assoc 2008; 106(8): 528-30, 32.",Initial systematic review,IND,India,Sardar Patel Medical College (PBM and AG Hospital),865,Rajasthan,2001,0,37,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
471,Lakshmi (2006),"Lakshmi V, Ashok R, Susmita J, Shailaja VV. Changing trends in the antibiograms of Salmonella isolates at a tertiary care hospital in Hyderabad. Indian J Med Microbiol 2006; 24(1): 45-8.",Initial systematic review,IND,India,Nizam's Institute of Medical Sciences,848,Andhra Pradesh,2002,2,26,7.7,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
118,Mohanty (2006),"Mohanty S, Renuka K, Sood S, Das BK, Kapil A. Antibiogram pattern and seasonality of Salmonella serotypes in a North Indian tertiary care hospital. Epidemiol Infect 2006; 134(5): 961-6.",Initial systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,2002,0,85,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
1933,Kumar (2008),"Kumar S, Rizvi M, Berry N. Rising prevalence of enteric fever due to multidrug-resistant Salmonella: an epidemiological study. J Med Microbiol 2008; 57(Pt 10): 1247-50.",Initial systematic review,IND,India,Lok Nayak Jai Prakash Narayan Hospital,850,Delhi,2002,5,48,10.4,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
2404,Capoor (2006),"Capoor MR, Nair D, Hasan AS, Aggarwal P, Gupta B. Typhoid fever: narrowing therapeutic options in India. Southeast Asian J Trop Med Public Health 2006; 37(6): 1170-4.",Initial systematic review,IND,India,Safdarjung Hospital,850,Delhi,2002,1,178,0.6,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
2807,Arora(2010),"Arora D, Singh R, Kaur M, Ahi RS. A changing pattern in antimicrobial susceptibility of Salmonella enterica serotype isolated in North India. African Journal of Microbiology Research 2010; 4(3): 197-203.",Extended systematic review,IND,India,Adesh Institute of Medical Sciences and Research,864,Punjab,2002,0,58,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
149,Reddy(2005),"Reddy KR, Rajesh PK, Krishnan M, Sekar U. Antibiotic susceptibility pattern and plasmid profile of multidrug resistant Salmonella Typhi. Indian J Med Microbiol 2005; 23(3): 208.",Extended systematic review,IND,India,Sri Ramachandra Medical College and Research Institute,867,Tamil Nadu,2002,0,63,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
1887,Mandal (2004),"Mandal S, Mandal MD, Pal NK. Reduced minimum inhibitory concentration of chloramphenicol for Salmonella enterica serovar Typhi. Indian J Med Sci 2004; 58(1): 16-23.",Initial systematic review,IND,India,Calcutta School of Tropical Medicine,869,West Bengal,2002,0,20,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
471,Lakshmi (2006),"Lakshmi V, Ashok R, Susmita J, Shailaja VV. Changing trends in the antibiograms of Salmonella isolates at a tertiary care hospital in Hyderabad. Indian J Med Microbiol 2006; 24(1): 45-8.",Initial systematic review,IND,India,Nizam's Institute of Medical Sciences,848,Andhra Pradesh,2003,1,22,4.5,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
118,Mohanty (2006),"Mohanty S, Renuka K, Sood S, Das BK, Kapil A. Antibiogram pattern and seasonality of Salmonella serotypes in a North Indian tertiary care hospital. Epidemiol Infect 2006; 134(5): 961-6.",Initial systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,2003,0,107,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
1499,Kumar (2007),"Kumar R, Gupta N, Shalini. Multidrug-resistant typhoid fever. Indian J Pediatr 2007; 74(1): 39-42.",Initial systematic review,IND,India,Batra Hospital and Medical Research Centre,850,Delhi,2003,2,93,2.2,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
1794,Tambekar(2007),"Tambekar DH, Dhanorkar DV, Gulhane SR, Dudhane MN. Prevalence, profile and antibiotic susceptibility pattern of bacterial isolates from blood. Journal of Medical Sciences 2007; 7(3): 439-42.",Extended systematic review,IND,India,Unknown hospitals in Amravati,858,Maharashtra,2003,5,6,83.3,1,Salmonella Typhi,Third-generation cephalosporin (3GC)
2807,Arora(2010),"Arora D, Singh R, Kaur M, Ahi RS. A changing pattern in antimicrobial susceptibility of Salmonella enterica serotype isolated in North India. African Journal of Microbiology Research 2010; 4(3): 197-203.",Extended systematic review,IND,India,Adesh Institute of Medical Sciences and Research,864,Punjab,2003,0,45,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
2284,Aggarwal (2007),"Aggarwal A, Vij AS, Oberoi A. A three-year retrospective study on the prevalence, drug susceptibility pattern, and phage types of Salmonella enterica subspecies Typhi and ParaTyphi in Christian Medical College and Hospital, Ludhiana, Punjab. J Indian Acad Clin Med 2007; 8(1): 32-5.",Initial systematic review,IND,India,Christian Medical College and Hospital (Ludhiana),864,Punjab,2003,2,80,2.5,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
858,Kownhar(2007),"Kownhar H, Shankar EM, Rajan R, Rao UA. Emergence of nalidixic acid-resistant Salmonella enterica serovar Typhi resistant to ciprofloxacin in India. J Med Microbiol 2007; 56(Pt 1): 136-7.",Extended systematic review,IND,India,Rajiv Gandhi Government General Hospital,867,Tamil Nadu,2003,11,14,78.6,1,Salmonella Typhi,Third-generation cephalosporin (3GC)
1887,Mandal (2004),"Mandal S, Mandal MD, Pal NK. Reduced minimum inhibitory concentration of chloramphenicol for Salmonella enterica serovar Typhi. Indian J Med Sci 2004; 58(1): 16-23.",Initial systematic review,IND,India,Calcutta School of Tropical Medicine,869,West Bengal,2003,0,23,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
690,Madhulika (2004),"Madhulika U, Harish BN, Parija SC. Current pattern in antimicrobial susceptibility of Salmonella Typhi isolates in Pondicherry. Indian J Med Res 2004; 120(2): 111-4.",Initial systematic review,IND,India,Government Hospital (Pondicherry);Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER),889,Puducherry,2003,0,157,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
362,Garg (2007),"Garg A, Anupurba S, Garg J, Goyal RK, Sen MR. Bacteriological profile and antimicrobial resistance of blood culture isolates from a university hospital. J Indian Acad Clin Med 2007; 8(2): 139-43.",Initial systematic review,IND,India,Sir Sunderlal Hospital,890,Uttar Pradesh,2003,5,66,7.6,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
471,Lakshmi (2006),"Lakshmi V, Ashok R, Susmita J, Shailaja VV. Changing trends in the antibiograms of Salmonella isolates at a tertiary care hospital in Hyderabad. Indian J Med Microbiol 2006; 24(1): 45-8.",Initial systematic review,IND,India,Nizam's Institute of Medical Sciences,848,Andhra Pradesh,2004,0,12,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
118,Mohanty (2006),"Mohanty S, Renuka K, Sood S, Das BK, Kapil A. Antibiogram pattern and seasonality of Salmonella serotypes in a North Indian tertiary care hospital. Epidemiol Infect 2006; 134(5): 961-6.",Initial systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,2004,0,99,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
1900,Arya(2008),"Arya SC, Agarwal N. Regarding ""Typhoid fever in travelers: time for re-assessment"". European Journal of Internal Medicine 2008; 19(2): 148-9.",Extended systematic review,IND,India,Sant Parmanand Hospital,850,Delhi,2004,0,15,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
1064,Joshi (2007),"Joshi S, Amarnath SK. Fluoroquinolone resistance in Salmonella Typhi and S. ParaTyphi A in Bangalore, India. Trans R Soc Trop Med Hyg 2007; 101(3): 308-10.",Initial systematic review,IND,India,Manipal Hospital (Airport road),855,Karnataka,2004,0,25,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
121,Das (2006),"Das U, Bhattacharya SS. Antibiogram, phage typing and biotyping of Salmonella Typhi and Salmonella ParaTyphi A from Rourkela, Orissa. Indian J Med Res 2006; 124(1): 109-11.",Initial systematic review,IND,India,Ispat General Hospital (Rourkela),863,Orissa,2004,0,105,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
2807,Arora(2010),"Arora D, Singh R, Kaur M, Ahi RS. A changing pattern in antimicrobial susceptibility of Salmonella enterica serotype isolated in North India. African Journal of Microbiology Research 2010; 4(3): 197-203.",Extended systematic review,IND,India,Adesh Institute of Medical Sciences and Research,864,Punjab,2004,0,45,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
2284,Aggarwal (2007),"Aggarwal A, Vij AS, Oberoi A. A three-year retrospective study on the prevalence, drug susceptibility pattern, and phage types of Salmonella enterica subspecies Typhi and ParaTyphi in Christian Medical College and Hospital, Ludhiana, Punjab. J Indian Acad Clin Med 2007; 8(1): 32-5.",Initial systematic review,IND,India,Christian Medical College and Hospital (Ludhiana),864,Punjab,2004,2,97,2.1,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
1188,Bhaswati(2008),"Bhaswati S, Manjira B, Niyogi SK. In vitro activity of cefpodoxime, an expanded-spectrum cephalosporin, against Salmonella enterica serotype Typhi. Antimicrob Agents Chemother 2008; 52(2): 802-3.",Extended systematic review,IND,India,"Wards 29 & 30, Kolkata",869,West Bengal,2004,0,90,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
1698,Bhaswati (2007),"Bhaswati S, Shanta D, Dipika S, et al. Phage typing, biotyping & antimicrobial resistance profile of Salmonella enterica serotype Typhi from Kolkata. Indian J Med Res 2007; 125(5): 685-8.",Initial systematic review,IND,India,"Wards 29 & 30, Kolkata",869,West Bengal,2004,0,195,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
1955,Dutta (2005),"Dutta S, Sur D, Manna B, Bhattacharya SK, Deen JL, Clemens JD. Rollback of Salmonella enterica serotype Typhi resistance to chloramphenicol and other antimicrobials in Kolkata, India. Antimicrob Agents Chemother 2005; 49(4): 1662-3.",Initial systematic review,IND,India,Kolkata,869,West Bengal,2004,0,129,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
787,Nath(2010),"Nath G, Maurya P. Drug resistance patterns in Salmonella enterica subspecies enterica serotype Typhi strains isolated over a period of two decades, with special reference to ciprofloxacin and ceftriaxone. Int J Antimicrob Agents 2010; 35(5): 482-5.",Extended systematic review,IND,India,Sir Sunderlal Hospital,890,Uttar Pradesh,2004,0,32,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
1933,Kumar (2008),"Kumar S, Rizvi M, Berry N. Rising prevalence of enteric fever due to multidrug-resistant Salmonella: an epidemiological study. J Med Microbiol 2008; 57(Pt 10): 1247-50.",Initial systematic review,IND,India,Lok Nayak Jai Prakash Narayan Hospital,850,Delhi,2005,7,45,15.6,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5110,Sharma (2018),"Sharma P, Dahiya S, Manral N, et al. Changing trends of culture-positive typhoid fever and antimicrobial susceptibility in a tertiary care North Indian Hospital over the last decade.Indian Journal of Medical Microbiology 2018;36(1):70-76",Initial systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,2005,0,84,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
2309,Manchanda (2006),"Manchanda V, Bhalla P, Sethi M, Sharma VK. Treatment of enteric fever in children on the basis of current trends of antimicrobial susceptibility of Salmonella enterica serovar Typhi and ParaTyphi A. Indian J Med Microbiol 2006; 24(2): 101-6.",Initial systematic review,IND,India,Chacha Nehru Bal Chikitsalaya Hospital,850,Delhi,2005,0,56,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
3774,Bhat (2009),"Bhat KG, Tripathy A, Rajagopal R, Ramachandran S. A simple broth-disk method to determine the minimum inhibitory concentration of ceftriaxone on Salmonella enterica serovar Typhi and ParaTyphi. Indian J Pathol Microbiol 2009; 52(2): 189-90.",Initial systematic review,IND,India,Kasturba Medical College Hospital (Mangaluru),855,Karnataka,2005,1,16,6.3,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
1807,Gupta(2009),"Gupta S, Handa A, Chadha DS, Ganjoo RK, Panda RC. Profile of culture positive enteric fever from Bangalore. Med J Armed Forces India 2009; 65(4): 328-31.",Extended systematic review,IND,India,Command Hospital (Bengaluru),855,Karnataka,2005,0,65,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
2807,Arora(2010),"Arora D, Singh R, Kaur M, Ahi RS. A changing pattern in antimicrobial susceptibility of Salmonella enterica serotype isolated in North India. African Journal of Microbiology Research 2010; 4(3): 197-203.",Extended systematic review,IND,India,Adesh Institute of Medical Sciences and Research,864,Punjab,2005,0,38,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
2284,Aggarwal (2007),"Aggarwal A, Vij AS, Oberoi A. A three-year retrospective study on the prevalence, drug susceptibility pattern, and phage types of Salmonella enterica subspecies Typhi and ParaTyphi in Christian Medical College and Hospital, Ludhiana, Punjab. J Indian Acad Clin Med 2007; 8(1): 32-5.",Initial systematic review,IND,India,Christian Medical College and Hospital (Ludhiana),864,Punjab,2005,0,80,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
246,Menezes (2012),"Menezes GA, Harish BN, Khan MA, Goessens WHF, Hays JP. Antimicrobial resistance trends in blood culture positive Salmonella Typhi isolates from Pondicherry, India, 2005-2009. Clin Microbiol Infect 2012; 18(3): 239-45.",Initial systematic review,IND,India,Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER);Indira Gandhi Government General Hospital,889,Puducherry,2005,0,70,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
1062,Harish (2006),"Harish BN, Menezes GA, Sarangapani K, Parija SC. Fluoroquinolone resistance among Salmonella enterica serovar ParaTyphi A in Pondicherry [2]. Indian J Med Res 2006; 124: 585-7.",Initial systematic review,IND,India,Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER);Indira Gandhi Government General Hospital,889,Puducherry,2005,0,27,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
904,Capoor(2007),"Capoor MR, Nair D, Deb M, Aggarwal P. Enteric fever perspective in India: emergence of high-level ciprofloxacin resistance and rising MIC to cephalosporins. J Med Microbiol 2007; 56(Pt 8): 1131-2.",Extended systematic review,IND,India,Safdarjung Hospital,850,Delhi,2006,0,142,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
1126,Raveendran (2008),"Raveendran R, Wattal C, Sharma A, Oberoi J, Prasad K, Datta S. High level ciprofloxacin resistance in Salmonella enterica isolated from blood. Indian J Med Microbiol 2008; 26(1): 50-3.",Initial systematic review,IND,India,Sir Ganga Ram Hospital,850,Delhi,2006,0,431,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
1900,Arya(2008),"Arya SC, Agarwal N. Regarding ""Typhoid fever in travelers: time for re-assessment"". European Journal of Internal Medicine 2008; 19(2): 148-9.",Extended systematic review,IND,India,Sant Parmanand Hospital,850,Delhi,2006,22,68,32.4,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5110,Sharma (2018),"Sharma P, Dahiya S, Manral N, et al. Changing trends of culture-positive typhoid fever and antimicrobial susceptibility in a tertiary care North Indian Hospital over the last decade.Indian Journal of Medical Microbiology 2018;36(1):70-76",Initial systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,2006,0,86,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
934,Vidyalakshmi (2008),"Vidyalakshmi K, Yashavanth R, Chakrapani M, et al. Epidemiological shift, seasonal variation and antimicrobial susceptibility patterns among enteric fever pathogens in South India. Trop Doct 2008; 38(2): 89-91.",Initial systematic review,IND,India,Kasturba Medical College Hospital (Mangaluru),855,Karnataka,2006,0,71,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
1893,Yashavanth (2010),"Yashavanth R, Vidyalakshmi K. The Re-Emergence of chloramphenicol sensitivity among enteric fever pathogens in Mangalore. J Clin Diagn Res 2010; 4(5): 3016-108.",Initial systematic review,IND,India,Kasturba Medical College Hospital (Mangaluru),855,Karnataka,2006,0,77,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
2807,Arora(2010),"Arora D, Singh R, Kaur M, Ahi RS. A changing pattern in antimicrobial susceptibility of Salmonella enterica serotype isolated in North India. African Journal of Microbiology Research 2010; 4(3): 197-203.",Extended systematic review,IND,India,Adesh Institute of Medical Sciences and Research,864,Punjab,2006,0,25,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
246,Menezes (2012),"Menezes GA, Harish BN, Khan MA, Goessens WHF, Hays JP. Antimicrobial resistance trends in blood culture positive Salmonella Typhi isolates from Pondicherry, India, 2005-2009. Clin Microbiol Infect 2012; 18(3): 239-45.",Initial systematic review,IND,India,Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER);Indira Gandhi Government General Hospital,889,Puducherry,2006,0,76,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
452,Beig (2009),"Beig FK, Ahmad F, Abqari S. Changing antibiotic sensitivity pattern and scope of chloramphenicol in the management of hospitalised patients of typhoid fever. J Indian Med Assoc 2009; 107(12): 862-5.",Initial systematic review,IND,India,Jawaharlal Nehru Medical College (Aligarh),890,Uttar Pradesh,2006,1,35,2.9,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
1412,Capoor (2009),"Capoor MR, Deepthi N, Jitendra P, et al. Minimum inhibitory concentration of carbapenems and tigecycline against Salmonella spp. J Med Microbiol 2009; 58(3): 337-41.",Initial systematic review,IND,India,Majeedia Hospital;Safdarjung Hospital,850,Delhi,2007,1,149,0.7,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5110,Sharma (2018),"Sharma P, Dahiya S, Manral N, et al. Changing trends of culture-positive typhoid fever and antimicrobial susceptibility in a tertiary care North Indian Hospital over the last decade.Indian Journal of Medical Microbiology 2018;36(1):70-76",Initial systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,2007,0,88,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
266,Kavita (2010),"Kavita N, Channappa ST, Gaddad SM. Antimicrobial susceptibility of Salmonella Typhi in India. J Infect Dev Ctries 2010; 4(2): 70-3.",Initial systematic review,IND,India,Unknown clinics private and public hospitals in Gulbarga region,855,Karnataka,2007,6,84,7.1,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5124,Joshi (2019),"Joshi S, Adhikary R, Beena HB, et al. Trends in antibiotic susceptibility of enteric fever isolates from South India, 2002–2013.Medical Journal Armed Forces India 2019;75(1):81-85",Initial systematic review,IND,India,Manipal Hospital (Airport road),855,Karnataka,2007,0,184,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
1617,Bhattacharya (2011),"Bhattacharya SS, Das U, Choudhury BK. Occurrence & antibiogram of Salmonella Typhi & S. ParaTyphi A isolated from Rourkela, Orissa. Indian J Med Res 2011; 133: 431-3.",Initial systematic review,IND,India,Ispat General Hospital (Rourkela),863,Orissa,2007,7,234,3,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
2807,Arora(2010),"Arora D, Singh R, Kaur M, Ahi RS. A changing pattern in antimicrobial susceptibility of Salmonella enterica serotype isolated in North India. African Journal of Microbiology Research 2010; 4(3): 197-203.",Extended systematic review,IND,India,Adesh Institute of Medical Sciences and Research,864,Punjab,2007,0,11,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
246,Menezes (2012),"Menezes GA, Harish BN, Khan MA, Goessens WHF, Hays JP. Antimicrobial resistance trends in blood culture positive Salmonella Typhi isolates from Pondicherry, India, 2005-2009. Clin Microbiol Infect 2012; 18(3): 239-45.",Initial systematic review,IND,India,Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER);Indira Gandhi Government General Hospital,889,Puducherry,2007,0,63,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
4278,Sudhaharan(2014),"Sudhaharan S, Padmaja K, Solanki R, Lakshmi V, Umabala P, Aparna B. Extra-intestinal salmonellosis in a tertiary care center in South India. J Infect Dev Ctries 2014; 8(7): 831-7.",Extended systematic review,IND,India,Nizam's Institute of Medical Sciences,848,Andhra Pradesh,2008,8,16,50,1,Salmonella Typhi,Third-generation cephalosporin (3GC)
439,Sabharwal (2010),Sabharwal ER. Ceftriaxone resistance in Salmonella Typhi - myth or a reality! Indian J Pathol Microbiol 2010; 53(2): 389.,Initial systematic review,IND,India,Dr Lal PathLabs,850,Delhi,2008,0,83,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5110,Sharma (2018),"Sharma P, Dahiya S, Manral N, et al. Changing trends of culture-positive typhoid fever and antimicrobial susceptibility in a tertiary care North Indian Hospital over the last decade.Indian Journal of Medical Microbiology 2018;36(1):70-76",Initial systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,2008,0,92,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
262,Kumar (2013)<U+1D47>,"Kumar MS, Kumar GSV, Prashanth HV, Prakash R, Veena K, Chandrashekar SC. Antimicrobial susceptibility of enteric fever Salmonellae isolated from blood culture. Res J Pharm Biol Chem Sci 2013b; 4(3): 318-24.",Initial systematic review,IND,India,Sri Siddhartha Medical College,855,Karnataka,2008,0,160,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5124,Joshi (2019),"Joshi S, Adhikary R, Beena HB, et al. Trends in antibiotic susceptibility of enteric fever isolates from South India, 2002–2013.Medical Journal Armed Forces India 2019;75(1):81-85",Initial systematic review,IND,India,Manipal Hospital (Airport road),855,Karnataka,2008,0,255,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
2807,Arora(2010),"Arora D, Singh R, Kaur M, Ahi RS. A changing pattern in antimicrobial susceptibility of Salmonella enterica serotype isolated in North India. African Journal of Microbiology Research 2010; 4(3): 197-203.",Extended systematic review,IND,India,Adesh Institute of Medical Sciences and Research,864,Punjab,2008,0,18,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
2334,Gupta (2013),"Gupta V, Singla N, Bansal N, Kaistha N, Chander J. Trends in the antibiotic resistance patterns of enteric fever isolates - a three year report from a tertiary care centre. Malays J Med Sci 2013; 20(4): 71-5.",Initial systematic review,IND,India,Government Medical College Hospital (Chandigarh),864,Punjab,2008,0,41,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
2165,Gopal(2011),"Gopal M, Arumugam S, Gnadesikan S, Ramesh S. Studies on antimicrobial susceptibility pattern of Salmonella isolates from Chennai, India. Int J Pharma Bio Sci 2011; 2(2).",Extended systematic review,IND,India,Rajiv Gandhi Government General Hospital;Other clinical laboratories Chennai,867,Tamil Nadu,2008,2,133,1.5,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5069,Bandyopadhyay(2018),"Bandyopadhyay R, Balaji V, Yadav B, Jasmine S, Sathyendra S, Rupali P. Effectiveness of treatment regimens for Typhoid fever in the nalidixic acid-resistant S. Typhi (NARST) era in South India. Trop Doct 2018; 48(3): 182-8.",Extended systematic review,IND,India,Christian Medical College (Vellore),867,Tamil Nadu,2008,0,32,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
1128,Pathak (2012),"Pathak A, Marothi Y, Kekre V, Mahadik K, Macaden R, Lundborg CS. High prevalence of extended-spectrum beta-lactamase-producing pathogens: results of a surveillance study in two hospitals in Ujjain, India. Infect Drug Resist 2012; 5: 65-73.",Initial systematic review,IND,India,Ruxmaniben Deepchand Gardi Medical College Hospital;Ujjain Charitable Trust Hospital,888,Madhya Pradesh,2008,3,21,14.3,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
246,Menezes (2012),"Menezes GA, Harish BN, Khan MA, Goessens WHF, Hays JP. Antimicrobial resistance trends in blood culture positive Salmonella Typhi isolates from Pondicherry, India, 2005-2009. Clin Microbiol Infect 2012; 18(3): 239-45.",Initial systematic review,IND,India,Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER);Indira Gandhi Government General Hospital,889,Puducherry,2008,0,69,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5110,Sharma (2018),"Sharma P, Dahiya S, Manral N, et al. Changing trends of culture-positive typhoid fever and antimicrobial susceptibility in a tertiary care North Indian Hospital over the last decade.Indian Journal of Medical Microbiology 2018;36(1):70-76",Initial systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,2009,0,101,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
425,Trivedi (2010),"Trivedi ND, Trivedi UN. Case report and pathological result based study on typhoid patients. Int J Pharm Sci Rev Res 2010; 2(2): 22-3.",Initial systematic review,IND,India,Unknown hositals in Banaskantha District,852,Gujarat,2009,0,46,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5124,Joshi (2019),"Joshi S, Adhikary R, Beena HB, et al. Trends in antibiotic susceptibility of enteric fever isolates from South India, 2002–2013.Medical Journal Armed Forces India 2019;75(1):81-85",Initial systematic review,IND,India,Manipal Hospital (Airport road),855,Karnataka,2009,0,197,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
2334,Gupta (2013),"Gupta V, Singla N, Bansal N, Kaistha N, Chander J. Trends in the antibiotic resistance patterns of enteric fever isolates - a three year report from a tertiary care centre. Malays J Med Sci 2013; 20(4): 71-5.",Initial systematic review,IND,India,Government Medical College Hospital (Chandigarh),864,Punjab,2009,0,91,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5069,Bandyopadhyay(2018),"Bandyopadhyay R, Balaji V, Yadav B, Jasmine S, Sathyendra S, Rupali P. Effectiveness of treatment regimens for Typhoid fever in the nalidixic acid-resistant S. Typhi (NARST) era in South India. Trop Doct 2018; 48(3): 182-8.",Extended systematic review,IND,India,Christian Medical College (Vellore),867,Tamil Nadu,2009,0,29,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
246,Menezes (2012),"Menezes GA, Harish BN, Khan MA, Goessens WHF, Hays JP. Antimicrobial resistance trends in blood culture positive Salmonella Typhi isolates from Pondicherry, India, 2005-2009. Clin Microbiol Infect 2012; 18(3): 239-45.",Initial systematic review,IND,India,Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER);Indira Gandhi Government General Hospital,889,Puducherry,2009,0,59,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
842,Thamizhmani(2012),"Thamizhmani R, Bhattacharya D, Sayi DS, et al. Emergence of fluoroquinolone resistance in Salmonella enterica serovar Typhi in Andaman and Nicobar Islands, India. Indian J Med Res 2012; 136(1): 98-101.",Extended systematic review,IND,India,Govind Ballabh Pant Hospital;INHS Dhanwantari,847,Andaman and Nicobar,2010,0,6,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
207,Jain (2013),"Jain S, Chugh TD. Antimicrobial resistance among blood culture isolates of Salmonella enterica in New Delhi. J Infect Dev Ctries 2013; 7(11): 788-95.",Initial systematic review,IND,India,BLK Super speciality Hospital,850,Delhi,2010,0,108,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
3082,Duggal (2016),"Duggal S, Banerjee P, Chugh TD. Review of fifty culture proven Salmonella cases. Indian J Med Sci 2016; 68(1): 67-72.",Initial systematic review,IND,India,Unknown Hospital(s) in Delhi,850,Delhi,2010,0,36,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5110,Sharma (2018),"Sharma P, Dahiya S, Manral N, et al. Changing trends of culture-positive typhoid fever and antimicrobial susceptibility in a tertiary care North Indian Hospital over the last decade.Indian Journal of Medical Microbiology 2018;36(1):70-76",Initial systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,2010,0,96,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
151,Suruchi (2014),"Suruchi B, Anil K, Ganju SA, Atal S. Antibiotic susceptibility pattern of Salmonella enterica serovar Typhi and ParaTyphi a from North India: the changing scenario. Int J Pharma Bio Sci 2014; 5(4).",Initial systematic review,IND,India,Indira Gandhi Medical College,854,Himachal Pradesh,2010,0,22,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
2820,Shetty (2012),"Shetty AK, Shetty IN, Furtado ZV, Antony B, Boloor R. Antibiogram of Salmonella isolates from blood with an emphasis on nalidixic acid and chloramphenicol susceptibility in a tertiary care hospital in coastal karnataka: a prospective study. J Lab Physicians 2012; 4(2): 74-7.",Initial systematic review,IND,India,Father Muller Medical College Hospital,855,Karnataka,2010,0,85,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5124,Joshi (2019),"Joshi S, Adhikary R, Beena HB, et al. Trends in antibiotic susceptibility of enteric fever isolates from South India, 2002–2013.Medical Journal Armed Forces India 2019;75(1):81-85",Initial systematic review,IND,India,Manipal Hospital (Airport road),855,Karnataka,2010,0,164,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
2334,Gupta (2013),"Gupta V, Singla N, Bansal N, Kaistha N, Chander J. Trends in the antibiotic resistance patterns of enteric fever isolates - a three year report from a tertiary care centre. Malays J Med Sci 2013; 20(4): 71-5.",Initial systematic review,IND,India,Government Medical College Hospital (Chandigarh),864,Punjab,2010,0,125,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
744,Elumalai (2014),"Elumalai S, Muthu G, Selvam RE, Ramesh S. Detection of TEM-, SHV- and CTX-M-type beta-lactamase production among clinical isolates of Salmonella species. J Med Microbiol 2014; 63(Pt 7): 962-7.",Initial systematic review,IND,India,Unknown hospitals and laboratories in Chennai,867,Tamil Nadu,2010,2,101,2,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5069,Bandyopadhyay(2018),"Bandyopadhyay R, Balaji V, Yadav B, Jasmine S, Sathyendra S, Rupali P. Effectiveness of treatment regimens for Typhoid fever in the nalidixic acid-resistant S. Typhi (NARST) era in South India. Trop Doct 2018; 48(3): 182-8.",Extended systematic review,IND,India,Christian Medical College (Vellore),867,Tamil Nadu,2010,0,32,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
1649,Singla (2013),"Singla N, Bansal N, Gupta V, Chander J. Outbreak of Salmonella Typhi enteric fever in sub-urban area of North India: a public health perspective. Asian Pac J Trop Med 2013; 6(2): 167-8.",Initial systematic review,IND,India,Ram Darbar,883,Chandigarh,2010,0,18,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
4650,Yadav (2016),"Yadav VC, Kiran VR, Sharma R. Enteric fever in Bastar tribal region-prevalence and sensitivity patterns. J Evol Med Dent Sci 2016; 5(53): 3526-30.",Initial systematic review,IND,India,Late Baliram Kashyap Memorial Government Medical College Jagdalpur,884,Chhattisgarh,2010,12,122,9.8,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
781,Pratap(2012),"Pratap CB, Patel SK, Shukla VK, Tripathi SK, Singh TB, Nath G. Drug resistance in Salmonella enterica serotype Typhi isolated from chronic typhoid carriers. Int J Antimicrob Agents 2012; 40(3): 279-80.",Extended systematic review,IND,India,Sir Sunderlal Hospital,890,Uttar Pradesh,2010,5,36,13.9,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
207,Jain (2013),"Jain S, Chugh TD. Antimicrobial resistance among blood culture isolates of Salmonella enterica in New Delhi. J Infect Dev Ctries 2013; 7(11): 788-95.",Initial systematic review,IND,India,BLK Super speciality Hospital,850,Delhi,2011,0,107,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
4235,Duggal (2014),"Duggal S, Rongpharpi SR, Gur R, Nayar R, Arora VM. Etiology and susceptibility of blood stream infections in a Referral Hospital in north Delhi: A one year study. Res J Pharm Biol Chem Sci 2014; 5(2): 1859-64.",Initial systematic review,IND,India,Unknown government Hospital in North Delhi,850,Delhi,2011,1,29,3.4,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5110,Sharma (2018),"Sharma P, Dahiya S, Manral N, et al. Changing trends of culture-positive typhoid fever and antimicrobial susceptibility in a tertiary care North Indian Hospital over the last decade.Indian Journal of Medical Microbiology 2018;36(1):70-76",Initial systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,2011,0,55,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
4642,Vala (2016),"Vala S, Shah U, Ahmad SA, Scolnik D, Glatstein M. Resistance patterns of typhoid fever in children: A longitudinal community-based study. Am J Ther 2016; 23(5): E1151-E4.",Initial systematic review,IND,India,The Synergy Neonatal and Pediatric Hospital (Maninagar);The Synergy Neonatal and Pediatric Hospital (Vasna);Unknown private clinics in Ahmedabad;Unknown community hospitals in Ahmedabad;Unknown private clinics in Vadodara;Unknown community hospitals in Vadodara;Unknown private clinics in Bhavangar;Unknown community hospitals in Bhavangar,852,Gujarat,2011,3,61,4.9,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
352,Kaur(2014),"Kaur A, Singh VA. Bacterial isolates and their antibiotic sensitivity pattern in clinically suspected cases of fever of unknown origin. JK Science 2014; 16(3): 105-9.",Extended systematic review,IND,India,Maharishi Markandeshwar Institute of Medical Sciences and Research,853,Haryana,2011,0,5,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
151,Suruchi (2014),"Suruchi B, Anil K, Ganju SA, Atal S. Antibiotic susceptibility pattern of Salmonella enterica serovar Typhi and ParaTyphi a from North India: the changing scenario. Int J Pharma Bio Sci 2014; 5(4).",Initial systematic review,IND,India,Indira Gandhi Medical College,854,Himachal Pradesh,2011,0,7,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5124,Joshi (2019),"Joshi S, Adhikary R, Beena HB, et al. Trends in antibiotic susceptibility of enteric fever isolates from South India, 2002–2013.Medical Journal Armed Forces India 2019;75(1):81-85",Initial systematic review,IND,India,Manipal Hospital (Airport road),855,Karnataka,2011,0,224,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5069,Bandyopadhyay(2018),"Bandyopadhyay R, Balaji V, Yadav B, Jasmine S, Sathyendra S, Rupali P. Effectiveness of treatment regimens for Typhoid fever in the nalidixic acid-resistant S. Typhi (NARST) era in South India. Trop Doct 2018; 48(3): 182-8.",Extended systematic review,IND,India,Christian Medical College (Vellore),867,Tamil Nadu,2011,0,34,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
4650,Yadav (2016),"Yadav VC, Kiran VR, Sharma R. Enteric fever in Bastar tribal region-prevalence and sensitivity patterns. J Evol Med Dent Sci 2016; 5(53): 3526-30.",Initial systematic review,IND,India,Late Baliram Kashyap Memorial Government Medical College Jagdalpur,884,Chhattisgarh,2011,9,103,8.7,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
1730,Geetha (2014),"Geetha VK, Yugendran T, Srinivasan R, Harish BN. Plasmid-mediated quinolone resistance in typhoidal Salmonellae: a preliminary report from South India. Indian J Med Microbiol 2014; 32(1): 31-4.",Initial systematic review,IND,India,Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER),889,Puducherry,2011,0,36,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
4411,Narain (2015),"Narain U, Gupta R. Emergence of resistance in community-acquired enteric fever. Indian Pediatr 2015; 52(8): 709-.",Initial systematic review,IND,India,"Priti Hospital, Medical Research and Charitable Trust",890,Uttar Pradesh,2011,56,220,25.5,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
2967,Iyer (2017),"Iyer RN, Jangam RR, Jacinth A, Venkatalakshmi A, Nahdi FB. Prevalence and trends in the antimicrobial susceptibility pattern of Salmonella enterica serovars Typhi and ParaTyphi A among children in a pediatric tertiary care hospital in South India over a period of ten years: a retrospective study. Eur J Clin Microbiol Infect Dis 2017; 07: 07.",Initial systematic review,IND,India,Rainbow Hospital for Women and Children,848,Andhra Pradesh,2012,0,208,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
207,Jain (2013),"Jain S, Chugh TD. Antimicrobial resistance among blood culture isolates of Salmonella enterica in New Delhi. J Infect Dev Ctries 2013; 7(11): 788-95.",Initial systematic review,IND,India,BLK Super speciality Hospital,850,Delhi,2012,1,51,2,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
4627,Sharma (2016),"Sharma P, Dahiya S, Balaji V, et al. Typhoidal Salmonellae: Use of multi-locus sequence typing to determine population structure. PLoS ONE 2016; 11(9).",Initial systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,2012,0,263,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5110,Sharma (2018),"Sharma P, Dahiya S, Manral N, et al. Changing trends of culture-positive typhoid fever and antimicrobial susceptibility in a tertiary care North Indian Hospital over the last decade.Indian Journal of Medical Microbiology 2018;36(1):70-76",Initial systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,2012,0,43,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
151,Suruchi (2014),"Suruchi B, Anil K, Ganju SA, Atal S. Antibiotic susceptibility pattern of Salmonella enterica serovar Typhi and ParaTyphi a from North India: the changing scenario. Int J Pharma Bio Sci 2014; 5(4).",Initial systematic review,IND,India,Indira Gandhi Medical College,854,Himachal Pradesh,2012,3,22,13.6,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
4627,Sharma (2016),"Sharma P, Dahiya S, Balaji V, et al. Typhoidal Salmonellae: Use of multi-locus sequence typing to determine population structure. PLoS ONE 2016; 11(9).",Initial systematic review,IND,India,Indira Gandhi Medical College,854,Himachal Pradesh,2012,0,20,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
117,Venkatesh (2013),"Venkatesh BM, Joshi S, Adhikary R, Bhaskar BH. Antibiogram of Salmonella Typhi and Salmonella ParaTyphi A in a tertiary care hospital in 2012. Indian J Pathol Microbiol 2013; 56(4): 484-5.",Initial systematic review,IND,India,Manipal Hospital (Airport road),855,Karnataka,2012,0,251,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5124,Joshi (2019),"Joshi S, Adhikary R, Beena HB, et al. Trends in antibiotic susceptibility of enteric fever isolates from South India, 2002–2013.Medical Journal Armed Forces India 2019;75(1):81-85",Initial systematic review,IND,India,Manipal Hospital (Airport road),855,Karnataka,2012,0,253,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
4519,Chatterjee(2016),"Chatterjee S, Eshwara VK, Tellapragada C, Mukhopadhyay C. Azithromycin susceptibility among clinical isolates of Salmonella: Interfacing guidelines with routine practices. Indian J Med Microbiol 2016; 34(3): 397-8.",Extended systematic review,IND,India,Kasturba Medical College and Hospital (Manipal),855,Karnataka,2012,0,95,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
2977,Harichandran (2017),"Harichandran D, Dinesh KR. Antimicrobial susceptibility profile, treatment outcome and serotype distribution of clinical isolates of Salmonella enterica subspecies enterica: a 2-year study from Kerala, South India. Infect Drug Resist 2017; 10: 97-101.",Initial systematic review,IND,India,Amrita Institute of Medical Sciences and Research Centre,856,Kerala,2012,0,79,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
4627,Sharma (2016),"Sharma P, Dahiya S, Balaji V, et al. Typhoidal Salmonellae: Use of multi-locus sequence typing to determine population structure. PLoS ONE 2016; 11(9).",Initial systematic review,IND,India,Mahatma Gandhi Institute of Medical Sciences (Sevagram),858,Maharashtra,2012,0,5,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
4625,Sania (2016),"Sania KM, Shyamasakhi PD, Krishna Pramodini KD, Sulochana KD. Evaluation of minimum inhibitory concentration of chloramphenicol for Salmonella spp. isolated from enteric fever cases in a tertiary hospital in Imphal. Int J Pharm Sci Res 2016; 7(9): 3815-9.",Initial systematic review,IND,India,Regional Institute of Medical Sciences,859,Manipur,2012,2,16,12.5,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
4627,Sharma (2016),"Sharma P, Dahiya S, Balaji V, et al. Typhoidal Salmonellae: Use of multi-locus sequence typing to determine population structure. PLoS ONE 2016; 11(9).",Initial systematic review,IND,India,North Eastern Indira Gandhi Regional Institute of Health and Medical Sciences,860,Meghalaya,2012,0,15,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
4627,Sharma (2016),"Sharma P, Dahiya S, Balaji V, et al. Typhoidal Salmonellae: Use of multi-locus sequence typing to determine population structure. PLoS ONE 2016; 11(9).",Initial systematic review,IND,India,Maharaja Krishna Chandra Gajapati Medical College & Hospital,863,Orissa,2012,0,15,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
3012,Behl(2017),"Behl P, Gupta V, Sachdev A, Guglani V, Chander J. Patterns in antimicrobial susceptibility of Salmonellae isolated at a tertiary care hospital in northern India. Indian J Med Res 2017; 145(1): 124-8.",Extended systematic review,IND,India,Government Medical College Hospital (Chandigarh),864,Punjab,2012,0,78,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
4440,Riyaz (2015),"Riyaz C, Jayavardhana A. Current pattern of Salmonella Typhi antimicrobial susceptibility in the era of antibiotic abuse. Indian J Basic Appl Med Res 2015; 5(1): 400-4.",Initial systematic review,IND,India,PSG Institute of Medical Sciences and Research,867,Tamil Nadu,2012,0,50,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
696,Mathew (2014),"Mathew R, Jobin SR. Current trends of antimicrobial susceptibility of Salmonella enterica serovar Typhi and ParaTyphi a from blood cultures in a tertiary care center of Chennai, Tamil Nadu, India. Res J Pharm Biol Chem Sci 2014; 5(2): 1167-74.",Initial systematic review,IND,India,Saveetha Medical College (Thandalam),867,Tamil Nadu,2012,0,29,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
4627,Sharma (2016),"Sharma P, Dahiya S, Balaji V, et al. Typhoidal Salmonellae: Use of multi-locus sequence typing to determine population structure. PLoS ONE 2016; 11(9).",Initial systematic review,IND,India,Sri Ramachandra Medical College and Research Institute,867,Tamil Nadu,2012,0,7,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
4627,Sharma (2016),"Sharma P, Dahiya S, Balaji V, et al. Typhoidal Salmonellae: Use of multi-locus sequence typing to determine population structure. PLoS ONE 2016; 11(9).",Initial systematic review,IND,India,Christian Medical College (Vellore),867,Tamil Nadu,2012,0,267,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5069,Bandyopadhyay(2018),"Bandyopadhyay R, Balaji V, Yadav B, Jasmine S, Sathyendra S, Rupali P. Effectiveness of treatment regimens for Typhoid fever in the nalidixic acid-resistant S. Typhi (NARST) era in South India. Trop Doct 2018; 48(3): 182-8.",Extended systematic review,IND,India,Christian Medical College (Vellore),867,Tamil Nadu,2012,0,19,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
4650,Yadav (2016),"Yadav VC, Kiran VR, Sharma R. Enteric fever in Bastar tribal region-prevalence and sensitivity patterns. J Evol Med Dent Sci 2016; 5(53): 3526-30.",Initial systematic review,IND,India,Late Baliram Kashyap Memorial Government Medical College Jagdalpur,884,Chhattisgarh,2012,16,111,14.4,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5110,Sharma (2018),"Sharma P, Dahiya S, Manral N, et al. Changing trends of culture-positive typhoid fever and antimicrobial susceptibility in a tertiary care North Indian Hospital over the last decade.Indian Journal of Medical Microbiology 2018;36(1):70-76",Initial systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,2013,0,21,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5100,Narasanna (2018),"Narasanna R, Chavadi M and Chandrakanth K. Prevalence of multidrug-resistant Salmonella Typhi in typhoid patients and detection of blaCTX-M2 and blaCTX-M9 genes in cefetoxime-mediated extended spectrum beta-lactamase-producing Salmonella Typhi isolates.Biomedical Research (India) 2018;29(14):3015-3021",Initial systematic review,IND,India,"Government Hospital Kalaburagi;Pooja Diagnostic Centre, Kalaburagi",855,Karnataka,2013,25,66,37.9,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
3039,Sharvani (2016),"Sharvani R, Hemavathi, Dayanand DK, Shenoy P, Sarmah P. Antibiogram of Salmonella isolates: time to consider antibiotic salvage. J Clin Diagn Res 2016; 10(5): DC6-DC8.",Initial systematic review,IND,India,Sapthagiri Hospital,855,Karnataka,2013,5,167,3,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5124,Joshi (2019),"Joshi S, Adhikary R, Beena HB, et al. Trends in antibiotic susceptibility of enteric fever isolates from South India, 2002–2013.Medical Journal Armed Forces India 2019;75(1):81-85",Initial systematic review,IND,India,Manipal Hospital (Airport road),855,Karnataka,2013,0,131,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5060,Rajashri (2017),Rajashri P and Amar P. Study of antibiotic sensitivity pattern of Salmonella Typhi in tertiary care centre.International Journal of Healthcare & Biomedical Research 2017;6(1):75-80,Initial systematic review,IND,India,Dr D Y Patil Vidyapeeth,858,Maharashtra,2013,0,21,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
3006,Chandane (2017),"Chandane P, Gandhi A, Bowalekar S. Study of antibiotic susceptibility pattern of Salmonella Typhi in children suffering from enteric fever. Ann Trop Med Public Health 2017; 10(2): 440-3.",Initial systematic review,IND,India,B J Wadia Hospital for Children,858,Maharashtra,2013,4,43,9.3,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
3016,Bakthavatchalam(2017),"Bakthavatchalam YD, Kumar DT, Tayubi IA, et al. In vitro efficacy and in silico analysis of cefixime-ofloxacin combination for Salmonella Typhi from bloodstream infection. J Appl Microbiol 2017; 123(3): 615-24.",Extended systematic review,IND,India,Christian Medical College (Vellore),867,Tamil Nadu,2013,0,283,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
4650,Yadav (2016),"Yadav VC, Kiran VR, Sharma R. Enteric fever in Bastar tribal region-prevalence and sensitivity patterns. J Evol Med Dent Sci 2016; 5(53): 3526-30.",Initial systematic review,IND,India,Late Baliram Kashyap Memorial Government Medical College Jagdalpur,884,Chhattisgarh,2013,29,193,15,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
2166,Srirangaraj (2014),"Srirangaraj S, Kali A, Charles MV. A study of antibiogram of Salmonella enterica serovar Typhi isolates from Pondicherry, India. Australas Med J 2014; 7(4): 185-90.",Initial systematic review,IND,India,Mahatma Gandhi Medical College and Research Institute,889,Puducherry,2013,1,16,6.3,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
4301,Anees (2015),"Anees A, Indu S, Fatima K, Anjum P. Multi-drug resistant Salmonella enterica subspecies enterica serotype Typhi: A diagnostic and therapeutic challenge. Int J Curr Microbiol Appl Sci 2015; 4(Special Issue 1): 19-25.",Initial systematic review,IND,India,Jawaharlal Nehru Medical College (Aligarh),890,Uttar Pradesh,2013,0,12,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
4597,Misra (2016),"Misra R, Thakare R, Amrin N, Prasad KN, Chopra S, Dhole TN. Antimicrobial susceptibility pattern and sequence analysis of DNA gyrase and DNA topoisomerase IV in Salmonella enterica serovars Typhi and ParaTyphi A isolates with decreased susceptibility to ciprofloxacin. Trans R Soc Trop Med Hyg 2016; 110(8): 472-9.",Initial systematic review,IND,India,Sanjay Gandhi Postgraduate Institute of Medical Sciences,890,Uttar Pradesh,2013,0,20,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
3043,Roy(2016),"Roy JS, Lahari S, Mithu M, Dipak T. Epidemiological investigation of an outbreak of typhoid fever in Jorhat town of Assam, India. Indian J Med Res 2016; 144(4): 592-6.",Extended systematic review,IND,India,Jorhat Town,849,Assam,2014,0,6,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5097,Makkar (2018),"Makkar A, Gupta S, Khan ID, et al. Epidemiological Profile and Antimicrobial Resistance Pattern of Enteric Fever in a Tertiary Care Hospital of North India - a Seven Year Ambispective Study.Acta Medica (Hradec Kralove) 2018;61(4):125-130",Initial systematic review,IND,India,Unknown Hospital(s) in Delhi,850,Delhi,2014,24,623,3.9,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5110,Sharma (2018),"Sharma P, Dahiya S, Manral N, et al. Changing trends of culture-positive typhoid fever and antimicrobial susceptibility in a tertiary care North Indian Hospital over the last decade.Indian Journal of Medical Microbiology 2018;36(1):70-76",Initial systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,2014,0,11,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
4452,Sharma (2015),"Sharma, Sharma R, Gupta S. Bacteriological analysis of blood culture isolates with their antibiogram from a tertiary care hospital. Int J Pharm Sci Res 2015; 6(11): 4847-51.",Initial systematic review,IND,India,Mahatma Gandhi Medical College and Hospital (Jaipur),865,Rajasthan,2014,2,20,10,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
4650,Yadav (2016),"Yadav VC, Kiran VR, Sharma R. Enteric fever in Bastar tribal region-prevalence and sensitivity patterns. J Evol Med Dent Sci 2016; 5(53): 3526-30.",Initial systematic review,IND,India,Late Baliram Kashyap Memorial Government Medical College Jagdalpur,884,Chhattisgarh,2014,31,101,30.7,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
4597,Misra (2016),"Misra R, Thakare R, Amrin N, Prasad KN, Chopra S, Dhole TN. Antimicrobial susceptibility pattern and sequence analysis of DNA gyrase and DNA topoisomerase IV in Salmonella enterica serovars Typhi and ParaTyphi A isolates with decreased susceptibility to ciprofloxacin. Trans R Soc Trop Med Hyg 2016; 110(8): 472-9.",Initial systematic review,IND,India,Sanjay Gandhi Postgraduate Institute of Medical Sciences,890,Uttar Pradesh,2014,0,29,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5110,Sharma (2018),"Sharma P, Dahiya S, Manral N, et al. Changing trends of culture-positive typhoid fever and antimicrobial susceptibility in a tertiary care North Indian Hospital over the last decade.Indian Journal of Medical Microbiology 2018;36(1):70-76",Initial systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,2015,0,23,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
4597,Misra (2016),"Misra R, Thakare R, Amrin N, Prasad KN, Chopra S, Dhole TN. Antimicrobial susceptibility pattern and sequence analysis of DNA gyrase and DNA topoisomerase IV in Salmonella enterica serovars Typhi and ParaTyphi A isolates with decreased susceptibility to ciprofloxacin. Trans R Soc Trop Med Hyg 2016; 110(8): 472-9.",Initial systematic review,IND,India,Sanjay Gandhi Postgraduate Institute of Medical Sciences,890,Uttar Pradesh,2015,0,31,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5110,Sharma (2018),"Sharma P, Dahiya S, Manral N, et al. Changing trends of culture-positive typhoid fever and antimicrobial susceptibility in a tertiary care North Indian Hospital over the last decade.Indian Journal of Medical Microbiology 2018;36(1):70-76",Initial systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,2016,0,72,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5058,Purighalla (2017),"Purighalla S, Esakimuthu S, Reddy M, et al. Investigation into a community outbreak of Salmonella Typhi in Bengaluru, India.Indian Journal of Medical Research 2017;146(July Supplement):15-22",Initial systematic review,IND,India,Unknown hospitals in Bengaluru,855,Karnataka,2016,5,42,11.9,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5061,Sucindar (2017),Sucindar M and Kumaran SS. Profile of culture positive enteric fever in children admitted in a tertiary care hospital.Journal of Evolution of Medical and Dental Sciences-Jemds 2017;6(88):6112-6117,Initial systematic review,IND,India,Sri Lakshmi Narayana Institute of Medical Sciences,889,Puducherry,2017,0,49,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
1187,Lari(1997),"Lari AR, Validi N, Ghaffarzadeh K, Shamshiri AR. In vitro activity of cefixime versus ceftizoxime against Salmonella Typhi. Pathologie Biologie 1997; 45(5): 415-9.",Extended systematic review,IRN,Iran,Labadi-nejad hospital,553,Tehran,1996,0,52,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
602,Pourshafie(2008),"Pourshafie MR, Saifi M, Mousavi SF, Sedaghat M, Nikbakht GH, Rubino S. Clonal diversity of Salmonella enterica serotype Typhi isolated from patients with typhoid fever in Tehran. Scandinavian Journal of Infectious Diseases 2008; 40(1): 18-23.",Extended systematic review,IRN,Iran,Three unknown hospitals in Tehran,553,Tehran,2004,0,15,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
1684,Soltan Dallal(2014),"Soltan Dallal MM, Rastegar Lari A, Sharifi Yazdi MK. Pattern of serotyping and antibiotic resistance of Salmonella in children with diarrhea. [Persian]. Journal of Gorgan University of Medical Sciences 2014; 16(1): e100-Pe4.",Extended systematic review,IRN,Iran,Unknown public health centers in Robat-Karim,553,Tehran,2010,0,7,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
3022,Aljanaby (2017),"Aljanaby AAJ, Medhat AR. Prevalence of some antimicrobials resistance associated-genes in Salmonella Typhi isolated from patients infected with typhoid fever. J Bio Sci 2017; 17(4): 171-84.",Initial systematic review,IRQ,Iraq,Al-Najaf Hospital,565,Najaf,2017,0,39,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5066,Al-Abbasy (2018),Al-Abbasy AJ. Molecular study of antibiotic resistance gene in Salmonella enterica serovar Typhi isolates.International Journal of Pharmaceutical Research 2018;10(3):378-384,Initial systematic review,IRQ,Iraq,Al-Hakim Hospital,565,Najaf,2018,10,30,33.3,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
3627,Brooks(2006),"Brooks JT, Ochieng JB, Kumar L, et al. Surveillance for bacterial diarrhea and antimicrobial resistance in rural western Kenya, 1997-2003. Clin Infect Dis 2006; 43(4): 393-401.",Extended systematic review,KEN,Kenya,Unknown hospitals and clinics in Asembo Bay,1108,Nyanza,2000,0,8,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
2332,Mengo (2010),"Mengo DM, Kariuki S, Muigai A, Revathi G. Trends in Salmonella enteric serovar Typhi in Nairobi, Kenya from 2004 to 2006. J Infect Dev Ctries 2010; 4(6): 393-6.",Initial systematic review,KEN,Kenya,Aga Khan University Hospital (Nairobi);Kenyatta National Hospital,1106,Nairobi,2004,4,32,12.5,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
2332,Mengo (2010),"Mengo DM, Kariuki S, Muigai A, Revathi G. Trends in Salmonella enteric serovar Typhi in Nairobi, Kenya from 2004 to 2006. J Infect Dev Ctries 2010; 4(6): 393-6.",Initial systematic review,KEN,Kenya,Aga Khan University Hospital (Nairobi);Kenyatta National Hospital,1106,Nairobi,2005,0,39,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
2332,Mengo (2010),"Mengo DM, Kariuki S, Muigai A, Revathi G. Trends in Salmonella enteric serovar Typhi in Nairobi, Kenya from 2004 to 2006. J Infect Dev Ctries 2010; 4(6): 393-6.",Initial systematic review,KEN,Kenya,Aga Khan University Hospital (Nairobi);Kenyatta National Hospital,1106,Nairobi,2006,0,29,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5099,Mutai (2018),"Mutai WC, Muigai AWT, Waiyaki P and Kariuki S. Multi-drug resistant Salmonella enterica serovar Typhi isolates with reduced susceptibility to ciprofloxacin in Kenya.BMC Microbiology 2018;18(1):187",Initial systematic review,KEN,Kenya,Aga Khan University Hospital (Nairobi);Kenyatta National Hospital,1106,Nairobi,2006,8,144,5.6,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
1743,Breiman (2012),"Breiman RF, Cosmas L, Njuguna H, et al. Population-based incidence of typhoid fever in an urban informal settlement and a rural area in Kenya: implications for typhoid vaccine use in Africa. PLoS ONE 2012; 7(1): e29119.",Initial systematic review,KEN,Kenya,Kibera,1106,Nairobi,2008,2,131,1.5,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
1743,Breiman (2012),"Breiman RF, Cosmas L, Njuguna H, et al. Population-based incidence of typhoid fever in an urban informal settlement and a rural area in Kenya: implications for typhoid vaccine use in Africa. PLoS ONE 2012; 7(1): e29119.",Initial systematic review,KEN,Kenya,Lwak,1108,Nyanza,2008,1,22,4.5,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
2946,Marks (2017),"Marks F, Kalckreuth V, Aaby P, et al. Incidence of invasive Salmonella disease in sub-Saharan Africa: A multicentre population-based surveillance study. Lancet Glob Health 2017; 5(3): e310-e23.",Initial systematic review,KEN,Kenya,Unkown Hospitals in Kibera,1106,Nairobi,2013,0,60,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5086,Kavai(2018),"Kavai SM, Kangogo M, Muigai AWT, Kariuki S. Analysis of Trends in Resistance to Fluoroquinolones and Extended Spectrum Beta-Lactams among Salmonella Typhi Isolates Obtained from Patients at Four Outpatient Clinics in Nairobi County, Kenya. Advances in Microbiology 2018; 8(7): 578-88.",Extended systematic review,KEN,Kenya,Mbagathi District Hospital;Unkown faciltlies in Mukuru Kwa Njenga;Unkown faciltlies in Mukuru Reuben,1106,Nairobi,2014,5,287,1.7,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
852,Kasper (2010),"Kasper MR, Sokhal B, Blair PJ, Wierzba TF, Putnam SD. Emergence of multidrug-resistant Salmonella enterica serovar Typhi with reduced susceptibility to fluoroquinolones in Cambodia. Diagn Microbiol Infect Dis 2010; 66(2): 207-9.",Initial systematic review,KHM,Cambodia,Unknown healthcare facilities in Kandal district;Unknown healthcare facilities in Oudong district,84,Kandal,2008,0,41,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
891,Ngoun (2012),"Ngoun C, Emary K, Khun PA, et al. Enteric fever in Cambodian children is dominated by multidrug resistant H58 Salmonella enterica serovar Typhi with decreased susceptibility to ciprofloxacin. Int J Infect Dis 2012; 16: e427.",Initial systematic review,KHM,Cambodia,Angkor Hospital for Children;Angkor Hospital for Children Satellite Clinic,97,Siemreap,2009,0,148,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
2955,Kuijpers (2017),"Kuijpers LMF, Phe T, Veng CH, et al. The clinical and microbiological characteristics of enteric fever in Cambodia, 2008-2015. PLoS Negl Trop Dis 2017; 11(9): e0005964.",Initial systematic review,KHM,Cambodia,Sihanouk Hospital Center of Hope,92,Phnom Penh,2010,0,35,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
2955,Kuijpers (2017),"Kuijpers LMF, Phe T, Veng CH, et al. The clinical and microbiological characteristics of enteric fever in Cambodia, 2008-2015. PLoS Negl Trop Dis 2017; 11(9): e0005964.",Initial systematic review,KHM,Cambodia,Sihanouk Hospital Center of Hope,92,Phnom Penh,2014,0,29,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5134,Turner(2019),Turner P. GRAM_data_AHC-COMRU_2015. Cambodia; 2019.,Dataset,KHM,Cambodia,Angkor Hospital for Children,97,Siemreap,2015,0,34,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5134,Turner(2019),Turner P. GRAM_data_AHC-COMRU_2015. Cambodia; 2019.,Dataset,KHM,Cambodia,Angkor Hospital for Children Satellite Clinic,97,Siemreap,2015,0,7,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
3585,Dimitrov (2005),"Dimitrov TS, Panigrahi D, Emara M, Al-Nakkas A, Awni F, Passadilla R. Incidence of bloodstream infections in a speciality hospital in Kuwait: 8-Year experience. Med Princ Pract 2005; 14(6): 417-21.",Initial systematic review,KWT,Kuwait,Infectious Diseases Hospital (Al Farwaniyah),592,Al Farwaniyah,1995,0,45,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
3585,Dimitrov (2005),"Dimitrov TS, Panigrahi D, Emara M, Al-Nakkas A, Awni F, Passadilla R. Incidence of bloodstream infections in a speciality hospital in Kuwait: 8-Year experience. Med Princ Pract 2005; 14(6): 417-21.",Initial systematic review,KWT,Kuwait,Infectious Diseases Hospital (Al Farwaniyah),592,Al Farwaniyah,1996,0,95,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
3585,Dimitrov (2005),"Dimitrov TS, Panigrahi D, Emara M, Al-Nakkas A, Awni F, Passadilla R. Incidence of bloodstream infections in a speciality hospital in Kuwait: 8-Year experience. Med Princ Pract 2005; 14(6): 417-21.",Initial systematic review,KWT,Kuwait,Infectious Diseases Hospital (Al Farwaniyah),592,Al Farwaniyah,1997,0,80,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
3585,Dimitrov (2005),"Dimitrov TS, Panigrahi D, Emara M, Al-Nakkas A, Awni F, Passadilla R. Incidence of bloodstream infections in a speciality hospital in Kuwait: 8-Year experience. Med Princ Pract 2005; 14(6): 417-21.",Initial systematic review,KWT,Kuwait,Infectious Diseases Hospital (Al Farwaniyah),592,Al Farwaniyah,1998,0,60,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
3585,Dimitrov (2005),"Dimitrov TS, Panigrahi D, Emara M, Al-Nakkas A, Awni F, Passadilla R. Incidence of bloodstream infections in a speciality hospital in Kuwait: 8-Year experience. Med Princ Pract 2005; 14(6): 417-21.",Initial systematic review,KWT,Kuwait,Infectious Diseases Hospital (Al Farwaniyah),592,Al Farwaniyah,1999,0,62,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
3585,Dimitrov (2005),"Dimitrov TS, Panigrahi D, Emara M, Al-Nakkas A, Awni F, Passadilla R. Incidence of bloodstream infections in a speciality hospital in Kuwait: 8-Year experience. Med Princ Pract 2005; 14(6): 417-21.",Initial systematic review,KWT,Kuwait,Infectious Diseases Hospital (Al Farwaniyah),592,Al Farwaniyah,2000,0,30,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
3585,Dimitrov (2005),"Dimitrov TS, Panigrahi D, Emara M, Al-Nakkas A, Awni F, Passadilla R. Incidence of bloodstream infections in a speciality hospital in Kuwait: 8-Year experience. Med Princ Pract 2005; 14(6): 417-21.",Initial systematic review,KWT,Kuwait,Infectious Diseases Hospital (Al Farwaniyah),592,Al Farwaniyah,2001,0,20,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
3585,Dimitrov (2005),"Dimitrov TS, Panigrahi D, Emara M, Al-Nakkas A, Awni F, Passadilla R. Incidence of bloodstream infections in a speciality hospital in Kuwait: 8-Year experience. Med Princ Pract 2005; 14(6): 417-21.",Initial systematic review,KWT,Kuwait,Infectious Diseases Hospital (Al Farwaniyah),592,Al Farwaniyah,2002,0,22,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
855,Rotimi(2008),"Rotimi VO, Jamal W, Pal T, Sonnevend A, Dimitrov TS, Albert MJ. Emergence of multidrug-resistant Salmonella spp. and isolates with reduced susceptibility to ciprofloxacin in Kuwait and the United Arab Emirates. Diagn Microbiol Infect Dis 2008; 60(1): 71-7.",Extended systematic review,KWT,Kuwait,Mubarak Al-Kabeer Hospital,596,Hawalli,2004,0,25,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5148,Roberts (2019),"Roberts T. LOMRU blood culture database. Vientiene, Laos; 2019",Dataset,LAO,Laos,Mahosot Hospital,117,Vientiane capital,2002,43,89,48.3,1,Salmonella Typhi,Third-generation cephalosporin (3GC)
5148,Roberts (2019),"Roberts T. LOMRU blood culture database. Vientiene, Laos; 2019",Dataset,LAO,Laos,Mahosot Hospital,117,Vientiane capital,2003,20,42,47.6,1,Salmonella Typhi,Third-generation cephalosporin (3GC)
5148,Roberts (2019),"Roberts T. LOMRU blood culture database. Vientiene, Laos; 2019",Dataset,LAO,Laos,Mahosot Hospital,117,Vientiane capital,2004,4,42,9.5,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5148,Roberts (2019),"Roberts T. LOMRU blood culture database. Vientiene, Laos; 2019",Dataset,LAO,Laos,Mahosot Hospital,117,Vientiane capital,2005,0,24,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5148,Roberts (2019),"Roberts T. LOMRU blood culture database. Vientiene, Laos; 2019",Dataset,LAO,Laos,Mahosot Hospital,117,Vientiane capital,2006,1,35,2.9,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5148,Roberts (2019),"Roberts T. LOMRU blood culture database. Vientiene, Laos; 2019",Dataset,LAO,Laos,Mahosot Hospital,117,Vientiane capital,2007,0,25,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5148,Roberts (2019),"Roberts T. LOMRU blood culture database. Vientiene, Laos; 2019",Dataset,LAO,Laos,Setthathirath Hospital,117,Vientiane capital,2007,0,5,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5148,Roberts (2019),"Roberts T. LOMRU blood culture database. Vientiene, Laos; 2019",Dataset,LAO,Laos,Mahosot Hospital,117,Vientiane capital,2008,1,36,2.8,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5148,Roberts (2019),"Roberts T. LOMRU blood culture database. Vientiene, Laos; 2019",Dataset,LAO,Laos,Setthathirath Hospital,117,Vientiane capital,2008,0,5,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
434,Mayxay (2013),"Mayxay M, Castonguay-Vanier J, Chansamouth V, et al. Causes of non-malarial fever in Laos: a prospective study. Lancet Glob Health 2013; 1(1): e46-54.",Initial systematic review,LAO,Laos,Luang Namtha Provincial Hospital,110,Louang-Namtha,2009,0,30,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5148,Roberts (2019),"Roberts T. LOMRU blood culture database. Vientiene, Laos; 2019",Dataset,LAO,Laos,Mahosot Hospital,117,Vientiane capital,2009,0,34,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5148,Roberts (2019),"Roberts T. LOMRU blood culture database. Vientiene, Laos; 2019",Dataset,LAO,Laos,Setthathirath Hospital,117,Vientiane capital,2009,0,7,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5148,Roberts (2019),"Roberts T. LOMRU blood culture database. Vientiene, Laos; 2019",Dataset,LAO,Laos,Mahosot Hospital,117,Vientiane capital,2010,0,32,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5148,Roberts (2019),"Roberts T. LOMRU blood culture database. Vientiene, Laos; 2019",Dataset,LAO,Laos,Mahosot Hospital,117,Vientiane capital,2011,0,15,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5148,Roberts (2019),"Roberts T. LOMRU blood culture database. Vientiene, Laos; 2019",Dataset,LAO,Laos,Mahosot Hospital,117,Vientiane capital,2012,0,8,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5148,Roberts (2019),"Roberts T. LOMRU blood culture database. Vientiene, Laos; 2019",Dataset,LAO,Laos,Mahosot Hospital,117,Vientiane capital,2013,0,28,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5148,Roberts (2019),"Roberts T. LOMRU blood culture database. Vientiene, Laos; 2019",Dataset,LAO,Laos,Setthathirath Hospital,117,Vientiane capital,2013,0,5,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5148,Roberts (2019),"Roberts T. LOMRU blood culture database. Vientiene, Laos; 2019",Dataset,LAO,Laos,Mahosot Hospital,117,Vientiane capital,2014,0,28,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5148,Roberts (2019),"Roberts T. LOMRU blood culture database. Vientiene, Laos; 2019",Dataset,LAO,Laos,Mahosot Hospital,117,Vientiane capital,2015,0,9,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5148,Roberts (2019),"Roberts T. LOMRU blood culture database. Vientiene, Laos; 2019",Dataset,LAO,Laos,Mahosot Hospital,117,Vientiane capital,2016,0,21,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5148,Roberts (2019),"Roberts T. LOMRU blood culture database. Vientiene, Laos; 2019",Dataset,LAO,Laos,Mahosot Hospital,117,Vientiane capital,2017,0,9,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5148,Roberts (2019),"Roberts T. LOMRU blood culture database. Vientiene, Laos; 2019",Dataset,LAO,Laos,Mahosot Hospital,117,Vientiane capital,2018,0,21,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
2033,Karunaratne(2000),"Karunaratne GK, Wickremesinghe RS, Perera KC. Salmonella Typhi and chloramphenicol resistance. Ceylon Med J 2000; 45(3): 136-7.",Extended systematic review,LKA,Sri Lanka,Medical Research Institute,128,Western,1998,0,72,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
2033,Karunaratne(2000),"Karunaratne GK, Wickremesinghe RS, Perera KC. Salmonella Typhi and chloramphenicol resistance. Ceylon Med J 2000; 45(3): 136-7.",Extended systematic review,LKA,Sri Lanka,Medical Research Institute,128,Western,1999,0,77,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
2188,Chuang(2009),"Chuang CH, Su LH, Perera J, et al. Surveillance of antimicrobial resistance of Salmonella enterica serotype Typhi in seven Asian countries. Epidemiol Infect 2009; 137(2): 266-9.",Extended systematic review,LKA,Sri Lanka,National Hospital of Sri Lanka,128,Western,2003,0,17,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
3098,Rouahi(2015),"Rouahi N, Zouhdi M. Antibioresistance of Moroccan strains of Salmonella Typhi: a need for updating the standardized treatment of typhoid fever set on 1994. Ann Biol Clin (Paris) 2015; 73(6): 749-50.",Extended systematic review,MAR,Morocco,Hopital Ibnou Sina (Ibn Sina);Institut National d'Hygiene,631,Nord Ouest,2000,0,18,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
390,Shwe (2002),"Shwe TN, Nyein MM, Yi W, Mon A. Blood culture isolates from children admitted to Medical Unit III, Yangon Children's Hospital, 1998. Southeast Asian J Trop Med Public Health 2002; 33(4): 764-71.",Initial systematic review,MMR,Myanmar,Yangon Children's Hospital,134,Yangon Division,1999,0,28,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5136,Musicha(2019)<U+1D43>,"Musicha P, Feasey N. MLWBC1998_2014. Blantyre, Malawi; 2019.",Dataset,MWI,Malawi,Queen Elizabeth Central Hospital,1185,Southern Region,2004,0,14,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5136,Musicha(2019)<U+1D43>,"Musicha P, Feasey N. MLWBC1998_2014. Blantyre, Malawi; 2019.",Dataset,MWI,Malawi,Queen Elizabeth Central Hospital,1185,Southern Region,2005,0,20,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5136,Musicha(2019)<U+1D43>,"Musicha P, Feasey N. MLWBC1998_2014. Blantyre, Malawi; 2019.",Dataset,MWI,Malawi,Queen Elizabeth Central Hospital,1185,Southern Region,2006,0,18,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5136,Musicha(2019)<U+1D43>,"Musicha P, Feasey N. MLWBC1998_2014. Blantyre, Malawi; 2019.",Dataset,MWI,Malawi,Queen Elizabeth Central Hospital,1185,Southern Region,2007,0,9,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5136,Musicha(2019)<U+1D43>,"Musicha P, Feasey N. MLWBC1998_2014. Blantyre, Malawi; 2019.",Dataset,MWI,Malawi,Queen Elizabeth Central Hospital,1185,Southern Region,2008,0,12,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5136,Musicha(2019)<U+1D43>,"Musicha P, Feasey N. MLWBC1998_2014. Blantyre, Malawi; 2019.",Dataset,MWI,Malawi,Queen Elizabeth Central Hospital,1185,Southern Region,2009,1,17,5.9,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5136,Musicha(2019)<U+1D43>,"Musicha P, Feasey N. MLWBC1998_2014. Blantyre, Malawi; 2019.",Dataset,MWI,Malawi,Queen Elizabeth Central Hospital,1185,Southern Region,2010,0,20,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5136,Musicha(2019)<U+1D43>,"Musicha P, Feasey N. MLWBC1998_2014. Blantyre, Malawi; 2019.",Dataset,MWI,Malawi,Queen Elizabeth Central Hospital,1185,Southern Region,2011,0,69,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5136,Musicha(2019)<U+1D43>,"Musicha P, Feasey N. MLWBC1998_2014. Blantyre, Malawi; 2019.",Dataset,MWI,Malawi,Queen Elizabeth Central Hospital,1185,Southern Region,2012,0,190,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5136,Musicha(2019)<U+1D43>,"Musicha P, Feasey N. MLWBC1998_2014. Blantyre, Malawi; 2019.",Dataset,MWI,Malawi,Queen Elizabeth Central Hospital,1185,Southern Region,2013,0,886,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5136,Musicha(2019)<U+1D43>,"Musicha P, Feasey N. MLWBC1998_2014. Blantyre, Malawi; 2019.",Dataset,MWI,Malawi,Queen Elizabeth Central Hospital,1185,Southern Region,2014,0,779,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
356,Okwori(2011),"Okwori EE, Nwadioha SI, Nwokedi EOP, Odimayo M, Jombo G. Bacterial pathogens and their antimicrobial susceptibility in Otukpo Benue state of Nigeria. Asian Pacific Journal of Tropical Biomedicine 2011; 2(12).",Extended systematic review,NGA,Nigeria,Otukpo General Hospital,1198,Benue,1999,427,1707,25,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
4209,Agada(2014),"Agada GOA, Abdullahi IO, Aminu M, et al. Prevalence and antibiotic resistance profile of Salmonella isolates from commercial poultry and poultry farm-handlers in Jos, Plateau State, Nigeria. Br Microbiol Res J 2014; 4(4): 462-79.",Extended systematic review,NGA,Nigeria,Jos North,1228,Plateau,2013,1,10,10,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5071,Bello (2018),"Bello N, Kudu ATD, Adetokun AB, et al. Characterization and Antimicrobial Susceptibility Profile of Bacteraemia Causing Pathogens Isolated from Febrile Children with and without Sickle Cell Disease in Kano, Nigeria.Mediterranean Journal of Hematology & Infectious Diseases 2018;10(1):e2018016",Initial systematic review,NGA,Nigeria,Aminu Kano Teaching Hospital;Hasiya Bayero Pediatric Hospital;Murtala Mohammed Specialist Hospital,1207,Kano,2016,10,35,28.6,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
3304,Acharya (1995),"Acharya G, Butler T, Ho M, et al. Treatment of typhoid fever: randomized trial of a three-day course of ceftriaxone versus a fourteen-day course of chloramphenicol. Am J Trop Med Hyg 1995; 52(2): 162-5.",Initial systematic review,NPL,Nepal,Tribhuvan University Teaching Hospital (Kathmandu);Kanti Children's Hospital (Kathmandu),892,Central,1991,0,38,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
274,Khanal (2007),"Khanal B, Sharma SK, Bhattacharya SK, Bhattarai NR, Deb M, Kanungo R. Antimicrobial susceptibility patterns of Salmonella enterica serotype Typhi in eastern Nepal. J Health Popul Nutr 2007; 25(1): 82-7.",Initial systematic review,NPL,Nepal,B.P. Koirala Institute of Health Sciences (Koshi),893,Eastern,2000,0,20,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
3669,Woods (2006),"Woods CW, Murdoch DR, Zimmerman MD, et al. Emergence of Salmonella enterica serotype ParaTyphi A as a major cause of enteric fever in Kathmandu, Nepal. Trans R Soc Trop Med Hyg 2006; 100(11): 1063-7.",Initial systematic review,NPL,Nepal,Patan Hospital (Lalitpur),892,Central,2001,0,60,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
274,Khanal (2007),"Khanal B, Sharma SK, Bhattacharya SK, Bhattarai NR, Deb M, Kanungo R. Antimicrobial susceptibility patterns of Salmonella enterica serotype Typhi in eastern Nepal. J Health Popul Nutr 2007; 25(1): 82-7.",Initial systematic review,NPL,Nepal,B.P. Koirala Institute of Health Sciences (Koshi),893,Eastern,2001,0,30,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
1967,Guha (2005),"Guha S, Jalan BY, Dey S, Easow JM, Wilson G, Shivananda PG. Salmonella bacteraemia in Pokhara: emergence of antibiotic resistance. Nepal Med Coll J 2005; 7(1): 23-5.",Initial systematic review,NPL,Nepal,Manipal Teaching Hospital (Pokhara),896,Western,2001,0,10,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
591,Bajracharya (2006),"Bajracharya BL, Baral MR, Shakya S, Tuladhar P, Paudel M, Acharya B. Clinical profile and antibiotics response in typhoid fever. Kathmandu Univ Med J (KUMJ) 2006; 4(1): 25-9.",Initial systematic review,NPL,Nepal,Kathmandu Medical College (Kathmandu),892,Central,2002,2,32,6.3,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5064,Zellweger (2017),"Zellweger RM, Basnyat B, Shrestha P, et al. A 23-year retrospective investigation of Salmonella Typhi and Salmonella ParaTyphi isolated in a tertiary Kathmandu hospital.PLoS Neglected Tropical Diseases [electronic resource] 2017;11(11):e0006051",Initial systematic review,NPL,Nepal,Patan Hospital (Lalitpur),892,Central,2002,1,14,7.1,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
2401,Lewis (2005),"Lewis MD, Serichantalergs O, Pitarangsi C, et al. Typhoid fever: a massive, single-point source, multidrug-resistant outbreak in Nepal. Clin Infect Dis 2005; 40(4): 554-61.",Initial systematic review,NPL,Nepal,Bharatpur College of Medical Sciences Hospital;Bharatpur Zonal Hospital,892,Central,2002,0,60,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
274,Khanal (2007),"Khanal B, Sharma SK, Bhattacharya SK, Bhattarai NR, Deb M, Kanungo R. Antimicrobial susceptibility patterns of Salmonella enterica serotype Typhi in eastern Nepal. J Health Popul Nutr 2007; 25(1): 82-7.",Initial systematic review,NPL,Nepal,B.P. Koirala Institute of Health Sciences (Koshi),893,Eastern,2002,0,25,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
1967,Guha (2005),"Guha S, Jalan BY, Dey S, Easow JM, Wilson G, Shivananda PG. Salmonella bacteraemia in Pokhara: emergence of antibiotic resistance. Nepal Med Coll J 2005; 7(1): 23-5.",Initial systematic review,NPL,Nepal,Manipal Teaching Hospital (Pokhara),896,Western,2002,0,29,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
712,Shirakawa (2006),"Shirakawa T, Acharya B, Kinoshita S, Kumagai S, Gotoh A, Kawabata M. Decreased susceptibility to fluoroquinolones and gyrA gene mutation in the Salmonella enterica serovar Typhi and ParaTyphi A isolated in Katmandu, Nepal, in 2003. Diagn Microbiol Infect Dis 2006; 54(4): 299-303.",Initial systematic review,NPL,Nepal,Unknown Hospital in Kathmandu,892,Central,2003,0,30,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
1144,Sharma (2006),"Sharma NP, Peacock SJ, Phumratanaprapin W, Day N, White N, Pukrittayakamee S. A hospital-based study of bloodstream infections in febrile patients in Dhulikhel Hospital Kathmandu University Teaching Hospital, Nepal. Southeast Asian J Trop Med Public Health 2006; 37(2): 351-6.",Initial systematic review,NPL,Nepal,Dhulikhel Hospital (Kathmandu),892,Central,2003,0,50,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
274,Khanal (2007),"Khanal B, Sharma SK, Bhattacharya SK, Bhattarai NR, Deb M, Kanungo R. Antimicrobial susceptibility patterns of Salmonella enterica serotype Typhi in eastern Nepal. J Health Popul Nutr 2007; 25(1): 82-7.",Initial systematic review,NPL,Nepal,B.P. Koirala Institute of Health Sciences (Koshi),893,Eastern,2003,0,34,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
908,Malla(2007),"Malla T, Malla KK, Thapalial A, Shaw C. Enteric fever: a retrospective 6-year analysis of 82 paediatric cases in a teaching hospital. Kathmandu Univ Med J (KUMJ) 2007; 5(2): 181-7.",Extended systematic review,NPL,Nepal,Manipal Teaching Hospital (Pokhara),896,Western,2003,0,15,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
1967,Guha (2005),"Guha S, Jalan BY, Dey S, Easow JM, Wilson G, Shivananda PG. Salmonella bacteraemia in Pokhara: emergence of antibiotic resistance. Nepal Med Coll J 2005; 7(1): 23-5.",Initial systematic review,NPL,Nepal,Manipal Teaching Hospital (Pokhara),896,Western,2003,0,37,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
1988,Maskey (2006),"Maskey AP, Day JN, Phung QT, et al. Salmonella enterica serovar ParaTyphi A and S. enterica serovar Typhi cause indistinguishable clinical syndromes in Kathmandu, Nepal. Clin Infect Dis 2006; 42(9): 1247-53.",Initial systematic review,NPL,Nepal,Patan Hospital (Lalitpur),892,Central,2004,0,409,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5064,Zellweger (2017),"Zellweger RM, Basnyat B, Shrestha P, et al. A 23-year retrospective investigation of Salmonella Typhi and Salmonella ParaTyphi isolated in a tertiary Kathmandu hospital.PLoS Neglected Tropical Diseases [electronic resource] 2017;11(11):e0006051",Initial systematic review,NPL,Nepal,Patan Hospital (Lalitpur),892,Central,2004,0,23,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
274,Khanal (2007),"Khanal B, Sharma SK, Bhattacharya SK, Bhattarai NR, Deb M, Kanungo R. Antimicrobial susceptibility patterns of Salmonella enterica serotype Typhi in eastern Nepal. J Health Popul Nutr 2007; 25(1): 82-7.",Initial systematic review,NPL,Nepal,B.P. Koirala Institute of Health Sciences (Koshi),893,Eastern,2004,0,23,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
971,Amatya (2007),"Amatya NM, Shrestha B, Lekhak B. Etiological agents of bacteraemia and antibiotic susceptibility pattern in Kathmandu Model Hospital. JNMA J Nepal Med Assoc 2007; 46(167): 112-8.",Initial systematic review,NPL,Nepal,Kathmandu Model Hospital (Kathmandu),892,Central,2005,0,78,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
2171,Mathura (2005),"Mathura KC, Chaudhary D, Simkhada R, Pradhan M, Shrestha P, Gurubacharya DL. Study of clinical profile and antibiotic sensitivity pattern in culture positive typhoid fever cases. Kathmandu Univ Med J (KUMJ) 2005; 3(4): 376-9.",Initial systematic review,NPL,Nepal,Kathmandu Medical College (Kathmandu),892,Central,2005,0,46,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
466,Neopane (2008),"Neopane A, Singh SB, Bhatta R, Dhital B, Karki DB. Changing spectrum of antibiotic sensitivity in enteric fever. Kathmandu Univ Med J (KUMJ) 2008; 6(1): 12-5.",Initial systematic review,NPL,Nepal,Kathmandu Medical College (Kathmandu),892,Central,2006,4,43,9.3,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
1139,Holt (2009),"Holt KE, Baker S, Dongol S, et al. High-throughput bacterial SNP typing identifies distinct clusters of Salmonella Typhi causing typhoid in Nepalese children. BMC Infect Dis 2009; 10(144).",Initial systematic review,NPL,Nepal,Patan Hospital (Lalitpur),892,Central,2006,0,62,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
1092,Arjyal (2011),"Arjyal A, Basnyat B, Koirala S, et al. Gatifloxacin versus chloramphenicol for uncomplicated enteric fever: an open-label, randomised, controlled trial. Lancet Infect Dis 2011; 11(6): 445-54.",Initial systematic review,NPL,Nepal,Patan Hospital (Lalitpur),892,Central,2007,0,243,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
393,Easow(2010),"Easow JM, Joseph NM, Dhungel BA, Chapagain B, Shivananda PG. Blood stream infections among febrile patients attending a teaching hospital in Western Region of Nepal. Australasian Medical Journal 2010; 3(10): 633-7.",Extended systematic review,NPL,Nepal,Manipal Teaching Hospital (Pokhara),896,Western,2007,0,8,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
1791,Prajapati (2008),"Prajapati B, Rai GK, Rai SK, et al. Prevalence of Salmonella Typhi and ParaTyphi infection in children: a hospital based study. Nepal Med Coll J 2008; 10(4): 238-41.",Initial systematic review,NPL,Nepal,Kanti Children's Hospital (Kathmandu),892,Central,2008,2,183,1.1,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
1132,Karki (2013),"Karki AB, Bhatta DR, Shrestha B, et al. Higher nalidixic acid resistance pattern of Salmonella isolates from enteric fever patients in kathmandu model hospital Nepal. Res J Pharm Biol Chem Sci 2013; 4(2): 1687-93.",Initial systematic review,NPL,Nepal,Kathmandu Model Hospital (Kathmandu),892,Central,2009,0,55,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
2821,Singh (2011),"Singh U, Neopane A, Thapa M, Aryal N, Agrawal K. Salmonella Typhi infections and effect of fluroquinolones and third generation cephalosporins in clinical outcome. Journal of Nepal Paediatric Society 2011; 31(3): 216-21.",Initial systematic review,NPL,Nepal,Shree Birendra Hospital (Kathmandu),892,Central,2010,2,21,9.5,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
1093,Koirala (2013),"Koirala S, Basnyat B, Arjyal A, et al. Gatifloxacin versus ofloxacin for the treatment of uncomplicated enteric fever in Nepal: an open-label, randomized, controlled trial. PLoS Negl Trop Dis 2013; 7(10): e2523.",Initial systematic review,NPL,Nepal,Patan (Lalitpur),892,Central,2010,0,132,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
150,Acharya (2012),"Acharya D, Trakulsomboon S, Madhup SK, Korbsrisate S. Antibiotic susceptibility pattern and the indicator of decreased ciprofloxacin susceptibility of Salmonella enterica serovar Typhi isolated from Dhulikhel Hospital, Nepal. Jpn J Infect Dis 2012; 65(3): 264-7.",Initial systematic review,NPL,Nepal,Dhulikhel Hospital (Kathmandu),892,Central,2010,4,114,3.5,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5064,Zellweger (2017),"Zellweger RM, Basnyat B, Shrestha P, et al. A 23-year retrospective investigation of Salmonella Typhi and Salmonella ParaTyphi isolated in a tertiary Kathmandu hospital.PLoS Neglected Tropical Diseases [electronic resource] 2017;11(11):e0006051",Initial systematic review,NPL,Nepal,Patan Hospital (Lalitpur),892,Central,2010,0,24,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
275,Raza (2012),"Raza S, Tamrakar R, Bhatt CP, Joshi SK. Antimicrobial susceptibility patterns of Salmonella Typhi and Salmonella ParaTyphi A in a tertiary care hospital. J Nepal Health Res Counc 2012; 10(22): 214-7.",Initial systematic review,NPL,Nepal,Kathmandu Medical College (Kathmandu),892,Central,2011,2,47,4.3,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
593,Joshi (2011),"Joshi BG, Keyal K, Pandey R, Shrestha BM. Clinical profile and sensitivity pattern of Salmonella serotypes in children: A hospital based study. Journal of Nepal Paediatric Society 2011; 31(3): 180-3.",Initial systematic review,NPL,Nepal,Civil Service Hospital (Kathmandu),892,Central,2011,0,25,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
1754,Awal(2015),"Awal BK, Koirala P, Jareju R, Dhungana GR, Wosti BP. Predictive value of NA resistance for increased minimum inhibitory concentration (MIC) of fluoroquinolone in clinical isolates of Salmonella enterica. Int J Antimicrob Agents 2015; 45: S80-S1.",Extended systematic review,NPL,Nepal,"Janamaitri Foundation Institute of Health Sciences (Balaju, Kathmandu)",892,Central,2011,0,20,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
2806,Adhikari (2012),"Adhikari D, Acharya D, Shrestha P, Amatya R. Ciprofloxacin susceptibility of Salmonella enteric serovar Typhi and ParaTyphi A from blood samples of suspected enteric fever patients. International Journal of Infection and Microbiology 2012; 1(1): 9-13.",Initial systematic review,NPL,Nepal,KIST Medical College (Kathmandu),892,Central,2011,0,41,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
1323,Rai (2012)<U+1D43>,"Rai GK, Karki S, Prajapati B. Is antimicrobial resistance pattern of enteric fever changing in Kathmandu valley? Journal of Nepal Paediatric Society 2012a; 32(3): 221-8.",Initial systematic review,NPL,Nepal,Kanti Children's Hospital (Kathmandu),892,Central,2012,14,31,45.2,1,Salmonella Typhi,Third-generation cephalosporin (3GC)
3182,Arjyal (2016),"Arjyal A, Basnyat B, Nhan HT, et al. Gatifloxacin versus ceftriaxone for uncomplicated enteric fever in Nepal: an open-label, two-centre, randomised controlled trial. Lancet Infect Dis 2016; 16(5): 535-45.",Initial systematic review,NPL,Nepal,Civil Service Hospital (Kathmandu);Patan Hospital (Lalitpur),892,Central,2013,0,78,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
4629,Shrestha (2016),"Shrestha KL, Pant ND, Bhandari R, Khatri S, Shrestha B, Lekhak B. Re-emergence of the susceptibility of the Salmonella spp. isolated from blood samples to conventional first line antibiotics. Antimicrob Resist Infect Control 2016; 5.",Initial systematic review,NPL,Nepal,Kathmandu Model Hospital (Kathmandu),892,Central,2013,0,48,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5104,Petersiel (2018),"Petersiel N, Shresta S, Tamrakar R, et al. The epidemiology of typhoid fever in the Dhulikhel area, Nepal: A prospective cohort study.PLoS ONE 2018;13 (9) (no pagination)(e0204479):",Initial systematic review,NPL,Nepal,Dhulikhel Hospital (Kathmandu),892,Central,2013,0,64,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
2979,Gurung (2017),"Gurung B, Pandey S, Shah DK, et al. Antibiogram pattern of Salmonella in blood samples of enteric fever patients at lalitpur, nepal. Asian Pac J Trop Dis 2017; 7(1): 21-4.",Initial systematic review,NPL,Nepal,KIST Medical College (Kathmandu),892,Central,2015,0,41,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5073,Britto (2018),"Britto CD, Dyson ZA, Duchene S, et al. Laboratory and molecular surveillance of paediatric typhoidal Salmonella in Nepal: Antimicrobial resistance and implications for vaccine policy.PLoS Neglected Tropical Diseases [electronic resource] 2018;12(4):e0006408",Initial systematic review,NPL,Nepal,Patan Hospital (Lalitpur),892,Central,2015,0,10,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
2958,Khanal (2017),"Khanal PR, Satyal D, Bhetwal A, et al. Renaissance of conventional first-line antibiotics in Salmonella enterica clinical isolates: Assessment of MICs for therapeutic antimicrobials in enteric fever cases from Nepal. Biomed Res Int 2017; 2017: 2868143.",Initial systematic review,NPL,Nepal,Manmohan Memorial Community Hospital (Kathmandu),892,Central,2016,0,74,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5049,Bhetwal (2017),"Bhetwal A, Maharjan A, Khanal PR and Parajuli NP. Enteric Fever Caused by Salmonella enterica Serovars with Reduced Susceptibility of Fluoroquinolones at a Community Based Teaching Hospital of Nepal.International Journal of Microbiology 2017;2017(2869458",Initial systematic review,NPL,Nepal,Manmohan Memorial Teaching Hospital (Kathmandu),892,Central,2016,0,162,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5073,Britto (2018),"Britto CD, Dyson ZA, Duchene S, et al. Laboratory and molecular surveillance of paediatric typhoidal Salmonella in Nepal: Antimicrobial resistance and implications for vaccine policy.PLoS Neglected Tropical Diseases [electronic resource] 2018;12(4):e0006408",Initial systematic review,NPL,Nepal,Patan Hospital (Lalitpur),892,Central,2016,0,59,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5151,SEAP (2021),Sabine Vaccine Institute. Surveillance for Enteric Fever in Asia Project (SEAP) dataset. 2021,Dataset,NPL,Nepal,Kathmandu,892,Central,2017,0,25,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5151,SEAP (2021),Sabine Vaccine Institute. Surveillance for Enteric Fever in Asia Project (SEAP) dataset. 2021,Dataset,NPL,Nepal,Kathmandu,892,Central,2018,0,71,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5151,SEAP (2021),Sabine Vaccine Institute. Surveillance for Enteric Fever in Asia Project (SEAP) dataset. 2021,Dataset,NPL,Nepal,Kathmandu,892,Central,2019,0,29,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
1496,Rathore (1996),"Rathore MH, Bux D, Hasan M. Multidrug-resistant Salmonella Typhi in Pakistani children: clinical features and treatment. South Med J 1996; 89(2): 235-7.",Initial systematic review,PAK,Pakistan,Children's Hospital (PIMS),899,Islamabad,1990,0,109,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
470,Butt (2005),"Butt T, Ahmad RN, Salman M, Kazmi SY. Changing trends in drug resistance among typhoid Salmonellae in Rawalpindi, Pakistan. East Mediterr Health J 2005; 11(5-6): 1038-44.",Initial systematic review,PAK,Pakistan,Armed Force Institute of Pathology,901,Punjab,1996,0,97,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
470,Butt (2005),"Butt T, Ahmad RN, Salman M, Kazmi SY. Changing trends in drug resistance among typhoid Salmonellae in Rawalpindi, Pakistan. East Mediterr Health J 2005; 11(5-6): 1038-44.",Initial systematic review,PAK,Pakistan,Armed Force Institute of Pathology,901,Punjab,1997,0,60,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
470,Butt (2005),"Butt T, Ahmad RN, Salman M, Kazmi SY. Changing trends in drug resistance among typhoid Salmonellae in Rawalpindi, Pakistan. East Mediterr Health J 2005; 11(5-6): 1038-44.",Initial systematic review,PAK,Pakistan,Armed Force Institute of Pathology,901,Punjab,1998,0,77,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
470,Butt (2005),"Butt T, Ahmad RN, Salman M, Kazmi SY. Changing trends in drug resistance among typhoid Salmonellae in Rawalpindi, Pakistan. East Mediterr Health J 2005; 11(5-6): 1038-44.",Initial systematic review,PAK,Pakistan,Armed Force Institute of Pathology,901,Punjab,1999,0,65,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
683,Saqib (2000),"Saqib A, Ahmed A. Culture and sensitivity of Salmonella species: analysis of a two year data. J Pak Med Assoc 2000; 50(8): 282-4.",Initial systematic review,PAK,Pakistan,Dr. Ziauddin Hospital Clifton campus;Dr. Ziauddin Hospital Kemari campus;Dr. Ziauddin Hospital North Nazimabad campus,902,Sind,1999,0,220,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
470,Butt (2005),"Butt T, Ahmad RN, Salman M, Kazmi SY. Changing trends in drug resistance among typhoid Salmonellae in Rawalpindi, Pakistan. East Mediterr Health J 2005; 11(5-6): 1038-44.",Initial systematic review,PAK,Pakistan,Armed Force Institute of Pathology,901,Punjab,2000,0,52,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
470,Butt (2005),"Butt T, Ahmad RN, Salman M, Kazmi SY. Changing trends in drug resistance among typhoid Salmonellae in Rawalpindi, Pakistan. East Mediterr Health J 2005; 11(5-6): 1038-44.",Initial systematic review,PAK,Pakistan,Armed Force Institute of Pathology,901,Punjab,2001,0,68,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
2463,Mushtaq (2006),Mushtaq MA. What after ciprofloxacin and ceftriaxone in treatment of Salmonella Typhi. Pak J Med Sci 2006; 22(1): 51-4.,Initial systematic review,PAK,Pakistan,Fatima Memorial Hospital,901,Punjab,2002,14,78,17.9,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
470,Butt (2005),"Butt T, Ahmad RN, Salman M, Kazmi SY. Changing trends in drug resistance among typhoid Salmonellae in Rawalpindi, Pakistan. East Mediterr Health J 2005; 11(5-6): 1038-44.",Initial systematic review,PAK,Pakistan,Armed Force Institute of Pathology,901,Punjab,2002,0,34,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
470,Butt (2005),"Butt T, Ahmad RN, Salman M, Kazmi SY. Changing trends in drug resistance among typhoid Salmonellae in Rawalpindi, Pakistan. East Mediterr Health J 2005; 11(5-6): 1038-44.",Initial systematic review,PAK,Pakistan,Armed Force Institute of Pathology,901,Punjab,2003,0,24,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
959,Khan (2012),"Khan MI, Soofi SB, Ochiai Leon R, et al. Epidemiology, clinical presentation, and patterns of drug resistance of Salmonella Typhi in Karachi, Pakistan. J Infect Dev Ctries 2012; 6(10): 704-14.",Initial systematic review,PAK,Pakistan,"Hijrat Colony, Sultanabad and Bilal Colony, Karachi",902,Sind,2003,0,127,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
2180,Ochiai (2008),"Ochiai RL, Acosta CJ, Danovaro-Holliday MC, et al. A study of typhoid fever in five Asian countries: Disease burden and implications for controls. Bull World Health Organ 2008; 86(4): 260-8.",Initial systematic review,PAK,Pakistan,"Hijrat Colony, Sultanabad and Bilal Colony, Karachi",902,Sind,2003,0,127,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
4363,Ikram (2015),"Ikram S, Hussain S, Aslam A, Khan MD, Ahmed I. Evaluation of the current trends in the antimicrobial susceptibility patterns of typhoid Salmonellae. Pak J Med Health Sci 2015; 9(4): 1247-50.",Initial systematic review,PAK,Pakistan,Islamabad Hospital (PIMS),899,Islamabad,2007,0,71,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5150,Shakoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Punjab,901,Punjab,2007,0,28,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5150,Shakoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Sindh,902,Sind,2007,0,855,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5150,Shakoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Gilgit–Baltistan,904,Administrative unit not available,2007,0,9,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
1238,Aatekah (2010),"Aatekah O, Shazia S, Umber Z, Arjumand R, Zaidi AKM. Incidence of typhoid bacteremia in infants and young children in southern coastal Pakistan. Pediatr Infect Dis J 2010; 29(11): 1035-9.",Initial systematic review,PAK,Pakistan,Karachi,902,Sind,2008,0,16,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5150,Shakoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Punjab,901,Punjab,2008,0,31,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5150,Shakoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Sindh,902,Sind,2008,1,709,0.1,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5150,Shakoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Gilgit–Baltistan,904,Administrative unit not available,2008,0,17,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
732,Abdul(2014),"Abdul H, Fizza K, Arshad MU. Detection of extended spectrum beta lactamases in typhoidal Salmonellae by phenotypic methods. African Journal of Microbiology Research 2014; 8(3): 313-5.",Extended systematic review,PAK,Pakistan,Lahore & Gujranwala,901,Punjab,2009,0,126,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
896,Abdullah (2012),"Abdullah FE, Faryal H, Kanwal F, Saboohi I, Iqbal MS. Enteric fever in Karachi: current antibiotic susceptibility of Salmonellae isolates. J Coll Physicians Surg Pak 2012; 22(3): 147-50.",Initial systematic review,PAK,Pakistan,Laboratory and Diagnostic Centre,902,Sind,2009,2,129,1.6,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
639,Ale(2010),"Ale Z, Naqvi BS, Bushra R, Ali SQ. Comparative study on resistance pattern of different pathogens against cefixime and cefepime. Jordan Journal of Pharmaceutical Sciences 2010; 3(2): 145-56.",Extended systematic review,PAK,Pakistan,Aga Khan University Hospital (Karachi);Liaquat College of Medicine and Dentistry (multiple affiliated hospitals),902,Sind,2009,2,20,10,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5150,Shakoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Sindh,902,Sind,2009,0,999,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5150,Shakoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Punjab,901,Punjab,2009,0,20,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5150,Shakoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Gilgit–Baltistan,904,Administrative unit not available,2009,0,9,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
142,Muhammad (2013),"Muhammad R, Ali Z, Mehmood K, Ziauddin, Afridi AR, Bari F. Antibiotic sensitivity pattern of Salmonella serotypes in patients with enteric fever in a teaching hospital. Journal of Postgraduate Medical Institute 2013; 27(4): 397-402.",Initial systematic review,PAK,Pakistan,Lady Reading Hospital,900,Nwfp,2010,0,58,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
463,Javaid (2012),"Javaid H, Zafar A, Ahmed JM, Ejaz H, Zubair M. Changing patterns of antimicrobial susceptibility of Salmonella Typhi at the children's hospital Lahore. Pak J Med Health Sci 2012; 6(1): 201-4.",Initial systematic review,PAK,Pakistan,The Children's Hospital (Lahore),901,Punjab,2010,0,60,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5150,Shakoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Punjab,901,Punjab,2010,0,19,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5150,Shakoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Sindh,902,Sind,2010,2,722,0.3,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5150,Shakoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Gilgit–Baltistan,904,Administrative unit not available,2010,0,9,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
693,Afzal(2012),"Afzal A, Sarwar Y, Ali A, Haque A. Current status of fluoroquinolone and cephalosporin resistance in Salmonella enterica serovar Typhi isolates from Faisalabad, Pakistan. Pak J Med Sci 2012; 28(4).",Extended systematic review,PAK,Pakistan,National Institute for Biotechnology and Genetic Engineering,901,Punjab,2011,4,30,13.3,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
633,Farheen(2015),"Farheen Z, Shahnaz U, Sakina F, Muhhammad M-u-H. Comparative study of antibiotics for their antimicrobial susceptibility in clinical isolates. Int J Pharm Sci Res 2015; 6(2): 630-5.",Extended systematic review,PAK,Pakistan,Unknown hospitals and laboratories in Karachi,902,Sind,2011,5,10,50,1,Salmonella Typhi,Third-generation cephalosporin (3GC)
1444,Afzal (2013),"Afzal A, Sarwar Y, Ali A, et al. Molecular evaluation of drug resistance in clinical isolates of Salmonella enterica serovar Typhi from Pakistan. J Infect Dev Ctries 2013; 7(12): 929-40.",Initial systematic review,PAK,Pakistan,Unknown public hospitals in Faisalabad,901,Punjab,2011,35,80,43.8,1,Salmonella Typhi,Third-generation cephalosporin (3GC)
5150,Shakoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Khyber Pakhtunkhwa,900,Nwfp,2011,0,14,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5150,Shakoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Punjab,901,Punjab,2011,0,47,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5150,Shakoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Sindh,902,Sind,2011,4,865,0.5,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
4588,Malik(2016),"Malik N, Ahmed M. In vitro effect of new antibiotics against clinical isolates of Salmonella Typhi. J Coll Physicians Surg Pak 2016; 26(4): 288-92.",Extended systematic review,PAK,Pakistan,Armed Force Institute of Pathology,901,Punjab,2012,4,128,3.1,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5106,Qamar (2018),"Qamar FN, Yousafzai MT, Sultana S, et al. A Retrospective Study of Laboratory-Based Enteric Fever Surveillance, Pakistan, 2012-2014.Journal of Infectious Diseases 2018;218(suppl_4):S201-S205",Initial systematic review,PAK,Pakistan,Aga Khan University Hospital (Karachi);Aga Khan Hospital for Women and Children;Aga Khan Hospital (Hyderadad),902,Sind,2012,0,585,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5150,Shakoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Khyber Pakhtunkhwa,900,Nwfp,2012,0,7,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5150,Shakoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Sindh,902,Sind,2012,0,560,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5150,Shakoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Punjab,901,Punjab,2012,0,43,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5150,Shakoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Gilgit–Baltistan,904,Administrative unit not available,2012,0,10,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5150,Shakoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Balochistan,897,Balochistan,2012,0,5,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
3023,Ali (2017),"Ali A, Ali HA, Shah FH, Zahid A, Aslam H, Javed B. Pattern of antimicrobial drug resistance of Salmonella Typhi and ParaTyphi a in a teaching hospital in Islamabad. J Pak Med Assoc 2017; 67(3): 375-9.",Initial systematic review,PAK,Pakistan,Khan Research Laboratories (KRL) Hospital,899,Islamabad,2013,0,155,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
4102,Abdullah (2013),"Abdullah MA, Adnan Z, Sattar NY. Susceptibility of Salmonella enterica serotype Typhi, to the usual line of antimicrobial treatment in Rawalpindi. Pakistan Journal of Public Health 2013; 3(2): 14-8.",Initial systematic review,PAK,Pakistan,District Headquarters (DHQ) Teaching Hospital,901,Punjab,2013,0,96,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
4508,Bushra(2016),"Bushra R, Sial AA, Rizvi M, Shafiq Y, Aslam N, Bano N. Sensitivity pattern of ceftriaxone against different clinical isolates. Pak 2016; 29(1): 249-53.",Extended systematic review,PAK,Pakistan,Dr Essa's Laboratory;Darul Sehat Hospital;Liaquat National Hospital;Aga Khan University Hospital (Karachi),902,Sind,2013,6,40,15,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5106,Qamar (2018),"Qamar FN, Yousafzai MT, Sultana S, et al. A Retrospective Study of Laboratory-Based Enteric Fever Surveillance, Pakistan, 2012-2014.Journal of Infectious Diseases 2018;218(suppl_4):S201-S205",Initial systematic review,PAK,Pakistan,Aga Khan University Hospital (Karachi);Aga Khan Hospital for Women and Children;Aga Khan Hospital (Hyderadad),902,Sind,2013,1,667,0.1,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5150,Shakoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Sindh,902,Sind,2013,0,631,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5150,Shakoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Punjab,901,Punjab,2013,2,35,5.7,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5150,Shakoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Gilgit–Baltistan,904,Administrative unit not available,2013,0,16,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5150,Shakoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Khyber Pakhtunkhwa,900,Nwfp,2013,0,15,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5106,Qamar (2018),"Qamar FN, Yousafzai MT, Sultana S, et al. A Retrospective Study of Laboratory-Based Enteric Fever Surveillance, Pakistan, 2012-2014.Journal of Infectious Diseases 2018;218(suppl_4):S201-S205",Initial systematic review,PAK,Pakistan,Aga Khan University Hospital (Karachi);Aga Khan Hospital for Women and Children;Aga Khan Hospital (Hyderadad),902,Sind,2014,3,706,0.4,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5150,Shakoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Khyber Pakhtunkhwa,900,Nwfp,2014,0,10,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5150,Shakoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Punjab,901,Punjab,2014,0,23,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5150,Shakoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Balochistan,897,Balochistan,2014,0,6,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5150,Shakoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Sindh,902,Sind,2014,2,695,0.3,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5063,Zehra (2017),"Zehra NM, Irfan F, Mirza IA, et al. Current Trends of Antimicrobial Susceptibility of Typhoidal Salmonellae Isolated at Tertiary Care Hospital.Jcpsp, Journal of the College of Physicians & Surgeons - Pakistan 2017;27(11):690-692",Initial systematic review,PAK,Pakistan,PNS Shifa Hospital,902,Sind,2015,0,270,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5150,Shakoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Khyber Pakhtunkhwa,900,Nwfp,2015,0,12,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5150,Shakoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Sindh,902,Sind,2015,11,868,1.3,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5150,Shakoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Punjab,901,Punjab,2015,0,32,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5151,SEAP (2021),Sabine Vaccine Institute. Surveillance for Enteric Fever in Asia Project (SEAP) dataset. 2021,Dataset,PAK,Pakistan,Karachi,902,Sind,2016,0,11,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5151,SEAP (2021),Sabine Vaccine Institute. Surveillance for Enteric Fever in Asia Project (SEAP) dataset. 2021,Dataset,PAK,Pakistan,Karachi,902,Sind,2017,37,117,31.6,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5146,PARN(2018),Pakistan Antimicrobial Resistance Network. Antimicrobial data. 2018. https://parn.org.pk/antimicrobial-data/.,Surveillance report,PAK,Pakistan,Aga Khan University Hospital (Karachi),902,Sind,2018,1182,3583,33,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5151,SEAP (2021),Sabine Vaccine Institute. Surveillance for Enteric Fever in Asia Project (SEAP) dataset. 2021,Dataset,PAK,Pakistan,Karachi,902,Sind,2018,264,346,76.3,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5150,Shakoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Gilgit–Baltistan,904,Administrative unit not available,2019,82,124,66.1,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5150,Shakoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Balochistan,897,Balochistan,2019,284,311,91.3,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5150,Shakoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Khyber Pakhtunkhwa,900,Nwfp,2019,17,43,39.5,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5151,SEAP (2021),Sabine Vaccine Institute. Surveillance for Enteric Fever in Asia Project (SEAP) dataset. 2021,Dataset,PAK,Pakistan,Karachi,902,Sind,2019,426,518,82.2,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5150,Shakoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Punjab,901,Punjab,2019,446,748,59.6,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5150,Shakoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Islamabad,899,Islamabad,2019,7,16,43.8,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5150,Shakoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Sindh,902,Sind,2019,4851,6458,75.1,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
388,Abucejo (2001),"Abucejo PE, Capeding MR, Lupisan SP, et al. Blood culture confirmed typhoid fever in a provincial hospital in the Philippines. Southeast Asian J Trop Med Public Health 2001; 32(3): 531-6.",Initial systematic review,PHL,Philippines,Governor Celestino Gallares Memorial Hospital,181,Region VII (Central Visayas),1996,0,422,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
2188,Chuang(2009),"Chuang CH, Su LH, Perera J, et al. Surveillance of antimicrobial resistance of Salmonella enterica serotype Typhi in seven Asian countries. Epidemiol Infect 2009; 137(2): 266-9.",Extended systematic review,PHL,Philippines,Research Institute for Tropical Medicine,176,National Capital region (NCR),2003,0,28,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
3874,Khan (2010),"Khan FY, Elshafie SS, Almaslamani M, et al. Epidemiology of bacteraemia in Hamad general hospital, Qatar: A one year hospital-based study. Travel Med Infect Dis 2010; 8(6): 377-87.",Initial systematic review,QAT,#N/A,Hamad general hospital (Doha),644,Ad Dawhah,2008,0,39,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
276,Ashok(2010),"Ashok R, Peter K, Joselyne N, Emma N. Antimicrobial susceptibility patterns of Salmonella Typhi from Kigali, Rwanda. Shiraz E Medical Journal 2010; 11(3): 117-21.",Extended systematic review,RWA,Rwanda,King Faisal Hospital,1233,Kigali City/Umujyi wa Kigali,2007,0,33,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
276,Ashok(2010),"Ashok R, Peter K, Joselyne N, Emma N. Antimicrobial susceptibility patterns of Salmonella Typhi from Kigali, Rwanda. Shiraz E Medical Journal 2010; 11(3): 117-21.",Extended systematic review,RWA,Rwanda,King Faisal Hospital,1233,Kigali City/Umujyi wa Kigali,2008,0,36,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
265,Al-Tawfiq(2007),Al-Tawfiq JA. Antimicrobial susceptibility of Salmonella Typhi and non-Typhi in a hospital in eastern Saudi Arabia. J Chemother 2007; 19(1): 62-5.,Extended systematic review,SAU,Saudi Arabia,Saudi Aramco Medical Services Organization,655,Eastern Province,2000,0,38,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
2376,Panhotra (2004),"Panhotra BR, Saxena AK, Al-Ghamdi AM. Typhoid fever due to multiresistant Salmonella enterica serovar Typhi having reduced susceptibility to ciprofloxacin and nalidixic acid resistance. Saudi Med J 2004; 25(10): 1509-11.",Initial systematic review,SAU,Saudi Arabia,King Fahd Hospital (Al-Hofif),655,Eastern Province,2003,0,12,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
2822,Somily(2012),"Somily AM, Sayyed SB, Habib HA, et al. Salmonella isolates serotypes and susceptibility to commonly used drugs at a tertiary care hospital in Riyadh, Saudi Arabia. J Infect Dev Ctries 2012; 6(6): 478-82.",Extended systematic review,SAU,Saudi Arabia,King Khalid University Hospital,664,Riyad,2008,0,5,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
1769,Harrois(2014),"Harrois D, Breurec S, Seck A, et al. Prevalence and characterization of extended-spectrum beta-lactamase-producing clinical Salmonella enterica isolates in Dakar, Senegal, from 1999 to 2009. Clin Microbiol Infect 2014; 20(2): O109-16.",Extended systematic review,SEN,Senegal,Bio24 Laboratory;Hopital Aristide Le Dantec;Hopital Principal;Institut Pasteur,1243,Dakar,1999,0,17,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
1769,Harrois(2014),"Harrois D, Breurec S, Seck A, et al. Prevalence and characterization of extended-spectrum beta-lactamase-producing clinical Salmonella enterica isolates in Dakar, Senegal, from 1999 to 2009. Clin Microbiol Infect 2014; 20(2): O109-16.",Extended systematic review,SEN,Senegal,Bio24 Laboratory;Hopital Aristide Le Dantec;Hopital Principal;Institut Pasteur,1243,Dakar,2000,0,10,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
3612,Seydi (2005),"Seydi M, Soumare M, Sow AI, Diop BM, Sow PS. Current aspects of Salmonella bacteremia cases in the Ibrahima Diop Mar infectious diseases clinic, Fann national hospital center (Senegal). Med Mal Infect 2005; 35(1): 23-7.",Initial systematic review,SEN,Senegal,Ibrahima Diop Mar Infectious Diseases clinic of Fann University Hospital,1243,Dakar,2000,0,32,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
1769,Harrois(2014),"Harrois D, Breurec S, Seck A, et al. Prevalence and characterization of extended-spectrum beta-lactamase-producing clinical Salmonella enterica isolates in Dakar, Senegal, from 1999 to 2009. Clin Microbiol Infect 2014; 20(2): O109-16.",Extended systematic review,SEN,Senegal,Bio24 Laboratory;Hopital Aristide Le Dantec;Hopital Principal;Institut Pasteur,1243,Dakar,2001,0,8,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
1769,Harrois(2014),"Harrois D, Breurec S, Seck A, et al. Prevalence and characterization of extended-spectrum beta-lactamase-producing clinical Salmonella enterica isolates in Dakar, Senegal, from 1999 to 2009. Clin Microbiol Infect 2014; 20(2): O109-16.",Extended systematic review,SEN,Senegal,Bio24 Laboratory;Hopital Aristide Le Dantec;Hopital Principal;Institut Pasteur,1243,Dakar,2002,0,12,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
1769,Harrois(2014),"Harrois D, Breurec S, Seck A, et al. Prevalence and characterization of extended-spectrum beta-lactamase-producing clinical Salmonella enterica isolates in Dakar, Senegal, from 1999 to 2009. Clin Microbiol Infect 2014; 20(2): O109-16.",Extended systematic review,SEN,Senegal,Bio24 Laboratory;Hopital Aristide Le Dantec;Hopital Principal;Institut Pasteur,1243,Dakar,2003,0,10,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
1769,Harrois(2014),"Harrois D, Breurec S, Seck A, et al. Prevalence and characterization of extended-spectrum beta-lactamase-producing clinical Salmonella enterica isolates in Dakar, Senegal, from 1999 to 2009. Clin Microbiol Infect 2014; 20(2): O109-16.",Extended systematic review,SEN,Senegal,Bio24 Laboratory;Hopital Aristide Le Dantec;Hopital Principal;Institut Pasteur,1243,Dakar,2007,0,5,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
1769,Harrois(2014),"Harrois D, Breurec S, Seck A, et al. Prevalence and characterization of extended-spectrum beta-lactamase-producing clinical Salmonella enterica isolates in Dakar, Senegal, from 1999 to 2009. Clin Microbiol Infect 2014; 20(2): O109-16.",Extended systematic review,SEN,Senegal,Bio24 Laboratory;Hopital Aristide Le Dantec;Hopital Principal;Institut Pasteur,1243,Dakar,2008,0,15,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
2946,Marks (2017),"Marks F, Kalckreuth V, Aaby P, et al. Incidence of invasive Salmonella disease in sub-Saharan Africa: A multicentre population-based surveillance study. Lancet Glob Health 2017; 5(3): e310-e23.",Initial systematic review,SEN,Senegal,Unknown hospitals in Pikine,1243,Dakar,2012,0,7,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
848,Dagnra(2007),"Dagnra AY, Akolly K, Gbadoe A, Aho K, David M. Emergence of multidrug resistant Salmonella strains in Lome (Togo). [French]. Med Mal Infect 2007; 37(5): 266-9.",Extended systematic review,TGO,Togo,Centre Hospitalier et Universitaire Tokoin (Lome),1315,Maritime,2000,0,65,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
848,Dagnra(2007),"Dagnra AY, Akolly K, Gbadoe A, Aho K, David M. Emergence of multidrug resistant Salmonella strains in Lome (Togo). [French]. Med Mal Infect 2007; 37(5): 266-9.",Extended systematic review,TGO,Togo,Centre Hospitalier et Universitaire Tokoin (Lome),1315,Maritime,2004,0,82,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
3394,Komolpis (1999),"Komolpis P, Srifuengfung S, Dhiraputra C, Pingwang B. Salmonella bacteremia: serotype distribution and antimicrobial susceptibility during 1991-1995. Journal of Infectious Diseases and Antimicrobial Agents 1999; 16(2): 49-52.",Initial systematic review,THA,Thailand,Siriraj Hospital,236,Bangkok,1993,0,16,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
2413,Limpitikul (2014),"Limpitikul W, Henpraserttae N, Saksawad R, Laoprasopwattana K. Typhoid outbreak in Songkhla, Thailand 2009-2011: Clinical outcomes, susceptibility patterns, and reliability of serology tests. PLoS ONE 2014; 9(11).",Initial systematic review,THA,Thailand,Hat Yai Hospital,296,Songkhla,2010,0,8,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
2413,Limpitikul (2014),"Limpitikul W, Henpraserttae N, Saksawad R, Laoprasopwattana K. Typhoid outbreak in Songkhla, Thailand 2009-2011: Clinical outcomes, susceptibility patterns, and reliability of serology tests. PLoS ONE 2014; 9(11).",Initial systematic review,THA,Thailand,Songklanagarind Hospital,296,Songkhla,2010,0,27,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
2413,Limpitikul (2014),"Limpitikul W, Henpraserttae N, Saksawad R, Laoprasopwattana K. Typhoid outbreak in Songkhla, Thailand 2009-2011: Clinical outcomes, susceptibility patterns, and reliability of serology tests. PLoS ONE 2014; 9(11).",Initial systematic review,THA,Thailand,Songkhla Hospital,296,Songkhla,2010,0,333,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
2042,Secmeer (1995),"Secmeer G, Kanra G, Cemeroglu AP, Ozen H, Ceyhan M, Ecevit Z. Salmonella Typhi infections. A 10-year retrospective study. Turk J Pediatr 1995; 37(4): 339-41.",Initial systematic review,TUR,Turkey,Hacettepe Children's Hospital,728,Ankara,1990,0,11,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
147,Akan(1997),"Akan O, Kanra G, Secmeer G, Ceyhan M, Ecevit Z, Berkman E. Antibiotic susceptibilities of Salmonella serogroups isolated from Turkish children. Turk J Pediatr 1997; 39(1): 7-11.",Extended systematic review,TUR,Turkey,Hacettepe Children's Hospital,728,Ankara,1995,0,20,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
929,Bayram(2011),"Bayram Y, Guducuoglu H, Otlu B, et al. Epidemiological characteristics and molecular typing of Salmonella enterica serovar Typhi during a waterborne outbreak in Eastern Anatolia. Ann Trop Med Parasitol 2011; 105(5): 359-65.",Extended systematic review,TUR,Turkey,Ercek town,798,Van,2008,0,91,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
1290,Crump (2011),"Crump JA, Ramadhani HO, Morrissey AB, et al. Invasive bacterial and fungal infections among hospitalized HIV-infected and HIV-uninfected adults and adolescents in northern Tanzania. Clin Infect Dis 2011; 52(3): 341-8.",Initial systematic review,TZA,Tanzania,Kilimanjaro Christian Medical Centre;Mawenzi Regional Hospital,1324,Kilimanjaro,2008,0,26,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
1291,Crump(2011),"Crump JA, Ramadhani HO, Morrissey AB, et al. Invasive bacterial and fungal infections among hospitalized HIV-infected and HIV-uninfected children and infants in northern Tanzania. Trop Med Int Health 2011; 16(7): 830-7.",Extended systematic review,TZA,Tanzania,Kilimanjaro Christian Medical Centre,1324,Kilimanjaro,2008,0,6,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
2946,Marks (2017),"Marks F, Kalckreuth V, Aaby P, et al. Incidence of invasive Salmonella disease in sub-Saharan Africa: A multicentre population-based surveillance study. Lancet Glob Health 2017; 5(3): e310-e23.",Initial systematic review,TZA,Tanzania,Unknown hospitals in Moshi (urban and rural),1324,Kilimanjaro,2012,0,10,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
394,Mahende (2015),"Mahende C, Ngasala B, Lusingu J, et al. Bloodstream bacterial infection among outpatient children with acute febrile illness in north-eastern Tanzania. BMC Res Notes 2015; 8: 289.",Initial systematic review,TZA,Tanzania,Korogwe District Hospital,1342,Tanga,2013,4,17,23.5,1,Salmonella Typhi,Third-generation cephalosporin (3GC)
2385,Nguyen(1993),"Nguyen TA, Ha Ba K, Nguyen TD. Typhoid fever in South Vietnam, 1990-1993. [French]. Bulletin de la Societe de pathologie exotique (1990) 1993; 86(5 Pt 2): 476-8.",Extended systematic review,VNM,Vietnam,Centre for Tropical Diseases,328,Ho Chi Minh,1992,0,20,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
651,Smith(1994),"Smith MD, Duong NM, Hoa NTT, et al. Comparison of ofloxacin and ceftriaxone for short-course treatment of enteric fever. Antimicrob Agents Chemother 1994; 38(8): 1716-20.",Extended systematic review,VNM,Vietnam,Centre for Tropical Diseases,328,Ho Chi Minh,1993,0,41,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
1859,Hien (1994),"Hien TT, Duong NM, Ha HD, et al. A randomized comparative study of fleroxacin and ceftriaxone in enteric fever. Trans R Soc Trop Med Hyg 1994; 88(4): 464-5.",Initial systematic review,VNM,Vietnam,Centre for Tropical Diseases;Cho Quan Hospital,328,Ho Chi Minh,1993,0,27,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
2124,Hien (1995),"Hien TT, Bethell DB, Hoa NTT, et al. Short course of ofloxacin for treatment of multidrug-resistant typhoid. Clin Infect Dis 1995; 20(4): 917-23.",Initial systematic review,VNM,Vietnam,Dong Hoa & Dong Thanh,369,Kien Giang,1993,0,207,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
621,Hoa (1998),"Hoa NTT, Diep TS, Wain J, et al. Community-acquired septicaemia in southern Viet Nam: The importance of multidrug-resistant Salmonella Typhi. Trans R Soc Trop Med Hyg 1998; 92(5): 503-8.",Initial systematic review,VNM,Vietnam,Centre for Tropical Diseases,328,Ho Chi Minh,1994,0,294,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
272,Nguyen Dac(2007),"Nguyen Dac T, Suthisarnsuntorn U, Kalambaheti T, Wonglumsom W, Tunyong W. Antimicrobial susceptibility patterns and phage types of Salmonella Typhi from Vietnam. Southeast Asian J Trop Med Public Health 2007; 38(3): 487-92.",Extended systematic review,VNM,Vietnam,National Hospital (HCMC),328,Ho Chi Minh,1996,0,14,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
272,Nguyen Dac(2007),"Nguyen Dac T, Suthisarnsuntorn U, Kalambaheti T, Wonglumsom W, Tunyong W. Antimicrobial susceptibility patterns and phage types of Salmonella Typhi from Vietnam. Southeast Asian J Trop Med Public Health 2007; 38(3): 487-92.",Extended systematic review,VNM,Vietnam,National Hospital (Hanoi),368,Ha Noi,1996,0,52,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
272,Nguyen Dac(2007),"Nguyen Dac T, Suthisarnsuntorn U, Kalambaheti T, Wonglumsom W, Tunyong W. Antimicrobial susceptibility patterns and phage types of Salmonella Typhi from Vietnam. Southeast Asian J Trop Med Public Health 2007; 38(3): 487-92.",Extended systematic review,VNM,Vietnam,National Hospital (Hue),373,Thua Thien Hue,1996,0,45,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
636,Phuong (1999),"Phuong CXT, Kneen R, Anh NT, Luat TD, White NJ, Parry CM. A comparative study of ofloxacin and cefixime for treatment of typhoid fever in children. Pediatr Infect Dis J 1999; 18(3): 245-8.",Initial systematic review,VNM,Vietnam,Dong Nai Pediatric Centre,374,Dong Nai,1996,0,82,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
1862,Parry(2007),"Parry CM, Ho VA, Phuong le T, et al. Randomized controlled comparison of ofloxacin, azithromycin, and an ofloxacin-azithromycin combination for treatment of multidrug-resistant and nalidixic acid-resistant typhoid fever. Antimicrob Agents Chemother 2007; 51(3): 819-25.",Extended systematic review,VNM,Vietnam,Dong Thap Provincial Hospital,360,Dong Thap,2000,0,192,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
2188,Chuang(2009),"Chuang CH, Su LH, Perera J, et al. Surveillance of antimicrobial resistance of Salmonella enterica serotype Typhi in seven Asian countries. Epidemiol Infect 2009; 137(2): 266-9.",Extended systematic review,VNM,Vietnam,University Hospital (HCMC),328,Ho Chi Minh,2003,0,102,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
2180,Ochiai (2008),"Ochiai RL, Acosta CJ, Danovaro-Holliday MC, et al. A study of typhoid fever in five Asian countries: Disease burden and implications for controls. Bull World Health Organ 2008; 86(4): 260-8.",Initial systematic review,VNM,Vietnam,Hue,373,Thua Thien Hue,2003,0,18,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
2030,Taha(2013),"Taha RR, Alghalibi SM, Saeed Saleh MG. Salmonella spp. in patients suffering from enteric fever and food poisoning in Thamar city, Yemen. East Mediterr Health J 2013; 19(1): 88-93.",Extended systematic review,YEM,Yemen,Dar Alshafaa Hospital;Dhamar General Hospital,811,Dhamar,2008,0,41,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
5056,Mashe(2017),"Mashe T, Mugabe M, Stray-Pedersen B, et al. Antibiotic resistance trends of Salmonella enterica serotype Typhi in Zimbabwe (2012-2017). Antimicrobial Resistance and Infection Control Conference: International Conference on Prevention and Infection Control, ICPIC 2017; 6(Supplement 3).",Extended systematic review,ZWE,Zimbabwe,Unknown clinics and hospitals in Harare,1466,Harare,2015,0,285,0,0,Salmonella Typhi,Third-generation cephalosporin (3GC)
1730,Geetha (2014),"Geetha VK, Yugendran T, Srinivasan R, Harish BN. Plasmid-mediated quinolone resistance in typhoidal Salmonellae: a preliminary report from South India. Indian J Med Microbiol 2014; 32(1): 31-4.",Initial systematic review,IND,India,Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER),889,Puducherry,2011,27,27,100,1,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
5146,PARN(2018),Pakistan Antimicrobial Resistance Network. Antimicrobial data. 2018. https://parn.org.pk/antimicrobial-data/.,Surveillance report,PAK,Pakistan,Aga Khan University Hospital (Karachi),902,Sind,2018,237,237,100,1,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
1253,Anup(2006),"Anup P, Subrata G, Sanjucta D, Dipika S, Bhattacharya MK, Bhattacharya SK. Increasing prevalence of Salmonella enterica serotype ParaTyphi-A in patients with enteric fever in a periurban slum setting of Kolkata, India. International Journal of Environmental Health Research 2006; 16(6): 455-9.",Extended systematic review,IND,India,Kalikapur,869,West Bengal,2005,7,9,77.8,1,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
1323,Rai (2012)<U+1D43>,"Rai GK, Karki S, Prajapati B. Is antimicrobial resistance pattern of enteric fever changing in Kathmandu valley? Journal of Nepal Paediatric Society 2012a; 32(3): 221-8.",Initial systematic review,NPL,Nepal,Kanti Children's Hospital (Kathmandu),892,Central,2012,3,9,33.3,1,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
4650,Yadav (2016),"Yadav VC, Kiran VR, Sharma R. Enteric fever in Bastar tribal region-prevalence and sensitivity patterns. J Evol Med Dent Sci 2016; 5(53): 3526-30.",Initial systematic review,IND,India,Late Baliram Kashyap Memorial Government Medical College Jagdalpur,884,Chhattisgarh,2012,3,14,21.4,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
4650,Yadav (2016),"Yadav VC, Kiran VR, Sharma R. Enteric fever in Bastar tribal region-prevalence and sensitivity patterns. J Evol Med Dent Sci 2016; 5(53): 3526-30.",Initial systematic review,IND,India,Late Baliram Kashyap Memorial Government Medical College Jagdalpur,884,Chhattisgarh,2014,1,5,20,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
4650,Yadav (2016),"Yadav VC, Kiran VR, Sharma R. Enteric fever in Bastar tribal region-prevalence and sensitivity patterns. J Evol Med Dent Sci 2016; 5(53): 3526-30.",Initial systematic review,IND,India,Late Baliram Kashyap Memorial Government Medical College Jagdalpur,884,Chhattisgarh,2011,2,11,18.2,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
5097,Makkar (2018),"Makkar A, Gupta S, Khan ID, et al. Epidemiological Profile and Antimicrobial Resistance Pattern of Enteric Fever in a Tertiary Care Hospital of North India - a Seven Year Ambispective Study.Acta Medica (Hradec Kralove) 2018;61(4):125-130",Initial systematic review,IND,India,Unknown Hospital(s) in Delhi,850,Delhi,2014,27,157,17.2,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
5064,Zellweger (2017),"Zellweger RM, Basnyat B, Shrestha P, et al. A 23-year retrospective investigation of Salmonella Typhi and Salmonella ParaTyphi isolated in a tertiary Kathmandu hospital.PLoS Neglected Tropical Diseases [electronic resource] 2017;11(11):e0006051",Initial systematic review,NPL,Nepal,Patan Hospital (Lalitpur),892,Central,2010,1,6,16.7,1,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
5148,Roberts (2019),"Roberts T. LOMRU blood culture database. Vientiene, Laos; 2019",Dataset,LAO,Laos,Mahosot Hospital,117,Vientiane capital,2014,1,6,16.7,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
2093,Gautam (2002),"Gautam V, Gupta NK, Chaudhary U, Arora DR. Sensitivity pattern of Salmonella serotypes in Northern India. Braz J Infect Dis 2002; 6(6): 281-7.",Initial systematic review,IND,India,Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences,853,Haryana,2001,7,47,14.9,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
471,Lakshmi (2006),"Lakshmi V, Ashok R, Susmita J, Shailaja VV. Changing trends in the antibiograms of Salmonella isolates at a tertiary care hospital in Hyderabad. Indian J Med Microbiol 2006; 24(1): 45-8.",Initial systematic review,IND,India,Nizam's Institute of Medical Sciences,848,Andhra Pradesh,2004,1,7,14.3,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
4650,Yadav (2016),"Yadav VC, Kiran VR, Sharma R. Enteric fever in Bastar tribal region-prevalence and sensitivity patterns. J Evol Med Dent Sci 2016; 5(53): 3526-30.",Initial systematic review,IND,India,Late Baliram Kashyap Memorial Government Medical College Jagdalpur,884,Chhattisgarh,2013,2,14,14.3,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
1683,Kadappu (2003),"Kadappu KK, Bhat R, Kurian B. Pattern of multiple drug resistance in enteric fever in Manipal, India. Trop Doct 2003; 33(3): 189-91.",Initial systematic review,IND,India,Kasturba Medical College and Hospital (Manipal),855,Karnataka,2000,1,10,10,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
4274,Shen(2014),"Shen M, Wu X, Wang L. Serotypes and drug resistance of Salmonella isolated from clinical infection cases in Pinghu, Zhejiang. [Chinese]. Disease Surveillance 2014; 29(7): 560-3.",Extended systematic review,CHN,China,First People's Hospital of Pinghu,35,Zhejiang Sheng,2011,1,10,10,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
1669,Bekur (2010),"Bekur R, Vandana KE, Shivashankara KN, Valsalan R, Sathyanarayanan V. Paratyphoid fever- Emerging problem in South India. Asian Pac J Trop Med 2010; 3(10): 815-7.",Initial systematic review,IND,India,Kasturba Medical College and Hospital (Manipal),855,Karnataka,2006,3,37,8.1,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
971,Amatya (2007),"Amatya NM, Shrestha B, Lekhak B. Etiological agents of bacteraemia and antibiotic susceptibility pattern in Kathmandu Model Hospital. JNMA J Nepal Med Assoc 2007; 46(167): 112-8.",Initial systematic review,NPL,Nepal,Kathmandu Model Hospital (Kathmandu),892,Central,2005,3,44,6.8,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
2820,Shetty (2012),"Shetty AK, Shetty IN, Furtado ZV, Antony B, Boloor R. Antibiogram of Salmonella isolates from blood with an emphasis on nalidixic acid and chloramphenicol susceptibility in a tertiary care hospital in coastal karnataka: a prospective study. J Lab Physicians 2012; 4(2): 74-7.",Initial systematic review,IND,India,Father Muller Medical College Hospital,855,Karnataka,2010,1,16,6.3,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
207,Jain (2013),"Jain S, Chugh TD. Antimicrobial resistance among blood culture isolates of Salmonella enterica in New Delhi. J Infect Dev Ctries 2013; 7(11): 788-95.",Initial systematic review,IND,India,BLK Super speciality Hospital,850,Delhi,2012,1,16,6.3,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
2165,Gopal(2011),"Gopal M, Arumugam S, Gnadesikan S, Ramesh S. Studies on antimicrobial susceptibility pattern of Salmonella isolates from Chennai, India. Int J Pharma Bio Sci 2011; 2(2).",Extended systematic review,IND,India,Rajiv Gandhi Government General Hospital;Other clinical laboratories Chennai,867,Tamil Nadu,2008,2,41,4.9,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
1617,Bhattacharya (2011),"Bhattacharya SS, Das U, Choudhury BK. Occurrence & antibiogram of Salmonella Typhi & S. ParaTyphi A isolated from Rourkela, Orissa. Indian J Med Res 2011; 133: 431-3.",Initial systematic review,IND,India,Ispat General Hospital (Rourkela),863,Orissa,2007,3,64,4.7,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
2978,Hardjo Lugito (2017),"Hardjo Lugito NP, Cucunawangsih. Antimicrobial resistance of Salmonella enterica serovars Typhi and ParaTyphi isolates from a general hospital in Karawaci, Tangerang, Indonesia: A five-year review. Int J Microbiol 2017; 2017: 6215136.",Initial systematic review,IDN,Indonesia,Siloam Hospital (Karawaci),69,BANTEN,2012,1,22,4.5,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
4646,Wang(2016),"Wang H, Qin B, Gao Y. Analysis of clinical characteristics and antimicrobial resistance of 24 cases of paratyphoid A. [Chinese]. Chongqing Medicine 2016; 45(22): 3083-5.",Extended systematic review,CHN,China,Jiangjin Central Hospital,6,Chongqing Shi,2016,1,24,4.2,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
151,Suruchi (2014),"Suruchi B, Anil K, Ganju SA, Atal S. Antibiotic susceptibility pattern of Salmonella enterica serovar Typhi and ParaTyphi a from North India: the changing scenario. Int J Pharma Bio Sci 2014; 5(4).",Initial systematic review,IND,India,Indira Gandhi Medical College,854,Himachal Pradesh,2012,1,25,4,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
1669,Bekur (2010),"Bekur R, Vandana KE, Shivashankara KN, Valsalan R, Sathyanarayanan V. Paratyphoid fever- Emerging problem in South India. Asian Pac J Trop Med 2010; 3(10): 815-7.",Initial systematic review,IND,India,Kasturba Medical College and Hospital (Manipal),855,Karnataka,2007,1,35,2.9,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
2284,Aggarwal (2007),"Aggarwal A, Vij AS, Oberoi A. A three-year retrospective study on the prevalence, drug susceptibility pattern, and phage types of Salmonella enterica subspecies Typhi and ParaTyphi in Christian Medical College and Hospital, Ludhiana, Punjab. J Indian Acad Clin Med 2007; 8(1): 32-5.",Initial systematic review,IND,India,Christian Medical College and Hospital (Ludhiana),864,Punjab,2004,1,36,2.8,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
1791,Prajapati (2008),"Prajapati B, Rai GK, Rai SK, et al. Prevalence of Salmonella Typhi and ParaTyphi infection in children: a hospital based study. Nepal Med Coll J 2008; 10(4): 238-41.",Initial systematic review,NPL,Nepal,Kanti Children's Hospital (Kathmandu),892,Central,2008,1,39,2.6,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
5104,Petersiel (2018),"Petersiel N, Shresta S, Tamrakar R, et al. The epidemiology of typhoid fever in the Dhulikhel area, Nepal: A prospective cohort study.PLoS ONE 2018;13 (9) (no pagination)(e0204479):",Initial systematic review,NPL,Nepal,Dhulikhel Hospital (Kathmandu),892,Central,2013,1,42,2.4,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
3039,Sharvani (2016),"Sharvani R, Hemavathi, Dayanand DK, Shenoy P, Sarmah P. Antibiogram of Salmonella isolates: time to consider antibiotic salvage. J Clin Diagn Res 2016; 10(5): DC6-DC8.",Initial systematic review,IND,India,Sapthagiri Hospital,855,Karnataka,2013,3,152,2,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
3394,Komolpis (1999),"Komolpis P, Srifuengfung S, Dhiraputra C, Pingwang B. Salmonella bacteremia: serotype distribution and antimicrobial susceptibility during 1991-1995. Journal of Infectious Diseases and Antimicrobial Agents 1999; 16(2): 49-52.",Initial systematic review,THA,Thailand,Siriraj Hospital,236,Bangkok,1993,2,100,2,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
1095,Wu (2010),"Wu W, Wang H, Lu J, et al. Genetic diversity of Salmonella enteric serovar Typhi and ParaTyphi in Shenzhen, China from 2002 through 2007. BMC Microbiol 2010; 10: 32.",Initial systematic review,CHN,China,Shenzhen People's Hospital,9,Guangdong Sheng,2005,1,64,1.6,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
896,Abdullah (2012),"Abdullah FE, Faryal H, Kanwal F, Saboohi I, Iqbal MS. Enteric fever in Karachi: current antibiotic susceptibility of Salmonellae isolates. J Coll Physicians Surg Pak 2012; 22(3): 147-50.",Initial systematic review,PAK,Pakistan,Laboratory and Diagnostic Centre,902,Sind,2009,1,67,1.5,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
1088,Das(2014),"Das SK, Chisti MJ, Afrad MH, et al. Gastroenteritis due to typhoidal Salmonella: a decade of observation at an urban and a rural diarrheal disease hospital in Bangladesh. BMC Infect Dis 2014; 14: 435.",Extended systematic review,BGD,Bangladesh,ICDDR;Matlab Hospital (ICDDR),823,Dhaka,2006,3,278,1.1,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
244,Jiang(2015),"Jiang Y, Zuo H, Niu H, et al. Antimicrobial resistance surveillance of Salmonella isolates from the First People's Hospital of Yunnan Province, China. J Infect Dev Ctries 2015; 9(4): 333-7.",Extended systematic review,CHN,China,First People’s Hospital of Yunnan Province,34,Yunnan Sheng,2006,8,784,1,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
1988,Maskey (2006),"Maskey AP, Day JN, Phung QT, et al. Salmonella enterica serovar ParaTyphi A and S. enterica serovar Typhi cause indistinguishable clinical syndromes in Kathmandu, Nepal. Clin Infect Dis 2006; 42(9): 1247-53.",Initial systematic review,NPL,Nepal,Patan Hospital (Lalitpur),892,Central,2004,1,200,0.5,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
5150,Shakoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Sindh,902,Sind,2014,1,271,0.4,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
5150,Shakoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Sindh,902,Sind,2008,1,536,0.2,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
5150,Shakoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Sindh,902,Sind,2011,1,629,0.2,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
1878,Islam (1993),"Islam MN, Afroza A, Hasan Z, Majumder B, Hossain A. Recent antibiogram pattern and clinical profile of typhoid fever in children - A study of 36 cases. Bangladesh J Child Health 1993; 17(3): 93-6.",Initial systematic review,BGD,Bangladesh,Institute of Postgraduate Medicine and Research,823,Dhaka,1993,0,7,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
405,Aliya (2010),"Aliya N, Ram PK, Brooks WA, et al. Burden of typhoid and paratyphoid fever in a densely populated urban community, Dhaka, Bangladesh. Int J Infect Dis 2010; 14(Suppl. 3): e93-e9.",Initial systematic review,BGD,Bangladesh,Kamalapur,823,Dhaka,2004,0,8,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
3026,Ahmed (2017),"Ahmed D, Nahid MA, Sami AB, et al. Bacterial etiology of bloodstream infections and antimicrobial resistance in Dhaka, Bangladesh, 2005-2014. Antimicrob Resist Infect Control 2017; 6.",Initial systematic review,BGD,Bangladesh,Dhaka Hospital (ICCDR);ICDDR,823,Dhaka,2005,0,85,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
1088,Das(2014),"Das SK, Chisti MJ, Afrad MH, et al. Gastroenteritis due to typhoidal Salmonella: a decade of observation at an urban and a rural diarrheal disease hospital in Bangladesh. BMC Infect Dis 2014; 14: 435.",Extended systematic review,BGD,Bangladesh,Unknown urban Dhaka hospital,823,Dhaka,2006,0,33,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
3026,Ahmed (2017),"Ahmed D, Nahid MA, Sami AB, et al. Bacterial etiology of bloodstream infections and antimicrobial resistance in Dhaka, Bangladesh, 2005-2014. Antimicrob Resist Infect Control 2017; 6.",Initial systematic review,BGD,Bangladesh,Dhaka Hospital (ICCDR);ICDDR,823,Dhaka,2006,0,133,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
3026,Ahmed (2017),"Ahmed D, Nahid MA, Sami AB, et al. Bacterial etiology of bloodstream infections and antimicrobial resistance in Dhaka, Bangladesh, 2005-2014. Antimicrob Resist Infect Control 2017; 6.",Initial systematic review,BGD,Bangladesh,Dhaka Hospital (ICCDR);ICDDR,823,Dhaka,2007,0,127,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
3026,Ahmed (2017),"Ahmed D, Nahid MA, Sami AB, et al. Bacterial etiology of bloodstream infections and antimicrobial resistance in Dhaka, Bangladesh, 2005-2014. Antimicrob Resist Infect Control 2017; 6.",Initial systematic review,BGD,Bangladesh,Dhaka Hospital (ICCDR);ICDDR,823,Dhaka,2008,0,146,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
3026,Ahmed (2017),"Ahmed D, Nahid MA, Sami AB, et al. Bacterial etiology of bloodstream infections and antimicrobial resistance in Dhaka, Bangladesh, 2005-2014. Antimicrob Resist Infect Control 2017; 6.",Initial systematic review,BGD,Bangladesh,Dhaka Hospital (ICCDR);ICDDR,823,Dhaka,2009,0,102,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
3026,Ahmed (2017),"Ahmed D, Nahid MA, Sami AB, et al. Bacterial etiology of bloodstream infections and antimicrobial resistance in Dhaka, Bangladesh, 2005-2014. Antimicrob Resist Infect Control 2017; 6.",Initial systematic review,BGD,Bangladesh,Dhaka Hospital (ICCDR);ICDDR,823,Dhaka,2010,0,179,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
501,Khanam (2014),"Khanam F, Qadri F. Characterization of the induced immune responses, clinical presentation and antibiotic susceptibility pattern in Bangladeshi S. ParaTyphi A bacteremic patients. Int J Infect Dis 2014; 21: 343.",Initial systematic review,BGD,Bangladesh,ICDDR,823,Dhaka,2010,0,25,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
1680,Afroze (2014),"Afroze SR, Rahim MA, Hasan MM, et al. Pattern of antibiotic sensitivity in enteric fever: A tertiary care hospital experience. Journal of Medicine (Bangladesh) 2014; 15(2): 122-4.",Initial systematic review,BGD,Bangladesh,"Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders (BIRDEM)",823,Dhaka,2011,0,26,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
3026,Ahmed (2017),"Ahmed D, Nahid MA, Sami AB, et al. Bacterial etiology of bloodstream infections and antimicrobial resistance in Dhaka, Bangladesh, 2005-2014. Antimicrob Resist Infect Control 2017; 6.",Initial systematic review,BGD,Bangladesh,Dhaka Hospital (ICCDR);ICDDR,823,Dhaka,2011,0,135,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
3026,Ahmed (2017),"Ahmed D, Nahid MA, Sami AB, et al. Bacterial etiology of bloodstream infections and antimicrobial resistance in Dhaka, Bangladesh, 2005-2014. Antimicrob Resist Infect Control 2017; 6.",Initial systematic review,BGD,Bangladesh,Dhaka Hospital (ICCDR);ICDDR,823,Dhaka,2012,0,129,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
3026,Ahmed (2017),"Ahmed D, Nahid MA, Sami AB, et al. Bacterial etiology of bloodstream infections and antimicrobial resistance in Dhaka, Bangladesh, 2005-2014. Antimicrob Resist Infect Control 2017; 6.",Initial systematic review,BGD,Bangladesh,Dhaka Hospital (ICCDR);ICDDR,823,Dhaka,2013,0,107,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
3026,Ahmed (2017),"Ahmed D, Nahid MA, Sami AB, et al. Bacterial etiology of bloodstream infections and antimicrobial resistance in Dhaka, Bangladesh, 2005-2014. Antimicrob Resist Infect Control 2017; 6.",Initial systematic review,BGD,Bangladesh,Dhaka Hospital (ICCDR);ICDDR,823,Dhaka,2014,0,110,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
5131,Saha (2018),"Saha S, Saha S, Das RC, et al. Enteric Fever and Related Contextual Factors in Bangladesh.American Journal of Tropical Medicine & Hygiene 2018;99(3_Suppl):20-25",Initial systematic review,BGD,Bangladesh,Dhaka Shishu Hospital;Shishu Sasthya Foundation Hospital,823,Dhaka,2014,0,38,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
5102,Okanda (2018),"Okanda T, Haque A, Ehara T, et al. Characteristics of resistance mechanisms and molecular epidemiology of fluoroquinolone-nonsusceptible Salmonella enterica serovar Typhi and Paratyphi a isolates from a tertiary hospital in Dhaka, Bangladesh.Microbial Drug Resistance 2018;24(10):1460-1465",Initial systematic review,BGD,Bangladesh,Bangabandhu Sheikh Mujib Medical University Hospital,823,Dhaka,2015,0,6,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
135,Mandal (2006),"Mandal S, Mandal M, Pal N. Antibiotic resistance of Salmonella enterica serovar ParaTyphi A in India: Emerging and reemerging problem. J Postgrad Med 2006; 52(3): 163-6.",Initial systematic review,IND,India,Calcutta School of Tropical Medicine,869,West Bengal,1991,0,13,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
135,Mandal (2006),"Mandal S, Mandal M, Pal N. Antibiotic resistance of Salmonella enterica serovar ParaTyphi A in India: Emerging and reemerging problem. J Postgrad Med 2006; 52(3): 163-6.",Initial systematic review,IND,India,Calcutta School of Tropical Medicine,869,West Bengal,1994,0,9,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
135,Mandal (2006),"Mandal S, Mandal M, Pal N. Antibiotic resistance of Salmonella enterica serovar ParaTyphi A in India: Emerging and reemerging problem. J Postgrad Med 2006; 52(3): 163-6.",Initial systematic review,IND,India,Calcutta School of Tropical Medicine,869,West Bengal,1995,0,12,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
1947,Chandel(2000)<U+1D47>,"Chandel DS, Nisar N, Thong KL, Pang T, Chaudhry R. Role of molecular typing in an outbreak of Salmonella Paratyphi A. Trop Gastroenterol 2000; 21(3): 121-3.",Extended systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,1996,0,36,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
2785,Kapil (1997),"Kapil A, Sood S, Reddaiah VP, Das B, Seth P. Paratyphoid fever due to Salmonella enterica serotype ParaTyphi A. Emerg Infect Dis 1997; 3(3): 407.",Initial systematic review,IND,India,New Delhi,850,Delhi,1996,0,36,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
135,Mandal (2006),"Mandal S, Mandal M, Pal N. Antibiotic resistance of Salmonella enterica serovar ParaTyphi A in India: Emerging and reemerging problem. J Postgrad Med 2006; 52(3): 163-6.",Initial systematic review,IND,India,Calcutta School of Tropical Medicine,869,West Bengal,1996,0,9,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
135,Mandal (2006),"Mandal S, Mandal M, Pal N. Antibiotic resistance of Salmonella enterica serovar ParaTyphi A in India: Emerging and reemerging problem. J Postgrad Med 2006; 52(3): 163-6.",Initial systematic review,IND,India,Calcutta School of Tropical Medicine,869,West Bengal,1997,0,10,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
135,Mandal (2006),"Mandal S, Mandal M, Pal N. Antibiotic resistance of Salmonella enterica serovar ParaTyphi A in India: Emerging and reemerging problem. J Postgrad Med 2006; 52(3): 163-6.",Initial systematic review,IND,India,Calcutta School of Tropical Medicine,869,West Bengal,1998,0,10,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
118,Mohanty (2006),"Mohanty S, Renuka K, Sood S, Das BK, Kapil A. Antibiogram pattern and seasonality of Salmonella serotypes in a North Indian tertiary care hospital. Epidemiol Infect 2006; 134(5): 961-6.",Initial systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,1999,0,28,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
118,Mohanty (2006),"Mohanty S, Renuka K, Sood S, Das BK, Kapil A. Antibiogram pattern and seasonality of Salmonella serotypes in a North Indian tertiary care hospital. Epidemiol Infect 2006; 134(5): 961-6.",Initial systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,2000,0,21,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
2093,Gautam (2002),"Gautam V, Gupta NK, Chaudhary U, Arora DR. Sensitivity pattern of Salmonella serotypes in Northern India. Braz J Infect Dis 2002; 6(6): 281-7.",Initial systematic review,IND,India,Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences,853,Haryana,2000,0,5,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
260,Safdar(2004),"Safdar A, Harjit K, Elting L, Rolston KVI. Antimicrobial susceptibility of 128 Salmonella enterica serovar Typhi and Paratyphi A isolates from Northern India. Chemotherapy 2004; 50(2): 88-91.",Extended systematic review,IND,India,Christian Medical College and Hospital (Ludhiana),864,Punjab,2000,0,27,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
135,Mandal (2006),"Mandal S, Mandal M, Pal N. Antibiotic resistance of Salmonella enterica serovar ParaTyphi A in India: Emerging and reemerging problem. J Postgrad Med 2006; 52(3): 163-6.",Initial systematic review,IND,India,Calcutta School of Tropical Medicine,869,West Bengal,2000,0,8,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
118,Mohanty (2006),"Mohanty S, Renuka K, Sood S, Das BK, Kapil A. Antibiogram pattern and seasonality of Salmonella serotypes in a North Indian tertiary care hospital. Epidemiol Infect 2006; 134(5): 961-6.",Initial systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,2001,0,28,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
119,Mehta (2002),"Mehta M, Joshi RM. Antibiogram pattern of Salmonella species causing bacteraemia/septicaemia in a teaching hospital. J Infect 2002; 45(2): 133.",Initial systematic review,IND,India,Government Medical College Hospital (Chandigarh),864,Punjab,2001,0,10,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
991,Saharan (2008),"Saharan G, Gupta A, Gupta BK, Sharma BP, Kochar DK, Purohit VP. Evaluation of antibiotic sensitivity pattern in cases of enteric fever in north west Rajasthan. J Indian Med Assoc 2008; 106(8): 528-30, 32.",Initial systematic review,IND,India,Sardar Patel Medical College (PBM and AG Hospital),865,Rajasthan,2001,0,13,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
135,Mandal (2006),"Mandal S, Mandal M, Pal N. Antibiotic resistance of Salmonella enterica serovar ParaTyphi A in India: Emerging and reemerging problem. J Postgrad Med 2006; 52(3): 163-6.",Initial systematic review,IND,India,Calcutta School of Tropical Medicine,869,West Bengal,2001,0,6,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
471,Lakshmi (2006),"Lakshmi V, Ashok R, Susmita J, Shailaja VV. Changing trends in the antibiograms of Salmonella isolates at a tertiary care hospital in Hyderabad. Indian J Med Microbiol 2006; 24(1): 45-8.",Initial systematic review,IND,India,Nizam's Institute of Medical Sciences,848,Andhra Pradesh,2002,0,13,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
118,Mohanty (2006),"Mohanty S, Renuka K, Sood S, Das BK, Kapil A. Antibiogram pattern and seasonality of Salmonella serotypes in a North Indian tertiary care hospital. Epidemiol Infect 2006; 134(5): 961-6.",Initial systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,2002,0,28,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
1933,Kumar (2008),"Kumar S, Rizvi M, Berry N. Rising prevalence of enteric fever due to multidrug-resistant Salmonella: an epidemiological study. J Med Microbiol 2008; 57(Pt 10): 1247-50.",Initial systematic review,IND,India,Lok Nayak Jai Prakash Narayan Hospital,850,Delhi,2002,0,16,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
2807,Arora(2010),"Arora D, Singh R, Kaur M, Ahi RS. A changing pattern in antimicrobial susceptibility of Salmonella enterica serotype isolated in North India. African Journal of Microbiology Research 2010; 4(3): 197-203.",Extended systematic review,IND,India,Adesh Institute of Medical Sciences and Research,864,Punjab,2002,0,6,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
118,Mohanty (2006),"Mohanty S, Renuka K, Sood S, Das BK, Kapil A. Antibiogram pattern and seasonality of Salmonella serotypes in a North Indian tertiary care hospital. Epidemiol Infect 2006; 134(5): 961-6.",Initial systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,2003,0,50,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
2807,Arora(2010),"Arora D, Singh R, Kaur M, Ahi RS. A changing pattern in antimicrobial susceptibility of Salmonella enterica serotype isolated in North India. African Journal of Microbiology Research 2010; 4(3): 197-203.",Extended systematic review,IND,India,Adesh Institute of Medical Sciences and Research,864,Punjab,2003,0,15,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
2284,Aggarwal (2007),"Aggarwal A, Vij AS, Oberoi A. A three-year retrospective study on the prevalence, drug susceptibility pattern, and phage types of Salmonella enterica subspecies Typhi and ParaTyphi in Christian Medical College and Hospital, Ludhiana, Punjab. J Indian Acad Clin Med 2007; 8(1): 32-5.",Initial systematic review,IND,India,Christian Medical College and Hospital (Ludhiana),864,Punjab,2003,0,28,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
118,Mohanty (2006),"Mohanty S, Renuka K, Sood S, Das BK, Kapil A. Antibiogram pattern and seasonality of Salmonella serotypes in a North Indian tertiary care hospital. Epidemiol Infect 2006; 134(5): 961-6.",Initial systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,2004,0,43,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
1064,Joshi (2007),"Joshi S, Amarnath SK. Fluoroquinolone resistance in Salmonella Typhi and S. ParaTyphi A in Bangalore, India. Trans R Soc Trop Med Hyg 2007; 101(3): 308-10.",Initial systematic review,IND,India,Manipal Hospital (Airport road),855,Karnataka,2004,0,25,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
900,Jog (2008),"Jog S, Soman R, Singhal T, Rodrigues C, Mehta A, Dastur FD. Enteric fever in Mumbai--clinical profile, sensitivity patterns and response to antimicrobials. J Assoc Physicians India 2008; 56: 237-40.",Initial systematic review,IND,India,P.D. Hinduja National Hospital and Medical Research Center,858,Maharashtra,2004,0,15,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
121,Das (2006),"Das U, Bhattacharya SS. Antibiogram, phage typing and biotyping of Salmonella Typhi and Salmonella ParaTyphi A from Rourkela, Orissa. Indian J Med Res 2006; 124(1): 109-11.",Initial systematic review,IND,India,Ispat General Hospital (Rourkela),863,Orissa,2004,0,31,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
2807,Arora(2010),"Arora D, Singh R, Kaur M, Ahi RS. A changing pattern in antimicrobial susceptibility of Salmonella enterica serotype isolated in North India. African Journal of Microbiology Research 2010; 4(3): 197-203.",Extended systematic review,IND,India,Adesh Institute of Medical Sciences and Research,864,Punjab,2004,0,7,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
5110,Sharma (2018),"Sharma P, Dahiya S, Manral N, et al. Changing trends of culture-positive typhoid fever and antimicrobial susceptibility in a tertiary care North Indian Hospital over the last decade.Indian Journal of Medical Microbiology 2018;36(1):70-76",Initial systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,2005,0,21,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
1807,Gupta(2009),"Gupta S, Handa A, Chadha DS, Ganjoo RK, Panda RC. Profile of culture positive enteric fever from Bangalore. Med J Armed Forces India 2009; 65(4): 328-31.",Extended systematic review,IND,India,Command Hospital (Bengaluru),855,Karnataka,2005,0,16,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
2807,Arora(2010),"Arora D, Singh R, Kaur M, Ahi RS. A changing pattern in antimicrobial susceptibility of Salmonella enterica serotype isolated in North India. African Journal of Microbiology Research 2010; 4(3): 197-203.",Extended systematic review,IND,India,Adesh Institute of Medical Sciences and Research,864,Punjab,2005,0,12,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
2284,Aggarwal (2007),"Aggarwal A, Vij AS, Oberoi A. A three-year retrospective study on the prevalence, drug susceptibility pattern, and phage types of Salmonella enterica subspecies Typhi and ParaTyphi in Christian Medical College and Hospital, Ludhiana, Punjab. J Indian Acad Clin Med 2007; 8(1): 32-5.",Initial systematic review,IND,India,Christian Medical College and Hospital (Ludhiana),864,Punjab,2005,0,90,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
1062,Harish (2006),"Harish BN, Menezes GA, Sarangapani K, Parija SC. Fluoroquinolone resistance among Salmonella enterica serovar ParaTyphi A in Pondicherry [2]. Indian J Med Res 2006; 124: 585-7.",Initial systematic review,IND,India,Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER);Indira Gandhi Government General Hospital,889,Puducherry,2005,0,24,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
904,Capoor(2007),"Capoor MR, Nair D, Deb M, Aggarwal P. Enteric fever perspective in India: emergence of high-level ciprofloxacin resistance and rising MIC to cephalosporins. J Med Microbiol 2007; 56(Pt 8): 1131-2.",Extended systematic review,IND,India,Safdarjung Hospital,850,Delhi,2006,0,56,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
1126,Raveendran (2008),"Raveendran R, Wattal C, Sharma A, Oberoi J, Prasad K, Datta S. High level ciprofloxacin resistance in Salmonella enterica isolated from blood. Indian J Med Microbiol 2008; 26(1): 50-3.",Initial systematic review,IND,India,Sir Ganga Ram Hospital,850,Delhi,2006,0,198,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
5110,Sharma (2018),"Sharma P, Dahiya S, Manral N, et al. Changing trends of culture-positive typhoid fever and antimicrobial susceptibility in a tertiary care North Indian Hospital over the last decade.Indian Journal of Medical Microbiology 2018;36(1):70-76",Initial systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,2006,0,24,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
934,Vidyalakshmi (2008),"Vidyalakshmi K, Yashavanth R, Chakrapani M, et al. Epidemiological shift, seasonal variation and antimicrobial susceptibility patterns among enteric fever pathogens in South India. Trop Doct 2008; 38(2): 89-91.",Initial systematic review,IND,India,Kasturba Medical College Hospital (Mangaluru),855,Karnataka,2006,0,85,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
1893,Yashavanth (2010),"Yashavanth R, Vidyalakshmi K. The Re-Emergence of chloramphenicol sensitivity among enteric fever pathogens in Mangalore. J Clin Diagn Res 2010; 4(5): 3016-108.",Initial systematic review,IND,India,Kasturba Medical College Hospital (Mangaluru),855,Karnataka,2006,0,111,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
2807,Arora(2010),"Arora D, Singh R, Kaur M, Ahi RS. A changing pattern in antimicrobial susceptibility of Salmonella enterica serotype isolated in North India. African Journal of Microbiology Research 2010; 4(3): 197-203.",Extended systematic review,IND,India,Adesh Institute of Medical Sciences and Research,864,Punjab,2006,0,12,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
1412,Capoor (2009),"Capoor MR, Deepthi N, Jitendra P, et al. Minimum inhibitory concentration of carbapenems and tigecycline against Salmonella spp. J Med Microbiol 2009; 58(3): 337-41.",Initial systematic review,IND,India,Majeedia Hospital;Safdarjung Hospital,850,Delhi,2007,0,43,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
5110,Sharma (2018),"Sharma P, Dahiya S, Manral N, et al. Changing trends of culture-positive typhoid fever and antimicrobial susceptibility in a tertiary care North Indian Hospital over the last decade.Indian Journal of Medical Microbiology 2018;36(1):70-76",Initial systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,2007,0,42,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
5124,Joshi (2019),"Joshi S, Adhikary R, Beena HB, et al. Trends in antibiotic susceptibility of enteric fever isolates from South India, 2002–2013.Medical Journal Armed Forces India 2019;75(1):81-85",Initial systematic review,IND,India,Manipal Hospital (Airport road),855,Karnataka,2007,0,132,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
2807,Arora(2010),"Arora D, Singh R, Kaur M, Ahi RS. A changing pattern in antimicrobial susceptibility of Salmonella enterica serotype isolated in North India. African Journal of Microbiology Research 2010; 4(3): 197-203.",Extended systematic review,IND,India,Adesh Institute of Medical Sciences and Research,864,Punjab,2007,0,13,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
4593,Menezes (2016),"Menezes GA, Harish BN, Khan MA, Goessens W, Hays JP. Antimicrobial resistance trends in blood culture positive Salmonella ParaTyphi A isolates from Pondicherry, India. Indian J Med Microbiol 2016; 34(2): 222-7.",Initial systematic review,IND,India,Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER);Government Hospital (Pondicherry),889,Puducherry,2007,0,284,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
5110,Sharma (2018),"Sharma P, Dahiya S, Manral N, et al. Changing trends of culture-positive typhoid fever and antimicrobial susceptibility in a tertiary care North Indian Hospital over the last decade.Indian Journal of Medical Microbiology 2018;36(1):70-76",Initial systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,2008,0,48,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
262,Kumar (2013)<U+1D47>,"Kumar MS, Kumar GSV, Prashanth HV, Prakash R, Veena K, Chandrashekar SC. Antimicrobial susceptibility of enteric fever Salmonellae isolated from blood culture. Res J Pharm Biol Chem Sci 2013b; 4(3): 318-24.",Initial systematic review,IND,India,Sri Siddhartha Medical College,855,Karnataka,2008,0,132,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
5124,Joshi (2019),"Joshi S, Adhikary R, Beena HB, et al. Trends in antibiotic susceptibility of enteric fever isolates from South India, 2002–2013.Medical Journal Armed Forces India 2019;75(1):81-85",Initial systematic review,IND,India,Manipal Hospital (Airport road),855,Karnataka,2008,0,204,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
1669,Bekur (2010),"Bekur R, Vandana KE, Shivashankara KN, Valsalan R, Sathyanarayanan V. Paratyphoid fever- Emerging problem in South India. Asian Pac J Trop Med 2010; 3(10): 815-7.",Initial systematic review,IND,India,Kasturba Medical College and Hospital (Manipal),855,Karnataka,2008,0,29,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
2334,Gupta (2013),"Gupta V, Singla N, Bansal N, Kaistha N, Chander J. Trends in the antibiotic resistance patterns of enteric fever isolates - a three year report from a tertiary care centre. Malays J Med Sci 2013; 20(4): 71-5.",Initial systematic review,IND,India,Government Medical College Hospital (Chandigarh),864,Punjab,2008,0,18,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
1424,Muthu(2014),"Muthu G, Suresh A, Elumalaisathishkumar, et al. Molecular analysis of gyramutations in Salmonella Paratyphi ABY PCR-RFLP and sequencing method. International Journal of Pharmacy and Pharmaceutical Sciences 2014; 6(4): 658-60.",Extended systematic review,IND,India,Unknown hospitals and laboratories in Chennai,867,Tamil Nadu,2008,0,41,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
5110,Sharma (2018),"Sharma P, Dahiya S, Manral N, et al. Changing trends of culture-positive typhoid fever and antimicrobial susceptibility in a tertiary care North Indian Hospital over the last decade.Indian Journal of Medical Microbiology 2018;36(1):70-76",Initial systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,2009,0,64,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
5124,Joshi (2019),"Joshi S, Adhikary R, Beena HB, et al. Trends in antibiotic susceptibility of enteric fever isolates from South India, 2002–2013.Medical Journal Armed Forces India 2019;75(1):81-85",Initial systematic review,IND,India,Manipal Hospital (Airport road),855,Karnataka,2009,0,106,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
2334,Gupta (2013),"Gupta V, Singla N, Bansal N, Kaistha N, Chander J. Trends in the antibiotic resistance patterns of enteric fever isolates - a three year report from a tertiary care centre. Malays J Med Sci 2013; 20(4): 71-5.",Initial systematic review,IND,India,Government Medical College Hospital (Chandigarh),864,Punjab,2009,0,16,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
207,Jain (2013),"Jain S, Chugh TD. Antimicrobial resistance among blood culture isolates of Salmonella enterica in New Delhi. J Infect Dev Ctries 2013; 7(11): 788-95.",Initial systematic review,IND,India,BLK Super speciality Hospital,850,Delhi,2010,0,28,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
3082,Duggal (2016),"Duggal S, Banerjee P, Chugh TD. Review of fifty culture proven Salmonella cases. Indian J Med Sci 2016; 68(1): 67-72.",Initial systematic review,IND,India,Unknown Hospital(s) in Delhi,850,Delhi,2010,0,12,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
5110,Sharma (2018),"Sharma P, Dahiya S, Manral N, et al. Changing trends of culture-positive typhoid fever and antimicrobial susceptibility in a tertiary care North Indian Hospital over the last decade.Indian Journal of Medical Microbiology 2018;36(1):70-76",Initial systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,2010,0,13,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
5124,Joshi (2019),"Joshi S, Adhikary R, Beena HB, et al. Trends in antibiotic susceptibility of enteric fever isolates from South India, 2002–2013.Medical Journal Armed Forces India 2019;75(1):81-85",Initial systematic review,IND,India,Manipal Hospital (Airport road),855,Karnataka,2010,0,60,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
2334,Gupta (2013),"Gupta V, Singla N, Bansal N, Kaistha N, Chander J. Trends in the antibiotic resistance patterns of enteric fever isolates - a three year report from a tertiary care centre. Malays J Med Sci 2013; 20(4): 71-5.",Initial systematic review,IND,India,Government Medical College Hospital (Chandigarh),864,Punjab,2010,0,11,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
744,Elumalai (2014),"Elumalai S, Muthu G, Selvam RE, Ramesh S. Detection of TEM-, SHV- and CTX-M-type beta-lactamase production among clinical isolates of Salmonella species. J Med Microbiol 2014; 63(Pt 7): 962-7.",Initial systematic review,IND,India,Unknown hospitals and laboratories in Chennai,867,Tamil Nadu,2010,0,31,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
5069,Bandyopadhyay(2018),"Bandyopadhyay R, Balaji V, Yadav B, Jasmine S, Sathyendra S, Rupali P. Effectiveness of treatment regimens for Typhoid fever in the nalidixic acid-resistant S. Typhi (NARST) era in South India. Trop Doct 2018; 48(3): 182-8.",Extended systematic review,IND,India,Christian Medical College (Vellore),867,Tamil Nadu,2010,0,18,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
4650,Yadav (2016),"Yadav VC, Kiran VR, Sharma R. Enteric fever in Bastar tribal region-prevalence and sensitivity patterns. J Evol Med Dent Sci 2016; 5(53): 3526-30.",Initial systematic review,IND,India,Late Baliram Kashyap Memorial Government Medical College Jagdalpur,884,Chhattisgarh,2010,0,16,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
207,Jain (2013),"Jain S, Chugh TD. Antimicrobial resistance among blood culture isolates of Salmonella enterica in New Delhi. J Infect Dev Ctries 2013; 7(11): 788-95.",Initial systematic review,IND,India,BLK Super speciality Hospital,850,Delhi,2011,0,33,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
5110,Sharma (2018),"Sharma P, Dahiya S, Manral N, et al. Changing trends of culture-positive typhoid fever and antimicrobial susceptibility in a tertiary care North Indian Hospital over the last decade.Indian Journal of Medical Microbiology 2018;36(1):70-76",Initial systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,2011,0,17,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
5124,Joshi (2019),"Joshi S, Adhikary R, Beena HB, et al. Trends in antibiotic susceptibility of enteric fever isolates from South India, 2002–2013.Medical Journal Armed Forces India 2019;75(1):81-85",Initial systematic review,IND,India,Manipal Hospital (Airport road),855,Karnataka,2011,0,73,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
2967,Iyer (2017),"Iyer RN, Jangam RR, Jacinth A, Venkatalakshmi A, Nahdi FB. Prevalence and trends in the antimicrobial susceptibility pattern of Salmonella enterica serovars Typhi and ParaTyphi A among children in a pediatric tertiary care hospital in South India over a period of ten years: a retrospective study. Eur J Clin Microbiol Infect Dis 2017; 07: 07.",Initial systematic review,IND,India,Rainbow Hospital for Women and Children,848,Andhra Pradesh,2012,0,25,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
4627,Sharma (2016),"Sharma P, Dahiya S, Balaji V, et al. Typhoidal Salmonellae: Use of multi-locus sequence typing to determine population structure. PLoS ONE 2016; 11(9).",Initial systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,2012,0,10,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
5110,Sharma (2018),"Sharma P, Dahiya S, Manral N, et al. Changing trends of culture-positive typhoid fever and antimicrobial susceptibility in a tertiary care North Indian Hospital over the last decade.Indian Journal of Medical Microbiology 2018;36(1):70-76",Initial systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,2012,0,17,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
117,Venkatesh (2013),"Venkatesh BM, Joshi S, Adhikary R, Bhaskar BH. Antibiogram of Salmonella Typhi and Salmonella ParaTyphi A in a tertiary care hospital in 2012. Indian J Pathol Microbiol 2013; 56(4): 484-5.",Initial systematic review,IND,India,Manipal Hospital (Airport road),855,Karnataka,2012,0,92,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
5124,Joshi (2019),"Joshi S, Adhikary R, Beena HB, et al. Trends in antibiotic susceptibility of enteric fever isolates from South India, 2002–2013.Medical Journal Armed Forces India 2019;75(1):81-85",Initial systematic review,IND,India,Manipal Hospital (Airport road),855,Karnataka,2012,0,91,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
4519,Chatterjee(2016),"Chatterjee S, Eshwara VK, Tellapragada C, Mukhopadhyay C. Azithromycin susceptibility among clinical isolates of Salmonella: Interfacing guidelines with routine practices. Indian J Med Microbiol 2016; 34(3): 397-8.",Extended systematic review,IND,India,Kasturba Medical College and Hospital (Manipal),855,Karnataka,2012,0,53,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
2977,Harichandran (2017),"Harichandran D, Dinesh KR. Antimicrobial susceptibility profile, treatment outcome and serotype distribution of clinical isolates of Salmonella enterica subspecies enterica: a 2-year study from Kerala, South India. Infect Drug Resist 2017; 10: 97-101.",Initial systematic review,IND,India,Amrita Institute of Medical Sciences and Research Centre,856,Kerala,2012,0,22,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
3012,Behl(2017),"Behl P, Gupta V, Sachdev A, Guglani V, Chander J. Patterns in antimicrobial susceptibility of Salmonellae isolated at a tertiary care hospital in northern India. Indian J Med Res 2017; 145(1): 124-8.",Extended systematic review,IND,India,Government Medical College Hospital (Chandigarh),864,Punjab,2012,0,16,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
696,Mathew (2014),"Mathew R, Jobin SR. Current trends of antimicrobial susceptibility of Salmonella enterica serovar Typhi and ParaTyphi a from blood cultures in a tertiary care center of Chennai, Tamil Nadu, India. Res J Pharm Biol Chem Sci 2014; 5(2): 1167-74.",Initial systematic review,IND,India,Saveetha Medical College (Thandalam),867,Tamil Nadu,2012,0,11,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
5110,Sharma (2018),"Sharma P, Dahiya S, Manral N, et al. Changing trends of culture-positive typhoid fever and antimicrobial susceptibility in a tertiary care North Indian Hospital over the last decade.Indian Journal of Medical Microbiology 2018;36(1):70-76",Initial systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,2013,0,6,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
5124,Joshi (2019),"Joshi S, Adhikary R, Beena HB, et al. Trends in antibiotic susceptibility of enteric fever isolates from South India, 2002–2013.Medical Journal Armed Forces India 2019;75(1):81-85",Initial systematic review,IND,India,Manipal Hospital (Airport road),855,Karnataka,2013,0,111,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
4597,Misra (2016),"Misra R, Thakare R, Amrin N, Prasad KN, Chopra S, Dhole TN. Antimicrobial susceptibility pattern and sequence analysis of DNA gyrase and DNA topoisomerase IV in Salmonella enterica serovars Typhi and ParaTyphi A isolates with decreased susceptibility to ciprofloxacin. Trans R Soc Trop Med Hyg 2016; 110(8): 472-9.",Initial systematic review,IND,India,Sanjay Gandhi Postgraduate Institute of Medical Sciences,890,Uttar Pradesh,2013,0,8,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
5110,Sharma (2018),"Sharma P, Dahiya S, Manral N, et al. Changing trends of culture-positive typhoid fever and antimicrobial susceptibility in a tertiary care North Indian Hospital over the last decade.Indian Journal of Medical Microbiology 2018;36(1):70-76",Initial systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,2014,0,5,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
4597,Misra (2016),"Misra R, Thakare R, Amrin N, Prasad KN, Chopra S, Dhole TN. Antimicrobial susceptibility pattern and sequence analysis of DNA gyrase and DNA topoisomerase IV in Salmonella enterica serovars Typhi and ParaTyphi A isolates with decreased susceptibility to ciprofloxacin. Trans R Soc Trop Med Hyg 2016; 110(8): 472-9.",Initial systematic review,IND,India,Sanjay Gandhi Postgraduate Institute of Medical Sciences,890,Uttar Pradesh,2014,0,6,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
5110,Sharma (2018),"Sharma P, Dahiya S, Manral N, et al. Changing trends of culture-positive typhoid fever and antimicrobial susceptibility in a tertiary care North Indian Hospital over the last decade.Indian Journal of Medical Microbiology 2018;36(1):70-76",Initial systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,2015,0,13,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
5110,Sharma (2018),"Sharma P, Dahiya S, Manral N, et al. Changing trends of culture-positive typhoid fever and antimicrobial susceptibility in a tertiary care North Indian Hospital over the last decade.Indian Journal of Medical Microbiology 2018;36(1):70-76",Initial systematic review,IND,India,All India Institute of Medical Sciences,850,Delhi,2016,0,24,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
3304,Acharya (1995),"Acharya G, Butler T, Ho M, et al. Treatment of typhoid fever: randomized trial of a three-day course of ceftriaxone versus a fourteen-day course of chloramphenicol. Am J Trop Med Hyg 1995; 52(2): 162-5.",Initial systematic review,NPL,Nepal,Tribhuvan University Teaching Hospital (Kathmandu);Kanti Children's Hospital (Kathmandu),892,Central,1991,0,8,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
3669,Woods (2006),"Woods CW, Murdoch DR, Zimmerman MD, et al. Emergence of Salmonella enterica serotype ParaTyphi A as a major cause of enteric fever in Kathmandu, Nepal. Trans R Soc Trop Med Hyg 2006; 100(11): 1063-7.",Initial systematic review,NPL,Nepal,Patan Hospital (Lalitpur),892,Central,2001,0,57,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
1967,Guha (2005),"Guha S, Jalan BY, Dey S, Easow JM, Wilson G, Shivananda PG. Salmonella bacteraemia in Pokhara: emergence of antibiotic resistance. Nepal Med Coll J 2005; 7(1): 23-5.",Initial systematic review,NPL,Nepal,Manipal Teaching Hospital (Pokhara),896,Western,2001,0,8,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
1967,Guha (2005),"Guha S, Jalan BY, Dey S, Easow JM, Wilson G, Shivananda PG. Salmonella bacteraemia in Pokhara: emergence of antibiotic resistance. Nepal Med Coll J 2005; 7(1): 23-5.",Initial systematic review,NPL,Nepal,Manipal Teaching Hospital (Pokhara),896,Western,2002,0,10,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
712,Shirakawa (2006),"Shirakawa T, Acharya B, Kinoshita S, Kumagai S, Gotoh A, Kawabata M. Decreased susceptibility to fluoroquinolones and gyrA gene mutation in the Salmonella enterica serovar Typhi and ParaTyphi A isolated in Katmandu, Nepal, in 2003. Diagn Microbiol Infect Dis 2006; 54(4): 299-303.",Initial systematic review,NPL,Nepal,Unknown Hospital in Kathmandu,892,Central,2003,0,39,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
1144,Sharma (2006),"Sharma NP, Peacock SJ, Phumratanaprapin W, Day N, White N, Pukrittayakamee S. A hospital-based study of bloodstream infections in febrile patients in Dhulikhel Hospital Kathmandu University Teaching Hospital, Nepal. Southeast Asian J Trop Med Public Health 2006; 37(2): 351-6.",Initial systematic review,NPL,Nepal,Dhulikhel Hospital (Kathmandu),892,Central,2003,0,13,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
1967,Guha (2005),"Guha S, Jalan BY, Dey S, Easow JM, Wilson G, Shivananda PG. Salmonella bacteraemia in Pokhara: emergence of antibiotic resistance. Nepal Med Coll J 2005; 7(1): 23-5.",Initial systematic review,NPL,Nepal,Manipal Teaching Hospital (Pokhara),896,Western,2003,0,20,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
5064,Zellweger (2017),"Zellweger RM, Basnyat B, Shrestha P, et al. A 23-year retrospective investigation of Salmonella Typhi and Salmonella ParaTyphi isolated in a tertiary Kathmandu hospital.PLoS Neglected Tropical Diseases [electronic resource] 2017;11(11):e0006051",Initial systematic review,NPL,Nepal,Patan Hospital (Lalitpur),892,Central,2004,0,23,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
1092,Arjyal (2011),"Arjyal A, Basnyat B, Koirala S, et al. Gatifloxacin versus chloramphenicol for uncomplicated enteric fever: an open-label, randomised, controlled trial. Lancet Infect Dis 2011; 11(6): 445-54.",Initial systematic review,NPL,Nepal,Patan Hospital (Lalitpur),892,Central,2007,0,102,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
393,Easow(2010),"Easow JM, Joseph NM, Dhungel BA, Chapagain B, Shivananda PG. Blood stream infections among febrile patients attending a teaching hospital in Western Region of Nepal. Australasian Medical Journal 2010; 3(10): 633-7.",Extended systematic review,NPL,Nepal,Manipal Teaching Hospital (Pokhara),896,Western,2007,0,6,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
1132,Karki (2013),"Karki AB, Bhatta DR, Shrestha B, et al. Higher nalidixic acid resistance pattern of Salmonella isolates from enteric fever patients in kathmandu model hospital Nepal. Res J Pharm Biol Chem Sci 2013; 4(2): 1687-93.",Initial systematic review,NPL,Nepal,Kathmandu Model Hospital (Kathmandu),892,Central,2009,0,47,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
1093,Koirala (2013),"Koirala S, Basnyat B, Arjyal A, et al. Gatifloxacin versus ofloxacin for the treatment of uncomplicated enteric fever in Nepal: an open-label, randomized, controlled trial. PLoS Negl Trop Dis 2013; 7(10): e2523.",Initial systematic review,NPL,Nepal,Patan (Lalitpur),892,Central,2010,0,86,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
275,Raza (2012),"Raza S, Tamrakar R, Bhatt CP, Joshi SK. Antimicrobial susceptibility patterns of Salmonella Typhi and Salmonella ParaTyphi A in a tertiary care hospital. J Nepal Health Res Counc 2012; 10(22): 214-7.",Initial systematic review,NPL,Nepal,Kathmandu Medical College (Kathmandu),892,Central,2011,0,31,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
593,Joshi (2011),"Joshi BG, Keyal K, Pandey R, Shrestha BM. Clinical profile and sensitivity pattern of Salmonella serotypes in children: A hospital based study. Journal of Nepal Paediatric Society 2011; 31(3): 180-3.",Initial systematic review,NPL,Nepal,Civil Service Hospital (Kathmandu),892,Central,2011,0,15,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
1754,Awal(2015),"Awal BK, Koirala P, Jareju R, Dhungana GR, Wosti BP. Predictive value of NA resistance for increased minimum inhibitory concentration (MIC) of fluoroquinolone in clinical isolates of Salmonella enterica. Int J Antimicrob Agents 2015; 45: S80-S1.",Extended systematic review,NPL,Nepal,"Janamaitri Foundation Institute of Health Sciences (Balaju, Kathmandu)",892,Central,2011,0,31,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
2806,Adhikari (2012),"Adhikari D, Acharya D, Shrestha P, Amatya R. Ciprofloxacin susceptibility of Salmonella enteric serovar Typhi and ParaTyphi A from blood samples of suspected enteric fever patients. International Journal of Infection and Microbiology 2012; 1(1): 9-13.",Initial systematic review,NPL,Nepal,KIST Medical College (Kathmandu),892,Central,2011,0,23,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
3182,Arjyal (2016),"Arjyal A, Basnyat B, Nhan HT, et al. Gatifloxacin versus ceftriaxone for uncomplicated enteric fever in Nepal: an open-label, two-centre, randomised controlled trial. Lancet Infect Dis 2016; 16(5): 535-45.",Initial systematic review,NPL,Nepal,Civil Service Hospital (Kathmandu);Patan Hospital (Lalitpur),892,Central,2013,0,34,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
4629,Shrestha (2016),"Shrestha KL, Pant ND, Bhandari R, Khatri S, Shrestha B, Lekhak B. Re-emergence of the susceptibility of the Salmonella spp. isolated from blood samples to conventional first line antibiotics. Antimicrob Resist Infect Control 2016; 5.",Initial systematic review,NPL,Nepal,Kathmandu Model Hospital (Kathmandu),892,Central,2013,0,35,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
2913,Sherchan(2017),"Sherchan JB, Morita M, Matono T, et al. Molecular and Clinical Epidemiology of Salmonella ParaTyphi A Isolated from Patients with Bacteremia in Nepal. Am J Trop Med Hyg 2017; 09: 09.",Extended systematic review,NPL,Nepal,Tribhuvan University Teaching Hospital (Kathmandu),892,Central,2015,0,23,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
2979,Gurung (2017),"Gurung B, Pandey S, Shah DK, et al. Antibiogram pattern of Salmonella in blood samples of enteric fever patients at lalitpur, nepal. Asian Pac J Trop Dis 2017; 7(1): 21-4.",Initial systematic review,NPL,Nepal,KIST Medical College (Kathmandu),892,Central,2015,0,35,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
2958,Khanal (2017),"Khanal PR, Satyal D, Bhetwal A, et al. Renaissance of conventional first-line antibiotics in Salmonella enterica clinical isolates: Assessment of MICs for therapeutic antimicrobials in enteric fever cases from Nepal. Biomed Res Int 2017; 2017: 2868143.",Initial systematic review,NPL,Nepal,Manmohan Memorial Community Hospital (Kathmandu),892,Central,2016,0,14,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
5049,Bhetwal (2017),"Bhetwal A, Maharjan A, Khanal PR and Parajuli NP. Enteric Fever Caused by Salmonella enterica Serovars with Reduced Susceptibility of Fluoroquinolones at a Community Based Teaching Hospital of Nepal.International Journal of Microbiology 2017;2017(2869458",Initial systematic review,NPL,Nepal,Manmohan Memorial Teaching Hospital (Kathmandu),892,Central,2016,0,83,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
470,Butt (2005),"Butt T, Ahmad RN, Salman M, Kazmi SY. Changing trends in drug resistance among typhoid Salmonellae in Rawalpindi, Pakistan. East Mediterr Health J 2005; 11(5-6): 1038-44.",Initial systematic review,PAK,Pakistan,Armed Force Institute of Pathology,901,Punjab,1996,0,50,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
470,Butt (2005),"Butt T, Ahmad RN, Salman M, Kazmi SY. Changing trends in drug resistance among typhoid Salmonellae in Rawalpindi, Pakistan. East Mediterr Health J 2005; 11(5-6): 1038-44.",Initial systematic review,PAK,Pakistan,Armed Force Institute of Pathology,901,Punjab,1997,0,41,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
455,Qureshi (2001),"Qureshi AH, Mushahid N, Ijaz A, et al. Changing drug susceptibility pattern of Salmonellae ParaTyphi A. J Coll Physicians Surg Pak 2001; 11(7): 449-51.",Initial systematic review,PAK,Pakistan,Combined Military Hospital (Quetta),897,Balochistan,1998,0,161,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
470,Butt (2005),"Butt T, Ahmad RN, Salman M, Kazmi SY. Changing trends in drug resistance among typhoid Salmonellae in Rawalpindi, Pakistan. East Mediterr Health J 2005; 11(5-6): 1038-44.",Initial systematic review,PAK,Pakistan,Armed Force Institute of Pathology,901,Punjab,1998,0,102,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
470,Butt (2005),"Butt T, Ahmad RN, Salman M, Kazmi SY. Changing trends in drug resistance among typhoid Salmonellae in Rawalpindi, Pakistan. East Mediterr Health J 2005; 11(5-6): 1038-44.",Initial systematic review,PAK,Pakistan,Armed Force Institute of Pathology,901,Punjab,1999,0,61,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
683,Saqib (2000),"Saqib A, Ahmed A. Culture and sensitivity of Salmonella species: analysis of a two year data. J Pak Med Assoc 2000; 50(8): 282-4.",Initial systematic review,PAK,Pakistan,Dr. Ziauddin Hospital Clifton campus;Dr. Ziauddin Hospital Kemari campus;Dr. Ziauddin Hospital North Nazimabad campus,902,Sind,1999,0,82,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
470,Butt (2005),"Butt T, Ahmad RN, Salman M, Kazmi SY. Changing trends in drug resistance among typhoid Salmonellae in Rawalpindi, Pakistan. East Mediterr Health J 2005; 11(5-6): 1038-44.",Initial systematic review,PAK,Pakistan,Armed Force Institute of Pathology,901,Punjab,2000,0,49,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
470,Butt (2005),"Butt T, Ahmad RN, Salman M, Kazmi SY. Changing trends in drug resistance among typhoid Salmonellae in Rawalpindi, Pakistan. East Mediterr Health J 2005; 11(5-6): 1038-44.",Initial systematic review,PAK,Pakistan,Armed Force Institute of Pathology,901,Punjab,2001,0,41,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
470,Butt (2005),"Butt T, Ahmad RN, Salman M, Kazmi SY. Changing trends in drug resistance among typhoid Salmonellae in Rawalpindi, Pakistan. East Mediterr Health J 2005; 11(5-6): 1038-44.",Initial systematic review,PAK,Pakistan,Armed Force Institute of Pathology,901,Punjab,2002,0,41,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
470,Butt (2005),"Butt T, Ahmad RN, Salman M, Kazmi SY. Changing trends in drug resistance among typhoid Salmonellae in Rawalpindi, Pakistan. East Mediterr Health J 2005; 11(5-6): 1038-44.",Initial systematic review,PAK,Pakistan,Armed Force Institute of Pathology,901,Punjab,2003,0,25,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
4363,Ikram (2015),"Ikram S, Hussain S, Aslam A, Khan MD, Ahmed I. Evaluation of the current trends in the antimicrobial susceptibility patterns of typhoid Salmonellae. Pak J Med Health Sci 2015; 9(4): 1247-50.",Initial systematic review,PAK,Pakistan,Islamabad Hospital (PIMS),899,Islamabad,2007,0,70,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
732,Abdul(2014),"Abdul H, Fizza K, Arshad MU. Detection of extended spectrum beta lactamases in typhoidal Salmonellae by phenotypic methods. African Journal of Microbiology Research 2014; 8(3): 313-5.",Extended systematic review,PAK,Pakistan,Lahore & Gujranwala,901,Punjab,2009,0,26,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
142,Muhammad (2013),"Muhammad R, Ali Z, Mehmood K, Ziauddin, Afridi AR, Bari F. Antibiotic sensitivity pattern of Salmonella serotypes in patients with enteric fever in a teaching hospital. Journal of Postgraduate Medical Institute 2013; 27(4): 397-402.",Initial systematic review,PAK,Pakistan,Lady Reading Hospital,900,Nwfp,2010,0,34,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
5106,Qamar (2018),"Qamar FN, Yousafzai MT, Sultana S, et al. A Retrospective Study of Laboratory-Based Enteric Fever Surveillance, Pakistan, 2012-2014.Journal of Infectious Diseases 2018;218(suppl_4):S201-S205",Initial systematic review,PAK,Pakistan,Aga Khan University Hospital (Karachi);Aga Khan Hospital for Women and Children;Aga Khan Hospital (Hyderadad),902,Sind,2012,0,301,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
3023,Ali (2017),"Ali A, Ali HA, Shah FH, Zahid A, Aslam H, Javed B. Pattern of antimicrobial drug resistance of Salmonella Typhi and ParaTyphi a in a teaching hospital in Islamabad. J Pak Med Assoc 2017; 67(3): 375-9.",Initial systematic review,PAK,Pakistan,Khan Research Laboratories (KRL) Hospital,899,Islamabad,2013,0,42,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
5106,Qamar (2018),"Qamar FN, Yousafzai MT, Sultana S, et al. A Retrospective Study of Laboratory-Based Enteric Fever Surveillance, Pakistan, 2012-2014.Journal of Infectious Diseases 2018;218(suppl_4):S201-S205",Initial systematic review,PAK,Pakistan,Aga Khan University Hospital (Karachi);Aga Khan Hospital for Women and Children;Aga Khan Hospital (Hyderadad),902,Sind,2013,0,308,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
5106,Qamar (2018),"Qamar FN, Yousafzai MT, Sultana S, et al. A Retrospective Study of Laboratory-Based Enteric Fever Surveillance, Pakistan, 2012-2014.Journal of Infectious Diseases 2018;218(suppl_4):S201-S205",Initial systematic review,PAK,Pakistan,Aga Khan University Hospital (Karachi);Aga Khan Hospital for Women and Children;Aga Khan Hospital (Hyderadad),902,Sind,2014,0,275,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
5063,Zehra (2017),"Zehra NM, Irfan F, Mirza IA, et al. Current Trends of Antimicrobial Susceptibility of Typhoidal Salmonellae Isolated at Tertiary Care Hospital.Jcpsp, Journal of the College of Physicians & Surgeons - Pakistan 2017;27(11):690-692",Initial systematic review,PAK,Pakistan,PNS Shifa Hospital,902,Sind,2015,0,190,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
47,Yu (2011),"Yu F, Fan S, Fan X, et al. Analysis of characteristics of paratyphoid A in 157 Chinese inpatients between 1998 and 2009. Eur J Clin Microbiol Infect Dis 2011; 30(1): 71-5.",Initial systematic review,CHN,China,First Afilliated Hospital of Wenzhou Medical College,35,Zhejiang Sheng,2004,0,55,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
3151,Amdani (1998),"Amdani SK. Antibiotic resistance pattern of pediatric typhoid fever patients at Harapan Kita Children and Maternity Hospital Jakarta, 1996. Med J Indones 1998; 7: 253-6.",Initial systematic review,IDN,Indonesia,Harapan Kita Children's and Maternity Hospital,57,DKI JAKARTA,1996,0,19,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
883,Punjabi (2013),"Punjabi NH, Agtini MD, Ochiai RL, et al. Enteric fever burden in North Jakarta, Indonesia: a prospective, community-based study. J Infect Dev Ctries 2013; 7(11): 781-7.",Initial systematic review,IDN,Indonesia,Tanjung Priok & Koja,57,DKI JAKARTA,2002,0,41,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
2978,Hardjo Lugito (2017),"Hardjo Lugito NP, Cucunawangsih. Antimicrobial resistance of Salmonella enterica serovars Typhi and ParaTyphi isolates from a general hospital in Karawaci, Tangerang, Indonesia: A five-year review. Int J Microbiol 2017; 2017: 6215136.",Initial systematic review,IDN,Indonesia,Siloam Hospital (Karawaci),69,BANTEN,2011,0,14,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
2978,Hardjo Lugito (2017),"Hardjo Lugito NP, Cucunawangsih. Antimicrobial resistance of Salmonella enterica serovars Typhi and ParaTyphi isolates from a general hospital in Karawaci, Tangerang, Indonesia: A five-year review. Int J Microbiol 2017; 2017: 6215136.",Initial systematic review,IDN,Indonesia,Siloam Hospital (Karawaci),69,BANTEN,2013,0,17,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
2978,Hardjo Lugito (2017),"Hardjo Lugito NP, Cucunawangsih. Antimicrobial resistance of Salmonella enterica serovars Typhi and ParaTyphi isolates from a general hospital in Karawaci, Tangerang, Indonesia: A five-year review. Int J Microbiol 2017; 2017: 6215136.",Initial systematic review,IDN,Indonesia,Siloam Hospital (Karawaci),69,BANTEN,2014,0,18,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
2955,Kuijpers (2017),"Kuijpers LMF, Phe T, Veng CH, et al. The clinical and microbiological characteristics of enteric fever in Cambodia, 2008-2015. PLoS Negl Trop Dis 2017; 11(9): e0005964.",Initial systematic review,KHM,Cambodia,Sihanouk Hospital Center of Hope,92,Phnom Penh,2010,0,12,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
2955,Kuijpers (2017),"Kuijpers LMF, Phe T, Veng CH, et al. The clinical and microbiological characteristics of enteric fever in Cambodia, 2008-2015. PLoS Negl Trop Dis 2017; 11(9): e0005964.",Initial systematic review,KHM,Cambodia,Sihanouk Hospital Center of Hope,92,Phnom Penh,2014,0,171,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
5148,Roberts (2019),"Roberts T. LOMRU blood culture database. Vientiene, Laos; 2019",Dataset,LAO,Laos,Mahosot Hospital,117,Vientiane capital,2009,0,6,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
2385,Nguyen(1993),"Nguyen TA, Ha Ba K, Nguyen TD. Typhoid fever in South Vietnam, 1990-1993. [French]. Bulletin de la Societe de pathologie exotique (1990) 1993; 86(5 Pt 2): 476-8.",Extended systematic review,VNM,Vietnam,Centre for Tropical Diseases,328,Ho Chi Minh,1992,0,5,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
651,Smith(1994),"Smith MD, Duong NM, Hoa NTT, et al. Comparison of ofloxacin and ceftriaxone for short-course treatment of enteric fever. Antimicrob Agents Chemother 1994; 38(8): 1716-20.",Extended systematic review,VNM,Vietnam,Centre for Tropical Diseases,328,Ho Chi Minh,1993,0,6,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
2124,Hien (1995),"Hien TT, Bethell DB, Hoa NTT, et al. Short course of ofloxacin for treatment of multidrug-resistant typhoid. Clin Infect Dis 1995; 20(4): 917-23.",Initial systematic review,VNM,Vietnam,Dong Hoa & Dong Thanh,369,Kien Giang,1993,0,19,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
621,Hoa (1998),"Hoa NTT, Diep TS, Wain J, et al. Community-acquired septicaemia in southern Viet Nam: The importance of multidrug-resistant Salmonella Typhi. Trans R Soc Trop Med Hyg 1998; 92(5): 503-8.",Initial systematic review,VNM,Vietnam,Centre for Tropical Diseases,328,Ho Chi Minh,1994,0,15,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
5151,SEAP (2021),Sabine Vaccine Institute. Surveillance for Enteric Fever in Asia Project (SEAP) dataset. 2021,Dataset,BGD,Bangladesh,Dhaka,823,Dhaka,2016,0,6,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
5151,SEAP (2021),Sabine Vaccine Institute. Surveillance for Enteric Fever in Asia Project (SEAP) dataset. 2021,Dataset,BGD,Bangladesh,Dhaka,823,Dhaka,2017,0,41,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
5151,SEAP (2021),Sabine Vaccine Institute. Surveillance for Enteric Fever in Asia Project (SEAP) dataset. 2021,Dataset,BGD,Bangladesh,Dhaka,823,Dhaka,2018,0,32,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
5151,SEAP (2021),Sabine Vaccine Institute. Surveillance for Enteric Fever in Asia Project (SEAP) dataset. 2021,Dataset,NPL,Nepal,Kathmandu,892,Central,2017,0,5,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
5151,SEAP (2021),Sabine Vaccine Institute. Surveillance for Enteric Fever in Asia Project (SEAP) dataset. 2021,Dataset,NPL,Nepal,Kathmandu,892,Central,2018,0,6,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
5150,Shakoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Sindh,902,Sind,2007,0,577,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
5150,Shakoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Punjab,901,Punjab,2007,0,15,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
5150,Shakoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Punjab,901,Punjab,2008,0,10,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
5150,Shakoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Sindh,902,Sind,2009,0,684,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
5150,Shakoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Punjab,901,Punjab,2009,0,12,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
5150,Shakoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Gilgit–Baltistan,904,Administrative unit not available,2009,0,9,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
5150,Shakoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Sindh,902,Sind,2010,0,421,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
5150,Shakoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Punjab,901,Punjab,2010,0,9,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
5150,Shakoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Punjab,901,Punjab,2011,0,12,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
5150,Shakoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Sindh,902,Sind,2012,0,290,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
5150,Shakoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Punjab,901,Punjab,2012,0,16,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
5150,Shakoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Sindh,902,Sind,2013,0,295,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
5150,Shakoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Punjab,901,Punjab,2013,0,10,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
5150,Shakoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Punjab,901,Punjab,2014,0,11,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
5150,Shakoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Khyber Pakhtunkhwa,900,Nwfp,2015,0,5,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
5150,Shakoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Sindh,902,Sind,2015,0,218,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
5150,Shakoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Punjab,901,Punjab,2015,0,8,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
5151,SEAP (2021),Sabine Vaccine Institute. Surveillance for Enteric Fever in Asia Project (SEAP) dataset. 2021,Dataset,PAK,Pakistan,Karachi,902,Sind,2017,0,20,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
5151,SEAP (2021),Sabine Vaccine Institute. Surveillance for Enteric Fever in Asia Project (SEAP) dataset. 2021,Dataset,PAK,Pakistan,Karachi,902,Sind,2018,0,7,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
5150,Shakoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Punjab,901,Punjab,2019,0,98,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
5151,SEAP (2021),Sabine Vaccine Institute. Surveillance for Enteric Fever in Asia Project (SEAP) dataset. 2021,Dataset,BGD,Bangladesh,Dhaka,823,Dhaka,2019,0,16,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
5151,SEAP (2021),Sabine Vaccine Institute. Surveillance for Enteric Fever in Asia Project (SEAP) dataset. 2021,Dataset,NPL,Nepal,Kathmandu,892,Central,2019,0,10,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
5150,Shakoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Sindh,902,Sind,2019,0,352,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
5150,Shakoor (2021),"Shakoor S, Malik FR, Qamar FN, Hasan R. Aga Khan University Hospital, Karachi GRAM dataset. Karachi, Pakistan 2021",Dataset,PAK,Pakistan,Balochistan,897,Balochistan,2019,0,7,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
5151,SEAP (2021),Sabine Vaccine Institute. Surveillance for Enteric Fever in Asia Project (SEAP) dataset. 2021,Dataset,PAK,Pakistan,Karachi,902,Sind,2019,0,7,0,0,Salmonella Paratyphi A,Third-generation cephalosporin (3GC)
